1	Eur	NNP	O	Eur	nn	4	SENT_1	[p1l54t82r105b107],
2	J	NNP	O	J	nn	4	SENT_1	[p1l115t82r128b107],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_1	[p1l140t81r199b107],
4	Pharmacol	NNP	PERSON	Pharmacol	dep	10	SENT_1	[p1l210t81r358b107],
5	(	CD	NUMBER	(	num	6	SENT_1	[p1l371t81r462b114],
6	2013	CD	DATE	2013	dep	4	SENT_1	[p1l371t81r462b114],
7	)	CD	NUMBER	)	dep	10	SENT_1	[p1l371t81r462b114],
8	69	CD	NUMBER	69	num	10	SENT_1	[p1l475t82r672b107],
9	:	:	O	:	_	0	SENT_1	[p1l475t82r672b107],
10	l09l	CD	NUMBER	l09l	dep	13	SENT_1	[p1l475t82r672b107],
11	—	CD	NUMBER	—	num	12	SENT_1	[p1l475t82r672b107],
12	ll0l	NN	O	ll0l	dep	10	SENT_1	[p1l475t82r672b107],
13	DOI	NN	O	dous	dep	16	SENT_1	[p1l54t129r115b154],
14	10.1007	CD	NUMBER	10.1007	num	13	SENT_1	[p1l130t129r526b154],
15	/	:	O	/	punct	16	SENT_1	[p1l130t129r526b154],
16	s00228-012-1429-9	NN	O	s00228-012-1429-9	_	0	SENT_1	[p1l130t129r526b154],

1	j	NN	O	j	_	0	SENT_2	[p1l54t220r530b251],
2	§	CD	NUMBER	§	num	1	SENT_2	[p1l54t220r530b251],
3	I	PRP	O	I	nsubj	4	SENT_2	[p1l54t220r530b251],
4	EENEIICS	VBP	O	eeneiic	rcmod	1	SENT_2	[p1l54t220r530b251],

1	NAT	NNP	ORGANIZATION	NAT	nsubj	4	SENT_3	[p1l51t326r200b376],
2	2	CD	NUMBER	2	num	3	SENT_3	[p1l194t326r229b375],
3	genotype	NN	O	genotype	dep	1	SENT_3	[p1l254t330r526b391],
4	guided	VBD	O	guide	_	0	SENT_3	[p1l551t326r755b391],
5	regimen	NN	O	regimen	nsubj	6	SENT_3	[p1l780t326r1026b391],
6	reduces	VBZ	O	reduce	ccomp	4	SENT_3	[p1l1052t327r1281b376],
7	isoniazid-induced	JJ	O	isoniazid-induced	amod	9	SENT_3	[p1l1306t326r1840b376],
8	liver	NN	O	liver	nn	9	SENT_3	[p1l55t408r192b458],
9	injury	NN	O	injury	dobj	6	SENT_3	[p1l215t408r404b473],
10	and	CC	O	and	_	0	SENT_3	[p1l430t409r542b458],
11	early	JJ	O	early	amod	13	SENT_3	[p1l567t409r719b473],
12	treatment	NN	O	treatment	nn	13	SENT_3	[p1l743t412r1041b458],
13	failure	NN	O	failure	conj_and	9	SENT_3	[p1l1065t408r1264b458],
14	in	IN	O	in	_	0	SENT_3	[p1l1288t408r1344b457],
15	the	DT	O	the	det	19	SENT_3	[p1l1369t409r1462b458],
16	6-month	JJ	DURATION	6-month	amod	19	SENT_3	[p1l1487t408r1741b458],
17	four-drug	JJ	O	four-drug	amod	19	SENT_3	[p1l56t490r352b555],
18	standard	JJ	O	standard	amod	19	SENT_3	[p1l378t491r649b540],
19	treatment	NN	O	treatment	prep_in	9	SENT_3	[p1l674t494r972b540],
20	of	IN	O	of	_	0	SENT_3	[p1l997t490r1060b540],
21	tuberculosis	NN	O	tuberculosis	prep_of	19	SENT_3	[p1l1077t490r1462b540],
22	:	:	O	:	_	0	SENT_3	[p1l1077t490r1462b540],
23	A	DT	O	a	dep	6	SENT_3	[p1l1490t490r1541b539],
24	randomized	VBN	O	randomize	dep	23	SENT_3	[p1l1566t490r1928b540],
25	controlled	JJ	O	controlled	amod	26	SENT_3	[p1l56t573r361b622],
26	trial	NN	O	trial	dobj	24	SENT_3	[p1l386t572r515b622],
27	for	IN	O	for	_	0	SENT_3	[p1l539t572r627b622],
28	pharmacogenetics	NNS	O	pharmacogenetic	prep_for	24	SENT_3	[p1l651t572r1401b637],
29	—	CD	NUMBER	—	num	28	SENT_3	[p1l651t572r1401b637],
30	based	VBN	O	base	partmod	28	SENT_3	[p1l651t572r1401b637],
31	therapy	NN	O	therapy	dobj	30	SENT_3	[p1l1425t573r1662b637],

1	J	NN	O	j	nn	2	SENT_4	[p1l54t713r74b742],
2	unichi	NNS	O	unichus	_	0	SENT_4	[p1l76t712r184b742],
3	Azuma	NNP	PERSON	Azuma	rcmod	2	SENT_4	[p1l197t712r321b742],
4	-	:	O	-	_	0	SENT_4	[p1l334t725r343b734],
5	Masako	NNP	PERSON	Masako	nn	6	SENT_4	[p1l358t713r496b742],
6	Ohno	NNP	PERSON	Ohno	dep	3	SENT_4	[p1l511t712r607b742],
7	-	:	O	-	_	0	SENT_4	[p1l621t725r629b734],
8	Ryuji	NNP	PERSON	Ryuji	nn	11	SENT_4	[p1l644t712r740b750],
9	Kubota	NNP	PERSON	Kubota	nn	11	SENT_4	[p1l754t713r885b742],
10	Soichiro	NNP	PERSON	Soichiro	nn	11	SENT_4	[p1l898t725r906b734, p1l55t764r199b793],
11	Yokota	NNP	PERSON	Yokota	dep	6	SENT_4	[p1l213t764r335b793],
12	-	:	O	-	_	0	SENT_4	[p1l348t777r357b785],
13	Takayuki	NNP	PERSON	Takayuki	nn	14	SENT_4	[p1l372t764r538b801],
14	N	NNP	PERSON	N	dep	3	SENT_4	[p1l550t764r579b793],
15	agai	SYM	O	agai	dep	3	SENT_4	[p1l582t764r654b801],
16	-	:	O	-	_	0	SENT_4	[p1l666t777r674b785],
17	Kazunari	NNP	PERSON	Kazunari	nn	18	SENT_4	[p1l689t764r855b793],
18	Tsuyuguchi	NNP	PERSON	Tsuyuguchi	dep	2	SENT_4	[p1l869t764r1071b801],
19	Yasuhisa	NNP	PERSON	Yasuhisa	nn	20	SENT_4	[p1l1083t777r1092b785, p1l54t815r209b844],
20	Okuda	NNP	PERSON	Okuda	dep	18	SENT_4	[p1l224t815r343b844],
21	-	:	O	-	_	0	SENT_4	[p1l356t828r365b836],
22	Tetsuya	NNP	PERSON	Tetsuya	nn	23	SENT_4	[p1l380t815r514b852],
23	Takashima	NNP	PERSON	Takashima	dep	18	SENT_4	[p1l529t815r721b844],
24	-	:	O	-	_	0	SENT_4	[p1l734t828r742b836],
25	Sayaka	NNP	PERSON	Sayaka	nn	28	SENT_4	[p1l758t815r884b852],
26	Kamimura	NNP	PERSON	Kamimura	nn	28	SENT_4	[p1l899t815r1091b844],
27	Yasushi	NNP	PERSON	Yasushi	nn	28	SENT_4	[p1l1104t828r1113b836, p1l54t866r189b895],
28	Fujio	NNP	PERSON	Fujio	dep	23	SENT_4	[p1l202t866r294b904],
29	-	:	O	-	_	0	SENT_4	[p1l307t879r316b888],
30	Ichiro	NNP	PERSON	Ichiro	nn	32	SENT_4	[p1l330t866r436b895],
31	Kawase	NNP	PERSON	Kawase	nn	32	SENT_4	[p1l450t867r586b896],
32	Pharmacogenetics	NNP	O	Pharmacogenetics	dep	18	SENT_4	[p1l599t879r607b888, p1l54t918r487b956],
33	—	NN	O	—	dep	32	SENT_4	[p1l599t879r607b888, p1l54t918r487b956],
34	based	VBN	O	base	dep	2	SENT_4	[p1l599t879r607b888, p1l54t918r487b956],
35	tuberculosis	NN	O	tuberculosis	nn	38	SENT_4	[p1l501t918r711b947],
36	therapy	NN	O	therapy	nn	38	SENT_4	[p1l726t919r862b956],
37	research	NN	O	research	nn	38	SENT_4	[p1l876t919r1023b947],
38	group	NN	O	group	dep	34	SENT_4	[p1l1038t927r1141b956],

1	Received	VBN	O	receive	_	0	SENT_5	[p1l54t1031r191b1057],
2	:	:	O	:	_	0	SENT_5	[p1l54t1031r191b1057],
3	29	CD	DATE	29	num	4	SENT_5	[p1l204t1032r238b1057],
4	July	NNP	DATE	July	nsubj	13	SENT_5	[p1l250t1031r308b1064],
5	2012	CD	DATE	2012	num	4	SENT_5	[p1l319t1032r388b1057],
6	/	:	O	/	punct	7	SENT_5	[p1l398t1031r408b1057],
7	Accepted	JJ	O	accepted	dep	4	SENT_5	[p1l412t1031r550b1064],
8	:	:	O	:	_	0	SENT_5	[p1l412t1031r550b1064],
9	4	CD	DATE	4	num	10	SENT_5	[p1l564t1032r580b1056],
10	October	NNP	DATE	October	dep	7	SENT_5	[p1l593t1031r705b1057],
11	2012	CD	DATE	2012	num	10	SENT_5	[p1l715t1032r784b1057],
12	/	:	O	/	punct	7	SENT_5	[p1l794t1031r804b1057],
13	Published	VBN	O	publish	parataxis	1	SENT_5	[p1l808t1031r946b1057],
14	online	NN	O	online	prep	13	SENT_5	[p1l957t1031r1051b1057],
15	:	:	O	:	_	0	SENT_5	[p1l957t1031r1051b1057],
16	14	CD	DATE	14	num	17	SENT_5	[p1l1068t1032r1098b1056],
17	November	NNP	DATE	November	tmod	25	SENT_5	[p1l1109t1031r1258b1057],
18	2012	CD	DATE	2012	num	19	SENT_5	[p1l1269t1032r1337b1057],
19	©	CD	NUMBER	©	nsubj	25	SENT_5	[p1l56t1069r86b1100],
20	The	DT	O	the	det	22	SENT_5	[p1l100t1072r153b1098],
21	Author	NN	O	author	nn	22	SENT_5	[p1l164t1072r299b1105],
22	(	NN	O	(	dep	19	SENT_5	[p1l164t1072r299b1105],
23	s	VBZ	O	s	cop	25	SENT_5	[p1l164t1072r299b1105],
24	)	CD	NUMBER	)	num	25	SENT_5	[p1l164t1072r299b1105],
25	2012	CD	DATE	2012	parataxis	1	SENT_5	[p1l311t1073r388b1098],
26	.	.	O	.	_	0	SENT_5	[p1l311t1073r388b1098],

1	This	DT	O	this	det	2	SENT_6	[p1l401t1072r462b1098],
2	article	NN	O	article	nsubjpass	4	SENT_6	[p1l474t1072r559b1098],
3	is	VBZ	O	be	auxpass	4	SENT_6	[p1l571t1072r593b1098],
4	published	VBN	O	publish	_	0	SENT_6	[p1l604t1072r741b1105],
5	with	IN	O	with	_	0	SENT_6	[p1l751t1072r813b1098],
6	open	JJ	O	open	amod	7	SENT_6	[p1l825t1080r892b1105],
7	access	NN	O	access	prep_with	4	SENT_6	[p1l904t1080r991b1098],
8	at	IN	O	at	_	0	SENT_6	[p1l1003t1076r1027b1097],
9	Springerlinkcom	NNP	LOCATION	Springerlinkcom	prep_at	4	SENT_6	[p1l1040t1072r1282b1105],

1	Abstract	JJ	O	abstract	amod	2	SENT_7	[p1l11t1267r340b1330],
2	Objective	NN	O	objective	nsubj	9	SENT_7	[p1l15t1373r359b1455],
3	This	DT	O	this	det	4	SENT_7	[p1l399t1373r555b1437],
4	study	NN	O	study	dep	2	SENT_7	[p1l605t1373r799b1455],
5	is	VBZ	O	be	cop	9	SENT_7	[p1l844t1373r899b1437],
6	a	DT	O	a	det	9	SENT_7	[p1l947t1394r984b1437],
7	pharrnacogenetic	JJ	O	pharrnacogenetic	amod	9	SENT_7	[p1l1026t1373r1648b1455],
8	clinical	JJ	O	clinical	amod	9	SENT_7	[p1l1696t1373r1961b1437],
9	trial	NN	O	trial	_	0	SENT_7	[p1l2005t1373r2149b1437],
10	designed	VBN	O	design	partmod	9	SENT_7	[p1l13t1484r327b1566],
11	to	TO	O	to	aux	12	SENT_7	[p1l362t1493r427b1548],
12	clarify	VB	O	clarify	xcomp	10	SENT_7	[p1l466t1484r692b1566],
13	whether	IN	O	whether	complm	26	SENT_7	[p1l727t1484r1013b1548],
14	the	DT	O	the	det	23	SENT_7	[p1l1047t1484r1152b1548],
15	N-acetyltransferase	NN	O	n-acetyltransferase	nn	23	SENT_7	[p1l1185t1484r1868b1566],
16	2	CD	NUMBER	2	num	23	SENT_7	[p1l1905t1486r1945b1547],
17	gene	NN	O	gene	nn	23	SENT_7	[p1l1985t1505r2148b1566],
18	(	CD	NUMBER	(	num	23	SENT_7	[p1l13t1595r209b1676],
19	NAT	NN	ORGANIZATION	nat	nn	23	SENT_7	[p1l13t1595r209b1676],
20	2	CD	NUMBER	2	num	23	SENT_7	[p1l201t1595r271b1676],
21	)	CD	NUMBER	)	num	23	SENT_7	[p1l201t1595r271b1676],
22	genotype-guided	JJ	O	genotype-guided	amod	23	SENT_7	[p1l310t1595r907b1677],
23	dosing	NN	O	dosing	nsubj	26	SENT_7	[p1l944t1595r1178b1677],
24	of	IN	O	of	_	0	SENT_7	[p1l1217t1595r1298b1659],
25	isoniazid	NN	O	isoniazid	prep_of	26	SENT_7	[p1l1324t1595r1642b1659],
26	improves	VBZ	O	improve	ccomp	12	SENT_7	[p1l1679t1595r2004b1677],
27	the	DT	O	the	det	28	SENT_7	[p1l2042t1595r2148b1659],
28	tolerability	NN	O	tolerability	dobj	26	SENT_7	[p1l11t1706r398b1788],
29	and	CC	O	and	_	0	SENT_7	[p1l432t1706r558b1770],
30	efficacy	NN	O	efficacy	dobj	26	SENT_7	[p1l592t1706r872b1788],
31	of	IN	O	of	_	0	SENT_7	[p1l906t1706r987b1770],
32	the	DT	O	the	det	36	SENT_7	[p1l1008t1706r1114b1770],
33	6-month	JJ	DURATION	6-month	amod	36	SENT_7	[p1l1150t1706r1448b1770],
34	four-drug	JJ	O	four-drug	amod	36	SENT_7	[p1l1482t1706r1817b1788],
35	standard	JJ	O	standard	amod	36	SENT_7	[p1l1853t1706r2150b1770],
36	regimen	NN	O	regimen	prep_of	28	SENT_7	[p1l11t1817r300b1899],
37	for	IN	O	for	_	0	SENT_7	[p1l331t1817r432b1881],
38	newly	RB	O	newly	advmod	39	SENT_7	[p1l458t1817r675b1899],
39	diagnosed	VBN	O	diagnose	amod	41	SENT_7	[p1l705t1817r1063b1899],
40	pulmonary	JJ	O	pulmonary	amod	41	SENT_7	[p1l1090t1817r1476b1899],
41	tuberculosis	NN	O	tuberculosis	prep_for	36	SENT_7	[p1l1504t1817r1948b1881],
42	.	.	O	.	_	0	SENT_7	[p1l1504t1817r1948b1881],

1	Methods	NNS	O	method	npadvmod	20	SENT_8	[p1l7t1928r315b1992],
2	In	IN	O	in	_	0	SENT_8	[p1l355t1931r425b1991],
3	a	DT	O	a	det	4	SENT_8	[p1l445t1949r482b1992],
4	multicenter	NN	O	multicenter	prep_in	20	SENT_8	[p1l498t1928r900b2006],
5	,	,	O	,	_	0	SENT_8	[p1l498t1928r900b2006],
6	parallel	NN	O	parallel	appos	4	SENT_8	[p1l921t1928r1193b2010],
7	,	,	O	,	_	0	SENT_8	[p1l921t1928r1193b2010],
8	randomized	VBN	O	randomize	dep	4	SENT_8	[p1l1214t1928r1640b2005],
9	,	,	O	,	_	0	SENT_8	[p1l1214t1928r1640b2005],
10	and	CC	O	and	_	0	SENT_8	[p1l1662t1928r1786b1992],
11	controlled	JJ	O	controlled	dep	4	SENT_8	[p1l1805t1928r2150b1992],
12	trial	NN	O	trial	dobj	11	SENT_8	[p1l11t2039r146b2102],
13	with	IN	O	with	_	0	SENT_8	[p1l178t2039r332b2103],
14	a	DT	O	a	det	16	SENT_8	[p1l367t2059r404b2102],
15	PROBE	NN	O	probe	nn	16	SENT_8	[p1l436t2040r716b2103],
16	design	NN	O	design	prep_with	11	SENT_8	[p1l752t2039r993b2120],
17	,	,	O	,	_	0	SENT_8	[p1l752t2039r993b2120],
18	patients	NNS	O	patient	nsubjpass	20	SENT_8	[p1l1028t2039r1293b2120],
19	were	VBD	O	be	auxpass	20	SENT_8	[p1l1327t2059r1493b2103],
20	assigned	VBN	O	assign	_	0	SENT_8	[p1l1530t2039r1824b2120],
21	to	TO	O	to	xcomp	20	SENT_8	[p1l1857t2048r1921b2103],
22	either	CC	O	either	prep	20	SENT_8	[p1l1959t2039r2152b2103],
23	conventional	JJ	O	conventional	amod	25	SENT_8	[p1l13t2150r476b2214],
24	standard	JJ	O	standard	amod	25	SENT_8	[p1l522t2150r823b2214],
25	treatment	NN	O	treatment	dep	22	SENT_8	[p1l864t2159r1203b2214],
26	(	CD	NUMBER	(	num	27	SENT_8	[p1l1246t2151r1829b2232],
27	STD-treatment	NN	O	std-treatment	dep	25	SENT_8	[p1l1246t2151r1829b2232],
28	:	:	O	:	_	0	SENT_8	[p1l1246t2151r1829b2232],
29	approx	RB	O	approx	advmod	25	SENT_8	[p1l1879t2171r2144b2232],
30	.	.	O	.	_	0	SENT_8	[p1l1879t2171r2144b2232],

1	5	CD	NUMBER	5	num	2	SENT_9	[p1l14t2264r49b2325],
2	mg/kg	NN	O	mg/kg	_	0	SENT_9	[p1l99t2261r328b2343],
3	of	IN	O	of	_	0	SENT_9	[p1l376t2261r457b2325],
4	isoniazid	NN	O	isoniazid	prep_of	2	SENT_9	[p1l492t2261r817b2325],
5	for	IN	O	for	_	0	SENT_9	[p1l863t2261r967b2325],
6	all	DT	O	all	det	12	SENT_9	[p1l1011t2261r1125b2343],
7	)	CD	NUMBER	)	nn	12	SENT_9	[p1l1011t2261r1125b2343],
8	or	CC	O	or	_	0	SENT_9	[p1l1173t2282r1246b2325],
9	NAT	NNP	O	NAT	dep	11	SENT_9	[p1l1285t2263r1459b2326],
10	2	CD	NUMBER	2	num	9	SENT_9	[p1l1452t2263r1493b2324],
11	genotype-guided	JJ	O	genotype-guided	nn	12	SENT_9	[p1l1541t2261r2150b2343],
12	treatment	NN	O	treatment	prep_for	2	SENT_9	[p1l11t2380r352b2436],
13	(	CD	NUMBER	(	num	14	SENT_9	[p1l389t2372r966b2453],
14	PGX-treatment	NN	O	pgx-treatment	dep	12	SENT_9	[p1l389t2372r966b2453],
15	:	:	O	:	_	0	SENT_9	[p1l389t2372r966b2453],
16	approx	RB	O	approx	advmod	12	SENT_9	[p1l1010t2392r1276b2454],
17	.	.	O	.	_	0	SENT_9	[p1l1010t2392r1276b2454],

1	7.5	CD	NUMBER	7.5	num	2	SENT_10	[p1l1319t2374r1424b2436],
2	mg/kg	NN	O	mg/kg	dep	5	SENT_10	[p1l1465t2372r1694b2454],
3	for	IN	O	for	_	0	SENT_10	[p1l1733t2372r1836b2436],
4	patients	NNS	O	patient	prep_for	2	SENT_10	[p1l1868t2372r2148b2454],
5	homozygous	JJ	O	homozygous	_	0	SENT_10	[p1l11t2483r475b2565],
6	for	IN	O	for	dep	5	SENT_10	[p1l536t2483r640b2547],
7	NAT	NNP	ORGANIZATION	NAT	pobj	6	SENT_10	[p1l691t2484r865b2547],
8	2	CD	NUMBER	2	num	7	SENT_10	[p1l859t2483r1014b2547],
9	*	CD	NUMBER	*	number	10	SENT_10	[p1l859t2483r1014b2547],
10	4	CD	NUMBER	4	dep	7	SENT_10	[p1l859t2483r1014b2547],
11	:	:	O	:	_	0	SENT_10	[p1l859t2483r1014b2547],
12	rapid	JJ	O	rapid	amod	13	SENT_10	[p1l1076t2483r1263b2565],
13	acetylators	NNS	O	acetylator	dep	7	SENT_10	[p1l1320t2483r1734b2565],
14	;	:	O	;	_	0	SENT_10	[p1l1320t2483r1734b2565],
15	5	CD	NUMBER	5	num	16	SENT_10	[p1l1797t2485r1832b2547],
16	mg/kg	NN	O	mg/kg	dep	13	SENT_10	[p1l1894t2483r2146b2565],
17	,	,	O	,	_	0	SENT_10	[p1l1894t2483r2146b2565],

1	Junichi	NNP	PERSON	Junichi	nn	2	SENT_11	[p1l12t2786r227b2840],
2	Azuma	NNP	PERSON	Azuma	nsubj	6	SENT_11	[p1l252t2787r470b2840],
3	and	CC	O	and	_	0	SENT_11	[p1l495t2786r602b2840],
4	Masako	NNP	PERSON	Masako	nn	5	SENT_11	[p1l625t2786r861b2840],
5	Ohno	NNP	PERSON	Ohno	nsubj	6	SENT_11	[p1l889t2786r1053b2840],
6	contributed	VBD	O	contribute	_	0	SENT_11	[p1l1081t2786r1421b2840],
7	equally	RB	O	equally	advmod	6	SENT_11	[p1l1447t2786r1666b2855],
8	to	TO	O	to	_	0	SENT_11	[p1l1690t2793r1745b2840],
9	this	DT	O	this	det	10	SENT_11	[p1l1771t2786r1877b2840],
10	work	NN	O	work	prep_to	6	SENT_11	[p1l1902t2786r2071b2840],
11	.	.	O	.	_	0	SENT_11	[p1l1902t2786r2071b2840],

1	Trial	NN	O	trial	nn	2	SENT_12	[p1l16t2927r166b2980],
2	Registration	NN	O	registration	_	0	SENT_12	[p1l183t2927r587b2995],
3	:	:	O	:	_	0	SENT_12	[p1l183t2927r587b2995],
4	ClinicalT	NN	O	clinicalt	nn	5	SENT_12	[p1l617t2926r897b2980],
5	rials	NNS	O	rial	dep	2	SENT_12	[p1l896t2926r1038b2980],
6	.	.	O	.	_	0	SENT_12	[p1l896t2926r1038b2980],

1	gov	NN	O	gov	nn	2	SENT_13	[p1l1045t2943r1157b2995],
2	Identiﬁer	NN	O	identiﬁer	_	0	SENT_13	[p1l1181t2926r1473b2980],
3	:	:	O	:	_	0	SENT_13	[p1l1181t2926r1473b2980],
4	NCT	NN	O	nct	dep	2	SENT_13	[p1l1501t2927r1652b2980],
5	00298870	CD	NUMBER	00298870	num	4	SENT_13	[p1l1679t2927r1978b2980],

1	J	NN	O	j	_	0	SENT_14	[p1l11t3068r39b3120],
2	.	.	O	.	_	0	SENT_14	[p1l45t3112r53b3120],

1	Azuma	NNP	PERSON	Azuma	nn	3	SENT_15	[p1l82t3067r300b3120],
2	(	CD	NUMBER	(	num	3	SENT_15	[p1l321t3064r450b3135],
3	E	NN	O	e	_	0	SENT_15	[p1l321t3064r450b3135],
4	)	CD	NUMBER	)	num	6	SENT_15	[p1l321t3064r450b3135],
5	Clinical	JJ	O	clinical	amod	6	SENT_15	[p1l13t3154r247b3209],
6	Pharmacology	NN	O	pharmacology	dep	3	SENT_15	[p1l272t3154r707b3224],
7	and	CC	O	and	_	0	SENT_15	[p1l732t3154r839b3209],
8	Pharrnacogenomics	NNS	PERSON	pharrnacogenomic	conj_and	3	SENT_15	[p1l863t3154r1468b3224],
9	,	,	O	,	_	0	SENT_15	[p1l863t3154r1468b3224],
10	School	NNP	ORGANIZATION	School	appos	8	SENT_15	[p1l15t3242r220b3297],
11	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l245t3243r314b3297],
12	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	10	SENT_15	[p1l330t3242r641b3312],
13	,	,	O	,	_	0	SENT_15	[p1l330t3242r641b3312],
14	Hyogo	NNP	ORGANIZATION	Hyogo	nn	15	SENT_15	[p1l11t3332r215b3400],
15	University	NNP	ORGANIZATION	University	appos	3	SENT_15	[p1l240t3330r557b3400],
16	of	IN	ORGANIZATION	of	_	0	SENT_15	[p1l583t3330r652b3384],
17	Health	NNP	ORGANIZATION	Health	nn	20	SENT_15	[p1l668t3330r867b3384],
18	Sciences	NNPS	ORGANIZATION	Sciences	nn	20	SENT_15	[p1l894t3330r1168b3396],
19	,	,	O	,	_	0	SENT_15	[p1l894t3330r1168b3396],
20	Kobe	NNP	LOCATION	Kobe	prep_of	15	SENT_15	[p1l11t3418r190b3484],
21	,	,	O	,	_	0	SENT_15	[p1l11t3418r190b3484],
22	Hyogo	NNP	LOCATION	Hyogo	nn	24	SENT_15	[p1l217t3421r439b3488],
23	,	,	O	,	_	0	SENT_15	[p1l217t3421r439b3488],
24	Japan	NNP	LOCATION	Japan	nsubj	25	SENT_15	[p1l467t3420r637b3488],
25	e-mail	VB	O	e-mail	rcmod	20	SENT_15	[p1l13t3506r216b3561],
26	:	:	O	:	_	0	SENT_15	[p1l13t3506r216b3561],
27	azuma@huhs.ac.jp	NN	O	azuma@huhs.ac.jp	dep	20	SENT_15	[p1l247t3506r815b3576],

1	J.	NNP	PERSON	J.	nn	2	SENT_16	[p2l11t63r53b116],
2	Azuma	NNP	PERSON	Azuma	_	0	SENT_16	[p2l82t63r300b116],
3	-	:	O	-	_	0	SENT_16	[p2l323t82r334b93],
4	M.	NNP	PERSON	M.	nn	5	SENT_16	[p2l358t63r438b115],
5	Ohno	NNP	PERSON	Ohno	dep	11	SENT_16	[p2l469t61r633b116],
6	°	NNP	O	°	nn	11	SENT_16	[p2l658t82r670b93],
7	R.	NNP	PERSON	R.	nn	11	SENT_16	[p2l695t63r758b115],
8	Kubota	NNP	PERSON	Kubota	nn	11	SENT_16	[p2l787t61r1010b115],
9	*	NNP	O	*	nn	11	SENT_16	[p2l1031t82r1043b93],
10	S.	NNP	PERSON	S.	nn	11	SENT_16	[p2l1071t62r1123b116],
11	Kamimura	NNP	PERSON	Kamimura	dep	2	SENT_16	[p2l1151t61r1473b116],
12	-	:	O	-	_	0	SENT_16	[p2l1495t82r1507b93],
13	Y.	NNP	PERSON	Y.	nn	14	SENT_16	[p2l1531t64r1589b115],
14	Fujio	NNP	PERSON	Fujio	dep	16	SENT_16	[p2l1618t61r1774b131],
15	Clinical	JJ	O	clinical	amod	16	SENT_16	[p2l13t149r247b204],
16	Pharmacology	NN	O	pharmacology	parataxis	11	SENT_16	[p2l272t149r707b219],
17	and	CC	O	and	_	0	SENT_16	[p2l732t149r839b204],
18	Pharrnacogenomics	NNS	O	pharrnacogenomic	parataxis	11	SENT_16	[p2l863t149r1468b219],
19	,	,	O	,	_	0	SENT_16	[p2l863t149r1468b219],
20	Graduate	NNP	ORGANIZATION	Graduate	nn	21	SENT_16	[p2l13t237r284b292],
21	School	NNP	ORGANIZATION	School	appos	16	SENT_16	[p2l313t237r518b292],
22	of	IN	ORGANIZATION	of	_	0	SENT_16	[p2l545t238r613b292],
23	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	nn	24	SENT_16	[p2l628t237r1089b292],
24	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	21	SENT_16	[p2l1118t238r1392b303],
25	,	,	O	,	_	0	SENT_16	[p2l1118t238r1392b303],
26	Osaka	NNP	ORGANIZATION	Osaka	nn	33	SENT_16	[p2l1421t237r1608b292],
27	University	NNP	ORGANIZATION	University	nn	33	SENT_16	[p2l1630t237r1959b307],
28	,	,	O	,	_	0	SENT_16	[p2l1630t237r1959b307],
29	Suita	NNP	O	Suita	appos	33	SENT_16	[p2l15t326r180b392],
30	,	,	O	,	_	0	SENT_16	[p2l15t326r180b392],
31	Osaka	NNP	LOCATION	Osaka	appos	33	SENT_16	[p2l209t326r411b391],
32	,	,	O	,	_	0	SENT_16	[p2l209t326r411b391],
33	Japan	NNP	LOCATION	Japan	appos	24	SENT_16	[p2l439t328r609b395],

1	M.	NNP	PERSON	M.	nn	2	SENT_17	[p2l11t506r91b558],
2	Ohno	NNP	PERSON	Ohno	_	0	SENT_17	[p2l122t503r286b558],
3	(	CD	NUMBER	(	num	4	SENT_17	[p2l309t501r439b573],
4	E	NN	O	e	amod	2	SENT_17	[p2l309t501r439b573],
5	)	CD	NUMBER	)	num	7	SENT_17	[p2l309t501r439b573],
6	Clinical	JJ	O	clinical	amod	7	SENT_17	[p2l13t592r247b646],
7	Pharmaceutics	NNS	O	pharmaceutic	dep	4	SENT_17	[p2l272t592r707b646],
8	and	CC	O	and	_	0	SENT_17	[p2l735t592r842b646],
9	Therapeutics	NNS	O	therapeutics	dep	4	SENT_17	[p2l867t592r1268b661],
10	,	,	O	,	_	0	SENT_17	[p2l867t592r1268b661],
11	School	NNP	ORGANIZATION	School	appos	7	SENT_17	[p2l15t679r220b734],
12	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l245t679r314b733],
13	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	11	SENT_17	[p2l330t679r641b749],
14	,	,	O	,	_	0	SENT_17	[p2l330t679r641b749],
15	Hyogo	NNP	ORGANIZATION	Hyogo	nn	16	SENT_17	[p2l11t770r215b837],
16	University	NNP	ORGANIZATION	University	appos	7	SENT_17	[p2l240t767r557b837],
17	of	IN	ORGANIZATION	of	_	0	SENT_17	[p2l583t768r652b822],
18	Health	NNP	ORGANIZATION	Health	nn	19	SENT_17	[p2l668t767r867b822],
19	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	16	SENT_17	[p2l894t768r1168b833],
20	,	,	O	,	_	0	SENT_17	[p2l894t768r1168b833],
21	Kobe	NNP	LOCATION	Kobe	nn	25	SENT_17	[p2l11t856r190b921],
22	,	,	O	,	_	0	SENT_17	[p2l11t856r190b921],
23	Hyogo	NNP	LOCATION	Hyogo	appos	25	SENT_17	[p2l217t858r438b925],
24	,	,	O	,	_	0	SENT_17	[p2l217t858r438b925],
25	Japan	NNP	LOCATION	Japan	nsubj	26	SENT_17	[p2l467t858r637b925],
26	e-mail	VB	O	e-mail	rcmod	16	SENT_17	[p2l13t944r216b998],
27	:	:	O	:	_	0	SENT_17	[p2l13t944r216b998],
28	ohno.mk@huhs.ac.jp	NN	O	ohno.mk@huhs.ac.jp	nn	29	SENT_17	[p2l247t944r887b1013],
29	patients	NNS	O	patient	dep	2	SENT_17	[p2l8t1045r275b1127],
30	heterozygous	JJ	O	heterozygous	amod	29	SENT_17	[p2l311t1045r774b1127],
31	for	IN	O	for	_	0	SENT_17	[p2l811t1046r911b1109],
32	NAT	NNP	ORGANIZATION	NAT	prep_for	30	SENT_17	[p2l939t1047r1109b1109],
33	2	CD	NUMBER	2	num	32	SENT_17	[p2l1101t1047r1142b1108],
34	*	CD	NUMBER	*	number	35	SENT_17	[p2l1150t1045r1232b1109],
35	4	CD	NUMBER	4	dep	32	SENT_17	[p2l1150t1045r1232b1109],
36	:	:	O	:	_	0	SENT_17	[p2l1239t1066r1249b1109],
37	intermediate	JJ	O	intermediate	amod	38	SENT_17	[p2l1290t1045r1720b1109],
38	acetylators	NNS	O	acetylator	dep	32	SENT_17	[p2l1756t1045r2147b1127],
39	;	:	O	;	_	0	SENT_17	[p2l1756t1045r2147b1127],
40	2.5	CD	NUMBER	2.5	num	41	SENT_17	[p2l10t1158r113b1220],
41	mg/kg	NN	O	mg/kg	dep	2	SENT_17	[p2l149t1156r391b1238],
42	,	,	O	,	_	0	SENT_17	[p2l149t1156r391b1238],
43	patients	NNS	O	patient	appos	41	SENT_17	[p2l424t1156r692b1238],
44	without	IN	O	without	_	0	SENT_17	[p2l724t1156r991b1220],
45	NAT	NNP	ORGANIZATION	NAT	prep_without	43	SENT_17	[p2l1018t1158r1189b1220],
46	2	CD	NUMBER	2	num	45	SENT_17	[p2l1180t1156r1311b1220],
47	*	CD	NUMBER	*	number	48	SENT_17	[p2l1180t1156r1311b1220],
48	4	CD	NUMBER	4	num	45	SENT_17	[p2l1180t1156r1311b1220],
49	:	:	O	:	_	0	SENT_17	[p2l1318t1177r1329b1220],
50	slow	JJ	O	slow	amod	51	SENT_17	[p2l1369t1156r1531b1220],
51	acetylators	NNS	O	acetylator	dep	2	SENT_17	[p2l1563t1156r1979b1238],
52	)	NN	O	)	dep	51	SENT_17	[p2l1563t1156r1979b1238],
53	.	.	O	.	_	0	SENT_17	[p2l1563t1156r1979b1238],

1	The	DT	O	the	det	3	SENT_18	[p2l2017t1156r2150b1220],
2	primary	JJ	O	primary	amod	3	SENT_18	[p2l8t1267r284b1349],
3	outcome	NN	O	outcome	nsubj	4	SENT_18	[p2l316t1276r613b1331],
4	included	VBD	O	include	_	0	SENT_18	[p2l646t1267r946b1331],
5	incidences	NNS	O	incidence	dobj	4	SENT_18	[p2l976t1267r1339b1331],
6	of	IN	O	of	_	0	SENT_18	[p2l1373t1268r1454b1331],
7	1	CD	NUMBER	1	number	8	SENT_18	[p2l1483t1268r1544b1349],
8	)	CD	NUMBER	)	num	14	SENT_18	[p2l1483t1268r1544b1349],
9	isoniazid-related	JJ	O	isoniazid-related	amod	14	SENT_18	[p2l1578t1267r2152b1331],
10	liver	NN	O	liver	nn	14	SENT_18	[p2l11t1378r168b1442],
11	injury	NN	O	injury	nn	14	SENT_18	[p2l199t1378r406b1460],
12	(	CD	NUMBER	(	num	14	SENT_18	[p2l439t1378r848b1459],
13	INH-DILI	NN	O	inh-dili	nn	14	SENT_18	[p2l439t1378r848b1459],
14	)	NN	O	)	prep_of	5	SENT_18	[p2l439t1378r848b1459],
15	during	IN	O	during	_	0	SENT_18	[p2l883t1378r1108b1460],
16	the	DT	DURATION	the	det	19	SENT_18	[p2l1140t1378r1244b1442],
17	first	JJ	DURATION	first	amod	19	SENT_18	[p2l1280t1378r1415b1442],
18	8	CD	DURATION	8	num	19	SENT_18	[p2l1450t1379r1485b1442],
19	weeks	NNS	NUMBER	week	prep_during	14	SENT_18	[p2l1521t1378r1737b1442],
20	of	IN	O	of	_	0	SENT_18	[p2l1773t1378r1854b1442],
21	therapy	NN	O	therapy	prep_of	14	SENT_18	[p2l1875t1378r2147b1460],
22	,	,	O	,	_	0	SENT_18	[p2l1875t1378r2147b1460],
23	and	CC	O	and	_	0	SENT_18	[p2l11t1489r137b1553],
24	2	CD	NUMBER	2	conj_and	14	SENT_18	[p2l176t1489r246b1570],
25	)	RB	O	)	advmod	26	SENT_18	[p2l176t1489r246b1570],
26	early	JJ	O	early	amod	28	SENT_18	[p2l290t1489r461b1571],
27	treatment	NN	O	treatment	nn	28	SENT_18	[p2l500t1498r833b1553],
28	failure	NN	O	failure	dep	24	SENT_18	[p2l873t1489r1097b1553],
29	as	IN	O	as	mark	30	SENT_18	[p2l1139t1510r1208b1553],
30	indicated	VBN	O	indicate	advcl	4	SENT_18	[p2l1250t1489r1572b1553],
31	by	IN	O	by	_	0	SENT_18	[p2l1609t1489r1698b1571],
32	a	DT	O	a	det	35	SENT_18	[p2l1740t1510r1777b1552],
33	persistent	JJ	O	persistent	amod	35	SENT_18	[p2l1813t1489r2152b1571],
34	positive	JJ	O	positive	amod	35	SENT_18	[p2l8t1600r283b1681],
35	culture	NN	O	culture	prep_by	30	SENT_18	[p2l321t1600r558b1664],
36	or	CC	O	or	_	0	SENT_18	[p2l597t1620r669b1664],
37	no	DT	O	no	det	38	SENT_18	[p2l702t1620r788b1664],
38	improvement	NN	O	improvement	conj_or	35	SENT_18	[p2l828t1600r1292b1681],
39	in	IN	O	in	_	0	SENT_18	[p2l1328t1600r1395b1662],
40	chest	NN	O	chest	nn	41	SENT_18	[p2l1431t1600r1608b1664],
41	radiographs	NNS	O	radiograph	prep_in	30	SENT_18	[p2l1643t1600r2051b1681],
42	at	IN	O	at	_	0	SENT_18	[p2l2091t1608r2153b1663],
43	the8th	NN	O	the8th	nn	44	SENT_18	[p2l9t1712r227b1776],
44	week	NN	DURATION	week	prep_at	30	SENT_18	[p2l250t1712r451b1776],
45	.	.	O	.	_	0	SENT_18	[p2l250t1712r451b1776],

1	Results	NNS	O	result	nsubjpass	22	SENT_19	[p2l6t1823r269b1887],
2	One	CD	NUMBER	one	num	3	SENT_19	[p2l310t1824r456b1887],
3	hundred	CD	NUMBER	hundred	dep	1	SENT_19	[p2l501t1823r800b1887],
4	and	CC	NUMBER	and	_	0	SENT_19	[p2l845t1823r973b1887],
5	seventy-two	CD	NUMBER	seventy-two	num	7	SENT_19	[p2l1020t1832r1458b1905],
6	Japanese	JJ	MISC	japanese	amod	7	SENT_19	[p2l1504t1825r1824b1905],
7	patients	NNS	O	patient	conj_and	1	SENT_19	[p2l1868t1823r2149b1905],
8	(	RB	O	(	advmod	9	SENT_19	[p2l11t1934r205b2015],
9	slow	JJ	O	slow	amod	10	SENT_19	[p2l11t1934r205b2015],
10	acetylators	NNS	O	acetylator	dep	7	SENT_19	[p2l247t1934r645b2016],
11	,	,	O	,	_	0	SENT_19	[p2l247t1934r645b2016],
12	9.3	CD	PERCENT	9.3	num	13	SENT_19	[p2l692t1935r794b1998],
13	%	NN	PERCENT	%	appos	7	SENT_19	[p2l842t1935r933b2011],
14	;	:	O	;	_	0	SENT_19	[p2l842t1935r933b2011],
15	rapid	JJ	O	rapid	amod	16	SENT_19	[p2l977t1934r1158b2016],
16	acetylators	NNS	O	acetylator	dep	7	SENT_19	[p2l1200t1934r1598b2016],
17	,	,	O	,	_	0	SENT_19	[p2l1200t1934r1598b2016],
18	53.5	CD	PERCENT	53.5	num	19	SENT_19	[p2l1646t1935r1793b1998],
19	%	NN	PERCENT	%	appos	16	SENT_19	[p2l1840t1934r1937b2015],
20	)	CD	NUMBER	)	dep	19	SENT_19	[p2l1840t1934r1937b2015],
21	were	VBD	O	be	auxpass	22	SENT_19	[p2l1979t1954r2149b1998],
22	enrolled	VBN	O	enrol	_	0	SENT_19	[p2l11t2045r299b2109],
23	in	IN	O	in	_	0	SENT_19	[p2l327t2045r394b2108],
24	this	DT	O	this	det	25	SENT_19	[p2l420t2045r545b2109],
25	trial	NN	O	trial	prep_in	22	SENT_19	[p2l574t2045r731b2109],
26	.	.	O	.	_	0	SENT_19	[p2l574t2045r731b2109],

1	In	IN	O	in	_	0	SENT_20	[p2l764t2047r836b2108],
2	the	DT	O	the	det	3	SENT_20	[p2l862t2045r968b2109],
3	intention-to-treat	NN	O	intention-to-treat	prep_in	10	SENT_20	[p2l998t2045r1597b2109],
4	(	CD	NUMBER	(	num	7	SENT_20	[p2l1625t2045r1814b2126],
5	ITT	NNP	ORGANIZATION	ITT	nn	7	SENT_20	[p2l1625t2045r1814b2126],
6	)	NN	O	)	nn	7	SENT_20	[p2l1625t2045r1814b2126],
7	analysis	NN	O	analysis	dep	3	SENT_20	[p2l1845t2045r2146b2126],
8	,	,	O	,	_	0	SENT_20	[p2l1845t2045r2146b2126],
9	INH-DILI	NN	O	inh-dili	nsubj	10	SENT_20	[p2l10t2159r371b2220],
10	occurred	VBD	O	occur	_	0	SENT_20	[p2l408t2156r716b2220],
11	in	IN	O	in	_	0	SENT_20	[p2l750t2156r816b2219],
12	78	CD	PERCENT	78	num	13	SENT_20	[p2l852t2158r934b2220],
13	%	NN	PERCENT	%	prep_in	10	SENT_20	[p2l974t2158r1043b2221],
14	of	IN	O	of	_	0	SENT_20	[p2l1080t2156r1161b2220],
15	the	DT	O	the	det	17	SENT_20	[p2l1184t2156r1290b2220],
16	slow	JJ	O	slow	amod	17	SENT_20	[p2l1329t2156r1492b2220],
17	acetylators	NNS	O	acetylator	prep_of	13	SENT_20	[p2l1528t2156r1906b2238],
18	in	IN	O	in	_	0	SENT_20	[p2l1943t2156r2010b2219],
19	the	DT	O	the	det	20	SENT_20	[p2l2043t2156r2149b2220],
20	STD-treatment	NN	O	std-treatment	prep_in	10	SENT_20	[p2l13t2268r558b2345],
21	,	,	O	,	_	0	SENT_20	[p2l13t2268r558b2345],
22	while	IN	O	while	mark	23	SENT_20	[p2l601t2267r796b2331],
23	none	NN	O	none	advcl	10	SENT_20	[p2l836t2288r1008b2331],
24	of	IN	O	of	_	0	SENT_20	[p2l1051t2267r1132b2331],
25	the	DT	O	the	det	27	SENT_20	[p2l1161t2267r1267b2331],
26	slow	JJ	O	slow	amod	27	SENT_20	[p2l1311t2267r1475b2331],
27	acetylators	NNS	O	acetylator	prep_of	23	SENT_20	[p2l1517t2267r1894b2349],
28	in	IN	O	in	dep	23	SENT_20	[p2l1938t2267r2004b2330],
29	the	DT	O	the	pobj	28	SENT_20	[p2l2043t2267r2149b2331],

1	S.	NNP	ORGANIZATION	S.	nn	8	SENT_21	[p2l12t2512r64b2565],
2	Yokota	NNP	ORGANIZATION	Yokota	nn	8	SENT_21	[p2l93t2511r309b2565],
3	National	NNP	ORGANIZATION	National	nn	8	SENT_21	[p2l7t2599r267b2654],
4	Hospital	NNP	ORGANIZATION	Hospital	nn	8	SENT_21	[p2l292t2599r546b2669],
5	Organization	NNP	ORGANIZATION	Organization	nn	8	SENT_21	[p2l572t2599r962b2669],
6	Toneyama	NNP	ORGANIZATION	Toneyama	nn	8	SENT_21	[p2l987t2602r1300b2669],
7	National	NNP	ORGANIZATION	National	nn	8	SENT_21	[p2l1321t2599r1581b2654],
8	Hospital	NNP	ORGANIZATION	Hospital	_	0	SENT_21	[p2l1606t2599r1876b2669],
9	,	,	O	,	_	0	SENT_21	[p2l1606t2599r1876b2669],
10	Toyonaka	NNP	PERSON	Toyonaka	nn	14	SENT_21	[p2l10t2687r322b2757],
11	,	,	O	,	_	0	SENT_21	[p2l10t2687r322b2757],
12	Osaka	NNP	LOCATION	Osaka	appos	14	SENT_21	[p2l351t2687r553b2753],
13	,	,	O	,	_	0	SENT_21	[p2l351t2687r553b2753],
14	Japan	NNP	LOCATION	Japan	appos	8	SENT_21	[p2l581t2690r752b2757],

1	T.	NNP	PERSON	T.	nn	2	SENT_22	[p2l10t2922r62b2973],
2	Nagai	NNP	PERSON	Nagai	poss	5	SENT_22	[p2l90t2919r270b2989],
3	'	POS	O	'	_	0	SENT_22	[p2l294t2939r305b2951],
4	T.	NNP	PERSON	T.	nn	5	SENT_22	[p2l331t2922r383b2973],
5	Takashima	NNP	PERSON	Takashima	_	0	SENT_22	[p2l413t2919r738b2973],
6	-	:	O	-	_	0	SENT_22	[p2l761t2939r772b2951],
7	I.	NN	ORGANIZATION	i.	dep	5	SENT_22	[p2l797t2921r834b2973],
8	Kawase	NNP	ORGANIZATION	Kawase	nn	9	SENT_22	[p2l863t2921r1100b2974],
9	Osaka	NNP	ORGANIZATION	Osaka	dep	7	SENT_22	[p2l10t3007r197b3061],
10	Prefectural	NNP	ORGANIZATION	Prefectural	nn	12	SENT_22	[p2l221t3007r547b3061],
11	Medical	NNP	ORGANIZATION	Medical	nn	12	SENT_22	[p2l573t3007r817b3061],
12	Center	NNP	ORGANIZATION	Center	dep	5	SENT_22	[p2l844t3008r1044b3061],
13	for	IN	ORGANIZATION	for	_	0	SENT_22	[p2l1068t3007r1154b3061],
14	Respiratory	JJ	ORGANIZATION	respiratory	amod	17	SENT_22	[p2l1177t3007r1527b3077],
15	and	CC	O	and	_	0	SENT_22	[p2l1553t3007r1660b3061],
16	Allergic	JJ	O	allergic	conj_and	14	SENT_22	[p2l1683t3007r1926b3077],
17	Diseases	NNS	O	disease	prep_for	12	SENT_22	[p2l9t3096r287b3162],
18	,	,	O	,	_	0	SENT_22	[p2l9t3096r287b3162],
19	Habikino	NNP	LOCATION	Habikino	nn	23	SENT_22	[p2l9t3184r305b3250],
20	,	,	O	,	_	0	SENT_22	[p2l9t3184r305b3250],
21	Osaka	NNP	LOCATION	Osaka	appos	23	SENT_22	[p2l334t3184r536b3250],
22	,	,	O	,	_	0	SENT_22	[p2l334t3184r536b3250],
23	Japan	NNP	LOCATION	Japan	appos	17	SENT_22	[p2l564t3186r735b3254],

1	K.	NNP	ORGANIZATION	K.	nn	6	SENT_23	[p2l9t3419r77b3470],
2	Tsuyuguchi	NNP	ORGANIZATION	Tsuyuguchi	nn	6	SENT_23	[p2l107t3416r457b3486],
3	National	NNP	ORGANIZATION	National	nn	6	SENT_23	[p2l7t3504r267b3559],
4	Hospital	NNP	ORGANIZATION	Hospital	nn	6	SENT_23	[p2l287t3504r541b3574],
5	Organization	NNP	ORGANIZATION	Organization	nn	6	SENT_23	[p2l562t3504r952b3574],
6	Kinki-Chuo	NNP	ORGANIZATION	Kinki-Chuo	_	0	SENT_23	[p2l972t3504r1330b3559],
7	Chest	NN	ORGANIZATION	chest	dep	6	SENT_23	[p2l1354t3504r1524b3559],
8	Medical	NNP	ORGANIZATION	Medical	nn	15	SENT_23	[p2l1543t3504r1787b3559],
9	Center	NNP	ORGANIZATION	Center	nn	15	SENT_23	[p2l1809t3505r2020b3570],
10	,	,	O	,	_	0	SENT_23	[p2l1809t3505r2020b3570],
11	Sakai	NNP	LOCATION	Sakai	appos	15	SENT_23	[p2l12t3592r191b3658],
12	,	,	O	,	_	0	SENT_23	[p2l12t3592r191b3658],
13	Osaka	NNP	LOCATION	Osaka	appos	15	SENT_23	[p2l220t3592r422b3658],
14	,	,	O	,	_	0	SENT_23	[p2l220t3592r422b3658],
15	Japan	NNP	LOCATION	Japan	dep	6	SENT_23	[p2l450t3595r621b3662],

1	Y.	NNP	ORGANIZATION	Y.	nn	7	SENT_24	[p3l8t91r68b143],
2	Okuda	NNP	ORGANIZATION	Okuda	nn	7	SENT_24	[p3l98t88r299b143],
3	Japan	NNP	ORGANIZATION	Japan	nn	7	SENT_24	[p3l9t179r180b246],
4	Anti-Tuberculosis	NNP	ORGANIZATION	Anti-Tuberculosis	nn	7	SENT_24	[p3l204t177r747b231],
5	Association	NNP	ORGANIZATION	Association	nn	7	SENT_24	[p3l773t177r1128b231],
6	Osaka	NNP	ORGANIZATION	Osaka	nn	7	SENT_24	[p3l1154t177r1342b231],
7	Hospital	NNP	ORGANIZATION	Hospital	_	0	SENT_24	[p3l1365t177r1635b246],
8	,	,	O	,	_	0	SENT_24	[p3l1365t177r1635b246],
9	Neyagawa	NNP	LOCATION	Neyagawa	nn	13	SENT_24	[p3l7t267r343b334],
10	,	,	O	,	_	0	SENT_24	[p3l7t267r343b334],
11	Osaka	NNP	LOCATION	Osaka	appos	13	SENT_24	[p3l372t265r574b330],
12	,	,	O	,	_	0	SENT_24	[p3l372t265r574b330],
13	Japan	NNP	LOCATION	Japan	appos	7	SENT_24	[p3l602t267r772b334],

1	Q	NNP	O	Q	nn	4	SENT_25	[p3l1789t490r1862b580],
2	Springer	NNP	O	Springer	nn	4	SENT_25	[p3l1888t513r2133b583],
3	1092	CD	DATE	1092	num	4	SENT_25	[p3l56t658r121b683],
4	Eur	NNP	O	Eur	_	0	SENT_25	[p3l1486t659r1536b683],
5	J	NNP	O	J	nn	7	SENT_25	[p3l1547t659r1560b683],
6	Clin	NNP	PERSON	Clin	nn	7	SENT_25	[p3l1571t658r1631b683],
7	Pharmacol	NNP	PERSON	Pharmacol	dep	4	SENT_25	[p3l1642t658r1790b683],
8	(	CD	NUMBER	(	num	9	SENT_25	[p3l1802t658r1893b690],
9	2013	CD	DATE	2013	dep	4	SENT_25	[p3l1802t658r1893b690],
10	)	CD	NUMBER	)	number	11	SENT_25	[p3l1802t658r1893b690],
11	69:1091	CD	NUMBER	69:1091	num	13	SENT_25	[p3l1906t658r2103b683],
12	—	CD	NUMBER	—	number	13	SENT_25	[p3l1906t658r2103b683],
13	1101	CD	DATE	1101	dep	9	SENT_25	[p3l1906t658r2103b683],

1	PGX-treatment	NN	O	pgx-treatment	nsubj	2	SENT_26	[p3l8t832r529b895],
2	experienced	VBD	O	experience	_	0	SENT_26	[p3l562t831r987b913],
3	either	CC	O	either	prep	2	SENT_26	[p3l1022t831r1221b895],
4	INH-DILI	NN	O	inh-dili	nn	8	SENT_26	[p3l1253t833r1612b894],
5	or	CC	O	or	_	0	SENT_26	[p3l1648t851r1721b895],
6	early	JJ	O	early	nn	8	SENT_26	[p3l1754t831r1926b913],
7	treatment	NN	O	treatment	nn	8	SENT_26	[p3l1959t839r2141b895, p3l8t951r185b1006],
8	failure	NN	O	failure	dep	3	SENT_26	[p3l221t942r464b1006],
9	.	.	O	.	_	0	SENT_26	[p3l221t942r464b1006],

1	Among	IN	O	among	_	0	SENT_27	[p3l504t944r769b1024],
2	the	DT	O	the	det	4	SENT_27	[p3l805t942r911b1006],
3	rapid	JJ	O	rapid	amod	4	SENT_27	[p3l947t942r1128b1024],
4	acetylators	NNS	O	acetylator	prep_among	10	SENT_27	[p3l1165t942r1563b1024],
5	,	,	O	,	_	0	SENT_27	[p3l1165t942r1563b1024],
6	early	JJ	O	early	amod	8	SENT_27	[p3l1604t942r1776b1024],
7	treatment	NN	O	treatment	nn	8	SENT_27	[p3l1811t951r2144b1006],
8	failure	NN	O	failure	nsubjpass	10	SENT_27	[p3l10t1053r234b1117],
9	was	VBD	O	be	auxpass	10	SENT_27	[p3l275t1074r410b1117],
10	observed	VBN	O	observe	_	0	SENT_27	[p3l454t1053r772b1117],
11	with	IN	O	with	_	0	SENT_27	[p3l810t1053r967b1117],
12	a	DT	O	a	det	16	SENT_27	[p3l1009t1074r1046b1117],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_27	[p3l1088t1053r1525b1135],
14	lower	JJR	O	lower	amod	16	SENT_27	[p3l1567t1053r1767b1117],
15	incidence	NN	O	incidence	nn	16	SENT_27	[p3l1806t1053r2141b1117],
16	rate	NN	O	rate	prep_with	10	SENT_27	[p3l7t1173r136b1228],
17	in	IN	O	in	_	0	SENT_27	[p3l162t1164r228b1227],
18	the	DT	O	the	det	19	SENT_27	[p3l250t1164r356b1228],
19	PGX-treatment	NN	O	pgx-treatment	prep_in	16	SENT_27	[p3l380t1166r900b1228],
20	than	IN	O	than	dep	10	SENT_27	[p3l920t1164r1072b1228],
21	in	IN	O	in	_	0	SENT_27	[p3l1096t1164r1162b1227],
22	the	DT	O	the	det	24	SENT_27	[p3l1184t1164r1290b1228],
23	STD-treatment	JJ	O	std-treatment	amod	24	SENT_27	[p3l1318t1166r1843b1228],
24	(	NN	O	(	prep_in	10	SENT_27	[p3l1867t1165r2046b1246],
25	15.0	CD	PERCENT	15.0	num	26	SENT_27	[p3l1867t1165r2046b1246],
26	%	NN	PERCENT	%	dep	24	SENT_27	[p3l2073t1166r2141b1229],
27	vs.	CC	O	vs.	_	0	SENT_27	[p3l8t1295r108b1339],
28	38	CD	PERCENT	38	num	29	SENT_27	[p3l164t1276r248b1338],
29	%	NN	PERCENT	%	dep	24	SENT_27	[p3l302t1275r423b1356],
30	)	CD	NUMBER	)	dep	29	SENT_27	[p3l302t1275r423b1356],
31	.	.	O	.	_	0	SENT_27	[p3l302t1275r423b1356],

1	Thus	RB	O	thus	advmod	7	SENT_28	[p3l477t1275r683b1352],
2	,	,	O	,	_	0	SENT_28	[p3l477t1275r683b1352],
3	the	DT	O	the	det	6	SENT_28	[p3l734t1275r845b1339],
4	NAT2	NN	O	nat2	nn	6	SENT_28	[p3l890t1276r1104b1339],
5	genotype-guided	JJ	O	genotype-guided	amod	6	SENT_28	[p3l1155t1275r1791b1356],
6	regimen	NN	O	regimen	nsubj	7	SENT_28	[p3l1837t1275r2144b1356],
7	resulted	VBD	O	result	_	0	SENT_28	[p3l8t1386r286b1449],
8	in	IN	O	in	_	0	SENT_28	[p3l328t1386r394b1448],
9	much	RB	O	much	advmod	10	SENT_28	[p3l433t1386r630b1449],
10	lower	JJR	O	lower	amod	11	SENT_28	[p3l671t1386r872b1449],
11	incidences	NNS	O	incidence	prep_in	7	SENT_28	[p3l911t1386r1279b1449],
12	of	IN	O	of	_	0	SENT_28	[p3l1324t1386r1404b1449],
13	unfavorable	JJ	O	unfavorable	amod	14	SENT_28	[p3l1432t1386r1854b1449],
14	events	NNS	O	event	prep_of	11	SENT_28	[p3l1897t1394r2139b1462],
15	,	,	O	,	_	0	SENT_28	[p3l1897t1394r2139b1462],
16	INH-DILI	NN	O	inh-dili	nn	20	SENT_28	[p3l9t1498r369b1559],
17	or	CC	O	or	_	0	SENT_28	[p3l404t1516r477b1560],
18	early	JJ	O	early	nn	20	SENT_28	[p3l509t1496r681b1577],
19	treatment	NN	O	treatment	nn	20	SENT_28	[p3l714t1504r1047b1560],
20	failure	NN	O	failure	appos	14	SENT_28	[p3l1081t1496r1325b1573],
21	,	,	O	,	_	0	SENT_28	[p3l1081t1496r1325b1573],
22	than	IN	O	than	_	0	SENT_28	[p3l1361t1496r1513b1559],
23	the	DT	O	the	det	26	SENT_28	[p3l1546t1496r1651b1560],
24	conventional	JJ	O	conventional	amod	26	SENT_28	[p3l1688t1496r2142b1560],
25	standard	JJ	O	standard	amod	26	SENT_28	[p3l11t1607r308b1671],
26	regimen	NN	O	regimen	prep_than	7	SENT_28	[p3l334t1607r640b1689],
27	.	.	O	.	_	0	SENT_28	[p3l334t1607r640b1689],

1	Conclusion	NN	O	conclusion	nsubj	5	SENT_29	[p3l13t1718r409b1782],
2	Our	PRP$	O	we	poss	3	SENT_29	[p3l452t1719r588b1782],
3	results	NNS	O	result	dep	1	SENT_29	[p3l617t1718r844b1782],
4	clearly	RB	O	clearly	advmod	5	SENT_29	[p3l879t1718r1116b1799],
5	indicate	VBP	O	indicate	_	0	SENT_29	[p3l1148t1718r1423b1782],
6	a	DT	O	a	det	8	SENT_29	[p3l1459t1738r1496b1781],
7	great	JJ	O	great	amod	8	SENT_29	[p3l1527t1726r1701b1799],
8	potential	NN	O	potential	dobj	5	SENT_29	[p3l1730t1718r2038b1799],
9	of	IN	O	of	_	0	SENT_29	[p3l2073t1718r2154b1782],
10	the	DT	O	the	det	14	SENT_29	[p3l8t1829r113b1893],
11	NAT2	NN	O	nat2	nn	14	SENT_29	[p3l137t1830r343b1893],
12	genotype-guided	JJ	O	genotype-guided	amod	14	SENT_29	[p3l372t1829r968b1910],
13	dosing	NN	O	dosing	nn	14	SENT_29	[p3l995t1829r1229b1910],
14	stratification	NN	O	stratification	prep_of	8	SENT_29	[p3l1259t1829r1700b1893],
15	of	IN	O	of	_	0	SENT_29	[p3l1728t1829r1809b1893],
16	isoniazid	NN	O	isoniazid	prep_of	14	SENT_29	[p3l1826t1829r2143b1893],
17	in	IN	O	in	_	0	SENT_29	[p3l9t1940r76b2003],
18	chemotherapy	NN	O	chemotherapy	prep_in	5	SENT_29	[p3l106t1940r605b2022],
19	for	IN	O	for	_	0	SENT_29	[p3l636t1940r737b2004],
20	tuberculosis	NN	O	tuberculosis	prep_for	18	SENT_29	[p3l763t1940r1206b2004],
21	.	.	O	.	_	0	SENT_29	[p3l763t1940r1206b2004],

1	Keywords	NNPS	O	Keywords	dep	6	SENT_30	[p3l9t2167r390b2246],
2	Arylamine	NNP	O	Arylamine	dep	1	SENT_30	[p3l431t2164r807b2246],
3	N-acetyltransferase	NN	O	n-acetyltransferase	dep	6	SENT_30	[p3l824t2164r1505b2246],
4	2	CD	NUMBER	2	num	3	SENT_30	[p3l1525t2166r1565b2227],
5	(	CD	NUMBER	(	num	6	SENT_30	[p3l1590t2164r1859b2245],
6	NAT2	NN	O	nat2	dep	11	SENT_30	[p3l1590t2164r1859b2245],
7	)	CD	NUMBER	)	num	8	SENT_30	[p3l1590t2164r1859b2245],
8	Isoniazid	NN	O	isoniazid	dep	6	SENT_30	[p3l1898t2200r1908b2210, p3l9t2274r332b2338],
9	-	:	O	-	_	0	SENT_30	[p3l368t2274r790b2356],
10	Pulmonary	JJ	O	pulmonary	amod	11	SENT_30	[p3l368t2274r790b2356],
11	tuberculosis	NN	O	tuberculosis	_	0	SENT_30	[p3l808t2274r1234b2338],
12	-	:	O	-	_	0	SENT_30	[p3l1272t2274r1997b2356],
13	Pharmacogenomics	NNP	O	Pharmacogenomics	nn	14	SENT_30	[p3l1272t2274r1997b2356],
14	Randomized	NNP	O	Randomized	dep	11	SENT_30	[p3l2036t2310r2046b2320, p3l8t2385r456b2450],
15	clinical	JJ	O	clinical	amod	16	SENT_30	[p3l476t2385r732b2450],
16	trial	NN	O	trial	dep	14	SENT_30	[p3l751t2385r890b2449],

1	Introduction	NN	O	introduction	_	0	SENT_31	[p3l8t2612r486b2674],

1	The	DT	O	the	det	3	SENT_32	[p3l9t2833r144b2897],
2	annual	JJ	SET	annual	amod	3	SENT_32	[p3l199t2833r435b2898],
3	incidence	NN	O	incidence	nsubj	6	SENT_32	[p3l489t2833r828b2898],
4	of	IN	O	of	_	0	SENT_32	[p3l882t2833r964b2897],
5	tuberculosis	NN	O	tuberculosis	prep_of	3	SENT_32	[p3l1005t2833r1435b2898],
6	is	VBZ	O	be	_	0	SENT_32	[p3l1490t2833r1544b2897],
7	still	RB	O	still	advmod	6	SENT_32	[p3l1601t2833r1729b2897],
8	over	IN	O	over	_	0	SENT_32	[p3l1783t2854r1941b2898],
9	nine	CD	NUMBER	nine	number	10	SENT_32	[p3l1990t2833r2142b2898],
10	million	CD	NUMBER	million	num	11	SENT_32	[p3l8t2944r267b3008],
11	cases	NNS	O	case	prep_over	6	SENT_32	[p3l320t2965r504b3008],
12	worldwide	JJ	O	worldwide	amod	13	SENT_32	[p3l557t2944r941b3008],
13	[	NN	O	[	dep	11	SENT_32	[p3l1000t2946r1113b3025],
14	1	CD	NUMBER	1	num	15	SENT_32	[p3l1000t2946r1113b3025],
15	]	NN	O	]	dep	13	SENT_32	[p3l1000t2946r1113b3025],
16	.	.	O	.	_	0	SENT_32	[p3l1000t2946r1113b3025],

1	With	IN	O	with	_	0	SENT_33	[p3l1171t2944r1346b3008],
2	supervision	NN	O	supervision	prep_with	17	SENT_33	[p3l1401t2944r1813b3026],
3	by	IN	O	by	_	0	SENT_33	[p3l1863t2944r1953b3026],
4	The	DT	O	the	det	7	SENT_33	[p3l2006t2944r2142b3008],
5	Stop	NN	O	stop	nn	7	SENT_33	[p3l12t3057r167b3137],
6	TB	NN	O	tb	nn	7	SENT_33	[p3l208t3058r315b3118],
7	Strategy	NN	O	strategy	prep_by	2	SENT_33	[p3l361t3057r663b3137],
8	,	,	O	,	_	0	SENT_33	[p3l361t3057r663b3137],
9	the	DT	O	the	det	13	SENT_33	[p3l704t3055r810b3119],
10	World	NNP	ORGANIZATION	World	nn	13	SENT_33	[p3l849t3055r1067b3119],
11	Health	NNP	ORGANIZATION	Health	nn	13	SENT_33	[p3l1105t3055r1339b3119],
12	Organization	NNP	ORGANIZATION	Organization	nn	13	SENT_33	[p3l1379t3055r1837b3137],
13	(	NNP	O	(	nsubj	17	SENT_33	[p3l1876t3055r2141b3137],
14	WHO	WP	O	who	nsubj	15	SENT_33	[p3l1876t3055r2141b3137],
15	)	VBP	O	)	rcmod	13	SENT_33	[p3l1876t3055r2141b3137],
16	has	VBZ	O	have	aux	17	SENT_33	[p3l8t3166r123b3230],
17	pursued	VBN	O	pursue	_	0	SENT_33	[p3l165t3166r448b3247],
18	standardized	JJ	O	standardized	amod	19	SENT_33	[p3l492t3166r935b3230],
19	treatments	NNS	O	treatment	nsubj	20	SENT_33	[p3l977t3174r1341b3230],
20	[	VBP	O	[	ccomp	17	SENT_33	[p3l1391t3167r1503b3246],
21	2	CD	NUMBER	2	number	22	SENT_33	[p3l1391t3167r1503b3246],
22	]	CD	NUMBER	]	dobj	20	SENT_33	[p3l1391t3167r1503b3246],
23	.	.	O	.	_	0	SENT_33	[p3l1391t3167r1503b3246],

1	The	DT	O	the	det	4	SENT_34	[p3l1551t3166r1685b3230],
2	most	RBS	O	most	advmod	3	SENT_34	[p3l1728t3174r1900b3230],
3	effective	JJ	O	effective	amod	4	SENT_34	[p3l1943t3166r2141b3230, p3l8t3277r141b3341],
4	treatment	NN	O	treatment	nsubj	11	SENT_34	[p3l195t3285r538b3341],
5	has	VBZ	O	have	aux	11	SENT_34	[p3l589t3277r707b3341],
6	been	VBN	O	be	cop	11	SENT_34	[p3l761t3277r932b3341],
7	a	DT	O	a	det	11	SENT_34	[p3l987t3297r1024b3340],
8	standard	JJ	O	standard	amod	11	SENT_34	[p3l1078t3277r1384b3341],
9	6-month	JJ	DURATION	6-month	amod	11	SENT_34	[p3l1439t3277r1743b3341],
10	four-drug	JJ	O	four-drug	amod	11	SENT_34	[p3l1798t3277r2142b3358],
11	regimen	NN	O	regimen	_	0	SENT_34	[p3l7t3388r296b3469],
12	for	IN	O	for	_	0	SENT_34	[p3l343t3388r443b3452],
13	the	DT	O	the	det	15	SENT_34	[p3l485t3388r591b3452],
14	initial	JJ	O	initial	amod	15	SENT_34	[p3l637t3388r838b3451],
15	treatment	NN	O	treatment	prep_for	11	SENT_34	[p3l882t3396r1216b3452],
16	of	IN	O	of	_	0	SENT_34	[p3l1260t3388r1341b3452],
17	drug-susceptible	JJ	O	drug-susceptible	amod	20	SENT_34	[p3l1376t3388r1956b3469],
18	pulmonary	JJ	O	pulmonary	amod	20	SENT_34	[p3l2000t3388r2141b3469, p3l8t3520r279b3581],
19	tuberculosis	NN	O	tuberculosis	nn	20	SENT_34	[p3l316t3499r740b3563],
20	[	NN	O	[	prep_of	15	SENT_34	[p3l786t3500r871b3579],
21	3	CD	NUMBER	3	dep	20	SENT_34	[p3l786t3500r871b3579],
22	,	,	O	,	_	0	SENT_34	[p3l786t3500r871b3579],
23	4	CD	NUMBER	4	num	24	SENT_34	[p3l913t3500r1001b3580],
24	]	NN	O	]	appos	20	SENT_34	[p3l913t3500r1001b3580],
25	.	.	O	.	_	0	SENT_34	[p3l913t3500r1001b3580],

1	However	RB	O	however	advmod	8	SENT_35	[p3l1045t3502r1385b3576],
2	,	,	O	,	_	0	SENT_35	[p3l1045t3502r1385b3576],
3	several	JJ	O	several	amod	6	SENT_35	[p3l1429t3499r1674b3563],
4	drug-related	JJ	O	drug-related	amod	6	SENT_35	[p3l1714t3499r2143b3581],
5	adverse	JJ	O	adverse	amod	6	SENT_35	[p3l10t3611r276b3675],
6	reactions	NNS	O	reaction	nsubj	8	SENT_35	[p3l308t3611r625b3675],
7	can	MD	O	can	aux	8	SENT_35	[p3l661t3632r780b3675],
8	result	VB	O	result	_	0	SENT_35	[p3l811t3611r1008b3675],
9	in	IN	O	in	_	0	SENT_35	[p3l1041t3611r1107b3674],
10	discontinuation	NN	O	discontinuation	prep_in	8	SENT_35	[p3l1140t3611r1685b3675],
11	of	IN	O	of	_	0	SENT_35	[p3l1719t3611r1800b3675],
12	the	DT	O	the	det	14	SENT_35	[p3l1820t3611r1926b3675],
13	treatment	NN	O	treatment	nn	14	SENT_35	[p3l1959t3620r2141b3675, p3l8t3730r185b3786],
14	[	NN	O	[	prep_of	10	SENT_35	[p3l241t3723r326b3802],
15	4	CD	NUMBER	4	tmod	8	SENT_35	[p3l241t3723r326b3802],
16	,	,	O	,	_	0	SENT_35	[p3l241t3723r326b3802],
17	5	CD	NUMBER	5	num	18	SENT_35	[p3l384t3723r469b3802],
18	]	NN	O	]	appos	15	SENT_35	[p3l384t3723r469b3802],
19	.	.	O	.	_	0	SENT_35	[p3l384t3723r469b3802],

1	There	EX	O	there	expl	6	SENT_36	[p3l527t3722r730b3786],
2	can	MD	O	can	aux	6	SENT_36	[p3l783t3743r904b3786],
3	also	RB	O	also	advmod	6	SENT_36	[p3l956t3722r1093b3786],
4	be	VB	O	be	cop	6	SENT_36	[p3l1145t3722r1228b3786],
5	considerable	JJ	O	considerable	amod	6	SENT_36	[p3l1281t3722r1725b3786],
6	morbidity	NN	O	morbidity	_	0	SENT_36	[p3l1777t3722r2139b3804],
7	,	,	O	,	_	0	SENT_36	[p3l1777t3722r2139b3804],

1	even	RB	O	even	advmod	2	SENT_37	[p4l10t42r174b85],
2	mortality	NN	O	mortality	_	0	SENT_37	[p4l212t21r547b103],
3	,	,	O	,	_	0	SENT_37	[p4l212t21r547b103],
4	particularly	RB	O	particularly	advmod	2	SENT_37	[p4l587t21r994b103],
5	with	IN	O	with	_	0	SENT_37	[p4l1031t21r1187b85],
6	drug-induced	JJ	O	drug-induced	amod	8	SENT_37	[p4l1227t21r1699b103],
7	liver	NN	O	liver	nn	8	SENT_37	[p4l1737t21r1897b85],
8	injury	NN	O	injury	prep_with	4	SENT_37	[p4l1934t21r2143b103],
9	(	CD	NUMBER	(	num	10	SENT_37	[p4l10t132r243b214],
10	DILI	NNP	O	DILI	dep	2	SENT_37	[p4l10t132r243b214],
11	)	CD	NUMBER	)	num	10	SENT_37	[p4l10t132r243b214],
12	[	CD	NUMBER	[	number	13	SENT_37	[p4l303t134r508b213],
13	6	CD	NUMBER	6	num	14	SENT_37	[p4l303t134r508b213],
14	—	NN	O	—	dep	2	SENT_37	[p4l303t134r508b213],
15	8	CD	NUMBER	8	num	16	SENT_37	[p4l303t134r508b213],
16	]	NN	O	]	dep	14	SENT_37	[p4l303t134r508b213],
17	.	.	O	.	_	0	SENT_37	[p4l303t134r508b213],

1	These	DT	O	these	det	2	SENT_38	[p4l567t132r777b196],
2	events	NNS	O	event	nsubj	3	SENT_38	[p4l833t141r1057b196],
3	incur	VBP	O	incur	_	0	SENT_38	[p4l1113t132r1297b196],
4	substantial	JJ	O	substantial	amod	6	SENT_38	[p4l1350t132r1731b196],
5	additional	JJ	O	additional	amod	6	SENT_38	[p4l1785t132r2142b196],
6	costs	NNS	O	cost	dobj	3	SENT_38	[p4l10t252r184b307],
7	because	IN	O	because	_	0	SENT_38	[p4l237t243r521b307],
8	of	IN	O	of	_	0	SENT_38	[p4l575t243r658b307],
9	the	DT	O	the	det	11	SENT_38	[p4l698t243r805b307],
10	increased	VBN	O	increase	amod	11	SENT_38	[p4l860t243r1197b307],
11	frequency	NN	O	frequency	prep_because_of	3	SENT_38	[p4l1251t243r1607b325],
12	of	IN	O	of	_	0	SENT_38	[p4l1661t243r1743b307],
13	outpatient	NN	O	outpatient	nn	14	SENT_38	[p4l1786t243r2144b325],
14	visits	NNS	O	visit	prep_of	11	SENT_38	[p4l8t354r211b431],
15	,	,	O	,	_	0	SENT_38	[p4l8t354r211b431],
16	laboratory	NN	O	laboratory	nn	17	SENT_38	[p4l252t354r612b435],
17	tests	NNS	O	test	prep_of	11	SENT_38	[p4l647t363r821b431],
18	,	,	O	,	_	0	SENT_38	[p4l647t363r821b431],
19	and	CC	O	and	_	0	SENT_38	[p4l862t354r988b418],
20	hospitalization	NN	O	hospitalization	prep_of	11	SENT_38	[p4l1021t354r1542b435],
21	in	IN	O	in	_	0	SENT_38	[p4l1578t354r1644b416],
22	more	RBR	O	more	advmod	23	SENT_38	[p4l1678t374r1857b418],
23	serious	JJ	O	serious	amod	24	SENT_38	[p4l1897t354r2140b418],
24	instances	NNS	O	instance	prep_in	20	SENT_38	[p4l10t465r349b529],
25	.	.	O	.	_	0	SENT_38	[p4l10t465r349b529],

1	Alternative	JJ	O	alternative	amod	2	SENT_39	[p4l405t465r800b529],
2	agents	NNS	O	agent	nsubj	13	SENT_39	[p4l855t474r1075b546],
3	can	MD	O	can	aux	4	SENT_39	[p4l1131t485r1251b529],
4	have	VB	O	have	_	0	SENT_39	[p4l1301t465r1467b529],
5	greater	JJR	O	greater	amod	6	SENT_39	[p4l1521t474r1765b546],
6	problems	NNS	O	problem	dobj	4	SENT_39	[p4l1812t465r2140b546],
7	with	IN	O	with	_	0	SENT_39	[p4l7t576r164b640],
8	toxicity	NN	O	toxicity	prep_with	6	SENT_39	[p4l211t576r481b657],
9	and	CC	O	and	_	0	SENT_39	[p4l530t576r656b640],
10	are	VBP	O	be	cop	13	SENT_39	[p4l705t596r807b640],
11	often	RB	O	often	advmod	13	SENT_39	[p4l857t576r1036b640],
12	less	RBR	O	less	advmod	13	SENT_39	[p4l1085t576r1212b640],
13	effective	JJ	O	effective	conj_and	4	SENT_39	[p4l1264t576r1586b653],
14	,	,	O	,	_	0	SENT_39	[p4l1264t576r1586b653],
15	and	CC	O	and	_	0	SENT_39	[p4l1639t576r1765b640],
16	treatment	NN	O	treatment	nsubj	19	SENT_39	[p4l1811t584r2144b640],
17	could	MD	O	could	aux	19	SENT_39	[p4l10t687r204b751],
18	be	VB	O	be	cop	19	SENT_39	[p4l239t687r322b751],
19	prolonged	JJ	O	prolonged	conj_and	4	SENT_39	[p4l358t687r719b769],
20	despite	IN	O	despite	_	0	SENT_39	[p4l757t687r1003b769],
21	attendant	JJ	O	attendant	amod	22	SENT_39	[p4l1043t687r1365b751],
22	challenges	NNS	O	challenge	prep_despite	19	SENT_39	[p4l1402t687r1771b769],
23	to	TO	O	to	aux	24	SENT_39	[p4l1809t696r1874b751],
24	ensure	VB	O	ensure	xcomp	19	SENT_39	[p4l1915t708r2141b751],
25	compliance	NN	O	compliance	dobj	24	SENT_39	[p4l10t798r432b880],
26	.	.	O	.	_	0	SENT_39	[p4l10t798r432b880],

1	As	IN	O	as	_	0	SENT_40	[p4l476t799r572b862],
2	a	DT	O	a	det	3	SENT_40	[p4l616t819r653b862],
3	result	NN	O	result	prep_as	15	SENT_40	[p4l691t798r904b876],
4	,	,	O	,	_	0	SENT_40	[p4l691t798r904b876],
5	the	DT	O	the	det	6	SENT_40	[p4l948t798r1053b862],
6	risk	NN	O	risk	nsubj	15	SENT_40	[p4l1094t798r1227b862],
7	of	IN	O	of	_	0	SENT_40	[p4l1267t798r1348b862],
8	treatment	NN	O	treatment	nn	9	SENT_40	[p4l1377t807r1710b862],
9	failure	NN	O	failure	prep_of	6	SENT_40	[p4l1750t798r1974b862],
10	and	CC	O	and	_	0	SENT_40	[p4l2018t798r2143b862],
11	relapse	NN	O	relapse	conj_and	9	SENT_40	[p4l7t909r256b991],
12	would	MD	O	would	aux	15	SENT_40	[p4l293t909r516b973],
13	become	VB	O	become	cop	15	SENT_40	[p4l552t909r826b973],
14	even	RB	O	even	advmod	15	SENT_40	[p4l867t929r1032b973],
15	higher	JJR	O	higher	_	0	SENT_40	[p4l1069t909r1306b991],
16	.	.	O	.	_	0	SENT_40	[p4l1069t909r1306b991],

1	Therefore	RB	O	therefore	advmod	21	SENT_41	[p4l1351t909r1715b986],
2	,	,	O	,	_	0	SENT_41	[p4l1351t909r1715b986],
3	individualized	VBN	O	individualize	csubj	21	SENT_41	[p4l1757t909r2141b973, p4l9t1020r154b1084],
4	drug	NN	O	drug	nn	5	SENT_41	[p4l194t1020r353b1102],
5	management	NN	O	management	dobj	3	SENT_41	[p4l393t1029r846b1102],
6	using	VBG	O	use	partmod	5	SENT_41	[p4l882t1020r1074b1102],
7	four	CD	NUMBER	four	num	9	SENT_41	[p4l1116t1021r1262b1084],
8	standard	JJ	O	standard	amod	9	SENT_41	[p4l1302t1020r1598b1084],
9	drugs	NNS	O	drug	dobj	6	SENT_41	[p4l1638t1020r1830b1102],
10	to	TO	O	to	aux	11	SENT_41	[p4l1871t1029r1936b1084],
11	minimize	VB	O	minimize	xcomp	6	SENT_41	[p4l1977t1020r2141b1083, p4l9t1131r201b1195],
12	the	DT	O	the	det	13	SENT_41	[p4l237t1131r343b1195],
13	incidence	NN	O	incidence	dobj	11	SENT_41	[p4l381t1131r716b1195],
14	of	IN	O	of	_	0	SENT_41	[p4l754t1131r835b1195],
15	adverse	JJ	O	adverse	amod	17	SENT_41	[p4l862t1131r1128b1195],
16	drug	NN	O	drug	nn	17	SENT_41	[p4l1165t1131r1324b1213],
17	reactions	NNS	O	reaction	prep_of	13	SENT_41	[p4l1359t1131r1676b1195],
18	is	VBZ	O	be	cop	21	SENT_41	[p4l1714t1131r1768b1195],
19	an	DT	O	a	det	21	SENT_41	[p4l1807t1152r1888b1195],
20	unmet	JJ	O	unmet	amod	21	SENT_41	[p4l1921t1140r2144b1195],
21	need	NN	O	need	_	0	SENT_41	[p4l7t1242r175b1306],
22	in	IN	O	in	_	0	SENT_41	[p4l213t1242r279b1305],
23	the	DT	O	the	det	26	SENT_41	[p4l316t1242r422b1306],
24	present	JJ	DATE	present	amod	26	SENT_41	[p4l459t1251r716b1324],
25	clinical	JJ	O	clinical	amod	26	SENT_41	[p4l754t1242r1009b1306],
26	circumstances	NNS	O	circumstance	prep_in	21	SENT_41	[p4l1049t1242r1562b1306],
27	.	.	O	.	_	0	SENT_41	[p4l1049t1242r1562b1306],

1	Isoniazid	NN	O	isoniazid	nn	4	SENT_42	[p4l111t1353r434b1417],
2	(	CD	NUMBER	(	num	4	SENT_42	[p4l467t1353r696b1434],
3	INH	NN	O	inh	nn	4	SENT_42	[p4l467t1353r696b1434],
4	)	NN	O	)	nsubjpass	20	SENT_42	[p4l467t1353r696b1434],
5	,	,	O	,	_	0	SENT_42	[p4l467t1353r696b1434],
6	a	DT	O	a	det	8	SENT_42	[p4l734t1373r771b1416],
7	key	JJ	O	key	amod	8	SENT_42	[p4l800t1353r928b1434],
8	drug	NN	O	drug	appos	4	SENT_42	[p4l961t1353r1119b1434],
9	of	IN	O	of	_	0	SENT_42	[p4l1154t1353r1235b1417],
10	the	DT	O	the	det	13	SENT_42	[p4l1255t1353r1360b1417],
11	currently	RB	DATE	currently	advmod	13	SENT_42	[p4l1395t1353r1710b1434],
12	recommended	VBN	O	recommend	amod	13	SENT_42	[p4l1741t1373r2140b1417, p4l10t1464r136b1528],
13	regimen	NN	O	regimen	prep_of	8	SENT_42	[p4l170t1464r460b1545],
14	for	IN	O	for	_	0	SENT_42	[p4l498t1464r598b1528],
15	patients	NNS	O	patient	prep_for	13	SENT_42	[p4l631t1464r904b1545],
16	with	IN	O	with	_	0	SENT_42	[p4l941t1464r1098b1528],
17	tuberculosis	NN	O	tuberculosis	prep_with	15	SENT_42	[p4l1133t1464r1578b1541],
18	,	,	O	,	_	0	SENT_42	[p4l1133t1464r1578b1541],
19	is	VBZ	O	be	auxpass	20	SENT_42	[p4l1620t1464r1674b1528],
20	metabolized	VBN	O	metabolize	_	0	SENT_42	[p4l1711t1464r2143b1528],
21	by	IN	O	by	_	0	SENT_42	[p4l7t1575r96b1656],
22	genetically	RB	O	genetically	advmod	23	SENT_42	[p4l139t1575r524b1656],
23	polymorphic	JJ	O	polymorphic	amod	24	SENT_42	[p4l565t1575r1017b1656],
24	N-acetyltransferase	NN	O	n-acetyltransferase	agent	20	SENT_42	[p4l1058t1575r1740b1656],
25	2	CD	NUMBER	2	number	26	SENT_42	[p4l1784t1576r1823b1637],
26	(	CD	NUMBER	(	num	24	SENT_42	[p4l1871t1575r2140b1656],
27	NAT2	NN	O	nat2	dep	24	SENT_42	[p4l1871t1575r2140b1656],
28	)	CD	NUMBER	)	num	27	SENT_42	[p4l1871t1575r2140b1656],
29	[	CD	NUMBER	[	number	30	SENT_42	[p4l14t1687r160b1766],
30	9	CD	NUMBER	9	num	34	SENT_42	[p4l14t1687r160b1766],
31	—	NN	O	—	nn	34	SENT_42	[p4l14t1687r160b1766],
32	l	NN	O	l	nn	34	SENT_42	[p4l14t1687r160b1766],
33	l	NN	O	l	nn	34	SENT_42	[p4l178t1687r257b1767],
34	]	NN	O	]	dep	27	SENT_42	[p4l178t1687r257b1767],
35	.	.	O	.	_	0	SENT_42	[p4l178t1687r257b1767],

1	The	DT	O	the	det	2	SENT_43	[p4l290t1686r424b1750],
2	rate	NN	O	rate	nsubjpass	9	SENT_43	[p4l451t1695r580b1750],
3	of	IN	O	of	_	0	SENT_43	[p4l610t1686r691b1750],
4	elimination	NN	O	elimination	prep_of	2	SENT_43	[p4l708t1686r1108b1750],
5	of	IN	O	of	_	0	SENT_43	[p4l1135t1686r1216b1750],
6	INH	NN	O	inh	prep_of	4	SENT_43	[p4l1232t1689r1386b1750],
7	is	VBZ	O	be	auxpass	9	SENT_43	[p4l1415t1686r1468b1750],
8	trimodally	RB	O	trimodally	advmod	9	SENT_43	[p4l1497t1686r1863b1768],
9	distributed	VBN	O	distribute	dep	37	SENT_43	[p4l1891t1686r2141b1750, p4l7t1797r160b1861],
10	in	IN	O	in	_	0	SENT_43	[p4l193t1797r259b1860],
11	accordance	NN	O	accordance	prep_in	9	SENT_43	[p4l293t1797r686b1861],
12	with	IN	O	with	_	0	SENT_43	[p4l719t1797r876b1861],
13	NAT2	NN	O	nat2	nn	15	SENT_43	[p4l905t1798r1121b1861],
14	metabolic	JJ	O	metabolic	amod	15	SENT_43	[p4l1156t1797r1502b1861],
15	activity	NN	O	activity	prep_with	9	SENT_43	[p4l1537t1797r1799b1879],
16	[	CD	NUMBER	[	number	17	SENT_43	[p4l1837t1798r1967b1877],
17	12	CD	NUMBER	12	dep	15	SENT_43	[p4l1837t1798r1967b1877],
18	,	,	O	,	_	0	SENT_43	[p4l1837t1798r1967b1877],
19	13	CD	NUMBER	13	num	20	SENT_43	[p4l2011t1798r2138b1878],
20	]	NN	O	]	appos	15	SENT_43	[p4l2011t1798r2138b1878],
21	;	:	O	;	_	0	SENT_43	[p4l2011t1798r2138b1878],
22	NAT2	NN	O	nat2	nn	24	SENT_43	[p4l6t1910r222b1972],
23	activity	NN	O	activity	nn	24	SENT_43	[p4l257t1908r518b1990],
24	status	NN	O	status	nsubj	30	SENT_43	[p4l553t1917r747b1972],
25	is	VBZ	O	be	auxpass	27	SENT_43	[p4l781t1908r835b1972],
26	genetically	RB	O	genetically	advmod	27	SENT_43	[p4l869t1908r1254b1990],
27	controlled	VBN	O	control	parataxis	9	SENT_43	[p4l1286t1908r1643b1972],
28	and	CC	O	and	_	0	SENT_43	[p4l1675t1908r1800b1972],
29	basically	RB	O	basically	advmod	30	SENT_43	[p4l1829t1908r2143b1990],
30	depends	VBZ	O	depend	conj_and	27	SENT_43	[p4l10t2019r296b2101],
31	on	IN	O	on	_	0	SENT_43	[p4l327t2040r414b2083],
32	the	DT	O	the	det	33	SENT_43	[p4l440t2019r546b2083],
33	number	NN	O	number	prep_on	30	SENT_43	[p4l573t2019r846b2083],
34	of	IN	O	of	_	0	SENT_43	[p4l872t2019r954b2083],
35	active	JJ	O	active	amod	36	SENT_43	[p4l972t2019r1178b2083],
36	alleles	NNS	O	allele	prep_of	33	SENT_43	[p4l1207t2019r1427b2083],
37	(	VBP	O	(	_	0	SENT_43	[p4l1458t2020r1653b2101],
38	NAT	NN	ORGANIZATION	nat	dobj	37	SENT_43	[p4l1458t2020r1653b2101],
39	2	CD	NUMBER	2	num	38	SENT_43	[p4l1645t2019r1777b2083],
40	*	CD	NUMBER	*	number	41	SENT_43	[p4l1645t2019r1777b2083],
41	4	CD	NUMBER	4	dep	38	SENT_43	[p4l1645t2019r1777b2083],
42	and	CC	O	and	_	0	SENT_43	[p4l1807t2019r1932b2083],
43	*	CD	NUMBER	*	number	44	SENT_43	[p4l1964t2019r2040b2082],
44	1	CD	NUMBER	1	conj_and	41	SENT_43	[p4l1964t2019r2040b2082],
45	2	CD	NUMBER	2	num	46	SENT_43	[p4l2049t2020r2137b2101],
46	)	NN	O	)	nsubj	37	SENT_43	[p4l2049t2020r2137b2101],
47	.	.	O	.	_	0	SENT_43	[p4l2049t2020r2137b2101],

1	Previous	JJ	O	previous	amod	2	SENT_44	[p4l8t2130r321b2194],
2	findings	NNS	O	finding	nsubj	3	SENT_44	[p4l372t2130r664b2212],
3	indicate	VBP	O	indicate	_	0	SENT_44	[p4l714t2130r997b2194],
4	that	IN	O	that	complm	9	SENT_44	[p4l1045t2130r1180b2194],
5	a	DT	O	a	det	7	SENT_44	[p4l1227t2151r1264b2194],
6	genetic	JJ	O	genetic	amod	7	SENT_44	[p4l1311t2130r1567b2212],
7	polymorphism	NN	O	polymorphism	nsubjpass	9	SENT_44	[p4l1614t2130r2144b2212],
8	is	VBZ	O	be	auxpass	9	SENT_44	[p4l10t2241r64b2305],
9	associated	VBN	O	associate	ccomp	3	SENT_44	[p4l106t2241r475b2305],
10	with	IN	O	with	_	0	SENT_44	[p4l511t2241r671b2305],
11	large	JJ	O	large	amod	13	SENT_44	[p4l710t2241r885b2323],
12	interindividual	JJ	O	interindividual	amod	13	SENT_44	[p4l924t2241r1455b2305],
13	differences	NNS	O	difference	prep_with	9	SENT_44	[p4l1495t2241r1889b2305],
14	in	IN	O	in	_	0	SENT_44	[p4l1930t2241r1997b2303],
15	the	DT	O	the	det	16	SENT_44	[p4l2034t2241r2141b2305],
16	toxicity	NN	O	toxicity	prep_in	13	SENT_44	[p4l8t2352r284b2433],
17	and	CC	O	and	_	0	SENT_44	[p4l329t2352r457b2416],
18	efﬁcacy	NN	O	efﬁcacy	prep_in	13	SENT_44	[p4l502t2352r788b2433],
19	of	IN	O	of	_	0	SENT_44	[p4l833t2352r915b2416],
20	INH	NN	O	inh	prep_of	16	SENT_44	[p4l948t2354r1105b2415],
21	[	CD	NUMBER	[	number	22	SENT_44	[p4l1156t2353r1452b2432],
22	13	CD	NUMBER	13	dep	20	SENT_44	[p4l1156t2353r1452b2432],
23	—	CD	NUMBER	—	num	25	SENT_44	[p4l1156t2353r1452b2432],
24	l9	NN	O	l9	nn	25	SENT_44	[p4l1156t2353r1452b2432],
25	]	NN	O	]	dep	22	SENT_44	[p4l1156t2353r1452b2432],
26	.	.	O	.	_	0	SENT_44	[p4l1156t2353r1452b2432],

1	Slow	JJ	O	slow	amod	2	SENT_45	[p4l1507t2352r1686b2416],
2	acetylators	NNS	O	acetylator	nsubj	10	SENT_45	[p4l1732t2352r2140b2433],
3	,	,	O	,	_	0	SENT_45	[p4l1732t2352r2140b2433],
4	patients	NNS	O	patient	appos	2	SENT_45	[p4l7t2463r286b2544],
5	without	IN	O	without	_	0	SENT_45	[p4l329t2463r606b2527],
6	any	DT	O	any	det	8	SENT_45	[p4l648t2483r775b2544],
7	active	JJ	O	active	amod	8	SENT_45	[p4l818t2463r1029b2527],
8	alleles	NNS	O	allele	prep_without	4	SENT_45	[p4l1074t2463r1320b2540],
9	,	,	O	,	_	0	SENT_45	[p4l1074t2463r1320b2540],
10	develop	VBP	O	develop	_	0	SENT_45	[p4l1367t2463r1648b2544],
11	hepatotoxicity	NN	O	hepatotoxicity	dobj	10	SENT_45	[p4l1691t2463r2141b2544, p4l9t2574r102b2656],
12	more	RBR	O	more	advmod	13	SENT_45	[p4l145t2595r328b2638],
13	often	RB	O	often	advmod	10	SENT_45	[p4l374t2574r556b2638],
14	than	IN	O	than	_	0	SENT_45	[p4l600t2574r754b2638],
15	rapid	JJ	O	rapid	amod	16	SENT_45	[p4l797t2574r982b2656],
16	acetylators	NNS	O	acetylator	prep_than	13	SENT_45	[p4l1027t2574r1435b2656],
17	,	,	O	,	_	0	SENT_45	[p4l1027t2574r1435b2656],
18	patients	NNS	O	patient	appos	16	SENT_45	[p4l1481t2574r1760b2656],
19	with	IN	O	with	_	0	SENT_45	[p4l1806t2574r1965b2638],
20	two	CD	NUMBER	two	num	22	SENT_45	[p4l2008t2583r2140b2638],
21	active	JJ	O	active	amod	22	SENT_45	[p4l10t2685r221b2749],
22	alleles	NNS	O	allele	prep_with	18	SENT_45	[p4l265t2685r512b2762],
23	,	,	O	,	_	0	SENT_45	[p4l265t2685r512b2762],
24	during	IN	O	during	_	0	SENT_45	[p4l559t2685r791b2767],
25	treatment	NN	O	treatment	prep_during	13	SENT_45	[p4l833t2694r1173b2749],
26	for	IN	O	for	_	0	SENT_45	[p4l1216t2685r1318b2749],
27	tuberculosis	NN	O	tuberculosis	prep_for	25	SENT_45	[p4l1357t2685r1792b2749],
28	with	IN	O	with	_	0	SENT_45	[p4l1834t2685r1994b2749],
29	the	DT	O	the	prep_with	27	SENT_45	[p4l2035t2685r2142b2749],

1	5	CD	NUMBER	5	_	0	SENT_46	[p4l7t2919r80b3009],
2	;	:	O	;	_	0	SENT_46	[p4l7t2919r80b3009],
3	Springer	NNP	PERSON	Springer	nn	5	SENT_46	[p4l105t2942r350b3012],
4	standard	JJ	O	standard	amod	5	SENT_46	[p4l13t3038r316b3102],
5	regimen	NN	O	regimen	dep	1	SENT_46	[p4l356t3038r651b3120],
6	[	CD	NUMBER	[	num	7	SENT_46	[p4l699t3039r832b3118],
7	18	CD	NUMBER	18	dep	1	SENT_46	[p4l699t3039r832b3118],
8	,	,	O	,	_	0	SENT_46	[p4l699t3039r832b3118],
9	19	CD	NUMBER	19	num	10	SENT_46	[p4l887t3039r1014b3118],
10	]	NN	O	]	appos	1	SENT_46	[p4l887t3039r1014b3118],
11	.	.	O	.	_	0	SENT_46	[p4l887t3039r1014b3118],

1	In	IN	O	in	_	0	SENT_47	[p4l1063t3040r1135b3101],
2	contrast	NN	O	contrast	prep_in	7	SENT_47	[p4l1179t3047r1480b3115],
3	,	,	O	,	_	0	SENT_47	[p4l1179t3047r1480b3115],
4	rapid	JJ	O	rapid	amod	5	SENT_47	[p4l1526t3038r1711b3120],
5	acetylators	NNS	O	acetylator	nsubj	7	SENT_47	[p4l1755t3038r2139b3120],
6	are	VBP	O	be	cop	7	SENT_47	[p4l12t3170r116b3213],
7	prone	JJ	O	prone	_	0	SENT_47	[p4l155t3170r360b3231],
8	to	TO	O	to	_	0	SENT_47	[p4l400t3158r467b3213],
9	treatment	NN	O	treatment	nn	10	SENT_47	[p4l509t3158r847b3213],
10	failure	NN	O	failure	prep_to	7	SENT_47	[p4l888t3149r1117b3213],
11	with	IN	O	with	_	0	SENT_47	[p4l1157t3149r1317b3213],
12	the	DT	O	the	det	14	SENT_47	[p4l1356t3149r1463b3213],
13	standard	JJ	O	standard	amod	14	SENT_47	[p4l1507t3149r1809b3213],
14	regimen	NN	O	regimen	prep_with	10	SENT_47	[p4l1847t3149r2142b3231],
15	[	CD	NUMBER	[	num	16	SENT_47	[p4l16t3262r315b3341],
16	l3	NN	O	l3	dep	10	SENT_47	[p4l16t3262r315b3341],
17	—	CD	NUMBER	—	num	19	SENT_47	[p4l16t3262r315b3341],
18	l6	NN	O	l6	nn	19	SENT_47	[p4l16t3262r315b3341],
19	]	NN	O	]	dep	16	SENT_47	[p4l16t3262r315b3341],
20	,	,	O	,	_	0	SENT_47	[p4l16t3262r315b3341],
21	probably	RB	O	probably	advmod	10	SENT_47	[p4l364t3260r686b3342],
22	due	JJ	O	due	amod	24	SENT_47	[p4l734t3260r859b3324],
23	to	TO	O	to	dep	24	SENT_47	[p4l907t3269r973b3324],
24	insufficient	JJ	O	insufficient	amod	25	SENT_47	[p4l1023t3260r1430b3324],
25	exposure	NN	O	exposure	dep	10	SENT_47	[p4l1478t3281r1799b3342],
26	to	TO	O	to	_	0	SENT_47	[p4l1847t3269r1912b3324],
27	INH	NN	O	inh	prep_to	25	SENT_47	[p4l1962t3263r2136b3324],
28	.	.	O	.	_	0	SENT_47	[p4l1962t3263r2136b3324],

1	These	DT	O	these	det	2	SENT_48	[p4l11t3371r223b3435],
2	observations	NNS	O	observation	nsubj	13	SENT_48	[p4l281t3371r734b3435],
3	imply	VBP	O	imply	rcmod	2	SENT_48	[p4l793t3371r1000b3453],
4	that	IN	O	that	complm	9	SENT_48	[p4l1054t3371r1189b3435],
5	current	JJ	DATE	current	amod	6	SENT_48	[p4l1245t3380r1497b3435],
6	dosage	NN	O	dosage	nsubj	9	SENT_48	[p4l1553t3371r1800b3453],
7	of	IN	O	of	_	0	SENT_48	[p4l1858t3371r1940b3435],
8	INH	NNP	O	INH	prep_of	6	SENT_48	[p4l1986t3374r2141b3435],
9	recommended	VBD	O	recommend	ccomp	3	SENT_48	[p4l9t3482r520b3546],
10	intemationally	RB	O	intemationally	advmod	13	SENT_48	[p4l565t3482r1090b3563],
11	is	VBZ	O	be	cop	13	SENT_48	[p4l1135t3482r1189b3546],
12	too	RB	O	too	advmod	13	SENT_48	[p4l1235t3491r1347b3546],
13	much	JJ	O	much	_	0	SENT_48	[p4l1393t3482r1592b3546],
14	for	IN	O	for	_	0	SENT_48	[p4l1638t3482r1740b3546],
15	slow	JJ	O	slow	amod	16	SENT_48	[p4l1785t3482r1951b3546],
16	acetylators	NNS	O	acetylator	prep_for	13	SENT_48	[p4l1997t3502r2140b3546, p4l10t3593r277b3674],
17	and	CC	O	and	_	0	SENT_48	[p4l327t3593r455b3657],
18	insufﬁcient	NN	O	insufﬁcient	conj_and	16	SENT_48	[p4l501t3593r909b3657],
19	for	IN	O	for	_	0	SENT_48	[p4l956t3593r1059b3657],
20	rapid	JJ	O	rapid	amod	21	SENT_48	[p4l1102t3593r1288b3674],
21	acetylators	NNS	O	acetylator	prep_for	13	SENT_48	[p4l1335t3593r1739b3674],
22	.	.	O	.	_	0	SENT_48	[p4l1335t3593r1739b3674],

1	Thus	RB	O	thus	advmod	5	SENT_49	[p4l1792t3593r1990b3670],
2	,	,	O	,	_	0	SENT_49	[p4l1792t3593r1990b3670],
3	we	PRP	O	we	nsubj	5	SENT_49	[p4l2039t3613r2141b3657],
4	should	MD	O	should	aux	5	SENT_49	[p4l13t3704r252b3768],
5	assume	VB	O	assume	_	0	SENT_49	[p4l301t3724r561b3768],
6	that	IN	O	that	_	0	SENT_49	[p4l609t3704r744b3767],
7	pharmacogenetically	RB	O	pharmacogenetically	advmod	8	SENT_49	[p4l788t3704r1541b3785],
8	stratiﬁed	JJ	O	stratiﬁed	amod	9	SENT_49	[p4l1592t3704r1908b3768],
9	treatment	NN	O	treatment	prep_that	5	SENT_49	[p4l1954t3712r2140b3768, p5l10t30r190b85],

1	has	VBZ	O	have	_	0	SENT_50	[p5l238t21r354b85],
2	the	DT	O	the	det	3	SENT_50	[p5l406t21r510b85],
3	potential	JJ	O	potential	dobj	1	SENT_50	[p5l540t21r839b103],
4	to	TO	O	to	aux	5	SENT_50	[p5l870t30r934b85],
5	avoid	VB	O	avoid	dep	3	SENT_50	[p5l970t21r1160b85],
6	unfavorable	JJ	O	unfavorable	amod	7	SENT_50	[p5l1189t21r1597b85],
7	outcomes	NNS	O	outcome	dobj	5	SENT_50	[p5l1631t30r1956b85],
8	with	IN	O	with	_	0	SENT_50	[p5l1989t21r2142b85],
9	improvements	NNS	O	improvement	prep_with	5	SENT_50	[p5l11t132r499b214],
10	in	IN	O	in	_	0	SENT_50	[p5l527t132r592b195],
11	the	DT	O	the	det	13	SENT_50	[p5l615t132r719b196],
12	cure	NN	O	cure	nn	13	SENT_50	[p5l745t153r889b196],
13	rate	NN	O	rate	prep_in	9	SENT_50	[p5l913t141r1056b196],
14	.	.	O	.	_	0	SENT_50	[p5l913t141r1056b196],

1	Before	IN	O	before	_	0	SENT_51	[p5l112t243r354b307],
2	the	DT	O	the	det	3	SENT_51	[p5l391t243r499b307],
3	start	NN	O	start	prep_before	21	SENT_51	[p5l539t252r690b307],
4	of	IN	O	of	_	0	SENT_51	[p5l727t243r809b307],
5	a	DT	O	a	det	8	SENT_51	[p5l837t264r874b306],
6	prospective	JJ	O	prospective	amod	8	SENT_51	[p5l907t243r1323b325],
7	clinical	JJ	O	clinical	amod	8	SENT_51	[p5l1362t243r1623b307],
8	trial	NN	O	trial	prep_of	3	SENT_51	[p5l1660t243r1803b306],
9	with	IN	O	with	_	0	SENT_51	[p5l1839t243r1998b307],
10	the	DT	O	the	det	14	SENT_51	[p5l2034t243r2141b307],
11	NAT	NNP	ORGANIZATION	NAT	dep	13	SENT_51	[p5l7t356r180b419],
12	2	CD	NUMBER	2	num	11	SENT_51	[p5l174t356r215b417],
13	genotype-guided	JJ	O	genotype-guided	amod	14	SENT_51	[p5l258t354r865b436],
14	regimen	NNS	O	regimen	prep_with	8	SENT_51	[p5l904t354r1218b436],
15	,	,	O	,	_	0	SENT_51	[p5l904t354r1218b436],
16	dose-ﬁnding	JJ	O	dose-ﬁnding	amod	18	SENT_51	[p5l1264t354r1718b436],
17	pharmacokinetic	JJ	O	pharmacokinetic	amod	18	SENT_51	[p5l1757t354r2140b436, p5l10t465r253b529],
18	studies	NNS	O	study	nsubjpass	21	SENT_51	[p5l295t465r540b529],
19	were	VBD	O	be	auxpass	21	SENT_51	[p5l579t486r751b529],
20	independently	RB	O	independently	advmod	21	SENT_51	[p5l792t465r1303b547],
21	carried	VBN	O	carry	_	0	SENT_51	[p5l1342t465r1588b529],
22	out	RP	O	out	prt	21	SENT_51	[p5l1627t474r1740b529],
23	in	IN	O	in	_	0	SENT_51	[p5l1779t465r1846b528],
24	Europe	NNP	LOCATION	Europe	prep_in	21	SENT_51	[p5l1884t468r2141b547],
25	and	CC	O	and	_	0	SENT_51	[p5l12t576r140b640],
26	Japan	NNP	LOCATION	Japan	prep_in	21	SENT_51	[p5l178t579r381b658],
27	to	TO	O	to	aux	28	SENT_51	[p5l420t585r486b640],
28	expect	VB	O	expect	xcomp	21	SENT_51	[p5l529t585r762b658],
29	appropriate	JJ	O	appropriate	amod	31	SENT_51	[p5l801t576r1207b658],
30	clinical	JJ	O	clinical	amod	31	SENT_51	[p5l1249t576r1510b640],
31	dosages	NNS	O	dosage	dobj	28	SENT_51	[p5l1551t576r1833b658],
32	of	IN	O	of	_	0	SENT_51	[p5l1874t576r1956b640],
33	INH	NN	O	inh	prep_of	31	SENT_51	[p5l1985t579r2141b640],
34	for	IN	O	for	_	0	SENT_51	[p5l12t687r115b751],
35	each	DT	O	each	det	37	SENT_51	[p5l159t687r321b751],
36	NAT2	NN	O	nat2	nn	37	SENT_51	[p5l361t688r568b751],
37	genotype	NN	O	genotype	prep_for	28	SENT_51	[p5l616t695r945b768],
38	[	CD	NUMBER	[	number	39	SENT_51	[p5l996t688r1128b767],
39	20	CD	NUMBER	20	dep	37	SENT_51	[p5l996t688r1128b767],
40	,	,	O	,	_	0	SENT_51	[p5l996t688r1128b767],
41	21	CD	NUMBER	21	num	42	SENT_51	[p5l1177t688r1312b767],
42	]	NN	O	]	appos	37	SENT_51	[p5l1177t688r1312b767],
43	.	.	O	.	_	0	SENT_51	[p5l1177t688r1312b767],

1	Based	VBN	O	base	_	0	SENT_52	[p5l1362t687r1582b751],
2	on	IN	O	on	prepc_based_on	19	SENT_52	[p5l1627t707r1714b751],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_52	[p5l1756t687r2140b768, p5l10t798r260b862],
4	parameters	NNS	O	parameter	pobj	19	SENT_52	[p5l318t806r720b879],
5	estimated	VBN	O	estimate	partmod	4	SENT_52	[p5l783t798r1135b862],
6	from	IN	O	from	_	0	SENT_52	[p5l1194t798r1369b862],
7	these	DT	O	these	det	9	SENT_52	[p5l1426t798r1613b862],
8	dose-ﬁnding	JJ	O	dose-ﬁnding	amod	9	SENT_52	[p5l1675t798r2141b879],
9	studies	NNS	O	study	prep_from	5	SENT_52	[p5l13t909r280b986],
10	,	,	O	,	_	0	SENT_52	[p5l13t909r280b986],
11	a	DT	O	a	det	13	SENT_52	[p5l335t929r371b972],
12	genotype-based	JJ	O	genotype-based	amod	13	SENT_52	[p5l420t909r986b991],
13	dosage	NN	O	dosage	nsubjpass	19	SENT_52	[p5l1035t909r1282b990],
14	for	IN	O	for	_	0	SENT_52	[p5l1334t909r1437b973],
15	the	DT	O	the	det	17	SENT_52	[p5l1482t909r1590b973],
16	present	JJ	DATE	present	amod	17	SENT_52	[p5l1638t918r1900b990],
17	study	NN	O	study	prep_for	13	SENT_52	[p5l1950t909r2143b990],
18	was	VBD	O	be	auxpass	19	SENT_52	[p5l9t1041r146b1083],
19	determined	VBN	O	determine	_	0	SENT_52	[p5l194t1020r597b1083],
20	as	IN	O	as	mark	21	SENT_52	[p5l642t1040r710b1083],
21	follows	VBZ	O	follow	advcl	19	SENT_52	[p5l758t1020r1047b1097],
22	;	:	O	;	_	0	SENT_52	[p5l758t1020r1047b1097],
23	half	PDT	O	half	predet	27	SENT_52	[p5l1094t1020r1244b1083],
24	the	DT	O	the	det	27	SENT_52	[p5l1276t1020r1383b1083],
25	standard	JJ	O	standard	amod	27	SENT_52	[p5l1431t1020r1734b1083],
26	INH	NN	O	inh	nn	27	SENT_52	[p5l1777t1023r1933b1083],
27	dose	NN	O	dose	dobj	21	SENT_52	[p5l1980t1020r2141b1083],
28	for	IN	O	for	_	0	SENT_52	[p5l12t1130r116b1194],
29	slow	JJ	O	slow	amod	30	SENT_52	[p5l173t1130r340b1194],
30	acetylators	NNS	O	acetylator	prep_for	27	SENT_52	[p5l398t1130r808b1212],
31	,	,	O	,	_	0	SENT_52	[p5l398t1130r808b1212],
32	1.5	CD	NUMBER	1.5	number	33	SENT_52	[p5l878t1131r975b1194],
33	times	NNS	O	time	num	36	SENT_52	[p5l1037t1130r1229b1194],
34	the	DT	O	the	det	36	SENT_52	[p5l1287t1130r1396b1194],
35	standard	JJ	O	standard	amod	36	SENT_52	[p5l1456t1130r1761b1194],
36	dose	NN	O	dose	appos	27	SENT_52	[p5l1818t1130r1980b1194],
37	for	IN	O	for	_	0	SENT_52	[p5l2041t1130r2144b1194],
38	rapid	JJ	O	rapid	amod	39	SENT_52	[p5l9t1241r195b1323],
39	acetylators	NNS	O	acetylator	prep_for	36	SENT_52	[p5l236t1241r642b1323],
40	,	,	O	,	_	0	SENT_52	[p5l236t1241r642b1323],
41	and	CC	O	and	_	0	SENT_52	[p5l687t1241r816b1305],
42	the	DT	O	the	det	44	SENT_52	[p5l854t1241r961b1305],
43	standard	JJ	O	standard	amod	44	SENT_52	[p5l1005t1241r1308b1305],
44	dose	NN	O	dose	dobj	21	SENT_52	[p5l1349t1241r1510b1305],
45	for	IN	O	for	_	0	SENT_52	[p5l1553t1241r1656b1305],
46	intermediate	JJ	O	intermediate	amod	47	SENT_52	[p5l1695t1241r2141b1305],
47	acetylators	NNS	O	acetylator	prep_for	44	SENT_52	[p5l12t1352r417b1434],
48	.	.	O	.	_	0	SENT_52	[p5l12t1352r417b1434],

1	Here	RB	O	here	advmod	4	SENT_53	[p5l112t1466r301b1541],
2	,	,	O	,	_	0	SENT_53	[p5l112t1466r301b1541],
3	we	PRP	O	we	nsubj	4	SENT_53	[p5l347t1484r448b1527],
4	report	VBP	O	report	_	0	SENT_53	[p5l493t1472r703b1545],
5	outcomes	NNS	O	outcome	dobj	4	SENT_53	[p5l748t1472r1082b1527],
6	of	IN	O	of	_	0	SENT_53	[p5l1129t1463r1210b1527],
7	a	DT	O	a	prep_of	5	SENT_53	[p5l1245t1484r1282b1527],
8	randomized	VBN	O	randomize	partmod	7	SENT_53	[p5l1324t1463r1741b1527],
9	controlled	JJ	O	controlled	amod	10	SENT_53	[p5l1787t1463r2143b1527],
10	trial	NN	O	trial	dobj	8	SENT_53	[p5l10t1574r148b1638],
11	for	IN	O	for	_	0	SENT_53	[p5l187t1574r288b1638],
12	pharmacogenetics-based	JJ	O	pharmacogenetics-based	amod	17	SENT_53	[p5l319t1574r1190b1656],
13	tuberculosis	NN	O	tuberculosis	nn	17	SENT_53	[p5l1224t1574r1648b1638],
14	therapy	NN	O	therapy	nn	17	SENT_53	[p5l1685t1574r1949b1656],
15	(	CD	NUMBER	(	num	17	SENT_53	[p5l1986t1574r2140b1656, p5l10t1685r258b1766],
16	RTPGTT	NN	O	rtpgtt	nn	17	SENT_53	[p5l1986t1574r2140b1656, p5l10t1685r258b1766],
17	)	NN	O	)	prep_for	8	SENT_53	[p5l1986t1574r2140b1656, p5l10t1685r258b1766],
18	conducted	VBN	O	conduct	partmod	17	SENT_53	[p5l308t1685r671b1749],
19	in	IN	O	in	_	0	SENT_53	[p5l719t1685r785b1747],
20	Japan	NNP	LOCATION	Japan	nn	22	SENT_53	[p5l833t1687r1033b1766],
21	(	CD	NUMBER	(	num	22	SENT_53	[p5l1082t1685r1745b1766],
22	ClinicalTrials	NNS	O	clinicaltrial	prep_in	18	SENT_53	[p5l1082t1685r1745b1766],
23	.	.	O	.	_	0	SENT_53	[p5l1082t1685r1745b1766],

1	gov	NN	O	gov	nn	2	SENT_54	[p5l1082t1685r1745b1766],
2	Identifier	NN	O	identifier	_	0	SENT_54	[p5l1794t1685r2135b1749],
3	:	:	O	:	_	0	SENT_54	[p5l1794t1685r2135b1749],
4	NCT	NN	O	nct	nn	6	SENT_54	[p5l8t1797r186b1860],
5	00298870	CD	NUMBER	00298870	num	6	SENT_54	[p5l233t1796r633b1877],
6	)	NN	O	)	dep	2	SENT_54	[p5l233t1796r633b1877],
7	.	.	O	.	_	0	SENT_54	[p5l233t1796r633b1877],

1	The	DT	O	the	det	2	SENT_55	[p5l685t1796r819b1860],
2	purpose	NN	O	purpose	nsubj	6	SENT_55	[p5l863t1816r1143b1877],
3	of	IN	O	of	_	0	SENT_55	[p5l1191t1796r1272b1860],
4	this	DT	O	this	det	5	SENT_55	[p5l1306t1796r1430b1860],
5	study	NN	O	study	prep_of	2	SENT_55	[p5l1480t1796r1668b1877],
6	was	VBD	O	be	_	0	SENT_55	[p5l1713t1816r1847b1860],
7	to	TO	O	to	aux	8	SENT_55	[p5l1894t1805r1959b1860],
8	elucidate	VB	O	elucidate	xcomp	6	SENT_55	[p5l2009t1796r2140b1860, p5l12t1907r220b1970],
9	whether	IN	O	whether	complm	20	SENT_55	[p5l277t1907r565b1970],
10	stratified	VBN	O	stratify	amod	11	SENT_55	[p5l622t1907r934b1970],
11	medicine	NN	O	medicine	nsubj	20	SENT_55	[p5l989t1907r1315b1970],
12	based	VBN	O	base	_	0	SENT_55	[p5l1370t1907r1575b1970],
13	on	IN	O	on	prepc_based_on	11	SENT_55	[p5l1631t1928r1719b1970],
14	the	DT	O	the	det	18	SENT_55	[p5l1773t1907r1880b1970],
15	NAT	NNP	ORGANIZATION	NAT	nn	18	SENT_55	[p5l1934t1908r2106b1970],
16	2	CD	NUMBER	2	num	18	SENT_55	[p5l2098t1909r2139b1969],
17	gene	NN	O	gene	nn	18	SENT_55	[p5l11t2038r176b2099],
18	polymorphism	NN	O	polymorphism	pobj	11	SENT_55	[p5l231t2017r751b2099],
19	could	MD	O	could	aux	20	SENT_55	[p5l808t2017r1004b2081],
20	improve	VB	O	improve	ccomp	8	SENT_55	[p5l1060t2017r1352b2099],
21	the	DT	O	the	det	22	SENT_55	[p5l1409t2017r1515b2081],
22	tolerability	NN	O	tolerability	dobj	20	SENT_55	[p5l1571t2017r1959b2099],
23	and	CC	O	and	_	0	SENT_55	[p5l2016t2017r2143b2081],
24	efficacy	NN	O	efficacy	dobj	20	SENT_55	[p5l12t2128r291b2210],
25	of	IN	O	of	_	0	SENT_55	[p5l336t2128r417b2192],
26	multidrug	JJ	O	multidrug	amod	27	SENT_55	[p5l448t2128r795b2210],
27	therapy	NN	O	therapy	prep_of	22	SENT_55	[p5l839t2128r1104b2210],
28	for	IN	O	for	_	0	SENT_55	[p5l1148t2128r1249b2192],
29	pulmonary	JJ	O	pulmonary	amod	30	SENT_55	[p5l1288t2128r1673b2210],
30	tuberculosis	NN	O	tuberculosis	prep_for	27	SENT_55	[p5l1715t2128r2139b2192],
31	with	IN	O	with	_	0	SENT_55	[p5l9t2240r166b2305],
32	INH	NN	O	inh	prep_with	20	SENT_55	[p5l209t2243r380b2304],
33	.	.	O	.	_	0	SENT_55	[p5l209t2243r380b2304],

1	Methods	NNS	O	method	_	0	SENT_56	[p5l10t2466r336b2526],

1	Study	NNP	O	Study	_	0	SENT_57	[p5l14t2686r216b2767],
2	design	NN	O	design	dep	1	SENT_57	[p5l247t2686r475b2767],

1	This	DT	O	this	det	2	SENT_58	[p5l11t2908r164b2972],
2	study	NN	O	study	nsubjpass	4	SENT_58	[p5l210t2908r399b2990],
3	was	VBD	O	be	auxpass	4	SENT_58	[p5l439t2929r574b2972],
4	designed	VBN	O	design	_	0	SENT_58	[p5l618t2908r932b2990],
5	as	IN	O	as	_	0	SENT_58	[p5l974t2929r1042b2972],
6	a	DT	O	a	det	7	SENT_58	[p5l1086t2929r1123b2972],
7	multicenter	NN	O	multicenter	prep_as	4	SENT_58	[p5l1162t2908r1580b2986],
8	,	,	O	,	_	0	SENT_58	[p5l1162t2908r1580b2986],
9	two-treatment	NN	O	two-treatment	appos	7	SENT_58	[p5l1624t2917r2138b2985],
10	,	,	O	,	_	0	SENT_58	[p5l1624t2917r2138b2985],
11	parallel	JJ	O	parallel	amod	12	SENT_58	[p5l9t3019r294b3101],
12	group	NN	O	group	appos	7	SENT_58	[p5l356t3040r595b3101],
13	,	,	O	,	_	0	SENT_58	[p5l356t3040r595b3101],
14	prospective	JJ	O	prospective	appos	7	SENT_58	[p5l658t3019r1120b3101],
15	,	,	O	,	_	0	SENT_58	[p5l658t3019r1120b3101],
16	randomized	VBN	O	randomize	partmod	7	SENT_58	[p5l1184t3019r1651b3097],
17	,	,	O	,	_	0	SENT_58	[p5l1184t3019r1651b3097],
18	open-label	JJ	O	open-label	nsubj	27	SENT_58	[p5l1717t3019r2138b3101],
19	,	,	O	,	_	0	SENT_58	[p5l1717t3019r2138b3101],
20	blinded-endpoint	JJ	O	blinded-endpoint	amod	25	SENT_58	[p5l9t3130r654b3212],
21	(	NN	O	(	nn	25	SENT_58	[p5l700t3130r1053b3211],
22	PROBE	NN	O	probe	nn	25	SENT_58	[p5l700t3130r1053b3211],
23	)	CD	NUMBER	)	num	25	SENT_58	[p5l700t3130r1053b3211],
24	controlled	JJ	O	controlled	amod	25	SENT_58	[p5l1102t3130r1481b3194],
25	trial	NN	O	trial	appos	18	SENT_58	[p5l1525t3130r1695b3207],
26	,	,	O	,	_	0	SENT_58	[p5l1525t3130r1695b3207],
27	comparing	VBG	O	compare	dep	16	SENT_58	[p5l1746t3130r2141b3212],
28	NAT2	NN	O	nat2	dep	29	SENT_58	[p5l8t3243r221b3305],
29	genotype-guided	JJ	O	genotype-guided	dobj	27	SENT_58	[p5l259t3241r842b3323],
30	and	CC	O	and	_	0	SENT_58	[p5l877t3241r1001b3305],
31	standard	JJ	O	standard	amod	32	SENT_58	[p5l1037t3241r1328b3305],
32	dosing	NN	O	dosing	dobj	27	SENT_58	[p5l1362t3241r1592b3323],
33	of	IN	O	of	_	0	SENT_58	[p5l1627t3241r1708b3305],
34	isoniazid	NN	O	isoniazid	prep_of	29	SENT_58	[p5l1732t3241r2042b3305],
35	in	IN	O	in	_	0	SENT_58	[p5l2077t3241r2143b3304],
36	the	DT	O	the	det	38	SENT_58	[p5l10t3352r114b3416],
37	intensive	JJ	O	intensive	amod	38	SENT_58	[p5l148t3352r456b3416],
38	phase	NN	O	phase	prep_in	27	SENT_58	[p5l486t3352r684b3434],
39	of	IN	O	of	_	0	SENT_58	[p5l718t3352r799b3416],
40	the	DT	O	the	det	44	SENT_58	[p5l818t3352r922b3416],
41	6-month	JJ	DURATION	6-month	amod	44	SENT_58	[p5l957t3352r1249b3416],
42	four-drug	JJ	O	four-drug	amod	44	SENT_58	[p5l1282t3352r1608b3434],
43	standard	JJ	O	standard	amod	44	SENT_58	[p5l1643t3352r1934b3416],
44	treatment	NN	O	treatment	prep_of	38	SENT_58	[p5l1963t3361r2141b3416, p5l10t3472r185b3527],
45	for	IN	O	for	_	0	SENT_58	[p5l215t3463r315b3527],
46	patients	NNS	O	patient	prep_for	44	SENT_58	[p5l341t3463r609b3545],
47	with	IN	O	with	_	0	SENT_58	[p5l640t3463r795b3527],
48	newly	RB	O	newly	advmod	49	SENT_58	[p5l824t3463r1036b3545],
49	diagnosed	VBN	O	diagnose	amod	51	SENT_58	[p5l1068t3463r1419b3545],
50	pulmonary	JJ	O	pulmonary	amod	51	SENT_58	[p5l1447t3463r1825b3545],
51	tuberculosis	NN	O	tuberculosis	prep_with	27	SENT_58	[p5l1855t3463r2141b3527, p5l12t3574r184b3638],
52	.	.	O	.	_	0	SENT_58	[p5l1855t3463r2141b3527, p5l12t3574r184b3638],

1	This	DT	O	this	det	2	SENT_59	[p5l225t3574r376b3638],
2	study	NN	O	study	nsubjpass	4	SENT_59	[p5l416t3574r601b3655],
3	was	VBD	O	be	auxpass	4	SENT_59	[p5l636t3594r768b3638],
4	approved	VBN	O	approve	_	0	SENT_59	[p5l808t3574r1131b3655],
5	by	IN	O	by	_	0	SENT_59	[p5l1163t3574r1252b3655],
6	the	DT	O	the	det	9	SENT_59	[p5l1286t3574r1391b3638],
7	Institutional	JJ	ORGANIZATION	institutional	amod	9	SENT_59	[p5l1428t3574r1841b3638],
8	Review	NN	ORGANIZATION	review	nn	9	SENT_59	[p5l1877t3574r2143b3638],
9	Boards	NNS	ORGANIZATION	board	agent	4	SENT_59	[p5l10t3685r254b3749],
10	of	IN	ORGANIZATION	of	_	0	SENT_59	[p5l292t3685r373b3749],
11	Osaka	NNP	ORGANIZATION	Osaka	nn	12	SENT_59	[p5l398t3685r615b3749],
12	University	NNP	ORGANIZATION	University	prep_of	9	SENT_59	[p5l647t3685r1011b3766],
13	and	CC	O	and	_	0	SENT_59	[p5l1048t3685r1172b3749],
14	the	DT	O	the	det	16	SENT_59	[p5l1206t3685r1310b3749],
15	participating	VBG	O	participate	amod	16	SENT_59	[p5l1344t3685r1779b3766],
16	hospitals	NNS	O	hospital	conj_and	12	SENT_59	[p5l1814t3685r2139b3766],
17	,	,	O	,	_	0	SENT_59	[p5l1814t3685r2139b3766],

1	and	CC	O	and	cc	4	SENT_60	[p6l12t21r136b85],
2	has	VBZ	O	have	aux	4	SENT_60	[p6l162t21r275b85],
3	been	VBN	O	be	auxpass	4	SENT_60	[p6l303t21r468b85],
4	registered	VBN	O	register	_	0	SENT_60	[p6l493t21r834b102],
5	on	IN	O	on	_	0	SENT_60	[p6l860t41r946b85],
6	ClinicalTrials	NNS	O	clinicaltrial	prep_on	4	SENT_60	[p6l974t21r1457b85],
7	.	.	O	.	_	0	SENT_60	[p6l974t21r1457b85],

1	gov.	NN	O	gov.	nsubj	11	SENT_61	[p6l1464t41r1604b103],
2	The	DT	O	the	dep	1	SENT_61	[p6l1637t21r1768b85],
3	participating	VBG	O	participate	partmod	1	SENT_61	[p6l1794t21r2140b102, p6l11t132r119b214],
4	hospitals	NNS	O	hospital	dobj	3	SENT_61	[p6l145t132r447b214],
5	were	VBD	O	be	cop	11	SENT_61	[p6l472t153r638b196],
6	National	NNP	ORGANIZATION	National	nn	11	SENT_61	[p6l662t132r959b196],
7	Hospital	NNP	ORGANIZATION	Hospital	nn	11	SENT_61	[p6l983t132r1273b214],
8	Organization	NNP	ORGANIZATION	Organization	nn	11	SENT_61	[p6l1300t132r1743b214],
9	Toneyama	NNP	ORGANIZATION	Toneyama	nn	11	SENT_61	[p6l1770t135r2144b214],
10	National	NNP	ORGANIZATION	National	nn	11	SENT_61	[p6l8t243r319b307],
11	Hospital	NNP	ORGANIZATION	Hospital	_	0	SENT_61	[p6l367t243r691b325],
12	,	,	O	,	_	0	SENT_61	[p6l367t243r691b325],
13	Osaka	NNP	ORGANIZATION	Osaka	nn	20	SENT_61	[p6l743t243r967b307],
14	Prefectural	NNP	ORGANIZATION	Prefectural	nn	20	SENT_61	[p6l1013t243r1406b307],
15	Hospital	NNP	ORGANIZATION	Hospital	nn	20	SENT_61	[p6l1453t243r1757b325],
16	Organization	NNP	ORGANIZATION	Organization	nn	20	SENT_61	[p6l1807t243r2141b325, p6l10t354r145b418],
17	Osaka	NNP	ORGANIZATION	Osaka	nn	20	SENT_61	[p6l184t354r401b419],
18	Prefectural	NNP	ORGANIZATION	Prefectural	nn	20	SENT_61	[p6l438t354r812b418],
19	Medical	NNP	ORGANIZATION	Medical	nn	20	SENT_61	[p6l851t354r1132b418],
20	Center	NNP	ORGANIZATION	Center	conj_and	11	SENT_61	[p6l1173t356r1403b419],
21	for	IN	ORGANIZATION	for	_	0	SENT_61	[p6l1441t354r1540b418],
22	Respiratory	JJ	ORGANIZATION	respiratory	amod	25	SENT_61	[p6l1577t354r1978b436],
23	and	CC	ORGANIZATION	and	_	0	SENT_61	[p6l2019t354r2143b418],
24	Allergic	JJ	ORGANIZATION	allergic	amod	25	SENT_61	[p6l10t465r297b547],
25	Diseases	NNS	ORGANIZATION	disease	prep_for	20	SENT_61	[p6l341t465r670b543],
26	,	,	O	,	_	0	SENT_61	[p6l341t465r670b543],
27	National	NNP	ORGANIZATION	National	nn	33	SENT_61	[p6l713t465r1021b529],
28	Hospital	NNP	ORGANIZATION	Hospital	nn	33	SENT_61	[p6l1063t465r1363b547],
29	Organization	NNP	ORGANIZATION	Organization	nn	33	SENT_61	[p6l1407t465r1869b547],
30	KinkiChuo	NNP	ORGANIZATION	KinkiChuo	nn	33	SENT_61	[p6l1911t465r2140b528, p6l12t576r195b640],
31	Chest	NN	ORGANIZATION	chest	nn	33	SENT_61	[p6l224t576r418b640],
32	Medical	NNP	ORGANIZATION	Medical	nn	33	SENT_61	[p6l441t576r720b640],
33	Center	NNP	ORGANIZATION	Center	conj_and	11	SENT_61	[p6l747t578r985b654],
34	,	,	O	,	_	0	SENT_61	[p6l747t578r985b654],
35	and	CC	O	and	_	0	SENT_61	[p6l1015t576r1138b640],
36	Japan	NNP	ORGANIZATION	Japan	nn	40	SENT_61	[p6l1162t579r1357b658],
37	Anti-Tuberculosis	NNP	ORGANIZATION	Anti-Tuberculosis	nn	40	SENT_61	[p6l1379t576r1992b640],
38	Association	NNP	ORGANIZATION	Association	nn	40	SENT_61	[p6l2018t578r2140b640, p6l13t687r317b751],
39	Osaka	NNP	ORGANIZATION	Osaka	nn	40	SENT_61	[p6l344t687r558b751],
40	Hospital	NNP	ORGANIZATION	Hospital	conj_and	11	SENT_61	[p6l582t687r887b768],
41	,	,	O	,	_	0	SENT_61	[p6l582t687r887b768],
42	all	DT	O	all	appos	40	SENT_61	[p6l919t687r999b750],
43	in	IN	O	in	_	0	SENT_61	[p6l1027t687r1092b749],
44	Osaka	NNP	LOCATION	Osaka	prep_in	42	SENT_61	[p6l1120t687r1349b764],
45	,	,	O	,	_	0	SENT_61	[p6l1120t687r1349b764],
46	Japan	NNP	LOCATION	Japan	appos	40	SENT_61	[p6l1379t689r1588b768],
47	.	.	O	.	_	0	SENT_61	[p6l1379t689r1588b768],

1	This	DT	O	this	det	2	SENT_62	[p6l1621t687r1769b751],
2	study	NN	O	study	nsubjpass	4	SENT_62	[p6l1800t687r1982b768],
3	was	VBD	O	be	auxpass	4	SENT_62	[p6l2008t707r2140b751],
4	conducted	VBN	O	conduct	_	0	SENT_62	[p6l12t798r363b862],
5	according	VBG	O	accord	_	0	SENT_62	[p6l402t798r735b879],
6	to	TO	O	to	prepc_according_to	4	SENT_62	[p6l773t807r837b862],
7	the	DT	O	the	det	8	SENT_62	[p6l877t798r980b862],
8	principles	NNS	O	principle	pobj	4	SENT_62	[p6l1017t798r1350b879],
9	of	IN	O	of	_	0	SENT_62	[p6l1391t798r1472b862],
10	the	DT	O	the	det	11	SENT_62	[p6l1497t798r1600b862],
11	Declaration	NN	O	declaration	prep_of	8	SENT_62	[p6l1639t798r2034b862],
12	of	IN	O	of	_	0	SENT_62	[p6l2073t798r2153b862],
13	Helsinki	NNP	LOCATION	Helsinki	prep_of	11	SENT_62	[p6l10t909r322b973],
14	and	CC	O	and	_	0	SENT_62	[p6l370t909r500b973],
15	in	IN	O	in	conj_and	4	SENT_62	[p6l545t909r614b971],
16	compliance	NN	O	compliance	pobj	15	SENT_62	[p6l660t909r1083b990],
17	with	IN	O	with	_	0	SENT_62	[p6l1128t909r1291b973],
18	applicable	JJ	O	applicable	amod	20	SENT_62	[p6l1338t909r1715b990],
19	regulatory	JJ	O	regulatory	amod	20	SENT_62	[p6l1760t909r2142b990],
20	requests	NNS	O	request	prep_with	16	SENT_62	[p6l9t1029r303b1102],
21	.	.	O	.	_	0	SENT_62	[p6l9t1029r303b1102],

1	All	DT	O	all	nsubj	7	SENT_63	[p6l329t1020r437b1083],
2	of	IN	O	of	_	0	SENT_63	[p6l460t1020r540b1084],
3	the	DT	O	the	det	4	SENT_63	[p6l550t1020r652b1084],
4	patients	NNS	O	patient	prep_of	1	SENT_63	[p6l673t1020r936b1102],
5	being	VBG	O	be	auxpass	6	SENT_63	[p6l957t1020r1148b1102],
6	tested	VBN	O	test	partmod	4	SENT_63	[p6l1169t1020r1367b1084],
7	gave	VBD	O	give	_	0	SENT_63	[p6l1389t1041r1548b1102],
8	written	VBN	O	write	amod	10	SENT_63	[p6l1569t1020r1809b1084],
9	informed	VBN	O	inform	amod	10	SENT_63	[p6l1831t1020r2143b1084],
10	consent	NN	O	consent	dobj	7	SENT_63	[p6l12t1140r272b1195],
11	before	IN	O	before	_	0	SENT_63	[p6l293t1131r509b1195],
12	the	DT	O	the	det	13	SENT_63	[p6l535t1131r637b1195],
13	study	NN	O	study	prep_before	7	SENT_63	[p6l666t1131r858b1213],
14	.	.	O	.	_	0	SENT_63	[p6l666t1131r858b1213],

1	Eur	NNP	O	Eur	nn	4	SENT_64	[p6l53t1289r103b1313],
2	J	NNP	O	J	nn	4	SENT_64	[p6l114t1289r127b1313],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_64	[p6l138t1288r197b1313],
4	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_64	[p6l208t1288r357b1313],
5	(	CD	NUMBER	(	num	6	SENT_64	[p6l369t1288r460b1320],
6	2013	CD	DATE	2013	dep	4	SENT_64	[p6l369t1288r460b1320],
7	)	CD	NUMBER	)	number	8	SENT_64	[p6l369t1288r460b1320],
8	69	CD	NUMBER	69	dep	6	SENT_64	[p6l473t1288r670b1313],
9	:	:	O	:	_	0	SENT_64	[p6l473t1288r670b1313],
10	l09l	CD	NUMBER	l09l	num	11	SENT_64	[p6l473t1288r670b1313],
11	—	CD	NUMBER	—	dep	6	SENT_64	[p6l473t1288r670b1313],
12	1l01	CD	NUMBER	1l01	num	13	SENT_64	[p6l473t1288r670b1313],
13	1093	CD	DATE	1093	dep	11	SENT_64	[p6l2041t1288r2105b1313],

1	Study	NNP	O	Study	_	0	SENT_65	[p6l11t1461r214b1543],
2	population	NN	O	population	dep	1	SENT_65	[p6l241t1461r621b1543],

1	The	DT	O	the	det	3	SENT_66	[p6l8t1684r142b1748],
2	eligible	JJ	O	eligible	amod	3	SENT_66	[p6l196t1684r456b1766],
3	population	NN	O	population	nsubjpass	5	SENT_66	[p6l506t1684r887b1766],
4	was	VBD	O	be	auxpass	5	SENT_66	[p6l937t1705r1072b1748],
5	identified	VBN	O	identify	_	0	SENT_66	[p6l1126t1684r1462b1748],
6	from	IN	O	from	_	0	SENT_66	[p6l1514t1684r1683b1748],
7	a	DT	O	a	det	8	SENT_66	[p6l1734t1705r1771b1748],
8	series	NN	O	series	prep_from	5	SENT_66	[p6l1824t1684r2017b1748],
9	of	IN	O	of	_	0	SENT_66	[p6l2072t1684r2153b1748],
10	patients	NNS	O	patient	prep_of	8	SENT_66	[p6l6t1795r288b1877],
11	newly	RB	O	newly	advmod	12	SENT_66	[p6l343t1795r565b1877],
12	diagnosed	VBN	O	diagnose	partmod	10	SENT_66	[p6l620t1795r988b1877],
13	with	IN	O	with	_	0	SENT_66	[p6l1039t1795r1200b1859],
14	pulmonary	JJ	O	pulmonary	amod	15	SENT_66	[p6l1252t1795r1648b1877],
15	tuberculosis	NN	O	tuberculosis	prep_with	12	SENT_66	[p6l1701t1795r2140b1859],
16	(	CD	NUMBER	(	num	17	SENT_66	[p6l9t1906r192b1987],
17	men	NNS	O	man	nsubjpass	5	SENT_66	[p6l9t1906r192b1987],
18	and	CC	O	and	_	0	SENT_66	[p6l247t1906r376b1970],
19	Women	NNS	O	woman	conj_and	17	SENT_66	[p6l428t1926r714b1983],
20	,	,	O	,	_	0	SENT_66	[p6l428t1926r714b1983],
21	20-75	CD	NUMBER	20-75	num	22	SENT_66	[p6l772t1907r993b1970],
22	years	NNS	NUMBER	year	npadvmod	23	SENT_66	[p6l1052t1926r1241b1987],
23	old	JJ	O	old	amod	24	SENT_66	[p6l1298t1906r1462b1987],
24	)	NN	O	)	appos	17	SENT_66	[p6l1298t1906r1462b1987],
25	,	,	O	,	_	0	SENT_66	[p6l1298t1906r1462b1987],
26	requiring	VBG	O	require	partmod	5	SENT_66	[p6l1518t1906r1852b1987],
27	the	DT	O	the	det	31	SENT_66	[p6l1906t1906r2014b1970],
28	6month	JJ	O	6month	amod	31	SENT_66	[p6l2071t1907r2140b1969, p6l7t2017r238b2081],
29	four-drug	JJ	O	four-drug	amod	31	SENT_66	[p6l293t2017r637b2099],
30	standard	JJ	O	standard	amod	31	SENT_66	[p6l694t2017r998b2081],
31	treatment	NN	O	treatment	dobj	26	SENT_66	[p6l1050t2025r1393b2081],
32	for	IN	O	for	_	0	SENT_66	[p6l1447t2017r1550b2081],
33	the	DT	O	the	det	35	SENT_66	[p6l1601t2017r1709b2081],
34	ﬁrst	JJ	O	ﬁrst	amod	35	SENT_66	[p6l1765t2017r1909b2081],
35	time	NN	O	time	prep_for	26	SENT_66	[p6l1960t2017r2137b2081],
36	.	.	O	.	_	0	SENT_66	[p6l1960t2017r2137b2081],

1	The	DT	O	the	dep	102	SENT_67	[p6l9t2128r142b2192],
2	exclusion	NN	O	exclusion	dep	102	SENT_67	[p6l197t2128r536b2192],
3	criteria	NNS	O	criterion	dep	102	SENT_67	[p6l589t2128r836b2192],
4	in	IN	O	in	dep	102	SENT_67	[p6l888t2128r954b2190],
5	the	DT	O	the	dep	102	SENT_67	[p6l1005t2128r1111b2192],
6	pre-study	JJ	O	pre-study	dep	102	SENT_67	[p6l1162t2128r1498b2209],
7	screening	NN	O	screening	dep	102	SENT_67	[p6l1553t2128r1888b2209],
8	phase	NN	O	phase	dep	102	SENT_67	[p6l1939t2128r2140b2209],
9	were	VBD	O	be	dep	102	SENT_67	[p6l7t2260r175b2303],
10	as	IN	O	as	dep	102	SENT_67	[p6l212t2260r280b2303],
11	follows	VBZ	O	follow	dep	102	SENT_67	[p6l316t2239r597b2303],
12	:	:	O	:	_	0	SENT_67	[p6l316t2239r597b2303],
13	abnormal	JJ	O	abnormal	dep	102	SENT_67	[p6l637t2239r968b2303],
14	test	NN	O	test	dep	102	SENT_67	[p6l1001t2248r1123b2303],
15	results	VBZ	O	result	dep	102	SENT_67	[p6l1154t2239r1381b2303],
16	for	IN	O	for	dep	102	SENT_67	[p6l1418t2239r1519b2303],
17	liver	NN	O	liver	dep	102	SENT_67	[p6l1551t2239r1711b2303],
18	and	CC	O	and	dep	102	SENT_67	[p6l1743t2239r1869b2303],
19	kidney	NN	O	kidney	dep	102	SENT_67	[p6l1901t2239r2142b2321],
20	ﬁanction	NN	O	ﬁanction	dep	102	SENT_67	[p6l9t2350r292b2414],
21	(	CD	NUMBER	(	dep	102	SENT_67	[p6l324t2350r560b2431],
22	serum	NN	O	serum	dep	102	SENT_67	[p6l324t2350r560b2431],
23	aspartate	NN	O	aspartate	dep	102	SENT_67	[p6l591t2359r889b2432],
24	aminotransferase	NN	O	aminotransferase	dep	102	SENT_67	[p6l922t2350r1523b2427],
25	;	:	O	;	_	0	SENT_67	[p6l922t2350r1523b2427],
26	AST	NNP	O	AST	dep	102	SENT_67	[p6l1555t2351r1866b2414],
27	>	JJR	O	>	dep	102	SENT_67	[p6l1555t2351r1866b2414],
28	45	CD	NUMBER	45	dep	102	SENT_67	[p6l1555t2351r1866b2414],
29	(	NN	O	(	dep	102	SENT_67	[p6l1903t2350r2138b2431],
30	IU/L	NN	O	iu/l	dep	102	SENT_67	[p6l1903t2350r2138b2431],
31	)	NN	O	)	dep	102	SENT_67	[p6l1903t2350r2138b2431],
32	,	,	O	,	_	0	SENT_67	[p6l1903t2350r2138b2431],
33	alanine	NN	O	alanine	dep	102	SENT_67	[p6l9t2461r253b2525],
34	aminotransferase	NN	O	aminotransferase	dep	102	SENT_67	[p6l284t2461r883b2538],
35	;	:	O	;	_	0	SENT_67	[p6l284t2461r883b2538],
36	ALT	NNP	O	ALT	dep	102	SENT_67	[p6l916t2462r1225b2525],
37	>	JJR	O	>	dep	102	SENT_67	[p6l916t2462r1225b2525],
38	5O	NN	O	5o	dep	102	SENT_67	[p6l916t2462r1225b2525],
39	(	CD	NUMBER	(	dep	102	SENT_67	[p6l1259t2461r1495b2542],
40	IU/L	NN	O	iu/l	dep	102	SENT_67	[p6l1259t2461r1495b2542],
41	)	NN	O	)	dep	102	SENT_67	[p6l1259t2461r1495b2542],
42	,	,	O	,	_	0	SENT_67	[p6l1259t2461r1495b2542],
43	alkaline	NN	O	alkaline	dep	102	SENT_67	[p6l1531t2461r1796b2525],
44	phosphatise	NN	O	phosphatise	dep	102	SENT_67	[p6l1825t2461r2140b2543, p6l7t2572r144b2650],
45	;	:	O	;	_	0	SENT_67	[p6l1825t2461r2140b2543, p6l7t2572r144b2650],
46	ALP	NNP	O	ALP	dep	102	SENT_67	[p6l169t2574r526b2635],
47	>	JJR	O	>	dep	102	SENT_67	[p6l169t2574r526b2635],
48	444	CD	NUMBER	444	dep	102	SENT_67	[p6l169t2574r526b2635],
49	(	NN	O	(	dep	102	SENT_67	[p6l553t2572r788b2654],
50	IU/L	NN	O	iu/l	dep	102	SENT_67	[p6l553t2572r788b2654],
51	)	NN	O	)	dep	102	SENT_67	[p6l553t2572r788b2654],
52	,	,	O	,	_	0	SENT_67	[p6l553t2572r788b2654],
53	total	JJ	O	total	dep	102	SENT_67	[p6l814t2572r965b2636],
54	bilirubin	NN	O	bilirubin	dep	102	SENT_67	[p6l986t2572r1336b2636],
55	>	JJR	O	>	dep	102	SENT_67	[p6l986t2572r1336b2636],
56	1.6	CD	NUMBER	1.6	dep	102	SENT_67	[p6l1354t2574r1449b2636],
57	(	NN	O	(	dep	102	SENT_67	[p6l1477t2572r1777b2654],
58	mg/dL	NN	O	mg/dl	dep	102	SENT_67	[p6l1477t2572r1777b2654],
59	)	NN	O	)	dep	102	SENT_67	[p6l1477t2572r1777b2654],
60	,	,	O	,	_	0	SENT_67	[p6l1477t2572r1777b2654],
61	and	CC	O	and	dep	102	SENT_67	[p6l1805t2572r1928b2636],
62	creatinine	NN	O	creatinine	dep	102	SENT_67	[p6l1952t2581r2140b2636, p6l9t2683r233b2747],
63	>	JJR	O	>	dep	102	SENT_67	[p6l1952t2581r2140b2636, p6l9t2683r233b2747],
64	1.4	CD	NUMBER	1.4	dep	102	SENT_67	[p6l251t2685r348b2747],
65	(	NN	O	(	dep	102	SENT_67	[p6l382t2683r690b2765],
66	mg/dL	NN	O	mg/dl	dep	102	SENT_67	[p6l382t2683r690b2765],
67	)	CD	NUMBER	)	dep	102	SENT_67	[p6l382t2683r690b2765],
68	)	NN	O	)	dep	102	SENT_67	[p6l382t2683r690b2765],
69	before	IN	O	before	dep	102	SENT_67	[p6l721t2683r938b2747],
70	the	DT	O	the	dep	102	SENT_67	[p6l970t2683r1072b2747],
71	study	NN	O	study	dep	102	SENT_67	[p6l1107t2683r1290b2765],
72	treatments	NNS	O	treatment	dep	102	SENT_67	[p6l1320t2692r1672b2747],
73	commenced	VBD	O	commence	dep	102	SENT_67	[p6l1706t2683r2138b2761],
74	,	,	O	,	_	0	SENT_67	[p6l1706t2683r2138b2761],
75	long-terrn	JJ	O	long-terrn	dep	102	SENT_67	[p6l9t2794r344b2876],
76	use	NN	O	use	dep	102	SENT_67	[p6l372t2815r486b2858],
77	of	IN	O	of	dep	102	SENT_67	[p6l518t2794r599b2858],
78	steroids	NNS	O	steroid	dep	102	SENT_67	[p6l620t2794r880b2858],
79	and/or	JJ	O	and/or	dep	102	SENT_67	[p6l912t2794r1132b2858],
80	immunosuppressants	NNS	O	immunosuppressant	dep	102	SENT_67	[p6l1159t2794r1896b2876],
81	,	,	O	,	_	0	SENT_67	[p6l1159t2794r1896b2876],
82	inadequate	JJ	O	inadequate	dep	102	SENT_67	[p6l1931t2794r2140b2858, p6l9t2913r191b2986],
83	clinical	JJ	O	clinical	dep	102	SENT_67	[p6l219t2905r465b2969],
84	conditions	NNS	O	condition	dep	102	SENT_67	[p6l491t2905r844b2969],
85	such	JJ	O	such	dep	102	SENT_67	[p6l874t2905r1029b2969],
86	as	IN	O	as	dep	102	SENT_67	[p6l1056t2925r1122b2969],
87	hyperglycemia	NN	O	hyperglycemia	dep	102	SENT_67	[p6l1148t2905r1659b2986],
88	diabetes	NN	O	diabetes	dep	102	SENT_67	[p6l1684t2905r1959b2969],
89	mellitus	NN	O	mellitus	dep	102	SENT_67	[p6l1986t2905r2140b2969, p6l9t3016r184b3093],
90	,	,	O	,	_	0	SENT_67	[p6l1986t2905r2140b2969, p6l9t3016r184b3093],
91	acute	JJ	O	acute	dep	102	SENT_67	[p6l233t3024r421b3080],
92	life-threatening	JJ	O	life-threatening	dep	102	SENT_67	[p6l467t3016r1028b3097],
93	chronic	JJ	O	chronic	dep	102	SENT_67	[p6l1074t3016r1344b3080],
94	progressive	JJ	O	progressive	dep	102	SENT_67	[p6l1388t3016r1810b3097],
95	disease	NN	O	disease	dep	102	SENT_67	[p6l1857t3016r2138b3093],
96	,	,	O	,	_	0	SENT_67	[p6l1857t3016r2138b3093],
97	pregnancy	NN	O	pregnancy	dep	102	SENT_67	[p6l6t3147r369b3208],
98	or	CC	O	or	dep	102	SENT_67	[p6l395t3147r467b3191],
99	lactation	NN	O	lactation	dep	102	SENT_67	[p6l491t3127r803b3204],
100	,	,	O	,	_	0	SENT_67	[p6l491t3127r803b3204],
101	and	CC	O	and	dep	102	SENT_67	[p6l833t3127r957b3191],
102	alcoholism	NN	O	alcoholism	_	0	SENT_67	[p6l983t3127r1376b3191],
103	.	.	O	.	_	0	SENT_67	[p6l983t3127r1376b3191],

1	Patients	NNS	O	patient	nsubjpass	14	SENT_68	[p6l1406t3127r1677b3191],
2	not	RB	O	not	neg	3	SENT_68	[p6l1702t3135r1815b3191],
3	expected	VBN	O	expect	amod	1	SENT_68	[p6l1840t3127r2143b3208],
4	to	TO	O	to	aux	5	SENT_68	[p6l7t3247r71b3302],
5	complete	VB	O	complete	xcomp	3	SENT_68	[p6l113t3238r426b3320],
6	the	DT	O	the	det	8	SENT_68	[p6l465t3238r568b3302],
7	study	NN	O	study	nn	8	SENT_68	[p6l611t3238r796b3320],
8	protocol	NN	O	protocol	dobj	5	SENT_68	[p6l831t3238r1119b3320],
9	for	IN	O	for	_	0	SENT_68	[p6l1159t3238r1258b3302],
10	social	JJ	O	social	amod	11	SENT_68	[p6l1297t3238r1493b3302],
11	reasons	NNS	O	reason	prep_for	5	SENT_68	[p6l1530t3259r1787b3302],
12	were	VBD	O	be	auxpass	14	SENT_68	[p6l1827t3259r1993b3302],
13	not	RB	O	not	neg	14	SENT_68	[p6l2032t3247r2144b3302],
14	recruited	VBN	O	recruit	_	0	SENT_68	[p6l7t3350r325b3414],
15	.	.	O	.	_	0	SENT_68	[p6l7t3350r325b3414],

1	After	IN	O	after	_	0	SENT_69	[p6l108t3461r295b3525],
2	the	DT	O	the	det	3	SENT_69	[p6l314t3461r420b3525],
3	allocation	NN	O	allocation	prep_after	20	SENT_69	[p6l444t3461r789b3525],
4	of	IN	O	of	_	0	SENT_69	[p6l812t3461r893b3525],
5	the	DT	O	the	det	6	SENT_69	[p6l904t3461r1010b3525],
6	patients	NNS	O	patient	prep_of	3	SENT_69	[p6l1031t3461r1324b3543],
7	,	,	O	,	_	0	SENT_69	[p6l1031t3461r1324b3543],
8	Mycobacterium	NN	O	mycobacterium	nn	14	SENT_69	[p6l1345t3461r1901b3543],
9	avium	NN	O	avium	nn	14	SENT_69	[p6l1927t3466r2139b3525],
10	complex	NN	O	complex	nn	14	SENT_69	[p6l9t3572r311b3654],
11	(	CD	NUMBER	(	num	14	SENT_69	[p6l349t3573r604b3654],
12	MAC	NNP	O	MAC	nn	14	SENT_69	[p6l349t3573r604b3654],
13	)	NN	O	)	nn	14	SENT_69	[p6l349t3573r604b3654],
14	infection	NN	O	infection	nsubjpass	20	SENT_69	[p6l642t3572r954b3636],
15	and	CC	O	and	_	0	SENT_69	[p6l991t3572r1116b3636],
16	resistance	NN	O	resistance	nn	18	SENT_69	[p6l1150t3572r1496b3636],
17	to	TO	O	to	dep	18	SENT_69	[p6l1532t3581r1597b3636],
18	INH	NN	O	inh	conj_and	14	SENT_69	[p6l1636t3575r1790b3636],
19	were	VBD	O	be	auxpass	20	SENT_69	[p6l1825t3593r1994b3636],
20	examined	VBN	O	examine	_	0	SENT_69	[p6l2032t3593r2140b3636, p6l9t3684r268b3748],
21	and	CC	O	and	_	0	SENT_69	[p6l303t3684r429b3748],
22	used	VBN	O	use	conj_and	20	SENT_69	[p6l462t3684r625b3748],
23	as	IN	O	as	_	0	SENT_69	[p6l662t3705r730b3748],
24	additional	JJ	O	additional	amod	26	SENT_69	[p6l769t3684r1119b3748],
25	exclusion	NN	O	exclusion	nn	26	SENT_69	[p6l1157t3684r1494b3748],
26	criteria	NNS	O	criterion	prep_as	20	SENT_69	[p6l1530t3684r1775b3748],
27	to	TO	O	to	aux	28	SENT_69	[p6l1809t3693r1875b3748],
28	ensure	VB	O	ensure	xcomp	20	SENT_69	[p6l1914t3705r2140b3748],
29	the	DT	O	the	det	30	SENT_69	[p7l7t30r112b94],
30	efﬁcacy	NN	O	efﬁcacy	dobj	28	SENT_69	[p7l158t30r438b112],
31	of	IN	O	of	_	0	SENT_69	[p7l481t30r563b94],
32	INH	NN	O	inh	prep_of	30	SENT_69	[p7l595t33r766b94],
33	.	.	O	.	_	0	SENT_69	[p7l595t33r766b94],

1	Patients	NNS	O	patient	nsubjpass	9	SENT_70	[p7l814t30r1091b94],
2	with	IN	O	with	_	0	SENT_70	[p7l1134t30r1291b94],
3	complex	JJ	O	complex	amod	4	SENT_70	[p7l1335t30r1637b112],
4	infections	NNS	O	infection	prep_with	1	SENT_70	[p7l1681t30r2026b94],
5	or	CC	O	or	_	0	SENT_70	[p7l2072t51r2144b94],
6	INH	NN	O	inh	nn	7	SENT_70	[p7l9t142r165b204],
7	resistance	NN	O	resistance	conj_or	4	SENT_70	[p7l207t140r558b204],
8	were	VBD	O	be	auxpass	9	SENT_70	[p7l601t160r772b204],
9	excluded	VBN	O	exclude	_	0	SENT_70	[p7l818t140r1139b204],
10	from	IN	O	from	_	0	SENT_70	[p7l1184t140r1354b204],
11	the	DT	O	the	det	13	SENT_70	[p7l1395t140r1502b204],
12	ﬁnal	JJ	O	ﬁnal	amod	13	SENT_70	[p7l1548t140r1707b203],
13	analysis	NN	O	analysis	prep_from	9	SENT_70	[p7l1752t140r2035b222],
14	as	IN	O	as	mark	15	SENT_70	[p7l2082t161r2151b204],
15	illustrated	VBN	O	illustrate	advcl	9	SENT_70	[p7l9t250r361b314],
16	in	IN	O	in	_	0	SENT_70	[p7l391t250r457b313],
17	Fig	NN	O	fig	prep_in	15	SENT_70	[p7l486t250r619b332],
18	.	.	O	.	_	0	SENT_70	[p7l486t250r619b332],

1	l.	IN	O	l.	_	0	SENT_71	[p7l663t252r714b314],

1	Randomization	NN	O	randomization	_	0	SENT_72	[p7l8t474r552b538],
2	and	CC	O	and	_	0	SENT_72	[p7l582t474r709b538],
3	study	NN	O	study	nn	4	SENT_72	[p7l740t474r929b556],
4	medication	NN	O	medication	conj_and	1	SENT_72	[p7l957t474r1352b538],

1	Before	IN	O	before	_	0	SENT_73	[p7l8t698r246b762],
2	the	DT	O	the	det	3	SENT_73	[p7l289t698r395b762],
3	allocation	NN	O	allocation	prep_before	16	SENT_73	[p7l439t698r786b762],
4	of	IN	O	of	_	0	SENT_73	[p7l829t698r910b762],
5	a	DT	O	a	det	7	SENT_73	[p7l942t718r979b761],
6	consenting	VBG	O	consent	amod	7	SENT_73	[p7l1021t698r1404b779],
7	patient	NN	O	patient	prep_of	3	SENT_73	[p7l1443t698r1704b779],
8	,	,	O	,	_	0	SENT_73	[p7l1443t698r1704b779],
9	an	DT	O	a	det	13	SENT_73	[p7l1751t718r1832b761],
10	individual	JJ	O	individual	amod	13	SENT_73	[p7l1874t698r2150b762, p7l7t809r114b873],
11	NAT	NNP	O	NAT	nn	13	SENT_73	[p7l157t811r329b874],
12	2	CD	NUMBER	2	num	13	SENT_73	[p7l322t811r363b872],
13	genotype	NN	O	genotype	nsubjpass	16	SENT_73	[p7l411t818r735b891],
14	status	NN	O	status	dep	13	SENT_73	[p7l785t818r980b874],
15	was	VBD	O	be	auxpass	16	SENT_73	[p7l1027t830r1162b873],
16	determined	VBN	O	determine	_	0	SENT_73	[p7l1212t809r1609b873],
17	at	IN	O	at	_	0	SENT_73	[p7l1656t818r1717b873],
18	the	DT	O	the	det	20	SENT_73	[p7l1761t809r1867b873],
19	central	JJ	O	central	amod	20	SENT_73	[p7l1915t809r2152b873],
20	laboratory	NN	O	laboratory	prep_at	16	SENT_73	[p7l10t920r372b1002],
21	and	CC	O	and	_	0	SENT_73	[p7l427t920r553b984],
22	ofﬁce	NN	O	ofﬁce	conj_and	20	SENT_73	[p7l607t920r807b984],
23	in	IN	O	in	_	0	SENT_73	[p7l862t920r929b983],
24	parallel	NN	O	parallel	prep_in	20	SENT_73	[p7l979t920r1244b1002],
25	with	IN	O	with	_	0	SENT_73	[p7l1296t920r1454b984],
26	clinical	JJ	O	clinical	amod	28	SENT_73	[p7l1508t920r1765b984],
27	pre-study	JJ	O	pre-study	amod	28	SENT_73	[p7l1816t920r2152b1002],
28	screening	NN	O	screening	prep_with	16	SENT_73	[p7l11t1031r347b1113],
29	at	IN	O	at	_	0	SENT_73	[p7l400t1040r461b1094],
30	each	DT	O	each	det	31	SENT_73	[p7l512t1031r672b1095],
31	site	NN	O	site	prep_at	28	SENT_73	[p7l726t1031r860b1095],
32	.	.	O	.	_	0	SENT_73	[p7l726t1031r860b1095],

1	Qualiﬁed	JJ	O	qualiﬁed	amod	2	SENT_74	[p7l918t1031r1251b1111],
2	patients	NNS	O	patient	nsubjpass	4	SENT_74	[p7l1299t1031r1573b1113],
3	were	VBD	O	be	auxpass	4	SENT_74	[p7l1625t1051r1795b1095],
4	assigned	VBN	O	assign	_	0	SENT_74	[p7l1849t1031r2153b1113],
5	randomly	RB	O	randomly	advmod	4	SENT_74	[p7l7t1142r349b1224],
6	to	TO	O	to	_	0	SENT_74	[p7l388t1150r454b1206],
7	the	DT	O	the	det	11	SENT_74	[p7l496t1142r602b1206],
8	pharmacogenetic-guided	JJ	O	pharmacogenetic-guided	amod	11	SENT_74	[p7l643t1142r1525b1224],
9	treatment	NN	O	treatment	nn	11	SENT_74	[p7l1563t1151r1898b1206],
10	(	NN	O	(	nn	11	SENT_74	[p7l1940t1142r2151b1223, p7l8t1253r368b1334],
11	PGXtreatment	NN	O	pgxtreatment	prep_to	4	SENT_74	[p7l1940t1142r2151b1223, p7l8t1253r368b1334],
12	)	CD	NUMBER	)	dep	11	SENT_74	[p7l1940t1142r2151b1223, p7l8t1253r368b1334],
13	or	CC	O	or	_	0	SENT_74	[p7l419t1273r493b1317],
14	the	DT	O	the	det	19	SENT_74	[p7l537t1253r643b1317],
15	conventional	JJ	O	conventional	amod	19	SENT_74	[p7l694t1253r1151b1317],
16	standard	NN	O	standard	nn	19	SENT_74	[p7l1202t1253r1500b1317],
17	treatment	NN	O	treatment	nn	19	SENT_74	[p7l1547t1262r1882b1317],
18	(	CD	NUMBER	(	num	19	SENT_74	[p7l1930t1253r2151b1334, p7l8t1365r374b1446],
19	STDtreatment	NN	O	stdtreatment	prep_to	4	SENT_74	[p7l1930t1253r2151b1334, p7l8t1365r374b1446],
20	)	CD	NUMBER	)	dep	19	SENT_74	[p7l1930t1253r2151b1334, p7l8t1365r374b1446],
21	according	VBG	O	accord	_	0	SENT_74	[p7l435t1364r787b1446],
22	to	TO	O	to	prepc_according_to	4	SENT_74	[p7l845t1373r911b1428],
23	a	DT	O	a	det	27	SENT_74	[p7l973t1385r1010b1428],
24	computer-generated	JJ	O	computer-generated	amod	27	SENT_74	[p7l1067t1364r1786b1446],
25	dynamic	JJ	O	dynamic	amod	27	SENT_74	[p7l1844t1364r2151b1446],
26	randomization	NN	O	randomization	nn	27	SENT_74	[p7l7t1476r521b1540],
27	schedule	NN	O	schedule	pobj	4	SENT_74	[p7l571t1476r896b1554],
28	,	,	O	,	_	0	SENT_74	[p7l571t1476r896b1554],
29	which	WDT	O	which	nsubj	30	SENT_74	[p7l946t1476r1163b1540],
30	minimized	VBD	O	minimize	rcmod	27	SENT_74	[p7l1210t1476r1589b1540],
31	the	DT	O	the	det	32	SENT_74	[p7l1635t1476r1741b1540],
32	imbalance	NN	O	imbalance	dobj	30	SENT_74	[p7l1790t1476r2151b1540],
33	of	IN	O	of	_	0	SENT_74	[p7l10t1587r91b1651],
34	patient	NN	O	patient	nn	35	SENT_74	[p7l130t1587r374b1669],
35	backgrounds	NNS	O	background	prep_of	32	SENT_74	[p7l422t1587r877b1669],
36	including	VBG	O	include	_	0	SENT_74	[p7l933t1587r1265b1669],
37	NAT	NNP	ORGANIZATION	NAT	nn	39	SENT_74	[p7l1315t1588r1487b1651],
38	2	CD	NUMBER	2	num	39	SENT_74	[p7l1479t1589r1520b1650],
39	genotype	NN	O	genotype	prep_including	32	SENT_74	[p7l1575t1596r1899b1669],
40	status	NN	O	status	npadvmod	42	SENT_74	[p7l1955t1596r2150b1651],
41	(	CD	NUMBER	(	num	40	SENT_74	[p7l10t1698r260b1779],
42	rapid	JJ	O	rapid	amod	39	SENT_74	[p7l10t1698r260b1779],
43	-	:	O	-	_	0	SENT_74	[p7l10t1698r260b1779],
44	,	,	O	,	_	0	SENT_74	[p7l10t1698r260b1779],
45	intermediate	JJ	O	intermediate	dep	30	SENT_74	[p7l297t1698r773b1775],
46	-	:	O	-	_	0	SENT_74	[p7l297t1698r773b1775],
47	,	,	O	,	_	0	SENT_74	[p7l297t1698r773b1775],
48	and	CC	O	and	dep	50	SENT_74	[p7l810t1698r935b1762],
49	slow-acetylator	NN	O	slow-acetylator	nn	50	SENT_74	[p7l968t1698r1501b1779],
50	genotypes	NNS	O	genotype	dep	30	SENT_74	[p7l1530t1698r1929b1779],
51	)	RB	O	)	advmod	50	SENT_74	[p7l1530t1698r1929b1779],
52	,	,	O	,	_	0	SENT_74	[p7l1530t1698r1929b1779],
53	study	NN	O	study	nn	54	SENT_74	[p7l1967t1698r2153b1779],
54	site	NN	O	site	dep	30	SENT_74	[p7l11t1809r144b1887],
55	,	,	O	,	_	0	SENT_74	[p7l11t1809r144b1887],
56	body	NN	O	body	nn	57	SENT_74	[p7l165t1809r344b1891],
57	weight	NN	O	weight	dep	30	SENT_74	[p7l360t1809r615b1891],
58	,	,	O	,	_	0	SENT_74	[p7l360t1809r615b1891],
59	age	NN	O	age	dep	30	SENT_74	[p7l640t1830r776b1891],
60	,	,	O	,	_	0	SENT_74	[p7l640t1830r776b1891],
61	and	CC	O	and	_	0	SENT_74	[p7l800t1809r925b1873],
62	baseline	NN	O	baseline	nn	63	SENT_74	[p7l941t1809r1225b1873],
63	y-glutamyltranspeptidase	NN	O	y-glutamyltranspeptidase	conj_and	54	SENT_74	[p7l1241t1809r2148b1891],
64	.	.	O	.	_	0	SENT_74	[p7l1241t1809r2148b1891],

1	Within	IN	O	within	_	0	SENT_75	[p7l8t1920r256b1985],
2	72	CD	NUMBER	72	num	3	SENT_75	[p7l301t1922r385b1984],
3	h	NN	O	h	prep_within	16	SENT_75	[p7l431t1920r475b1983],
4	after	IN	O	after	mark	9	SENT_75	[p7l520t1920r683b1984],
5	a	DT	O	a	det	7	SENT_75	[p7l726t1941r763b1984],
6	blood	NN	O	blood	nn	7	SENT_75	[p7l804t1920r1012b1984],
7	sample	NN	O	sample	nsubjpass	9	SENT_75	[p7l1057t1920r1308b2002],
8	was	VBD	O	be	auxpass	9	SENT_75	[p7l1351t1941r1489b1985],
9	drawn	VBN	O	draw	dep	3	SENT_75	[p7l1536t1920r1759b1984],
10	for	IN	O	for	_	0	SENT_75	[p7l1804t1921r1907b1984],
11	genotyping	NN	O	genotyping	prep_for	9	SENT_75	[p7l1948t1941r2151b2002, p7l8t2031r259b2113],
12	,	,	O	,	_	0	SENT_75	[p7l1948t1941r2151b2002, p7l8t2031r259b2113],
13	site	NN	O	site	nn	14	SENT_75	[p7l302t2031r421b2095],
14	investigators	NNS	O	investigator	nsubjpass	16	SENT_75	[p7l461t2031r921b2113],
15	were	VBD	O	be	auxpass	16	SENT_75	[p7l959t2051r1131b2095],
16	informed	VBN	O	inform	dep	28	SENT_75	[p7l1170t2031r1501b2095],
17	of	IN	O	of	_	0	SENT_75	[p7l1538t2031r1620b2095],
18	only	RB	O	only	advmod	20	SENT_75	[p7l1648t2031r1807b2113],
19	the	DT	O	the	det	20	SENT_75	[p7l1842t2031r1950b2095],
20	dose	NN	O	dose	prep_of	16	SENT_75	[p7l1989t2031r2151b2095],
21	of	IN	O	of	_	0	SENT_75	[p7l10t2142r92b2206],
22	INH	NNP	O	INH	prep_of	20	SENT_75	[p7l140t2144r298b2206],
23	assigned	VBN	O	assign	partmod	22	SENT_75	[p7l357t2142r671b2224],
24	to	TO	O	to	_	0	SENT_75	[p7l727t2151r794b2206],
25	each	DT	O	each	det	26	SENT_75	[p7l855t2142r1019b2206],
26	patient	NN	O	patient	prep_to	23	SENT_75	[p7l1074t2142r1325b2224],
27	(	CD	NUMBER	(	num	26	SENT_75	[p7l1383t2142r1525b2223],
28	see	VBP	O	see	_	0	SENT_75	[p7l1383t2142r1525b2223],
29	Table	NNP	O	Table	dobj	28	SENT_75	[p7l1584t2142r1781b2206],
30	1	CD	NUMBER	1	num	29	SENT_75	[p7l1849t2142r1930b2223],
31	)	CD	NUMBER	)	nsubj	28	SENT_75	[p7l1849t2142r1930b2223],
32	.	.	O	.	_	0	SENT_75	[p7l1849t2142r1930b2223],

1	INH	NN	O	inh	nn	2	SENT_76	[p7l1994t2144r2152b2206],
2	dosage	NN	O	dosage	nsubjpass	15	SENT_76	[p7l10t2253r266b2335],
3	for	IN	O	for	_	0	SENT_76	[p7l329t2253r436b2317],
4	patients	NNS	O	patient	prep_for	2	SENT_76	[p7l491t2253r783b2335],
5	with	IN	O	with	_	0	SENT_76	[p7l844t2253r1010b2317],
6	more	JJR	O	more	mwe	7	SENT_76	[p7l1069t2273r1257b2317],
7	than	IN	O	than	quantmod	8	SENT_76	[p7l1317t2253r1477b2316],
8	80	CD	NUMBER	80	num	9	SENT_76	[p7l1540t2254r1624b2317],
9	kg	NN	O	kg	prep_with	4	SENT_76	[p7l1686t2253r1777b2335],
10	in	IN	O	in	_	0	SENT_76	[p7l1838t2253r1908b2316],
11	body	NN	O	body	nn	12	SENT_76	[p7l1966t2253r2153b2335],
12	weight	NN	O	weight	prep_in	9	SENT_76	[p7l7t2364r246b2446],
13	was	VBD	O	be	auxpass	15	SENT_76	[p7l265t2385r400b2428],
14	not	RB	O	not	neg	15	SENT_76	[p7l422t2373r534b2428],
15	set	VBN	O	set	_	0	SENT_76	[p7l557t2373r651b2428],
16	up	RP	O	up	prt	15	SENT_76	[p7l669t2385r776b2446],
17	,	,	O	,	_	0	SENT_76	[p7l669t2385r776b2446],
18	in	IN	O	in	_	0	SENT_76	[p7l802t2364r869b2427],
19	consideration	NN	O	consideration	prep_in	15	SENT_76	[p7l891t2364r1356b2428],
20	for	IN	O	for	_	0	SENT_76	[p7l1379t2364r1479b2428],
21	average	JJ	O	average	amod	23	SENT_76	[p7l1500t2385r1766b2446],
22	body	NN	O	body	nn	23	SENT_76	[p7l1788t2364r1966b2446],
23	sizes	NNS	O	size	prep_for	19	SENT_76	[p7l1989t2364r2151b2428],
24	of	IN	O	of	_	0	SENT_76	[p7l10t2475r90b2539],
25	the	DT	O	the	det	27	SENT_76	[p7l99t2475r204b2539],
26	Japanese	JJ	MISC	japanese	amod	27	SENT_76	[p7l224t2478r528b2557],
27	population	NN	O	population	prep_of	23	SENT_76	[p7l548t2475r934b2557],
28	.	.	O	.	_	0	SENT_76	[p7l548t2475r934b2557],

1	The	DT	O	the	det	2	SENT_77	[p7l961t2475r1092b2539],
2	allocation	NN	O	allocation	_	0	SENT_77	[p7l1115t2475r1451b2539],
3	and	CC	O	and	_	0	SENT_77	[p7l1472t2475r1596b2539],
4	NAT	NN	O	nat	conj_and	2	SENT_77	[p7l1612t2477r1782b2539],
5	2	CD	NUMBER	2	num	6	SENT_77	[p7l1773t2477r1814b2538],
6	genotype	NN	O	genotype	dep	2	SENT_77	[p7l1837t2484r2152b2557],

1	Fig	NN	O	fig	_	0	SENT_78	[p7l8t2919r275b3073],
2	.	.	O	.	_	0	SENT_78	[p7l8t2919r275b3073],

1	1	CD	NUMBER	1	num	2	SENT_79	[p7l344t2919r405b3035],
2	Tria	NN	ORGANIZATION	trium	_	0	SENT_79	[p7l529t2917r791b3037],
3	proﬁle	NN	O	proﬁle	dep	2	SENT_79	[p7l877t2917r1340b3071],
4	.	.	O	.	_	0	SENT_79	[p7l877t2917r1340b3071],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_80	[p7l6t3116r966b3236],
2	:	:	O	:	_	0	SENT_80	[p7l6t3116r966b3236],
3	RA-type	JJ	O	ra-type	amod	7	SENT_80	[p7l1023t3118r1619b3272],
4	,	,	O	,	_	0	SENT_80	[p7l1023t3118r1619b3272],
5	rapid	JJ	O	rapid	amod	7	SENT_80	[p7l1674t3116r2008b3270],
6	acetylator	NN	O	acetylator	nn	7	SENT_80	[p7l11t3312r652b3468],
7	genotype	NN	O	genotype	dep	1	SENT_80	[p7l681t3329r1278b3468],
8	homozygous	JJ	O	homozygous	amod	7	SENT_80	[p7l1314t3312r2152b3468],
9	for	IN	O	for	_	0	SENT_80	[p7l13t3514r201b3634],
10	NAT	NNP	ORGANIZATION	NAT	prep_for	8	SENT_80	[p7l236t3516r556b3634],
11	2	CD	NUMBER	2	num	10	SENT_80	[p7l541t3514r822b3660],
12	*	CD	NUMBER	*	number	13	SENT_80	[p7l541t3514r822b3660],
13	4	CD	NUMBER	4	num	10	SENT_80	[p7l541t3514r822b3660],
14	;	:	O	;	_	0	SENT_80	[p7l541t3514r822b3660],
15	IA-type	JJ	O	ia-type	amod	17	SENT_80	[p7l879t3516r1415b3670],
16	,	,	O	,	_	0	SENT_80	[p7l879t3516r1415b3670],
17	intermediate	JJ	O	intermediate	amod	10	SENT_80	[p7l1472t3514r2140b3634, p8l11t45r193b148],

1	acetylator	NN	O	acetylator	nn	2	SENT_81	[p8l246t28r885b184],
2	genotypes	NNS	O	genotype	dep	3	SENT_81	[p8l927t45r1585b184],
3	heterozygous	JJ	O	heterozygous	_	0	SENT_81	[p8l1633t28r2092b148, p8l8t265r469b380],
4	for	IN	O	for	_	0	SENT_81	[p8l524t224r714b344],
5	NAT	NNP	ORGANIZATION	NAT	prep_for	3	SENT_81	[p8l748t227r1067b346],
6	2	CD	NUMBER	2	num	5	SENT_81	[p8l1052t224r1335b371],
7	*	CD	NUMBER	*	number	8	SENT_81	[p8l1052t224r1335b371],
8	4	CD	NUMBER	4	dep	5	SENT_81	[p8l1052t224r1335b371],
9	;	:	O	;	_	0	SENT_81	[p8l1052t224r1335b371],
10	SA-type	JJ	O	sa-type	amod	15	SENT_81	[p8l1398t227r1969b380],
11	,	,	O	,	_	0	SENT_81	[p8l1398t227r1969b380],
12	slow	JJ	O	slow	amod	15	SENT_81	[p8l13t423r316b545],
13	acety	NN	O	acety	nn	15	SENT_81	[p8l366t442r707b579],
14	ator	NN	O	ator	nn	15	SENT_81	[p8l757t442r1005b545],
15	genotypes	NNS	O	genotype	dep	5	SENT_81	[p8l1048t442r1708b579],
16	Without	IN	O	without	rcmod	15	SENT_81	[p8l6t625r510b745],
17	NAT	NNP	ORGANIZATION	NAT	pobj	16	SENT_81	[p8l546t627r868b745],
18	2	CD	NUMBER	2	num	17	SENT_81	[p8l851t625r1096b745],
19	*	CD	NUMBER	*	number	20	SENT_81	[p8l851t625r1096b745],
20	4	CD	NUMBER	4	num	21	SENT_81	[p8l851t625r1096b745],
21	_	NN	O	_	dep	15	SENT_81	[p8l1108t664r1134b771],
22	;	:	O	;	_	0	SENT_81	[p8l1108t664r1134b771],
23	PGX	NNP	O	PGX	nn	25	SENT_81	[p8l1189t627r1514b771],
24	,	,	O	,	_	0	SENT_81	[p8l1189t627r1514b771],
25	NAT	NNP	ORGANIZATION	NAT	dep	5	SENT_81	[p8l1561t627r1883b745],
26	2	CD	NUMBER	2	num	25	SENT_81	[p8l1868t627r1946b743],
27	genotype-guided	JJ	O	genotype-guided	amod	28	SENT_81	[p8l11t821r1110b977],
28	treatment	NN	O	treatment	dep	25	SENT_81	[p8l1155t838r1768b941],
29	in	IN	O	in	_	0	SENT_81	[p8l1816t821r1938b941],
30	which	WDT	O	which	rel	35	SENT_81	[p8l6t1020r409b1142],
31	INHJ	NNP	O	INHJ	nn	32	SENT_81	[p8l457t1027r745b1142],
32	dosage	NN	O	dosage	nsubj	35	SENT_81	[p8l796t1020r1245b1176],
33	was	VBD	O	be	cop	35	SENT_81	[p8l1292t1061r1545b1142],
34	phannacogenetically	RB	O	phannacogenetically	advmod	35	SENT_81	[p8l1592t1020r2135b1176, p8l11t1219r875b1375],
35	stratiﬁed	JJ	O	stratiﬁed	rcmod	5	SENT_81	[p8l927t1219r1492b1341],
36	based	VBN	O	base	_	0	SENT_81	[p8l1535t1219r1912b1341],
37	on	IN	O	on	prepc_based_on	35	SENT_81	[p8l1959t1260r2123b1341],
38	individual	JJ	O	individual	amod	39	SENT_81	[p8l11t1418r666b1540],
39	NAT2	NN	O	nat2	pobj	35	SENT_81	[p8l709t1421r1115b1538],
40	genotype	NN	O	genotype	dep	39	SENT_81	[p8l1168t1435r1804b1574],
41	;	:	O	;	_	0	SENT_81	[p8l1168t1435r1804b1574],
42	S	NN	O	s	nn	43	SENT_81	[p8l16t1622r90b1740],
43	TD	NN	O	td	dep	39	SENT_81	[p8l104t1625r354b1764],
44	,	,	O	,	_	0	SENT_81	[p8l104t1625r354b1764],
45	conventional	JJ	O	conventional	amod	47	SENT_81	[p8l409t1618r1249b1740],
46	standard	JJ	O	standard	amod	47	SENT_81	[p8l1302t1618r1849b1740],
47	treatment	NN	O	treatment	appos	43	SENT_81	[p8l8t1836r623b1939],
48	with	IN	O	with	_	0	SENT_81	[p8l664t1817r957b1939],
49	standardized	JJ	O	standardized	amod	50	SENT_81	[p8l1007t1817r1825b1939],
50	dosage	NN	O	dosage	prep_with	47	SENT_81	[p8l11t2015r462b2171],
51	for	IN	O	for	_	0	SENT_81	[p8l513t2015r702b2135],
52	all	DT	O	all	prep_for	50	SENT_81	[p8l747t2015r937b2162],
53	;	:	O	;	_	0	SENT_81	[p8l747t2015r937b2162],
54	Low-dose	NN	O	low-dose	dep	39	SENT_81	[p8l993t2015r1681b2162],
55	,	,	O	,	_	0	SENT_81	[p8l993t2015r1681b2162],
56	half	PDT	O	half	predet	60	SENT_81	[p8l1734t2015r2008b2135],
57	the	DT	O	the	det	60	SENT_81	[p8l8t2215r203b2337],
58	conventional	JJ	O	conventional	amod	60	SENT_81	[p8l258t2215r1094b2337],
59	standard	NN	O	standard	nn	60	SENT_81	[p8l1148t2215r1698b2337],
60	dose	NN	O	dose	appos	54	SENT_81	[p8l1744t2215r2075b2361],
61	;	:	O	;	_	0	SENT_81	[p8l1744t2215r2075b2361],
62	High-dose	JJ	O	high-dose	dep	39	SENT_81	[p8l8t2413r724b2569],
63	,	,	O	,	_	0	SENT_81	[p8l8t2413r724b2569],
64	1.5	CD	NUMBER	1.5	number	65	SENT_81	[p8l795t2418r971b2535],
65	times	NNS	O	time	appos	62	SENT_81	[p8l1028t2415r1374b2535],
66	the	DT	O	the	det	68	SENT_81	[p8l1424t2413r1621b2535],
67	standard	JJ	O	standard	amod	68	SENT_81	[p8l13t2615r561b2735],
68	dose	NN	O	dose	dep	65	SENT_81	[p8l608t2615r942b2759],
69	;	:	O	;	_	0	SENT_81	[p8l608t2615r942b2759],
70	St-dose	NN	O	st-dose	dep	39	SENT_81	[p8l1004t2615r1518b2761],
71	,	,	O	,	_	0	SENT_81	[p8l1004t2615r1518b2761],
72	convntional	JJ	O	convntional	amod	74	SENT_81	[p8l11t2812r851b2934],
73	standard	JJ	O	standard	amod	74	SENT_81	[p8l904t2812r1451b2934],
74	dos	NNS	O	do	appos	70	SENT_81	[p8l1499t2812r1832b2958],
75	;	:	O	;	_	0	SENT_81	[p8l1499t2812r1832b2958],
76	INH-DILI	NN	O	inh-dili	dep	39	SENT_81	[p8l10t3017r711b3157],
77	,	,	O	,	_	0	SENT_81	[p8l10t3017r711b3157],
78	Drug-induced	JJ	O	drug-induced	amod	80	SENT_81	[p8l764t3010r1674b3166],
79	liver	NN	O	liver	nn	80	SENT_81	[p8l1724t3010r2020b3132],
80	injury	NN	O	injury	appos	76	SENT_81	[p8l11t3212r397b3366],
81	associated	VBN	O	associate	partmod	39	SENT_81	[p8l445t3212r1110b3332],
82	with	IN	O	with	_	0	SENT_81	[p8l1155t3212r1446b3332],
83	isoniazid	NN	O	isoniazid	prep_with	81	SENT_81	[p8l1496t3212r2082b3332],

1	Provided	VBN	O	provide	_	0	SENT_82	[p9l420t136r614b174],
2	informed	JJ	O	informed	amod	3	SENT_82	[p9l628t136r823b174],
3	consents	NNS	O	consent	nn	11	SENT_82	[p9l840t142r1022b174],
4	for	IN	O	for	_	0	SENT_82	[p9l1040t136r1102b174],
5	the	DT	O	the	det	8	SENT_82	[p9l1117t137r1180b174],
6	study	NN	O	study	nn	8	SENT_82	[p9l1198t136r1311b185],
7	(	NN	O	(	nn	8	SENT_82	[p9l1342t137r1513b183],
8	n	NN	O	n	prep_for	3	SENT_82	[p9l1342t137r1513b183],
9	=	JJ	O	=	amod	11	SENT_82	[p9l1342t137r1513b183],
10	173	CD	NUMBER	173	tmod	9	SENT_82	[p9l1342t137r1513b183],
11	)	NN	O	)	dobj	1	SENT_82	[p9l1342t137r1513b183],

1	NAT2	NN	O	nat2	nn	3	SENT_83	[p9l46t412r170b449],
2	genotyping	NN	O	genotyping	nn	3	SENT_83	[p9l188t411r426b460],
3	g	NN	O	g	_	0	SENT_83	[p9l1055t420r1422b464],
4	Screening	VBG	O	screen	partmod	3	SENT_83	[p9l1552t417r1763b466],
5	test	NN	O	test	nn	6	SENT_83	[p9l1781t423r1855b455],
6	(	NN	O	(	dobj	4	SENT_83	[p9l49t476r104b523],
7	at	IN	O	at	_	0	SENT_83	[p9l49t476r104b523],
8	a	DT	O	a	det	12	SENT_83	[p9l119t488r142b514],
9	Central	NNP	MISC	Central	nn	12	SENT_83	[p9l157t476r301b514],
10	laboratory	NN	O	laboratory	nn	12	SENT_83	[p9l318t476r554b525],
11	)	CD	NUMBER	)	num	12	SENT_83	[p9l318t476r554b525],
12	(	NN	O	(	prep_at	4	SENT_83	[p9l1175t482r1229b528],
13	at	IN	O	at	_	0	SENT_83	[p9l1175t482r1229b528],
14	each	DT	O	each	det	16	SENT_83	[p9l1244t481r1340b519],
15	hospital	NN	O	hospital	nn	16	SENT_83	[p9l1356t481r1525b530],
16	laboratory	NN	O	laboratory	prep_at	12	SENT_83	[p9l1541t481r1762b530],
17	as	IN	O	as	_	0	SENT_83	[p9l1778t493r1819b519],
18	routine	JJ	O	routine	amod	19	SENT_83	[p9l1835t481r2002b528],
19	)	NN	O	)	prep_as	16	SENT_83	[p9l1835t481r2002b528],

1	e	LS	O	e	dep	4	SENT_84	[p9l1061t628r1429b672],
2	Ineligible	JJ	O	ineligible	amod	4	SENT_84	[p9l1474t630r1689b682],
3	(	NN	O	(	nn	4	SENT_84	[p9l1721t631r1842b680],
4	n	NN	O	n	_	0	SENT_84	[p9l1721t631r1842b680],
5	=	JJ	O	=	prep	4	SENT_84	[p9l1721t631r1842b680],
6	1	CD	NUMBER	1	dep	5	SENT_84	[p9l1721t631r1842b680],
7	)	NN	O	)	dep	4	SENT_84	[p9l1721t631r1842b680],

1	Computer	NNP	O	Computer	nsubj	2	SENT_85	[p9l81t882r295b931],
2	generated	VBD	O	generate	_	0	SENT_85	[p9l311t882r518b931],
3	randomized	VBN	O	randomize	dep	2	SENT_85	[p9l535t882r788b919],
4	dynamic	JJ	O	dynamic	amod	5	SENT_85	[p9l805t882r985b931],
5	allocation	NN	O	allocation	dobj	3	SENT_85	[p9l1005t882r1215b919],
6	'	''	O	'	_	0	SENT_85	[p9l6t1378r23b1421],

1	\	NN	O	\	nn	2	SENT_86	[p9l6t1378r23b1421],
2	St-dose	NN	MISC	st-dose	_	0	SENT_86	[p9l175t1374r333b1412],
3	Low-dose	JJ	MISC	low-dose	amod	4	SENT_86	[p9l461t1374r673b1412],
4	Middle	NN	MISC	middle	rcmod	2	SENT_86	[p9l869t1374r1024b1412],
5	(	CD	NUMBER	(	num	6	SENT_86	[p9l1041t1374r1235b1421],
6	St	NNP	O	St	dep	4	SENT_86	[p9l1041t1374r1235b1421],
7	)	SYM	O	)	dep	4	SENT_86	[p9l1041t1374r1235b1421],
8	-	:	O	-	_	0	SENT_86	[p9l1041t1374r1235b1421],
9	dose	NN	O	dose	nn	11	SENT_86	[p9l1041t1374r1235b1421],
10	High-dose	JJ	O	high-dose	amod	11	SENT_86	[p9l1473t1374r1694b1423],
11	St-dose	NN	O	st-dose	dep	2	SENT_86	[p9l1829t1374r1987b1412],
12	‘	CD	NUMBER	‘	dep	11	SENT_86	[p9l2131t1388r2152b1430],
13	I	PRP	O	I	nsubj	14	SENT_86	[p9l2131t1388r2152b1430],
14	‘	VBP	O	‘	rcmod	12	SENT_86	[p9l27t1432r34b1439],
15	'	''	O	'	_	0	SENT_86	[p9l73t1469r80b1476],
16	—	CD	NUMBER	—	dep	14	SENT_86	[p9l94t1475r116b1484],
17	.	.	O	.	_	0	SENT_86	[p9l132t1478r138b1484],

1	_	NN	O	_	_	0	SENT_87	[p9l153t1478r176b1484],
2	.	.	O	.	_	0	SENT_87	[p9l191t1478r260b1534],

1	_	NN	O	_	_	0	SENT_88	[p9l191t1478r260b1534],
2	.	.	O	.	_	0	SENT_88	[p9l191t1478r260b1534],

1	|	NN	O	|	_	0	SENT_89	[p9l191t1478r260b1534],
2	_	NN	O	_	dep	1	SENT_89	[p9l272t1478r294b1484],
3	.	.	O	.	_	0	SENT_89	[p9l310t1478r316b1484],

1	_	NN	O	_	_	0	SENT_90	[p9l332t1478r354b1484],
2	.	.	O	.	_	0	SENT_90	[p9l369t1478r375b1484],

1	_	NN	O	_	_	0	SENT_91	[p9l391t1478r413b1484],
2	.	.	O	.	_	0	SENT_91	[p9l429t1478r435b1484],

1	_	NN	O	_	_	0	SENT_92	[p9l450t1478r473b1484],
2	.	.	O	.	_	0	SENT_92	[p9l488t1478r494b1484],

1	_	NN	O	_	_	0	SENT_93	[p9l510t1478r532b1484],
2	.	.	O	.	_	0	SENT_93	[p9l548t1478r616b1534],

1	_	NN	O	_	_	0	SENT_94	[p9l548t1478r616b1534],
2	l	NN	O	l	nn	3	SENT_94	[p9l548t1478r616b1534],
3	_	NN	O	_	dep	1	SENT_94	[p9l629t1478r651b1484],
4	.	.	O	.	_	0	SENT_94	[p9l666t1478r672b1484],

1	_	NN	O	_	_	0	SENT_95	[p9l688t1478r710b1484],
2	.	.	O	.	_	0	SENT_95	[p9l726t1478r732b1484],

1	_	NN	O	_	_	0	SENT_96	[p9l747t1478r769b1484],
2	.	.	O	.	_	0	SENT_96	[p9l785t1478r791b1484],

1	_	NN	O	_	_	0	SENT_97	[p9l807t1478r829b1484],
2	.	.	O	.	_	0	SENT_97	[p9l845t1478r850b1484],

1	_	NN	O	_	_	0	SENT_98	[p9l866t1478r888b1484],
2	.	.	O	.	_	0	SENT_98	[p9l904t1478r910b1484],

1	_	NN	O	_	_	0	SENT_99	[p9l926t1478r948b1484],
2	.	.	O	.	_	0	SENT_99	[p9l963t1478r969b1484],

1	_	NN	O	_	_	0	SENT_100	[p9l985t1478r1007b1484],
2	.	.	O	.	_	0	SENT_100	[p9l1023t1478r1093b1534],

1	_	NN	O	_	_	0	SENT_101	[p9l1023t1478r1093b1534],
2	.	.	O	.	_	0	SENT_101	[p9l1023t1478r1093b1534],

1	|	NN	O	|	_	0	SENT_102	[p9l1023t1478r1093b1534],
2	_	NN	O	_	dep	1	SENT_102	[p9l1104t1478r1126b1484],
3	.	.	O	.	_	0	SENT_102	[p9l1142t1478r1147b1484],

1	_	NN	O	_	_	0	SENT_103	[p9l1163t1478r1185b1484],
2	.	.	O	.	_	0	SENT_103	[p9l1201t1478r1207b1484],

1	_	NN	O	_	_	0	SENT_104	[p9l1222t1478r1245b1484],
2	.	.	O	.	_	0	SENT_104	[p9l1260t1478r1266b1484],

1	_	NN	O	_	_	0	SENT_105	[p9l1282t1478r1304b1484],
2	.	.	O	.	_	0	SENT_105	[p9l1320t1478r1326b1484],

1	_	NN	O	_	_	0	SENT_106	[p9l1341t1478r1364b1484],
2	.	.	O	.	_	0	SENT_106	[p9l1379t1478r1385b1484],

1	_	NN	O	_	_	0	SENT_107	[p9l1401t1478r1423b1484],
2	.	.	O	.	_	0	SENT_107	[p9l1439t1478r1444b1484],

1	_	NN	O	_	_	0	SENT_108	[p9l1460t1478r1482b1484],
2	.	.	O	.	_	0	SENT_108	[p9l1498t1478r1504b1484],

1	_	NN	O	_	_	0	SENT_109	[p9l1520t1478r1601b1534],
2	.	.	O	.	_	0	SENT_109	[p9l1520t1478r1601b1534],

1	.	.	O	.	_	0	SENT_110	[p9l1520t1478r1601b1534],

1	|	NN	O	|	_	0	SENT_111	[p9l1520t1478r1601b1534],
2	.	.	O	.	_	0	SENT_111	[p9l1520t1478r1601b1534],

1	.	.	O	.	_	0	SENT_112	[p9l1617t1478r1623b1484],

1	_	NN	O	_	_	0	SENT_113	[p9l1638t1478r1660b1484],
2	.	.	O	.	_	0	SENT_113	[p9l1676t1478r1682b1484],

1	_	NN	O	_	_	0	SENT_114	[p9l1698t1478r1720b1484],
2	.	.	O	.	_	0	SENT_114	[p9l1735t1478r1742b1484],

1	_	NN	O	_	_	0	SENT_115	[p9l1757t1478r1779b1484],
2	.	.	O	.	_	0	SENT_115	[p9l1795t1478r1801b1484],

1	_	NN	O	_	_	0	SENT_116	[p9l1817t1478r1839b1484],
2	.	.	O	.	_	0	SENT_116	[p9l1854t1478r1860b1484],

1	_	NN	O	_	_	0	SENT_117	[p9l1876t1464r2096b1534],
2	.	.	O	.	_	0	SENT_117	[p9l1876t1464r2096b1534],

1	_	NN	O	_	_	0	SENT_118	[p9l1876t1464r2096b1534],
2	|	NN	O	|	dep	1	SENT_118	[p9l1876t1464r2096b1534],
3	.	.	O	.	_	0	SENT_118	[p9l1876t1464r2096b1534],

1	_	NN	O	_	_	0	SENT_119	[p9l1876t1464r2096b1534],
2	.	.	O	.	_	0	SENT_119	[p9l1876t1464r2096b1534],

1	r	NN	O	r	_	0	SENT_120	[p9l1876t1464r2096b1534],
2	'	''	O	'	_	0	SENT_120	[p9l1876t1464r2096b1534],

1	Informed	VBN	O	inform	_	0	SENT_121	[p9l531t1568r729b1606],
2	only	RB	O	only	advmod	1	SENT_121	[p9l747t1568r840b1617],
3	assigned	VBN	O	assign	amod	4	SENT_121	[p9l857t1568r1039b1617],
4	dose	NN	O	dose	dobj	1	SENT_121	[p9l1056t1568r1152b1606],
5	of	IN	O	of	_	0	SENT_121	[p9l1168t1568r1215b1606],
6	INH	NN	O	inh	prep_of	4	SENT_121	[p9l1226t1569r1320b1606],
7	to	TO	O	to	_	0	SENT_121	[p9l1336t1574r1376b1606],
8	investigators	NNS	O	investigator	prep_to	6	SENT_121	[p9l1391t1568r1663b1617],

1	.	.	O	.	_	0	SENT_122	[p9l6t883r19b1362],

1	—	SYM	O	—	dep	10	SENT_123	[p9l6t883r19b1362],
2	. . .	FW	O	. . .	nn	10	SENT_123	[p9l6t883r19b1362],[p9l6t883r19b1362],
3	—	FW	O	—	nn	10	SENT_123	[p9l6t883r19b1362],
4	. . .	FW	O	. . .	nn	10	SENT_123	[p9l6t883r19b1362],[p9l6t883r19b1362],
5	—	FW	O	—	nn	10	SENT_123	[p9l6t883r19b1362],
6	. . .	FW	O	. . .	nn	10	SENT_123	[p9l6t883r19b1362],[p9l6t883r19b1362],
7	—	FW	O	—	nn	10	SENT_123	[p9l6t883r19b1362],
8	. . .	FW	O	. . .	nn	10	SENT_123	[p9l6t883r19b1362],[p9l6t883r19b1362],
9	—	FW	O	—	nn	10	SENT_123	[p9l6t883r19b1362],
10	. . .	FW	O	. . .	_	0	SENT_123	[p9l6t883r19b1362],[p9l6t883r19b1362],
11	—	FW	O	—	dep	10	SENT_123	[p9l6t883r19b1362],
12	.	.	O	.	_	0	SENT_123	[p9l6t883r19b1362],

1	.	.	O	.	_	0	SENT_124	[p9l6t883r19b1362],

1	_	NN	O	_	_	0	SENT_125	[p9l6t883r19b1362],
2	.	.	O	.	_	0	SENT_125	[p9l6t883r19b1362],

1	:	:	O	:	_	0	SENT_126	[p9l6t883r19b1362],
2	.	.	O	.	_	0	SENT_126	[p9l6t883r19b1362],

1	. . .	FW	O	. . .	_	0	SENT_127	[p9l2143t892r2154b1373],[p9l6t883r19b1362],
2	—	FW	O	—	nn	16	SENT_127	[p9l2143t892r2154b1373],
3	. . .	FW	O	. . .	nn	16	SENT_127	[p9l2143t892r2154b1373],[p9l2143t892r2154b1373],
4	—	FW	O	—	nn	16	SENT_127	[p9l2143t892r2154b1373],
5	. . .	FW	O	. . .	nn	16	SENT_127	[p9l2143t892r2154b1373],[p9l2143t892r2154b1373],
6	—	FW	O	—	nn	16	SENT_127	[p9l2143t892r2154b1373],
7	. . .	FW	O	. . .	nn	16	SENT_127	[p9l2143t892r2154b1373],[p9l2143t892r2154b1373],
8	—	FW	O	—	nn	16	SENT_127	[p9l2143t892r2154b1373],
9	. . .	FW	O	. . .	nn	16	SENT_127	[p9l2143t892r2154b1373],[p9l2143t892r2154b1373],
10	—	FW	O	—	nn	16	SENT_127	[p9l2143t892r2154b1373],
11	. . .	FW	O	. . .	nn	16	SENT_127	[p9l2143t892r2154b1373],[p9l2143t892r2154b1373],
12	—	FW	O	—	nn	16	SENT_127	[p9l2143t892r2154b1373],
13	. . .	FW	O	. . .	nn	16	SENT_127	[p9l2143t892r2154b1373],[p9l2143t892r2154b1373],
14	—	FW	O	—	nn	16	SENT_127	[p9l2143t892r2154b1373],
15	. . .	FW	O	. . .	nn	16	SENT_127	[p9l2143t892r2154b1373],[p9l2143t892r2154b1373],
16	—	FW	O	—	dep	1	SENT_127	[p9l2143t892r2154b1373],
17	.	.	O	.	_	0	SENT_127	[p9l2143t892r2154b1373],

1	I	PRP	O	I	_	0	SENT_128	[p9l2143t892r2154b1373],

1	Valid	JJ	O	valid	_	0	SENT_129	[p9l6t1934r233b2007],
2	for	IN	O	for	_	0	SENT_129	[p9l263t1934r381b2007],
3	INH	NN	O	inh	prep_for	1	SENT_129	[p9l409t1937r829b2007],
4	.	.	O	.	_	0	SENT_129	[p9l409t1937r829b2007],

1	—	NN	O	—	_	0	SENT_130	[p9l409t1937r829b2007],
2	.	.	O	.	_	0	SENT_130	[p9l409t1937r829b2007],

1	DILI	NNP	O	DILI	_	0	SENT_131	[p9l409t1937r829b2007],

1	—	NNP	O	—	nn	2	SENT_132	[p9l233t2421r259b2428],
2	Non	NNP	O	Non	_	0	SENT_132	[p9l317t2376r1022b2449],
3	—	FW	O	—	nn	6	SENT_132	[p9l317t2376r1022b2449],
4	tuberculosis	FW	O	tuberculosis	nn	6	SENT_132	[p9l317t2376r1022b2449],
5	Micobacterium	NN	O	micobacterium	nn	6	SENT_132	[p9l231t2501r861b2574],
6	infection	NN	O	infection	dep	2	SENT_132	[p9l888t2501r1253b2574],

1	—	NN	O	—	nn	2	SENT_133	[p9l228t2919r254b2927],
2	INH	NN	O	inh	dep	4	SENT_133	[p9l313t2876r872b2948],
3	—	CD	NUMBER	—	dep	2	SENT_133	[p9l313t2876r872b2948],
4	resistant	JJ	O	resistant	_	0	SENT_133	[p9l313t2876r872b2948],

1	Valid	JJ	O	valid	_	0	SENT_134	[p9l6t3257r233b3329],
2	for	IN	O	for	_	0	SENT_134	[p9l262t3257r381b3329],
3	early	JJ	O	early	amod	5	SENT_134	[p9l7t3382r209b3475],
4	treatment	NN	O	treatment	nn	5	SENT_134	[p9l240t3392r627b3453],
5	failure	NN	O	failure	prep_for	1	SENT_134	[p9l658t3382r922b3453],

1	@	IN	O	@	_	0	SENT_135	[p10l1655t2151r1761b2281],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_135	[p10l1798t2184r2153b2285],

1	1094	CD	DATE	1094	_	0	SENT_136	[p10l56t2360r122b2385],
2	Eur	NNP	O	Eur	nn	5	SENT_136	[p10l1486t2361r1536b2385],
3	J	NNP	O	J	nn	5	SENT_136	[p10l1547t2361r1560b2385],
4	Clin	NNP	PERSON	Clin	nn	5	SENT_136	[p10l1571t2360r1631b2385],
5	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_136	[p10l1642t2360r1790b2385],
6	(	CD	NUMBER	(	num	7	SENT_136	[p10l1802t2360r1893b2392],
7	2013	CD	DATE	2013	dep	1	SENT_136	[p10l1802t2360r1893b2392],
8	)	CD	NUMBER	)	number	9	SENT_136	[p10l1802t2360r1893b2392],
9	69:1091	CD	NUMBER	69:1091	num	11	SENT_136	[p10l1906t2360r2103b2385],
10	—	CD	NUMBER	—	number	11	SENT_136	[p10l1906t2360r2103b2385],
11	1101	CD	DATE	1101	dep	7	SENT_136	[p10l1906t2360r2103b2385],

1	Table	NNP	O	Table	nn	3	SENT_137	[p10l11t2522r188b2574],
2	1	CD	NUMBER	1	num	3	SENT_137	[p10l229t2521r257b2573],
3	Dose	NN	O	dose	dep	20	SENT_137	[p10l312t2522r466b2574],
4	of	IN	O	of	_	0	SENT_137	[p10l506t2520r575b2574],
5	isoniazid	NN	O	isoniazid	prep_of	3	SENT_137	[p10l603t2520r876b2574],
6	in	IN	O	in	_	0	SENT_137	[p10l914t2520r971b2573],
7	NAT	NNP	O	NAT	nn	9	SENT_137	[p10l1004t2521r1151b2574],
8	2-genotype-guided	JJ	O	2-genotype-guided	amod	9	SENT_137	[p10l1145t2520r1723b2589],
9	treatment	NN	O	treatment	prep_in	5	SENT_137	[p10l1758t2527r2045b2574],
10	or	CC	O	or	_	0	SENT_137	[p10l2082t2537r2144b2574],
11	conventional	JJ	O	conventional	amod	14	SENT_137	[p10l11t2608r397b2663],
12	standard	JJ	O	standard	amod	14	SENT_137	[p10l424t2608r675b2663],
13	treatment	NN	O	treatment	nn	14	SENT_137	[p10l699t2616r980b2663],
14	NAT	NN	O	nat	prep_in	5	SENT_137	[p10l7t2774r152b2827],
15	2	CD	NUMBER	2	num	16	SENT_137	[p10l146t2774r181b2826],
16	status	NN	O	status	dep	20	SENT_137	[p10l209t2780r374b2827],
17	SA-type	JJ	O	sa-type	amod	20	SENT_137	[p10l690t2774r935b2842],
18	IA-type	JJ	O	ia-type	amod	20	SENT_137	[p10l1219t2774r1449b2842],
19	RA-type	JJ	O	ra-type	amod	20	SENT_137	[p10l1750t2774r2006b2842],
20	Body	NN	O	body	dep	25	SENT_137	[p10l10t2949r173b3018],
21	weight	NN	O	weight	nn	24	SENT_137	[p10l197t2949r547b3018],
22	(	CD	NUMBER	(	num	24	SENT_137	[p10l197t2949r547b3018],
23	kg	NN	O	kg	nn	24	SENT_137	[p10l197t2949r547b3018],
24	)	NN	O	)	dep	20	SENT_137	[p10l197t2949r547b3018],
25	<	JJR	O	<	dep	46	SENT_137	[p10l687t2950r802b3003],
26	40	CD	NUMBER	40	number	27	SENT_137	[p10l687t2950r802b3003],
27	40	CD	NUMBER	40	dep	25	SENT_137	[p10l942t2950r1058b3008],
28	:	:	O	:	_	0	SENT_137	[p10l942t2950r1058b3008],
29	<	JJR	O	<	dep	25	SENT_137	[p10l1218t2950r1333b3003],
30	40	CD	NUMBER	40	number	31	SENT_137	[p10l1218t2950r1333b3003],
31	40	CD	NUMBER	40	dep	29	SENT_137	[p10l1473t2950r1590b3008],
32	:	:	O	:	_	0	SENT_137	[p10l1473t2950r1590b3008],
33	<	JJR	O	<	dep	25	SENT_137	[p10l1750t2950r1864b3003],
34	40	CD	NUMBER	40	number	35	SENT_137	[p10l1750t2950r1864b3003],
35	40	CD	NUMBER	40	dep	33	SENT_137	[p10l2005t2950r2121b3008],
36	:	:	O	:	_	0	SENT_137	[p10l2005t2950r2121b3008],
37	Dose	NN	O	dose	dep	25	SENT_137	[p10l10t3141r163b3192],
38	of	IN	O	of	_	0	SENT_137	[p10l189t3138r258b3192],
39	isoniazid	NN	O	isoniazid	nn	41	SENT_137	[p10l275t3138r543b3192],
40	(	CD	NUMBER	(	num	41	SENT_137	[p10l569t3139r702b3208],
41	mg	NN	O	mg	prep_of	37	SENT_137	[p10l569t3139r702b3208],
42	,	,	O	,	_	0	SENT_137	[p10l569t3139r702b3208],
43	once	RB	DATE	once	advmod	25	SENT_137	[p10l731t3156r869b3192],
44	a	DT	DURATION	a	det	45	SENT_137	[p10l896t3156r927b3192],
45	day	NN	DURATION	day	dep	25	SENT_137	[p10l952t3138r1081b3208],
46	)	CD	NUMBER	)	_	0	SENT_137	[p10l952t3138r1081b3208],

1	PGX-treatment	JJ	O	pgx-treatment	amod	2	SENT_138	[p10l61t3234r501b3287],
2	100 150 200 300	CD	NUMBER	100 150 200 300	dep	8	SENT_138	[p10l1475t3234r1584b3287],[p10l695t3234r797b3287],
3	300	CD	NUMBER	300	number	4	SENT_138	[p10l1752t3234r1860b3287],
4	450	CD	NUMBER	450	dep	2	SENT_138	[p10l2005t3234r2115b3287],
5	STD-treatment	NN	O	std-treatment	dep	4	SENT_138	[p10l65t3348r509b3401],
6	200	CD	NUMBER	200	dep	8	SENT_138	[p10l687t3348r797b3401],
7	300a	CD	NUMBER	300a	num	8	SENT_138	[p10l944t3343r1080b3401],
8	200 3003 200 300	CD	NUMBER	200 3003 200 300	dep	14	SENT_138	[p10l2007t3343r2143b3401],[p10l1218t3348r1329b3401],
9	a	DT	O	a	det	12	SENT_138	[p10l2007t3343r2143b3401],
10	lsoniazid	NN	O	lsoniazid	nn	12	SENT_138	[p11l11t35r284b89],
11	tablet	NN	O	tablet	nn	12	SENT_138	[p11l309t35r475b89],
12	(	NN	O	(	dep	8	SENT_138	[p11l501t35r634b104],
13	100	CD	NUMBER	100	num	14	SENT_138	[p11l501t35r634b104],
14	mg	NN	O	mg	dep	20	SENT_138	[p11l662t53r773b105],
15	,	,	O	,	_	0	SENT_138	[p11l662t53r773b105],
16	50	CD	NUMBER	50	num	18	SENT_138	[p11l804t36r874b89],
17	mg	NN	O	mg	nn	18	SENT_138	[p11l901t35r1019b105],
18	)	NN	O	)	nsubjpass	20	SENT_138	[p11l901t35r1019b105],
19	was	VBD	O	be	auxpass	20	SENT_138	[p11l1045t53r1160b89],
20	used	VBN	O	use	_	0	SENT_138	[p11l1186t35r1325b89],
21	practically	RB	O	practically	advmod	20	SENT_138	[p11l1349t35r1673b105],
22	.	.	O	.	_	0	SENT_138	[p11l1349t35r1673b105],

1	Stratiﬁed	JJ	O	stratiﬁed	amod	2	SENT_139	[p11l1707t35r1980b89],
2	dose	NN	O	dose	nsubj	4	SENT_139	[p11l2007t35r2141b89],
3	was	VBD	O	be	cop	4	SENT_139	[p11l9t141r124b178],
4	2.5	CD	NUMBER	2.5	_	0	SENT_139	[p11l153t125r262b189],
5	,	,	O	,	_	0	SENT_139	[p11l153t125r262b189],
6	5	CD	NUMBER	5	appos	4	SENT_139	[p11l294t125r344b189],
7	,	,	O	,	_	0	SENT_139	[p11l294t125r344b189],
8	7.5	CD	NUMBER	7.5	num	9	SENT_139	[p11l376t126r463b178],
9	mg/kg	NN	O	mg/kg	appos	4	SENT_139	[p11l494t123r684b193],
10	b.	NNP	O	b.	nn	11	SENT_139	[p11l711t123r763b177],
11	W.	NNP	O	W.	dep	9	SENT_139	[p11l794t142r857b178],
12	for	IN	O	for	_	0	SENT_139	[p11l890t123r976b178],
13	patients	NNS	O	patient	prep_for	11	SENT_139	[p11l999t123r1231b193],
14	with	IN	O	with	_	0	SENT_139	[p11l1258t123r1392b178],
15	SA	NNP	O	SA	prep_with	13	SENT_139	[p11l1421t124r1553b189],
16	-	:	O	-	_	0	SENT_139	[p11l1421t124r1553b189],
17	,	,	O	,	_	0	SENT_139	[p11l1421t124r1553b189],
18	IA	SYM	ORGANIZATION	ia	dep	13	SENT_139	[p11l1584t125r1701b189],
19	-	:	O	-	_	0	SENT_139	[p11l1584t125r1701b189],
20	,	,	O	,	_	0	SENT_139	[p11l1584t125r1701b189],
21	and	CC	O	and	_	0	SENT_139	[p11l1733t123r1839b178],
22	RA-type	NN	O	ra-type	conj_and	4	SENT_139	[p11l1865t124r2139b193],
23	,	,	O	,	_	0	SENT_139	[p11l1865t124r2139b193],
24	respectively	RB	O	respectively	advmod	4	SENT_139	[p11l9t211r380b280],
25	.	.	O	.	_	0	SENT_139	[p11l9t211r380b280],

1	SA-type	JJ	O	sa-type	amod	5	SENT_140	[p11l408t212r670b280],
2	,	,	O	,	_	0	SENT_140	[p11l408t212r670b280],
3	slow	JJ	O	slow	amod	5	SENT_140	[p11l696t211r834b265],
4	acetylator	NN	O	acetylator	nn	5	SENT_140	[p11l855t211r1150b280],
5	genotypes	NNS	O	genotype	_	0	SENT_140	[p11l1168t218r1469b280],
6	without	IN	O	without	dep	5	SENT_140	[p11l1491t211r1721b265],
7	NAT2	NN	O	nat2	pobj	6	SENT_140	[p11l1738t211r2017b277],
8	*	CD	NUMBER	*	number	9	SENT_140	[p11l1738t211r2017b277],
9	4	CD	NUMBER	4	num	7	SENT_140	[p11l1738t211r2017b277],
10	;	:	O	;	_	0	SENT_140	[p11l1738t211r2017b277],
11	IAtype	NN	O	iatype	nn	15	SENT_140	[p11l2041t212r2140b264, p11l10t306r157b369],
12	,	,	O	,	_	0	SENT_140	[p11l2041t212r2140b264, p11l10t306r157b369],
13	intermediate	JJ	O	intermediate	amod	15	SENT_140	[p11l198t299r575b353],
14	acetylator	NN	O	acetylator	nn	15	SENT_140	[p11l613t299r912b369],
15	genotypes	NNS	O	genotype	dep	16	SENT_140	[p11l948t306r1254b369],
16	heterozygous	JJ	O	heterozygous	parataxis	5	SENT_140	[p11l1292t299r1697b369],
17	for	IN	O	for	_	0	SENT_140	[p11l1737t299r1824b353],
18	NAT2	NN	O	nat2	prep_for	16	SENT_140	[p11l1856t299r2138b365],
19	*	CD	NUMBER	*	number	20	SENT_140	[p11l1856t299r2138b365],
20	4	CD	NUMBER	4	num	18	SENT_140	[p11l1856t299r2138b365],
21	;	:	O	;	_	0	SENT_140	[p11l1856t299r2138b365],
22	RAtype	NN	O	ratype	nn	26	SENT_140	[p11l10t389r259b457],
23	,	,	O	,	_	0	SENT_140	[p11l10t389r259b457],
24	rapid	JJ	O	rapid	amod	26	SENT_140	[p11l298t387r452b457],
25	acetylator	NN	O	acetylator	nn	26	SENT_140	[p11l489t387r783b457],
26	genotype	NN	O	genotype	dep	27	SENT_140	[p11l817t395r1091b457],
27	homozygous	JJ	O	homozygous	parataxis	5	SENT_140	[p11l1127t387r1511b457],
28	for	IN	O	for	_	0	SENT_140	[p11l1551t387r1636b441],
29	NAT2	NN	O	nat2	prep_for	27	SENT_140	[p11l1668t387r1944b441],
30	*	CD	NUMBER	*	number	31	SENT_140	[p11l1668t387r1944b441],
31	4	CD	NUMBER	4	num	29	SENT_140	[p11l1668t387r1944b441],
32	.	.	O	.	_	0	SENT_140	[p11l1668t387r1944b441],

1	PGxtreatment	NN	O	pgxtreatment	nsubj	5	SENT_141	[p11l1984t388r2140b442, p11l10t483r306b541],
2	,	,	O	,	_	0	SENT_141	[p11l1984t388r2140b442, p11l10t483r306b541],
3	NAT	NNP	O	NAT	nn	4	SENT_141	[p11l336t477r481b530],
4	2-genotype	NN	O	2-genotype	appos	1	SENT_141	[p11l475t477r811b545],
5	guided	VBD	O	guide	_	0	SENT_141	[p11l843t475r1046b545],
6	treatment	NN	O	treatment	dobj	5	SENT_141	[p11l1075t483r1372b541],
7	;	:	O	;	_	0	SENT_141	[p11l1075t483r1372b541],
8	STD-treatment	NN	O	std-treatment	dep	6	SENT_141	[p11l1409t476r1868b541],
9	,	,	O	,	_	0	SENT_141	[p11l1409t476r1868b541],
10	conventional	JJ	O	conventional	amod	12	SENT_141	[p11l1902t493r2140b530, p11l10t564r179b618],
11	standard	JJ	O	standard	amod	12	SENT_141	[p11l206t564r457b618],
12	treatment	NN	O	treatment	appos	8	SENT_141	[p11l481t571r776b618],
13	.	.	O	.	_	0	SENT_141	[p11l481t571r776b618],

1	a	DT	O	a	det	3	SENT_142	[p11l11t653r35b677],
2	Maximum	NNP	O	Maximum	nn	3	SENT_142	[p11l49t657r361b711],
3	dose	NN	O	dose	_	0	SENT_142	[p11l385t657r520b711],
4	regardless	RB	O	regardless	_	0	SENT_142	[p11l543t657r844b726],
5	of	IN	O	of	_	0	SENT_142	[p11l870t657r939b711],
6	body	NN	O	body	nn	7	SENT_142	[p11l952t657r1104b726],
7	weight	NN	O	weight	prep_regardless_of	3	SENT_142	[p11l1125t657r1330b726],
8	according	VBG	O	accord	_	0	SENT_142	[p11l1354t657r1647b726],
9	to	TO	O	to	prepc_according_to	3	SENT_142	[p11l1670t664r1726b711],
10	guidelines	NNS	O	guideline	pobj	3	SENT_142	[p11l1752t657r2056b726],
11	of	IN	O	of	_	0	SENT_142	[p11l2082t657r2151b711],
12	ATS	NN	O	at	prep_of	10	SENT_142	[p11l9t747r140b800],
13	and	CC	O	and	_	0	SENT_142	[p11l169t746r276b800],
14	JATA	NN	O	ja	conj_and	12	SENT_142	[p11l300t747r469b800],

1	status	NN	O	status	nsubjpass	5	SENT_143	[p11l13t970r201b1025],
2	of	IN	O	of	_	0	SENT_143	[p11l238t961r317b1025],
3	patients	NNS	O	patient	prep_of	1	SENT_143	[p11l338t961r602b1042],
4	were	VBD	O	be	auxpass	5	SENT_143	[p11l636t981r801b1025],
5	semi-concealed	VBN	O	semi-conceal	_	0	SENT_143	[p11l838t961r1368b1025],
6	from	IN	O	from	_	0	SENT_143	[p11l1400t961r1565b1025],
7	all	DT	O	all	det	9	SENT_143	[p11l1599t961r1680b1024],
8	clinical	JJ	O	clinical	amod	9	SENT_143	[p11l1715t961r1962b1025],
9	staff	NN	O	staff	prep_from	5	SENT_143	[p11l1997t961r2153b1025],
10	and	CC	O	and	_	0	SENT_143	[p11l12t1072r136b1136],
11	patients	NNS	O	patient	prep_from	5	SENT_143	[p11l157t1072r439b1154],
12	.	.	O	.	_	0	SENT_143	[p11l157t1072r439b1154],

1	In	IN	O	in	_	0	SENT_144	[p11l113t1186r184b1246],
2	this	DT	O	this	det	3	SENT_144	[p11l204t1183r327b1247],
3	trial	NN	O	trial	prep_in	8	SENT_144	[p11l350t1183r505b1260],
4	,	,	O	,	_	0	SENT_144	[p11l350t1183r505b1260],
5	all	DT	O	all	det	6	SENT_144	[p11l531t1183r613b1247],
6	patients	NNS	O	patient	nsubjpass	8	SENT_144	[p11l634t1183r901b1265],
7	were	VBD	O	be	auxpass	8	SENT_144	[p11l923t1204r1091b1247],
8	treated	VBN	O	treat	_	0	SENT_144	[p11l1113t1183r1346b1247],
9	according	VBG	O	accord	_	0	SENT_144	[p11l1369t1183r1708b1265],
10	to	TO	O	to	prepc_according_to	8	SENT_144	[p11l1730t1192r1795b1247],
11	the	DT	O	the	det	16	SENT_144	[p11l1818t1183r1922b1247],
12	Japan	NNP	ORGANIZATION	Japan	nn	16	SENT_144	[p11l1945t1186r2142b1265],
13	Anti-Tuberculosis	NNP	ORGANIZATION	Anti-Tuberculosis	nn	16	SENT_144	[p11l10t1294r639b1358],
14	Association	NNP	ORGANIZATION	Association	nn	16	SENT_144	[p11l679t1294r1091b1358],
15	(	NN	O	(	nn	16	SENT_144	[p11l1132t1294r1440b1375],
16	JATA	NN	O	ja	pobj	8	SENT_144	[p11l1132t1294r1440b1375],
17	)	CD	NUMBER	)	poss	19	SENT_144	[p11l1132t1294r1440b1375],
18	’s	POS	O	’s	_	0	SENT_144	[p11l1132t1294r1440b1375],
19	guideline	NN	O	guideline	dep	16	SENT_144	[p11l1482t1294r1804b1376],
20	with	IN	O	with	_	0	SENT_144	[p11l1843t1294r1998b1358],
21	the	DT	O	the	det	22	SENT_144	[p11l2036t1294r2141b1358],
22	exception	NN	O	exception	prep_with	19	SENT_144	[p11l12t1405r352b1487],
23	of	IN	O	of	_	0	SENT_144	[p11l393t1405r474b1469],
24	INH	NN	O	inh	nn	25	SENT_144	[p11l503t1408r657b1469],
25	dosage	NN	O	dosage	prep_of	22	SENT_144	[p11l699t1405r962b1487],
26	;	:	O	;	_	0	SENT_144	[p11l699t1405r962b1487],
27	a	DT	O	a	det	29	SENT_144	[p11l1007t1426r1044b1469],
28	6-month	JJ	DURATION	6-month	amod	29	SENT_144	[p11l1085t1405r1381b1469],
29	regimen	NN	O	regimen	dep	19	SENT_144	[p11l1420t1405r1708b1487],
30	comprising	VBG	O	comprise	partmod	29	SENT_144	[p11l1748t1405r2141b1487],
31	INH	NNP	MISC	INH	dobj	30	SENT_144	[p11l11t1519r183b1594],
32	,	,	O	,	_	0	SENT_144	[p11l11t1519r183b1594],
33	rifampicin	NN	O	rifampicin	appos	31	SENT_144	[p11l209t1516r585b1598],
34	,	,	O	,	_	0	SENT_144	[p11l209t1516r585b1598],
35	pyrazinamide	NN	O	pyrazinamide	appos	31	SENT_144	[p11l611t1516r1101b1598],
36	,	,	O	,	_	0	SENT_144	[p11l611t1516r1101b1598],
37	and	CC	O	and	_	0	SENT_144	[p11l1131t1516r1255b1580],
38	ethambutol/streptomycin	NN	O	ethambutol/streptomycin	appos	31	SENT_144	[p11l1280t1516r2143b1598],
39	for	IN	O	for	_	0	SENT_144	[p11l12t1627r111b1691],
40	the	DT	DURATION	the	det	43	SENT_144	[p11l138t1627r242b1691],
41	first	JJ	DURATION	first	amod	43	SENT_144	[p11l275t1627r409b1691],
42	2	CD	DURATION	2	num	43	SENT_144	[p11l438t1629r477b1690],
43	months	NNS	NUMBER	month	prep_for	33	SENT_144	[p11l509t1627r764b1691],
44	followed	VBN	O	follow	partmod	33	SENT_144	[p11l796t1627r1103b1691],
45	by	IN	O	by	_	0	SENT_144	[p11l1129t1627r1218b1709],
46	rifampicin	NN	O	rifampicin	agent	44	SENT_144	[p11l1246t1627r1605b1709],
47	and	CC	O	and	_	0	SENT_144	[p11l1635t1627r1759b1691],
48	INH	NN	O	inh	conj_and	46	SENT_144	[p11l1788t1630r1941b1691],
49	for	IN	O	for	_	0	SENT_144	[p11l1972t1627r2072b1691],
50	4	CD	DURATION	4	num	51	SENT_144	[p11l2099t1629r2140b1690],
51	months	NNS	NUMBER	month	prep_for	44	SENT_144	[p11l10t1738r282b1801],
52	.	.	O	.	_	0	SENT_144	[p11l10t1738r282b1801],

1	This	DT	O	this	det	3	SENT_145	[p11l325t1738r474b1801],
2	treatment	NN	O	treatment	nn	3	SENT_145	[p11l512t1746r838b1801],
3	schedule	NN	O	schedule	nsubj	4	SENT_145	[p11l875t1738r1175b1801],
4	is	VBZ	O	be	dep	12	SENT_145	[p11l1213t1738r1265b1801],
5	in	IN	O	in	_	0	SENT_145	[p11l1305t1738r1370b1800],
6	line	NN	O	line	prep_in	4	SENT_145	[p11l1407t1738r1533b1801],
7	with	IN	O	with	_	0	SENT_145	[p11l1569t1738r1723b1801],
8	the	DT	O	the	det	11	SENT_145	[p11l1758t1738r1862b1801],
9	current	JJ	DATE	current	amod	11	SENT_145	[p11l1901t1747r2143b1801],
10	standard	JJ	O	standard	amod	11	SENT_145	[p11l13t1848r304b1912],
11	treatment	NN	O	treatment	prep_with	6	SENT_145	[p11l323t1856r648b1912],
12	recommended	VBD	O	recommend	_	0	SENT_145	[p11l667t1848r1161b1912],
13	intemationally	RB	O	intemationally	advmod	12	SENT_145	[p11l1182t1848r1681b1929],
14	for	IN	O	for	_	0	SENT_145	[p11l1704t1848r1804b1912],
15	adult	JJ	O	adult	amod	18	SENT_145	[p11l1824t1848r1995b1912],
16	respiratory	JJ	O	respiratory	amod	18	SENT_145	[p11l2014t1868r2141b1912, p11l9t1959r283b2040],
17	tuberculosis	NN	O	tuberculosis	nn	18	SENT_145	[p11l307t1959r721b2023],
18	[	NN	O	[	prep_for	12	SENT_145	[p11l754t1960r863b2039],
19	4	CD	NUMBER	4	num	20	SENT_145	[p11l754t1960r863b2039],
20	]	NN	O	]	nsubj	12	SENT_145	[p11l754t1960r863b2039],
21	.	.	O	.	_	0	SENT_145	[p11l754t1960r863b2039],

1	Table	NNP	O	Table	nsubj	3	SENT_146	[p11l113t2070r308b2134],
2	1	CD	NUMBER	1	num	1	SENT_146	[p11l350t2071r374b2133],
3	summarizes	VBZ	O	summarize	_	0	SENT_146	[p11l419t2070r842b2134],
4	the	DT	O	the	det	6	SENT_146	[p11l875t2070r983b2134],
5	assigned	VBN	O	assign	amod	6	SENT_146	[p11l1017t2070r1326b2152],
6	dose	NN	O	dose	dobj	3	SENT_146	[p11l1358t2070r1520b2134],
7	of	IN	O	of	_	0	SENT_146	[p11l1554t2070r1636b2134],
8	INH	NN	O	inh	prep_of	6	SENT_146	[p11l1657t2073r1813b2134],
9	for	IN	O	for	_	0	SENT_146	[p11l1847t2070r1950b2134],
10	each	DT	O	each	det	12	SENT_146	[p11l1982t2070r2143b2134],
11	parallel	JJ	O	parallel	amod	12	SENT_146	[p11l9t2181r279b2263],
12	group	NN	O	group	prep_for	8	SENT_146	[p11l332t2202r558b2263],
13	.	.	O	.	_	0	SENT_146	[p11l332t2202r558b2263],

1	All	DT	O	all	det	2	SENT_147	[p11l615t2181r728b2244],
2	patients	NNS	O	patient	nsubj	3	SENT_147	[p11l779t2181r1058b2263],
3	started	VBD	O	start	_	0	SENT_147	[p11l1115t2181r1351b2245],
4	taking	VBG	O	take	xcomp	3	SENT_147	[p11l1401t2181r1626b2263],
5	the	DT	O	the	det	9	SENT_147	[p11l1678t2181r1785b2245],
6	standard	JJ	O	standard	amod	9	SENT_147	[p11l1841t2181r2143b2245],
7	oral	JJ	O	oral	amod	9	SENT_147	[p11l12t2292r148b2356],
8	dose	NN	O	dose	nn	9	SENT_147	[p11l188t2292r350b2356],
9	(	NN	O	(	dobj	4	SENT_147	[p11l392t2292r686b2374],
10	approx	RB	O	approx	advmod	4	SENT_147	[p11l392t2292r686b2374],
11	.	.	O	.	_	0	SENT_147	[p11l392t2292r686b2374],

1	5	CD	NUMBER	5	num	3	SENT_148	[p11l733t2295r768b2356],
2	mg/kg	NN	O	mg/kg	nn	3	SENT_148	[p11l811t2292r1041b2374],
3	b.w.	NN	O	b.w.	_	0	SENT_148	[p11l1079t2292r1249b2369],
4	,	,	O	,	_	0	SENT_148	[p11l1079t2292r1249b2369],
5	once	RB	DATE	once	dep	14	SENT_148	[p11l1293t2313r1458b2356],
6	daily	JJ	SET	daily	amod	7	SENT_148	[p11l1500t2292r1705b2374],
7	)	NN	O	)	pobj	5	SENT_148	[p11l1500t2292r1705b2374],
8	throughout	IN	O	throughout	prep	5	SENT_148	[p11l1745t2292r2143b2374],
9	the	DT	O	the	det	10	SENT_148	[p11l10t2403r118b2467],
10	course	NN	O	course	npadvmod	11	SENT_148	[p11l152t2424r383b2467],
11	so	RB	O	so	pcomp	8	SENT_148	[p11l419t2424r492b2467],
12	as	IN	O	as	mark	14	SENT_148	[p11l528t2424r598b2467],
13	to	TO	O	to	aux	14	SENT_148	[p11l631t2413r697b2467],
14	avoid	VB	O	avoid	dep	3	SENT_148	[p11l733t2403r932b2467],
15	delay	NN	O	delay	dobj	14	SENT_148	[p11l965t2403r1157b2485],
16	in	IN	O	in	_	0	SENT_148	[p11l1190t2403r1257b2466],
17	initial	JJ	O	initial	amod	18	SENT_148	[p11l1290t2403r1497b2467],
18	treatment	NN	O	treatment	prep_in	14	SENT_148	[p11l1529t2412r1888b2481],
19	,	,	O	,	_	0	SENT_148	[p11l1529t2412r1888b2481],
20	which	WDT	O	which	nsubj	24	SENT_148	[p11l1923t2403r2143b2467],
21	was	VBD	O	be	cop	24	SENT_148	[p11l9t2535r146b2578],
22	the	DT	O	the	det	24	SENT_148	[p11l184t2514r291b2578],
23	same	JJ	O	same	amod	24	SENT_148	[p11l331t2535r510b2578],
24	dosing	NN	O	dosing	rcmod	3	SENT_148	[p11l549t2514r786b2596],
25	for	IN	O	for	_	0	SENT_148	[p11l825t2514r928b2578],
26	the	DT	O	the	det	27	SENT_148	[p11l962t2514r1069b2578],
27	STD-treatment	NN	O	std-treatment	prep_for	24	SENT_148	[p11l1110t2516r1662b2579],
28	.	.	O	.	_	0	SENT_148	[p11l1110t2516r1662b2579],

1	For	IN	O	for	_	0	SENT_149	[p11l1704t2517r1828b2578],
2	patients	NNS	O	patient	prep_for	9	SENT_149	[p11l1861t2514r2140b2596],
3	in	IN	O	in	_	0	SENT_149	[p11l11t2625r79b2688],
4	the	DT	O	the	det	5	SENT_149	[p11l129t2625r236b2689],
5	PGx-treatment	NN	O	pgx-treatment	prep_in	2	SENT_149	[p11l288t2627r836b2703],
6	,	,	O	,	_	0	SENT_149	[p11l288t2627r836b2703],
7	dosages	NNS	O	dosage	nsubjpass	9	SENT_149	[p11l892t2625r1173b2707],
8	were	VBD	O	be	auxpass	9	SENT_149	[p11l1225t2646r1397b2689],
9	adjusted	VBN	O	adjust	_	0	SENT_149	[p11l1450t2625r1749b2707],
10	based	VBN	O	base	_	0	SENT_149	[p11l1798t2625r2004b2689],
11	on	IN	O	on	prepc_based_on	9	SENT_149	[p11l2055t2646r2142b2689],
12	individual	JJ	O	individual	amod	13	SENT_149	[p11l11t2736r379b2800],
13	NAT	NNP	ORGANIZATION	NAT	pobj	9	SENT_149	[p11l429t2737r603b2800],
14	2	CD	NUMBER	2	num	15	SENT_149	[p11l596t2737r637b2799],
15	status	NN	O	status	npadvmod	16	SENT_149	[p11l696t2745r897b2800],
16	within	IN	O	within	advmod	13	SENT_149	[p11l951t2736r1183b2800],
17	3	CD	DURATION	3	num	18	SENT_149	[p11l1238t2737r1272b2800],
18	days	NNS	NUMBER	day	tmod	13	SENT_149	[p11l1333t2736r1514b2818],
19	.	.	O	.	_	0	SENT_149	[p11l1333t2736r1514b2818],

1	Modiﬁed	JJ	O	modiﬁed	amod	4	SENT_150	[p11l1572t2736r1911b2800],
2	daily	JJ	SET	daily	amod	4	SENT_150	[p11l1964t2736r2143b2818],
3	INH	NN	O	inh	nn	4	SENT_150	[p11l11t2849r168b2910],
4	doses	NNS	O	dose	nsubj	12	SENT_150	[p11l223t2847r421b2911],
5	were	VBD	O	be	cop	12	SENT_150	[p11l474t2867r647b2911],
6	approximately	RB	O	approximately	amod	12	SENT_150	[p11l703t2847r1227b2928],
7	7.5	CD	NUMBER	7.5	tmod	6	SENT_150	[p11l1282t2849r1412b2924],
8	,	,	O	,	_	0	SENT_150	[p11l1282t2849r1412b2924],
9	5	CD	NUMBER	5	num	7	SENT_150	[p11l1471t2849r1506b2910],
10	and	CC	O	and	_	0	SENT_150	[p11l1566t2847r1694b2911],
11	2.5	CD	NUMBER	2.5	tmod	6	SENT_150	[p11l1747t2848r1853b2911],
12	mg/kg	NN	O	mg/kg	_	0	SENT_150	[p11l1911t2847r2141b2928],
13	for	IN	O	for	_	0	SENT_150	[p11l12t2958r115b3022],
14	rapid	JJ	O	rapid	amod	19	SENT_150	[p11l147t2958r351b3039],
15	,	,	O	,	_	0	SENT_150	[p11l147t2958r351b3039],
16	intermediate	JJ	O	intermediate	conj_and	14	SENT_150	[p11l392t2958r838b3022],
17	and	CC	O	and	_	0	SENT_150	[p11l876t2958r1004b3022],
18	slow	JJ	O	slow	conj_and	14	SENT_150	[p11l1041t2958r1207b3022],
19	acetylators	NNS	O	acetylator	prep_for	12	SENT_150	[p11l1244t2958r1651b3039],
20	,	,	O	,	_	0	SENT_150	[p11l1244t2958r1651b3039],
21	respectively	RB	O	respectively	advmod	12	SENT_150	[p11l1689t2958r2137b3039],
22	.	.	O	.	_	0	SENT_150	[p11l1689t2958r2137b3039],

1	Approximately	RB	O	approximately	quantmod	2	SENT_151	[p11l10t3069r557b3151],
2	5	CD	NUMBER	5	num	3	SENT_151	[p11l595t3072r630b3133],
3	mg/kg	NN	O	mg/kg	nsubjpass	15	SENT_151	[p11l670t3069r899b3151],
4	of	IN	O	of	_	0	SENT_151	[p11l937t3069r1019b3133],
5	INH	NNP	MISC	INH	prep_of	3	SENT_151	[p11l1044t3072r1221b3146],
6	,	,	O	,	_	0	SENT_151	[p11l1044t3072r1221b3146],
7	as	IN	O	as	mark	8	SENT_151	[p11l1262t3090r1330b3133],
8	same	JJ	O	same	dep	15	SENT_151	[p11l1371t3090r1550b3133],
9	as	IN	O	as	dep	8	SENT_151	[p11l1588t3090r1657b3133],
10	the	DT	O	the	det	12	SENT_151	[p11l1694t3069r1801b3133],
11	standard	JJ	O	standard	amod	12	SENT_151	[p11l1841t3069r2143b3133],
12	dose	NN	O	dose	pobj	9	SENT_151	[p11l12t3180r195b3257],
13	,	,	O	,	_	0	SENT_151	[p11l12t3180r195b3257],
14	was	VBD	O	be	auxpass	15	SENT_151	[p11l251t3201r388b3244],
15	given	VBN	O	give	_	0	SENT_151	[p11l444t3180r644b3262],
16	to	TO	O	to	_	0	SENT_151	[p11l695t3189r762b3244],
17	all	DT	O	all	prep_to	15	SENT_151	[p11l819t3180r905b3244],
18	of	IN	O	of	_	0	SENT_151	[p11l959t3180r1041b3244],
19	the	DT	O	the	det	21	SENT_151	[p11l1082t3180r1191b3244],
20	intermediate	JJ	O	intermediate	amod	21	SENT_151	[p11l1245t3180r1696b3244],
21	acetylators	NNS	O	acetylator	prep_of	17	SENT_151	[p11l1751t3180r2140b3262],
22	throughout	IN	O	throughout	amod	21	SENT_151	[p11l10t3291r425b3373],
23	.	.	O	.	_	0	SENT_151	[p11l10t3291r425b3373],

1	Regarding	VBG	O	regard	_	0	SENT_152	[p11l478t3291r852b3373],
2	the	DT	O	the	det	4	SENT_152	[p11l899t3291r1007b3355],
3	other	JJ	O	other	amod	4	SENT_152	[p11l1057t3291r1241b3355],
4	drugs	NNS	O	drug	dobj	1	SENT_152	[p11l1287t3291r1483b3373],
5	for	IN	O	for	_	0	SENT_152	[p11l1535t3291r1637b3355],
6	the	DT	O	the	det	8	SENT_152	[p11l1682t3291r1789b3355],
7	standard	JJ	O	standard	amod	8	SENT_152	[p11l1840t3291r2143b3355],
8	regimen	NN	O	regimen	prep_for	1	SENT_152	[p11l10t3402r323b3484],
9	,	,	O	,	_	0	SENT_152	[p11l10t3402r323b3484],
10	standard	JJ	O	standard	amod	12	SENT_152	[p11l375t3402r677b3466],
11	daily	JJ	SET	daily	amod	12	SENT_152	[p11l723t3402r901b3484],
12	doses	NNS	O	dose	appos	8	SENT_152	[p11l947t3402r1143b3466],
13	of	IN	O	of	_	0	SENT_152	[p11l1192t3403r1274b3466],
14	rifampicin	NN	O	rifampicin	prep_of	12	SENT_152	[p11l1307t3402r1682b3484],
15	(	CD	NUMBER	(	num	14	SENT_152	[p11l1729t3403r1842b3484],
16	10	CD	NUMBER	10	num	17	SENT_152	[p11l1729t3403r1842b3484],
17	mg/kg	NN	O	mg/kg	tmod	1	SENT_152	[p11l1889t3402r2139b3484],
18	,	,	O	,	_	0	SENT_152	[p11l1889t3402r2139b3484],
19	max	NN	O	max	appos	17	SENT_152	[p11l10t3534r181b3577],
20	.	.	O	.	_	0	SENT_152	[p11l10t3534r181b3577],

1	600	CD	NUMBER	600	num	3	SENT_153	[p11l224t3515r354b3577],
2	mg/body	JJ	O	mg/body	amod	3	SENT_153	[p11l391t3513r761b3595],
3	)	NN	O	)	_	0	SENT_153	[p11l391t3513r761b3595],
4	,	,	O	,	_	0	SENT_153	[p11l391t3513r761b3595],
5	pyrazinamide	NN	O	pyrazinamide	appos	3	SENT_153	[p11l798t3513r1288b3595],
6	(	CD	NUMBER	(	number	7	SENT_153	[p11l1327t3514r1438b3595],
7	25	CD	NUMBER	25	num	8	SENT_153	[p11l1327t3514r1438b3595],
8	mg/kg	NN	O	mg/kg	dep	3	SENT_153	[p11l1478t3513r1727b3595],
9	,	,	O	,	_	0	SENT_153	[p11l1478t3513r1727b3595],
10	1,500	CD	NUMBER	1,500	num	11	SENT_153	[p11l1775t3515r1966b3591],
11	mg	NN	O	mg	appos	8	SENT_153	[p11l2004t3513r2143b3595],
12	/	:	O	/	punct	13	SENT_153	[p11l2004t3513r2143b3595],
13	body	NN	O	body	dep	11	SENT_153	[p11l9t3624r248b3706],
14	)	RB	O	)	advmod	13	SENT_153	[p11l9t3624r248b3706],
15	,	,	O	,	_	0	SENT_153	[p11l9t3624r248b3706],
16	ethambutol	NN	O	ethambutol	appos	13	SENT_153	[p11l308t3624r725b3688],
17	(	CD	NUMBER	(	num	16	SENT_153	[p11l783t3625r897b3706],
18	15	CD	NUMBER	15	num	19	SENT_153	[p11l783t3625r897b3706],
19	(	NN	O	(	dep	16	SENT_153	[p11l959t3625r1108b3706],
20	20	CD	NUMBER	20	number	21	SENT_153	[p11l959t3625r1108b3706],
21	)	CD	NUMBER	)	num	22	SENT_153	[p11l959t3625r1108b3706],
22	mg/kg	NN	O	mg/kg	dep	19	SENT_153	[p11l1165t3624r1422b3706],
23	,	,	O	,	_	0	SENT_153	[p11l1165t3624r1422b3706],
24	750	CD	NUMBER	750	num	25	SENT_153	[p11l1483t3626r1616b3688],
25	(	NN	O	(	appos	13	SENT_153	[p11l1675t3625r1943b3706],
26	1,000	CD	NUMBER	1,000	number	27	SENT_153	[p11l1675t3625r1943b3706],
27	)	CD	NUMBER	)	num	28	SENT_153	[p11l1675t3625r1943b3706],
28	mg	NN	O	mg	dep	25	SENT_153	[p11l2000t3624r2143b3706],
29	/	:	O	/	punct	13	SENT_153	[p11l2000t3624r2143b3706],

1	body	NN	O	body	nsubj	19	SENT_154	[p12l9t21r239b103],
2	)	CD	NUMBER	)	num	1	SENT_154	[p12l9t21r239b103],
3	,	,	O	,	_	0	SENT_154	[p12l9t21r239b103],
4	and	CC	O	and	_	0	SENT_154	[p12l284t21r412b85],
5	streptomycin	NN	O	streptomycin	nsubj	19	SENT_154	[p12l453t21r920b103],
6	(	CD	NUMBER	(	number	7	SENT_154	[p12l961t21r1072b102],
7	15	CD	NUMBER	15	num	8	SENT_154	[p12l961t21r1072b102],
8	mg/kg	NN	O	mg/kg	dep	5	SENT_154	[p12l1116t21r1365b103],
9	,	,	O	,	_	0	SENT_154	[p12l1116t21r1365b103],
10	750	CD	NUMBER	750	num	12	SENT_154	[p12l1410t22r1540b85],
11	mg/body	JJ	O	mg/body	amod	12	SENT_154	[p12l1580t21r1929b103],
12	)	NN	O	)	nsubjpass	14	SENT_154	[p12l1580t21r1929b103],
13	were	VBD	O	be	auxpass	14	SENT_154	[p12l1970t41r2141b85],
14	recommended	VBN	O	recommend	parataxis	19	SENT_154	[p12l9t132r520b196],
15	with	IN	O	with	_	0	SENT_154	[p12l556t132r716b196],
16	the	DT	O	the	det	18	SENT_154	[p12l753t132r861b196],
17	following	VBG	O	follow	amod	18	SENT_154	[p12l901t132r1249b213],
18	dose	NN	O	dose	prep_with	14	SENT_154	[p12l1288t132r1450b196],
19	ranges	VBZ	O	range	_	0	SENT_154	[p12l1487t152r1720b213],
20	allowed	VBN	O	allow	dep	19	SENT_154	[p12l1761t132r2043b196],
21	at	IN	O	at	_	0	SENT_154	[p12l2082t141r2144b195],
22	the	DT	O	the	det	23	SENT_154	[p12l10t243r117b307],
23	discretion	NN	O	discretion	prep_at	20	SENT_154	[p12l168t243r521b307],
24	of	IN	O	of	_	0	SENT_154	[p12l571t243r652b307],
25	the	DT	O	the	det	26	SENT_154	[p12l690t243r797b307],
26	physician	NN	O	physician	prep_of	23	SENT_154	[p12l845t243r1178b324],
27	in	IN	O	in	_	0	SENT_154	[p12l1213t243r1280b305],
28	charge	NN	O	charge	prep_in	26	SENT_154	[p12l1315t243r1541b325],
29	of	IN	O	of	_	0	SENT_154	[p12l1578t243r1659b307],
30	treatment	NN	O	treatment	prep_of	28	SENT_154	[p12l1681t251r2024b307],
31	:	:	O	:	_	0	SENT_154	[p12l1681t251r2024b307],
32	rifampicin	NN	O	rifampicin	dep	28	SENT_154	[p12l2063t243r2140b305, p12l12t354r334b436],
33	,	,	O	,	_	0	SENT_154	[p12l2063t243r2140b305, p12l12t354r334b436],
34	8-12	CD	NUMBER	8-12	num	35	SENT_154	[p12l374t355r542b418],
35	mg/kg	NN	O	mg/kg	appos	32	SENT_154	[p12l575t354r818b436],
36	;	:	O	;	_	0	SENT_154	[p12l575t354r818b436],
37	pyrazinamide	NN	O	pyrazinamide	dep	28	SENT_154	[p12l851t354r1341b436],
38	,	,	O	,	_	0	SENT_154	[p12l851t354r1341b436],
39	20-30	CD	NUMBER	20-30	num	40	SENT_154	[p12l1377t356r1593b418],
40	mg/kg	NN	O	mg/kg	appos	37	SENT_154	[p12l1626t354r1868b436],
41	;	:	O	;	_	0	SENT_154	[p12l1626t354r1868b436],
42	ethambutol	NN	O	ethambutol	dep	28	SENT_154	[p12l1905t354r2141b418, p12l9t465r244b542],
43	,	,	O	,	_	0	SENT_154	[p12l1905t354r2141b418, p12l9t465r244b542],
44	15-20	CD	NUMBER	15-20	num	45	SENT_154	[p12l310t467r547b529],
45	mg/kg	NN	O	mg/kg	appos	42	SENT_154	[p12l603t465r883b547],
46	;	:	O	;	_	0	SENT_154	[p12l603t465r883b547],
47	streptomycin	NN	O	streptomycin	dep	28	SENT_154	[p12l943t465r1500b547],
48	,	,	O	,	_	0	SENT_154	[p12l943t465r1500b547],
49	12-1	CD	NUMBER	12-1	number	50	SENT_154	[p12l1567t466r1745b528],
50	8	CD	NUMBER	8	num	51	SENT_154	[p12l1768t467r1802b529],
51	mg/kg	NN	O	mg/kg	appos	28	SENT_154	[p12l1859t465r2137b547],
52	.	.	O	.	_	0	SENT_154	[p12l1859t465r2137b547],

1	Administration	NN	O	administration	nsubjpass	7	SENT_155	[p12l10t576r534b639],
2	of	IN	O	of	_	0	SENT_155	[p12l560t576r641b639],
3	vitamin	NN	O	vitamin	nn	4	SENT_155	[p12l654t576r918b639],
4	B6	NN	O	b6	prep_of	1	SENT_155	[p12l943t577r1043b639],
5	was	VBD	O	be	auxpass	7	SENT_155	[p12l1070t597r1204b639],
6	also	RB	O	also	advmod	7	SENT_155	[p12l1232t576r1367b639],
7	allowed	VBN	O	allow	_	0	SENT_155	[p12l1396t576r1668b639],
8	at	IN	O	at	_	0	SENT_155	[p12l1695t585r1756b639],
9	the	DT	O	the	det	10	SENT_155	[p12l1779t576r1883b639],
10	discretion	NN	O	discretion	prep_at	7	SENT_155	[p12l1911t576r2140b639, p12l10t686r145b750],
11	of	IN	O	of	_	0	SENT_155	[p12l167t686r248b750],
12	the	DT	O	the	det	13	SENT_155	[p12l258t686r362b750],
13	physician	NN	O	physician	prep_of	10	SENT_155	[p12l384t686r733b768],
14	.	.	O	.	_	0	SENT_155	[p12l384t686r733b768],

1	Primary	JJ	O	primary	amod	2	SENT_156	[p12l760t686r1037b768],
2	outcomes	NNS	O	outcome	nsubjpass	4	SENT_156	[p12l1061t696r1389b750],
3	were	VBD	O	be	auxpass	4	SENT_156	[p12l1412t707r1580b750],
4	evaluated	VBN	O	evaluate	_	0	SENT_156	[p12l1604t686r1934b750],
5	at	IN	O	at	_	0	SENT_156	[p12l1956t695r2018b750],
6	the	DT	O	the	det	8	SENT_156	[p12l2037t686r2141b750],
7	8th	JJ	ORDINAL	8th	amod	8	SENT_156	[p12l14t798r121b862],
8	week	NN	DURATION	week	prep_at	4	SENT_156	[p12l138t798r338b863],
9	.	.	O	.	_	0	SENT_156	[p12l138t798r338b863],

1	The	DT	O	the	det	3	SENT_157	[p12l364t798r496b863],
2	same	JJ	O	same	amod	3	SENT_157	[p12l519t819r693b863],
3	treatments	NNS	O	treatment	nsubj	4	SENT_157	[p12l711t807r1068b862],
4	continued	VBD	O	continue	_	0	SENT_157	[p12l1090t798r1431b863],
5	for	IN	O	for	_	0	SENT_157	[p12l1451t798r1550b862],
6	6	CD	DURATION	6	num	7	SENT_157	[p12l1569t800r1607b862],
7	months	NNS	NUMBER	month	prep_for	4	SENT_157	[p12l1628t798r1883b863],
8	in	IN	O	in	_	0	SENT_157	[p12l1904t798r1970b861],
9	both	DT	O	both	det	10	SENT_157	[p12l1987t798r2143b863],
10	groups	NNS	O	group	prep_in	7	SENT_157	[p12l12t930r245b991],
11	if	IN	O	if	mark	15	SENT_157	[p12l269t909r330b972],
12	patients	NNS	O	patient	nsubj	15	SENT_157	[p12l339t909r606b991],
13	did	VBD	O	do	aux	15	SENT_157	[p12l631t909r740b973],
14	not	RB	O	not	neg	15	SENT_157	[p12l760t918r872b973],
15	have	VB	O	have	advcl	4	SENT_157	[p12l892t909r1056b973],
16	any	DT	O	any	det	18	SENT_157	[p12l1080t930r1203b991],
17	clinical	JJ	O	clinical	amod	18	SENT_157	[p12l1226t909r1476b973],
18	need	NN	O	need	dobj	15	SENT_157	[p12l1496t909r1662b973],
19	to	TO	O	to	aux	20	SENT_157	[p12l1682t918r1747b973],
20	change	VB	O	change	infmod	18	SENT_157	[p12l1772t909r2015b991],
21	the	DT	O	the	det	23	SENT_157	[p12l2037t909r2141b973],
22	ongoing	JJ	O	ongoing	amod	23	SENT_157	[p12l12t1020r295b1102],
23	treatment	NN	O	treatment	dobj	20	SENT_157	[p12l320t1028r661b1084],
24	.	.	O	.	_	0	SENT_157	[p12l320t1028r661b1084],

1	@	IN	O	@	_	0	SENT_158	[p12l9t1258r81b1347],
2	Springer	NNP	O	Springer	nn	4	SENT_158	[p12l107t1280r351b1350],
3	Study	NNP	O	Study	nn	4	SENT_158	[p12l14t1378r216b1460],
4	procedures	NNS	O	procedure	pobj	1	SENT_158	[p12l243t1378r630b1460],

1	The	DT	O	the	det	4	SENT_159	[p12l11t1600r143b1664],
2	baseline	NN	O	baseline	nn	4	SENT_159	[p12l174t1600r452b1664],
3	clinical	JJ	O	clinical	amod	4	SENT_159	[p12l486t1600r733b1664],
4	assessment	NN	O	assessment	nsubj	5	SENT_159	[p12l766t1609r1146b1664],
5	consisted	VBD	O	consist	ccomp	11	SENT_159	[p12l1177t1600r1494b1664],
6	of	IN	O	of	_	0	SENT_159	[p12l1525t1600r1605b1664],
7	chest	NN	O	chest	nn	8	SENT_159	[p12l1627t1600r1801b1664],
8	radiography	NN	O	radiography	prep_of	5	SENT_159	[p12l1830t1600r2140b1682, p12l9t1711r152b1793],
9	,	,	O	,	_	0	SENT_159	[p12l1830t1600r2140b1682, p12l9t1711r152b1793],
10	demographics	NNS	O	demographic	nsubj	11	SENT_159	[p12l184t1711r663b1793],
11	(	VBP	O	(	_	0	SENT_159	[p12l693t1711r854b1793],
12	age	NN	O	age	dobj	11	SENT_159	[p12l693t1711r854b1793],
13	,	,	O	,	_	0	SENT_159	[p12l693t1711r854b1793],
14	sex	NN	O	sex	conj_and	12	SENT_159	[p12l888t1732r1016b1789],
15	,	,	O	,	_	0	SENT_159	[p12l888t1732r1016b1789],
16	body	NN	O	body	nn	17	SENT_159	[p12l1046t1711r1222b1793],
17	weight	NN	O	weight	conj_and	12	SENT_159	[p12l1247t1711r1498b1793],
18	,	,	O	,	_	0	SENT_159	[p12l1247t1711r1498b1793],
19	and	CC	O	and	_	0	SENT_159	[p12l1530t1711r1654b1775],
20	body	NN	O	body	nn	22	SENT_159	[p12l1679t1711r1853b1793],
21	height	NN	O	height	nn	22	SENT_159	[p12l1880t1711r2138b1793],
22	)	NN	O	)	conj_and	12	SENT_159	[p12l1880t1711r2138b1793],
23	,	,	O	,	_	0	SENT_159	[p12l1880t1711r2138b1793],
24	sputum	NN	O	sputum	nn	25	SENT_159	[p12l13t1831r268b1903],
25	examinations	NNS	O	examination	conj_and	12	SENT_159	[p12l307t1822r784b1899],
26	,	,	O	,	_	0	SENT_159	[p12l307t1822r784b1899],
27	and	CC	O	and	_	0	SENT_159	[p12l828t1822r952b1886],
28	serum	NN	O	serum	nn	30	SENT_159	[p12l993t1842r1202b1886],
29	biochemistry	NN	O	biochemistry	nn	30	SENT_159	[p12l1239t1822r1691b1903],
30	tests	NNS	O	test	conj_and	12	SENT_159	[p12l1729t1830r1897b1886],
31	.	.	O	.	_	0	SENT_159	[p12l1729t1830r1897b1886],

1	Three	CD	NUMBER	three	num	4	SENT_160	[p12l1942t1822r2141b1886],
2	consecutive	JJ	O	consecutive	amod	4	SENT_160	[p12l12t1933r413b1997],
3	sputum	NN	O	sputum	nn	4	SENT_160	[p12l452t1942r704b2014],
4	samples	NNS	O	sample	nsubjpass	6	SENT_160	[p12l741t1933r1011b2014],
5	were	VBD	O	be	auxpass	6	SENT_160	[p12l1048t1953r1213b1997],
6	collected	VBN	O	collect	_	0	SENT_160	[p12l1251t1933r1556b1997],
7	for	IN	O	for	_	0	SENT_160	[p12l1593t1933r1691b1997],
8	detection	NN	O	detection	prep_for	6	SENT_160	[p12l1726t1933r2036b1997],
9	of	IN	O	of	_	0	SENT_160	[p12l2073t1933r2153b1997],
10	M	NN	O	m	nn	11	SENT_160	[p12l6t2047r93b2108],
11	tuberculosis	NN	O	tuberculosis	prep_of	8	SENT_160	[p12l133t2044r542b2108],
12	which	WDT	O	which	nsubjpass	14	SENT_160	[p12l570t2044r782b2108],
13	was	VBD	O	be	auxpass	14	SENT_160	[p12l808t2065r939b2108],
14	performed	VBN	O	perform	rcmod	8	SENT_160	[p12l967t2044r1326b2126],
15	by	IN	O	by	_	0	SENT_160	[p12l1350t2044r1438b2126],
16	microscopy	NN	O	microscopy	agent	14	SENT_160	[p12l1464t2044r1876b2126],
17	,	,	O	,	_	0	SENT_160	[p12l1464t2044r1876b2126],
18	culture	NN	O	culture	conj_and	16	SENT_160	[p12l1908t2044r2141b2108],
19	and	CC	O	and	_	0	SENT_160	[p12l12t2155r136b2219],
20	polymerase	NN	O	polymerase	nn	26	SENT_160	[p12l160t2155r554b2237],
21	chain	NN	O	chain	nn	26	SENT_160	[p12l583t2155r767b2219],
22	reaction	NN	O	reaction	nn	26	SENT_160	[p12l793t2155r1067b2219],
23	(	CD	NUMBER	(	num	26	SENT_160	[p12l1095t2155r1310b2236],
24	PCR	NN	O	pcr	nn	26	SENT_160	[p12l1095t2155r1310b2236],
25	)	NN	O	)	nn	26	SENT_160	[p12l1095t2155r1310b2236],
26	assay	NN	O	assay	conj_and	16	SENT_160	[p12l1341t2176r1535b2237],
27	,	,	O	,	_	0	SENT_160	[p12l1341t2176r1535b2237],
28	and	CC	O	and	_	0	SENT_160	[p12l1567t2155r1690b2219],
29	for	IN	O	for	_	0	SENT_160	[p12l1718t2155r1816b2219],
30	susceptibility	NN	O	susceptibility	nn	31	SENT_160	[p12l1843t2155r2140b2237, p12l9t2266r189b2348],
31	testing	NN	O	testing	prep_for	38	SENT_160	[p12l207t2266r434b2348],
32	of	IN	O	of	_	0	SENT_160	[p12l453t2266r534b2330],
33	M.	NN	O	m.	nn	34	SENT_160	[p12l538t2268r625b2329],
34	tuberculosis	NN	O	tuberculosis	prep_of	31	SENT_160	[p12l656t2266r1066b2330],
35	to	TO	O	to	_	0	SENT_160	[p12l1086t2275r1150b2330],
36	INH	NNP	MISC	INH	prep_to	34	SENT_160	[p12l1172t2268r1341b2343],
37	,	,	O	,	_	0	SENT_160	[p12l1172t2268r1341b2343],
38	rifampicin	NN	O	rifampicin	conj_and	14	SENT_160	[p12l1363t2266r1734b2348],
39	,	,	O	,	_	0	SENT_160	[p12l1363t2266r1734b2348],
40	ethambutol	NN	O	ethambutol	conj_and	14	SENT_160	[p12l1759t2266r2141b2330],
41	and	CC	O	and	_	0	SENT_160	[p12l12t2377r136b2441],
42	pyrazinamide	NN	O	pyrazinamide	conj_and	14	SENT_160	[p12l166t2377r648b2459],
43	.	.	O	.	_	0	SENT_160	[p12l166t2377r648b2459],

1	A	DT	O	a	det	3	SENT_161	[p12l687t2378r750b2440],
2	blood	NN	O	blood	nn	3	SENT_161	[p12l782t2377r980b2441],
3	sample	NN	O	sample	nsubjpass	5	SENT_161	[p12l1015t2377r1253b2459],
4	was	VBD	O	be	auxpass	5	SENT_161	[p12l1287t2398r1419b2441],
5	drawn	VBN	O	draw	_	0	SENT_161	[p12l1456t2377r1669b2441],
6	to	TO	O	to	aux	7	SENT_161	[p12l1702t2386r1766b2441],
7	determine	VB	O	determine	xcomp	5	SENT_161	[p12l1803t2377r2141b2441],
8	serum	NN	O	serum	nn	9	SENT_161	[p12l13t2509r220b2551],
9	concentrations	NNS	O	concentration	dobj	7	SENT_161	[p12l244t2488r737b2551],
10	of	IN	O	of	_	0	SENT_161	[p12l764t2488r844b2551],
11	ALT	NNP	LOCATION	ALT	prep_of	9	SENT_161	[p12l854t2490r1027b2565],
12	,	,	O	,	_	0	SENT_161	[p12l854t2490r1027b2565],
13	AST	NNP	ORGANIZATION	AST	prep_of	9	SENT_161	[p12l1053t2490r1227b2565],
14	,	,	O	,	_	0	SENT_161	[p12l1053t2490r1227b2565],
15	ALP	NNP	O	ALP	prep_of	9	SENT_161	[p12l1253t2490r1425b2565],
16	,	,	O	,	_	0	SENT_161	[p12l1253t2490r1425b2565],
17	bilirubin	NN	O	bilirubin	nn	26	SENT_161	[p12l1450t2488r1762b2565],
18	,	,	O	,	_	0	SENT_161	[p12l1450t2488r1762b2565],
19	creatinine	NN	O	creatinine	dep	26	SENT_161	[p12l1789t2488r2138b2565],
20	,	,	O	,	_	0	SENT_161	[p12l1789t2488r2138b2565],
21	y-glutamyltranspeptidase	NN	O	y-glutamyltranspeptidase	dep	26	SENT_161	[p12l7t2598r919b2680],
22	,	,	O	,	_	0	SENT_161	[p12l7t2598r919b2680],
23	albumin	NN	O	albumin	dep	26	SENT_161	[p12l964t2598r1266b2676],
24	,	,	O	,	_	0	SENT_161	[p12l964t2598r1266b2676],
25	C-reactive	JJ	O	c-reactive	amod	26	SENT_161	[p12l1310t2598r1669b2662],
26	protein	NN	O	protein	prep_of	9	SENT_161	[p12l1708t2598r1974b2680],
27	,	,	O	,	_	0	SENT_161	[p12l1708t2598r1974b2680],
28	and	CC	O	and	_	0	SENT_161	[p12l2018t2598r2144b2662],
29	glucose	NN	O	glucose	prep_of	9	SENT_161	[p12l11t2709r289b2791],
30	,	,	O	,	_	0	SENT_161	[p12l11t2709r289b2791],
31	a	DT	O	a	det	34	SENT_161	[p12l319t2730r356b2773],
32	full	JJ	O	full	amod	34	SENT_161	[p12l381t2709r495b2773],
33	blood	NN	O	blood	nn	34	SENT_161	[p12l518t2709r716b2773],
34	count	NN	O	count	conj_and	11	SENT_161	[p12l741t2718r947b2787],
35	,	,	O	,	_	0	SENT_161	[p12l741t2718r947b2787],
36	and	CC	O	and	_	0	SENT_161	[p12l978t2709r1100b2773],
37	the	DT	O	the	det	40	SENT_161	[p12l1123t2709r1226b2773],
38	erythrocyte	NN	O	erythrocyte	nn	40	SENT_161	[p12l1254t2709r1638b2791],
39	sedimentation	NN	O	sedimentation	nn	40	SENT_161	[p12l1666t2709r2142b2773],
40	rate	NN	O	rate	conj_and	11	SENT_161	[p12l10t2828r151b2884],
41	.	.	O	.	_	0	SENT_161	[p12l10t2828r151b2884],

1	Sputum	NN	O	sputum	nn	4	SENT_162	[p12l194t2821r459b2901],
2	and	CC	O	and	_	0	SENT_162	[p12l493t2820r618b2884],
3	blood	NN	O	blood	conj_and	1	SENT_162	[p12l647t2820r845b2884],
4	samples	NNS	O	sample	nsubjpass	6	SENT_162	[p12l881t2820r1151b2901],
5	were	VBD	O	be	auxpass	6	SENT_162	[p12l1185t2840r1350b2884],
6	collected	VBN	O	collect	_	0	SENT_162	[p12l1386t2820r1691b2884],
7	from	IN	O	from	_	0	SENT_162	[p12l1726t2820r1891b2884],
8	all	DT	O	all	predet	10	SENT_162	[p12l1924t2820r2005b2883],
9	the	DT	O	the	det	10	SENT_162	[p12l2038t2820r2141b2884],
10	patients	NNS	O	patient	prep_from	6	SENT_162	[p12l9t2931r272b3012],
11	to	TO	O	to	aux	12	SENT_162	[p12l299t2940r363b2995],
12	analyze	VB	O	analyze	conj_and	12	SENT_162	[p12l393t2931r651b3012],
13	the	DT	O	the	det	14	SENT_162	[p12l676t2931r780b2995],
14	items	NNS	O	item	dobj	12	SENT_162	[p12l807t2931r988b2995],
15	above	IN	O	above	prep	14	SENT_162	[p12l1016t2931r1220b2995],
16	at	IN	O	at	pcomp	15	SENT_162	[p12l1247t2939r1308b2994],
17	weeks	NNS	DURATION	week	xcomp	12	SENT_162	[p12l1330t2931r1544b2995],
18	1	CD	NUMBER	1	num	17	SENT_162	[p12l1580t2932r1633b3008],
19	,	,	O	,	_	0	SENT_162	[p12l1580t2932r1633b3008],
20	2	CD	NUMBER	2	num	17	SENT_162	[p12l1661t2932r1722b3008],
21	,	,	O	,	_	0	SENT_162	[p12l1661t2932r1722b3008],
22	3	CD	NUMBER	3	num	17	SENT_162	[p12l1752t2932r1811b3008],
23	,	,	O	,	_	0	SENT_162	[p12l1752t2932r1811b3008],
24	4	CD	NUMBER	4	num	17	SENT_162	[p12l1839t2932r1900b3008],
25	,	,	O	,	_	0	SENT_162	[p12l1839t2932r1900b3008],
26	6	CD	NUMBER	6	num	17	SENT_162	[p12l1931t2932r1990b3008],
27	,	,	O	,	_	0	SENT_162	[p12l1931t2932r1990b3008],
28	and	CC	NUMBER	and	_	0	SENT_162	[p12l2020t2931r2143b2995],
29	8	CD	NUMBER	8	xcomp	12	SENT_162	[p12l14t3044r49b3106],
30	during	IN	O	during	_	0	SENT_162	[p12l93t3042r316b3124],
31	the	DT	O	the	det	33	SENT_162	[p12l354t3042r459b3106],
32	intensive	JJ	O	intensive	amod	33	SENT_162	[p12l498t3042r805b3106],
33	phase	NN	O	phase	prep_during	12	SENT_162	[p12l842t3042r1059b3124],
34	,	,	O	,	_	0	SENT_162	[p12l842t3042r1059b3124],
35	and	CC	O	and	_	0	SENT_162	[p12l1102t3042r1225b3106],
36	then	RB	O	then	advmod	37	SENT_162	[p12l1262t3042r1412b3106],
37	monthly	JJ	SET	monthly	advmod	12	SENT_162	[p12l1448t3042r1737b3124],
38	during	IN	O	during	_	0	SENT_162	[p12l1777t3042r1998b3124],
39	the	DT	O	the	det	41	SENT_162	[p12l2037t3042r2141b3106],
40	continuation	NN	O	continuation	nn	41	SENT_162	[p12l12t3153r438b3217],
41	phase	NN	O	phase	prep_during	37	SENT_162	[p12l461t3153r658b3235],
42	for	IN	O	for	_	0	SENT_162	[p12l685t3153r783b3217],
43	6	CD	DURATION	6	num	44	SENT_162	[p12l809t3154r847b3217],
44	months	NNS	NUMBER	month	prep_for	12	SENT_162	[p12l874t3153r1143b3217],
45	.	.	O	.	_	0	SENT_162	[p12l874t3153r1143b3217],

1	At	IN	O	at	_	0	SENT_163	[p12l1173t3154r1261b3216],
2	each	DT	O	each	det	3	SENT_163	[p12l1286t3153r1441b3217],
3	point	NN	O	point	prep_at	7	SENT_163	[p12l1464t3153r1659b3235],
4	,	,	O	,	_	0	SENT_163	[p12l1464t3153r1659b3235],
5	patients	NNS	O	patient	nsubjpass	7	SENT_163	[p12l1686t3153r1949b3235],
6	were	VBD	O	be	auxpass	7	SENT_163	[p12l1976t3174r2141b3217],
7	asked	VBN	O	ask	_	0	SENT_163	[p12l12t3264r206b3328],
8	about	IN	O	about	_	0	SENT_163	[p12l227t3264r419b3328],
9	any	DT	O	any	det	11	SENT_163	[p12l438t3285r562b3346],
10	adverse	JJ	O	adverse	amod	11	SENT_163	[p12l583t3264r840b3328],
11	events	NNS	O	event	prep_about	7	SENT_163	[p12l864t3272r1077b3328],
12	that	WDT	O	that	nsubj	15	SENT_163	[p12l1099t3264r1229b3327],
13	might	MD	O	might	aux	15	SENT_163	[p12l1246t3264r1449b3346],
14	have	VB	O	have	aux	15	SENT_163	[p12l1466t3264r1627b3328],
15	occurred	VBN	O	occur	rcmod	11	SENT_163	[p12l1651t3264r1948b3328],
16	since	IN	O	since	_	0	SENT_163	[p12l1970t3264r2141b3328],
17	the	DT	O	the	det	19	SENT_163	[p12l10t3375r113b3439],
18	last	JJ	O	last	amod	19	SENT_163	[p12l145t3375r261b3439],
19	point	NN	O	point	prep_since	15	SENT_163	[p12l286t3375r479b3457],
20	.	.	O	.	_	0	SENT_163	[p12l286t3375r479b3457],

1	Chest	NN	O	chest	nn	2	SENT_164	[p12l516t3375r710b3439],
2	radiographs	NNS	O	radiograph	nsubjpass	4	SENT_164	[p12l737t3375r1139b3457],
3	were	VBD	O	be	auxpass	4	SENT_164	[p12l1170t3395r1335b3439],
4	taken	VBN	O	take	_	0	SENT_164	[p12l1365t3375r1550b3439],
5	at	IN	O	at	_	0	SENT_164	[p12l1581t3384r1642b3438],
6	the	DT	O	the	det	8	SENT_164	[p12l1668t3375r1772b3439],
7	8th	JJ	ORDINAL	8th	amod	8	SENT_164	[p12l1806t3375r1911b3439],
8	week	NN	DURATION	week	prep_at	4	SENT_164	[p12l1939t3375r2138b3452],
9	,	,	O	,	_	0	SENT_164	[p12l1939t3375r2138b3452],
10	and	CC	O	and	_	0	SENT_164	[p12l12t3486r136b3549],
11	the	DT	O	the	det	13	SENT_164	[p12l159t3486r262b3549],
12	24th	JJ	ORDINAL	24th	amod	13	SENT_164	[p12l288t3486r441b3549],
13	week	NN	DURATION	week	prep_at	4	SENT_164	[p12l464t3486r647b3549],
14	or	CC	O	or	_	0	SENT_164	[p12l672t3507r745b3549],
15	the	DT	O	the	det	16	SENT_164	[p12l765t3486r869b3549],
16	end	NN	O	end	prep_at	4	SENT_164	[p12l896t3486r1019b3549],
17	of	IN	O	of	_	0	SENT_164	[p12l1044t3486r1125b3549],
18	treatment	NN	O	treatment	prep_of	16	SENT_164	[p12l1137t3495r1472b3549],
19	.	.	O	.	_	0	SENT_164	[p12l1137t3495r1472b3549],

1	Outcome	NN	O	outcome	nn	2	SENT_165	[p12l12t3711r333b3772],
2	measures	NNS	O	measure	_	0	SENT_165	[p12l362t3730r687b3772],
3	and	CC	O	and	_	0	SENT_165	[p12l720t3709r845b3772],
4	assessments	NNS	O	assessment	conj_and	2	SENT_165	[p12l875t3718r1297b3772],

1	The	DT	O	the	det	4	SENT_166	[p13l11t136r145b200],
2	primary	JJ	O	primary	amod	4	SENT_166	[p13l176t136r455b217],
3	outcome	NN	O	outcome	nn	4	SENT_166	[p13l489t145r790b200],
4	measures	NNS	O	measure	nsubj	7	SENT_166	[p13l822t156r1147b200],
5	were	VBD	O	be	cop	7	SENT_166	[p13l1180t156r1349b200],
6	the	DT	O	the	det	7	SENT_166	[p13l1381t136r1486b200],
7	incidences	NNS	O	incidence	_	0	SENT_166	[p13l1521t136r1889b200],
8	of	IN	O	of	_	0	SENT_166	[p13l1924t136r2005b200],
9	unfavorable	JJ	O	unfavorable	amod	10	SENT_166	[p13l2024t156r2140b200, p13l12t247r350b311],
10	events	NNS	O	event	prep_of	7	SENT_166	[p13l397t256r624b311],
11	in	IN	O	in	_	0	SENT_166	[p13l671t247r739b310],
12	two	CD	NUMBER	two	num	15	SENT_166	[p13l782t256r915b311],
13	different	JJ	O	different	amod	15	SENT_166	[p13l962t247r1271b311],
14	treatment	NN	O	treatment	nn	15	SENT_166	[p13l1313t256r1656b311],
15	regimens	NNS	O	regimen	prep_in	10	SENT_166	[p13l1698t247r2027b329],
16	in	IN	O	in	_	0	SENT_166	[p13l2075t247r2142b310],
17	population	NN	O	population	prep_in	15	SENT_166	[p13l9t358r390b440],
18	who	WP	O	who	nsubj	19	SENT_166	[p13l432t358r583b422],
19	required	VBD	O	require	rcmod	7	SENT_166	[p13l626t358r921b440],
20	dose	NN	O	dose	nn	21	SENT_166	[p13l965t358r1124b422],
21	modiﬁcation	NN	O	modiﬁcation	dobj	19	SENT_166	[p13l1167t358r1619b422],
22	based	VBN	O	base	_	0	SENT_166	[p13l1660t358r1863b422],
23	on	IN	O	on	prepc_based_on	19	SENT_166	[p13l1907t379r1994b422],
24	the	DT	O	the	det	28	SENT_166	[p13l2035t358r2141b422],
25	NAT	NNP	ORGANIZATION	NAT	nn	28	SENT_166	[p13l7t470r178b533],
26	2	CD	NUMBER	2	num	28	SENT_166	[p13l170t470r211b532],
27	gene	NN	O	gene	nn	28	SENT_166	[p13l253t489r416b551],
28	polymorphism	NN	O	polymorphism	pobj	19	SENT_166	[p13l454t469r990b551],
29	:	:	O	:	_	0	SENT_166	[p13l454t469r990b551],
30	(	CD	NUMBER	(	conj_and	7	SENT_166	[p13l1037t469r1133b550],
31	1	CD	NUMBER	1	number	32	SENT_166	[p13l1037t469r1133b550],
32	)	CD	NUMBER	)	num	34	SENT_166	[p13l1037t469r1133b550],
33	the	DT	O	the	det	34	SENT_166	[p13l1173t469r1278b533],
34	incidences	NNS	O	incidence	nsubj	38	SENT_166	[p13l1319t469r1687b533],
35	of	IN	O	of	_	0	SENT_166	[p13l1730t469r1811b533],
36	drug	NN	O	drug	nn	37	SENT_166	[p13l1840t469r2140b551, p13l12t580r221b644],
37	—	NN	O	—	prep_of	34	SENT_166	[p13l1840t469r2140b551, p13l12t580r221b644],
38	induced	VBD	O	induce	rcmod	30	SENT_166	[p13l1840t469r2140b551, p13l12t580r221b644],
39	liver	NN	O	liver	nn	40	SENT_166	[p13l257t580r417b644],
40	injury	NN	O	injury	dobj	38	SENT_166	[p13l451t580r659b662],
41	associated	VBN	O	associate	partmod	40	SENT_166	[p13l696t580r1044b644],
42	with	IN	O	with	_	0	SENT_166	[p13l1073t580r1226b644],
43	INH	NN	O	inh	nn	46	SENT_166	[p13l1257t582r1408b644],
44	(	CD	NUMBER	(	num	46	SENT_166	[p13l1442t580r1845b661],
45	INH-DILI	NN	O	inh-dili	nn	46	SENT_166	[p13l1442t580r1845b661],
46	)	NN	O	)	prep_with	41	SENT_166	[p13l1442t580r1845b661],
47	that	WDT	O	that	nsubj	48	SENT_166	[p13l1876t580r2005b643],
48	occurred	VBD	O	occur	rcmod	40	SENT_166	[p13l2035t601r2140b644, p13l12t691r229b755],
49	within	IN	O	within	_	0	SENT_166	[p13l247t691r466b755],
50	8	CD	DURATION	8	num	51	SENT_166	[p13l490t693r524b755],
51	weeks	NNS	NUMBER	week	prep_within	48	SENT_166	[p13l549t691r762b755],
52	of	IN	O	of	_	0	SENT_166	[p13l786t691r866b755],
53	the	DT	O	the	det	54	SENT_166	[p13l875t691r979b755],
54	treatments	NNS	O	treatment	prep_of	51	SENT_166	[p13l999t700r1370b769],
55	,	,	O	,	_	0	SENT_166	[p13l999t700r1370b769],
56	and	CC	O	and	_	0	SENT_166	[p13l1396t691r1520b755],
57	(	NN	O	(	conj_and	7	SENT_166	[p13l1541t691r1636b773],
58	2	CD	NUMBER	2	number	59	SENT_166	[p13l1541t691r1636b773],
59	)	CD	NUMBER	)	num	61	SENT_166	[p13l1541t691r1636b773],
60	the	DT	O	the	det	61	SENT_166	[p13l1657t691r1760b755],
61	incidences	NNS	O	incidence	dep	57	SENT_166	[p13l1783t691r2140b755],
62	of	IN	O	of	_	0	SENT_166	[p13l12t802r93b866],
63	early	JJ	O	early	amod	65	SENT_166	[p13l124t802r295b884],
64	treatment	NN	O	treatment	nn	65	SENT_166	[p13l334t811r665b866],
65	failure	NN	O	failure	prep_of	61	SENT_166	[p13l704t802r926b866],
66	at	IN	O	at	_	0	SENT_166	[p13l970t811r1031b866],
67	the	DT	O	the	det	69	SENT_166	[p13l1068t802r1174b866],
68	8th	JJ	DATE	8th	amod	69	SENT_166	[p13l1218t802r1326b866],
69	week	NN	DATE	week	prep_at	65	SENT_166	[p13l1365t802r1566b866],
70	.	.	O	.	_	0	SENT_166	[p13l1365t802r1566b866],

1	The	DT	O	the	det	4	SENT_167	[p13l1613t802r1746b866],
2	secondary	JJ	O	secondary	amod	4	SENT_167	[p13l1790t802r2142b884],
3	outcome	NN	O	outcome	nn	4	SENT_167	[p13l12t922r305b977],
4	measures	NNS	O	measure	nsubj	8	SENT_167	[p13l329t934r646b977],
5	were	VBD	O	be	cop	8	SENT_167	[p13l671t934r836b977],
6	other	JJ	O	other	amod	8	SENT_167	[p13l863t913r1038b977],
7	adverse	JJ	O	adverse	amod	8	SENT_167	[p13l1061t913r1318b977],
8	events	NNS	O	event	_	0	SENT_167	[p13l1345t922r1559b977],
9	observed	VBN	O	observe	partmod	8	SENT_167	[p13l1587t913r1895b977],
10	during	IN	O	during	_	0	SENT_167	[p13l1920t913r2141b995],
11	the	DT	O	the	det	14	SENT_167	[p13l10t1024r113b1088],
12	8-week	JJ	DURATION	8-week	amod	14	SENT_167	[p13l142t1024r393b1088],
13	study	NN	O	study	nn	14	SENT_167	[p13l418t1024r603b1105],
14	period	NN	O	period	prep_during	9	SENT_167	[p13l624t1024r859b1105],
15	.	.	O	.	_	0	SENT_167	[p13l624t1024r859b1105],

1	INH-DILI	NN	O	inh-dili	nsubjpass	3	SENT_168	[p13l113t1137r467b1198],
2	was	VBD	O	be	auxpass	3	SENT_168	[p13l486t1155r619b1199],
3	assessed	VBN	O	assess	_	0	SENT_168	[p13l644t1135r935b1199],
4	according	VBG	O	accord	_	0	SENT_168	[p13l956t1135r1294b1216],
5	to	TO	O	to	prepc_according_to	3	SENT_168	[p13l1315t1143r1380b1199],
6	the	DT	O	the	det	8	SENT_168	[p13l1401t1135r1506b1199],
7	diagnostic	JJ	O	diagnostic	amod	8	SENT_168	[p13l1529t1135r1880b1216],
8	criteria	NNS	O	criterion	pobj	3	SENT_168	[p13l1903t1135r2144b1199],
9	of	IN	O	of	_	0	SENT_168	[p13l12t1246r93b1310],
10	the	DT	O	the	det	11	SENT_168	[p13l102t1246r206b1310],
11	Manual	NNP	O	Manual	prep_of	8	SENT_168	[p13l230t1246r495b1310],
12	for	IN	O	for	_	0	SENT_168	[p13l518t1247r617b1310],
13	Serious	NNP	O	Serious	nn	14	SENT_168	[p13l641t1246r894b1311],
14	Side-Effects	NNP	O	Side-Effects	prep_for	11	SENT_168	[p13l921t1246r1337b1311],
15	of	IN	O	of	_	0	SENT_168	[p13l1363t1247r1444b1310],
16	Drug-induced	JJ	O	drug-induced	amod	18	SENT_168	[p13l1453t1246r1936b1328],
17	Liver	NN	O	liver	nn	18	SENT_168	[p13l1957t1246r2144b1310],
18	Injury	NNP	O	Injury	prep_of	14	SENT_168	[p13l11t1357r222b1439],
19	from	IN	O	from	_	0	SENT_168	[p13l263t1357r430b1421],
20	the	DT	O	the	det	34	SENT_168	[p13l466t1357r572b1421],
21	Ministry	NNP	ORGANIZATION	Ministry	dep	34	SENT_168	[p13l611t1357r910b1439],
22	of	IN	ORGANIZATION	of	_	0	SENT_168	[p13l950t1357r1031b1421],
23	Health	NNP	ORGANIZATION	Health	prep_of	21	SENT_168	[p13l1059t1357r1307b1435],
24	,	,	O	,	_	0	SENT_168	[p13l1059t1357r1307b1435],
25	Labor	NNP	ORGANIZATION	Labor	prep_of	21	SENT_168	[p13l1350t1357r1560b1421],
26	and	CC	O	and	_	0	SENT_168	[p13l1598t1357r1723b1421],
27	Welfare	NNP	O	Welfare	prep_of	21	SENT_168	[p13l1760t1357r2031b1421],
28	of	IN	O	of	_	0	SENT_168	[p13l2072t1357r2153b1421],
29	Japan	NNP	LOCATION	Japan	prep_of	23	SENT_168	[p13l11t1470r208b1550],
30	[	CD	NUMBER	[	num	29	SENT_168	[p13l242t1469r527b1548],
31	22	CD	NUMBER	22	dep	21	SENT_168	[p13l242t1469r527b1548],
32	—	NN	O	—	nn	34	SENT_168	[p13l242t1469r527b1548],
33	24	CD	NUMBER	24	num	34	SENT_168	[p13l242t1469r527b1548],
34	]	NN	O	]	prep_from	18	SENT_168	[p13l242t1469r527b1548],
35	.	.	O	.	_	0	SENT_168	[p13l242t1469r527b1548],

1	In	IN	O	in	_	0	SENT_169	[p13l562t1470r633b1531],
2	brief	NN	O	brief	prep_in	7	SENT_169	[p13l659t1468r839b1545],
3	,	,	O	,	_	0	SENT_169	[p13l659t1468r839b1545],
4	hepatocellular	JJ	O	hepatocellular	amod	5	SENT_169	[p13l870t1468r1361b1550],
5	injury	NN	O	injury	nsubjpass	7	SENT_169	[p13l1388t1468r1592b1550],
6	was	VBD	O	be	auxpass	7	SENT_169	[p13l1620t1488r1753b1532],
7	defined	VBN	O	define	_	0	SENT_169	[p13l1785t1468r2043b1532],
8	as	IN	O	as	_	0	SENT_169	[p13l2073t1489r2141b1532],
9	a	DT	O	a	det	55	SENT_169	[p13l12t1600r49b1642],
10	more	JJR	O	more	amod	55	SENT_169	[p13l69t1599r247b1643],
11	than	IN	O	than	_	0	SENT_169	[p13l269t1579r418b1642],
12	two-fold	JJ	O	two-fold	amod	13	SENT_169	[p13l439t1579r738b1643],
13	increase	NN	O	increase	prep_than	10	SENT_169	[p13l760t1579r1039b1643],
14	in	IN	O	in	_	0	SENT_169	[p13l1063t1579r1129b1642],
15	the	DT	O	the	det	17	SENT_169	[p13l1149t1579r1253b1643],
16	upper	JJ	O	upper	amod	17	SENT_169	[p13l1275t1599r1475b1661],
17	limit	NN	O	limit	prep_in	13	SENT_169	[p13l1497t1579r1657b1642],
18	of	IN	O	of	_	0	SENT_169	[p13l1680t1579r1761b1643],
19	the	DT	O	the	det	22	SENT_169	[p13l1770t1579r1874b1643],
20	normal	JJ	O	normal	amod	22	SENT_169	[p13l1897t1579r2142b1643],
21	(	NN	O	(	nn	22	SENT_169	[p13l12t1690r244b1772],
22	ULN	NN	O	uln	prep_of	17	SENT_169	[p13l12t1690r244b1772],
23	)	CD	NUMBER	)	num	24	SENT_169	[p13l12t1690r244b1772],
24	concentration	NN	O	concentration	dep	17	SENT_169	[p13l268t1690r736b1754],
25	of	IN	O	of	_	0	SENT_169	[p13l759t1690r840b1754],
26	ALT	NN	O	alt	prep_of	24	SENT_169	[p13l849t1692r1010b1753],
27	alone	RB	O	alone	advmod	26	SENT_169	[p13l1028t1690r1212b1754],
28	or	CC	O	or	_	0	SENT_169	[p13l1236t1711r1308b1754],
29	a	DT	O	a	det	33	SENT_169	[p13l1329t1711r1366b1754],
30	serum	NN	O	serum	nn	33	SENT_169	[p13l1389t1711r1597b1754],
31	ALT	NN	O	alt	nn	33	SENT_169	[p13l1617t1692r1778b1753],
32	ratio/ALP	NN	O	ratio/alp	nn	33	SENT_169	[p13l1797t1690r2140b1754],
33	ratio	NN	O	ratio	conj_or	17	SENT_169	[p13l9t1801r164b1865],
34	greater	JJR	O	greater	mwe	35	SENT_169	[p13l191t1810r429b1883],
35	than	IN	O	than	quantmod	36	SENT_169	[p13l449t1801r599b1865],
36	5	CD	NUMBER	5	dep	33	SENT_169	[p13l624t1804r682b1879],
37	,	,	O	,	_	0	SENT_169	[p13l624t1804r682b1879],
38	where	WRB	O	where	advmod	42	SENT_169	[p13l707t1801r918b1865],
39	the	DT	O	the	det	41	SENT_169	[p13l942t1801r1046b1865],
40	ALT	NNP	O	ALT	nn	41	SENT_169	[p13l1069t1803r1231b1864],
41	ratio	NN	O	ratio	nsubj	42	SENT_169	[p13l1251t1801r1634b1865],
42	=	JJ	O	=	rcmod	13	SENT_169	[p13l1251t1801r1634b1865],
43	ALT	NN	O	alt	nn	45	SENT_169	[p13l1251t1801r1634b1865],
44	value/U	NN	O	value/u	nn	45	SENT_169	[p13l1657t1801r1932b1865],
45	LN	NN	O	ln	dobj	42	SENT_169	[p13l1934t1804r2048b1865],
46	of	IN	O	of	_	0	SENT_169	[p13l2073t1801r2153b1865],
47	ALT	NNP	O	ALT	prep_of	45	SENT_169	[p13l9t1914r183b1989],
48	,	,	O	,	_	0	SENT_169	[p13l9t1914r183b1989],
49	and	CC	O	and	_	0	SENT_169	[p13l225t1912r349b1975],
50	ALP	NNP	O	ALP	nn	53	SENT_169	[p13l384t1914r547b1974],
51	ratio	NN	O	ratio	nn	53	SENT_169	[p13l584t1912r970b1975],
52	=	JJ	O	=	amod	53	SENT_169	[p13l584t1912r970b1975],
53	ALP	NN	O	alp	conj_and	13	SENT_169	[p13l584t1912r970b1975],
54	Value/U	NN	O	value/u	nn	55	SENT_169	[p13l1008t1912r1281b1976],
55	LN	NN	O	ln	prep_as	7	SENT_169	[p13l1283t1915r1398b1975],
56	of	IN	O	of	_	0	SENT_169	[p13l1436t1912r1517b1975],
57	ALP	NN	O	alp	prep_of	55	SENT_169	[p13l1541t1914r1713b1975],
58	.	.	O	.	_	0	SENT_169	[p13l1541t1914r1713b1975],

1	Cholestatic	JJ	MISC	cholestatic	amod	2	SENT_170	[p13l1756t1912r2140b1975],
2	injury	NN	O	injury	nsubjpass	4	SENT_170	[p13l12t2022r217b2103],
3	was	VBD	O	be	auxpass	4	SENT_170	[p13l237t2042r370b2086],
4	defined	VBN	O	define	_	0	SENT_170	[p13l396t2022r654b2086],
5	as	IN	O	as	_	0	SENT_170	[p13l678t2042r746b2086],
6	an	DT	O	a	det	7	SENT_170	[p13l771t2042r851b2085],
7	increase	NN	O	increase	prep_as	4	SENT_170	[p13l874t2022r1153b2086],
8	above	IN	O	above	prep	7	SENT_170	[p13l1178t2022r1382b2086],
9	two-fold	RB	O	two-fold	pcomp	8	SENT_170	[p13l1405t2022r1704b2086],
10	of	IN	O	of	_	0	SENT_170	[p13l1726t2022r1807b2086],
11	the	DT	O	the	det	13	SENT_170	[p13l1818t2022r1921b2086],
12	upper	JJ	O	upper	amod	13	SENT_170	[p13l1944t2042r2144b2103],
13	limit	NN	O	limit	prep_of	7	SENT_170	[p13l12t2133r173b2196],
14	of	IN	O	of	_	0	SENT_170	[p13l200t2133r281b2197],
15	the	DT	O	the	det	17	SENT_170	[p13l296t2133r400b2197],
16	normal	JJ	O	normal	amod	17	SENT_170	[p13l428t2133r674b2197],
17	range	NN	O	range	prep_of	13	SENT_170	[p13l700t2153r891b2214],
18	of	IN	O	of	_	0	SENT_170	[p13l921t2133r1002b2197],
19	ALP	NN	O	alp	prep_of	17	SENT_170	[p13l1018t2134r1180b2195],
20	or	CC	O	or	_	0	SENT_170	[p13l1212t2153r1284b2197],
21	a	DT	O	a	det	25	SENT_170	[p13l1310t2153r1347b2196],
22	serum	NN	O	serum	nn	25	SENT_170	[p13l1376t2153r1585b2197],
23	ALT	NN	O	alt	nn	25	SENT_170	[p13l1611t2134r1772b2195],
24	ratio/ALP	NN	O	ratio/alp	nn	25	SENT_170	[p13l1797t2133r2140b2197],
25	ratio	NN	O	ratio	conj_or	7	SENT_170	[p13l10t2244r164b2308],
26	less	JJR	O	less	mwe	27	SENT_170	[p13l198t2244r323b2308],
27	than	IN	O	than	quantmod	28	SENT_170	[p13l354t2244r504b2308],
28	2	CD	NUMBER	2	dep	25	SENT_170	[p13l533t2246r592b2308],
29	.	.	O	.	_	0	SENT_170	[p13l533t2246r592b2308],

1	Mixed	JJ	O	mixed	amod	2	SENT_171	[p13l627t2244r854b2308],
2	injury	NN	O	injury	nsubjpass	4	SENT_171	[p13l885t2244r1090b2326],
3	was	VBD	O	be	auxpass	4	SENT_171	[p13l1118t2265r1251b2308],
4	defmed	VBN	O	defm	_	0	SENT_171	[p13l1285t2244r1542b2308],
5	as	IN	O	as	_	0	SENT_171	[p13l1573t2265r1641b2308],
6	a	DT	O	a	det	10	SENT_171	[p13l1674t2265r1711b2308],
7	serum	NN	O	serum	nn	10	SENT_171	[p13l1743t2265r1952b2308],
8	ALT	NN	O	alt	nn	10	SENT_171	[p13l1980t2246r2141b2307],
9	ratio/ALP	NN	O	ratio/alp	nn	10	SENT_171	[p13l9t2355r353b2419],
10	ratio	NN	O	ratio	prep_as	4	SENT_171	[p13l391t2355r545b2419],
11	of	IN	O	of	_	0	SENT_171	[p13l586t2355r667b2419],
12	between	IN	O	between	quantmod	13	SENT_171	[p13l692t2355r982b2419],
13	2	CD	NUMBER	2	prep_of	10	SENT_171	[p13l1019t2357r1058b2418],
14	and	CC	NUMBER	and	_	0	SENT_171	[p13l1100t2355r1224b2419],
15	5	CD	NUMBER	5	conj_and	13	SENT_171	[p13l1264t2358r1320b2419],
16	.	.	O	.	_	0	SENT_171	[p13l1264t2358r1320b2419],

1	Causality	NN	MISC	causality	nn	2	SENT_172	[p13l1365t2355r1689b2437],
2	assessments	NNS	O	assessment	nsubj	3	SENT_172	[p13l1727t2364r2140b2419],
3	showed	VBD	O	show	_	0	SENT_172	[p13l13t2466r278b2530],
4	a	DT	O	a	det	5	SENT_172	[p13l311t2487r348b2529],
5	relationship	NN	O	relationship	dobj	3	SENT_172	[p13l378t2466r783b2548],
6	to	TO	O	to	_	0	SENT_172	[p13l817t2475r882b2530],
7	the	DT	O	the	det	9	SENT_172	[p13l916t2466r1020b2530],
8	INH	NNP	O	INH	nn	9	SENT_172	[p13l1054t2468r1207b2530],
9	administration	NN	O	administration	prep_to	3	SENT_172	[p13l1242t2466r1739b2530],
10	if	IN	O	if	mark	16	SENT_172	[p13l1771t2466r1833b2529],
11	the	DT	O	the	det	13	SENT_172	[p13l1853t2466r1957b2530],
12	total	JJ	O	total	amod	13	SENT_172	[p13l1990t2466r2141b2530],
13	score	NN	NUMBER	score	nsubj	16	SENT_172	[p13l13t2598r190b2641],
14	was	VBD	O	be	cop	16	SENT_172	[p13l215t2598r349b2641],
15	more	JJR	O	more	quantmod	16	SENT_172	[p13l375t2598r552b2641],
16	than	IN	O	than	advcl	3	SENT_172	[p13l577t2577r727b2641],
17	grade	NN	O	grade	dep	16	SENT_172	[p13l752t2577r941b2659],
18	3	CD	NUMBER	3	num	17	SENT_172	[p13l970t2579r1029b2655],
19	,	,	O	,	_	0	SENT_172	[p13l970t2579r1029b2655],
20	i.e.	FW	O	i.e.	nn	23	SENT_172	[p13l1058t2577r1155b2641],
21	‘	FW	O	‘	dep	23	SENT_172	[p13l1192t2577r1540b2659],
22	possible	JJ	O	possible	amod	23	SENT_172	[p13l1192t2577r1540b2659],
23	’	NN	O	’	advmod	16	SENT_172	[p13l1192t2577r1540b2659],
24	.	.	O	.	_	0	SENT_172	[p13l1192t2577r1540b2659],

1	Early	JJ	O	early	amod	3	SENT_173	[p13l112t2688r298b2770],
2	treatment	NN	O	treatment	nn	3	SENT_173	[p13l329t2697r655b2752],
3	failure	NN	O	failure	nsubjpass	5	SENT_173	[p13l686t2688r905b2752],
4	was	VBD	O	be	auxpass	5	SENT_173	[p13l936t2709r1070b2752],
5	deﬁned	VBN	O	deﬁned	_	0	SENT_173	[p13l1105t2688r1363b2752],
6	as	IN	O	as	_	0	SENT_173	[p13l1395t2709r1463b2752],
7	a	DT	O	a	det	10	SENT_173	[p13l1497t2709r1534b2752],
8	combined	JJ	O	combined	amod	10	SENT_173	[p13l1566t2688r1907b2752],
9	surrogate	JJ	O	surrogate	amod	10	SENT_173	[p13l1941t2709r2141b2752, p13l11t2808r152b2881],
10	endpoint	NN	O	endpoint	prep_as	5	SENT_173	[p13l185t2799r504b2881],
11	:	:	O	:	_	0	SENT_173	[p13l185t2799r504b2881],
12	(	CD	NUMBER	(	num	13	SENT_173	[p13l542t2800r637b2881],
13	l	NN	O	l	dep	10	SENT_173	[p13l542t2800r637b2881],
14	)	CD	NUMBER	)	dep	13	SENT_173	[p13l542t2800r637b2881],
15	a	DT	O	a	det	18	SENT_173	[p13l671t2820r708b2863],
16	positive	JJ	O	positive	amod	18	SENT_173	[p13l735t2799r1008b2881],
17	sputum	NN	O	sputum	nn	18	SENT_173	[p13l1042t2808r1296b2881],
18	culture	NN	O	culture	dep	10	SENT_173	[p13l1327t2799r1562b2863],
19	at	IN	O	at	_	0	SENT_173	[p13l1595t2809r1656b2863],
20	the	DT	O	the	det	23	SENT_173	[p13l1683t2799r1788b2863],
21	8th	JJ	ORDINAL	8th	amod	23	SENT_173	[p13l1823t2799r1929b2863],
22	week	NN	DURATION	week	nn	23	SENT_173	[p13l1958t2799r2143b2863],
23	examination	NN	O	examination	prep_at	18	SENT_173	[p13l12t2910r467b2987],
24	,	,	O	,	_	0	SENT_173	[p13l12t2910r467b2987],
25	or	CC	O	or	_	0	SENT_173	[p13l513t2931r585b2974],
26	(	NN	O	(	prep_as	5	SENT_173	[p13l626t2910r722b2991],
27	2	CD	NUMBER	2	number	28	SENT_173	[p13l626t2910r722b2991],
28	)	CD	NUMBER	)	dep	26	SENT_173	[p13l626t2910r722b2991],
29	no	DT	O	no	det	30	SENT_173	[p13l765t2930r851b2974],
30	sign	NN	O	sign	dep	28	SENT_173	[p13l897t2910r1041b2992],
31	of	IN	O	of	_	0	SENT_173	[p13l1083t2910r1164b2974],
32	improvement	NN	O	improvement	prep_of	28	SENT_173	[p13l1195t2910r1667b2992],
33	in	IN	O	in	_	0	SENT_173	[p13l1708t2910r1774b2973],
34	the	DT	O	the	det	36	SENT_173	[p13l1813t2910r1920b2974],
35	chest	NN	O	chest	nn	36	SENT_173	[p13l1963t2910r2143b2974],
36	radiograph	NN	O	radiograph	prep_in	32	SENT_173	[p13l9t3021r386b3103],
37	at	IN	O	at	_	0	SENT_173	[p13l423t3030r484b3084],
38	8	CD	DURATION	8	num	39	SENT_173	[p13l523t3022r558b3085],
39	weeks	NNS	NUMBER	week	prep_at	5	SENT_173	[p13l599t3021r815b3085],
40	for	IN	O	for	_	0	SENT_173	[p13l855t3021r954b3085],
41	patients	NNS	O	patient	prep_for	39	SENT_173	[p13l987t3021r1254b3103],
42	with	IN	O	with	_	0	SENT_173	[p13l1292t3021r1446b3085],
43	a	DT	O	a	det	46	SENT_173	[p13l1485t3042r1521b3084],
44	negative	JJ	O	negative	amod	46	SENT_173	[p13l1557t3021r1849b3103],
45	sputum	NN	O	sputum	nn	46	SENT_173	[p13l1889t3030r2144b3103],
46	culture	NN	O	culture	prep_with	5	SENT_173	[p13l12t3132r248b3196],
47	at	IN	O	at	_	0	SENT_173	[p13l277t3141r338b3195],
48	baseline	NN	O	baseline	prep_at	46	SENT_173	[p13l361t3132r660b3196],
49	.	.	O	.	_	0	SENT_173	[p13l361t3132r660b3196],

1	Secondary	JJ	O	secondary	amod	3	SENT_174	[p13l696t3132r1058b3213],
2	outcome	NN	O	outcome	nn	3	SENT_174	[p13l1085t3141r1381b3196],
3	measure	NN	O	measure	nsubjpass	5	SENT_174	[p13l1409t3152r1695b3196],
4	was	VBD	O	be	auxpass	5	SENT_174	[p13l1722t3152r1855b3196],
5	defmed	VBN	O	defm	_	0	SENT_174	[p13l1885t3132r2143b3196],
6	by	IN	O	by	_	0	SENT_174	[p13l9t3243r98b3325],
7	the	DT	O	the	det	10	SENT_174	[p13l116t3243r220b3307],
8	other	JJ	O	other	amod	10	SENT_174	[p13l240t3243r418b3307],
9	adverse	JJ	O	adverse	amod	10	SENT_174	[p13l436t3243r696b3307],
10	events	NNS	O	event	agent	5	SENT_174	[p13l717t3252r934b3307],
11	during	IN	O	during	_	0	SENT_174	[p13l956t3243r1180b3325],
12	the	DT	DURATION	the	det	14	SENT_174	[p13l1198t3243r1302b3307],
13	8	CD	DURATION	8	num	14	SENT_174	[p13l1326t3245r1361b3307],
14	weeks	NNS	NUMBER	week	prep_during	5	SENT_174	[p13l1383t3243r1598b3307],
15	of	IN	O	of	_	0	SENT_174	[p13l1620t3243r1701b3307],
16	the	DT	O	the	det	18	SENT_174	[p13l1708t3243r1812b3307],
17	intensive	JJ	O	intensive	amod	18	SENT_174	[p13l1833t3243r2141b3307],
18	phase	NN	O	phase	prep_of	14	SENT_174	[p13l9t3354r206b3436],
19	of	IN	O	of	_	0	SENT_174	[p13l234t3354r315b3418],
20	the	DT	O	the	det	22	SENT_174	[p13l327t3354r432b3418],
21	anti-tuberculosis	JJ	O	anti-tuberculosis	amod	22	SENT_174	[p13l459t3354r1029b3418],
22	therapy	NN	O	therapy	prep_of	18	SENT_174	[p13l1055t3354r1324b3436],
23	.	.	O	.	_	0	SENT_174	[p13l1055t3354r1324b3436],

1	Eur	NNP	O	Eur	nn	4	SENT_175	[p13l53t3512r103b3536],
2	J	NNP	O	J	nn	4	SENT_175	[p13l114t3512r127b3536],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_175	[p13l138t3511r197b3536],
4	Pharrnacol	NNP	PERSON	Pharrnacol	_	0	SENT_175	[p13l208t3511r357b3536],
5	(	CD	NUMBER	(	num	6	SENT_175	[p13l369t3511r460b3543],
6	2013	CD	DATE	2013	dep	4	SENT_175	[p13l369t3511r460b3543],
7	)	CD	NUMBER	)	number	8	SENT_175	[p13l369t3511r460b3543],
8	69	CD	NUMBER	69	dep	6	SENT_175	[p13l473t3511r670b3536],
9	:	:	O	:	_	0	SENT_175	[p13l473t3511r670b3536],
10	l09l	CD	NUMBER	l09l	num	11	SENT_175	[p13l473t3511r670b3536],
11	—	CD	NUMBER	—	dep	6	SENT_175	[p13l473t3511r670b3536],
12	ll01	NN	O	ll01	dep	11	SENT_175	[p13l473t3511r670b3536],
13	1095	CD	DATE	1095	num	12	SENT_175	[p13l2041t3511r2105b3536],

1	All	DT	O	all	det	2	SENT_176	[p13l111t3684r225b3747],
2	outcomes	NNS	O	outcome	nsubjpass	4	SENT_176	[p13l271t3693r614b3748],
3	were	VBD	O	be	auxpass	4	SENT_176	[p13l659t3704r832b3748],
4	determined	VBN	O	determine	_	0	SENT_176	[p13l879t3684r1284b3748],
5	by	IN	O	by	_	0	SENT_176	[p13l1327t3684r1417b3766],
6	the	DT	O	the	det	7	SENT_176	[p13l1460t3684r1568b3748],
7	members	NNS	O	member	agent	4	SENT_176	[p13l1614t3684r1941b3748],
8	of	IN	O	of	_	0	SENT_176	[p13l1989t3684r2071b3748],
9	a	DT	O	a	det	15	SENT_176	[p13l2107t3705r2143b3747],
10	separate	JJ	O	separate	amod	15	SENT_176	[p14l13t30r296b103],
11	central	JJ	O	central	amod	15	SENT_176	[p14l324t21r560b85],
12	end	NN	O	end	nn	15	SENT_176	[p14l588t21r714b85],
13	point	NN	O	point	nn	15	SENT_176	[p14l737t21r921b103],
14	adjudication	NN	O	adjudication	nn	15	SENT_176	[p14l947t21r1381b103],
15	committee	NN	O	committee	prep_of	7	SENT_176	[p14l1408t21r1776b85],
16	who	WP	O	who	nsubj	22	SENT_176	[p14l1802t21r1953b85],
17	used	VBD	O	use	rcmod	15	SENT_176	[p14l1979t21r2142b85],
18	standard	JJ	O	standard	amod	19	SENT_176	[p14l13t132r309b195],
19	deﬁnitions	NNS	O	deﬁnitions	dobj	17	SENT_176	[p14l342t132r714b195],
20	and	CC	O	and	_	0	SENT_176	[p14l750t132r876b195],
21	were	VBD	O	be	cop	22	SENT_176	[p14l906t153r1076b195],
22	unaware	JJ	O	unaware	rcmod	15	SENT_176	[p14l1107t153r1405b195],
23	of	IN	O	of	_	0	SENT_176	[p14l1440t132r1521b195],
24	treatment	NN	O	treatment	nn	25	SENT_176	[p14l1541t141r1874b195],
25	allocation	NN	O	allocation	prep_of	22	SENT_176	[p14l1906t132r2140b195, p14l10t242r147b306],
26	and	CC	O	and	_	0	SENT_176	[p14l177t242r303b306],
27	NAT	NN	ORGANIZATION	nat	conj_and	25	SENT_176	[p14l327t244r499b306],
28	2	CD	NUMBER	2	num	29	SENT_176	[p14l491t244r532b305],
29	genotypes	NNS	O	genotype	dobj	17	SENT_176	[p14l564t251r938b324],
30	.	.	O	.	_	0	SENT_176	[p14l564t251r938b324],

1	An	DT	O	a	det	3	SENT_177	[p14l972t244r1080b305],
2	independent	JJ	O	independent	amod	3	SENT_177	[p14l1109t242r1541b324],
3	Data	NNS	O	datum	nsubj	9	SENT_177	[p14l1569t245r1735b306],
4	and	CC	O	and	_	0	SENT_177	[p14l1765t242r1890b306],
5	Safety	NN	ORGANIZATION	safety	nn	7	SENT_177	[p14l1922t242r2141b324],
6	Monitoring	NN	ORGANIZATION	monitoring	nn	7	SENT_177	[p14l10t353r412b434],
7	Committee	NNP	ORGANIZATION	Committee	conj_and	3	SENT_177	[p14l437t353r825b417],
8	could	MD	O	could	aux	9	SENT_177	[p14l852t353r1046b417],
9	advise	VB	O	advise	_	0	SENT_177	[p14l1070t353r1292b417],
10	early	JJ	O	early	amod	11	SENT_177	[p14l1318t353r1490b434],
11	termination	NN	O	termination	dobj	9	SENT_177	[p14l1512t353r1919b417],
12	of	IN	O	of	_	0	SENT_177	[p14l1943t353r2024b417],
13	the	DT	O	the	det	14	SENT_177	[p14l2035t353r2140b417],
14	trial	NN	O	trial	prep_of	11	SENT_177	[p14l10t464r148b527],
15	for	IN	O	for	_	0	SENT_177	[p14l180t464r281b528],
16	safety	NN	O	safety	nn	18	SENT_177	[p14l310t464r529b545],
17	,	,	O	,	_	0	SENT_177	[p14l310t464r529b545],
18	scientiﬁc	NN	O	scientiﬁc	nn	21	SENT_177	[p14l564t464r879b528],
19	or	CC	O	or	_	0	SENT_177	[p14l912t484r984b528],
20	ethical	JJ	O	ethical	conj_or	18	SENT_177	[p14l1012t464r1243b528],
21	reasons	NNS	O	reason	prep_for	14	SENT_177	[p14l1271t484r1553b528],
22	.	.	O	.	_	0	SENT_177	[p14l1271t484r1553b528],

1	NAT2	NN	O	nat2	nn	2	SENT_178	[p14l8t687r223b750],
2	genotyping	NN	O	genotyping	_	0	SENT_178	[p14l256t686r653b768],

1	Genomic	JJ	O	genomic	amod	2	SENT_179	[p14l12t909r327b973],
2	DNA	NN	O	dna	nsubjpass	4	SENT_179	[p14l352t910r541b973],
3	was	VBD	O	be	auxpass	4	SENT_179	[p14l556t930r690b973],
4	extracted	VBN	O	extract	_	0	SENT_179	[p14l717t909r1030b973],
5	from	IN	O	from	_	0	SENT_179	[p14l1055t909r1221b973],
6	peripheral	JJ	O	peripheral	amod	8	SENT_179	[p14l1241t909r1592b991],
7	whole	JJ	O	whole	amod	8	SENT_179	[p14l1613t909r1825b973],
8	blood	NN	O	blood	prep_from	4	SENT_179	[p14l1848t909r2049b973],
9	of	IN	O	of	_	0	SENT_179	[p14l2073t909r2154b973],
10	each	DT	O	each	det	11	SENT_179	[p14l12t1020r169b1084],
11	subject	NN	O	subject	prep_of	8	SENT_179	[p14l190t1020r432b1102],
12	using	VBG	O	use	partmod	11	SENT_179	[p14l448t1020r636b1102],
13	a	DT	O	a	det	18	SENT_179	[p14l657t1041r694b1084],
14	QLA	NN	O	qlum	nn	18	SENT_179	[p14l712t1022r865b1101],
15	amp	NN	O	amp	nn	18	SENT_179	[p14l885t1041r1031b1102],
16	Blood	NN	O	blood	nn	18	SENT_179	[p14l1052t1020r1266b1084],
17	Mini	NNP	O	Mini	nn	18	SENT_179	[p14l1283t1020r1451b1083],
18	Kit	NN	O	kit	dobj	12	SENT_179	[p14l1469t1020r1580b1084],
19	(	CD	NUMBER	(	num	20	SENT_179	[p14l1599t1021r2003b1102],
20	QIAGEN	NNP	O	QIAGEN	dep	18	SENT_179	[p14l1599t1021r2003b1102],
21	)	CD	NUMBER	)	num	20	SENT_179	[p14l1599t1021r2003b1102],
22	.	.	O	.	_	0	SENT_179	[p14l1599t1021r2003b1102],

1	Six	CD	NUMBER	six	num	4	SENT_180	[p14l2031t1020r2142b1085],
2	single	JJ	O	single	amod	4	SENT_180	[p14l13t1131r219b1213],
3	nucleotide	NN	O	nucleotide	nn	4	SENT_180	[p14l261t1131r630b1195],
4	polymorphisms	NNS	O	polymorphism	nsubjpass	11	SENT_180	[p14l669t1131r1222b1213],
5	in	IN	O	in	_	0	SENT_180	[p14l1266t1131r1333b1194],
6	the	DT	O	the	det	9	SENT_180	[p14l1372t1131r1478b1195],
7	NAT	NNP	ORGANIZATION	NAT	nn	9	SENT_180	[p14l1516t1133r1689b1195],
8	2	CD	NUMBER	2	num	9	SENT_180	[p14l1681t1133r1722b1194],
9	gene	NN	O	gene	prep_in	4	SENT_180	[p14l1766t1152r1930b1213],
10	were	VBD	O	be	auxpass	11	SENT_180	[p14l1971t1152r2140b1195],
11	analyzed	VBN	O	analyze	_	0	SENT_180	[p14l12t1242r336b1324],
12	:	:	O	:	_	0	SENT_180	[p14l12t1242r336b1324],
13	190C	CD	NUMBER	190c	dep	19	SENT_180	[p14l390t1244r567b1306],
14	to	TO	O	to	_	0	SENT_180	[p14l608t1251r674b1306],
15	T	NN	O	t	prep_to	13	SENT_180	[p14l715t1245r765b1305],
16	(	CD	NUMBER	(	num	17	SENT_180	[p14l807t1243r999b1324],
17	NAT	NN	ORGANIZATION	nat	dep	19	SENT_180	[p14l807t1243r999b1324],
18	2	CD	NUMBER	2	number	19	SENT_180	[p14l991t1242r1212b1324],
19	*	CD	NUMBER	*	dep	68	SENT_180	[p14l991t1242r1212b1324],
20	19	CD	NUMBER	19	num	21	SENT_180	[p14l991t1242r1212b1324],
21	)	NN	O	)	dep	19	SENT_180	[p14l991t1242r1212b1324],
22	,	,	O	,	_	0	SENT_180	[p14l991t1242r1212b1324],
23	191	CD	NUMBER	191	num	24	SENT_180	[p14l1264t1244r1375b1306],
24	G	NN	O	g	advmod	21	SENT_180	[p14l1425t1244r1486b1306],
25	to	TO	O	to	_	0	SENT_180	[p14l1525t1251r1590b1306],
26	A	DT	O	a	det	28	SENT_180	[p14l1629t1244r1693b1305],
27	(	CD	NUMBER	(	num	28	SENT_180	[p14l1734t1243r1925b1324],
28	NAT	NN	ORGANIZATION	nat	prep_to	24	SENT_180	[p14l1734t1243r1925b1324],
29	2	CD	NUMBER	2	number	30	SENT_180	[p14l1918t1242r2041b1305],
30	*	CD	NUMBER	*	num	31	SENT_180	[p14l1918t1242r2041b1305],
31	]	NN	O	]	dep	21	SENT_180	[p14l1918t1242r2041b1305],
32	4	CD	NUMBER	4	num	33	SENT_180	[p14l2051t1243r2138b1324],
33	)	NN	O	)	dep	31	SENT_180	[p14l2051t1243r2138b1324],
34	,	,	O	,	_	0	SENT_180	[p14l2051t1243r2138b1324],
35	341	CD	NUMBER	341	num	36	SENT_180	[p14l12t1354r131b1416],
36	T	NN	O	t	dep	43	SENT_180	[p14l180t1355r230b1415],
37	to	TO	O	to	_	0	SENT_180	[p14l267t1361r333b1417],
38	C	NN	O	c	prep_to	36	SENT_180	[p14l373t1354r427b1417],
39	(	CD	NUMBER	(	num	38	SENT_180	[p14l469t1353r830b1434],
40	NAT2	NN	O	nat2	dep	43	SENT_180	[p14l469t1353r830b1434],
41	*	CD	NUMBER	*	num	40	SENT_180	[p14l469t1353r830b1434],
42	5	CD	NUMBER	5	num	43	SENT_180	[p14l469t1353r830b1434],
43	)	NN	O	)	dep	21	SENT_180	[p14l469t1353r830b1434],
44	,	,	O	,	_	0	SENT_180	[p14l469t1353r830b1434],
45	481C	NN	O	481c	nn	47	SENT_180	[p14l870t1354r1058b1417],
46	to	TO	O	to	dep	47	SENT_180	[p14l1096t1361r1160b1417],
47	T	NN	O	t	appos	43	SENT_180	[p14l1202t1355r1264b1430],
48	,	,	O	,	_	0	SENT_180	[p14l1202t1355r1264b1430],
49	590	CD	NUMBER	590	num	50	SENT_180	[p14l1308t1354r1433b1417],
50	G	NN	O	g	appos	43	SENT_180	[p14l1474t1354r1535b1417],
51	to	TO	O	to	_	0	SENT_180	[p14l1572t1362r1638b1417],
52	A	DT	O	a	det	54	SENT_180	[p14l1676t1354r1739b1415],
53	(	NN	O	(	nn	54	SENT_180	[p14l1779t1353r2139b1434],
54	NAT2	NN	O	nat2	prep_to	19	SENT_180	[p14l1779t1353r2139b1434],
55	*	CD	NUMBER	*	number	56	SENT_180	[p14l1779t1353r2139b1434],
56	6	CD	NUMBER	6	num	57	SENT_180	[p14l1779t1353r2139b1434],
57	)	NN	O	)	dep	54	SENT_180	[p14l1779t1353r2139b1434],
58	,	,	O	,	_	0	SENT_180	[p14l1779t1353r2139b1434],
59	and	CC	O	and	_	0	SENT_180	[p14l12t1464r136b1528],
60	857	CD	NUMBER	857	number	61	SENT_180	[p14l166t1465r289b1528],
61	G	NN	O	g	prep_to	19	SENT_180	[p14l319t1465r380b1528],
62	to	TO	O	to	_	0	SENT_180	[p14l405t1472r469b1528],
63	A	DT	O	a	det	66	SENT_180	[p14l496t1465r560b1526],
64	(	JJ	O	(	amod	66	SENT_180	[p14l587t1464r946b1545],
65	NAT2	NN	O	nat2	nn	66	SENT_180	[p14l587t1464r946b1545],
66	*	NN	O	*	prep_to	19	SENT_180	[p14l587t1464r946b1545],
67	7	CD	NUMBER	7	num	68	SENT_180	[p14l587t1464r946b1545],
68	)	NN	O	)	dep	11	SENT_180	[p14l587t1464r946b1545],
69	.	.	O	.	_	0	SENT_180	[p14l587t1464r946b1545],

1	Detections	NNS	O	detection	nsubj	4	SENT_181	[p14l977t1464r1344b1528],
2	were	VBD	O	be	cop	4	SENT_181	[p14l1370t1484r1537b1528],
3	separately	RB	O	separately	advmod	4	SENT_181	[p14l1566t1464r1911b1545],
4	duplicated	JJ	O	duplicated	_	0	SENT_181	[p14l1938t1464r2141b1545, p14l12t1575r193b1639],
5	for	IN	O	for	_	0	SENT_181	[p14l233t1575r334b1639],
6	quality	NN	O	quality	nn	7	SENT_181	[p14l370t1575r610b1656],
7	control	NN	O	control	prep_for	4	SENT_181	[p14l650t1575r893b1639],
8	of	IN	O	of	_	0	SENT_181	[p14l933t1575r1014b1639],
9	genotyping	NN	O	genotyping	prep_of	7	SENT_181	[p14l1043t1575r1452b1656],
10	.	.	O	.	_	0	SENT_181	[p14l1043t1575r1452b1656],

1	In	IN	O	in	_	0	SENT_182	[p14l1495t1577r1566b1637],
2	brief	NN	O	brief	prep_in	32	SENT_182	[p14l1603t1575r1784b1652],
3	,	,	O	,	_	0	SENT_182	[p14l1603t1575r1784b1652],
4	the	DT	O	the	det	30	SENT_182	[p14l1826t1575r1931b1639],
5	three	CD	NUMBER	three	num	6	SENT_182	[p14l1970t1575r2141b1639],
6	mutations	NNS	O	mutation	amod	30	SENT_182	[p14l10t1686r349b1749],
7	481C	CD	NUMBER	481c	dep	6	SENT_182	[p14l369t1687r556b1749],
8	to	TO	O	to	_	0	SENT_182	[p14l576t1695r641b1749],
9	T	NN	O	t	prep_to	7	SENT_182	[p14l662t1689r724b1763],
10	,	,	O	,	_	0	SENT_182	[p14l662t1689r724b1763],
11	590	CD	NUMBER	590	num	12	SENT_182	[p14l749t1688r875b1749],
12	G	NN	O	g	appos	7	SENT_182	[p14l896t1687r957b1749],
13	to	TO	O	to	_	0	SENT_182	[p14l975t1695r1040b1749],
14	A	DT	O	a	det	17	SENT_182	[p14l1059t1687r1122b1748],
15	and	CC	O	and	cc	16	SENT_182	[p14l1142t1686r1266b1749],
16	857	CD	NUMBER	857	num	17	SENT_182	[p14l1288t1688r1411b1749],
17	G	NN	O	g	prep_to	12	SENT_182	[p14l1434t1687r1494b1749],
18	to	TO	O	to	aux	19	SENT_182	[p14l1512t1695r1578b1749],
19	Awere	VB	O	awere	infmod	12	SENT_182	[p14l1596t1687r1837b1749],
20	detected	VBN	O	detect	dep	19	SENT_182	[p14l1857t1686r2143b1749],
21	by	IN	O	by	_	0	SENT_182	[p14l9t1796r98b1878],
22	a	DT	O	a	det	27	SENT_182	[p14l127t1817r164b1860],
23	PCR-RFLP	NN	O	pcr-rflp	nn	27	SENT_182	[p14l192t1797r592b1860],
24	(	NN	O	(	nn	27	SENT_182	[p14l624t1796r996b1878],
25	restriction	NN	O	restriction	nn	27	SENT_182	[p14l624t1796r996b1878],
26	fragment	NN	O	fragment	nn	27	SENT_182	[p14l1027t1796r1338b1878],
27	length	NN	O	length	prep_by	20	SENT_182	[p14l1365t1796r1580b1878],
28	polymorphism	NN	O	polymorphism	nn	30	SENT_182	[p14l1606t1796r2140b1878],
29	)	NN	O	)	nn	30	SENT_182	[p14l1606t1796r2140b1878],
30	method	NN	O	method	nsubj	32	SENT_182	[p14l10t1907r272b1971],
31	as	IN	O	as	prep	30	SENT_182	[p14l292t1928r360b1971],
32	described	VBN	O	describe	_	0	SENT_182	[p14l383t1907r712b1971],
33	previously	RB	DATE	previously	advmod	32	SENT_182	[p14l729t1907r1096b1989],
34	[	CD	NUMBER	[	num	36	SENT_182	[p14l1122t1908r1275b1987],
35	17	CD	NUMBER	17	num	36	SENT_182	[p14l1122t1908r1275b1987],
36	]	NN	O	]	dobj	32	SENT_182	[p14l1122t1908r1275b1987],
37	.	.	O	.	_	0	SENT_182	[p14l1122t1908r1275b1987],

1	After	IN	O	after	_	0	SENT_183	[p14l1299t1907r1482b1971],
2	PCR	NN	O	pcr	nn	3	SENT_183	[p14l1499t1908r1666b1971],
3	ampliﬁcation	NN	O	ampliﬁcation	prep_after	12	SENT_183	[p14l1686t1907r2142b1989],
4	using	VBG	O	use	partmod	3	SENT_183	[p14l9t2018r197b2100],
5	speciﬁc	NN	O	speciﬁc	nn	6	SENT_183	[p14l228t2018r490b2100],
6	primers	NNS	O	primer	dobj	4	SENT_183	[p14l517t2018r800b2100],
7	,	,	O	,	_	0	SENT_183	[p14l517t2018r800b2100],
8	the	DT	O	the	det	10	SENT_183	[p14l829t2018r934b2082],
9	PCR	NN	MISC	pcr	nn	10	SENT_183	[p14l962t2020r1128b2083],
10	products	NNS	O	product	nsubjpass	12	SENT_183	[p14l1153t2018r1451b2100],
11	were	VBD	O	be	auxpass	12	SENT_183	[p14l1479t2039r1646b2082],
12	digested	VBN	O	digest	_	0	SENT_183	[p14l1675t2018r1963b2100],
13	with	IN	O	with	_	0	SENT_183	[p14l1988t2018r2143b2082],
14	the	DT	O	the	det	16	SENT_183	[p14l10t2129r114b2193],
15	restriction	NN	O	restriction	nn	16	SENT_183	[p14l134t2129r481b2193],
16	enzymes	NNS	O	enzyme	prep_with	12	SENT_183	[p14l504t2150r803b2211],
17	Kpn	NNP	ORGANIZATION	Kpn	dep	12	SENT_183	[p14l821t2132r967b2211],
18	1	CD	NUMBER	1	num	17	SENT_183	[p14l991t2132r1036b2207],
19	,	,	O	,	_	0	SENT_183	[p14l991t2132r1036b2207],
20	Tag	NN	O	tag	nn	21	SENT_183	[p14l1064t2132r1186b2211],
21	I	NN	O	i	appos	17	SENT_183	[p14l1208t2132r1252b2207],
22	,	,	O	,	_	0	SENT_183	[p14l1208t2132r1252b2207],
23	and	CC	O	and	_	0	SENT_183	[p14l1278t2129r1402b2193],
24	Bam	UH	O	bam	dep	25	SENT_183	[p14l1418t2132r1577b2193],
25	HI	NN	O	hus	conj_and	12	SENT_183	[p14l1601t2132r1692b2192],
26	to	TO	O	to	aux	27	SENT_183	[p14l1711t2138r1776b2193],
27	determine	VB	O	determine	xcomp	25	SENT_183	[p14l1799t2129r2141b2193],
28	the	DT	O	the	det	30	SENT_183	[p14l10t2240r114b2304],
29	nucleotide	NN	O	nucleotide	nn	30	SENT_183	[p14l138t2240r498b2304],
30	substitution	NN	O	substitution	dobj	27	SENT_183	[p14l525t2240r925b2304],
31	at	IN	O	at	_	0	SENT_183	[p14l950t2249r1011b2304],
32	481	CD	NUMBER	481	prep_at	27	SENT_183	[p14l1034t2242r1182b2318],
33	,	,	O	,	_	0	SENT_183	[p14l1034t2242r1182b2318],
34	590	CD	NUMBER	590	num	32	SENT_183	[p14l1213t2242r1358b2318],
35	,	,	O	,	_	0	SENT_183	[p14l1213t2242r1358b2318],
36	and	CC	NUMBER	and	_	0	SENT_183	[p14l1387t2240r1511b2304],
37	857	CD	NUMBER	857	conj_and	32	SENT_183	[p14l1539t2242r1684b2318],
38	,	,	O	,	_	0	SENT_183	[p14l1539t2242r1684b2318],
39	respectively	RB	O	respectively	advmod	32	SENT_183	[p14l1710t2240r2136b2322],
40	.	.	O	.	_	0	SENT_183	[p14l1710t2240r2136b2322],

1	A	DT	O	a	det	4	SENT_184	[p14l10t2352r73b2413],
2	mismatch	NN	O	mismatch	nn	4	SENT_184	[p14l105t2351r442b2415],
3	PCR-RFLP	NN	O	pcr-rflp	nn	4	SENT_184	[p14l472t2352r873b2415],
4	procedure	NN	O	procedure	nsubj	6	SENT_184	[p14l904t2351r1250b2432],
5	was	VBD	O	be	aux	6	SENT_184	[p14l1282t2371r1415b2415],
6	performed	VBN	O	perform	_	0	SENT_184	[p14l1447t2351r1808b2432],
7	to	TO	O	to	aux	8	SENT_184	[p14l1839t2359r1904b2415],
8	detect	VB	O	detect	xcomp	6	SENT_184	[p14l1939t2351r2144b2415],
9	the	DT	O	the	det	11	SENT_184	[p14l10t2462r114b2525],
10	341	CD	NUMBER	341	num	11	SENT_184	[p14l147t2463r266b2525],
11	T	NN	O	t	dobj	8	SENT_184	[p14l307t2464r357b2524],
12	to	TO	O	to	_	0	SENT_184	[p14l388t2470r452b2525],
13	C	NN	O	c	prep_to	8	SENT_184	[p14l486t2463r561b2538],
14	,	,	O	,	_	0	SENT_184	[p14l486t2463r561b2538],
15	190C	NN	O	190c	nn	17	SENT_184	[p14l604t2463r781b2525],
16	to	TO	O	to	dep	17	SENT_184	[p14l813t2470r878b2525],
17	T	NN	O	t	prep_to	8	SENT_184	[p14l911t2464r961b2524],
18	and	CC	O	and	_	0	SENT_184	[p14l989t2462r1112b2525],
19	191	CD	NUMBER	191	num	20	SENT_184	[p14l1151t2463r1263b2525],
20	G	NN	O	g	prep_to	8	SENT_184	[p14l1304t2463r1364b2525],
21	to	TO	O	to	_	0	SENT_184	[p14l1395t2470r1460b2525],
22	A	DT	O	a	det	23	SENT_184	[p14l1490t2463r1554b2524],
23	substitutions	NNS	O	substitution	prep_to	8	SENT_184	[p14l1587t2462r2037b2538],
24	,	,	O	,	_	0	SENT_184	[p14l1587t2462r2037b2538],
25	as	IN	O	as	_	0	SENT_184	[p14l2073t2482r2141b2525],
26	described	VBN	O	describe	conj_as	6	SENT_184	[p14l12t2572r342b2636],
27	previously	RB	DATE	previously	advmod	26	SENT_184	[p14l363t2572r731b2653],
28	[	RB	O	[	advmod	26	SENT_184	[p14l759t2573r912b2652],
29	20	CD	NUMBER	20	num	30	SENT_184	[p14l759t2573r912b2652],
30	]	NN	O	]	dobj	6	SENT_184	[p14l759t2573r912b2652],
31	.	.	O	.	_	0	SENT_184	[p14l759t2573r912b2652],

1	The	DT	O	the	det	3	SENT_185	[p14l942t2572r1075b2636],
2	restriction	NN	O	restriction	nn	3	SENT_185	[p14l1099t2572r1447b2636],
3	enzymes	NNS	O	enzyme	nsubj	4	SENT_185	[p14l1472t2592r1771b2653],
4	Dde	VBP	O	dde	_	0	SENT_185	[p14l1794t2572r1942b2635],
5	I	PRP	O	I	dobj	4	SENT_185	[p14l1967t2574r1993b2634],
6	and	CC	O	and	_	0	SENT_185	[p14l2018t2572r2143b2636],
7	Msp	NNP	O	Msp	nsubjpass	10	SENT_185	[p14l6t2686r160b2765],
8	I	PRP	O	I	dep	7	SENT_185	[p14l204t2686r230b2746],
9	were	VBD	O	be	auxpass	10	SENT_185	[p14l270t2704r441b2747],
10	used	VBN	O	use	conj_and	4	SENT_185	[p14l481t2683r646b2747],
11	for	IN	O	for	_	0	SENT_185	[p14l688t2683r790b2747],
12	the	DT	O	the	det	14	SENT_185	[p14l828t2683r934b2747],
13	PCR	NN	O	pcr	nn	14	SENT_185	[p14l976t2684r1145b2747],
14	products	NNS	O	product	prep_for	10	SENT_185	[p14l1182t2683r1489b2765],
15	to	TO	O	to	aux	16	SENT_185	[p14l1531t2692r1596b2747],
16	determine	VB	O	determine	xcomp	10	SENT_185	[p14l1641t2683r1993b2747],
17	the	DT	O	the	det	19	SENT_185	[p14l2034t2683r2141b2747],
18	nucleotide	NN	O	nucleotide	nn	19	SENT_185	[p14l9t2794r376b2858],
19	substitutions	NNS	O	substitution	dobj	16	SENT_185	[p14l421t2794r863b2858],
20	at	IN	O	at	_	0	SENT_185	[p14l907t2803r968b2858],
21	341	CD	NUMBER	341	prep_at	16	SENT_185	[p14l1009t2795r1129b2858],
22	and	CC	O	and	_	0	SENT_185	[p14l1181t2794r1307b2858],
23	190/191	CD	DATE	190/191	prep_at	16	SENT_185	[p14l1355t2794r1655b2871],
24	,	,	O	,	_	0	SENT_185	[p14l1355t2794r1655b2871],
25	respectively	RB	O	respectively	advmod	16	SENT_185	[p14l1699t2794r2136b2876],
26	.	.	O	.	_	0	SENT_185	[p14l1699t2794r2136b2876],

1	Alleles	NNS	O	allele	nsubjpass	7	SENT_186	[p14l10t2905r251b2969],
2	without	IN	O	without	_	0	SENT_186	[p14l274t2905r540b2969],
3	any	DT	O	any	det	5	SENT_186	[p14l563t2925r686b2987],
4	defective	JJ	O	defective	amod	5	SENT_186	[p14l708t2905r1020b2969],
5	forms	NNS	O	form	prep_without	1	SENT_186	[p14l1045t2905r1242b2969],
6	were	VBD	O	be	auxpass	7	SENT_186	[p14l1265t2925r1431b2969],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_186	[p14l1455t2905r1713b2969],
8	as	IN	O	as	_	0	SENT_186	[p14l1736t2925r1804b2969],
9	functional	JJ	O	functional	amod	10	SENT_186	[p14l1829t2905r2140b2969, p14l12t3016r72b3079],
10	allele	NN	O	allele	prep_as	7	SENT_186	[p14l98t3016r298b3093],
11	,	,	O	,	_	0	SENT_186	[p14l98t3016r298b3093],
12	NAT	NNP	ORGANIZATION	NAT	appos	10	SENT_186	[p14l323t3018r492b3080],
13	2	CD	NUMBER	2	num	12	SENT_186	[p14l484t3018r525b3078],
14	*	CD	NUMBER	*	number	15	SENT_186	[p14l534t3016r614b3079],
15	4	CD	NUMBER	4	dep	12	SENT_186	[p14l534t3016r614b3079],
16	.	.	O	.	_	0	SENT_186	[p14l621t3069r631b3080],

1	Sample	VB	O	sample	_	0	SENT_187	[p14l14t3239r273b3321],
2	size	NN	O	size	nn	3	SENT_187	[p14l306t3239r436b3303],
3	calculation	NN	O	calculation	dobj	1	SENT_187	[p14l468t3239r853b3303],

1	On	IN	O	on	_	0	SENT_188	[p14l12t3463r118b3526],
2	the	DT	O	the	det	3	SENT_188	[p14l150t3462r256b3526],
3	basis	NN	O	basis	prep_on	17	SENT_188	[p14l289t3462r463b3526],
4	of	IN	O	of	_	0	SENT_188	[p14l500t3462r581b3526],
5	data	NNS	O	datum	prep_of	3	SENT_188	[p14l605t3462r750b3526],
6	from	IN	O	from	_	0	SENT_188	[p14l784t3462r953b3526],
7	our	PRP$	O	we	poss	9	SENT_188	[p14l987t3482r1104b3526],
8	previous	JJ	O	previous	amod	9	SENT_188	[p14l1133t3462r1437b3543],
9	study	NN	O	study	prep_from	5	SENT_188	[p14l1474t3462r1663b3543],
10	[	CD	NUMBER	[	number	11	SENT_188	[p14l1702t3463r1832b3542],
11	18	CD	NUMBER	18	num	9	SENT_188	[p14l1702t3463r1832b3542],
12	,	,	O	,	_	0	SENT_188	[p14l1702t3463r1832b3542],
13	25	CD	NUMBER	25	num	14	SENT_188	[p14l1869t3463r2004b3542],
14	]	NN	O	]	appos	5	SENT_188	[p14l1869t3463r2004b3542],
15	,	,	O	,	_	0	SENT_188	[p14l1869t3463r2004b3542],
16	we	PRP	O	we	nsubj	17	SENT_188	[p14l2039t3482r2140b3526],
17	assumed	VBD	O	assume	_	0	SENT_188	[p14l12t3573r315b3637],
18	that	IN	O	that	complm	31	SENT_188	[p14l349t3573r481b3636],
19	the	DT	O	the	det	20	SENT_188	[p14l514t3573r620b3637],
20	incidence	NN	O	incidence	nsubj	31	SENT_188	[p14l657t3573r991b3637],
21	of	IN	O	of	_	0	SENT_188	[p14l1030t3573r1111b3637],
22	INH-induced	JJ	O	inh-induced	amod	24	SENT_188	[p14l1136t3573r1602b3637],
23	liver	NN	O	liver	nn	24	SENT_188	[p14l1637t3573r1797b3637],
24	injury	NN	O	injury	prep_of	20	SENT_188	[p14l1831t3573r2040b3654],
25	in	IN	O	in	_	0	SENT_188	[p14l2076t3573r2142b3635],
26	slow	JJ	O	slow	amod	27	SENT_188	[p14l13t3684r176b3748],
27	acetylators	NNS	O	acetylator	prep_in	24	SENT_188	[p14l212t3684r589b3766],
28	would	MD	O	would	aux	31	SENT_188	[p14l624t3684r846b3748],
29	be	VB	O	be	cop	31	SENT_188	[p14l879t3684r961b3748],
30	65	CD	PERCENT	65	num	31	SENT_188	[p14l999t3685r1079b3748],
31	%	NN	PERCENT	%	ccomp	17	SENT_188	[p14l1120t3685r1189b3749],
32	in	IN	O	in	_	0	SENT_188	[p14l1225t3684r1291b3747],
33	the	DT	O	the	det	37	SENT_188	[p14l1325t3684r1430b3748],
34	control	NN	O	control	nn	37	SENT_188	[p14l1468t3684r1714b3748],
35	arm	NN	O	arm	nn	37	SENT_188	[p14l1751t3705r1885b3748],
36	(	CD	NUMBER	(	num	37	SENT_188	[p14l1921t3684r2140b3765, p15l10t30r361b99],
37	STDtreatment	NN	O	stdtreatment	prep_in	31	SENT_188	[p14l1921t3684r2140b3765, p15l10t30r361b99],
38	;	:	O	;	_	0	SENT_188	[p14l1921t3684r2140b3765, p15l10t30r361b99],

1	conventional	JJ	O	conventional	amod	3	SENT_189	[p15l397t21r852b85],
2	standard	JJ	O	standard	amod	3	SENT_189	[p15l886t21r1181b85],
3	dosing	NN	O	dosing	_	0	SENT_189	[p15l1213t21r1446b103],
4	of	IN	O	of	_	0	SENT_189	[p15l1480t21r1560b85],
5	INH	NN	MISC	inh	nn	6	SENT_189	[p15l1581t21r1762b102],
6	)	NN	O	)	prep_of	3	SENT_189	[p15l1581t21r1762b102],
7	and	CC	O	and	_	0	SENT_189	[p15l1797t21r1922b85],
8	15	CD	PERCENT	15	num	9	SENT_189	[p15l1961t23r2035b85],
9	%	NN	PERCENT	%	conj_and	3	SENT_189	[p15l2072t22r2140b86],
10	in	IN	O	in	_	0	SENT_189	[p15l12t132r78b195],
11	the	DT	O	the	det	15	SENT_189	[p15l103t132r208b196],
12	test	NN	O	test	nn	15	SENT_189	[p15l235t140r358b196],
13	arm	NN	O	arm	nn	15	SENT_189	[p15l384t152r518b195],
14	(	CD	NUMBER	(	num	15	SENT_189	[p15l545t132r1110b213],
15	PGX-treatment	NN	O	pgx-treatment	prep_in	9	SENT_189	[p15l545t132r1110b213],
16	;	:	O	;	_	0	SENT_189	[p15l545t132r1110b213],
17	NAT	NNP	ORGANIZATION	NAT	dep	3	SENT_189	[p15l1137t133r1308b196],
18	2	CD	NUMBER	2	num	17	SENT_189	[p15l1300t133r1341b195],
19	genotype-guided	JJ	O	genotype-guided	amod	20	SENT_189	[p15l1371t132r1966b214],
20	dosing	NN	O	dosing	dep	17	SENT_189	[p15l1993t132r2140b196, p15l12t243r121b325],
21	of	IN	O	of	_	0	SENT_189	[p15l156t244r237b307],
22	INH	NN	MISC	inh	nn	23	SENT_189	[p15l260t244r460b325],
23	)	NN	O	)	prep_of	20	SENT_189	[p15l260t244r460b325],
24	.	.	O	.	_	0	SENT_189	[p15l260t244r460b325],

1	We	PRP	O	we	nsubj	2	SENT_190	[p15l498t246r611b308],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_190	[p15l644t243r1113b325],
3	that	IN	O	that	complm	15	SENT_190	[p15l1143t243r1276b307],
4	the	DT	O	the	det	5	SENT_190	[p15l1306t243r1411b307],
5	occurrence	NN	O	occurrence	nsubjpass	15	SENT_190	[p15l1447t264r1830b307],
6	of	IN	O	of	_	0	SENT_190	[p15l1865t243r1946b307],
7	early	JJ	O	early	amod	9	SENT_190	[p15l1969t243r2141b325],
8	therapeutic	JJ	O	therapeutic	amod	9	SENT_190	[p15l10t354r399b436],
9	failure	NN	O	failure	prep_of	5	SENT_190	[p15l434t354r657b418],
10	in	IN	O	in	_	0	SENT_190	[p15l691t354r757b417],
11	rapid	JJ	O	rapid	amod	12	SENT_190	[p15l787t354r968b436],
12	acetylators	NNS	O	acetylator	prep_in	9	SENT_190	[p15l1000t354r1376b436],
13	would	MD	O	would	aux	15	SENT_190	[p15l1408t354r1630b418],
14	be	VB	O	be	auxpass	15	SENT_190	[p15l1659t354r1741b418],
15	decreased	VBN	O	decrease	ccomp	2	SENT_190	[p15l1774t354r2138b432],
16	,	,	O	,	_	0	SENT_190	[p15l1774t354r2138b432],
17	from	IN	O	from	_	0	SENT_190	[p15l12t466r184b530],
18	35	CD	PERCENT	35	num	19	SENT_190	[p15l230t468r311b530],
19	%	NN	PERCENT	%	prep_from	15	SENT_190	[p15l362t468r431b531],
20	in	IN	O	in	_	0	SENT_190	[p15l478t466r546b529],
21	the	DT	O	the	det	22	SENT_190	[p15l589t466r696b530],
22	STD-treatment	NN	O	std-treatment	prep_in	19	SENT_190	[p15l746t468r1283b530],
23	to	TO	O	to	_	0	SENT_190	[p15l1326t475r1392b530],
24	15	CD	PERCENT	15	num	25	SENT_190	[p15l1448t468r1522b530],
25	%	NN	PERCENT	%	prep_to	22	SENT_190	[p15l1573t468r1642b531],
26	in	IN	O	in	_	0	SENT_190	[p15l1689t466r1756b529],
27	the	DT	O	the	det	29	SENT_190	[p15l1799t466r1907b530],
28	PG	NN	O	pg	nn	29	SENT_190	[p15l1953t468r2140b530, p15l10t585r343b641],
29	)	NN	O	)	prep_in	25	SENT_190	[p15l1953t468r2140b530, p15l10t585r343b641],
30	;	:	O	;	_	0	SENT_190	[p15l1953t468r2140b530, p15l10t585r343b641],
31	treatment	NN	O	treatment	dep	25	SENT_190	[p15l1953t468r2140b530, p15l10t585r343b641],
32	[	CD	NUMBER	[	number	33	SENT_190	[p15l378t578r534b657],
33	26	CD	NUMBER	26	num	34	SENT_190	[p15l378t578r534b657],
34	]	NN	O	]	dep	31	SENT_190	[p15l378t578r534b657],
35	.	.	O	.	_	0	SENT_190	[p15l378t578r534b657],

1	To	TO	O	to	aux	2	SENT_191	[p15l571t579r659b641],
2	achieve	VB	O	achieve	purpcl	14	SENT_191	[p15l693t577r959b641],
3	a	DT	O	a	det	4	SENT_191	[p15l992t597r1029b640],
4	power	NN	O	power	dobj	2	SENT_191	[p15l1056t597r1280b658],
5	of	IN	O	of	_	0	SENT_191	[p15l1310t577r1391b641],
6	0.8	CD	NUMBER	0.8	prep_of	4	SENT_191	[p15l1412t578r1516b641],
7	with	IN	O	with	_	0	SENT_191	[p15l1550t577r1706b641],
8	an	DT	O	a	det	9	SENT_191	[p15l1739t597r1820b640],
9	alpha	NN	O	alpha	prep_with	2	SENT_191	[p15l1852t577r2040b658],
10	of	IN	O	of	_	0	SENT_191	[p15l2072t577r2153b641],
11	0.05	CD	NUMBER	0.05	prep_of	9	SENT_191	[p15l12t689r184b765],
12	,	,	O	,	_	0	SENT_191	[p15l12t689r184b765],
13	we	PRP	O	we	nsubj	14	SENT_191	[p15l212t708r313b752],
14	aimed	VBD	O	aim	_	0	SENT_191	[p15l342t688r555b752],
15	to	TO	O	to	aux	16	SENT_191	[p15l580t696r645b752],
16	enroll	VB	O	enroll	xcomp	14	SENT_191	[p15l675t688r877b752],
17	22	CD	NUMBER	22	num	19	SENT_191	[p15l903t689r987b750],
18	slow	JJ	O	slow	amod	19	SENT_191	[p15l1019t688r1181b752],
19	acetylators	NNS	O	acetylator	dobj	16	SENT_191	[p15l1209t688r1585b769],
20	and	CC	O	and	_	0	SENT_191	[p15l1615t688r1740b752],
21	156	CD	NUMBER	156	num	24	SENT_191	[p15l1774t689r1895b751],
22	evaluable	JJ	O	evaluable	amod	24	SENT_191	[p15l1925t688r2139b752, p15l12t799r154b863],
23	rapid	JJ	O	rapid	amod	24	SENT_191	[p15l191t799r372b881],
24	acetylators	NNS	O	acetylator	conj_and	19	SENT_191	[p15l409t799r785b881],
25	in	IN	O	in	_	0	SENT_191	[p15l824t799r891b862],
26	the	DT	O	the	det	27	SENT_191	[p15l925t799r1031b863],
27	trial	NN	O	trial	prep_in	16	SENT_191	[p15l1067t799r1223b863],
28	.	.	O	.	_	0	SENT_191	[p15l1067t799r1223b863],

1	According	VBG	O	accord	_	0	SENT_192	[p15l1264t799r1636b881],
2	to	TO	O	to	prepc_according_to	15	SENT_192	[p15l1673t808r1738b863],
3	our	PRP$	O	we	poss	4	SENT_192	[p15l1778t820r1895b863],
4	calculations	NNS	O	calculation	pobj	15	SENT_192	[p15l1930t799r2139b863, p15l12t910r262b988],
5	,	,	O	,	_	0	SENT_192	[p15l1930t799r2139b863, p15l12t910r262b988],
6	a	DT	O	a	det	9	SENT_192	[p15l304t931r341b974],
7	maximum	NN	O	maximum	nn	9	SENT_192	[p15l373t910r733b974],
8	sample	NN	O	sample	nn	9	SENT_192	[p15l770t910r1015b992],
9	size	NN	O	size	nsubjpass	15	SENT_192	[p15l1054t910r1185b974],
10	of	IN	O	of	_	0	SENT_192	[p15l1223t910r1304b974],
11	360	CD	NUMBER	360	num	12	SENT_192	[p15l1331t911r1458b974],
12	patients	NNS	O	patient	prep_of	9	SENT_192	[p15l1494t910r1767b992],
13	would	MD	O	would	aux	15	SENT_192	[p15l1803t910r2025b974],
14	be	VB	O	be	auxpass	15	SENT_192	[p15l2058t910r2140b974],
15	needed	VBN	O	need	_	0	SENT_192	[p15l10t1021r261b1085],
16	to	TO	O	to	aux	17	SENT_192	[p15l288t1030r353b1085],
17	test	VB	O	test	xcomp	15	SENT_192	[p15l384t1029r506b1085],
18	this	DT	O	this	det	19	SENT_192	[p15l533t1021r657b1085],
19	hypothesis	NN	O	hypothesis	dobj	17	SENT_192	[p15l687t1021r1084b1103],
20	,	,	O	,	_	0	SENT_192	[p15l687t1021r1084b1103],
21	allowing	VBG	O	allow	partmod	17	SENT_192	[p15l1120t1021r1424b1103],
22	for	IN	O	for	_	0	SENT_192	[p15l1457t1021r1558b1085],
23	a	DT	O	a	det	27	SENT_192	[p15l1586t1042r1623b1084],
24	15	CD	PERCENT	15	number	25	SENT_192	[p15l1659t1022r1732b1085],
25	%	NN	PERCENT	%	amod	27	SENT_192	[p15l1768t1022r1837b1086],
26	dropout	NN	O	dropout	nn	27	SENT_192	[p15l1868t1021r2142b1103],
27	rate	NN	O	rate	prep_for	21	SENT_192	[p15l10t1141r158b1210],
28	,	,	O	,	_	0	SENT_192	[p15l10t1141r158b1210],
29	with	IN	O	with	_	0	SENT_192	[p15l195t1132r351b1196],
30	frequencies	NNS	O	frequency	prep_with	15	SENT_192	[p15l387t1132r788b1214],
31	of	IN	O	of	_	0	SENT_192	[p15l826t1132r907b1196],
32	rapid	JJ	O	rapid	amod	37	SENT_192	[p15l928t1132r1128b1214],
33	,	,	O	,	_	0	SENT_192	[p15l928t1132r1128b1214],
34	intermediate	JJ	O	intermediate	conj_and	32	SENT_192	[p15l1167t1132r1603b1196],
35	and	CC	O	and	_	0	SENT_192	[p15l1640t1132r1765b1196],
36	slow	JJ	O	slow	conj_and	32	SENT_192	[p15l1801t1132r1964b1196],
37	acetylators	NNS	O	acetylator	prep_of	30	SENT_192	[p15l1999t1153r2140b1196, p15l10t1243r271b1325],
38	estimated	VBN	O	estimate	partmod	37	SENT_192	[p15l317t1243r652b1307],
39	at	IN	O	at	_	0	SENT_192	[p15l694t1252r755b1307],
40	0.50	CD	NUMBER	0.50	prep_at	38	SENT_192	[p15l797t1245r968b1321],
41	,	,	O	,	_	0	SENT_192	[p15l797t1245r968b1321],
42	0.42	CD	NUMBER	0.42	num	40	SENT_192	[p15l1015t1245r1165b1307],
43	and	CC	O	and	_	0	SENT_192	[p15l1211t1243r1337b1307],
44	0.08	CD	NUMBER	0.08	prep_at	38	SENT_192	[p15l1380t1245r1551b1321],
45	,	,	O	,	_	0	SENT_192	[p15l1380t1245r1551b1321],
46	respectively	RB	O	respectively	advmod	38	SENT_192	[p15l1595t1243r2032b1325],
47	.	.	O	.	_	0	SENT_192	[p15l1595t1243r2032b1325],

1	A	DT	O	a	det	4	SENT_193	[p15l2079t1245r2142b1306],
2	group	NN	O	group	nn	4	SENT_193	[p15l12t1375r214b1436],
3	sequential	JJ	O	sequential	amod	4	SENT_193	[p15l258t1354r612b1436],
4	analysis	NN	O	analysis	nsubjpass	7	SENT_193	[p15l653t1354r932b1436],
5	would	MD	O	would	aux	7	SENT_193	[p15l972t1354r1194b1418],
6	be	VB	O	be	auxpass	7	SENT_193	[p15l1232t1354r1314b1418],
7	performed	VBN	O	perform	_	0	SENT_193	[p15l1352t1354r1721b1436],
8	if	IN	O	if	mark	13	SENT_193	[p15l1760t1354r1821b1417],
9	16	CD	NUMBER	16	num	11	SENT_193	[p15l1859t1356r1934b1418],
10	slow	JJ	O	slow	amod	11	SENT_193	[p15l1979t1354r2142b1418],
11	acetylators	NNS	O	acetylator	nsubj	13	SENT_193	[p15l12t1465r414b1546],
12	were	VBD	O	be	cop	13	SENT_193	[p15l461t1485r638b1529],
13	assessable	JJ	O	assessable	advcl	7	SENT_193	[p15l688t1465r1090b1529],
14	.	.	O	.	_	0	SENT_193	[p15l688t1465r1090b1529],

1	The	DT	O	the	det	2	SENT_194	[p15l1143t1465r1282b1529],
2	enrollment	NN	O	enrollment	nsubjpass	5	SENT_194	[p15l1332t1465r1734b1529],
3	would	MD	O	would	aux	5	SENT_194	[p15l1779t1465r2011b1529],
4	be	VB	O	be	auxpass	5	SENT_194	[p15l2056t1465r2141b1529],
5	stopped	VBN	O	stop	_	0	SENT_194	[p15l13t1576r286b1657],
6	when	WRB	O	when	advmod	15	SENT_194	[p15l316t1576r508b1640],
7	p	NN	O	p	nn	8	SENT_194	[p15l528t1598r581b1657],
8	values	NNS	O	value	nsubj	15	SENT_194	[p15l614t1576r836b1640],
9	regarding	VBG	O	regard	_	0	SENT_194	[p15l870t1576r1207b1657],
10	INH-DILI	NN	O	inh-dili	prep_regarding	8	SENT_194	[p15l1240t1578r1600b1639],
11	in	IN	O	in	_	0	SENT_194	[p15l1633t1576r1699b1638],
12	slow	JJ	O	slow	amod	13	SENT_194	[p15l1734t1576r1897b1640],
13	acetylators	NNS	O	acetylator	prep_in	10	SENT_194	[p15l1930t1584r2139b1657, p15l12t1687r202b1751],
14	were	VBD	O	be	cop	15	SENT_194	[p15l227t1707r396b1751],
15	less	JJR	O	less	advcl	5	SENT_194	[p15l423t1687r550b1751],
16	than	IN	O	than	_	0	SENT_194	[p15l576t1687r727b1750],
17	O’Brien-Fleming	JJ	O	o’brien-fleming	amod	18	SENT_194	[p15l753t1687r1362b1768],
18	type	NN	O	type	prep_than	15	SENT_194	[p15l1387t1695r1537b1768],
19	stopping	VBG	O	stop	partmod	18	SENT_194	[p15l1566t1687r1866b1768],
20	boundary	NN	O	boundary	dobj	19	SENT_194	[p15l1890t1687r2140b1751, p15l12t1819r121b1880],
21	determined	VBN	O	determine	partmod	20	SENT_194	[p15l165t1798r561b1862],
22	by	IN	O	by	_	0	SENT_194	[p15l601t1798r691b1880],
23	Lan-DeMets	JJ	O	lan-demets	amod	24	SENT_194	[p15l733t1801r1176b1862],
24	approach	NN	O	approach	agent	21	SENT_194	[p15l1222t1798r1561b1880],
25	.	.	O	.	_	0	SENT_194	[p15l1222t1798r1561b1880],

1	Then	RB	O	then	advmod	7	SENT_195	[p15l1610t1798r1809b1875],
2	,	,	O	,	_	0	SENT_195	[p15l1610t1798r1809b1875],
3	the	DT	O	the	det	4	SENT_195	[p15l1854t1798r1959b1862],
4	trial	NN	O	trial	nsubjpass	7	SENT_195	[p15l2002t1798r2141b1862],
5	would	MD	O	would	aux	7	SENT_195	[p15l9t1909r232b1973],
6	be	VB	O	be	auxpass	7	SENT_195	[p15l258t1909r341b1973],
7	ﬁnalized	VBN	O	ﬁnalized	_	0	SENT_195	[p15l372t1909r677b1973],
8	early	RB	O	early	advmod	7	SENT_195	[p15l708t1909r880b1991],
9	because	IN	O	because	_	0	SENT_195	[p15l907t1909r1185b1973],
10	of	IN	O	of	_	0	SENT_195	[p15l1217t1909r1298b1973],
11	ethical	JJ	O	ethical	amod	12	SENT_195	[p15l1318t1909r1548b1973],
12	considerations	NNS	O	consideration	prep_because_of	7	SENT_195	[p15l1579t1909r2104b1973],
13	.	.	O	.	_	0	SENT_195	[p15l1579t1909r2104b1973],

1	Statistical	JJ	O	statistical	amod	2	SENT_196	[p15l19t2022r358b2086],
2	analysis	NN	O	analysis	_	0	SENT_196	[p15l389t2022r668b2104],

1	The	DT	O	the	det	2	SENT_197	[p15l16t2244r151b2308],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_197	[p15l210t2244r511b2326],
3	were	VBD	O	be	auxpass	4	SENT_197	[p15l568t2265r739b2308],
4	based	VBN	O	base	_	0	SENT_197	[p15l795t2244r1001b2308],
5	on	IN	O	on	_	0	SENT_197	[p15l1058t2265r1145b2308],
6	the	DT	O	the	det	8	SENT_197	[p15l1200t2244r1307b2308],
7	intention-to-treat	JJ	O	intention-to-treat	amod	8	SENT_197	[p15l1366t2244r1976b2308],
8	approach	NN	O	approach	prep_on	4	SENT_197	[p15l2033t2265r2141b2326, p15l13t2355r284b2437],
9	,	,	O	,	_	0	SENT_197	[p15l2033t2265r2141b2326, p15l13t2355r284b2437],
10	including	VBG	O	include	_	0	SENT_197	[p15l347t2355r695b2437],
11	all	DT	O	all	det	14	SENT_197	[p15l756t2355r843b2419],
12	assessable	JJ	O	assessable	amod	14	SENT_197	[p15l904t2355r1280b2419],
13	randomized	JJ	O	randomized	amod	14	SENT_197	[p15l1338t2355r1774b2419],
14	patients	NNS	O	patient	prep_including	8	SENT_197	[p15l1830t2355r2137b2437],
15	.	.	O	.	_	0	SENT_197	[p15l1830t2355r2137b2437],

1	Since	IN	O	since	mark	7	SENT_198	[p15l19t2466r212b2530],
2	the	DT	O	the	det	3	SENT_198	[p15l265t2466r372b2530],
3	patients	NNS	O	patient	nsubj	7	SENT_198	[p15l424t2466r703b2547],
4	with	IN	O	with	_	0	SENT_198	[p15l756t2466r915b2530],
5	intermediate	JJ	O	intermediate	amod	6	SENT_198	[p15l969t2466r1415b2530],
6	genotypes	NNS	O	genotype	prep_with	3	SENT_198	[p15l1469t2474r1831b2547],
7	receive	VBP	O	receive	advcl	24	SENT_198	[p15l1885t2466r2142b2530],
8	the	DT	O	the	det	10	SENT_198	[p15l14t2577r122b2641],
9	same	JJ	O	same	amod	10	SENT_198	[p15l169t2598r347b2641],
10	dose	NN	O	dose	dobj	7	SENT_198	[p15l393t2577r554b2641],
11	of	IN	O	of	_	0	SENT_198	[p15l600t2577r682b2641],
12	INH	NN	O	inh	prep_of	10	SENT_198	[p15l715t2580r870b2641],
13	irrespective	RB	O	irrespective	_	0	SENT_198	[p15l916t2577r1332b2659],
14	of	IN	O	of	_	0	SENT_198	[p15l1378t2577r1460b2641],
15	the	DT	O	the	det	16	SENT_198	[p15l1491t2577r1598b2641],
16	results	NNS	O	result	prep_irrespective_of	12	SENT_198	[p15l1642t2577r1875b2641],
17	of	IN	O	of	_	0	SENT_198	[p15l1921t2577r2003b2641],
18	the	DT	O	the	det	19	SENT_198	[p15l2035t2577r2143b2641],
19	randomization	NN	O	randomization	prep_of	16	SENT_198	[p15l14t2688r554b2766],
20	,	,	O	,	_	0	SENT_198	[p15l14t2688r554b2766],
21	their	PRP$	O	they	poss	22	SENT_198	[p15l603t2688r768b2752],
22	data	NNS	O	datum	nsubjpass	24	SENT_198	[p15l813t2688r960b2752],
23	were	VBD	O	be	auxpass	24	SENT_198	[p15l1004t2709r1176b2752],
24	analyzed	VBN	O	analyze	_	0	SENT_198	[p15l1224t2688r1542b2770],
25	as	IN	O	as	_	0	SENT_198	[p15l1589t2709r1658b2752],
26	a	DT	O	a	det	28	SENT_198	[p15l1707t2709r1744b2752],
27	combined	JJ	O	combined	amod	28	SENT_198	[p15l1790t2688r2144b2752],
28	group	NN	O	group	prep_as	24	SENT_198	[p15l16t2819r242b2881],
29	.	.	O	.	_	0	SENT_198	[p15l16t2819r242b2881],

1	A	DT	O	a	det	4	SENT_199	[p15l286t2800r350b2862],
2	two-tailed	JJ	O	two-tailed	amod	4	SENT_199	[p15l388t2799r753b2863],
3	signiﬁcance	NN	O	signiﬁcance	nn	4	SENT_199	[p15l794t2799r1224b2881],
4	test	NN	O	test	nsubjpass	6	SENT_199	[p15l1264t2807r1389b2863],
5	was	VBD	O	be	auxpass	6	SENT_199	[p15l1426t2819r1563b2863],
6	used	VBN	O	use	_	0	SENT_199	[p15l1603t2799r1785b2863],
7	.	.	O	.	_	0	SENT_199	[p15l1603t2799r1785b2863],

1	Categorical	JJ	O	categorical	amod	2	SENT_200	[p15l1832t2800r2141b2881, p15l16t2910r142b2974],
2	data	NNS	O	datum	nsubjpass	4	SENT_200	[p15l193t2910r341b2974],
3	were	VBD	O	be	auxpass	4	SENT_200	[p15l388t2930r559b2974],
4	compared	VBN	O	compare	_	0	SENT_200	[p15l611t2910r964b2992],
5	using	VBG	O	use	xcomp	4	SENT_200	[p15l1012t2910r1206b2992],
6	the	DT	O	the	det	8	SENT_200	[p15l1255t2910r1363b2974],
7	X2	NN	O	x2	nn	8	SENT_200	[p15l1415t2911r1510b2991],
8	test	NN	O	test	dobj	5	SENT_200	[p15l1562t2919r1687b2974],
9	or	CC	O	or	_	0	SENT_200	[p15l1736t2930r1810b2974],
10	Fisher	NNP	PERSON	Fisher	poss	13	SENT_200	[p15l1857t2910r2141b2974],
11	’s	POS	O	’s	_	0	SENT_200	[p15l1857t2910r2141b2974],
12	exact	JJ	O	exact	amod	13	SENT_200	[p15l17t3030r204b3085],
13	test	NN	O	test	nsubjpass	20	SENT_200	[p15l254t3030r378b3085],
14	as	IN	O	as	_	0	SENT_200	[p15l430t3042r499b3085],
15	appropriate	JJ	O	appropriate	amod	18	SENT_200	[p15l555t3021r961b3103],
16	and	CC	O	and	_	0	SENT_200	[p15l1015t3021r1142b3085],
17	Cochran-Mantel-Haenszel	JJ	O	cochran-mantel-haenszel	conj_and	15	SENT_200	[p15l1195t3021r2142b3085],
18	test	NN	O	test	prep_as	13	SENT_200	[p15l14t3141r139b3196],
19	was	VBD	O	be	auxpass	20	SENT_200	[p15l177t3153r314b3196],
20	used	VBN	O	use	conj_or	4	SENT_200	[p15l355t3132r520b3196],
21	for	IN	O	for	_	0	SENT_200	[p15l562t3132r664b3196],
22	multivariate	JJ	O	multivariate	amod	23	SENT_200	[p15l703t3132r1135b3196],
23	analyses	NNS	O	analysis	prep_for	20	SENT_200	[p15l1179t3132r1498b3214],
24	.	.	O	.	_	0	SENT_200	[p15l1179t3132r1498b3214],

1	Continuous	JJ	O	continuous	amod	2	SENT_201	[p15l1547t3132r1959b3196],
2	Variables	NNS	O	variable	nsubjpass	28	SENT_201	[p15l2001t3153r2141b3196, p15l16t3243r221b3307],
3	are	VBP	O	be	auxpass	4	SENT_201	[p15l267t3264r371b3307],
4	presented	VBN	O	present	_	0	SENT_201	[p15l412t3243r757b3325],
5	as	IN	O	as	_	0	SENT_201	[p15l800t3264r869b3307],
6	the	DT	O	the	det	7	SENT_201	[p15l911t3243r1018b3307],
7	mean	NN	O	mean	prep_as	4	SENT_201	[p15l1060t3264r1253b3307],
8	and	CC	O	and	_	0	SENT_201	[p15l1296t3243r1423b3307],
9	standard	JJ	O	standard	amod	10	SENT_201	[p15l1466t3243r1768b3307],
10	deviation	NN	O	deviation	conj_and	7	SENT_201	[p15l1810t3243r2144b3307],
11	(	CD	NUMBER	(	num	12	SENT_201	[p15l17t3354r185b3435],
12	SD	NN	O	sd	dep	7	SENT_201	[p15l17t3354r185b3435],
13	)	CD	NUMBER	)	num	16	SENT_201	[p15l17t3354r185b3435],
14	or	CC	O	or	_	0	SENT_201	[p15l227t3375r300b3418],
15	25	CD	PERCENT	25	num	16	SENT_201	[p15l337t3356r419b3418],
16	%	NN	PERCENT	%	dep	12	SENT_201	[p15l464t3355r554b3431],
17	,	,	O	,	_	0	SENT_201	[p15l464t3355r554b3431],
18	50	CD	PERCENT	50	number	22	SENT_201	[p15l598t3356r682b3418],
19	%	NN	PERCENT	%	dep	22	SENT_201	[p15l724t3355r793b3419],
20	and	CC	O	and	_	0	SENT_201	[p15l834t3354r962b3418],
21	75	CD	PERCENT	75	num	23	SENT_201	[p15l1001t3357r1083b3418],
22	%	NN	PERCENT	%	num	23	SENT_201	[p15l1128t3355r1196b3419],
23	percentiles	NNS	O	percentile	appos	7	SENT_201	[p15l1235t3354r1623b3436],
24	as	IN	O	as	_	0	SENT_201	[p15l1664t3375r1733b3418],
25	applicable	JJ	O	applicable	prep_as	4	SENT_201	[p15l1776t3354r2142b3436],
26	and	CC	O	and	_	0	SENT_201	[p15l17t3465r144b3529],
27	were	VBD	O	be	auxpass	28	SENT_201	[p15l197t3485r369b3529],
28	analyzed	VBN	O	analyze	conj_and	4	SENT_201	[p15l427t3465r746b3546],
29	by	IN	O	by	_	0	SENT_201	[p15l798t3465r888b3546],
30	ANOVA	NN	ORGANIZATION	anova	agent	28	SENT_201	[p15l943t3466r1255b3529],
31	with	IN	O	with	_	0	SENT_201	[p15l1302t3465r1461b3529],
32	posthoc	JJ	O	posthoc	amod	41	SENT_201	[p15l1514t3465r1794b3546],
33	and	CC	O	and	_	0	SENT_201	[p15l1853t3465r1980b3529],
34	the	DT	O	the	det	37	SENT_201	[p15l2035t3465r2142b3529],
35	Student-t	JJ	MISC	student-t	amod	37	SENT_201	[p15l19t3576r347b3641],
36	test	NN	O	test	nn	37	SENT_201	[p15l391t3585r516b3640],
37	(	NN	O	(	amod	41	SENT_201	[p15l564t3576r696b3658],
38	for	IN	O	for	_	0	SENT_201	[p15l564t3576r696b3658],
39	parametric	JJ	O	parametric	amod	40	SENT_201	[p15l740t3576r1122b3658],
40	variables	NNS	O	variable	prep_for	37	SENT_201	[p15l1171t3576r1523b3658],
41	)	NN	O	)	prep_with	28	SENT_201	[p15l1171t3576r1523b3658],
42	and	CC	O	and	_	0	SENT_201	[p15l1575t3576r1702b3640],
43	the	DT	O	the	det	47	SENT_201	[p15l1749t3576r1856b3640],
44	MannWhitney	NNP	O	MannWhitney	nn	47	SENT_201	[p15l1905t3579r2141b3640, p15l14t3686r324b3768],
45	U	NNP	O	U	nn	47	SENT_201	[p15l370t3689r434b3751],
46	test	NN	O	test	nn	47	SENT_201	[p15l463t3696r588b3751],
47	(	NN	O	(	nsubj	51	SENT_201	[p15l627t3687r760b3768],
48	for	IN	O	for	_	0	SENT_201	[p15l627t3687r760b3768],
49	non-parametric	JJ	O	non-parametric	amod	50	SENT_201	[p15l796t3687r1344b3768],
50	variables	NNS	O	variable	prep_for	47	SENT_201	[p15l1384t3687r1756b3768],
51	)	VBP	O	)	conj_and	4	SENT_201	[p15l1384t3687r1756b3768],
52	.	.	O	.	_	0	SENT_201	[p15l1384t3687r1756b3768],

1	The	DT	O	the	det	2	SENT_202	[p15l1801t3687r1937b3751],
2	LanDeMets	NNPS	O	LanDeMets	_	0	SENT_202	[p15l1977t3689r2142b3750, p16l15t25r295b86],

1	alpha	NN	O	alpha	dep	2	SENT_203	[p16l342t22r534b104],
2	spending	NN	O	spending	amod	3	SENT_203	[p16l579t22r900b104],
3	function	NN	O	function	nsubjpass	5	SENT_203	[p16l946t22r1244b86],
4	was	VBD	O	be	auxpass	5	SENT_203	[p16l1284t43r1421b86],
5	employed	VBN	O	employ	_	0	SENT_203	[p16l1467t22r1819b104],
6	for	IN	O	for	_	0	SENT_203	[p16l1864t22r1966b86],
7	major	JJ	O	major	amod	8	SENT_203	[p16l2006t43r2141b86, p16l7t133r115b215],
8	outcomes	NNS	O	outcome	prep_for	5	SENT_203	[p16l163t142r522b197],
9	.	.	O	.	_	0	SENT_203	[p16l163t142r522b197],

1	Multivariable	JJ	O	multivariable	amod	3	SENT_204	[p16l577t133r1065b197],
2	logistic	JJ	O	logistic	amod	3	SENT_204	[p16l1117t133r1377b215],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_204	[p16l1429t133r1729b215],
4	were	VBD	O	be	auxpass	5	SENT_204	[p16l1779t154r1950b197],
5	performed	VBN	O	perform	_	0	SENT_204	[p16l1999t154r2140b215, p16l17t244r273b308],
6	to	TO	O	to	aux	7	SENT_204	[p16l314t252r380b308],
7	evaluate	VB	O	evaluate	xcomp	5	SENT_204	[p16l408t244r692b308],
8	the	DT	O	the	det	9	SENT_204	[p16l716t244r820b308],
9	relationship	NN	O	relationship	dobj	7	SENT_204	[p16l845t244r1249b326],
10	between	IN	O	between	_	0	SENT_204	[p16l1275t244r1564b308],
11	the	DT	O	the	det	12	SENT_204	[p16l1588t244r1691b308],
12	incidence	NN	O	incidence	prep_between	9	SENT_204	[p16l1719t244r2046b308],
13	of	IN	O	of	_	0	SENT_204	[p16l2074t244r2154b308],
14	unfavorable	JJ	O	unfavorable	amod	15	SENT_204	[p16l13t355r444b419],
15	events	NNS	O	event	prep_of	12	SENT_204	[p16l503t364r728b419],
16	and	CC	O	and	_	0	SENT_204	[p16l788t355r915b419],
17	the	DT	O	the	det	19	SENT_204	[p16l970t355r1077b418],
18	baseline	NN	O	baseline	nn	19	SENT_204	[p16l1133t355r1428b419],
19	factors/covariates	NNS	O	factors/covariates	prep_of	12	SENT_204	[p16l1487t355r2137b419],
20	.	.	O	.	_	0	SENT_204	[p16l1487t355r2137b419],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_205	[p16l14t465r342b547],
2	were	VBD	O	be	auxpass	3	SENT_205	[p16l392t486r564b529],
3	performed	VBN	O	perform	_	0	SENT_205	[p16l613t465r988b547],
4	using	VBG	O	use	xcomp	3	SENT_205	[p16l1036t465r1231b547],
5	SPSS	NNP	ORGANIZATION	SPSS	nn	6	SENT_205	[p16l1286t467r1477b529],
6	ver	NN	O	ver	dobj	4	SENT_205	[p16l1529t486r1656b529],
7	.	.	O	.	_	0	SENT_205	[p16l1529t486r1656b529],

1	11.0	CD	NUMBER	11.0	_	0	SENT_206	[p16l1721t467r1863b529],
2	(	CD	NUMBER	(	num	5	SENT_206	[p16l1918t466r2139b547],
3	SPSS	NNP	ORGANIZATION	SPSS	nn	5	SENT_206	[p16l1918t466r2139b547],
4	Inc.	NNP	ORGANIZATION	Inc.	nn	5	SENT_206	[p16l16t577r178b658],
5	)	NN	O	)	dep	1	SENT_206	[p16l16t577r178b658],
6	and	CC	O	and	_	0	SENT_206	[p16l218t576r346b640],
7	R	NN	O	r	nn	8	SENT_206	[p16l382t579r441b639],
8	ver	NN	O	ver	conj_and	5	SENT_206	[p16l475t597r601b640],
9	.	.	O	.	_	0	SENT_206	[p16l475t597r601b640],

1	2.10.1	CD	NUMBER	2.10.1	number	2	SENT_207	[p16l643t578r859b640],
2	(	CD	NUMBER	(	num	4	SENT_207	[p16l908t576r1071b658],
3	The	DT	O	the	det	4	SENT_207	[p16l908t576r1071b658],
4	R	NN	O	r	_	0	SENT_207	[p16l1109t579r1169b639],
5	Foundation	NNP	O	Foundation	dep	4	SENT_207	[p16l1204t576r1615b640],
6	for	IN	O	for	_	0	SENT_207	[p16l1653t576r1756b640],
7	Statistical	NNP	O	Statistical	nn	9	SENT_207	[p16l1794t576r2143b640],
8	Computing	NNP	O	Computing	nn	9	SENT_207	[p16l17t687r468b768],
9	)	NN	O	)	prep_for	5	SENT_207	[p16l17t687r468b768],
10	.	.	O	.	_	0	SENT_207	[p16l17t687r468b768],

1	Results	NNS	O	result	_	0	SENT_208	[p16l15t930r285b990],

1	Patient	NN	O	patient	nn	2	SENT_209	[p16l15t1149r259b1213],
2	enrollment	NN	O	enrollment	_	0	SENT_209	[p16l288t1149r668b1213],
3	and	CC	O	and	_	0	SENT_209	[p16l697t1149r822b1213],
4	demographics	NNS	O	demographic	conj_and	2	SENT_209	[p16l852t1149r1343b1231],

1	In	IN	O	in	_	0	SENT_210	[p16l15t1374r87b1434],
2	all	DT	O	all	prep_in	8	SENT_210	[p16l125t1371r226b1449],
3	,	,	O	,	_	0	SENT_210	[p16l125t1371r226b1449],
4	172	CD	NUMBER	172	num	5	SENT_210	[p16l276t1373r396b1435],
5	patients	NNS	O	patient	nsubjpass	8	SENT_210	[p16l433t1371r705b1453],
6	were	VBD	O	be	auxpass	8	SENT_210	[p16l743t1392r912b1435],
7	randomly	RB	O	randomly	advmod	8	SENT_210	[p16l948t1371r1288b1453],
8	assigned	VBN	O	assign	_	0	SENT_210	[p16l1325t1371r1627b1453],
9	to	TO	O	to	_	0	SENT_210	[p16l1662t1380r1728b1435],
10	one	CD	NUMBER	one	prep_to	8	SENT_210	[p16l1768t1392r1891b1435],
11	of	IN	O	of	_	0	SENT_210	[p16l1930t1371r2011b1435],
12	the	DT	O	the	det	15	SENT_210	[p16l2036t1371r2141b1435],
13	two	CD	NUMBER	two	num	15	SENT_210	[p16l14t1491r147b1546],
14	study	NN	O	study	nn	15	SENT_210	[p16l197t1482r390b1564],
15	regimens	NNS	O	regimen	prep_of	10	SENT_210	[p16l433t1482r787b1564],
16	,	,	O	,	_	0	SENT_210	[p16l433t1482r787b1564],
17	the	DT	O	the	det	25	SENT_210	[p16l835t1482r943b1546],
18	NAT	NNP	ORGANIZATION	NAT	dep	20	SENT_210	[p16l985t1484r1159b1546],
19	2	CD	NUMBER	2	num	18	SENT_210	[p16l1153t1484r1194b1545],
20	genotype-guided	JJ	O	genotype-guided	amod	25	SENT_210	[p16l1242t1482r1856b1564],
21	dosing	NN	O	dosing	nn	25	SENT_210	[p16l1902t1482r2142b1564],
22	treatment	NN	O	treatment	nn	25	SENT_210	[p16l14t1601r351b1657],
23	(	CD	NUMBER	(	num	25	SENT_210	[p16l394t1593r971b1674],
24	PGX-treatment	NN	O	pgx-treatment	nn	25	SENT_210	[p16l394t1593r971b1674],
25	)	NN	O	)	conj_and	15	SENT_210	[p16l394t1593r971b1674],
26	and	CC	O	and	_	0	SENT_210	[p16l1018t1593r1145b1657],
27	the	DT	O	the	det	34	SENT_210	[p16l1186t1593r1293b1657],
28	conventional	JJ	O	conventional	amod	34	SENT_210	[p16l1339t1593r1799b1657],
29	standard	JJ	O	standard	amod	34	SENT_210	[p16l1844t1593r2144b1657],
30	dosing	NN	O	dosing	nn	34	SENT_210	[p16l16t1704r246b1785],
31	treatment	NN	O	treatment	nn	34	SENT_210	[p16l277t1712r602b1768],
32	(	CD	NUMBER	(	num	34	SENT_210	[p16l635t1704r1222b1785],
33	STD-treatment	NN	O	std-treatment	nn	34	SENT_210	[p16l635t1704r1222b1785],
34	)	NN	O	)	prep_of	10	SENT_210	[p16l635t1704r1222b1785],
35	,	,	O	,	_	0	SENT_210	[p16l635t1704r1222b1785],
36	as	IN	O	as	mark	37	SENT_210	[p16l1259t1724r1327b1768],
37	summarized	VBN	O	summarize	advcl	8	SENT_210	[p16l1363t1704r1782b1768],
38	in	IN	O	in	_	0	SENT_210	[p16l1815t1704r1880b1766],
39	Fig	NN	O	fig	prep_in	37	SENT_210	[p16l1911t1704r2041b1785],
40	.	.	O	.	_	0	SENT_210	[p16l1911t1704r2041b1785],

1	1	LS	NUMBER	1	_	0	SENT_211	[p16l2088t1705r2138b1768],
2	.	.	O	.	_	0	SENT_211	[p16l2088t1705r2138b1768],

1	The	DT	O	the	det	2	SENT_212	[p16l16t1815r148b1879],
2	patients	NNS	O	patient	nsubj	5	SENT_212	[p16l187t1815r480b1896],
3	’	IN	O	’	_	0	SENT_212	[p16l187t1815r480b1896],
4	backgrounds	NNS	O	background	prep_’	5	SENT_212	[p16l524t1815r971b1896],
5	showed	VBD	O	show	_	0	SENT_212	[p16l1015t1815r1279b1879],
6	a	DT	O	a	det	8	SENT_212	[p16l1320t1835r1357b1878],
7	balanced	JJ	O	balanced	amod	8	SENT_212	[p16l1393t1815r1705b1879],
8	distribution	NN	O	distribution	dobj	5	SENT_212	[p16l1744t1815r2144b1879],
9	(	RB	O	(	dep	10	SENT_212	[p16l17t1926r232b2007],
10	Table	NNP	O	Table	dep	8	SENT_212	[p16l17t1926r232b2007],
11	2	CD	NUMBER	2	number	12	SENT_212	[p16l270t1926r357b2008],
12	)	CD	NUMBER	)	num	10	SENT_212	[p16l270t1926r357b2008],
13	.	.	O	.	_	0	SENT_212	[p16l270t1926r357b2008],

1	Eighty	CD	NUMBER	eighty	num	3	SENT_213	[p16l400t1926r630b2008],
2	three	CD	NUMBER	three	num	3	SENT_213	[p16l666t1926r836b1990],
3	patients	NNS	O	patient	nsubj	5	SENT_213	[p16l872t1926r1139b2008],
4	were	VBD	O	be	aux	5	SENT_213	[p16l1177t1947r1344b1990],
5	assigned	VBN	O	assign	_	0	SENT_213	[p16l1383t1926r1680b2008],
6	to	TO	O	to	_	0	SENT_213	[p16l1715t1935r1780b1990],
7	the	DT	O	the	det	9	SENT_213	[p16l1819t1926r1922b1990],
8	PG	NN	O	pg	nn	9	SENT_213	[p16l1961t1927r2141b1990, p16l16t2037r251b2119],
9	)	NN	O	)	prep_to	5	SENT_213	[p16l1961t1927r2141b1990, p16l16t2037r251b2119],
10	:	:	O	:	_	0	SENT_213	[p16l1961t1927r2141b1990, p16l16t2037r251b2119],
11	guided	VBN	O	guide	dep	5	SENT_213	[p16l1961t1927r2141b1990, p16l16t2037r251b2119],
12	therapy	NN	O	therapy	dobj	11	SENT_213	[p16l272t2037r531b2119],
13	and	CC	O	and	_	0	SENT_213	[p16l555t2037r678b2101],
14	89	CD	NUMBER	89	dobj	11	SENT_213	[p16l704t2039r784b2101],
15	to	TO	O	to	_	0	SENT_213	[p16l809t2046r874b2101],
16	the	DT	O	the	det	18	SENT_213	[p16l897t2037r1000b2101],
17	empirical	JJ	O	empirical	amod	18	SENT_213	[p16l1026t2037r1347b2119],
18	therapy	NN	O	therapy	prep_to	5	SENT_213	[p16l1369t2037r1638b2119],
19	.	.	O	.	_	0	SENT_213	[p16l1369t2037r1638b2119],

1	Among	IN	O	among	_	0	SENT_214	[p16l1665t2038r1926b2119],
2	them	PRP	O	they	prep_among	8	SENT_214	[p16l1949t2037r2140b2114],
3	,	,	O	,	_	0	SENT_214	[p16l1949t2037r2140b2114],
4	17	CD	NUMBER	17	num	5	SENT_214	[p16l24t2150r100b2212],
5	patients	NNS	O	patient	nsubj	8	SENT_214	[p16l142t2148r416b2230],
6	were	VBD	O	be	cop	8	SENT_214	[p16l459t2169r628b2212],
7	not	RB	O	not	neg	8	SENT_214	[p16l670t2158r784b2212],
8	eligible	JJ	O	eligible	_	0	SENT_214	[p16l826t2148r1087b2230],
9	for	IN	O	for	_	0	SENT_214	[p16l1131t2148r1233b2212],
10	analysis	NN	O	analysis	prep_for	8	SENT_214	[p16l1273t2148r1554b2230],
11	since	IN	O	since	mark	13	SENT_214	[p16l1601t2148r1777b2212],
12	they	PRP	O	they	nsubj	13	SENT_214	[p16l1819t2148r1972b2230],
13	met	VBD	O	meet	advcl	8	SENT_214	[p16l2011t2157r2144b2212],
14	exclusion	NN	O	exclusion	nn	15	SENT_214	[p16l17t2259r361b2323],
15	criteria	NNS	O	criterion	dobj	13	SENT_214	[p16l404t2259r656b2323],
16	after	IN	O	after	_	0	SENT_214	[p16l698t2259r861b2323],
17	their	PRP$	O	they	poss	18	SENT_214	[p16l900t2259r1066b2323],
18	allocation	NN	O	allocation	prep_after	13	SENT_214	[p16l1108t2259r1482b2337],
19	;	:	O	;	_	0	SENT_214	[p16l1108t2259r1482b2337],
20	12	CD	NUMBER	12	dep	18	SENT_214	[p16l1538t2261r1614b2322],
21	with	IN	O	with	_	0	SENT_214	[p16l1659t2259r1818b2323],
22	primary	JJ	O	primary	amod	24	SENT_214	[p16l1858t2259r2143b2341],
23	INH-resistant	JJ	O	inh-resistant	amod	24	SENT_214	[p16l15t2370r493b2433],
24	tuberculosis	NN	O	tuberculosis	prep_with	20	SENT_214	[p16l532t2370r954b2433],
25	and	CC	O	and	_	0	SENT_214	[p16l999t2370r1124b2433],
26	ﬁve	NN	O	ﬁve	conj_and	24	SENT_214	[p16l1165t2370r1297b2433],
27	with	IN	O	with	_	0	SENT_214	[p16l1338t2370r1494b2433],
28	MAC	NNP	O	MAC	nn	29	SENT_214	[p16l1533t2372r1732b2433],
29	infections	NNS	O	infection	prep_with	13	SENT_214	[p16l1776t2370r2137b2433],
30	.	.	O	.	_	0	SENT_214	[p16l1776t2370r2137b2433],

1	The	DT	O	the	det	2	SENT_215	[p16l16t2480r148b2544],
2	rest	NN	O	rest	nsubjpass	8	SENT_215	[p16l187t2489r312b2544],
3	of	IN	O	of	_	0	SENT_215	[p16l350t2480r431b2544],
4	the	DT	O	the	det	6	SENT_215	[p16l457t2480r561b2544],
5	155	CD	NUMBER	155	num	6	SENT_215	[p16l610t2481r726b2544],
6	patients	NNS	O	patient	prep_of	2	SENT_215	[p16l768t2480r1036b2562],
7	were	VBD	O	be	auxpass	8	SENT_215	[p16l1075t2500r1242b2544],
8	infected	VBN	O	infect	_	0	SENT_215	[p16l1283t2480r1559b2544],
9	with	IN	O	with	_	0	SENT_215	[p16l1596t2480r1750b2544],
10	organisms	NNS	O	organism	prep_with	8	SENT_215	[p16l1790t2480r2141b2562],
11	sensitive	JJ	O	sensitive	amod	10	SENT_215	[p16l18t2591r313b2655],
12	to	TO	O	to	_	0	SENT_215	[p16l353t2600r417b2655],
13	all	DT	O	all	det	16	SENT_215	[p16l459t2591r541b2654],
14	first-line	JJ	O	first-line	amod	16	SENT_215	[p16l581t2591r870b2655],
15	anti-TB	JJ	O	anti-tb	amod	16	SENT_215	[p16l911t2591r1172b2654],
16	drugs	NNS	O	drug	prep_to	11	SENT_215	[p16l1216t2591r1423b2673],
17	.	.	O	.	_	0	SENT_215	[p16l1216t2591r1423b2673],

1	The	DT	O	the	det	2	SENT_216	[p16l1467t2591r1599b2655],
2	distribution	NN	O	distribution	nsubj	8	SENT_216	[p16l1640t2591r2035b2655],
3	of	IN	O	of	_	0	SENT_216	[p16l2074t2591r2154b2655],
4	NAT2	NN	MISC	nat2	nn	6	SENT_216	[p16l11t2703r213b2766],
5	genotype	NN	O	genotype	nn	6	SENT_216	[p16l236t2711r551b2783],
6	frequencies	NNS	O	frequency	prep_of	2	SENT_216	[p16l573t2702r965b2783],
7	was	VBD	O	be	cop	8	SENT_216	[p16l985t2722r1118b2766],
8	similar	JJ	O	similar	_	0	SENT_216	[p16l1142t2702r1378b2766],
9	to	TO	O	to	_	0	SENT_216	[p16l1394t2710r1459b2766],
10	that	DT	O	that	prep_to	8	SENT_216	[p16l1480t2702r1610b2765],
11	in	IN	O	in	_	0	SENT_216	[p16l1628t2702r1694b2764],
12	our	PRP$	O	we	poss	15	SENT_216	[p16l1714t2722r1829b2766],
13	previous	JJ	O	previous	amod	15	SENT_216	[p16l1844t2702r2142b2783],
14	study	NN	O	study	nn	15	SENT_216	[p16l18t2813r203b2895],
15	[	NN	O	[	prep_in	8	SENT_216	[p16l232t2814r287b2893],
16	1	CD	NUMBER	1	number	17	SENT_216	[p16l232t2814r287b2893],
17	8	CD	NUMBER	8	num	18	SENT_216	[p16l303t2814r386b2894],
18	]	NN	O	]	dep	8	SENT_216	[p16l303t2814r386b2894],
19	.	.	O	.	_	0	SENT_216	[p16l303t2814r386b2894],

1	Primary	JJ	O	primary	amod	2	SENT_217	[p16l15t3036r296b3118],
2	Outcomes	NNS	O	outcome	_	0	SENT_217	[p16l327t3037r680b3100],

1	Drug-induced	JJ	O	drug-induced	amod	3	SENT_218	[p16l11t3259r514b3340],
2	liver	NN	O	liver	nn	3	SENT_218	[p16l541t3258r700b3322],
3	injury	NN	O	injury	nsubj	4	SENT_218	[p16l729t3263r937b3340],
4	associated	VBN	O	associate	_	0	SENT_218	[p16l965t3259r1341b3322],
5	with	IN	O	with	_	0	SENT_218	[p16l1365t3259r1512b3322],
6	isoniazid	NN	O	isoniazid	nn	8	SENT_218	[p16l1547t3259r1867b3322],
7	(	CD	NUMBER	(	num	8	SENT_218	[p16l19t3369r418b3451],
8	INH	NN	O	inh	prep_with	4	SENT_218	[p16l19t3369r418b3451],
9	.	.	O	.	_	0	SENT_218	[p16l19t3369r418b3451],

1	—	NN	O	—	_	0	SENT_219	[p16l19t3369r418b3451],
2	.	.	O	.	_	0	SENT_219	[p16l19t3369r418b3451],

1	DILI	NNP	LOCATION	DILI	_	0	SENT_220	[p16l19t3369r418b3451],
2	)	CD	NUMBER	)	dep	1	SENT_220	[p16l19t3369r418b3451],

1	Seven	CD	TIME	seven	npadvmod	2	SENT_221	[p16l19t3593r230b3656],
2	of	IN	TIME	of	advmod	9	SENT_221	[p16l263t3592r343b3656],
3	nine	CD	TIME	nine	num	5	SENT_221	[p16l363t3592r514b3656],
4	slow	JJ	O	slow	amod	5	SENT_221	[p16l549t3592r712b3656],
5	acetylators	NNS	O	acetylator	pobj	2	SENT_221	[p16l745t3592r1121b3673],
6	in	IN	O	in	_	0	SENT_221	[p16l1156t3592r1221b3654],
7	the	DT	O	the	det	8	SENT_221	[p16l1253t3592r1358b3656],
8	STD-treatment	NN	O	std-treatment	prep_in	5	SENT_221	[p16l1395t3593r1918b3656],
9	experienced	VBD	O	experience	_	0	SENT_221	[p16l1950t3612r2141b3673, p16l14t3703r273b3767],
10	INH	NNP	O	INH	dobj	9	SENT_221	[p16l301t3703r723b3767],
11	—	CD	NUMBER	—	num	14	SENT_221	[p16l301t3703r723b3767],
12	related	JJ	O	related	amod	14	SENT_221	[p16l301t3703r723b3767],
13	liver	NN	O	liver	nn	14	SENT_221	[p16l752t3703r911b3767],
14	injury	NN	O	injury	nsubj	9	SENT_221	[p16l939t3703r1146b3784],
15	(	CD	NUMBER	(	num	17	SENT_221	[p16l1176t3703r1590b3784],
16	INH-DILI	NN	O	inh-dili	nn	17	SENT_221	[p16l1176t3703r1590b3784],
17	)	NN	O	)	dep	9	SENT_221	[p16l1176t3703r1590b3784],
18	within	IN	O	within	_	0	SENT_221	[p16l1618t3703r1843b3767],
19	the	DT	O	the	det	20	SENT_221	[p16l1870t3703r1976b3767],
20	first	JJ	ORDINAL	first	prep_within	9	SENT_221	[p16l2006t3703r2144b3767],

1	4	CD	DURATION	4	num	2	SENT_222	[p17l15t22r55b84],
2	weeks	NNS	DURATION	week	_	0	SENT_222	[p17l95t21r334b98],
3	,	,	O	,	_	0	SENT_222	[p17l95t21r334b98],
4	while	IN	O	while	mark	14	SENT_222	[p17l375t21r569b85],
5	none	NN	O	none	nsubj	14	SENT_222	[p17l608t42r778b85],
6	of	IN	O	of	_	0	SENT_222	[p17l820t21r900b85],
7	the	DT	O	the	det	10	SENT_222	[p17l927t21r1032b85],
8	seven	CD	NUMBER	seven	num	10	SENT_222	[p17l1075t42r1272b85],
9	slow	JJ	O	slow	amod	10	SENT_222	[p17l1313t21r1476b85],
10	acetylators	NNS	O	acetylator	prep_of	5	SENT_222	[p17l1516t21r1891b103],
11	in	IN	O	in	_	0	SENT_222	[p17l1933t21r1999b84],
12	the	DT	O	the	det	13	SENT_222	[p17l2036t21r2141b85],
13	PGX-treatment	NN	O	pgx-treatment	prep_in	10	SENT_222	[p17l15t133r533b196],
14	did	VBD	O	do	dep	2	SENT_222	[p17l573t132r683b196],
15	during	IN	O	during	_	0	SENT_222	[p17l723t132r951b214],
16	the	DT	O	the	det	17	SENT_222	[p17l990t132r1095b196],
17	ﬁrst	NN	O	ﬁrst	prep_during	14	SENT_222	[p17l1137t132r1275b196],
18	8	CD	DURATION	8	num	19	SENT_222	[p17l1317t134r1351b196],
19	Weeks	NNS	DURATION	week	tmod	14	SENT_222	[p17l1394t132r1612b196],
20	(	CD	NUMBER	(	num	22	SENT_222	[p17l1656t132r1972b213],
21	attribute	NN	O	attribute	nn	22	SENT_222	[p17l1656t132r1972b213],
22	risk	NN	O	risk	dep	19	SENT_222	[p17l2012t132r2144b196],

1	@	IN	O	@	_	0	SENT_223	[p17l1784t366r1856b455],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_223	[p17l1882t388r2126b458],

1	Eur	NNP	O	Eur	nn	4	SENT_224	[p17l1486t534r1536b558],
2	J	NNP	O	J	nn	4	SENT_224	[p17l1547t534r1560b558],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_224	[p17l1571t533r1631b558],
4	Pharrnacol	NNP	PERSON	Pharrnacol	_	0	SENT_224	[p17l1642t533r1790b558],
5	(	CD	NUMBER	(	num	6	SENT_224	[p17l1802t533r1893b565],
6	2013	CD	DATE	2013	dep	4	SENT_224	[p17l1802t533r1893b565],
7	)	CD	NUMBER	)	number	8	SENT_224	[p17l1802t533r1893b565],
8	69:1091	CD	NUMBER	69:1091	num	10	SENT_224	[p17l1906t533r2103b558],
9	—	CD	NUMBER	—	number	10	SENT_224	[p17l1906t533r2103b558],
10	1101	CD	DATE	1101	dep	6	SENT_224	[p17l1906t533r2103b558],

1	Table	NNP	O	Table	_	0	SENT_225	[p17l53t634r134b658],
2	2	CD	NUMBER	2	num	4	SENT_225	[p17l147t633r162b658],
3	Baseline	NN	O	baseline	nn	4	SENT_225	[p17l186t633r305b658],
4	characteristics	NNS	O	characteristic	nsubj	7	SENT_225	[p17l319t633r515b658],
5	of	IN	O	of	_	0	SENT_225	[p17l529t633r561b658],
6	all	DT	O	all	prep_of	4	SENT_225	[p17l569t633r602b658],
7	randomized	VBN	O	randomize	rcmod	1	SENT_225	[p17l614t633r779b658],
8	participants	NNS	O	participant	nsubj	9	SENT_225	[p17l790t633r952b665],
9	valid	JJ	O	valid	xcomp	7	SENT_225	[p17l965t633r1034b658],
10	for	IN	O	for	_	0	SENT_225	[p17l1047t633r1087b658],
11	evaluation	NN	O	evaluation	prep_for	9	SENT_225	[p17l1099t633r1243b658],
12	of	IN	O	of	_	0	SENT_225	[p17l1256t633r1288b658],
13	isoniazid-related	JJ	O	isoniazid-related	amod	15	SENT_225	[p17l1296t633r1527b658],
14	liver	NN	O	liver	nn	15	SENT_225	[p17l1540t633r1603b658],
15	injury	NN	O	injury	prep_of	11	SENT_225	[p17l1614t633r1696b665],
16	and	CC	O	and	_	0	SENT_225	[p17l1710t633r1759b658],
17	other	JJ	O	other	amod	19	SENT_225	[p17l1772t633r1843b658],
18	adverse	JJ	O	adverse	amod	19	SENT_225	[p17l1855t633r1960b658],
19	events	NNS	O	event	prep_for	9	SENT_225	[p17l1973t637r2060b658],
20	on	IN	O	on	_	0	SENT_225	[p17l2074t641r2108b658],
21	intention-to-treat	JJ	O	intention-to-treat	amod	22	SENT_225	[p17l53t674r288b700],
22	bases	NNS	O	basis	prep_on	19	SENT_225	[p17l298t674r373b700],

1	Parameters	NNS	O	parameter	_	0	SENT_226	[p17l52t761r205b785],
2	NAT2	NN	O	nat2	nn	3	SENT_226	[p17l300t760r385b785],
3	genotype	NN	O	genotype	dep	1	SENT_226	[p17l398t763r525b792],
4	status	NN	O	status	nn	9	SENT_226	[p17l538t764r615b785],
5	SA-type	JJ	O	sa-type	amod	9	SENT_226	[p17l711t760r825b792],
6	IA-type	JJ	O	ia-type	amod	9	SENT_226	[p17l1226t761r1333b792],
7	RA-type	NN	O	ra-type	nn	9	SENT_226	[p17l1485t760r1604b792],
8	p	NN	O	p	nn	9	SENT_226	[p17l2000t769r2021b792],
9	value	NN	O	value	dep	1	SENT_226	[p17l2032t760r2107b785],

1	Treatments	NNS	O	treatment	nsubj	2	SENT_227	[p17l301t850r455b874],
2	STD	VBP	O	std	_	0	SENT_227	[p17l711t849r774b874],
3	PGX	NN	O	pgx	nn	4	SENT_227	[p17l967t849r1029b874],
4	PGx	NN	O	pgx	dobj	2	SENT_227	[p17l1225t849r1297b874],
5	/	:	O	/	punct	6	SENT_227	[p17l1225t849r1297b874],
6	STD	NN	O	std	dep	4	SENT_227	[p17l1299t849r1362b874],
7	PGX	NN	O	pgx	nn	8	SENT_227	[p17l1485t849r1547b874],
8	STD	NN	O	std	dep	6	SENT_227	[p17l1746t849r1809b874],

1	Patients	NNS	O	patient	nsubj	18	SENT_228	[p17l8t964r224b1014],
2	(	CD	NUMBER	(	num	3	SENT_228	[p17l251t965r326b1028],
3	n	NN	O	n	dep	1	SENT_228	[p17l251t965r326b1028],
4	)	CD	NUMBER	)	number	5	SENT_228	[p17l251t965r326b1028],
5	9	CD	NUMBER	9	dep	1	SENT_228	[p17l1317t966r1347b1015],
6	7	CD	NUMBER	7	num	9	SENT_228	[p17l1830t966r1860b1015],
7	Sex	NN	O	sex	nn	9	SENT_228	[p17l11t1065r111b1115],
8	(	NN	O	(	nn	9	SENT_228	[p17l135t1064r285b1128],
9	M/F	NN	O	m/f	dep	5	SENT_228	[p17l135t1064r285b1128],
10	,	,	O	,	_	0	SENT_228	[p17l135t1064r285b1128],
11	n	NN	O	n	nsubj	18	SENT_228	[p17l310t1064r365b1128],
12	)	CD	NUMBER	)	num	11	SENT_228	[p17l310t1064r365b1128],
13	4/5	CD	NUMBER	4/5	num	17	SENT_228	[p17l1315t1064r1399b1114],
14	4/3	CD	NUMBER	4/3	num	17	SENT_228	[p17l1828t1064r1911b1114],
15	Age	NNP	O	Age	nn	17	SENT_228	[p17l7t1164r122b1227],
16	(	CD	NUMBER	(	num	17	SENT_228	[p17l147t1159r360b1227],
17	years	NNS	NUMBER	year	dep	11	SENT_228	[p17l147t1159r360b1227],
18	)	VBP	O	)	_	0	SENT_228	[p17l147t1159r360b1227],
19	a	DT	O	a	quantmod	21	SENT_228	[p17l147t1159r360b1227],
20	35.0	CD	NUMBER	35.0	number	21	SENT_228	[p17l1317t1164r1435b1213],
21	48.0	CD	NUMBER	48.0	dobj	18	SENT_228	[p17l1828t1164r1948b1213],

1	Weight	NNP	O	Weight	_	0	SENT_229	[p17l8t1345r207b1409],
2	(	CD	NUMBER	(	num	4	SENT_229	[p17l231t1341r367b1409],
3	kg	NN	O	kg	nn	4	SENT_229	[p17l231t1341r367b1409],
4	)	NN	O	)	dep	1	SENT_229	[p17l231t1341r367b1409],
5	a	DT	O	a	det	7	SENT_229	[p17l231t1341r367b1409],
6	55.0	CD	NUMBER	55.0	number	7	SENT_229	[p17l1318t1346r1435b1395],
7	59.5	CD	NUMBER	59.5	dep	4	SENT_229	[p17l1831t1346r1946b1395],

1	AST	NNP	O	AST	_	0	SENT_230	[p17l7t1528r138b1577],
2	(	CD	NUMBER	(	num	1	SENT_230	[p17l162t1523r363b1591],
3	IU/L	NN	O	iu/l	dep	1	SENT_230	[p17l162t1523r363b1591],
4	)	CD	NUMBER	)	num	3	SENT_230	[p17l162t1523r363b1591],
5	a	DT	O	a	det	7	SENT_230	[p17l162t1523r363b1591],
6	18	CD	NUMBER	18	number	7	SENT_230	[p17l1323t1528r1381b1577],
7	17	CD	NUMBER	17	dep	3	SENT_230	[p17l1835t1528r1895b1577],

1	ALT	NNP	O	ALT	_	0	SENT_231	[p17l7t1708r135b1757],
2	(	CD	NUMBER	(	num	1	SENT_231	[p17l160t1704r361b1771],
3	IU/L	NN	O	iu/l	dep	1	SENT_231	[p17l160t1704r361b1771],
4	)	CD	NUMBER	)	num	3	SENT_231	[p17l160t1704r361b1771],
5	a	DT	O	a	det	7	SENT_231	[p17l160t1704r361b1771],
6	12	CD	NUMBER	12	number	7	SENT_231	[p17l1323t1709r1382b1757],
7	15	CD	NUMBER	15	dep	3	SENT_231	[p17l1835t1709r1893b1757],

1	ALP	NN	O	alp	_	0	SENT_232	[p17l7t1889r137b1938],
2	(	CD	NUMBER	(	num	1	SENT_232	[p17l162t1884r363b1952],
3	IU/L	NN	O	iu/l	dep	1	SENT_232	[p17l162t1884r363b1952],
4	)	CD	NUMBER	)	num	3	SENT_232	[p17l162t1884r363b1952],
5	a	DT	O	a	det	7	SENT_232	[p17l162t1884r363b1952],
6	241	CD	NUMBER	241	number	7	SENT_232	[p17l1316t1890r1412b1938],
7	244	CD	NUMBER	244	dep	3	SENT_232	[p17l1829t1890r1931b1938],

1	Total-bilirubin	NN	O	total-bilirubin	_	0	SENT_233	[p17l9t2069r410b2119],
2	(	CD	NUMBER	(	num	1	SENT_233	[p17l435t2065r687b2134],
3	mg/dL	NN	O	mg/dl	dep	1	SENT_233	[p17l435t2065r687b2134],
4	)	CD	NUMBER	)	num	3	SENT_233	[p17l435t2065r687b2134],
5	"	``	O	"	punct	3	SENT_233	[p17l435t2065r687b2134],
6	"	``	O	"	punct	7	SENT_233	[p17l435t2065r687b2134],
7	0.3	CD	NUMBER	0.3	dep	3	SENT_233	[p17l1317t2071r1397b2119],
8	0.5	CD	NUMBER	0.5	dep	1	SENT_233	[p17l1830t2071r1911b2119],

1	Creatinine	NN	O	creatinine	_	0	SENT_234	[p17l10t2250r294b2301],
2	(	CD	NUMBER	(	num	1	SENT_234	[p17l320t2246r571b2315],
3	mg/dL	NN	O	mg/dl	dep	1	SENT_234	[p17l320t2246r571b2315],
4	)	CD	NUMBER	)	num	3	SENT_234	[p17l320t2246r571b2315],
5	a	DT	O	a	det	7	SENT_234	[p17l320t2246r571b2315],
6	0.6	CD	NUMBER	0.6	num	7	SENT_234	[p17l1317t2252r1400b2300],
7	0.6	CD	NUMBER	0.6	dep	1	SENT_234	[p17l1830t2252r1913b2300],

1	Anti	JJ	O	anti	amod	4	SENT_235	[p17l7t2431r487b2482],
2	—	NN	O	—	nn	4	SENT_235	[p17l7t2431r487b2482],
3	tuberculosis	NN	O	tuberculosis	nn	4	SENT_235	[p17l7t2431r487b2482],
4	drugs	NNS	O	drug	nsubj	5	SENT_235	[p17l512t2431r663b2496],
5	(	VBP	O	(	_	0	SENT_235	[p17l689t2432r866b2495],
6	Dose	NN	O	dose	nn	10	SENT_235	[p17l689t2432r866b2495],
7	,	,	O	,	_	0	SENT_235	[p17l689t2432r866b2495],
8	mg/kg/day	JJ	O	mg/kg/day	amod	10	SENT_235	[p17l892t2416r1237b2496],
9	)	NN	O	)	nn	10	SENT_235	[p17l892t2416r1237b2496],
10	b	NN	O	b	dobj	5	SENT_235	[p17l892t2416r1237b2496],

1	Isoniazidb	NNP	O	Isoniazidb	dep	10	SENT_236	[p17l78t2516r357b2581],
2	5.5	CD	NUMBER	5.5	num	1	SENT_236	[p17l1318t2533r1398b2581],
3	(	CD	NUMBER	(	num	4	SENT_236	[p17l1426t2531r1555b2595],
4	0.8	CD	NUMBER	0.8	dep	1	SENT_236	[p17l1426t2531r1555b2595],
5	)	NN	O	)	dep	10	SENT_236	[p17l1426t2531r1555b2595],
6	2.6	CD	NUMBER	2.6	num	5	SENT_236	[p17l1828t2532r1913b2581],
7	(	NN	O	(	nn	10	SENT_236	[p17l1939t2531r2068b2595],
8	0.3	CD	NUMBER	0.3	num	10	SENT_236	[p17l1939t2531r2068b2595],
9	)	NN	O	)	nn	10	SENT_236	[p17l1939t2531r2068b2595],
10	Rifampicinb	NN	O	rifampicinb	dep	15	SENT_236	[p17l78t2615r414b2694],
11	8.7	CD	NUMBER	8.7	number	12	SENT_236	[p17l1319t2631r1400b2680],
12	(	CD	NUMBER	(	dep	10	SENT_236	[p17l1426t2630r1555b2694],
13	1.4	CD	NUMBER	1.4	num	14	SENT_236	[p17l1426t2630r1555b2694],
14	)	NN	O	)	dep	12	SENT_236	[p17l1426t2630r1555b2694],
15	8.9	CD	NUMBER	8.9	dep	22	SENT_236	[p17l1831t2631r1912b2680],
16	(	CD	NUMBER	(	number	17	SENT_236	[p17l1939t2630r2068b2694],
17	1.7	CD	NUMBER	1.7	num	19	SENT_236	[p17l1939t2630r2068b2694],
18	)	NN	O	)	nn	19	SENT_236	[p17l1939t2630r2068b2694],
19	Pyrazinamideb	NN	O	pyrazinamideb	dep	15	SENT_236	[p17l78t2713r484b2793],
20	23.7	CD	NUMBER	23.7	amod	19	SENT_236	[p17l1316t2730r1435b2779],
21	(	CD	NUMBER	(	num	22	SENT_236	[p17l1461t2729r1590b2793],
22	3.0	CD	NUMBER	3.0	dep	30	SENT_236	[p17l1461t2729r1590b2793],
23	)	CD	NUMBER	)	num	24	SENT_236	[p17l1461t2729r1590b2793],
24	20.7	CD	NUMBER	20.7	dep	22	SENT_236	[p17l1829t2730r1947b2779],
25	(	NN	O	(	nn	28	SENT_236	[p17l1974t2729r2102b2793],
26	4.3	CD	NUMBER	4.3	num	28	SENT_236	[p17l1974t2729r2102b2793],
27	)	NN	O	)	nn	28	SENT_236	[p17l1974t2729r2102b2793],
28	Ethambutolb	NN	O	ethambutolb	dep	24	SENT_236	[p17l78t2812r427b2878],
29	14.5	CD	NUMBER	14.5	num	30	SENT_236	[p17l1323t2829r1433b2878],
30	(	NN	O	(	dep	36	SENT_236	[p17l1461t2828r1590b2892],
31	2.0	CD	NUMBER	2.0	number	32	SENT_236	[p17l1461t2828r1590b2892],
32	)	CD	NUMBER	)	dep	30	SENT_236	[p17l1461t2828r1590b2892],
33	15.4	CD	NUMBER	15.4	num	34	SENT_236	[p17l1836t2829r1948b2878],
34	(	NN	O	(	dep	32	SENT_236	[p17l1974t2828r2102b2892],
35	3.2	CD	NUMBER	3.2	num	36	SENT_236	[p17l1974t2828r2102b2892],
36	)	NN	O	)	_	0	SENT_236	[p17l1974t2828r2102b2892],

1	Concomitant	JJ	O	concomitant	amod	2	SENT_237	[p17l9t2927r367b2977],
2	drug	NN	O	drug	_	0	SENT_237	[p17l390t2926r515b2991],
3	(	CD	PERCENT	(	num	4	SENT_237	[p17l540t2927r638b2991],
4	%	NN	PERCENT	%	dep	2	SENT_237	[p17l540t2927r638b2991],
5	)	CD	NUMBER	)	dep	2	SENT_237	[p17l540t2927r638b2991],

1	Vitamin	NN	O	vitamin	nn	2	SENT_238	[p17l77t3025r301b3076],
2	B6	NN	O	b6	_	0	SENT_238	[p17l323t3027r401b3075],
3	44.4	CD	NUMBER	44.4	num	4	SENT_238	[p17l1315t3027r1436b3075],
4	50.0	CD	NUMBER	50.0	dep	2	SENT_238	[p17l1831t3027r1948b3075],

1	Primary	JJ	O	primary	amod	3	SENT_239	[p17l8t3125r230b3190],
2	sputum	NN	O	sputum	nn	3	SENT_239	[p17l254t3132r457b3189],
3	culture	NN	O	culture	_	0	SENT_239	[p17l480t3125r669b3175],
4	(	CD	NUMBER	(	number	5	SENT_239	[p17l694t3125r770b3189],
5	77	CD	NUMBER	77	num	6	SENT_239	[p17l694t3125r770b3189],
6	)	NN	O	)	dep	3	SENT_239	[p17l694t3125r770b3189],
7	of	IN	O	of	_	0	SENT_239	[p17l795t3125r859b3175],
8	complex	NN	O	complex	prep_of	6	SENT_239	[p17l874t3125r1111b3189],
9	infection	NN	O	infection	dep	20	SENT_239	[p17l1135t3125r1379b3175],
10	or	CC	O	or	_	0	SENT_239	[p17l1402t3142r1459b3175],
11	INH	NN	O	inh	dep	20	SENT_239	[p17l1480t3127r1602b3175],
12	resistance	NN	O	resistance	dep	13	SENT_239	[p17l1624t3125r1895b3175],
13	Negative	JJ	O	negative	prep	9	SENT_239	[p17l76t3224r327b3288],
14	1	CD	NUMBER	1	num	16	SENT_239	[p17l1323t3225r1341b3273],
15	o	NN	O	o	nn	16	SENT_239	[p17l1830t3225r1860b3274],
16	Positive-low	NN	O	positive-low	dep	13	SENT_239	[p17l78t3323r428b3373],
17	(	CD	NUMBER	(	npadvmod	18	SENT_239	[p17l452t3323r511b3387],
18	<	JJR	O	<	dep	13	SENT_239	[p17l452t3323r511b3387],
19	+	CC	O	+	dep	20	SENT_239	[p17l533t3323r672b3387],
20	+	CC	O	+	rcmod	8	SENT_239	[p17l533t3323r672b3387],
21	+	CC	O	+	_	0	SENT_239	[p17l533t3323r672b3387],
22	)	CD	NUMBER	)	num	25	SENT_239	[p17l533t3323r672b3387],
23	7	CD	NUMBER	7	number	24	SENT_239	[p17l1317t3325r1347b3373],
24	6	CD	NUMBER	6	amod	25	SENT_239	[p17l1830t3324r1860b3373],
25	Positive-high	NN	O	positive-high	dep	3	SENT_239	[p17l78t3421r447b3486],
26	(	CD	NUMBER	(	dep	30	SENT_239	[p17l472t3422r721b3485],
27	>	JJR	O	>	amod	26	SENT_239	[p17l472t3422r721b3485],
28	=	JJ	O	=	prep	26	SENT_239	[p17l472t3422r721b3485],
29	+	CC	O	+	dep	30	SENT_239	[p17l472t3422r721b3485],
30	+	CC	O	+	rcmod	25	SENT_239	[p17l472t3422r721b3485],
31	+	CC	O	+	_	0	SENT_239	[p17l472t3422r721b3485],
32	)	CD	NUMBER	)	number	33	SENT_239	[p17l472t3422r721b3485],
33	1	CD	NUMBER	1	conj_+	6	SENT_239	[p17l1323t3423r1341b3471],
34	1	CD	NUMBER	1	dep	33	SENT_239	[p17l1835t3423r1854b3471],

1	44/20	CD	NUMBER	44/20	num	2	SENT_240	[p18l6t42r203b105],
2	48.5	CD	NUMBER	48.5	_	0	SENT_240	[p18l6t162r154b223],
3	(	NN	O	(	dep	2	SENT_240	[p18l8t264r207b344],
4	34.0	CD	NUMBER	34.0	num	3	SENT_240	[p18l8t264r207b344],
5	,	,	O	,	_	0	SENT_240	[p18l8t264r207b344],
6	60.0	CD	NUMBER	60.0	appos	3	SENT_240	[p18l240t265r418b344],
7	)	CD	NUMBER	)	number	8	SENT_240	[p18l240t265r418b344],
8	54.1	CD	NUMBER	54.1	dep	2	SENT_240	[p18l9t385r149b446],
9	(	NN	O	(	dep	8	SENT_240	[p18l8t487r414b567],
10	50	CD	NUMBER	50	num	9	SENT_240	[p18l8t487r414b567],
11	.	.	O	.	_	0	SENT_240	[p18l8t487r414b567],

1	l	NN	O	l	_	0	SENT_241	[p18l8t487r414b567],
2	—	CD	NUMBER	—	number	3	SENT_241	[p18l8t487r414b567],
3	62.2	CD	NUMBER	62.2	dep	1	SENT_241	[p18l8t487r414b567],
4	)	NN	O	)	dep	3	SENT_241	[p18l8t487r414b567],
5	18	CD	NUMBER	18	number	6	SENT_241	[p18l16t607r89b668],
6	(	CD	NUMBER	(	dep	1	SENT_241	[p18l8t709r281b789],
7	15	CD	NUMBER	15	num	8	SENT_241	[p18l8t709r281b789],
8	—	NN	O	—	dep	6	SENT_241	[p18l8t709r281b789],
9	24	CD	NUMBER	24	number	10	SENT_241	[p18l8t709r281b789],
10	)	CD	NUMBER	)	dep	1	SENT_241	[p18l8t709r281b789],
11	14	CD	NUMBER	14	num	12	SENT_241	[p18l15t829r91b889],
12	(	NN	O	(	dep	10	SENT_241	[p18l8t931r281b1011],
13	10	CD	NUMBER	10	number	14	SENT_241	[p18l8t931r281b1011],
14	—	CD	NUMBER	—	dep	1	SENT_241	[p18l8t931r281b1011],
15	21	CD	NUMBER	21	num	16	SENT_241	[p18l8t931r281b1011],
16	)	NN	O	)	dep	14	SENT_241	[p18l8t931r281b1011],
17	238	CD	NUMBER	238	number	18	SENT_241	[p18l7t1051r133b1111],
18	(	CD	NUMBER	(	dep	1	SENT_241	[p18l8t1153r369b1233],
19	184-285	CD	NUMBER	184-285	num	20	SENT_241	[p18l8t1153r369b1233],
20	)	NN	O	)	dep	18	SENT_241	[p18l8t1153r369b1233],
21	0.6	CD	NUMBER	0.6	dep	1	SENT_241	[p18l8t1273r113b1333],
22	(	CD	NUMBER	(	number	23	SENT_241	[p18l8t1375r326b1455],
23	04407	CD	NUMBER	04407	num	24	SENT_241	[p18l8t1375r326b1455],
24	)	NN	O	)	dep	21	SENT_241	[p18l8t1375r326b1455],
25	0.7	CD	NUMBER	0.7	num	26	SENT_241	[p18l8t1502r112b1563],
26	(	CD	NUMBER	(	dep	1	SENT_241	[p18l8t1604r326b1684],
27	O.	NNP	O	O.	dep	26	SENT_241	[p18l8t1604r326b1684],
28	6	CD	NUMBER	6	num	27	SENT_241	[p18l8t1604r326b1684],
29	.	.	O	.	_	0	SENT_241	[p18l8t1604r326b1684],

1	—	NN	O	—	_	0	SENT_242	[p18l8t1604r326b1684],
2	.	.	O	.	_	0	SENT_242	[p18l8t1604r326b1684],

1	O.	NNP	O	O.	_	0	SENT_243	[p18l8t1604r326b1684],
2	8	CD	NUMBER	8	num	3	SENT_243	[p18l8t1604r326b1684],
3	)	NN	O	)	dep	1	SENT_243	[p18l8t1604r326b1684],

1	8	CD	NUMBER	8	nsubjpass	7	SENT_244	[p18l705t2767r740b2828],
2	22	CD	NUMBER	22	num	5	SENT_244	[p18l658t2893r741b2953],
3	9	CD	NUMBER	9	num	5	SENT_244	[p18l704t3019r741b3080],
4	“	NNP	O	“	nn	5	SENT_244	[p18l53t3143r136b3170],
5	Data	NNS	O	datum	dep	1	SENT_244	[p18l53t3143r136b3170],
6	are	VBP	O	be	auxpass	7	SENT_244	[p18l147t3153r188b3170],
7	presented	VBN	O	present	_	0	SENT_244	[p18l199t3145r333b3177],
8	as	IN	O	as	_	0	SENT_244	[p18l345t3153r372b3170],
9	the	DT	O	the	det	11	SENT_244	[p18l383t3145r425b3170],
10	median	JJ	O	median	amod	11	SENT_244	[p18l437t3145r539b3170],
11	(	NN	O	(	prep_as	7	SENT_244	[p18l551t3145r594b3177],
12	25	CD	PERCENT	25	number	13	SENT_244	[p18l551t3145r594b3177],
13	%	NN	PERCENT	%	amod	11	SENT_244	[p18l608t3145r644b3175],
14	,	,	O	,	_	0	SENT_244	[p18l608t3145r644b3175],
15	75	CD	PERCENT	75	num	16	SENT_244	[p18l657t3146r689b3170],
16	%	NN	PERCENT	%	appos	11	SENT_244	[p18l703t3145r748b3177],
17	)	CD	NUMBER	)	dep	16	SENT_244	[p18l703t3145r748b3177],
18	.	.	O	.	_	0	SENT_244	[p18l703t3145r748b3177],

1	b	NN	O	b	nn	2	SENT_245	[p18l52t3191r64b3208],
2	Data	NNS	O	datum	nsubjpass	4	SENT_245	[p18l72t3199r138b3224],
3	are	VBP	O	be	auxpass	4	SENT_245	[p18l149t3207r190b3224],
4	presented	VBN	O	present	_	0	SENT_245	[p18l201t3198r335b3231],
5	as	IN	O	as	_	0	SENT_245	[p18l346t3207r373b3224],
6	means	NNS	O	means	prep_as	4	SENT_245	[p18l385t3207r473b3224],
7	(	CD	NUMBER	(	num	9	SENT_245	[p18l486t3198r559b3231],
8	SD	NN	O	sd	nn	9	SENT_245	[p18l486t3198r559b3231],
9	)	NN	O	)	dep	6	SENT_245	[p18l486t3198r559b3231],
10	.	.	O	.	_	0	SENT_245	[p18l486t3198r559b3231],

1	NA	NNP	O	NA	_	0	SENT_246	[p18l1955t1869r2084b1931],
2	0.076	CD	NUMBER	0.076	number	3	SENT_246	[p18l1960t1998r2153b2060],
3	0.676	CD	NUMBER	0.676	dep	1	SENT_246	[p18l1960t2126r2153b2188],
4	0.555	CD	NUMBER	0.555	dep	3	SENT_246	[p18l1960t2254r2150b2316],

1	There	EX	O	there	expl	2	SENT_247	[p18l53t3242r133b3268],
2	was	VBD	O	be	_	0	SENT_247	[p18l143t3250r196b3268],
3	no	DT	O	no	det	5	SENT_247	[p18l207t3250r241b3268],
4	statistical	JJ	O	statistical	amod	5	SENT_247	[p18l253t3242r382b3268],
5	difference	NN	O	difference	nsubj	2	SENT_247	[p18l393t3242r532b3268],
6	between	IN	O	between	_	0	SENT_247	[p18l542t3242r658b3268],
7	PGX	NNP	O	PGX	prep_between	5	SENT_247	[p18l668t3243r730b3268],
8	and	CC	O	and	_	0	SENT_247	[p18l741t3242r791b3268],
9	STD	NNP	O	STD	prep_between	5	SENT_247	[p18l802t3243r865b3268],
10	in	IN	O	in	_	0	SENT_247	[p18l877t3242r903b3267],
11	IA	NNP	LOCATION	IA	prep_in	5	SENT_247	[p18l914t3243r956b3268],
12	.	.	O	.	_	0	SENT_247	[p18l914t3243r956b3268],

1	Five	CD	NUMBER	five	num	2	SENT_248	[p18l968t3242r1029b3268],
2	groups	NNS	O	group	nsubjpass	4	SENT_248	[p18l1040t3250r1134b3275],
3	were	VBD	O	be	auxpass	4	SENT_248	[p18l1145t3250r1212b3268],
4	compared	VBN	O	compare	_	0	SENT_248	[p18l1223t3242r1360b3275],
5	by	IN	O	by	_	0	SENT_248	[p18l1369t3242r1405b3275],
6	ANOVA	NNP	ORGANIZATION	ANOVA	agent	4	SENT_248	[p18l1414t3243r1543b3268],
7	.	.	O	.	_	0	SENT_248	[p18l1414t3243r1543b3268],

1	PGX	NNP	O	PGX	nn	3	SENT_249	[p18l1555t3243r1624b3273],
2	,	,	O	,	_	0	SENT_249	[p18l1555t3243r1624b3273],
3	NAT	NNP	ORGANIZATION	NAT	dep	7	SENT_249	[p18l1635t3243r1704b3268],
4	2	CD	NUMBER	2	num	7	SENT_249	[p18l1705t3243r1720b3267],
5	genotype-guided	JJ	O	genotype-guided	amod	7	SENT_249	[p18l1732t3242r1967b3275],
6	treatment	NN	O	treatment	nn	7	SENT_249	[p18l1977t3246r2108b3268],
7	group	NN	O	group	_	0	SENT_249	[p18l53t3291r142b3315],
8	;	:	O	;	_	0	SENT_249	[p18l53t3291r142b3315],
9	STD	NNP	O	STD	dep	14	SENT_249	[p18l154t3283r225b3313],
10	,	,	O	,	_	0	SENT_249	[p18l154t3283r225b3313],
11	conventional	JJ	O	conventional	amod	14	SENT_249	[p18l236t3283r416b3308],
12	standard	JJ	O	standard	amod	14	SENT_249	[p18l426t3283r543b3308],
13	treatment	NN	O	treatment	nn	14	SENT_249	[p18l552t3286r683b3308],
14	group	NN	O	group	parataxis	7	SENT_249	[p18l692t3291r781b3315],
15	;	:	O	;	_	0	SENT_249	[p18l692t3291r781b3315],
16	RA-type	NN	O	ra-type	nn	20	SENT_249	[p18l791t3284r919b3315],
17	,	,	O	,	_	0	SENT_249	[p18l791t3284r919b3315],
18	rapid	JJ	O	rapid	amod	20	SENT_249	[p18l929t3283r1001b3315],
19	acetylator	NN	O	acetylator	nn	20	SENT_249	[p18l1010t3283r1147b3315],
20	genotype	NN	O	genotype	dep	21	SENT_249	[p18l1155t3287r1282b3315],
21	homozygous	JJ	O	homozygous	parataxis	7	SENT_249	[p18l1292t3283r1470b3315],
22	for	IN	O	for	_	0	SENT_249	[p18l1481t3283r1521b3308],
23	NAT	NNP	ORGANIZATION	NAT	prep_for	21	SENT_249	[p18l1527t3283r1595b3308],
24	2	CD	NUMBER	2	num	23	SENT_249	[p18l1592t3283r1644b3308],
25	*	CD	NUMBER	*	number	26	SENT_249	[p18l1592t3283r1644b3308],
26	4	CD	NUMBER	4	dep	23	SENT_249	[p18l1592t3283r1644b3308],
27	;	:	O	;	_	0	SENT_249	[p18l1647t3291r1652b3313],
28	IA-type	JJ	O	ia-type	amod	32	SENT_249	[p18l1663t3283r1778b3315],
29	,	,	O	,	_	0	SENT_249	[p18l1663t3283r1778b3315],
30	intermediate	JJ	O	intermediate	amod	32	SENT_249	[p18l1789t3283r1961b3308],
31	acetylator	NN	O	acetylator	nn	32	SENT_249	[p18l1972t3283r2108b3315],
32	genotypes	NNS	O	genotype	dep	33	SENT_249	[p18l53t3328r193b3357],
33	heterozygous	JJ	O	heterozygous	parataxis	7	SENT_249	[p18l205t3324r391b3357],
34	for	IN	O	for	_	0	SENT_249	[p18l403t3324r443b3350],
35	NAT2	NN	O	nat2	prep_for	33	SENT_249	[p18l452t3324r577b3355],
36	*	CD	NUMBER	*	number	37	SENT_249	[p18l452t3324r577b3355],
37	4	CD	NUMBER	4	num	35	SENT_249	[p18l452t3324r577b3355],
38	;	:	O	;	_	0	SENT_249	[p18l452t3324r577b3355],
39	SA-type	JJ	O	sa-type	amod	43	SENT_249	[p18l592t3325r713b3357],
40	,	,	O	,	_	0	SENT_249	[p18l592t3325r713b3357],
41	slow	JJ	O	slow	amod	43	SENT_249	[p18l727t3324r792b3350],
42	acetylator	NN	O	acetylator	nn	43	SENT_249	[p18l804t3324r940b3357],
43	genotypes	NNS	O	genotype	dep	48	SENT_249	[p18l951t3328r1091b3357],
44	without	IN	O	without	_	0	SENT_249	[p18l1103t3324r1210b3350],
45	NAT	NNP	ORGANIZATION	NAT	prep_without	43	SENT_249	[p18l1219t3325r1287b3349],
46	2	CD	NUMBER	2	num	45	SENT_249	[p18l1284t3324r1343b3350],
47	*	CD	NUMBER	*	num	48	SENT_249	[p18l1284t3324r1343b3350],
48	4	CD	NUMBER	4	parataxis	7	SENT_249	[p18l1284t3324r1343b3350],
49	.	.	O	.	_	0	SENT_249	[p18l1284t3324r1343b3350],

1	NA	NNP	O	NA	nsubj	15	SENT_250	[p18l1355t3325r1414b3355],
2	,	,	O	,	_	0	SENT_250	[p18l1355t3325r1414b3355],
3	not	RB	O	not	dep	4	SENT_250	[p18l1426t3328r1471b3350],
4	applied	VBN	O	apply	dep	15	SENT_250	[p18l1483t3324r1585b3357],
5	difference	NN	O	difference	dobj	4	SENT_250	[p18l10t3519r384b3597],
6	;	:	O	;	_	0	SENT_250	[p18l10t3519r384b3597],
7	77.8	CD	PERCENT	77.8	num	8	SENT_250	[p18l433t3521r582b3583],
8	%	NN	PERCENT	%	dep	5	SENT_250	[p18l630t3521r719b3597],
9	,	,	O	,	_	0	SENT_250	[p18l630t3521r719b3597],
10	p	NN	O	p	appos	8	SENT_250	[p18l754t3521r1095b3601],
11	=	JJ	O	=	amod	10	SENT_250	[p18l754t3521r1095b3601],
12	0.003	CD	NUMBER	0.003	tmod	11	SENT_250	[p18l754t3521r1095b3601],
13	,	,	O	,	_	0	SENT_250	[p18l754t3521r1095b3601],
14	Table	NNP	O	Table	nsubj	15	SENT_250	[p18l1143t3519r1335b3583],
15	3a	VBD	O	3a	_	0	SENT_250	[p18l1381t3520r1506b3601],
16	)	CD	NUMBER	)	dobj	15	SENT_250	[p18l1381t3520r1506b3601],
17	.	.	O	.	_	0	SENT_250	[p18l1381t3520r1506b3601],

1	Conversely	RB	O	conversely	advmod	9	SENT_251	[p18l1557t3519r1973b3601],
2	,	,	O	,	_	0	SENT_251	[p18l1557t3519r1973b3601],
3	few	JJ	O	few	amod	5	SENT_251	[p18l2021t3519r2150b3583],
4	rapid	JJ	O	rapid	amod	5	SENT_251	[p18l7t3630r189b3712],
5	acetylators	NNS	O	acetylator	nsubj	9	SENT_251	[p18l246t3630r624b3712],
6	in	IN	O	in	_	0	SENT_251	[p18l682t3630r749b3693],
7	either	DT	O	either	det	8	SENT_251	[p18l805t3630r1005b3694],
8	group	NN	O	group	prep_in	5	SENT_251	[p18l1058t3651r1261b3712],
9	had	VBD	O	have	_	0	SENT_251	[p18l1318t3630r1447b3694],
10	INH-DILI	NN	O	inh-dili	dobj	9	SENT_251	[p18l1502t3633r1862b3694],
11	during	IN	O	during	_	0	SENT_251	[p18l1920t3630r2149b3712],
12	the	DT	O	the	det	13	SENT_251	[p19l8t21r114b85],
13	ﬁrst	NN	O	ﬁrst	prep_during	10	SENT_251	[p19l173t21r312b85],
14	8	CD	DURATION	8	num	15	SENT_251	[p19l372t22r406b85],
15	weeks	NNS	NUMBER	week	tmod	13	SENT_251	[p19l466t21r708b98],
16	;	:	O	;	_	0	SENT_251	[p19l466t21r708b98],
17	4.2	CD	PERCENT	4.2	num	18	SENT_251	[p19l768t22r876b85],
18	%	NN	PERCENT	%	dep	10	SENT_251	[p19l937t22r1006b86],
19	(	CD	NUMBER	(	number	20	SENT_251	[p19l1066t21r1246b102],
20	2/48	CD	NUMBER	2/48	num	21	SENT_251	[p19l1066t21r1246b102],
21	patients	NNS	O	patient	dep	18	SENT_251	[p19l1305t21r1608b103],
22	)	RB	O	)	advmod	9	SENT_251	[p19l1305t21r1608b103],
23	in	IN	O	in	_	0	SENT_251	[p19l1668t21r1734b84],
24	the	DT	O	the	det	25	SENT_251	[p19l1789t21r1896b85],
25	STDtreatment	NN	O	stdtreatment	prep_in	9	SENT_251	[p19l1957t22r2148b85, p19l8t140r378b196],
26	and	CC	O	and	_	0	SENT_251	[p19l442t132r577b196],
27	4.6	CD	PERCENT	4.6	num	28	SENT_251	[p19l641t133r757b196],
28	%	NN	PERCENT	%	prep_in	9	SENT_251	[p19l827t133r895b197],
29	(	CD	NUMBER	(	number	30	SENT_251	[p19l963t132r1163b213],
30	2/44	CD	NUMBER	2/44	num	31	SENT_251	[p19l963t132r1163b213],
31	patients	NNS	O	patient	dep	28	SENT_251	[p19l1227t132r1567b213],
32	)	RB	O	)	advmod	9	SENT_251	[p19l1227t132r1567b213],
33	in	IN	O	in	_	0	SENT_251	[p19l1634t132r1705b194],
34	the	DT	O	the	det	36	SENT_251	[p19l1769t132r1884b196],
35	PG	NN	O	pg	nn	36	SENT_251	[p19l1950t133r2147b196, p19l8t252r342b307],
36	)	NN	O	)	prep_in	9	SENT_251	[p19l1950t133r2147b196, p19l8t252r342b307],
37	;	:	O	;	_	0	SENT_251	[p19l1950t133r2147b196, p19l8t252r342b307],
38	treatment	NN	O	treatment	nsubj	53	SENT_251	[p19l1950t133r2147b196, p19l8t252r342b307],
39	receiving	VBG	O	receive	partmod	38	SENT_251	[p19l394t243r722b325],
40	high-dose	JJ	O	high-dose	amod	41	SENT_251	[p19l777t243r1126b325],
41	INH	NN	MISC	inh	dobj	39	SENT_251	[p19l1183t246r1357b321],
42	,	,	O	,	_	0	SENT_251	[p19l1183t246r1357b321],
43	which	WDT	O	which	nsubj	46	SENT_251	[p19l1414t243r1632b307],
44	were	VBD	O	be	cop	46	SENT_251	[p19l1685t264r1855b307],
45	importantly	RB	O	importantly	advmod	46	SENT_251	[p19l1912t243r2148b325, p19l8t354r208b436],
46	equivalent	JJ	O	equivalent	rcmod	41	SENT_251	[p19l259t354r627b436],
47	to	TO	O	to	_	0	SENT_251	[p19l673t363r739b418],
48	the	DT	O	the	det	49	SENT_251	[p19l789t354r894b418],
49	incidence	NN	O	incidence	prep_to	46	SENT_251	[p19l945t354r1281b418],
50	in	IN	O	in	_	0	SENT_251	[p19l1332t354r1398b417],
51	intermediate	JJ	O	intermediate	amod	52	SENT_251	[p19l1447t354r1885b418],
52	acetylators	NNS	O	acetylator	prep_in	49	SENT_251	[p19l1937t363r2147b436, p19l10t465r200b529],
53	(	VBP	O	(	parataxis	9	SENT_251	[p19l255t465r389b546],
54	4.7	CD	PERCENT	4.7	num	55	SENT_251	[p19l255t465r389b546],
55	%	NN	PERCENT	%	dobj	53	SENT_251	[p19l443t466r532b543],
56	,	,	O	,	_	0	SENT_251	[p19l443t466r532b543],
57	3/64	CD	NUMBER	3/64	num	58	SENT_251	[p19l588t465r741b529],
58	patients	NNS	O	patient	appos	55	SENT_251	[p19l791t465r1113b547],
59	)	CD	NUMBER	)	dep	58	SENT_251	[p19l791t465r1113b547],
60	.	.	O	.	_	0	SENT_251	[p19l791t465r1113b547],

1	These	DT	O	these	det	2	SENT_252	[p19l1169t465r1377b529],
2	outcomes	NNS	O	outcome	nsubj	5	SENT_252	[p19l1429t474r1766b529],
3	were	VBD	O	be	cop	5	SENT_252	[p19l1816t486r1987b529],
4	not	RB	O	not	neg	5	SENT_252	[p19l2036t474r2151b529],
5	different	JJ	O	different	_	0	SENT_252	[p19l10t576r311b640],
6	in	IN	O	in	_	0	SENT_252	[p19l351t576r417b639],
7	a	DT	O	a	det	8	SENT_252	[p19l458t597r495b640],
8	population	NN	O	population	prep_in	5	SENT_252	[p19l533t576r914b658],
9	valid	JJ	O	valid	amod	8	SENT_252	[p19l954t576r1131b640],
10	for	IN	O	for	_	0	SENT_252	[p19l1172t577r1273b640],
11	early	JJ	O	early	amod	13	SENT_252	[p19l1314t576r1486b658],
12	treatment	NN	O	treatment	nn	13	SENT_252	[p19l1526t585r1860b640],
13	failure	NN	O	failure	prep_for	9	SENT_252	[p19l1901t576r2143b640],
14	.	.	O	.	_	0	SENT_252	[p19l1901t576r2143b640],

1	Multivariable	JJ	O	multivariable	amod	3	SENT_253	[p19l8t687r488b751],
2	logistic	JJ	O	logistic	amod	3	SENT_253	[p19l539t687r795b769],
3	analysis	NN	O	analysis	nsubj	39	SENT_253	[p19l847t687r1127b769],
4	using	VBG	O	use	partmod	3	SENT_253	[p19l1177t687r1369b769],
5	the	DT	O	the	det	6	SENT_253	[p19l1417t687r1523b751],
6	baseline	NN	O	baseline	dobj	4	SENT_253	[p19l1571t687r1860b751],
7	patient	NN	O	patient	nn	8	SENT_253	[p19l1908t687r2150b769],
8	characteristics	NNS	O	characteristic	nsubj	9	SENT_253	[p19l10t798r519b862],
9	revealed	VBD	O	reveal	rcmod	6	SENT_253	[p19l577t798r883b863],
10	that	IN	O	that	complm	17	SENT_253	[p19l938t798r1073b862],
11	the	DT	O	the	det	12	SENT_253	[p19l1128t798r1236b862],
12	NAT2	NN	MISC	nat2	nsubjpass	17	SENT_253	[p19l1291t800r1509b862],
13	slow	JJ	O	slow	amod	15	SENT_253	[p19l1572t798r1739b862],
14	acetylator	NN	O	acetylator	nn	15	SENT_253	[p19l1798t798r2152b880],
15	genotype	NN	O	genotype	dep	12	SENT_253	[p19l9t918r339b991],
16	was	VBD	O	be	auxpass	17	SENT_253	[p19l396t930r533b973],
17	associated	VBN	O	associate	ccomp	9	SENT_253	[p19l594t909r963b973],
18	with	IN	O	with	_	0	SENT_253	[p19l1019t909r1179b973],
19	INH-DILI	NN	O	inh-dili	prep_with	17	SENT_253	[p19l1236t911r1603b973],
20	in	IN	O	in	prep	17	SENT_253	[p19l1662t909r1729b972],
21	the	DT	O	the	det	22	SENT_253	[p19l1786t909r1893b973],
22	STDtreatment	NN	O	stdtreatment	pobj	20	SENT_253	[p19l1955t910r2148b973, p19l8t1028r359b1097],
23	,	,	O	,	_	0	SENT_253	[p19l1955t910r2148b973, p19l8t1028r359b1097],
24	but	CC	O	but	_	0	SENT_253	[p19l401t1020r516b1084],
25	not	RB	O	not	conj_but	20	SENT_253	[p19l554t1029r668b1084],
26	in	IN	O	in	dep	20	SENT_253	[p19l708t1020r774b1083],
27	the	DT	O	the	det	28	SENT_253	[p19l813t1020r919b1084],
28	PGX-treatment	NN	O	pgx-treatment	pobj	26	SENT_253	[p19l960t1021r1482b1084],
29	at	IN	O	at	advmod	28	SENT_253	[p19l1521t1029r1584b1083],
30	all	DT	O	all	pobj	29	SENT_253	[p19l1623t1020r1726b1097],
31	,	,	O	,	_	0	SENT_253	[p19l1623t1020r1726b1097],
32	suggesting	VBG	O	suggest	xcomp	17	SENT_253	[p19l1773t1020r2149b1102],
33	standard	JJ	O	standard	amod	34	SENT_253	[p19l11t1131r309b1195],
34	dose	NN	O	dose	dobj	32	SENT_253	[p19l355t1131r514b1195],
35	of	IN	O	of	_	0	SENT_253	[p19l563t1131r644b1195],
36	INH	NN	O	inh	prep_of	34	SENT_253	[p19l681t1133r835b1194],
37	is	VBZ	O	be	cop	39	SENT_253	[p19l883t1131r937b1195],
38	too	RB	O	too	advmod	39	SENT_253	[p19l984t1140r1095b1195],
39	much	JJ	O	much	_	0	SENT_253	[p19l1143t1131r1340b1195],
40	for	IN	O	for	_	0	SENT_253	[p19l1387t1131r1489b1195],
41	slow	JJ	O	slow	amod	42	SENT_253	[p19l1535t1131r1699b1195],
42	acetylators	NNS	O	acetylator	prep_for	39	SENT_253	[p19l1747t1131r2144b1212],
43	.	.	O	.	_	0	SENT_253	[p19l1747t1131r2144b1212],

1	There	EX	O	there	expl	2	SENT_254	[p19l9t1242r208b1306],
2	was	VBD	O	be	_	0	SENT_254	[p19l239t1263r374b1306],
3	not	RB	O	not	neg	2	SENT_254	[p19l406t1251r518b1306],
4	any	DT	O	any	det	6	SENT_254	[p19l550t1263r674b1324],
5	other	JJ	O	other	amod	6	SENT_254	[p19l707t1242r884b1306],
6	factors	NNS	O	factor	nsubj	2	SENT_254	[p19l914t1242r1144b1306],
7	and	CC	O	and	_	0	SENT_254	[p19l1179t1242r1303b1306],
8	confounders	NNS	O	confounder	nsubj	2	SENT_254	[p19l1335t1242r1762b1306],
9	associated	VBN	O	associate	partmod	6	SENT_254	[p19l1797t1242r2151b1306],
10	with	IN	O	with	_	0	SENT_254	[p19l7t1354r163b1418],
11	INH-DILI	NN	O	inh-dili	prep_with	9	SENT_254	[p19l187t1357r559b1418],
12	.	.	O	.	_	0	SENT_254	[p19l187t1357r559b1418],

1	Q	NNP	O	Q	nn	3	SENT_255	[p19l7t1580r80b1670],
2	Springer	NNP	O	Springer	nn	3	SENT_255	[p19l106t1603r351b1673],
3	Early	NNP	O	Early	_	0	SENT_255	[p19l6t1697r206b1779],
4	treatment	NN	O	treatment	nn	5	SENT_255	[p19l236t1709r573b1761],
5	failure	NN	O	failure	dep	3	SENT_255	[p19l582t1697r831b1779],

1	The	DT	O	the	det	3	SENT_256	[p19l10t1921r143b1985],
2	therapeutic	JJ	O	therapeutic	amod	3	SENT_256	[p19l175t1921r557b2002],
3	effects	NNS	O	effect	nsubjpass	16	SENT_256	[p19l592t1921r815b1985],
4	of	IN	O	of	_	0	SENT_256	[p19l850t1921r931b1985],
5	NAT2	NN	O	nat2	nn	7	SENT_256	[p19l947t1922r1151b1985],
6	genotype-guided	JJ	O	genotype-guided	amod	7	SENT_256	[p19l1184t1921r1769b2002],
7	dosing	NN	O	dosing	prep_of	3	SENT_256	[p19l1801t1921r2032b2002],
8	on	IN	O	on	_	0	SENT_256	[p19l2065t1941r2152b1985],
9	early	JJ	O	early	amod	11	SENT_256	[p19l11t2032r181b2113],
10	treatment	NN	O	treatment	nn	11	SENT_256	[p19l208t2040r535b2096],
11	failure	NN	O	failure	prep_on	7	SENT_256	[p19l563t2032r783b2096],
12	against	IN	O	against	_	0	SENT_256	[p19l813t2032r1057b2113],
13	drug-sensitive	JJ	O	drug-sensitive	amod	14	SENT_256	[p19l1085t2032r1573b2113],
14	tuberculosis	NN	O	tuberculosis	prep_against	11	SENT_256	[p19l1601t2032r2018b2096],
15	are	VBP	O	be	auxpass	16	SENT_256	[p19l2049t2052r2150b2096],
16	shown	VBN	O	show	_	0	SENT_256	[p19l12t2143r242b2207],
17	in	IN	O	in	_	0	SENT_256	[p19l282t2143r349b2206],
18	Table	NNP	O	Table	nn	20	SENT_256	[p19l390t2143r582b2207],
19	3b	NN	O	3b	nn	20	SENT_256	[p19l626t2143r758b2224],
20	)	NN	O	)	prep_in	16	SENT_256	[p19l626t2143r758b2224],
21	.	.	O	.	_	0	SENT_256	[p19l626t2143r758b2224],

1	The	DT	O	the	det	2	SENT_257	[p19l805t2143r938b2207],
2	NAT	NNP	O	NAT	nsubj	7	SENT_257	[p19l977t2144r1149b2207],
3	2	CD	NUMBER	2	num	5	SENT_257	[p19l1141t2145r1182b2206],
4	genotype-guided	JJ	O	genotype-guided	amod	5	SENT_257	[p19l1225t2143r1822b2225],
5	regimen	NNS	O	regimen	dep	2	SENT_257	[p19l1860t2143r2150b2225],
6	successﬁilly	RB	O	successﬁilly	advmod	7	SENT_257	[p19l12t2254r433b2336],
7	reduced	VBD	O	reduce	_	0	SENT_257	[p19l462t2254r738b2318],
8	the	DT	O	the	det	9	SENT_257	[p19l767t2254r872b2318],
9	incidence	NN	O	incidence	dobj	7	SENT_257	[p19l905t2254r1234b2318],
10	of	IN	O	of	_	0	SENT_257	[p19l1269t2254r1350b2318],
11	early	JJ	O	early	amod	13	SENT_257	[p19l1371t2254r1541b2336],
12	treatment	NN	O	treatment	nn	13	SENT_257	[p19l1571t2263r1898b2318],
13	failure	NN	O	failure	prep_of	9	SENT_257	[p19l1929t2254r2150b2318],
14	in	IN	O	in	_	0	SENT_257	[p19l10t2365r78b2428],
15	rapid	JJ	O	rapid	amod	16	SENT_257	[p19l119t2365r304b2447],
16	acetylators	NNS	O	acetylator	prep_in	13	SENT_257	[p19l347t2365r757b2447],
17	;	:	O	;	_	0	SENT_257	[p19l347t2365r757b2447],
18	15.0	CD	PERCENT	15.0	num	19	SENT_257	[p19l813t2366r959b2429],
19	%	NN	PERCENT	%	dep	13	SENT_257	[p19l1005t2366r1074b2430],
20	(	CD	NUMBER	(	number	21	SENT_257	[p19l1119t2365r1305b2446],
21	6/40	CD	NUMBER	6/40	num	22	SENT_257	[p19l1119t2365r1305b2446],
22	patients	NNS	O	patient	dep	19	SENT_257	[p19l1347t2365r1657b2447],
23	)	RB	O	)	advmod	22	SENT_257	[p19l1347t2365r1657b2447],
24	in	IN	O	in	_	0	SENT_257	[p19l1702t2365r1770b2428],
25	the	DT	O	the	det	27	SENT_257	[p19l1811t2365r1918b2429],
26	PG	NN	O	pg	nn	27	SENT_257	[p19l1962t2366r2149b2429, p19l9t2485r336b2540],
27	)	NN	O	)	prep_in	22	SENT_257	[p19l1962t2366r2149b2429, p19l9t2485r336b2540],
28	:	:	O	:	_	0	SENT_257	[p19l1962t2366r2149b2429, p19l9t2485r336b2540],
29	treatment	NN	O	treatment	dep	13	SENT_257	[p19l1962t2366r2149b2429, p19l9t2485r336b2540],
30	and	CC	O	and	_	0	SENT_257	[p19l368t2476r492b2540],
31	39.5	CD	PERCENT	39.5	num	32	SENT_257	[p19l525t2478r671b2540],
32	%	NN	PERCENT	%	dep	13	SENT_257	[p19l709t2478r778b2542],
33	(	CD	NUMBER	(	number	34	SENT_257	[p19l813t2476r1032b2558],
34	17/43	CD	NUMBER	17/43	num	35	SENT_257	[p19l813t2476r1032b2558],
35	patients	NNS	O	patient	dep	29	SENT_257	[p19l1067t2476r1364b2558],
36	)	RB	O	)	advmod	35	SENT_257	[p19l1067t2476r1364b2558],
37	in	IN	O	in	_	0	SENT_257	[p19l1399t2476r1464b2539],
38	the	DT	O	the	det	42	SENT_257	[p19l1494t2476r1599b2540],
39	STD-treatment	JJ	O	std-treatment	amod	42	SENT_257	[p19l1636t2478r2152b2541],
40	(	NN	O	(	nn	42	SENT_257	[p19l11t2587r293b2669],
41	relative	JJ	O	relative	amod	42	SENT_257	[p19l11t2587r293b2669],
42	risk	NN	O	risk	prep_in	35	SENT_257	[p19l322t2587r471b2665],
43	;	:	O	;	_	0	SENT_257	[p19l322t2587r471b2665],
44	0.379	CD	PERCENT	0.379	number	45	SENT_257	[p19l505t2589r697b2651],
45	[	CD	PERCENT	[	dep	13	SENT_257	[p19l735t2589r839b2668],
46	95	CD	PERCENT	95	num	48	SENT_257	[p19l735t2589r839b2668],
47	%	NN	PERCENT	%	nn	48	SENT_257	[p19l874t2589r943b2653],
48	CI	NN	O	ci	dep	45	SENT_257	[p19l976t2589r1078b2652],
49	:	:	O	:	_	0	SENT_257	[p19l976t2589r1078b2652],
50	0.116	CD	NUMBER	0.116	dep	13	SENT_257	[p19l1114t2589r1323b2665],
51	,	,	O	,	_	0	SENT_257	[p19l1114t2589r1323b2665],
52	0.866	CD	NUMBER	0.866	num	53	SENT_257	[p19l1358t2588r1981b2669],
53	]	NN	O	]	appos	50	SENT_257	[p19l1358t2588r1981b2669],
54	,	,	O	,	_	0	SENT_257	[p19l1358t2588r1981b2669],
55	p	NN	O	p	appos	13	SENT_257	[p19l1358t2588r1981b2669],
56	=	JJ	O	=	amod	59	SENT_257	[p19l1358t2588r1981b2669],
57	0.0	CD	NUMBER	0.0	tmod	56	SENT_257	[p19l1358t2588r1981b2669],
58	l3	NN	O	l3	nn	59	SENT_257	[p19l1358t2588r1981b2669],
59	)	NN	O	)	dep	55	SENT_257	[p19l1358t2588r1981b2669],
60	.	.	O	.	_	0	SENT_257	[p19l1358t2588r1981b2669],

1	The	DT	O	the	det	2	SENT_258	[p19l2017t2587r2150b2651],
2	difference	NN	O	difference	nsubj	4	SENT_258	[p19l11t2698r356b2762],
3	was	VBD	O	be	cop	4	SENT_258	[p19l390t2719r524b2762],
4	distinct	JJ	O	distinct	dep	15	SENT_258	[p19l560t2698r814b2762],
5	on	IN	O	on	_	0	SENT_258	[p19l847t2719r934b2762],
6	multivariate	JJ	O	multivariate	amod	7	SENT_258	[p19l965t2698r1382b2762],
7	analysis	NN	O	analysis	prep_on	4	SENT_258	[p19l1417t2698r1692b2780],
8	stratified	VBN	O	stratify	partmod	7	SENT_258	[p19l1729t2698r2032b2762],
9	by	IN	O	by	_	0	SENT_258	[p19l2062t2698r2152b2780],
10	high-excretion	JJ	O	high-excretion	amod	11	SENT_258	[p19l9t2809r520b2891],
11	level	NN	O	level	agent	8	SENT_258	[p19l560t2809r727b2873],
12	of	IN	O	of	_	0	SENT_258	[p19l767t2809r849b2873],
13	tubercle	JJ	O	tubercle	amod	14	SENT_258	[p19l876t2809r1156b2873],
14	bacilli	NNS	O	bacillus	prep_of	11	SENT_258	[p19l1195t2809r1412b2873],
15	(	VBP	O	(	_	0	SENT_258	[p19l1454t2809r1725b2890],
16	Pooled	JJ	O	pooled	amod	18	SENT_258	[p19l1454t2809r1725b2890],
17	odds	NNS	O	odds	nn	18	SENT_258	[p19l1765t2809r1927b2873],
18	ratio	NN	O	ratio	dobj	15	SENT_258	[p19l1968t2809r2147b2886],
19	;	:	O	;	_	0	SENT_258	[p19l1968t2809r2147b2886],
20	0.274	CD	PERCENT	0.274	num	24	SENT_258	[p19l11t2921r204b2984],
21	[	CD	PERCENT	[	number	22	SENT_258	[p19l231t2921r334b3000],
22	95	CD	PERCENT	95	dep	23	SENT_258	[p19l231t2921r334b3000],
23	%	NN	PERCENT	%	dep	24	SENT_258	[p19l360t2921r428b2985],
24	CI	NN	O	ci	dep	18	SENT_258	[p19l451t2921r553b2984],
25	:	:	O	:	_	0	SENT_258	[p19l451t2921r553b2984],
26	0.097	CD	NUMBER	0.097	nsubj	15	SENT_258	[p19l578t2921r792b2997],
27	,	,	O	,	_	0	SENT_258	[p19l578t2921r792b2997],
28	0.776	CD	NUMBER	0.776	num	29	SENT_258	[p19l815t2921r1056b3000],
29	]	NN	O	]	appos	26	SENT_258	[p19l815t2921r1056b3000],
30	,	,	O	,	_	0	SENT_258	[p19l815t2921r1056b3000],
31	p	NN	O	p	appos	29	SENT_258	[p19l1066t2920r1428b3001],
32	=	JJ	O	=	amod	34	SENT_258	[p19l1066t2920r1428b3001],
33	0.015	CD	NUMBER	0.015	tmod	32	SENT_258	[p19l1066t2920r1428b3001],
34	)	NN	O	)	dep	31	SENT_258	[p19l1066t2920r1428b3001],
35	.	.	O	.	_	0	SENT_258	[p19l1066t2920r1428b3001],

1	One	CD	NUMBER	one	num	3	SENT_259	[p19l1454t2921r1596b2984],
2	rapid	JJ	O	rapid	amod	3	SENT_259	[p19l1615t2920r1794b3001],
3	acetylator	NN	O	acetylator	nsubj	10	SENT_259	[p19l1814t2920r2153b3001],
4	in	IN	O	in	_	0	SENT_259	[p19l11t3031r77b3093],
5	the	DT	O	the	det	6	SENT_259	[p19l117t3031r223b3095],
6	STD-treatment	NN	O	std-treatment	prep_in	3	SENT_259	[p19l269t3032r798b3095],
7	who	WP	O	who	nsubj	8	SENT_259	[p19l836t3031r988b3095],
8	developed	VBD	O	develop	rcmod	6	SENT_259	[p19l1033t3031r1398b3112],
9	INH-DILI	NN	O	inh-dili	dobj	8	SENT_259	[p19l1439t3033r1801b3094],
10	failed	VBD	O	fail	_	0	SENT_259	[p19l1844t3031r2043b3095],
11	to	TO	O	to	aux	12	SENT_259	[p19l2082t3039r2148b3095],
12	achieve	VB	O	achieve	xcomp	10	SENT_259	[p19l11t3142r272b3206],
13	any	DT	O	any	det	15	SENT_259	[p19l308t3163r433b3224],
14	clinical	JJ	O	clinical	amod	15	SENT_259	[p19l467t3142r718b3206],
15	improvement	NN	O	improvement	dobj	12	SENT_259	[p19l752t3142r1216b3224],
16	by	IN	O	by	_	0	SENT_259	[p19l1246t3142r1336b3224],
17	the	DT	O	the	det	19	SENT_259	[p19l1368t3142r1472b3206],
18	8th	JJ	ORDINAL	8th	amod	19	SENT_259	[p19l1510t3142r1617b3206],
19	week	NN	DURATION	week	prep_by	12	SENT_259	[p19l1649t3142r1836b3206],
20	of	IN	O	of	_	0	SENT_259	[p19l1869t3142r1950b3206],
21	treatment	NN	O	treatment	prep_of	19	SENT_259	[p19l1971t3151r2149b3206, p19l9t3262r198b3317],
22	.	.	O	.	_	0	SENT_259	[p19l1971t3151r2149b3206, p19l9t3262r198b3317],

1	Importantly	RB	O	importantly	_	0	SENT_260	[p19l227t3253r647b3335],
2	,	,	O	,	_	0	SENT_260	[p19l227t3253r647b3335],
3	two	CD	TIME	two	npadvmod	4	SENT_260	[p19l673t3262r801b3317],
4	of	IN	TIME	of	dep	1	SENT_260	[p19l828t3253r909b3317],
5	nine	CD	TIME	nine	pobj	4	SENT_260	[p19l918t3253r1068b3317],
6	(	CD	PERCENT	(	number	7	SENT_260	[p19l1092t3253r1268b3334],
7	22.2	CD	PERCENT	22.2	num	8	SENT_260	[p19l1092t3253r1268b3334],
8	%	NN	PERCENT	%	dep	5	SENT_260	[p19l1295t3253r1392b3334],
9	)	CD	NUMBER	)	num	11	SENT_260	[p19l1295t3253r1392b3334],
10	slow	JJ	O	slow	amod	11	SENT_260	[p19l1419t3253r1581b3317],
11	acetylators	NNS	O	acetylator	dep	8	SENT_260	[p19l1604t3253r1973b3335],
12	with	IN	O	with	prep	4	SENT_260	[p19l1996t3253r2152b3317],

1	Eur	NNP	O	Eur	nn	4	SENT_261	[p19l53t3411r103b3435],
2	J	NNP	O	J	nn	4	SENT_261	[p19l114t3411r127b3435],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_261	[p19l138t3410r197b3435],
4	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_261	[p19l208t3410r357b3435],
5	(	CD	NUMBER	(	num	6	SENT_261	[p19l369t3410r460b3442],
6	2013	CD	DATE	2013	dep	4	SENT_261	[p19l369t3410r460b3442],
7	)	CD	NUMBER	)	number	8	SENT_261	[p19l369t3410r460b3442],
8	69	CD	NUMBER	69	dep	6	SENT_261	[p19l473t3410r670b3435],
9	:	:	O	:	_	0	SENT_261	[p19l473t3410r670b3435],
10	l09l	CD	NUMBER	l09l	num	11	SENT_261	[p19l473t3410r670b3435],
11	—	CD	NUMBER	—	dep	6	SENT_261	[p19l473t3410r670b3435],
12	ll0l	NN	O	ll0l	dep	11	SENT_261	[p19l473t3410r670b3435],
13	1097	CD	DATE	1097	num	12	SENT_261	[p19l2041t3410r2106b3435],

1	Table	NNP	O	Table	_	0	SENT_262	[p19l53t3511r134b3535],
2	3	CD	NUMBER	3	num	5	SENT_262	[p19l146t3510r161b3535],
3	Primary	JJ	O	primary	amod	5	SENT_262	[p19l186t3510r297b3542],
4	end	NN	O	end	nn	5	SENT_262	[p19l309t3510r359b3535],
5	point	NN	O	point	nsubj	6	SENT_262	[p19l369t3510r442b3542],
6	results	VBZ	O	result	rcmod	1	SENT_262	[p19l452t3510r542b3535],
7	in	IN	O	in	_	0	SENT_262	[p19l554t3510r580b3535],
8	slow	JJ	O	slow	amod	12	SENT_262	[p19l593t3510r657b3535],
9	and	CC	O	and	_	0	SENT_262	[p19l669t3510r719b3535],
10	rapid	JJ	O	rapid	amod	12	SENT_262	[p19l729t3510r801b3542],
11	acetylator	NN	O	acetylator	nn	12	SENT_262	[p19l813t3510r950b3542],
12	genotypes	NNS	O	genotype	prep_in	6	SENT_262	[p19l960t3513r1100b3542],
13	NAT	NNP	O	NAT	dobj	6	SENT_262	[p19l51t3594r119b3619],
14	2	CD	NUMBER	2	num	13	SENT_262	[p19l116t3594r132b3619],
15	genotype	NN	O	genotype	nn	17	SENT_262	[p19l144t3597r271b3626],
16	status	NN	O	status	nn	17	SENT_262	[p19l284t3597r361b3619],
17	Groups	NNS	O	group	nsubj	18	SENT_262	[p19l411t3594r512b3626],
18	(	VBP	O	(	rcmod	13	SENT_262	[p19l562t3594r600b3626],
19	n	NN	O	n	nn	21	SENT_262	[p19l562t3594r600b3626],
20	)	CD	NUMBER	)	num	21	SENT_262	[p19l562t3594r600b3626],
21	Incidence	NN	O	incidence	dobj	18	SENT_262	[p19l667t3594r801b3619],
22	(	CD	PERCENT	(	num	23	SENT_262	[p19l814t3594r864b3626],
23	%	NN	PERCENT	%	dep	21	SENT_262	[p19l814t3594r864b3626],
24	)	CD	NUMBER	)	num	26	SENT_262	[p19l814t3594r864b3626],
25	Univariate	NNP	O	Univariate	nn	26	SENT_262	[p19l912t3594r1059b3619],
26	Multivariate	NNP	O	Multivariate	dep	23	SENT_262	[p19l1492t3594r1663b3619],
27	6	CD	NUMBER	6	num	26	SENT_262	[p19l1676t3592r1686b3603],

1	p	NN	O	p	nn	2	SENT_263	[p19l908t3692r929b3715],
2	values	NNS	O	value	dep	9	SENT_263	[p19l941t3683r1029b3708],
3	Relative	JJ	O	relative	amod	5	SENT_263	[p19l1089t3683r1204b3708],
4	risk	NN	O	risk	nn	5	SENT_263	[p19l1216t3683r1268b3708],
5	(	NN	O	(	dep	2	SENT_263	[p19l1280t3683r1323b3715],
6	95	CD	PERCENT	95	num	7	SENT_263	[p19l1280t3683r1323b3715],
7	%	NN	PERCENT	%	dep	9	SENT_263	[p19l1337t3683r1364b3709],
8	CI	NN	O	ci	nn	9	SENT_263	[p19l1377t3683r1421b3715],
9	)	NN	O	)	dep	13	SENT_263	[p19l1377t3683r1421b3715],
10	p	NN	O	p	nn	11	SENT_263	[p19l1488t3692r1509b3715],
11	values	NNS	O	value	dep	9	SENT_263	[p19l1521t3683r1609b3708],
12	Pooled	JJ	MISC	pooled	amod	13	SENT_263	[p19l1669t3683r1766b3708],
13	odds	NNS	O	odds	_	0	SENT_263	[p19l1778t3683r1843b3708],
14	ratios	NNS	O	ratio	nsubj	15	SENT_263	[p19l1854t3683r1930b3708],
15	(	VBP	O	(	rcmod	13	SENT_263	[p19l1943t3683r1986b3715],
16	95	CD	PERCENT	95	number	17	SENT_263	[p19l1943t3683r1986b3715],
17	%	NN	PERCENT	%	amod	19	SENT_263	[p19l2000t3683r2027b3709],
18	CI	NN	O	ci	nn	19	SENT_263	[p19l2040t3683r2084b3715],
19	)	NN	O	)	dobj	15	SENT_263	[p19l2040t3683r2084b3715],

1	a	DT	O	a	det	5	SENT_264	[p20l9t37r62b107],
2	)	NN	O	)	nn	5	SENT_264	[p20l9t37r62b107],
3	Isoniazid-related	JJ	O	isoniazid-related	amod	5	SENT_264	[p20l89t37r595b92],
4	liver	NN	O	liver	nn	5	SENT_264	[p20l621t37r758b92],
5	injury	NN	O	injury	_	0	SENT_264	[p20l782t37r960b107],
6	SA-type	JJ	O	sa-type	amod	11	SENT_264	[p20l11t148r257b217],
7	PGX	NN	O	pgx	nn	11	SENT_264	[p20l784t148r918b202],
8	(	NN	O	(	nn	11	SENT_264	[p20l1114t147r1197b217],
9	7	CD	NUMBER	7	num	11	SENT_264	[p20l1114t147r1197b217],
10	)	NN	O	)	nn	11	SENT_264	[p20l1114t147r1197b217],
11	o.o	NN	O	o.o	dep	5	SENT_264	[p20l1344t148r1435b202],
12	0.0038	CD	NUMBER	0.0038	num	13	SENT_264	[p20l1878t143r2073b202],
13	‘	NN	O	‘	dep	5	SENT_264	[p20l1878t143r2073b202],

1	STD	NN	O	std	_	0	SENT_265	[p20l788t260r924b314],
2	(	CD	NUMBER	(	number	3	SENT_265	[p20l1114t259r1197b329],
3	9	CD	NUMBER	9	dep	1	SENT_265	[p20l1114t259r1197b329],
4	)	NN	O	)	dep	3	SENT_265	[p20l1114t259r1197b329],
5	77.8	CD	NUMBER	77.8	num	4	SENT_265	[p20l1344t260r1471b314],

1	RA-type	JJ	O	ra-type	amod	3	SENT_266	[p20l7t366r292b440],
2	°	NN	O	°	nn	3	SENT_266	[p20l7t366r292b440],
3	PGX	NN	O	pgx	_	0	SENT_266	[p20l784t371r918b425],
4	(	CD	NUMBER	(	num	6	SENT_266	[p20l1114t370r1235b440],
5	44	CD	NUMBER	44	num	6	SENT_266	[p20l1114t370r1235b440],
6	)	NN	O	)	dep	3	SENT_266	[p20l1114t370r1235b440],
7	4.5	CD	NUMBER	4.5	number	8	SENT_266	[p20l1342t371r1432b425],
8	1.000	CD	NUMBER	1.000	dep	6	SENT_266	[p20l1884t371r2045b425],

1	STD	NN	O	std	dep	11	SENT_267	[p20l788t483r925b537],
2	(	CD	NUMBER	(	number	3	SENT_267	[p20l1114t482r1235b552],
3	48	CD	NUMBER	48	dep	1	SENT_267	[p20l1114t482r1235b552],
4	)	NN	O	)	nn	7	SENT_267	[p20l1114t482r1235b552],
5	4.2	CD	NUMBER	4.2	num	7	SENT_267	[p20l1342t483r1434b537],
6	reference	NN	O	reference	nn	7	SENT_267	[p20l1875t482r2153b537],
7	b	NN	O	b	dep	3	SENT_267	[p20l6t594r67b664],
8	)	CD	NUMBER	)	dep	11	SENT_267	[p20l6t594r67b664],
9	Early	JJ	O	early	amod	11	SENT_267	[p20l94t594r256b664],
10	treatment	NN	O	treatment	nn	11	SENT_267	[p20l280t601r565b649],
11	failure	NN	O	failure	dep	19	SENT_267	[p20l590t594r782b649],
12	SA-type	JJ	O	sa-type	amod	18	SENT_267	[p20l10t706r257b775],
13	‘’	NN	O	‘’	nn	18	SENT_267	[p20l284t700r306b725],
14	PGX	NN	O	pgx	nn	18	SENT_267	[p20l784t706r918b760],
15	(	NN	O	(	nn	18	SENT_267	[p20l1114t705r1197b775],
16	7	CD	NUMBER	7	num	18	SENT_267	[p20l1114t705r1197b775],
17	)	NN	O	)	nn	18	SENT_267	[p20l1114t705r1197b775],
18	o.o	NN	O	o.o	dep	11	SENT_267	[p20l1344t706r1435b760],
19	0.475	CD	NUMBER	0.475	_	0	SENT_267	[p20l1878t706r2042b760],

1	STD	NN	O	std	_	0	SENT_268	[p20l788t817r925b872],
2	(	CD	NUMBER	(	number	3	SENT_268	[p20l1114t816r1197b886],
3	9	CD	NUMBER	9	dep	1	SENT_268	[p20l1114t816r1197b886],
4	)	NN	O	)	dep	3	SENT_268	[p20l1114t816r1197b886],
5	22.2	CD	NUMBER	22.2	num	4	SENT_268	[p20l1343t818r1472b871],

1	RA-type	JJ	O	ra-type	amod	2	SENT_269	[p20l7t929r267b998],
2	PGX	NN	O	pgx	_	0	SENT_269	[p20l784t929r918b983],
3	(	CD	NUMBER	(	number	4	SENT_269	[p20l1114t928r1235b997],
4	40	CD	NUMBER	40	num	5	SENT_269	[p20l1114t928r1235b997],
5	)	NN	O	)	dep	2	SENT_269	[p20l1114t928r1235b997],
6	15.0	CD	NUMBER	15.0	number	7	SENT_269	[p20l1350t929r1473b982],
7	0013	CD	DATE	0013	dep	2	SENT_269	[p20l1878t911r2075b982],
8	*	CD	NUMBER	*	num	9	SENT_269	[p20l1878t911r2075b982],
9	’	NN	O	’	dep	7	SENT_269	[p20l1878t911r2075b982],

1	STD	NN	O	std	_	0	SENT_270	[p20l788t1041r925b1095],
2	(	CD	NUMBER	(	num	1	SENT_270	[p20l1114t1040r1235b1110],
3	43	CD	NUMBER	43	num	4	SENT_270	[p20l1114t1040r1235b1110],
4	)	NN	O	)	dep	1	SENT_270	[p20l1114t1040r1235b1110],
5	39.5	CD	NUMBER	39.5	num	6	SENT_270	[p20l1344t1041r1470b1095],
6	reference	NN	O	reference	dep	1	SENT_270	[p20l1876t1040r2153b1095],

1	—	NN	O	—	dep	9	SENT_271	[p20l7t1201r49b1204],
2	NAd	SYM	O	nad	dep	4	SENT_271	[p20l906t1150r1050b1222],
3	1.091	CD	NUMBER	1.091	number	4	SENT_271	[p20l18t1296r176b1351],
4	(	CD	NUMBER	(	dep	1	SENT_271	[p20l327t1295r727b1366],
5	O.	NNP	O	O.	dep	4	SENT_271	[p20l327t1295r727b1366],
6	160	CD	NUMBER	160	num	5	SENT_271	[p20l327t1295r727b1366],
7	—	CD	NUMBER	—	dep	9	SENT_271	[p20l327t1295r727b1366],
8	7.42	CD	NUMBER	7.42	num	9	SENT_271	[p20l327t1295r727b1366],
9	)	CD	NUMBER	)	_	0	SENT_271	[p20l327t1295r727b1366],
10	NAd	NNP	O	NAd	dep	9	SENT_271	[p20l906t1278r1050b1350],
11	—	CD	NUMBER	—	num	10	SENT_271	[p20l7t1419r49b1422],
12	—	CD	NUMBER	—	number	13	SENT_271	[p20l323t1419r365b1422],
13	0.595	CD	NUMBER	0.595	num	15	SENT_271	[p20l910t1386r1079b1441],
14	—	NN	O	—	nn	15	SENT_271	[p20l1300t1419r1341b1422],
15	—	NN	O	—	dep	10	SENT_271	[p20l1708t1419r1750b1422],

1	0.379	CD	NUMBER	0.379	number	2	SENT_272	[p20l11t1624r182b1678],
2	(	CD	NUMBER	(	num	3	SENT_272	[p20l327t1623r766b1694],
3	O.	NNP	O	O.	_	0	SENT_272	[p20l327t1623r766b1694],
4	166	CD	NUMBER	166	number	5	SENT_272	[p20l327t1623r766b1694],
5	—	CD	NUMBER	—	num	7	SENT_272	[p20l327t1623r766b1694],
6	0.866	CD	NUMBER	0.866	number	7	SENT_272	[p20l327t1623r766b1694],
7	)	CD	NUMBER	)	dep	3	SENT_272	[p20l327t1623r766b1694],
8	0015	CD	DATE	0015	dep	3	SENT_272	[p20l910t1605r1112b1678],
9	'	''	O	'	_	0	SENT_272	[p20l910t1605r1112b1678],
10	’	CD	NUMBER	’	dep	8	SENT_272	[p20l910t1605r1112b1678],
11	0.274	CD	NUMBER	0.274	num	12	SENT_272	[p20l1303t1624r1475b1678],
12	(	NN	O	(	dep	8	SENT_272	[p20l1713t1622r2151b1694],
13	0.097	CD	NUMBER	0.097	number	14	SENT_272	[p20l1713t1622r2151b1694],
14	—	CD	NUMBER	—	dep	8	SENT_272	[p20l1713t1622r2151b1694],
15	0.776	CD	NUMBER	0.776	num	16	SENT_272	[p20l1713t1622r2151b1694],
16	)	NN	O	)	dep	14	SENT_272	[p20l1713t1622r2151b1694],

1	reference	NN	O	reference	_	0	SENT_273	[p20l908t1740r1193b1796],

1	$	$	MONEY	$	_	0	SENT_274	[p20l53t1824r263b1900],
2	Q$	CD	MONEY	q$	number	1	SENT_274	[p20l53t1824r263b1900],
3	K	NN	O	k	dep	1	SENT_274	[p20l53t1824r263b1900],
4	+	CC	O	+	_	0	SENT_274	[p20l53t1824r263b1900],
5	Q$	NN	O	q$	nn	6	SENT_274	[p20l276t1828r357b1854],
6	K	NN	O	k	nsubj	11	SENT_274	[p20l276t1828r357b1854],
7	+	CC	O	+	_	0	SENT_274	[p20l276t1828r357b1854],
8	“	CD	NUMBER	“	num	10	SENT_274	[p20l371t1824r1620b1944],
9	Ce	NN	O	ce	nn	10	SENT_274	[p20l371t1824r1620b1944],
10	P$	NN	O	p$	conj_+	6	SENT_274	[p20l1670t1868r1747b1893],
11	K	NN	O	k	rcmod	1	SENT_274	[p20l1670t1868r1747b1893],
12	+	CC	O	+	dep	34	SENT_274	[p20l1670t1868r1747b1893],
13	@	SYM	O	@	dep	15	SENT_274	[p20l1853t1867r2050b1900],
14	P$	NN	O	p$	nn	15	SENT_274	[p20l1853t1867r2050b1900],
15	K	NN	O	k	dep	19	SENT_274	[p20l1853t1867r2050b1900],
16	+	CC	O	+	cc	17	SENT_274	[p20l1853t1867r2050b1900],
17	PGx	NN	O	pgx	dep	15	SENT_274	[p20l52t1999r219b2024],
18	=	JJ	O	=	amod	19	SENT_274	[p20l52t1999r219b2024],
19	NAT2	NN	O	nat2	dep	34	SENT_274	[p20l52t1999r219b2024],
20	genotype-guided	JJ	O	genotype-guided	amod	22	SENT_274	[p20l232t1999r467b2031],
21	dosing	NN	O	dosing	nn	22	SENT_274	[p20l478t1999r571b2031],
22	group	NN	O	group	dep	19	SENT_274	[p20l583t2007r671b2031],
23	,	,	O	,	_	0	SENT_274	[p20l583t2007r671b2031],
24	STD	NN	O	std	nn	26	SENT_274	[p20l685t1999r957b2024],
25	=	JJ	O	=	amod	26	SENT_274	[p20l685t1999r957b2024],
26	Conventiona1	NN	O	conventiona1	appos	22	SENT_274	[p20l685t1999r957b2024],
27	standard	JJ	O	standard	amod	29	SENT_274	[p20l970t1999r1087b2024],
28	dosing	NN	O	dosing	nn	29	SENT_274	[p20l1099t1999r1191b2031],
29	group	NN	O	group	dep	34	SENT_274	[p20l1203t2007r1283b2031],
30	aless	JJ	O	aless	dep	34	SENT_274	[p20l53t2040r121b2068],
31	than	IN	O	than	_	0	SENT_274	[p20l133t2042r193b2068],
32	O’Brien-Fleming	JJ	O	o’brien-fleming	amod	33	SENT_274	[p20l205t2042r445b2075],
33	type	NN	O	type	prep_than	30	SENT_274	[p20l457t2046r516b2075],
34	stopping	VBG	O	stop	dep	11	SENT_274	[p20l529t2042r648b2075],
35	boundaries	NNS	O	boundary	dobj	34	SENT_274	[p20l659t2042r811b2068],
36	of	IN	O	of	_	0	SENT_274	[p20l824t2042r856b2068],
37	the	DT	O	the	det	38	SENT_274	[p20l863t2042r905b2068],
38	Lan-DeMets	NN	O	lan-demet	nn	42	SENT_274	[p20l917t2043r1091b2068],
39	alpha	NN	O	alpha	dep	40	SENT_274	[p20l1104t2042r1179b2075],
40	spending	NN	O	spending	amod	42	SENT_274	[p20l1191t2042r1316b2075],
41	function	NN	O	function	nn	42	SENT_274	[p20l1328t2042r1443b2068],
42	b	NN	O	b	prep_of	35	SENT_274	[p20l52t2079r64b2096],
43	less	JJR	O	less	advmod	44	SENT_274	[p20l72t2086r123b2112],
44	than	IN	O	than	dep	34	SENT_274	[p20l135t2086r194b2112],
45	Pocock	NNP	PERSON	Pocock	nn	46	SENT_274	[p20l206t2086r308b2112],
46	type	NN	O	type	pobj	44	SENT_274	[p20l319t2090r379b2119],
47	stopping	VBG	O	stop	partmod	46	SENT_274	[p20l391t2086r510b2119],
48	boundaries	NNS	O	boundary	dobj	47	SENT_274	[p20l521t2086r674b2112],
49	°	CD	NUMBER	°	num	52	SENT_274	[p20l53t2129r63b2140],
50	secondary	JJ	O	secondary	amod	52	SENT_274	[p20l71t2131r211b2163],
51	end	NN	O	end	nn	52	SENT_274	[p20l224t2131r273b2156],
52	point	NN	O	point	nsubj	60	SENT_274	[p20l283t2131r356b2163],
53	of	IN	O	of	_	0	SENT_274	[p20l367t2131r399b2156],
54	each	DT	O	each	det	58	SENT_274	[p20l407t2131r470b2156],
55	NAT2	NN	O	nat2	nn	58	SENT_274	[p20l480t2131r565b2156],
56	genotype	NN	O	genotype	nn	58	SENT_274	[p20l578t2134r705b2163],
57	status	NN	O	status	nn	58	SENT_274	[p20l718t2134r795b2156],
58	d	NN	O	d	prep_of	52	SENT_274	[p20l53t2167r65b2184],
59	not	RB	O	not	neg	60	SENT_274	[p20l72t2178r117b2200],
60	applied	VBD	O	apply	rcmod	48	SENT_274	[p20l128t2174r230b2207],
61	because	IN	O	because	mark	62	SENT_274	[p20l241t2174r351b2200],
62	of	IN	O	of	advcl	60	SENT_274	[p20l363t2175r395b2200],
63	no	DT	O	no	det	64	SENT_274	[p20l402t2183r436b2200],
64	confounder	NN	O	confounder	pobj	62	SENT_274	[p20l448t2175r613b2205],
65	,	,	O	,	_	0	SENT_274	[p20l448t2175r613b2205],
66	and	CC	O	and	_	0	SENT_274	[p20l626t2175r676b2200],
67	d	NN	O	d	conj_and	60	SENT_274	[p20l53t2211r65b2228],
68	Cochrane	NNP	PERSON	Cochrane	nn	73	SENT_274	[p20l72t2218r467b2244],
69	~	NNP	O	~	nn	73	SENT_274	[p20l72t2218r467b2244],
70	Mantel	NNP	O	Mantel	nn	73	SENT_274	[p20l72t2218r467b2244],
71	~	NNP	O	~	nn	73	SENT_274	[p20l72t2218r467b2244],
72	Haenszel	NNP	PERSON	Haenszel	nn	73	SENT_274	[p20l72t2218r467b2244],
73	test	NN	O	test	dobj	67	SENT_274	[p20l479t2222r527b2244],
74	stratiﬁed	VBN	O	stratiﬁed	partmod	73	SENT_274	[p20l539t2218r660b2244],
75	by	IN	O	by	_	0	SENT_274	[p20l671t2218r706b2251],
76	high-excretion	JJ	O	high-excretion	amod	78	SENT_274	[p20l717t2218r920b2251],
77	quantity	NN	O	quantity	nn	78	SENT_274	[p20l932t2218r1046b2251],
78	level	NN	O	level	agent	74	SENT_274	[p20l1057t2218r1124b2244],
79	of	IN	O	of	_	0	SENT_274	[p20l1136t2218r1168b2244],
80	tubercle	JJ	O	tubercle	amod	81	SENT_274	[p20l1175t2218r1286b2244],
81	bacilli	NNS	O	bacillus	prep_of	78	SENT_274	[p20l1297t2218r1383b2244],
82	of	IN	O	of	_	0	SENT_274	[p20l1396t2218r1428b2244],
83	sputum	NN	O	sputum	nn	84	SENT_274	[p20l1436t2222r1537b2251],
84	culture	NN	O	culture	prep_of	81	SENT_274	[p20l1549t2219r1644b2244],
85	at	IN	O	at	_	0	SENT_274	[p20l1656t2222r1680b2244],
86	the	DT	O	the	det	88	SENT_274	[p20l1691t2218r1733b2244],
87	screening	JJ	O	screening	amod	88	SENT_274	[p20l1746t2219r1877b2251],
88	test	NN	O	test	prep_at	74	SENT_274	[p20l1889t2222r1937b2244],

1	INH-DILI	NN	O	inh-dili	nsubj	11	SENT_275	[p20l8t2375r361b2436],
2	in	IN	O	in	_	0	SENT_275	[p20l389t2372r456b2435],
3	the	DT	O	the	det	5	SENT_275	[p20l480t2372r584b2436],
4	STD-treatment	JJ	O	std-treatment	amod	5	SENT_275	[p20l616t2373r1130b2436],
5	(	NN	O	(	prep_in	1	SENT_275	[p20l1158t2372r1222b2454],
6	5	CD	NUMBER	5	num	8	SENT_275	[p20l1158t2372r1222b2454],
7	mg/kg	NN	O	mg/kg	nn	8	SENT_275	[p20l1253t2372r1502b2454],
8	)	NN	O	)	dep	5	SENT_275	[p20l1253t2372r1502b2454],
9	did	VBD	O	do	aux	11	SENT_275	[p20l1531t2372r1641b2436],
10	not	RB	O	not	neg	11	SENT_275	[p20l1666t2381r1778b2436],
11	show	VB	O	show	_	0	SENT_275	[p20l1806t2372r1988b2436],
12	any	DT	O	any	det	14	SENT_275	[p20l2015t2393r2139b2454],
13	clinical	JJ	O	clinical	amod	14	SENT_275	[p20l9t2483r259b2547],
14	improvement	NN	O	improvement	dobj	11	SENT_275	[p20l284t2483r761b2565],
15	.	.	O	.	_	0	SENT_275	[p20l284t2483r761b2565],

1	In	IN	O	in	_	0	SENT_276	[p20l792t2486r863b2546],
2	these	DT	O	these	det	3	SENT_276	[p20l887t2483r1063b2547],
3	cases	NNS	O	case	prep_in	10	SENT_276	[p20l1091t2504r1289b2560],
4	,	,	O	,	_	0	SENT_276	[p20l1091t2504r1289b2560],
5	their	PRP$	O	they	poss	7	SENT_276	[p20l1316t2483r1475b2547],
6	standard	JJ	O	standard	amod	7	SENT_276	[p20l1501t2483r1792b2547],
7	treatment	NN	O	treatment	nsubj	10	SENT_276	[p20l1814t2492r2140b2547],
8	was	VBD	O	be	cop	10	SENT_276	[p20l6t2614r139b2658],
9	interrupted	JJ	O	interrupted	amod	10	SENT_276	[p20l169t2594r545b2676],
10	due	JJ	O	due	_	0	SENT_276	[p20l572t2594r694b2658],
11	to	TO	O	to	_	0	SENT_276	[p20l721t2603r786b2658],
12	the	DT	O	the	det	13	SENT_276	[p20l813t2594r917b2658],
13	INH-DILI	NN	O	inh-dili	prep_to	10	SENT_276	[p20l945t2596r1298b2658],
14	and	CC	O	and	_	0	SENT_276	[p20l1326t2594r1450b2658],
15	it	PRP	O	it	nsubj	17	SENT_276	[p20l1477t2594r1524b2657],
16	was	VBD	O	be	cop	17	SENT_276	[p20l1546t2615r1680b2658],
17	inevitable	JJ	O	inevitable	conj_and	10	SENT_276	[p20l1709t2594r2046b2658],
18	to	TO	O	to	aux	19	SENT_276	[p20l2072t2603r2137b2658],
19	withdraw	VB	O	withdraw	xcomp	17	SENT_276	[p20l6t2705r342b2768],
20	INH	NNP	O	INH	dobj	19	SENT_276	[p20l383t2708r537b2768],
21	for	IN	O	for	_	0	SENT_276	[p20l582t2705r683b2768],
22	one	CD	NUMBER	one	prep_for	20	SENT_276	[p20l723t2726r847b2768],
23	of	IN	O	of	_	0	SENT_276	[p20l891t2705r972b2768],
24	them	PRP	O	they	prep_of	20	SENT_276	[p20l1002t2705r1195b2768],
25	.	.	O	.	_	0	SENT_276	[p20l1002t2705r1195b2768],

1	In	IN	O	in	_	0	SENT_277	[p20l1242t2708r1315b2767],
2	contrast	NN	O	contrast	prep_in	11	SENT_277	[p20l1356t2714r1653b2782],
3	,	,	O	,	_	0	SENT_277	[p20l1356t2714r1653b2782],
4	all	PDT	O	all	predet	7	SENT_277	[p20l1699t2705r1783b2768],
5	the	DT	O	the	det	7	SENT_277	[p20l1824t2705r1930b2768],
6	slow	JJ	O	slow	amod	7	SENT_277	[p20l1975t2705r2138b2768],
7	acetylators	NNS	O	acetylator	nsubj	11	SENT_277	[p20l9t2815r377b2897],
8	in	IN	O	in	_	0	SENT_277	[p20l413t2815r479b2878],
9	the	DT	O	the	det	10	SENT_277	[p20l511t2815r615b2879],
10	PGX-treatment	NN	O	pgx-treatment	prep_in	7	SENT_277	[p20l649t2817r1158b2879],
11	achieved	VBD	O	achieve	_	0	SENT_277	[p20l1192t2815r1498b2879],
12	8	CD	DURATION	8	num	13	SENT_277	[p20l1534t2817r1568b2879],
13	weeks	NNS	NUMBER	week	tmod	11	SENT_277	[p20l1606t2815r1822b2879],
14	of	IN	O	of	_	0	SENT_277	[p20l1858t2815r1938b2879],
15	treatment	NN	O	treatment	prep_of	11	SENT_277	[p20l1960t2824r2137b2879, p20l7t2935r182b2990],
16	successfully	RB	O	successfully	advmod	11	SENT_277	[p20l205t2926r635b3008],
17	,	,	O	,	_	0	SENT_277	[p20l205t2926r635b3008],
18	even	RB	O	even	advmod	11	SENT_277	[p20l662t2947r824b2990],
19	with	IN	O	with	_	0	SENT_277	[p20l844t2926r999b2990],
20	a	DT	O	a	det	22	SENT_277	[p20l1022t2947r1059b2990],
21	lower	JJR	O	lower	amod	22	SENT_277	[p20l1081t2926r1277b2990],
22	dose	NN	O	dose	prep_with	11	SENT_277	[p20l1298t2926r1454b2990],
23	of	IN	O	of	_	0	SENT_277	[p20l1479t2926r1560b2990],
24	isoniazid	NN	O	isoniazid	prep_of	22	SENT_277	[p20l1571t2926r1882b2990],
25	than	IN	O	than	prep	11	SENT_277	[p20l1902t2926r2052b2990],
26	in	IN	O	in	pcomp	25	SENT_277	[p20l2073t2926r2140b2989],
27	convention	NN	O	convention	nn	28	SENT_277	[p20l9t3037r394b3101],
28	therapy	NN	O	therapy	pobj	26	SENT_277	[p20l417t3037r686b3118],
29	.	.	O	.	_	0	SENT_277	[p20l417t3037r686b3118],

1	Combined	VBN	O	combine	_	0	SENT_278	[p20l12t3280r376b3344],
2	unfavorable	JJ	O	unfavorable	amod	3	SENT_278	[p20l402t3280r828b3362],
3	events	NNS	O	event	dep	1	SENT_278	[p20l858t3292r1074b3344],

1	The	DT	O	the	det	2	SENT_279	[p20l8t3503r140b3567],
2	incidence	NN	O	incidence	nsubj	21	SENT_279	[p20l179t3503r507b3567],
3	of	IN	O	of	_	0	SENT_279	[p20l546t3503r627b3567],
4	combined	JJ	O	combined	amod	6	SENT_279	[p20l653t3503r996b3567],
5	unfavorable	JJ	O	unfavorable	amod	6	SENT_279	[p20l1029t3503r1442b3567],
6	events	NNS	O	event	prep_of	2	SENT_279	[p20l1481t3512r1717b3580],
7	,	,	O	,	_	0	SENT_279	[p20l1481t3512r1717b3580],
8	defined	VBN	O	define	partmod	2	SENT_279	[p20l1758t3503r2016b3567],
9	by	IN	O	by	_	0	SENT_279	[p20l2051t3503r2140b3585],
10	early	JJ	O	early	amod	12	SENT_279	[p20l9t3614r180b3696],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_279	[p20l218t3614r603b3696],
12	failure	NN	O	failure	agent	8	SENT_279	[p20l646t3614r867b3678],
13	or	CC	O	or	_	0	SENT_279	[p20l909t3635r981b3678],
14	INH-related	JJ	O	inh-related	amod	17	SENT_279	[p20l1019t3614r1438b3678],
15	drug-induced	JJ	O	drug-induced	amod	17	SENT_279	[p20l1478t3614r1943b3696],
16	liver	NN	O	liver	nn	17	SENT_279	[p20l1983t3614r2141b3678],
17	injury	NN	O	injury	conj_or	12	SENT_279	[p20l8t3725r225b3807],
18	,	,	O	,	_	0	SENT_279	[p20l8t3725r225b3807],
19	was	VBD	O	be	cop	21	SENT_279	[p20l266t3746r400b3789],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	21	SENT_279	[p20l442t3725r869b3807],
21	lower	JJR	O	lower	_	0	SENT_279	[p20l908t3725r1106b3789],
22	in	IN	O	in	_	0	SENT_279	[p20l1142t3725r1208b3788],
23	the	DT	O	the	det	25	SENT_279	[p20l1244t3725r1348b3789],
24	combined	JJ	O	combined	amod	25	SENT_279	[p20l1389t3725r1732b3789],
25	population	NN	O	population	prep_in	21	SENT_279	[p20l1767t3725r2140b3807],
26	of	IN	O	of	_	0	SENT_279	[p21l9t22r90b86],
27	rapid	JJ	O	rapid	amod	30	SENT_279	[p21l111t22r289b104],
28	and	CC	O	and	_	0	SENT_279	[p21l323t22r447b86],
29	slow	JJ	O	slow	conj_and	27	SENT_279	[p21l482t22r644b86],
30	acetylators	NNS	O	acetylator	prep_of	25	SENT_279	[p21l678t22r1067b104],
31	;	:	O	;	_	0	SENT_279	[p21l678t22r1067b104],
32	17.0	CD	PERCENT	17.0	num	33	SENT_279	[p21l1113t24r1254b86],
33	%	NN	PERCENT	%	dep	25	SENT_279	[p21l1291t24r1360b87],
34	in	IN	O	in	_	0	SENT_279	[p21l1395t22r1461b85],
35	the	DT	O	the	det	36	SENT_279	[p21l1493t22r1597b86],
36	PGX-treatment	NN	O	pgx-treatment	prep_in	33	SENT_279	[p21l1632t24r2141b86],
37	and	CC	O	and	_	0	SENT_279	[p21l9t133r133b197],
38	48.1	CD	PERCENT	48.1	num	39	SENT_279	[p21l151t134r293b197],
39	%	NN	PERCENT	%	dep	25	SENT_279	[p21l323t134r392b198],
40	in	IN	O	in	_	0	SENT_279	[p21l413t133r478b195],
41	the	DT	O	the	det	45	SENT_279	[p21l496t133r601b197],
42	STD-treatment	JJ	O	std-treatment	amod	45	SENT_279	[p21l624t134r1139b197],
43	(	NN	O	(	nn	45	SENT_279	[p21l1157t133r1437b214],
44	relative	JJ	O	relative	amod	45	SENT_279	[p21l1157t133r1437b214],
45	risk	NN	O	risk	prep_in	39	SENT_279	[p21l1456t133r1604b210],
46	;	:	O	;	_	0	SENT_279	[p21l1456t133r1604b210],
47	0.354	CD	PERCENT	0.354	number	48	SENT_279	[p21l1629t134r1821b197],
48	[	CD	PERCENT	[	dep	25	SENT_279	[p21l1847t134r1950b213],
49	95	CD	PERCENT	95	num	51	SENT_279	[p21l1847t134r1950b213],
50	%	NN	PERCENT	%	nn	51	SENT_279	[p21l1959t134r2134b198],
51	CI	NN	O	ci	dep	48	SENT_279	[p21l1959t134r2134b198],
52	:	:	O	:	_	0	SENT_279	[p21l1959t134r2134b198],
53	0.177	CD	NUMBER	0.177	dep	25	SENT_279	[p21l9t245r224b321],
54	,	,	O	,	_	0	SENT_279	[p21l9t245r224b321],
55	0.707	CD	NUMBER	0.707	num	56	SENT_279	[p21l269t245r512b324],
56	]	NN	O	]	appos	53	SENT_279	[p21l269t245r512b324],
57	,	,	O	,	_	0	SENT_279	[p21l269t245r512b324],
58	p	NN	O	p	nn	63	SENT_279	[p21l545t245r854b325],
59	=	JJ	O	=	amod	63	SENT_279	[p21l545t245r854b325],
60	0.001	CD	NUMBER	0.001	number	61	SENT_279	[p21l545t245r854b325],
61	(	CD	NUMBER	(	dep	59	SENT_279	[p21l905t244r1124b325],
62	Table	NNP	O	Table	nn	63	SENT_279	[p21l905t244r1124b325],
63	3c	NN	O	3c	appos	25	SENT_279	[p21l1167t244r1320b325],
64	)	CD	NUMBER	)	num	65	SENT_279	[p21l1167t244r1320b325],
65	)	NN	O	)	dep	63	SENT_279	[p21l1167t244r1320b325],
66	.	.	O	.	_	0	SENT_279	[p21l1167t244r1320b325],

1	Furthermore	RB	O	furthermore	advmod	8	SENT_280	[p21l1365t244r1820b321],
2	,	,	O	,	_	0	SENT_280	[p21l1365t244r1820b321],
3	the	DT	O	the	det	5	SENT_280	[p21l1863t244r1968b308],
4	risk	NN	O	risk	nn	5	SENT_280	[p21l2008t244r2140b308],
5	reduction	NN	O	reduction	nsubj	8	SENT_280	[p21l6t355r343b419],
6	was	VBD	O	be	cop	8	SENT_280	[p21l382t375r517b419],
7	more	RBR	O	more	advmod	8	SENT_280	[p21l559t375r739b419],
8	conspicuous	JJ	O	conspicuous	dep	32	SENT_280	[p21l783t355r1220b436],
9	when	WRB	O	when	advmod	13	SENT_280	[p21l1261t355r1455b419],
10	the	DT	O	the	det	11	SENT_280	[p21l1494t355r1601b419],
11	subjects	NNS	O	subject	nsubjpass	13	SENT_280	[p21l1646t355r1925b436],
12	were	VBD	O	be	auxpass	13	SENT_280	[p21l1968t375r2137b419],
13	stratified	VBN	O	stratify	ccomp	8	SENT_280	[p21l10t466r311b530],
14	by	IN	O	by	_	0	SENT_280	[p21l332t466r421b548],
15	the	DT	O	the	det	16	SENT_280	[p21l443t466r547b530],
16	level	NN	O	level	agent	13	SENT_280	[p21l573t466r737b530],
17	of	IN	O	of	_	0	SENT_280	[p21l763t466r844b530],
18	primary	JJ	O	primary	amod	20	SENT_280	[p21l854t466r1128b548],
19	sputum	NN	O	sputum	nn	20	SENT_280	[p21l1154t475r1409b548],
20	culture	NN	O	culture	prep_of	16	SENT_280	[p21l1432t466r1688b543],
21	;	:	O	;	_	0	SENT_280	[p21l1432t466r1688b543],
22	pooled	JJ	O	pooled	amod	24	SENT_280	[p21l1713t466r1952b548],
23	odds	NNS	O	odds	nn	24	SENT_280	[p21l1976t466r2137b530],
24	ratios	NNS	O	ratio	nsubj	25	SENT_280	[p21l6t577r195b641],
25	[	VBP	O	[	parataxis	8	SENT_280	[p21l227t578r518b657],
26	95	CD	PERCENT	95	number	27	SENT_280	[p21l227t578r518b657],
27	%	NN	PERCENT	%	amod	29	SENT_280	[p21l227t578r518b657],
28	CI	NN	O	ci	nn	29	SENT_280	[p21l227t578r518b657],
29	]	NN	O	]	dobj	25	SENT_280	[p21l227t578r518b657],
30	were	VBD	O	be	cop	32	SENT_280	[p21l547t598r715b641],
31	0.229	CD	NUMBER	0.229	num	32	SENT_280	[p21l741t579r933b641],
32	[	CD	NUMBER	[	_	0	SENT_280	[p21l966t578r1202b657],
33	0.09	CD	NUMBER	0.09	num	34	SENT_280	[p21l966t578r1202b657],
34	l	NN	O	l	nsubj	32	SENT_280	[p21l966t578r1202b657],
35	,	,	O	,	_	0	SENT_280	[p21l966t578r1202b657],
36	0.548	CD	NUMBER	0.548	num	37	SENT_280	[p21l1232t578r1449b657],
37	]	NN	O	]	appos	34	SENT_280	[p21l1232t578r1449b657],
38	in	IN	O	in	_	0	SENT_280	[p21l1480t577r1546b640],
39	combined	JJ	O	combined	amod	40	SENT_280	[p21l1571t577r1912b641],
40	population	NN	O	population	prep_in	37	SENT_280	[p21l1934t598r2137b659, p21l9t688r203b752],
41	of	IN	O	of	_	0	SENT_280	[p21l229t689r310b752],
42	rapid	JJ	O	rapid	amod	45	SENT_280	[p21l323t688r500b770],
43	and	CC	O	and	_	0	SENT_280	[p21l526t688r650b752],
44	slow	JJ	O	slow	amod	45	SENT_280	[p21l677t688r839b752],
45	acetylators	NNS	O	acetylator	prep_of	40	SENT_280	[p21l864t688r1251b770],
46	.	.	O	.	_	0	SENT_280	[p21l864t688r1251b770],

1	Although	IN	O	although	mark	14	SENT_281	[p21l108t799r432b881],
2	the	DT	O	the	det	3	SENT_281	[p21l451t799r553b863],
3	dose	NN	O	dose	nsubj	14	SENT_281	[p21l576t799r729b863],
4	of	IN	O	of	_	0	SENT_281	[p21l751t800r830b863],
5	INH	NN	O	inh	prep_of	3	SENT_281	[p21l840t802r990b863],
6	for	IN	O	for	_	0	SENT_281	[p21l1013t799r1110b863],
7	intermediate	JJ	O	intermediate	amod	8	SENT_281	[p21l1129t799r1548b863],
8	acetylators	NNS	O	acetylator	prep_for	5	SENT_281	[p21l1570t799r1928b881],
9	in	IN	O	in	_	0	SENT_281	[p21l1951t799r2016b862],
10	the	DT	O	the	det	11	SENT_281	[p21l2035t799r2138b863],
11	PGX-treatment	NN	O	pgx-treatment	prep_in	8	SENT_281	[p21l7t912r517b973],
12	was	VBD	O	be	cop	14	SENT_281	[p21l552t931r685b973],
13	the	DT	O	the	det	14	SENT_281	[p21l724t910r828b973],
14	same	JJ	O	same	csubjpass	29	SENT_281	[p21l869t931r1043b973],
15	as	IN	O	as	_	0	SENT_281	[p21l1083t931r1151b973],
16	that	DT	O	that	prep_as	14	SENT_281	[p21l1189t910r1320b973],
17	in	IN	O	in	_	0	SENT_281	[p21l1356t910r1423b972],
18	the	DT	O	the	det	23	SENT_281	[p21l1458t910r1562b973],
19	STD-treatrnent	JJ	O	std-treatrnent	amod	23	SENT_281	[p21l1605t912r2136b987],
20	,	,	O	,	_	0	SENT_281	[p21l1605t912r2136b987],
21	overall	JJ	O	overall	amod	23	SENT_281	[p21l9t1020r248b1084],
22	clinical	JJ	O	clinical	amod	23	SENT_281	[p21l289t1020r542b1084],
23	usefulness	NN	O	usefulness	prep_in	16	SENT_281	[p21l580t1020r943b1084],
24	of	IN	O	of	_	0	SENT_281	[p21l985t1020r1066b1084],
25	the	DT	O	the	det	27	SENT_281	[p21l1094t1020r1200b1084],
26	PGX-guided	JJ	O	pgx-guided	amod	27	SENT_281	[p21l1239t1020r1665b1102],
27	therapy	NN	O	therapy	prep_of	23	SENT_281	[p21l1702t1020r1965b1102],
28	was	VBD	O	be	auxpass	29	SENT_281	[p21l2002t1041r2137b1084],
29	compared	VBN	O	compare	_	0	SENT_281	[p21l9t1131r350b1212],
30	with	IN	O	with	_	0	SENT_281	[p21l374t1131r529b1195],
31	the	DT	O	the	det	33	SENT_281	[p21l554t1131r658b1195],
32	empirical	JJ	O	empirical	amod	33	SENT_281	[p21l687t1131r1008b1212],
33	therapy	NN	O	therapy	prep_with	29	SENT_281	[p21l1035t1131r1312b1212],
34	:	:	O	:	_	0	SENT_281	[p21l1035t1131r1312b1212],
35	the	DT	O	the	det	38	SENT_281	[p21l1343t1131r1447b1195],
36	combined	JJ	O	combined	amod	38	SENT_281	[p21l1476t1131r1819b1195],
37	unfavorable	JJ	O	unfavorable	amod	38	SENT_281	[p21l1841t1131r2137b1195, p21l9t1242r152b1306],
38	events	NNS	O	event	nsubj	41	SENT_281	[p21l196t1250r419b1306],
39	were	VBD	O	be	cop	41	SENT_281	[p21l461t1262r631b1306],
40	20.5	CD	PERCENT	20.5	num	41	SENT_281	[p21l673t1243r823b1305],
41	%	NN	PERCENT	%	parataxis	29	SENT_281	[p21l871t1243r939b1307],
42	(	CD	NUMBER	(	number	43	SENT_281	[p21l984t1242r1165b1323],
43	16/7	CD	NUMBER	16/7	num	41	SENT_281	[p21l984t1242r1165b1323],
44	8	CD	NUMBER	8	num	45	SENT_281	[p21l1175t1243r1209b1305],
45	patients	NNS	O	patient	dep	46	SENT_281	[p21l1253t1242r1557b1323],
46	)	RB	O	)	amod	41	SENT_281	[p21l1253t1242r1557b1323],
47	in	IN	O	in	_	0	SENT_281	[p21l1601t1242r1668b1304],
48	PGX-guided	JJ	O	pgx-guided	amod	49	SENT_281	[p21l1708t1242r2140b1323],
49	therapy	NN	O	therapy	prep_in	41	SENT_281	[p21l7t1353r266b1435],
50	and	CC	O	and	_	0	SENT_281	[p21l295t1353r419b1417],
51	42.9	CD	PERCENT	42.9	num	52	SENT_281	[p21l447t1354r596b1417],
52	%	NN	PERCENT	%	parataxis	29	SENT_281	[p21l628t1354r697b1418],
53	(	CD	NUMBER	(	number	54	SENT_281	[p21l728t1353r950b1434],
54	33/77	CD	NUMBER	33/77	num	55	SENT_281	[p21l728t1353r950b1434],
55	patients	NNS	O	patient	dep	52	SENT_281	[p21l978t1353r1272b1435],
56	)	RB	O	)	advmod	41	SENT_281	[p21l978t1353r1272b1435],
57	in	IN	O	in	_	0	SENT_281	[p21l1303t1353r1370b1416],
58	the	DT	O	the	det	61	SENT_281	[p21l1396t1353r1499b1417],
59	empirical	JJ	O	empirical	amod	61	SENT_281	[p21l1531t1353r1852b1435],
60	therapy	NN	O	therapy	nn	61	SENT_281	[p21l1880t1353r2139b1435],
61	(	NN	O	(	prep_in	41	SENT_281	[p21l9t1464r290b1546],
62	relative	JJ	O	relative	amod	63	SENT_281	[p21l9t1464r290b1546],
63	risk	NN	O	risk	dep	61	SENT_281	[p21l311t1464r459b1541],
64	;	:	O	;	_	0	SENT_281	[p21l311t1464r459b1541],
65	0.479	CD	PERCENT	0.479	number	66	SENT_281	[p21l487t1465r678b1528],
66	[	CD	PERCENT	[	dep	61	SENT_281	[p21l708t1465r994b1544],
67	95	CD	PERCENT	95	num	69	SENT_281	[p21l708t1465r994b1544],
68	%	NN	PERCENT	%	nn	69	SENT_281	[p21l708t1465r994b1544],
69	CI	NN	O	ci	dep	66	SENT_281	[p21l708t1465r994b1544],
70	:	:	O	:	_	0	SENT_281	[p21l708t1465r994b1544],
71	0.288	CD	NUMBER	0.288	dep	61	SENT_281	[p21l1023t1466r1236b1541],
72	,	,	O	,	_	0	SENT_281	[p21l1023t1466r1236b1541],
73	0.795	CD	NUMBER	0.795	num	74	SENT_281	[p21l1262t1465r1502b1544],
74	]	NN	O	]	appos	71	SENT_281	[p21l1262t1465r1502b1544],
75	,	,	O	,	_	0	SENT_281	[p21l1262t1465r1502b1544],
76	p	NN	O	p	appos	61	SENT_281	[p21l1516t1464r1859b1546],
77	=	JJ	O	=	advmod	81	SENT_281	[p21l1516t1464r1859b1546],
78	0.003	CD	NUMBER	0.003	dep	77	SENT_281	[p21l1516t1464r1859b1546],
79	)	CD	NUMBER	)	number	80	SENT_281	[p21l1516t1464r1859b1546],
80	(	CD	NUMBER	(	num	81	SENT_281	[p21l1884t1464r2040b1546],
81	Fig	NN	O	fig	rcmod	76	SENT_281	[p21l1884t1464r2040b1546],
82	.	.	O	.	_	0	SENT_281	[p21l1884t1464r2040b1546],

1	2	CD	NUMBER	2	num	2	SENT_282	[p21l2067t1464r2154b1546],
2	)	CD	NUMBER	)	_	0	SENT_282	[p21l2067t1464r2154b1546],
3	.	.	O	.	_	0	SENT_282	[p21l2067t1464r2154b1546],

1	Sub	NN	O	sub	_	0	SENT_283	[p21l7t1574r473b1656],
2	—	CD	NUMBER	—	num	3	SENT_283	[p21l7t1574r473b1656],
3	cmalyses	NNS	O	cmalys	dep	1	SENT_283	[p21l7t1574r473b1656],

1	The	DT	O	the	det	3	SENT_284	[p21l8t1798r141b1862],
2	cumulative	JJ	O	cumulative	amod	3	SENT_284	[p21l163t1798r545b1862],
3	incidence	NN	O	incidence	nsubjpass	9	SENT_284	[p21l566t1798r894b1862],
4	of	IN	O	of	_	0	SENT_284	[p21l916t1798r997b1862],
5	INH-DILI	NN	O	inh-dili	prep_of	3	SENT_284	[p21l1006t1800r1361b1862],
6	over	IN	O	over	_	0	SENT_284	[p21l1381t1819r1536b1862],
7	time	NN	O	time	prep_over	5	SENT_284	[p21l1552t1798r1704b1862],
8	is	VBZ	O	be	auxpass	9	SENT_284	[p21l1726t1798r1779b1862],
9	illustrated	VBN	O	illustrate	_	0	SENT_284	[p21l1801t1798r2143b1862],
10	in	IN	O	in	_	0	SENT_284	[p21l8t1909r75b1972],
11	Fig	NN	O	fig	prep_in	9	SENT_284	[p21l98t1909r230b1991],
12	.	.	O	.	_	0	SENT_284	[p21l98t1909r230b1991],

1	3	LS	NUMBER	3	_	0	SENT_285	[p21l262t1911r318b1973],
2	.	.	O	.	_	0	SENT_285	[p21l262t1911r318b1973],

1	Mean	NN	O	mean	nn	3	SENT_286	[p21l349t1912r548b1973],
2	(	CD	NUMBER	(	num	3	SENT_286	[p21l574t1910r737b1991],
3	SD	NN	O	sd	nsubj	11	SENT_286	[p21l574t1910r737b1991],
4	)	CD	NUMBER	)	num	5	SENT_286	[p21l574t1910r737b1991],
5	time	NN	O	time	nsubj	7	SENT_286	[p21l763t1909r916b1973],
6	to	TO	O	to	aux	7	SENT_286	[p21l940t1918r1005b1973],
7	detect	VB	O	detect	infmod	3	SENT_286	[p21l1034t1909r1238b1973],
8	INH-DILI	NN	O	inh-dili	dobj	7	SENT_286	[p21l1262t1912r1617b1973],
9	was	VBD	O	be	cop	11	SENT_286	[p21l1640t1930r1774b1973],
10	15.6	CD	NUMBER	15.6	number	11	SENT_286	[p21l1809t1911r1951b1973],
11	(	CD	NUMBER	(	_	0	SENT_286	[p21l1980t1910r2140b1991],
12	6.9	CD	NUMBER	6.9	number	13	SENT_286	[p21l1980t1910r2140b1991],
13	)	CD	NUMBER	)	num	14	SENT_286	[p21l1980t1910r2140b1991],
14	days	NNS	NUMBER	day	npadvmod	11	SENT_286	[p21l9t2020r165b2102],
15	in	IN	O	in	_	0	SENT_286	[p21l197t2020r263b2083],
16	slow	JJ	O	slow	amod	17	SENT_286	[p21l295t2020r456b2084],
17	acetylators	NNS	O	acetylator	prep_in	11	SENT_286	[p21l487t2020r855b2102],
18	receiving	VBG	O	receive	partmod	17	SENT_286	[p21l887t2020r1207b2102],
19	the	DT	O	the	det	22	SENT_286	[p21l1237t2020r1341b2084],
20	conventional	JJ	O	conventional	amod	22	SENT_286	[p21l1373t2020r1820b2084],
21	standard	JJ	O	standard	amod	22	SENT_286	[p21l1853t2020r2143b2084],
22	treatment	NN	O	treatment	dobj	18	SENT_286	[p21l7t2140r348b2195],
23	.	.	O	.	_	0	SENT_286	[p21l7t2140r348b2195],

1	As	IN	O	as	_	0	SENT_287	[p21l389t2133r484b2195],
2	for	IN	O	for	prepc_as_for	16	SENT_287	[p21l526t2131r624b2195],
3	intermediate	JJ	O	intermediate	amod	4	SENT_287	[p21l661t2131r1089b2195],
4	acetylators	NNS	O	acetylator	pobj	16	SENT_287	[p21l1129t2131r1517b2213],
5	,	,	O	,	_	0	SENT_287	[p21l1129t2131r1517b2213],
6	INH-DILI	NN	O	inh-dili	nsubj	16	SENT_287	[p21l1558t2134r1930b2209],
7	,	,	O	,	_	0	SENT_287	[p21l1558t2134r1930b2209],
8	early	JJ	O	early	amod	10	SENT_287	[p21l1973t2131r2142b2213],
9	therapeutic	JJ	O	therapeutic	amod	10	SENT_287	[p21l7t2242r388b2323],
10	failure	NN	O	failure	nsubj	16	SENT_287	[p21l422t2242r641b2306],
11	and	CC	O	and	_	0	SENT_287	[p21l675t2242r800b2306],
12	the	DT	O	the	det	15	SENT_287	[p21l828t2242r932b2306],
13	combined	JJ	O	combined	amod	15	SENT_287	[p21l966t2242r1309b2306],
14	unfavorable	JJ	O	unfavorable	amod	15	SENT_287	[p21l1337t2242r1749b2306],
15	events	NNS	O	event	conj_and	6	SENT_287	[p21l1784t2250r2001b2306],
16	occurred	VBD	O	occur	_	0	SENT_287	[p21l2034t2262r2140b2306, p21l9t2353r228b2417],
17	in	IN	O	in	_	0	SENT_287	[p21l258t2353r324b2415],
18	4.7	CD	PERCENT	4.7	num	19	SENT_287	[p21l353t2354r458b2417],
19	%	NN	PERCENT	%	prep_in	16	SENT_287	[p21l493t2354r562b2418],
20	(	CD	NUMBER	(	number	21	SENT_287	[p21l596t2353r773b2434],
21	3/64	CD	NUMBER	3/64	num	22	SENT_287	[p21l596t2353r773b2434],
22	patients	NNS	O	patient	dep	19	SENT_287	[p21l803t2353r1119b2434],
23	)	RB	O	)	advmod	22	SENT_287	[p21l803t2353r1119b2434],
24	,	,	O	,	_	0	SENT_287	[p21l803t2353r1119b2434],
25	26.8	CD	PERCENT	26.8	num	26	SENT_287	[p21l1152t2354r1300b2417],
26	%	NN	PERCENT	%	prep_in	16	SENT_287	[p21l1336t2354r1404b2418],
27	(	CD	NUMBER	(	number	28	SENT_287	[p21l1438t2353r1660b2434],
28	15/56	CD	NUMBER	15/56	num	29	SENT_287	[p21l1438t2353r1660b2434],
29	patients	NNS	O	patient	dep	26	SENT_287	[p21l1690t2353r1985b2434],
30	)	CD	NUMBER	)	dep	26	SENT_287	[p21l1690t2353r1985b2434],
31	and	CC	O	and	_	0	SENT_287	[p21l2018t2353r2143b2417],
32	28.6	CD	PERCENT	28.6	num	33	SENT_287	[p21l8t2466r158b2528],
33	%	NN	PERCENT	%	prep_in	16	SENT_287	[p21l187t2466r255b2530],
34	(	CD	NUMBER	(	number	35	SENT_287	[p21l284t2464r459b2546],
35	16/5	CD	NUMBER	16/5	num	33	SENT_287	[p21l284t2464r459b2546],
36	6	CD	NUMBER	6	num	37	SENT_287	[p21l469t2466r506b2528],
37	patients	NNS	O	patient	dep	38	SENT_287	[p21l532t2464r847b2546],
38	)	RB	O	)	amod	33	SENT_287	[p21l532t2464r847b2546],
39	,	,	O	,	_	0	SENT_287	[p21l532t2464r847b2546],
40	respectively	RB	O	respectively	advmod	16	SENT_287	[p21l875t2464r1301b2546],
41	.	.	O	.	_	0	SENT_287	[p21l875t2464r1301b2546],

1	Overall	JJ	O	overall	amod	2	SENT_288	[p21l1335t2464r1591b2529],
2	probabilities	NNS	O	probability	_	0	SENT_288	[p21l1614t2464r2044b2546],
3	of	IN	O	of	prep	2	SENT_288	[p21l2073t2465r2153b2528],

1	Incidence	NN	O	incidence	_	0	SENT_289	[p22l385t712r438b1003],
2	(	CD	PERCENT	(	num	3	SENT_289	[p22l386t544r451b651],
3	%	NN	PERCENT	%	dep	1	SENT_289	[p22l386t544r451b651],
4	)	CD	NUMBER	)	dep	1	SENT_289	[p22l386t544r451b651],

1	A	DT	O	a	det	2	SENT_290	[p22l513t884r546b934],
2	o	NN	O	o	_	0	SENT_290	[p22l548t884r581b934],

1	PGx	NN	O	pgx	nn	3	SENT_291	[p22l736t1487r1120b1555],
2	—	NN	O	—	nn	3	SENT_291	[p22l736t1487r1120b1555],
3	therapy	NN	O	therapy	_	0	SENT_291	[p22l736t1487r1120b1555],
4	Empirical	JJ	O	empirical	amod	5	SENT_291	[p22l1233t1487r1528b1555],
5	therapy	NN	O	therapy	dep	3	SENT_291	[p22l1548t1487r1772b1555],

1	(	NN	O	(	nn	2	SENT_292	[p22l819t1611r1009b1672],
2	n	NN	O	n	_	0	SENT_292	[p22l819t1611r1009b1672],
3	=	JJ	O	=	dep	2	SENT_292	[p22l819t1611r1009b1672],
4	78	CD	NUMBER	78	number	5	SENT_292	[p22l819t1611r1009b1672],
5	)	CD	NUMBER	)	num	11	SENT_292	[p22l819t1611r1009b1672],
6	(	NN	O	(	nn	11	SENT_292	[p22l1380t1598r1509b1659],
7	n	NN	O	n	nn	11	SENT_292	[p22l1380t1598r1509b1659],
8	=	JJ	O	=	amod	11	SENT_292	[p22l1380t1598r1509b1659],
9	7	CD	NUMBER	7	number	10	SENT_292	[p22l1380t1598r1509b1659],
10	7	CD	NUMBER	7	dep	8	SENT_292	[p22l1514t1599r1545b1647],
11	)	NN	O	)	dep	3	SENT_292	[p22l1551t1598r1569b1659],

1	Fig	NN	O	fig	_	0	SENT_293	[p22l7t1775r130b1843],
2	.	.	O	.	_	0	SENT_293	[p22l7t1775r130b1843],

1	2	CD	NUMBER	2	num	3	SENT_294	[p22l172t1775r205b1827],
2	Overall	JJ	O	overall	amod	3	SENT_294	[p22l260t1773r489b1828],
3	incidence	NN	O	incidence	_	0	SENT_294	[p22l529t1773r824b1828],
4	of	IN	O	of	_	0	SENT_294	[p22l864t1774r935b1828],
5	combined	JJ	O	combined	amod	7	SENT_294	[p22l965t1773r1270b1828],
6	unfavorable	JJ	O	unfavorable	amod	7	SENT_294	[p22l1307t1773r1677b1828],
7	events	NNS	O	event	prep_of	3	SENT_294	[p22l1718t1781r1913b1828],
8	in	IN	O	in	_	0	SENT_294	[p22l1954t1774r2011b1827],
9	the	DT	O	the	det	10	SENT_294	[p22l2049t1773r2141b1828],
10	patients	NNS	O	patient	prep_in	7	SENT_294	[p22l6t1862r237b1931],
11	who	WP	O	who	nsubj	12	SENT_294	[p22l265t1862r393b1916],
12	received	VBD	O	receive	rcmod	10	SENT_294	[p22l420t1862r674b1916],
13	PGX-therapy	JJ	O	pgx-therapy	acomp	12	SENT_294	[p22l700t1862r1083b1931],
14	and	CC	O	and	_	0	SENT_294	[p22l1111t1862r1218b1916],
15	in	IN	O	in	_	0	SENT_294	[p22l1244t1862r1301b1915],
16	those	DT	O	those	prep_in	7	SENT_294	[p22l1326t1862r1483b1916],
17	who	WP	O	who	nsubj	18	SENT_294	[p22l1510t1862r1638b1916],
18	received	VBD	O	receive	rcmod	16	SENT_294	[p22l1665t1862r1919b1916],
19	empirical	JJ	O	empirical	amod	20	SENT_294	[p22l1946t1862r2141b1931, p22l8t1950r113b2004],
20	therapy	NN	O	therapy	dobj	18	SENT_294	[p22l137t1950r361b2019],

1	@	IN	O	@	_	0	SENT_295	[p22l1782t2175r1855b2265],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_295	[p22l1880t2198r2125b2268],

1	1098	CD	DATE	1098	nsubj	35	SENT_296	[p22l56t2343r121b2368],
2	Eur	NNP	O	Eur	nn	5	SENT_296	[p22l1486t2344r1536b2368],
3	J	NNP	O	J	nn	5	SENT_296	[p22l1547t2344r1560b2368],
4	Clin	NNP	PERSON	Clin	nn	5	SENT_296	[p22l1571t2343r1631b2368],
5	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_296	[p22l1642t2343r1790b2368],
6	(	CD	NUMBER	(	num	5	SENT_296	[p22l1802t2343r1893b2375],
7	2013	CD	DATE	2013	amod	1	SENT_296	[p22l1802t2343r1893b2375],
8	)	CD	NUMBER	)	number	9	SENT_296	[p22l1802t2343r1893b2375],
9	69	CD	NUMBER	69	dep	7	SENT_296	[p22l1907t2343r2103b2368],
10	:	:	O	:	_	0	SENT_296	[p22l1907t2343r2103b2368],
11	l09l	CD	NUMBER	l09l	num	13	SENT_296	[p22l1907t2343r2103b2368],
12	—	CD	NUMBER	—	num	13	SENT_296	[p22l1907t2343r2103b2368],
13	l10l	NN	O	l10l	dep	9	SENT_296	[p22l1907t2343r2103b2368],
14	the	DT	O	the	det	17	SENT_296	[p22l7t2516r116b2580],
15	combined	JJ	O	combined	amod	17	SENT_296	[p22l162t2516r521b2580],
16	unfavorable	JJ	O	unfavorable	amod	17	SENT_296	[p22l562t2516r999b2580],
17	events	NNS	O	event	nsubj	20	SENT_296	[p22l1046t2525r1275b2580],
18	were	VBD	O	be	cop	20	SENT_296	[p22l1319t2536r1493b2580],
19	23.3	CD	PERCENT	23.3	num	20	SENT_296	[p22l1539t2517r1691b2580],
20	%	NN	PERCENT	%	rcmod	13	SENT_296	[p22l1743t2517r1812b2581],
21	(	CD	NUMBER	(	number	22	SENT_296	[p22l1858t2516r2135b2597],
22	24/103	CD	NUMBER	24/103	num	23	SENT_296	[p22l1858t2516r2135b2597],
23	patients	NNS	O	patient	attr	20	SENT_296	[p22l6t2627r301b2709],
24	)	RB	O	)	advmod	23	SENT_296	[p22l6t2627r301b2709],
25	in	IN	O	in	_	0	SENT_296	[p22l330t2627r396b2690],
26	the	DT	O	the	det	27	SENT_296	[p22l420t2627r524b2691],
27	PGX-treatment	NN	O	pgx-treatment	prep_in	23	SENT_296	[p22l551t2629r1061b2691],
28	(	CD	NUMBER	(	number	29	SENT_296	[p22l1087t2627r1265b2709],
29	8/47	CD	NUMBER	8/47	num	30	SENT_296	[p22l1087t2627r1265b2709],
30	patients	NNS	O	patient	dep	31	SENT_296	[p22l1291t2627r1587b2709],
31	)	IN	O	)	prep	23	SENT_296	[p22l1291t2627r1587b2709],
32	plus	CC	O	plus	_	0	SENT_296	[p22l1612t2627r1757b2709],
33	intermediate	JJ	O	intermediate	amod	34	SENT_296	[p22l1786t2627r2141b2691, p22l9t2747r105b2802],
34	acetylators	NNS	O	acetylator	prep	23	SENT_296	[p22l131t2738r499b2820],
35	(	VBP	O	(	_	0	SENT_296	[p22l526t2738r701b2820],
36	16/5	CD	NUMBER	16/5	number	37	SENT_296	[p22l526t2738r701b2820],
37	6	CD	NUMBER	6	num	38	SENT_296	[p22l710t2740r748b2802],
38	patients	NNS	O	patient	dobj	35	SENT_296	[p22l771t2738r1066b2820],
39	)	CD	NUMBER	)	dep	38	SENT_296	[p22l771t2738r1066b2820],
40	and	CC	O	and	_	0	SENT_296	[p22l1092t2738r1217b2802],
41	48.1	CD	PERCENT	48.1	num	42	SENT_296	[p22l1239t2740r1382b2802],
42	%	NN	PERCENT	%	dobj	35	SENT_296	[p22l1415t2740r1484b2803],
43	(	CD	NUMBER	(	number	44	SENT_296	[p22l1511t2738r1732b2820],
44	25/52	CD	NUMBER	25/52	num	45	SENT_296	[p22l1511t2738r1732b2820],
45	patients	NNS	O	patient	dep	42	SENT_296	[p22l1756t2738r2051b2820],
46	)	RB	O	)	advmod	35	SENT_296	[p22l1756t2738r2051b2820],
47	in	IN	O	in	_	0	SENT_296	[p22l2077t2738r2143b2801],
48	the	DT	O	the	det	49	SENT_296	[p22l7t2850r111b2914],
49	STD-treatment	NN	O	std-treatment	prep_in	35	SENT_296	[p22l141t2852r670b2914],
50	.	.	O	.	_	0	SENT_296	[p22l141t2852r670b2914],

1	Further	JJ	O	further	amod	3	SENT_297	[p22l109t2961r375b3025],
2	explorative	JJ	O	explorative	amod	3	SENT_297	[p22l427t2961r829b3042],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_297	[p22l884t2961r1185b3042],
4	were	VBD	O	be	auxpass	5	SENT_297	[p22l1239t2981r1411b3025],
5	performed	VBN	O	perform	_	0	SENT_297	[p22l1463t2961r1839b3042],
6	in	IN	O	in	_	0	SENT_297	[p22l1892t2961r1959b3023],
7	118	CD	NUMBER	118	num	8	SENT_297	[p22l2020t2962r2138b3024],
8	patients	NNS	O	patient	prep_in	5	SENT_297	[p22l6t3072r279b3153],
9	presenting	VBG	O	present	partmod	8	SENT_297	[p22l310t3072r678b3153],
10	as	IN	O	as	_	0	SENT_297	[p22l712t3092r780b3136],
11	sputum	NN	O	sputum	prep_as	9	SENT_297	[p22l817t3080r1074b3153],
12	culture-positive	JJ	O	culture-positive	amod	11	SENT_297	[p22l1106t3072r1657b3153],
13	at	IN	O	at	_	0	SENT_297	[p22l1691t3081r1752b3135],
14	screening	NN	O	screening	prep_at	12	SENT_297	[p22l1785t3072r2138b3153],
15	,	,	O	,	_	0	SENT_297	[p22l1785t3072r2138b3153],
16	who	WP	O	who	nsubjpass	18	SENT_297	[p22l6t3184r157b3248],
17	were	VBD	O	be	auxpass	18	SENT_297	[p22l197t3204r366b3248],
18	infected	VBN	O	infect	rcmod	11	SENT_297	[p22l407t3184r690b3248],
19	with	IN	O	with	_	0	SENT_297	[p22l726t3184r884b3248],
20	M.	NN	MISC	m.	nn	21	SENT_297	[p22l917t3186r1006b3247],
21	tuberculosis	NN	O	tuberculosis	prep_with	18	SENT_297	[p22l1057t3184r1482b3248],
22	sensitive	JJ	O	sensitive	amod	21	SENT_297	[p22l1525t3184r1828b3248],
23	to	TO	O	to	aux	24	SENT_297	[p22l1867t3193r1933b3248],
24	ﬁrstline	VB	O	ﬁrstline	xcomp	22	SENT_297	[p22l1976t3184r2139b3248, p22l9t3295r136b3359],
25	anti-tuberculosis	JJ	O	anti-tuberculosis	amod	26	SENT_297	[p22l174t3295r758b3359],
26	drugs	NNS	O	drug	dobj	24	SENT_297	[p22l796t3295r1006b3377],
27	.	.	O	.	_	0	SENT_297	[p22l796t3295r1006b3377],

1	As	RB	O	as	advmod	2	SENT_298	[p22l1046t3296r1141b3359],
2	well	RB	O	well	advmod	36	SENT_298	[p22l1177t3295r1328b3359],
3	as	IN	O	as	_	0	SENT_298	[p22l1364t3316r1432b3359],
4	primary	JJ	O	primary	amod	5	SENT_298	[p22l1467t3295r1746b3377],
5	outcomes	NNS	O	outcome	prep_as	2	SENT_298	[p22l1782t3304r2137b3373],
6	,	,	O	,	_	0	SENT_298	[p22l1782t3304r2137b3373],
7	PGX-guided	JJ	O	pgx-guided	amod	8	SENT_298	[p22l7t3406r444b3488],
8	treatment	NN	O	treatment	nsubj	36	SENT_298	[p22l496t3415r836b3470],
9	reduced	VBD	O	reduce	rcmod	8	SENT_298	[p22l887t3406r1172b3470],
10	INH-DILI	NN	O	inh-dili	dobj	9	SENT_298	[p22l1226t3409r1592b3470],
11	with	IN	O	with	_	0	SENT_298	[p22l1644t3406r1804b3470],
12	keeping	VBG	O	keep	prepc_with	9	SENT_298	[p22l1856t3406r2141b3488],
13	enough	JJ	O	enough	amod	15	SENT_298	[p22l9t3517r268b3599],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_298	[p22l303t3517r692b3599],
15	efﬁcacies	NNS	O	efﬁcacies	dobj	12	SENT_298	[p22l731t3517r1061b3581],
16	in	IN	O	in	_	0	SENT_298	[p22l1100t3517r1166b3580],
17	slow	JJ	O	slow	amod	18	SENT_298	[p22l1203t3517r1366b3581],
18	acetylators	NNS	O	acetylator	prep_in	12	SENT_298	[p22l1403t3517r1800b3599],
19	,	,	O	,	_	0	SENT_298	[p22l1403t3517r1800b3599],
20	and	CC	O	and	_	0	SENT_298	[p22l1841t3517r1967b3581],
21	also	RB	O	also	advmod	22	SENT_298	[p22l2003t3517r2139b3581],
22	reduced	VBD	O	reduce	conj_and	9	SENT_298	[p22l6t3628r288b3692],
23	incidence	NN	O	incidence	dobj	22	SENT_298	[p22l340t3628r677b3692],
24	of	IN	O	of	_	0	SENT_298	[p22l731t3629r812b3692],
25	persistent	JJ	O	persistent	amod	27	SENT_298	[p22l851t3628r1193b3710],
26	positive	JJ	O	positive	amod	27	SENT_298	[p22l1241t3628r1521b3710],
27	culture	NN	O	culture	prep_of	23	SENT_298	[p22l1577t3628r1818b3692],
28	without	IN	O	without	_	0	SENT_298	[p22l1870t3628r2143b3692],
29	increase	NN	O	increase	prep_without	22	SENT_298	[p23l8t21r312b85],
30	of	IN	O	of	_	0	SENT_298	[p23l370t21r454b85],
31	INH-DILI	NN	O	inh-dili	nn	32	SENT_298	[p23l500t24r877b85],
32	frequency	NN	O	frequency	prep_of	29	SENT_298	[p23l936t21r1308b103],
33	in	IN	O	in	_	0	SENT_298	[p23l1365t21r1434b84],
34	rapid	JJ	O	rapid	amod	35	SENT_298	[p23l1488t21r1680b103],
35	acetylators	NNS	O	acetylator	prep_in	32	SENT_298	[p23l1737t21r2140b103],
36	(	VBP	O	(	_	0	SENT_298	[p23l9t132r169b214],
37	Fig	NN	O	fig	dobj	36	SENT_298	[p23l9t132r169b214],
38	.	.	O	.	_	0	SENT_298	[p23l9t132r169b214],

1	4	CD	NUMBER	4	_	0	SENT_299	[p23l221t133r310b214],
2	)	NN	O	)	dep	1	SENT_299	[p23l221t133r310b214],
3	.	.	O	.	_	0	SENT_299	[p23l221t133r310b214],

1	Regarding	VBG	O	regard	_	0	SENT_300	[p23l362t132r730b214],
2	persistent	JJ	O	persistent	amod	5	SENT_300	[p23l775t132r1114b214],
3	positive	JJ	O	positive	amod	5	SENT_300	[p23l1158t132r1436b214],
4	sputum	NN	O	sputum	nn	5	SENT_300	[p23l1487t141r1745b214],
5	culture	NN	O	culture	prep_regarding	15	SENT_300	[p23l1792t132r2033b196],
6	at	IN	O	at	_	0	SENT_300	[p23l2082t141r2143b196],
7	the	DT	O	the	det	9	SENT_300	[p23l7t243r112b307],
8	8th	JJ	ORDINAL	8th	amod	9	SENT_300	[p23l169t243r277b306],
9	week	NN	DURATION	week	prep_at	5	SENT_300	[p23l328t243r533b320],
10	,	,	O	,	_	0	SENT_300	[p23l328t243r533b320],
11	the	DT	O	the	det	13	SENT_300	[p23l587t243r693b307],
12	risk	NN	O	risk	nn	13	SENT_300	[p23l745t243r877b307],
13	difference	NN	O	difference	nsubj	15	SENT_300	[p23l930t243r1281b307],
14	was	VBD	O	be	cop	15	SENT_300	[p23l1333t263r1468b307],
15	striking	JJ	O	striking	_	0	SENT_300	[p23l1525t243r1791b324],
16	in	IN	O	in	_	0	SENT_300	[p23l1845t243r1911b305],
17	rapid	JJ	O	rapid	amod	18	SENT_300	[p23l1961t243r2142b324],
18	acetylators	NNS	O	acetylator	prep_in	15	SENT_300	[p23l9t354r398b435],
19	with	IN	O	with	_	0	SENT_300	[p23l453t354r614b418],
20	highly-positive	JJ	O	highly-positive	amod	21	SENT_300	[p23l666t354r1218b435],
21	level	NN	O	level	prep_with	18	SENT_300	[p23l1274t354r1447b418],
22	of	IN	O	of	_	0	SENT_300	[p23l1503t354r1585b418],
23	organisms	NNS	O	organism	prep_of	21	SENT_300	[p23l1629t354r1997b435],
24	on	IN	O	on	_	0	SENT_300	[p23l2054t374r2142b418],
25	primary	JJ	O	primary	amod	27	SENT_300	[p23l6t465r289b546],
26	sputum	NN	O	sputum	nn	27	SENT_300	[p23l344t473r605b546],
27	culture	NN	O	culture	prep_on	23	SENT_300	[p23l658t465r925b542],
28	;	:	O	;	_	0	SENT_300	[p23l658t465r925b542],
29	10.0	CD	PERCENT	10.0	num	30	SENT_300	[p23l991t466r1136b528],
30	%	NN	PERCENT	%	dep	23	SENT_300	[p23l1192t466r1261b530],
31	(	CD	NUMBER	(	number	32	SENT_300	[p23l1317t465r1500b546],
32	1/10	CD	NUMBER	1/10	num	33	SENT_300	[p23l1317t465r1500b546],
33	patients	NNS	O	patient	dep	30	SENT_300	[p23l1553t465r1860b546],
34	)	RB	O	)	advmod	15	SENT_300	[p23l1553t465r1860b546],
35	in	IN	O	in	_	0	SENT_300	[p23l1916t465r1983b527],
36	the	DT	O	the	det	37	SENT_300	[p23l2034t465r2140b529],
37	PGX-treatment	NN	O	pgx-treatment	prep_in	15	SENT_300	[p23l7t577r538b640],
38	and	CC	O	and	_	0	SENT_300	[p23l590t576r718b640],
39	66.7	CD	PERCENT	66.7	num	40	SENT_300	[p23l772t577r924b640],
40	%	NN	PERCENT	%	prep_in	15	SENT_300	[p23l981t577r1050b641],
41	(	CD	NUMBER	(	number	42	SENT_300	[p23l1107t576r1245b658],
42	6/9	CD	NUMBER	6/9	num	43	SENT_300	[p23l1107t576r1245b658],
43	patients	NNS	O	patient	dep	40	SENT_300	[p23l1299t576r1608b658],
44	)	RB	O	)	advmod	15	SENT_300	[p23l1299t576r1608b658],
45	in	IN	O	in	_	0	SENT_300	[p23l1664t576r1731b639],
46	the	DT	O	the	det	49	SENT_300	[p23l1783t576r1890b640],
47	STDtreatment	NN	O	stdtreatment	nn	49	SENT_300	[p23l1948t577r2140b640, p23l7t696r340b751],
48	(	NN	O	(	nn	49	SENT_300	[p23l387t687r770b769],
49	p	NN	O	p	prep_in	15	SENT_300	[p23l387t687r770b769],
50	=	JJ	O	=	amod	49	SENT_300	[p23l387t687r770b769],
51	0.020	CD	NUMBER	0.020	num	52	SENT_300	[p23l387t687r770b769],
52	)	NN	O	)	dep	50	SENT_300	[p23l387t687r770b769],
53	.	.	O	.	_	0	SENT_300	[p23l387t687r770b769],

1	Incidence	NN	O	incidence	nsubj	16	SENT_301	[p23l823t687r1163b751],
2	of	IN	O	of	_	0	SENT_301	[p23l1213t687r1294b751],
3	unfavorable	JJ	O	unfavorable	amod	4	SENT_301	[p23l1328t687r1750b751],
4	events	NNS	O	event	prep_of	1	SENT_301	[p23l1800t696r2021b751],
5	of	IN	O	of	_	0	SENT_301	[p23l2072t687r2153b751],
6	the	DT	O	the	det	8	SENT_301	[p23l7t798r113b862],
7	combined	JJ	O	combined	amod	8	SENT_301	[p23l167t798r518b862],
8	population	NN	O	population	prep_of	4	SENT_301	[p23l567t798r952b880],
9	of	IN	O	of	_	0	SENT_301	[p23l1004t798r1085b862],
10	rapid	JJ	O	rapid	amod	13	SENT_301	[p23l1126t798r1309b880],
11	and	CC	O	and	_	0	SENT_301	[p23l1362t798r1489b862],
12	slow	JJ	O	slow	conj_and	10	SENT_301	[p23l1542t798r1707b862],
13	acetylators	NNS	O	acetylator	prep_of	8	SENT_301	[p23l1760t798r2140b880],
14	was	VBD	O	be	cop	16	SENT_301	[p23l6t930r141b973],
15	obviously	RB	O	obviously	advmod	16	SENT_301	[p23l185t909r533b991],
16	higher	JJR	O	higher	_	0	SENT_301	[p23l572t909r800b991],
17	in	IN	O	in	prep	16	SENT_301	[p23l839t909r905b972],
18	the	DT	O	the	det	19	SENT_301	[p23l944t909r1049b973],
19	STD-treatment	NN	O	std-treatment	npadvmod	20	SENT_301	[p23l1095t911r1619b974],
20	than	IN	O	than	pcomp	17	SENT_301	[p23l1658t909r1810b973],
21	in	IN	O	in	_	0	SENT_301	[p23l1850t909r1917b972],
22	PGxtreatment	NN	O	pgxtreatment	prep_in	16	SENT_301	[p23l1956t911r2140b973, p23l7t1029r355b1084],
23	.	.	O	.	_	0	SENT_301	[p23l1956t911r2140b973, p23l7t1029r355b1084],

1	In	IN	O	in	_	0	SENT_302	[p23l406t1023r478b1083],
2	contrast	NN	O	contrast	prep_in	8	SENT_302	[p23l524t1029r819b1098],
3	,	,	O	,	_	0	SENT_302	[p23l524t1029r819b1098],
4	the	DT	O	the	det	7	SENT_302	[p23l867t1020r973b1084],
5	PGX-guided	JJ	O	pgx-guided	amod	7	SENT_302	[p23l1019t1020r1448b1102],
6	dose	NN	O	dose	nn	7	SENT_302	[p23l1494t1020r1653b1084],
7	stratiﬁcation	NN	O	stratiﬁcation	nsubj	8	SENT_302	[p23l1702t1020r2141b1084],
8	reduced	VBD	O	reduce	_	0	SENT_302	[p23l6t1132r286b1196],
9	unfavorable	JJ	O	unfavorable	amod	10	SENT_302	[p23l335t1132r757b1196],
10	events	NNS	O	event	nsubj	17	SENT_302	[p23l811t1141r1032b1196],
11	to	TO	O	to	_	0	SENT_302	[p23l1084t1141r1150b1196],
12	the	DT	O	the	det	13	SENT_302	[p23l1202t1132r1308b1196],
13	level	NN	O	level	prep_to	10	SENT_302	[p23l1361t1132r1529b1196],
14	of	IN	O	of	_	0	SENT_302	[p23l1582t1132r1663b1196],
15	intermediate	JJ	O	intermediate	amod	16	SENT_302	[p23l1704t1132r2141b1196],
16	acetylators	NNS	O	acetylator	prep_of	13	SENT_302	[p23l9t1243r411b1324],
17	’	VBP	O	’	ccomp	8	SENT_302	[p23l9t1243r411b1324],
18	(	CD	NUMBER	(	num	19	SENT_302	[p23l457t1243r616b1324],
19	Fig	NN	O	fig	dobj	17	SENT_302	[p23l457t1243r616b1324],
20	.	.	O	.	_	0	SENT_302	[p23l457t1243r616b1324],

1	5	CD	NUMBER	5	_	0	SENT_303	[p23l663t1243r749b1324],
2	)	NN	O	)	dep	1	SENT_303	[p23l663t1243r749b1324],
3	.	.	O	.	_	0	SENT_303	[p23l663t1243r749b1324],

1	Secondary	JJ	O	secondary	amod	2	SENT_304	[p23l7t1487r382b1569],
2	outcomes	NNS	O	outcome	_	0	SENT_304	[p23l411t1499r742b1551],

1	Other	JJ	O	other	amod	3	SENT_305	[p23l9t1711r212b1775],
2	adverse	JJ	O	adverse	amod	3	SENT_305	[p23l255t1711r525b1775],
3	events	NNS	O	event	nsubj	4	SENT_305	[p23l572t1720r797b1775],
4	observed	VBN	O	observe	dep	15	SENT_305	[p23l844t1711r1168b1775],
5	during	IN	O	during	_	0	SENT_305	[p23l1213t1711r1445b1793],
6	the	DT	O	the	det	9	SENT_305	[p23l1488t1711r1595b1775],
7	8-week	JJ	DURATION	8-week	amod	9	SENT_305	[p23l1645t1711r1905b1775],
8	study	NN	O	study	nn	9	SENT_305	[p23l1950t1711r2142b1792],
9	period	NN	O	period	prep_during	4	SENT_305	[p23l6t1822r233b1903],
10	were	VBD	O	be	cop	15	SENT_305	[p23l262t1842r431b1886],
11	skin	NN	O	skin	nn	15	SENT_305	[p23l467t1822r611b1886],
12	and	CC	O	and	_	0	SENT_305	[p23l643t1822r769b1886],
13	subcutaneous	JJ	O	subcutaneous	conj_and	11	SENT_305	[p23l802t1822r1275b1886],
14	tissue	NN	O	tissue	nn	15	SENT_305	[p23l1308t1822r1507b1886],
15	disorders	NNS	O	disorder	_	0	SENT_305	[p23l1540t1822r1860b1886],
16	including	VBG	O	include	_	0	SENT_305	[p23l1894t1822r2140b1886, p23l9t1933r122b2014],
17	rashes	NNS	O	rash	prep_including	15	SENT_305	[p23l168t1933r395b1997],
18	(	CD	NUMBER	(	num	19	SENT_305	[p23l444t1933r725b2014],
19	n	NN	O	n	npadvmod	20	SENT_305	[p23l444t1933r725b2014],
20	=	JJ	O	=	amod	17	SENT_305	[p23l444t1933r725b2014],
21	48	CD	NUMBER	48	num	22	SENT_305	[p23l444t1933r725b2014],
22	)	NN	O	)	nsubj	15	SENT_305	[p23l444t1933r725b2014],
23	,	,	O	,	_	0	SENT_305	[p23l444t1933r725b2014],
24	nervous	JJ	O	nervous	amod	26	SENT_305	[p23l774t1953r1064b1997],
25	system	NN	O	system	nn	26	SENT_305	[p23l1115t1942r1366b2014],
26	disorders	NNS	O	disorder	appos	22	SENT_305	[p23l1412t1933r1746b1997],
27	including	VBG	O	include	_	0	SENT_305	[p23l1794t1933r2141b2014],
28	headaches	NNS	O	headache	prep_including	26	SENT_305	[p23l7t2044r373b2108],
29	(	CD	NUMBER	(	num	30	SENT_305	[p23l420t2044r696b2125],
30	n	NN	O	n	nsubj	37	SENT_305	[p23l420t2044r696b2125],
31	=	JJ	O	=	amod	30	SENT_305	[p23l420t2044r696b2125],
32	22	CD	NUMBER	22	num	33	SENT_305	[p23l420t2044r696b2125],
33	)	NN	O	)	tmod	31	SENT_305	[p23l420t2044r696b2125],
34	,	,	O	,	_	0	SENT_305	[p23l420t2044r696b2125],
35	gastrointestinal	JJ	O	gastrointestinal	amod	36	SENT_305	[p23l744t2044r1290b2126],
36	disorders	NNS	O	disorder	appos	33	SENT_305	[p23l1335t2044r1660b2108],
37	(	VBP	O	(	rcmod	28	SENT_305	[p23l1707t2044r1983b2126],
38	n	NN	O	n	dobj	37	SENT_305	[p23l1707t2044r1983b2126],
39	=	JJ	O	=	amod	41	SENT_305	[p23l1707t2044r1983b2126],
40	22	CD	NUMBER	22	tmod	39	SENT_305	[p23l1707t2044r1983b2126],
41	)	NN	O	)	dep	38	SENT_305	[p23l1707t2044r1983b2126],
42	,	,	O	,	_	0	SENT_305	[p23l1707t2044r1983b2126],
43	peripheral	JJ	O	peripheral	amod	46	SENT_305	[p23l2028t2065r2140b2126, p23l6t2155r279b2237],
44	neuropathy	NN	O	neuropathy	nn	46	SENT_305	[p23l311t2155r710b2237],
45	(	NN	O	(	nn	46	SENT_305	[p23l745t2155r872b2236],
46	n	NN	O	n	conj_and	38	SENT_305	[p23l745t2155r872b2236],
47	=	JJ	O	=	amod	49	SENT_305	[p23l745t2155r872b2236],
48	13	CD	NUMBER	13	tmod	47	SENT_305	[p23l891t2155r1017b2237],
49	)	NN	O	)	dep	46	SENT_305	[p23l891t2155r1017b2237],
50	,	,	O	,	_	0	SENT_305	[p23l891t2155r1017b2237],
51	visual	JJ	O	visual	amod	54	SENT_305	[p23l1052t2155r1263b2219],
52	impediment	NN	O	impediment	nn	54	SENT_305	[p23l1297t2155r1718b2237],
53	(	NN	O	(	nn	54	SENT_305	[p23l1752t2155r1979b2237],
54	n	NN	O	n	conj_and	38	SENT_305	[p23l1752t2155r1979b2237],
55	=	JJ	O	=	amod	57	SENT_305	[p23l1752t2155r1979b2237],
56	3	CD	NUMBER	3	tmod	55	SENT_305	[p23l1752t2155r1979b2237],
57	)	NN	O	)	dep	54	SENT_305	[p23l1752t2155r1979b2237],
58	,	,	O	,	_	0	SENT_305	[p23l1752t2155r1979b2237],
59	and	CC	O	and	_	0	SENT_305	[p23l2017t2155r2142b2219],
60	hearing	NN	O	hearing	nn	61	SENT_305	[p23l7t2266r286b2348],
61	impairment	NN	O	impairment	conj_and	38	SENT_305	[p23l335t2266r764b2348],
62	(	CD	NUMBER	(	num	63	SENT_305	[p23l812t2266r1048b2347],
63	n	NN	O	n	dep	61	SENT_305	[p23l812t2266r1048b2347],
64	=	JJ	O	=	amod	66	SENT_305	[p23l812t2266r1048b2347],
65	3	CD	NUMBER	3	tmod	64	SENT_305	[p23l812t2266r1048b2347],
66	)	NN	O	)	dep	63	SENT_305	[p23l812t2266r1048b2347],
67	.	.	O	.	_	0	SENT_305	[p23l812t2266r1048b2347],

1	Peripheral	JJ	O	peripheral	amod	2	SENT_306	[p23l1100t2266r1484b2348],
2	neuropathy	NN	O	neuropathy	nsubj	3	SENT_306	[p23l1531t2266r1953b2348],
3	was	VBD	O	be	_	0	SENT_306	[p23l1999t2287r2140b2330],

1	0-8	CD	NUMBER	0-8	num	2	SENT_307	[p24l120t372r187b412],
2	—	CD	NUMBER	—	_	0	SENT_307	[p24l1630t417r1725b422],
3	SA-type	JJ	O	sa-type	amod	5	SENT_307	[p24l1750t394r1957b451],
4	(	NN	O	(	nn	5	SENT_307	[p24l1977t394r2133b448],
5	STD	NN	O	std	dep	2	SENT_307	[p24l1977t394r2133b448],
6	)	CD	NUMBER	)	dep	2	SENT_307	[p24l1977t394r2133b448],

1	Probability	NN	O	probability	_	0	SENT_308	[p24l16t576r79b884],

1	.	.	O	.	_	0	SENT_309	[p24l120t898r158b937],

1	o	NN	O	o	_	0	SENT_310	[p24l120t898r158b937],
2	.	.	O	.	_	0	SENT_310	[p24l120t633r158b673],

1	o	NN	O	o	_	0	SENT_311	[p24l120t633r158b673],
2	-	:	O	-	_	0	SENT_311	[p24l162t898r188b937],
3	lk	NN	O	lk	nn	4	SENT_311	[p24l162t898r188b937],
4	O	NN	O	o	dep	1	SENT_311	[p24l163t633r188b673],
5	‘	CD	NUMBER	‘	num	6	SENT_311	[p24l163t633r188b673],
6	\	NN	O	\	dep	4	SENT_311	[p24l163t633r188b673],

1	.....	NN	O	.....	_	0	SENT_312	[p24l1640t1221r1699b1227],
2	.	.	O	.	_	0	SENT_312	[p24l1640t1221r1699b1227],

1	.	.	O	.	_	0	SENT_313	[p24l1704t1221r1719b1227],

1	.	.	O	.	_	0	SENT_314	[p24l1704t1221r1719b1227],

1	P	NN	O	p	_	0	SENT_315	[p24l1749t1200r1944b1257],
2	?	.	O	?	_	0	SENT_315	[p24l1749t1200r1944b1257],

1	%	NN	O	%	_	0	SENT_316	[p24l1749t1200r1944b1257],
2	*	SYM	O	*	dep	1	SENT_316	[p24l1749t1200r1944b1257],
3	-	:	O	-	_	0	SENT_316	[p24l1630t1301r1651b1307],
4	-	:	O	-	_	0	SENT_316	[p24l1667t1301r1688b1307],
5	-	:	O	-	_	0	SENT_316	[p24l1704t1301r1725b1307],
6	RA	NN	O	ra	dep	4	SENT_316	[p24l1749t1280r1964b1337],
7	—	CD	NUMBER	—	num	8	SENT_316	[p24l1749t1280r1964b1337],
8	type	NN	O	type	rcmod	6	SENT_316	[p24l1749t1280r1964b1337],
9	(	CD	NUMBER	(	num	10	SENT_316	[p24l1984t1280r2140b1334],
10	STD	NN	O	std	dep	8	SENT_316	[p24l1984t1280r2140b1334],
11	)	SYM	O	)	dep	8	SENT_316	[p24l1984t1280r2140b1334],
12	-	:	O	-	_	0	SENT_316	[p24l1630t1376r1651b1382],
13	-	:	O	-	_	0	SENT_316	[p24l1667t1376r1672b1381],
14	—	CD	NUMBER	—	num	17	SENT_316	[p24l1688t1376r1709b1382],
15	RA-type	JJ	O	ra-type	amod	17	SENT_316	[p24l1749t1354r1964b1411],
16	(	NN	O	(	nn	17	SENT_316	[p24l1984t1354r2133b1408],
17	PGX	NN	O	pgx	dep	4	SENT_316	[p24l1984t1354r2133b1408],
18	)	CD	NUMBER	)	num	19	SENT_316	[p24l1984t1354r2133b1408],
19	o-o	NN	O	o-o	dep	17	SENT_316	[p24l120t1423r188b1462],
20	—	CD	NUMBER	—	number	21	SENT_316	[p24l1630t1449r1672b1455],
21	—	CD	NUMBER	—	num	24	SENT_316	[p24l1688t1449r1725b1455],
22	SA-type	JJ	O	sa-type	amod	24	SENT_316	[p24l1750t1427r1957b1484],
23	(	NN	O	(	nn	24	SENT_316	[p24l1977t1427r2126b1482],
24	PGX	NN	O	pgx	dep	17	SENT_316	[p24l1977t1427r2126b1482],
25	)	CD	NUMBER	)	dep	24	SENT_316	[p24l1977t1427r2126b1482],

1	O	NN	O	o	_	0	SENT_317	[p24l285t1562r311b1602],
2	7	CD	NUMBER	7	number	3	SENT_317	[p24l441t1561r465b1599],
3	14	CD	NUMBER	14	num	5	SENT_317	[p24l585t1560r634b1599],
4	21	CD	NUMBER	21	number	5	SENT_317	[p24l736t1560r785b1599],
5	28	CD	NUMBER	28	dep	1	SENT_317	[p24l888t1560r940b1599],
6	35	CD	NUMBER	35	number	7	SENT_317	[p24l1043t1560r1094b1599],
7	42	CD	NUMBER	42	dep	1	SENT_317	[p24l1198t1560r1253b1599],
8	49	CD	NUMBER	49	num	9	SENT_317	[p24l1352t1560r1406b1600],
9	56	CD	NUMBER	56	dep	7	SENT_317	[p24l1508t1560r1561b1599],

1	Time	NNP	O	Time	_	0	SENT_318	[p24l750t1654r895b1703],
2	(	CD	NUMBER	(	num	3	SENT_318	[p24l917t1654r1086b1717],
3	days	NNS	NUMBER	day	dep	1	SENT_318	[p24l917t1654r1086b1717],
4	)	IN	O	)	amod	3	SENT_318	[p24l917t1654r1086b1717],

1	Fig	NN	O	fig	_	0	SENT_319	[p24l7t1816r126b1884],
2	.	.	O	.	_	0	SENT_319	[p24l7t1816r126b1884],

1	3	CD	NUMBER	3	num	4	SENT_320	[p24l152t1816r185b1869],
2	Cumulative	JJ	O	cumulative	amod	4	SENT_320	[p24l240t1815r587b1869],
3	incidence	NN	O	incidence	nn	4	SENT_320	[p24l613t1815r897b1869],
4	curves	NNS	O	curve	nsubj	7	SENT_320	[p24l922t1832r1114b1869],
5	of	IN	O	of	_	0	SENT_320	[p24l1140t1815r1209b1869],
6	isoniazid	NN	O	isoniazid	prep_of	4	SENT_320	[p24l1225t1815r1494b1869],
7	related	JJ	O	related	_	0	SENT_320	[p24l1516t1815r1719b1869],
8	drug-induced	JJ	O	drug-induced	amod	13	SENT_320	[p24l1743t1815r2142b1884],
9	liver	NN	O	liver	nn	13	SENT_320	[p24l8t1903r144b1957],
10	injury	NN	O	injury	nn	13	SENT_320	[p24l174t1903r351b1972],
11	(	CD	NUMBER	(	num	13	SENT_320	[p24l382t1903r733b1972],
12	INH-DILI	NN	O	inh-dili	nn	13	SENT_320	[p24l382t1903r733b1972],
13	)	NN	O	)	dobj	7	SENT_320	[p24l382t1903r733b1972],
14	over	IN	O	over	_	0	SENT_320	[p24l766t1920r899b1957],
15	time	NN	O	time	prep_over	13	SENT_320	[p24l927t1903r1058b1957],
16	among	IN	O	among	_	0	SENT_320	[p24l1089t1920r1292b1972],
17	the	DT	O	the	det	19	SENT_320	[p24l1322t1903r1411b1957],
18	172	CD	NUMBER	172	num	19	SENT_320	[p24l1450t1904r1552b1957],
19	patients	NNS	O	patient	prep_among	7	SENT_320	[p24l1582t1903r1830b1972],
20	.	.	O	.	_	0	SENT_320	[p24l1582t1903r1830b1972],

1	RA-type	JJ	O	ra-type	amod	5	SENT_321	[p24l1865t1904r2139b1972],
2	,	,	O	,	_	0	SENT_321	[p24l1865t1904r2139b1972],
3	rapid	JJ	O	rapid	amod	5	SENT_321	[p24l6t1991r160b2060],
4	acetylator	NN	O	acetylator	nn	5	SENT_321	[p24l187t1991r481b2061],
5	genotype	NN	O	genotype	_	0	SENT_321	[p24l504t1999r795b2061],
6	;	:	O	;	_	0	SENT_321	[p24l504t1999r795b2061],
7	IA-type	JJ	O	ia-type	amod	11	SENT_321	[p24l825t1992r1072b2061],
8	,	,	O	,	_	0	SENT_321	[p24l825t1992r1072b2061],
9	intermediate	JJ	O	intermediate	amod	11	SENT_321	[p24l1102t1991r1472b2045],
10	acetylator	NN	O	acetylator	nn	11	SENT_321	[p24l1500t1991r1794b2061],
11	genotypes	NNS	O	genotype	dep	5	SENT_321	[p24l1818t1999r2138b2061],
12	;	:	O	;	_	0	SENT_321	[p24l1818t1999r2138b2061],
13	SA-type	JJ	O	sa-type	amod	17	SENT_321	[p24l10t2080r272b2149],
14	,	,	O	,	_	0	SENT_321	[p24l10t2080r272b2149],
15	slow	JJ	O	slow	amod	17	SENT_321	[p24l297t2079r435b2133],
16	acetylator	NN	O	acetylator	nn	17	SENT_321	[p24l455t2079r749b2149],
17	genotypes	NNS	O	genotype	dep	11	SENT_321	[p24l766t2087r1087b2149],
18	;	:	O	;	_	0	SENT_321	[p24l766t2087r1087b2149],
19	PGX	NN	O	pgx	dep	11	SENT_321	[p24l1109t2080r1258b2145],
20	;	:	O	;	_	0	SENT_321	[p24l1109t2080r1258b2145],
21	PGX-guided	JJ	O	pgx-guided	amod	22	SENT_321	[p24l1280t2079r1644b2149],
22	treatment	NN	O	treatment	dep	19	SENT_321	[p24l1662t2086r1960b2145],
23	;	:	O	;	_	0	SENT_321	[p24l1662t2086r1960b2145],
24	STD	NNP	O	STD	dep	11	SENT_321	[p24l1986t2080r2139b2145],
25	,	,	O	,	_	0	SENT_321	[p24l1986t2080r2139b2145],
26	conventional	JJ	O	conventional	amod	27	SENT_321	[p24l8t2168r395b2222],
27	standard-treatment	NN	O	standard-treatment	appos	24	SENT_321	[p24l422t2168r981b2222],

1	@	IN	O	@	_	0	SENT_322	[p24l6t2384r78b2474],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_322	[p24l104t2407r349b2477],

1	100	CD	NUMBER	100	nsubj	3	SENT_323	[p25l274t88r379b142],
2	I	PRP	O	I	nsubj	3	SENT_323	[p25l1135t105r1212b163],
3	INH	VBP	O	inh	_	0	SENT_323	[p25l1273t116r1559b164],
4	.	.	O	.	_	0	SENT_323	[p25l1273t116r1559b164],

1	—	NN	O	—	_	0	SENT_324	[p25l1273t116r1559b164],
2	.	.	O	.	_	0	SENT_324	[p25l1273t116r1559b164],

1	DILI	NNP	O	DILI	_	0	SENT_325	[p25l1273t116r1559b164],

1	p	NN	O	p	_	0	SENT_326	[p25l614t246r883b319],
2	=	JJ	O	=	amod	4	SENT_326	[p25l614t246r883b319],
3	0_021	CD	NUMBER	0_021	tmod	2	SENT_326	[p25l614t246r883b319],
4	E	NN	O	e	dep	1	SENT_326	[p25l1135t224r1212b282],
5	Persistent	JJ	O	persistent	amod	7	SENT_326	[p25l1273t228r1544b277],
6	positive	JJ	O	positive	amod	7	SENT_326	[p25l1561t228r1782b291],
7	culture	NN	O	culture	dep	4	SENT_326	[p25l1802t228r1993b277],

1	§	RB	O	§	dep	2	SENT_327	[p25l89t479r159b595],
2	60	CD	NUMBER	60	_	0	SENT_327	[p25l308t567r381b621],
3	§	CD	NUMBER	§	num	6	SENT_327	[p25l107t620r146b731],
4	_	NN	O	_	nn	6	SENT_327	[p25l89t733r146b807],
5	é	NN	O	é	nn	6	SENT_327	[p25l89t733r146b807],
6	p	NN	O	p	nsubj	7	SENT_327	[p25l1263t703r1535b775],
7	=	JJ	O	=	rcmod	2	SENT_327	[p25l1263t703r1535b775],
8	0.048	CD	NUMBER	0.048	dobj	7	SENT_327	[p25l1263t703r1535b775],
9	'	''	O	'	_	0	SENT_327	[p25l89t811r146b866],
10	5	CD	NUMBER	5	num	12	SENT_327	[p25l89t811r146b866],
11	40	CD	NUMBER	40	num	12	SENT_327	[p25l306t807r381b861],
12	|	NN	O	|	nsubj	14	SENT_327	[p25l1316t789r1324b1013],
13	I	PRP	O	I	dep	12	SENT_327	[p25l1511t793r1519b843],
14	.5	VBP	NUMBER	.5	rcmod	8	SENT_327	[p25l90t869r145b934],

1	Treatments	NNS	O	treatment	_	0	SENT_328	[p25l8t1405r371b1460],
2	PGX	NNP	O	PGX	nn	6	SENT_328	[p25l665t1394r808b1451],
3	STD	NNP	O	STD	nn	6	SENT_328	[p25l909t1394r1057b1451],
4	PGX	NNP	O	PGX	nn	6	SENT_328	[p25l1199t1394r1342b1451],
5	STD	NN	O	std	nn	6	SENT_328	[p25l1443t1394r1591b1451],
6	n	NN	O	n	dep	1	SENT_328	[p25l51t1527r88b1565],
7	6	CD	NUMBER	6	number	8	SENT_328	[p25l709t1497r744b1551],
8	7	CD	NUMBER	7	num	10	SENT_328	[p25l950t1498r983b1550],
9	32	CD	NUMBER	32	number	10	SENT_328	[p25l1228t1497r1300b1551],
10	36	CD	NUMBER	36	dep	6	SENT_328	[p25l1469t1497r1541b1551],
11	37	CD	NUMBER	37	dep	1	SENT_328	[p25l1829t1497r1900b1551],

1	NAT2	NN	O	nat2	nn	2	SENT_329	[p25l8t1648r214b1704],
2	genotype	NN	O	genotype	_	0	SENT_329	[p25l237t1656r533b1721],
3	SA	NNP	O	SA	nn	5	SENT_329	[p25l707t1638r973b1711],
4	—	CD	NUMBER	—	num	5	SENT_329	[p25l707t1638r973b1711],
5	type	NN	O	type	dep	2	SENT_329	[p25l707t1638r973b1711],
6	RA-type	JJ	O	ra-type	amod	7	SENT_329	[p25l1258t1638r1535b1711],
7	IA-type	JJ	O	ia-type	amod	5	SENT_329	[p25l1776t1638r2026b1711],

1	Fig	NN	O	fig	_	0	SENT_330	[p25l8t1821r128b1889],
2	.	.	O	.	_	0	SENT_330	[p25l8t1821r128b1889],

1	4	CD	NUMBER	4	num	2	SENT_331	[p25l160t1821r194b1873],
2	Incidence	NN	O	incidence	nsubj	5	SENT_331	[p25l247t1819r526b1874],
3	of	IN	O	of	_	0	SENT_331	[p25l554t1820r622b1874],
4	isoniazid	NN	O	isoniazid	prep_of	2	SENT_331	[p25l640t1819r899b1874],
5	induced	VBD	O	induce	_	0	SENT_331	[p25l925t1819r1155b1874],
6	liver	NN	O	liver	nn	7	SENT_331	[p25l1181t1819r1312b1874],
7	injury	NN	O	injury	dobj	5	SENT_331	[p25l1337t1819r1508b1889],
8	(	CD	NUMBER	(	num	10	SENT_331	[p25l1536t1820r1877b1889],
9	INH-DILI	NN	O	inh-dili	nn	10	SENT_331	[p25l1536t1820r1877b1889],
10	)	NN	O	)	dep	7	SENT_331	[p25l1536t1820r1877b1889],
11	and	CC	O	and	_	0	SENT_331	[p25l1906t1819r2010b1874],
12	persistent	JJ	O	persistent	amod	14	SENT_331	[p25l2034t1837r2148b1889, p25l10t1907r192b1962],
13	positive	JJ	O	positive	amod	14	SENT_331	[p25l207t1907r436b1977],
14	culture	NN	O	culture	conj_and	7	SENT_331	[p25l456t1907r653b1962],
15	among	IN	O	among	_	0	SENT_331	[p25l673t1925r870b1977],
16	the	DT	O	the	det	17	SENT_331	[p25l888t1907r976b1962],
17	patients	NNS	O	patient	prep_among	14	SENT_331	[p25l993t1908r1216b1977],
18	with	IN	O	with	_	0	SENT_331	[p25l1234t1907r1364b1962],
19	drug	NN	O	drug	nn	21	SENT_331	[p25l1382t1907r1514b1977],
20	sensitive	JJ	O	sensitive	amod	21	SENT_331	[p25l1535t1907r1783b1962],
21	tuberculosis	NN	O	tuberculosis	prep_with	5	SENT_331	[p25l1801t1907r2148b1962],
22	on	IN	O	on	_	0	SENT_331	[p25l9t2013r82b2049],
23	sputum	NN	O	sputum	nn	24	SENT_331	[p25l114t2003r328b2065],
24	culture	NN	O	culture	prep_on	21	SENT_331	[p25l358t1995r555b2050],
25	at	IN	O	at	_	0	SENT_331	[p25l587t2003r638b2049],
26	screening	NN	O	screening	prep_at	5	SENT_331	[p25l670t1995r957b2065],
27	.	.	O	.	_	0	SENT_331	[p25l670t1995r957b2065],

1	Closed	JJ	O	closed	amod	2	SENT_332	[p25l993t1995r1194b2050],
2	columns	NNS	O	column	_	0	SENT_332	[p25l1225t1995r1486b2061],
3	,	,	O	,	_	0	SENT_332	[p25l1225t1995r1486b2061],
4	INH-DILI	NN	O	inh-dili	appos	2	SENT_332	[p25l1520t1997r1832b2061],
5	;	:	O	;	_	0	SENT_332	[p25l1520t1997r1832b2061],
6	open	JJ	O	open	amod	7	SENT_332	[p25l1868t2013r2009b2065],
7	columns	NNS	O	column	dep	2	SENT_332	[p25l2040t1995r2148b2050, p25l7t2101r182b2149],
8	,	,	O	,	_	0	SENT_332	[p25l2040t1995r2148b2050, p25l7t2101r182b2149],
9	persistent	JJ	O	persistent	amod	11	SENT_332	[p25l203t2083r480b2153],
10	positive	JJ	O	positive	amod	11	SENT_332	[p25l497t2084r727b2153],
11	culture	NN	O	culture	appos	7	SENT_332	[p25l748t2083r962b2149],
12	;	:	O	;	_	0	SENT_332	[p25l748t2083r962b2149],
13	RA-type	NN	O	ra-type	dep	2	SENT_332	[p25l986t2085r1251b2153],
14	,	,	O	,	_	0	SENT_332	[p25l986t2085r1251b2153],
15	rapid	JJ	O	rapid	amod	17	SENT_332	[p25l1274t2083r1423b2153],
16	acetylator	NN	O	acetylator	nn	17	SENT_332	[p25l1443t2083r1728b2153],
17	genotype	NN	O	genotype	appos	13	SENT_332	[p25l1745t2091r2027b2153],
18	;	:	O	;	_	0	SENT_332	[p25l1745t2091r2027b2153],
19	IAtype	NN	O	iatype	dep	2	SENT_332	[p25l2050t2085r2148b2137, p25l8t2179r147b2241],
20	,	,	O	,	_	0	SENT_332	[p25l2050t2085r2148b2137, p25l8t2179r147b2241],
21	intermediate	JJ	O	intermediate	amod	23	SENT_332	[p25l180t2171r537b2226],
22	acetylator	NN	O	acetylator	nn	23	SENT_332	[p25l568t2171r851b2241],
23	genotypes	NNS	O	genotype	appos	19	SENT_332	[p25l878t2179r1188b2241],
24	;	:	O	;	_	0	SENT_332	[p25l878t2179r1188b2241],
25	SA-type	JJ	O	sa-type	dep	2	SENT_332	[p25l1224t2173r1477b2241],
26	,	,	O	,	_	0	SENT_332	[p25l1224t2173r1477b2241],
27	slow	JJ	O	slow	amod	29	SENT_332	[p25l1511t2171r1646b2226],
28	acetylator	NN	O	acetylator	nn	29	SENT_332	[p25l1676t2171r1959b2241],
29	genotypes	NNS	O	genotype	appos	25	SENT_332	[p25l1986t2189r2148b2241, p25l8t2267r177b2329],
30	;	:	O	;	_	0	SENT_332	[p25l1986t2189r2148b2241, p25l8t2267r177b2329],
31	PGX	NNP	O	PGX	dep	2	SENT_332	[p25l198t2261r343b2326],
32	,	,	O	,	_	0	SENT_332	[p25l198t2261r343b2326],
33	PGX-guided	JJ	O	pgx-guided	amod	34	SENT_332	[p25l364t2260r718b2329],
34	treatment	NN	O	treatment	appos	31	SENT_332	[p25l735t2267r1022b2325],
35	;	:	O	;	_	0	SENT_332	[p25l735t2267r1022b2325],
36	STD	NNP	O	STD	dep	2	SENT_332	[p25l1047t2261r1196b2325],
37	,	,	O	,	_	0	SENT_332	[p25l1047t2261r1196b2325],
38	conventional	JJ	O	conventional	amod	39	SENT_332	[p25l1219t2260r1592b2314],
39	standard-treatment	NN	O	standard-treatment	appos	36	SENT_332	[p25l1613t2260r2151b2314],
40	observed	VBN	O	observe	partmod	2	SENT_332	[p25l10t2491r343b2555],
41	in	IN	O	in	_	0	SENT_332	[p25l390t2491r458b2553],
42	two	CD	TIME	two	prep_in	40	SENT_332	[p25l504t2499r637b2555],
43	of	IN	TIME	of	_	0	SENT_332	[p25l687t2491r771b2555],
44	nine	CD	TIME	nine	num	46	SENT_332	[p25l805t2491r962b2555],
45	slow	JJ	O	slow	amod	46	SENT_332	[p25l1012t2491r1182b2555],
46	acetylators	NNS	O	acetylator	prep_of	42	SENT_332	[p25l1230t2491r1627b2572],
47	in	IN	O	in	_	0	SENT_332	[p25l1677t2491r1745b2553],
48	the	DT	O	the	det	49	SENT_332	[p25l1790t2491r1901b2555],
49	STDtreatment	NN	O	stdtreatment	prep_in	46	SENT_332	[p25l1952t2492r2148b2555, p25l8t2610r364b2679],
50	,	,	O	,	_	0	SENT_332	[p25l1952t2492r2148b2555, p25l8t2610r364b2679],
51	but	CC	O	but	_	0	SENT_332	[p25l410t2602r526b2666],
52	not	RB	O	not	_	0	SENT_332	[p25l567t2610r683b2666],
53	at	IN	O	at	advmod	54	SENT_332	[p25l727t2610r789b2665],
54	all	DT	O	all	conj_negcc	46	SENT_332	[p25l832t2602r918b2665],
55	in	IN	O	in	_	0	SENT_332	[p25l963t2602r1030b2665],
56	the	DT	O	the	det	58	SENT_332	[p25l1072t2602r1179b2666],
57	PGX-treatment	JJ	O	pgx-treatment	amod	58	SENT_332	[p25l1223t2603r1752b2666],
58	(	NN	O	(	prep_in	54	SENT_332	[p25l1796t2602r1909b2683],
59	22	CD	PERCENT	22	number	60	SENT_332	[p25l1796t2602r1909b2683],
60	%	NN	PERCENT	%	amod	58	SENT_332	[p25l1957t2603r2026b2667],
61	vs	CC	O	vs	_	0	SENT_332	[p25l2071t2622r2148b2666],
62	o	NN	O	o	nn	63	SENT_332	[p25l10t2714r49b2776],
63	%	NN	O	%	conj_vs	54	SENT_332	[p25l96t2713r213b2794],
64	)	CD	NUMBER	)	dep	63	SENT_332	[p25l96t2713r213b2794],
65	.	.	O	.	_	0	SENT_332	[p25l96t2713r213b2794],

1	As	IN	O	as	_	0	SENT_333	[p25l260t2714r356b2777],
2	for	IN	O	for	prepc_as_for	10	SENT_333	[p25l403t2713r504b2777],
3	the	DT	O	the	det	5	SENT_333	[p25l545t2713r651b2777],
4	other	JJ	O	other	amod	5	SENT_333	[p25l697t2713r879b2777],
5	genotypes	NNS	O	genotype	pobj	10	SENT_333	[p25l919t2722r1299b2795],
6	,	,	O	,	_	0	SENT_333	[p25l919t2722r1299b2795],
7	peripheral	JJ	O	peripheral	amod	8	SENT_333	[p25l1344t2713r1705b2794],
8	neuropathy	NN	O	neuropathy	nsubjpass	10	SENT_333	[p25l1747t2713r2150b2794],
9	was	VBD	O	be	auxpass	10	SENT_333	[p25l7t2845r147b2888],
10	observed	VBN	O	observe	_	0	SENT_333	[p25l197t2824r529b2888],
11	in	IN	O	in	_	0	SENT_333	[p25l576t2824r645b2887],
12	four	CD	NUMBER	four	prep_in	10	SENT_333	[p25l692t2824r844b2888],
13	of	IN	O	of	_	0	SENT_333	[p25l889t2824r973b2888],
14	48	CD	NUMBER	48	num	15	SENT_333	[p25l1008t2825r1094b2888],
15	patients	NNS	O	patient	prep_of	12	SENT_333	[p25l1142t2824r1430b2906],
16	who	WP	O	who	nsubj	17	SENT_333	[p25l1477t2824r1632b2888],
17	received	VBD	O	receive	rcmod	15	SENT_333	[p25l1680t2824r1994b2888],
18	the	DT	O	the	det	19	SENT_333	[p25l2038t2824r2149b2888],
19	STD-treatment	NN	O	std-treatment	dobj	17	SENT_333	[p25l12t2936r539b2999],
20	and	CC	O	and	_	0	SENT_333	[p25l579t2935r706b2999],
21	three	CD	NUMBER	three	conj_and	19	SENT_333	[p25l744t2935r918b2999],
22	of	IN	O	of	_	0	SENT_333	[p25l961t2935r1042b2999],
23	44	CD	NUMBER	44	num	24	SENT_333	[p25l1071t2936r1157b2998],
24	patients	NNS	O	patient	prep_of	21	SENT_333	[p25l1197t2935r1470b3017],
25	who	WP	O	who	nsubj	26	SENT_333	[p25l1511t2935r1663b2999],
26	received	VBD	O	receive	rcmod	24	SENT_333	[p25l1704t2935r2004b2999],
27	the	DT	O	the	det	29	SENT_333	[p25l2042t2935r2148b2999],
28	PGX-treatment	JJ	O	pgx-treatment	amod	29	SENT_333	[p25l8t3047r530b3110],
29	(	NN	O	(	dobj	26	SENT_333	[p25l559t3046r624b3127],
30	8	CD	PERCENT	8	number	31	SENT_333	[p25l559t3046r624b3127],
31	%	NN	PERCENT	%	amod	29	SENT_333	[p25l658t3047r728b3111],
32	vs	CC	O	vs	_	0	SENT_333	[p25l756t3066r832b3110],
33	7	CD	PERCENT	7	number	34	SENT_333	[p25l864t3048r902b3110],
34	%	NN	PERCENT	%	amod	35	SENT_333	[p25l935t3046r1032b3127],
35	)	CD	NUMBER	)	conj_vs	29	SENT_333	[p25l935t3046r1032b3127],
36	in	IN	O	in	_	0	SENT_333	[p25l1063t3046r1130b3109],
37	the	DT	O	the	det	38	SENT_333	[p25l1157t3046r1263b3110],
38	group	NN	O	group	prep_in	35	SENT_333	[p25l1303t3066r1505b3128],
39	of	IN	O	of	_	0	SENT_333	[p25l1547t3046r1628b3110],
40	rapid	JJ	O	rapid	amod	41	SENT_333	[p25l1653t3046r1835b3128],
41	acetylators	NNS	O	acetylator	prep_of	38	SENT_333	[p25l1873t3046r2147b3128, p25l8t3166r157b3235],
42	,	,	O	,	_	0	SENT_333	[p25l1873t3046r2147b3128, p25l8t3166r157b3235],
43	and	CC	O	and	_	0	SENT_333	[p25l208t3157r334b3221],
44	four	CD	NUMBER	four	dobj	26	SENT_333	[p25l379t3157r526b3221],
45	of	IN	O	of	_	0	SENT_333	[p25l570t3157r651b3221],
46	64	CD	PERCENT	64	number	47	SENT_333	[p25l687t3159r770b3221],
47	(	CD	PERCENT	(	prep_of	44	SENT_333	[p25l819t3158r886b3239],
48	6	CD	PERCENT	6	number	49	SENT_333	[p25l819t3158r886b3239],
49	%	NN	PERCENT	%	amod	47	SENT_333	[p25l935t3158r1032b3239],
50	)	CD	NUMBER	)	tmod	26	SENT_333	[p25l935t3158r1032b3239],
51	in	IN	O	in	_	0	SENT_333	[p25l1080t3157r1146b3220],
52	the	DT	O	the	det	53	SENT_333	[p25l1189t3157r1296b3221],
53	group	NN	O	group	prep_in	50	SENT_333	[p25l1342t3178r1545b3239],
54	of	IN	O	of	_	0	SENT_333	[p25l1594t3157r1675b3221],
55	intermediate	JJ	O	intermediate	amod	56	SENT_333	[p25l1710t3157r2148b3221],
56	acetylators	NNS	O	acetylator	prep_of	53	SENT_333	[p25l10t3268r407b3350],
57	.	.	O	.	_	0	SENT_333	[p25l10t3268r407b3350],

1	Among	IN	O	among	_	0	SENT_334	[p25l462t3270r729b3350],
2	the	DT	O	the	det	4	SENT_334	[p25l779t3268r884b3332],
3	13	CD	NUMBER	13	num	4	SENT_334	[p25l945t3270r1017b3332],
4	patients	NNS	O	patient	prep_among	12	SENT_334	[p25l1072t3268r1345b3350],
5	presenting	VBG	O	present	partmod	4	SENT_334	[p25l1397t3268r1766b3350],
6	with	IN	O	with	_	0	SENT_334	[p25l1816t3268r1973b3332],
7	this	DT	O	this	det	8	SENT_334	[p25l2023t3268r2147b3332],
8	event	NN	O	event	prep_with	5	SENT_334	[p25l10t3388r227b3457],
9	,	,	O	,	_	0	SENT_334	[p25l10t3388r227b3457],
10	seven	CD	NUMBER	seven	num	11	SENT_334	[p25l288t3400r494b3443],
11	patients	NNS	O	patient	nsubj	12	SENT_334	[p25l547t3379r832b3461],
12	received	VBD	O	receive	_	0	SENT_334	[p25l889t3379r1201b3443],
13	vitamin	NN	O	vitamin	nn	14	SENT_334	[p25l1254t3379r1535b3443],
14	B6	NN	O	b6	dobj	12	SENT_334	[p25l1589t3381r1716b3443],
15	:	:	O	:	_	0	SENT_334	[p25l1589t3381r1716b3443],
16	one	CD	NUMBER	one	num	18	SENT_334	[p25l1784t3400r1913b3443],
17	slow	JJ	O	slow	amod	18	SENT_334	[p25l1978t3379r2150b3443],
18	acetylator	NN	O	acetylator	dep	14	SENT_334	[p25l10t3490r390b3571],
19	and	CC	O	and	_	0	SENT_334	[p25l451t3490r585b3554],
20	three	CD	NUMBER	three	num	22	SENT_334	[p25l645t3490r834b3554],
21	rapid	JJ	O	rapid	amod	22	SENT_334	[p25l897t3490r1094b3571],
22	acetylators	NNS	O	acetylator	dep	14	SENT_334	[p25l1156t3490r1570b3571],
23	in	IN	O	in	_	0	SENT_334	[p25l1635t3490r1705b3552],
24	the	DT	O	the	det	26	SENT_334	[p25l1766t3490r1880b3554],
25	STD	NN	O	std	nn	26	SENT_334	[p25l1947t3491r2148b3554, p26l93t523r166b643],
26	§	NN	O	§	prep_in	12	SENT_334	[p25l1947t3491r2148b3554, p26l93t523r166b643],

1	60	CD	NUMBER	60	number	2	SENT_335	[p26l281t585r357b641],
2	8	CD	NUMBER	8	_	0	SENT_335	[p26l112t667r152b739],
3	:	:	O	:	_	0	SENT_335	[p26l112t742r152b782],
4	'	''	O	'	_	0	SENT_335	[p26l93t865r152b922],
5	8	CD	NUMBER	8	dep	2	SENT_335	[p26l93t865r152b922],
6	'	''	O	'	_	0	SENT_335	[p26l93t785r152b861],
7	8	CD	NUMBER	8	number	8	SENT_335	[p26l93t785r152b861],
8	40	CD	NUMBER	40	dobj	5	SENT_335	[p26l279t834r357b890],
9	E	NN	O	e	dep	8	SENT_335	[p26l95t925r152b992],

1	O	NN	O	o	_	0	SENT_336	[p26l321t1331r358b1387],

1	Treatments	NNS	O	treatment	_	0	SENT_337	[p26l8t1457r382b1515],
2	PGX	NNP	O	PGX	dep	1	SENT_337	[p26l728t1456r878b1515],
3	STD	NN	O	std	nn	4	SENT_337	[p26l1226t1456r1380b1515],
4	n	NN	O	n	dep	2	SENT_337	[p26l52t1584r91b1623],
5	38	CD	NUMBER	38	number	6	SENT_337	[p26l758t1560r830b1616],
6	43	CD	NUMBER	43	dep	1	SENT_337	[p26l1241t1560r1316b1616],
7	37	CD	NUMBER	37	num	9	SENT_337	[p26l1744t1560r1818b1616],
8	NAT2	NN	O	nat2	nn	9	SENT_337	[p26l8t1712r222b1771],
9	genotype	NN	O	genotype	dep	6	SENT_337	[p26l246t1721r550b1788],
10	RA+SA	NN	O	ra+sa	nn	13	SENT_337	[p26l875t1712r1318b1788],
11	—	CD	NUMBER	—	num	13	SENT_337	[p26l875t1712r1318b1788],
12	type	NN	O	type	nn	13	SENT_337	[p26l875t1712r1318b1788],
13	IA	NN	O	ia	dep	1	SENT_337	[p26l1673t1712r1929b1788],
14	—	CD	NUMBER	—	num	16	SENT_337	[p26l1673t1712r1929b1788],
15	type	NN	O	type	nn	16	SENT_337	[p26l1673t1712r1929b1788],
16	Fig	NN	O	fig	dep	13	SENT_337	[p26l8t1888r128b1956],
17	.	.	O	.	_	0	SENT_337	[p26l8t1888r128b1956],

1	5	CD	NUMBER	5	num	2	SENT_338	[p26l157t1889r190b1941],
2	Incidence	NN	O	incidence	_	0	SENT_338	[p26l243t1887r533b1941],
3	of	IN	O	of	_	0	SENT_338	[p26l561t1887r629b1941],
4	combined	JJ	O	combined	amod	6	SENT_338	[p26l647t1887r943b1941],
5	unfavorable	JJ	O	unfavorable	amod	6	SENT_338	[p26l967t1887r1326b1941],
6	events	NNS	O	event	prep_of	2	SENT_338	[p26l1355t1894r1543b1941],
7	among	IN	O	among	_	0	SENT_338	[p26l1572t1904r1774b1956],
8	the	DT	O	the	det	9	SENT_338	[p26l1800t1887r1891b1941],
9	patients	NNS	O	patient	prep_among	2	SENT_338	[p26l1915t1887r2148b1956],
10	with	IN	O	with	_	0	SENT_338	[p26l7t1975r141b2029],
11	drug	NN	O	drug	nn	13	SENT_338	[p26l167t1975r302b2044],
12	sensitive	JJ	O	sensitive	amod	13	SENT_338	[p26l331t1975r589b2029],
13	tuberculosis	NN	O	tuberculosis	prep_with	9	SENT_338	[p26l614t1975r976b2029],
14	on	IN	O	on	_	0	SENT_338	[p26l1004t1992r1078b2029],
15	sputum	NN	O	sputum	nn	16	SENT_338	[p26l1105t1982r1325b2044],
16	culture	NN	O	culture	prep_on	13	SENT_338	[p26l1350t1975r1555b2029],
17	at	IN	O	at	_	0	SENT_338	[p26l1583t1982r1635b2029],
18	screening	NN	O	screening	prep_at	2	SENT_338	[p26l1661t1975r1961b2044],
19	.	.	O	.	_	0	SENT_338	[p26l1661t1975r1961b2044],

1	RA	NN	O	ra	_	0	SENT_339	[p26l1990t1976r2143b2028],
2	+	CC	O	+	_	0	SENT_339	[p26l1990t1976r2143b2028],
3	IA-type	JJ	O	ia-type	conj_+	1	SENT_339	[p26l9t2064r256b2133],
4	,	,	O	,	_	0	SENT_339	[p26l9t2064r256b2133],
5	combined	VBN	O	combine	partmod	1	SENT_339	[p26l290t2063r586b2117],
6	with	IN	O	with	_	0	SENT_339	[p26l614t2063r748b2117],
7	rapid	JJ	O	rapid	amod	11	SENT_339	[p26l776t2063r930b2132],
8	or	CC	O	or	_	0	SENT_339	[p26l960t2081r1022b2117],
9	slow	JJ	O	slow	amod	11	SENT_339	[p26l1051t2063r1191b2117],
10	acetylator	NN	O	acetylator	nn	11	SENT_339	[p26l1221t2063r1516b2133],
11	genotypes	NNS	O	genotype	prep_with	5	SENT_339	[p26l1544t2071r1865b2133],
12	;	:	O	;	_	0	SENT_339	[p26l1544t2071r1865b2133],
13	IA-type	JJ	O	ia-type	dep	1	SENT_339	[p26l1899t2064r2147b2133],
14	,	,	O	,	_	0	SENT_339	[p26l1899t2064r2147b2133],
15	intermediate	JJ	O	intermediate	amod	17	SENT_339	[p26l9t2151r381b2205],
16	acetylator	NN	O	acetylator	nn	17	SENT_339	[p26l412t2151r706b2221],
17	genotypes	NNS	O	genotype	appos	13	SENT_339	[p26l733t2159r1055b2221],
18	;	:	O	;	_	0	SENT_339	[p26l733t2159r1055b2221],
19	PGX	NNP	O	PGX	dep	1	SENT_339	[p26l1086t2152r1235b2217],
20	,	,	O	,	_	0	SENT_339	[p26l1086t2152r1235b2217],
21	PGX-guided	JJ	O	pgx-guided	amod	22	SENT_339	[p26l1266t2151r1631b2221],
22	treatment	NN	O	treatment	appos	19	SENT_339	[p26l1658t2158r1958b2217],
23	;	:	O	;	_	0	SENT_339	[p26l1658t2158r1958b2217],
24	STD	NNP	O	STD	nn	31	SENT_339	[p26l1993t2152r2147b2217],
25	,	,	O	,	_	0	SENT_339	[p26l1993t2152r2147b2217],
26	conventional	JJ	O	conventional	amod	31	SENT_339	[p26l9t2240r397b2294],
27	standard-treatment	JJ	O	standard-treatment	amod	31	SENT_339	[p26l424t2240r985b2294],
28	Eur	NNP	O	Eur	nn	31	SENT_339	[p26l53t2370r103b2394],
29	J	NNP	O	J	nn	31	SENT_339	[p26l114t2370r127b2394],
30	Clin	NNP	PERSON	Clin	nn	31	SENT_339	[p26l138t2369r197b2394],
31	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_339	[p26l208t2369r357b2394],
32	(	CD	NUMBER	(	num	33	SENT_339	[p26l369t2369r460b2401],
33	2013	CD	DATE	2013	dep	31	SENT_339	[p26l369t2369r460b2401],
34	)	CD	NUMBER	)	number	35	SENT_339	[p26l369t2369r460b2401],
35	69:1091	CD	NUMBER	69:1091	num	37	SENT_339	[p26l473t2369r670b2394],
36	—	CD	NUMBER	—	number	37	SENT_339	[p26l473t2369r670b2394],
37	1101	CD	DATE	1101	dep	33	SENT_339	[p26l473t2369r670b2394],
38	1099	CD	DATE	1099	dep	1	SENT_339	[p26l2041t2369r2106b2394],

1	treatment	NN	O	treatment	_	0	SENT_340	[p26l8t2550r372b2619],
2	,	,	O	,	_	0	SENT_340	[p26l8t2550r372b2619],
3	one	CD	NUMBER	one	num	5	SENT_340	[p26l436t2562r564b2606],
4	rapid	JJ	O	rapid	amod	5	SENT_340	[p26l621t2542r810b2624],
5	acetylator	NN	O	acetylator	appos	1	SENT_340	[p26l868t2542r1230b2624],
6	in	IN	O	in	_	0	SENT_340	[p26l1287t2542r1355b2605],
7	the	DT	O	the	det	8	SENT_340	[p26l1412t2542r1521b2606],
8	PGX-treatment	NN	O	pgx-treatment	prep_in	5	SENT_340	[p26l1580t2543r2139b2619],
9	,	,	O	,	_	0	SENT_340	[p26l1580t2543r2139b2619],
10	and	CC	O	and	_	0	SENT_340	[p26l10t2652r138b2716],
11	three	CD	NUMBER	three	num	13	SENT_340	[p26l179t2652r357b2716],
12	intermediate	JJ	O	intermediate	amod	13	SENT_340	[p26l402t2652r849b2716],
13	acetylators	NNS	O	acetylator	conj_and	5	SENT_340	[p26l895t2652r1301b2734],
14	.	.	O	.	_	0	SENT_340	[p26l895t2652r1301b2734],

1	There	EX	O	there	expl	2	SENT_341	[p26l1351t2652r1557b2716],
2	was	VBD	O	be	_	0	SENT_341	[p26l1599t2673r1736b2716],
3	no	DT	O	no	det	6	SENT_341	[p26l1781t2673r1867b2716],
4	statistically	RB	O	statistically	advmod	5	SENT_341	[p26l1896t2652r2141b2716, p26l10t2762r175b2844],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_341	[p26l208t2762r569b2844],
6	difference	NN	O	difference	nsubj	2	SENT_341	[p26l600t2762r944b2826],
7	in	IN	O	in	_	0	SENT_341	[p26l978t2762r1044b2825],
8	the	DT	O	the	det	9	SENT_341	[p26l1073t2762r1177b2826],
9	incidence	NN	O	incidence	prep_in	6	SENT_341	[p26l1210t2762r1538b2826],
10	of	IN	O	of	_	0	SENT_341	[p26l1572t2762r1653b2826],
11	these	DT	O	these	det	13	SENT_341	[p26l1672t2762r1848b2826],
12	adverse	JJ	O	adverse	amod	13	SENT_341	[p26l1882t2762r2142b2826],
13	events	NNS	O	event	prep_of	9	SENT_341	[p26l10t2881r228b2936],
14	between	IN	O	between	_	0	SENT_341	[p26l255t2872r546b2936],
15	the	DT	O	the	det	19	SENT_341	[p26l573t2872r677b2936],
16	PGx	NN	O	pgx	nn	19	SENT_341	[p26l706t2874r1215b2936],
17	—	NN	O	—	nn	19	SENT_341	[p26l706t2874r1215b2936],
18	treatment	NN	O	treatment	nn	19	SENT_341	[p26l706t2874r1215b2936],
19	group	NN	O	group	prep_between	13	SENT_341	[p26l1243t2893r1442b2954],
20	and	CC	O	and	_	0	SENT_341	[p26l1474t2872r1599b2936],
21	STD-treatment	NN	O	std-treatment	nn	22	SENT_341	[p26l1630t2874r2144b2936],
22	group	NN	O	group	conj_and	19	SENT_341	[p26l9t2981r228b3041],
23	.	.	O	.	_	0	SENT_341	[p26l9t2981r228b3041],

1	Discussion	NN	O	discussion	_	0	SENT_342	[p26l8t3204r404b3266],

1	In	IN	O	in	_	0	SENT_343	[p26l9t3428r80b3489],
2	the	DT	O	the	det	4	SENT_343	[p26l116t3426r221b3490],
3	present	JJ	DATE	present	amod	4	SENT_343	[p26l257t3435r514b3508],
4	study	NN	O	study	prep_in	7	SENT_343	[p26l552t3426r740b3508],
5	we	PRP	O	we	nsubj	7	SENT_343	[p26l776t3446r877b3490],
6	have	VBP	O	have	aux	7	SENT_343	[p26l914t3426r1079b3490],
7	demonstrated	VBN	O	demonstrate	_	0	SENT_343	[p26l1118t3426r1593b3490],
8	the	DT	O	the	det	11	SENT_343	[p26l1628t3426r1734b3490],
9	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_343	[p26l1775t3426r2144b3508],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_343	[p26l8t3537r397b3619],
11	potential	NN	O	potential	dobj	7	SENT_343	[p26l434t3537r744b3619],
12	of	IN	O	of	_	0	SENT_343	[p26l783t3537r863b3601],
13	the	DT	O	the	det	17	SENT_343	[p26l889t3537r995b3601],
14	NAT	NNP	ORGANIZATION	NAT	nn	17	SENT_343	[p26l1030t3539r1201b3602],
15	2	CD	NUMBER	2	num	17	SENT_343	[p26l1193t3539r1235b3600],
16	genotype-guided	JJ	O	genotype-guided	amod	17	SENT_343	[p26l1275t3537r1870b3619],
17	dosing	NN	O	dosing	prep_of	11	SENT_343	[p26l1908t3537r2142b3619],
18	of	IN	O	of	_	0	SENT_343	[p26l10t3648r91b3712],
19	INH	NN	MISC	inh	prep_of	11	SENT_343	[p26l120t3651r274b3712],
20	in	IN	O	in	_	0	SENT_343	[p26l316t3648r382b3711],
21	the	DT	O	the	det	23	SENT_343	[p26l420t3648r526b3712],
22	intensive	JJ	O	intensive	amod	23	SENT_343	[p26l568t3648r884b3712],
23	phase	NN	O	phase	prep_in	7	SENT_343	[p26l922t3648r1123b3730],
24	of	IN	O	of	_	0	SENT_343	[p26l1165t3648r1246b3712],
25	the	DT	O	the	det	27	SENT_343	[p26l1274t3648r1380b3712],
26	intemationally	RB	O	intemationally	advmod	27	SENT_343	[p26l1421t3648r1934b3730],
27	standardized	JJ	O	standardized	prep_of	23	SENT_343	[p26l1976t3657r2140b3712, p27l10t21r312b85],

1	6-month	JJ	DURATION	6-month	amod	3	SENT_344	[p27l353t21r650b85],
2	four-drug	JJ	O	four-drug	amod	3	SENT_344	[p27l690t21r1024b103],
3	regimen	NN	O	regimen	_	0	SENT_344	[p27l1062t21r1352b103],
4	for	IN	O	for	_	0	SENT_344	[p27l1393t21r1493b85],
5	newly	RB	O	newly	advmod	6	SENT_344	[p27l1529t21r1745b103],
6	diagnosed	VBN	O	diagnose	amod	8	SENT_344	[p27l1785t21r2143b103],
7	pulmonary	JJ	O	pulmonary	amod	8	SENT_344	[p27l7t132r392b213],
8	tuberculosis	NN	O	tuberculosis	prep_for	3	SENT_344	[p27l432t132r876b196],
9	.	.	O	.	_	0	SENT_344	[p27l432t132r876b196],

1	The	DT	O	the	det	4	SENT_345	[p27l924t132r1058b196],
2	new	JJ	O	new	amod	4	SENT_345	[p27l1101t154r1242b195],
3	dosing	NN	O	dosing	nn	4	SENT_345	[p27l1285t132r1518b213],
4	regimen	NN	O	regimen	nsubj	6	SENT_345	[p27l1560t132r1849b213],
5	signiﬁcantly	RB	O	signiﬁcantly	advmod	6	SENT_345	[p27l1893t132r2141b213, p27l10t243r230b324],
6	reduced	VBD	O	reduce	_	0	SENT_345	[p27l283t243r572b307],
7	the	DT	O	the	det	8	SENT_345	[p27l625t243r734b307],
8	incidences	NNS	O	incidence	dobj	6	SENT_345	[p27l790t243r1171b307],
9	of	IN	O	of	_	0	SENT_345	[p27l1229t243r1311b307],
10	INH-DILI	NN	O	inh-dili	nn	14	SENT_345	[p27l1355t245r1725b306],
11	and	CC	O	and	_	0	SENT_345	[p27l1781t243r1910b307],
12	early	JJ	O	early	nn	14	SENT_345	[p27l1964t243r2143b324],
13	treatment	NN	O	treatment	nn	14	SENT_345	[p27l8t362r341b418],
14	failure	NN	O	failure	prep_of	8	SENT_345	[p27l383t354r626b431],
15	,	,	O	,	_	0	SENT_345	[p27l383t354r626b431],
16	compared	VBN	O	compare	_	0	SENT_345	[p27l674t354r1020b435],
17	to	TO	O	to	prepc_compared_to	6	SENT_345	[p27l1061t362r1126b418],
18	the	DT	O	the	det	21	SENT_345	[p27l1169t354r1275b418],
19	conventional	JJ	O	conventional	amod	21	SENT_345	[p27l1319t354r1774b418],
20	standardized	JJ	O	standardized	amod	21	SENT_345	[p27l1819t354r2140b418, p27l9t465r154b529],
21	regimen	NN	O	regimen	pobj	6	SENT_345	[p27l194t465r500b547],
22	.	.	O	.	_	0	SENT_345	[p27l194t465r500b547],

1	The	DT	O	the	det	3	SENT_346	[p27l549t465r682b529],
2	slow	JJ	O	slow	amod	3	SENT_346	[p27l728t465r891b529],
3	acetylators	NNS	O	acetylator	nsubj	21	SENT_346	[p27l935t465r1312b547],
4	assigned	VBN	O	assign	partmod	3	SENT_346	[p27l1356t465r1660b547],
5	to	TO	O	to	_	0	SENT_346	[p27l1700t474r1765b529],
6	the	DT	O	the	det	7	SENT_346	[p27l1809t465r1915b529],
7	PGXtreatment	NN	O	pgxtreatment	prep_to	4	SENT_346	[p27l1957t466r2141b529, p27l8t586r358b655],
8	,	,	O	,	_	0	SENT_346	[p27l1957t466r2141b529, p27l8t586r358b655],
9	who	WP	O	who	nsubjpass	11	SENT_346	[p27l408t577r558b641],
10	were	VBD	O	be	auxpass	11	SENT_346	[p27l608t598r777b641],
11	administered	VBN	O	administer	rcmod	3	SENT_346	[p27l827t577r1281b641],
12	a	DT	O	a	det	14	SENT_346	[p27l1330t598r1366b641],
13	lower	JJR	O	lower	amod	14	SENT_346	[p27l1414t577r1615b641],
14	dose	NN	O	dose	dobj	11	SENT_346	[p27l1661t577r1819b641],
15	of	IN	O	of	_	0	SENT_346	[p27l1870t577r1951b641],
16	INH	NN	O	inh	prep_of	14	SENT_346	[p27l1988t580r2142b641],
17	than	IN	O	than	_	0	SENT_346	[p27l8t688r160b751],
18	the	DT	O	the	det	19	SENT_346	[p27l207t688r313b752],
19	STD-treatment	NN	O	std-treatment	prep_than	11	SENT_346	[p27l367t689r910b765],
20	,	,	O	,	_	0	SENT_346	[p27l367t689r910b765],
21	developed	VBD	O	develop	_	0	SENT_346	[p27l963t688r1326b770],
22	no	DT	O	no	det	25	SENT_346	[p27l1373t708r1460b752],
23	INH-related	JJ	O	inh-related	amod	25	SENT_346	[p27l1511t688r1936b752],
24	liver	NN	O	liver	nn	25	SENT_346	[p27l1985t688r2145b752],
25	injury	NN	O	injury	dobj	21	SENT_346	[p27l9t799r231b881],
26	,	,	O	,	_	0	SENT_346	[p27l9t799r231b881],
27	but	CC	O	but	_	0	SENT_346	[p27l263t799r378b863],
28	achieved	VBD	O	achieve	conj_but	21	SENT_346	[p27l408t799r721b863],
29	clinical	JJ	O	clinical	amod	30	SENT_346	[p27l752t799r1007b863],
30	improvements	NNS	O	improvement	dobj	28	SENT_346	[p27l1039t799r1540b881],
31	within	IN	O	within	_	0	SENT_346	[p27l1572t799r1799b864],
32	8	CD	DURATION	8	num	33	SENT_346	[p27l1832t801r1867b863],
33	weeks	NNS	NUMBER	week	prep_within	28	SENT_346	[p27l1900t799r2137b863],
34	.	.	O	.	_	0	SENT_346	[p27l1900t799r2137b863],

1	On	IN	O	on	_	0	SENT_347	[p27l10t912r119b974],
2	the	DT	O	the	det	4	SENT_347	[p27l164t910r276b974],
3	other	JJ	O	other	amod	4	SENT_347	[p27l325t910r519b974],
4	hand	NN	O	hand	prep_on	20	SENT_347	[p27l562t910r766b988],
5	,	,	O	,	_	0	SENT_347	[p27l562t910r766b988],
6	the	DT	O	the	det	8	SENT_347	[p27l815t910r927b974],
7	rapid	JJ	O	rapid	amod	8	SENT_347	[p27l974t910r1168b992],
8	acetylators	NNS	O	acetylator	nsubj	20	SENT_347	[p27l1215t910r1624b992],
9	in	IN	O	in	_	0	SENT_347	[p27l1673t910r1743b973],
10	the	DT	O	the	det	11	SENT_347	[p27l1788t910r1900b974],
11	PGxtreatment	NN	O	pgxtreatment	prep_in	8	SENT_347	[p27l1947t912r2141b974, p27l8t1030r358b1099],
12	,	,	O	,	_	0	SENT_347	[p27l1947t912r2141b974, p27l8t1030r358b1099],
13	receiving	VBG	O	receive	partmod	20	SENT_347	[p27l388t1021r715b1103],
14	a	DT	O	a	det	16	SENT_347	[p27l745t1042r782b1085],
15	higher	JJR	O	higher	amod	16	SENT_347	[p27l807t1021r1034b1103],
16	dose	NN	O	dose	dobj	13	SENT_347	[p27l1061t1021r1219b1085],
17	of	IN	O	of	_	0	SENT_347	[p27l1249t1021r1331b1085],
18	INH	NNP	MISC	INH	prep_of	16	SENT_347	[p27l1347t1024r1521b1099],
19	,	,	O	,	_	0	SENT_347	[p27l1347t1024r1521b1099],
20	achieved	VBD	O	achieve	_	0	SENT_347	[p27l1553t1021r1866b1085],
21	a	DT	O	a	det	25	SENT_347	[p27l1894t1042r1931b1085],
22	25	CD	PERCENT	25	num	23	SENT_347	[p27l1957t1023r2039b1085],
23	%	NN	PERCENT	%	npadvmod	24	SENT_347	[p27l2073t1023r2141b1086],
24	higher	JJR	O	higher	amod	25	SENT_347	[p27l8t1132r235b1213],
25	rate	NN	O	rate	dobj	20	SENT_347	[p27l270t1141r399b1196],
26	of	IN	O	of	_	0	SENT_347	[p27l439t1132r520b1196],
27	clinical	JJ	O	clinical	amod	28	SENT_347	[p27l549t1132r803b1196],
28	improvement	NN	O	improvement	prep_of	25	SENT_347	[p27l843t1132r1314b1213],
29	by	IN	O	by	_	0	SENT_347	[p27l1349t1132r1438b1213],
30	the	DT	O	the	det	32	SENT_347	[p27l1475t1132r1580b1196],
31	8th	JJ	ORDINAL	8th	amod	32	SENT_347	[p27l1623t1132r1731b1195],
32	Week	NN	DURATION	week	prep_by	20	SENT_347	[p27l1768t1132r1956b1196],
33	than	IN	O	than	_	0	SENT_347	[p27l1991t1132r2143b1195],
34	those	DT	O	those	prep_than	20	SENT_347	[p27l8t1243r192b1306],
35	in	IN	O	in	_	0	SENT_347	[p27l215t1243r281b1305],
36	the	DT	O	the	det	37	SENT_347	[p27l299t1243r404b1306],
37	STD-treatment	NN	O	std-treatment	prep_in	34	SENT_347	[p27l429t1244r972b1319],
38	,	,	O	,	_	0	SENT_347	[p27l429t1244r972b1319],
39	with	IN	O	with	_	0	SENT_347	[p27l994t1243r1151b1306],
40	an	DT	O	a	det	41	SENT_347	[p27l1171t1263r1252b1305],
41	incidence	NN	O	incidence	prep_with	20	SENT_347	[p27l1272t1243r1606b1306],
42	of	IN	O	of	_	0	SENT_347	[p27l1629t1243r1710b1306],
43	INH-related	JJ	O	inh-related	amod	45	SENT_347	[p27l1719t1243r2144b1306],
44	liver	NN	O	liver	nn	45	SENT_347	[p27l10t1353r170b1417],
45	injury	NN	O	injury	prep_of	41	SENT_347	[p27l198t1353r406b1434],
46	of	IN	O	of	_	0	SENT_347	[p27l436t1353r517b1417],
47	less	JJR	O	less	mwe	48	SENT_347	[p27l537t1353r664b1417],
48	than	IN	O	than	quantmod	49	SENT_347	[p27l694t1353r845b1416],
49	5	CD	PERCENT	5	num	50	SENT_347	[p27l877t1355r912b1416],
50	%	NN	PERCENT	%	prep_of	45	SENT_347	[p27l947t1354r1034b1418],
51	.	.	O	.	_	0	SENT_347	[p27l947t1354r1034b1418],

1	The	DT	O	the	det	4	SENT_348	[p27l1069t1353r1203b1417],
2	absolute	JJ	O	absolute	amod	4	SENT_348	[p27l1234t1353r1525b1417],
3	risk	NN	O	risk	nn	4	SENT_348	[p27l1554t1353r1687b1417],
4	reduction	NN	O	reduction	nsubj	16	SENT_348	[p27l1713t1353r2048b1417],
5	in	IN	O	in	_	0	SENT_348	[p27l2077t1353r2143b1415],
6	the	DT	O	the	det	8	SENT_348	[p27l8t1464r113b1528],
7	combined	JJ	O	combined	amod	8	SENT_348	[p27l146t1464r494b1528],
8	population	NN	O	population	prep_in	4	SENT_348	[p27l521t1464r902b1546],
9	of	IN	O	of	_	0	SENT_348	[p27l934t1464r1015b1528],
10	rapid	JJ	O	rapid	amod	13	SENT_348	[p27l1033t1464r1214b1546],
11	and	CC	O	and	_	0	SENT_348	[p27l1245t1464r1371b1528],
12	slow	JJ	O	slow	conj_and	10	SENT_348	[p27l1403t1464r1566b1528],
13	acetylators	NNS	O	acetylator	prep_of	8	SENT_348	[p27l1598t1464r1975b1546],
14	was	VBD	O	be	cop	16	SENT_348	[p27l2006t1485r2141b1528],
15	31	CD	PERCENT	31	num	16	SENT_348	[p27l10t1576r86b1639],
16	%	NN	PERCENT	%	_	0	SENT_348	[p27l128t1576r197b1640],
17	with	IN	O	with	_	0	SENT_348	[p27l228t1575r384b1639],
18	respect	NN	O	respect	prep_with	16	SENT_348	[p27l414t1584r664b1657],
19	to	TO	O	to	_	0	SENT_348	[p27l693t1584r758b1639],
20	unfavorable	JJ	O	unfavorable	amod	21	SENT_348	[p27l790t1575r1211b1639],
21	events	NNS	O	event	prep_to	16	SENT_348	[p27l1245t1584r1487b1652],
22	,	,	O	,	_	0	SENT_348	[p27l1245t1584r1487b1652],
23	i.e.	FW	O	i.e.	prep_to	16	SENT_348	[p27l1522t1575r1645b1652],
24	,	,	O	,	_	0	SENT_348	[p27l1522t1575r1645b1652],
25	INH-DILI	NN	O	inh-dili	prep_to	16	SENT_348	[p27l1681t1578r2039b1639],
26	or	CC	O	or	_	0	SENT_348	[p27l2073t1596r2145b1639],
27	early	JJ	O	early	amod	29	SENT_348	[p27l10t1686r183b1768],
28	treatment	NN	O	treatment	nn	29	SENT_348	[p27l208t1695r541b1750],
29	failure	NN	O	failure	prep_to	16	SENT_348	[p27l568t1686r810b1750],
30	.	.	O	.	_	0	SENT_348	[p27l568t1686r810b1750],

1	NAT	NNP	ORGANIZATION	NAT	dep	3	SENT_349	[p27l106t1799r278b1862],
2	2	CD	NUMBER	2	num	1	SENT_349	[p27l271t1799r312b1860],
3	genotypic	JJ	O	genotypic	amod	4	SENT_349	[p27l340t1797r686b1879],
4	status	NN	O	status	nsubjpass	7	SENT_349	[p27l715t1806r910b1861],
5	has	VBZ	O	have	aux	7	SENT_349	[p27l936t1797r1051b1861],
6	been	VBN	O	be	auxpass	7	SENT_349	[p27l1076t1797r1244b1861],
7	focused	VBN	O	focus	_	0	SENT_349	[p27l1271t1797r1543b1861],
8	on	IN	O	on	dep	7	SENT_349	[p27l1569t1818r1656b1861],
9	as	IN	O	as	_	0	SENT_349	[p27l1682t1818r1750b1861],
10	a	DT	O	a	det	12	SENT_349	[p27l1778t1818r1815b1861],
11	genomic	JJ	O	genomic	amod	12	SENT_349	[p27l1840t1797r2141b1879],
12	biomarker	NN	O	biomarker	prep_as	7	SENT_349	[p27l7t1908r381b1972],
13	for	IN	O	for	_	0	SENT_349	[p27l425t1908r527b1972],
14	individualized	JJ	O	individualized	amod	15	SENT_349	[p27l570t1908r1088b1972],
15	medicine	NN	O	medicine	prep_for	12	SENT_349	[p27l1130t1908r1460b1972],
16	to	TO	O	to	aux	17	SENT_349	[p27l1505t1917r1571b1972],
17	preempt	VB	O	preempt	xcomp	7	SENT_349	[p27l1615t1917r1913b1990],
18	INHrelated	JJ	O	inhrelated	amod	20	SENT_349	[p27l1956t1911r2141b1972, p27l7t2019r246b2083],
19	unfavorable	JJ	O	unfavorable	amod	20	SENT_349	[p27l272t2019r693b2083],
20	events	NNS	O	event	dobj	17	SENT_349	[p27l723t2028r963b2083],
21	.	.	O	.	_	0	SENT_349	[p27l723t2028r963b2083],

1	In	IN	O	in	_	0	SENT_350	[p27l996t2022r1068b2082],
2	fact	NN	O	fact	prep_in	8	SENT_350	[p27l1095t2019r1241b2097],
3	,	,	O	,	_	0	SENT_350	[p27l1095t2019r1241b2097],
4	INH-induced	JJ	O	inh-induced	amod	5	SENT_350	[p27l1273t2019r1739b2083],
5	hepatotoXicity	NN	O	hepatotoxicity	nsubjpass	8	SENT_350	[p27l1765t2019r2140b2101, p27l10t2130r163b2211],
6	has	VBZ	O	have	aux	8	SENT_350	[p27l196t2130r311b2194],
7	been	VBN	O	be	auxpass	8	SENT_350	[p27l345t2130r513b2194],
8	studied	VBN	O	study	_	0	SENT_350	[p27l549t2130r802b2194],
9	enthusiastically	RB	O	enthusiastically	advmod	8	SENT_350	[p27l836t2130r1382b2211],
10	worldwide	RB	O	worldwide	advmod	8	SENT_350	[p27l1415t2130r1793b2194],
11	since	IN	O	since	mark	13	SENT_350	[p27l1831t2130r2007b2194],
12	we	PRP	O	we	nsubj	13	SENT_350	[p27l2040t2150r2141b2194],
13	reported	VBD	O	report	advcl	8	SENT_350	[p27l7t2241r302b2322],
14	its	PRP$	O	its	poss	15	SENT_350	[p27l328t2241r405b2305],
15	association	NN	O	association	nsubj	20	SENT_350	[p27l434t2241r824b2305],
16	with	IN	O	with	_	0	SENT_350	[p27l848t2241r1005b2305],
17	slow	JJ	O	slow	amod	19	SENT_350	[p27l1033t2241r1196b2305],
18	acetylator	NN	O	acetylator	nn	19	SENT_350	[p27l1222t2241r1568b2322],
19	genotypes	NNS	O	genotype	prep_with	15	SENT_350	[p27l1592t2249r1948b2323],
20	[	VBP	O	[	ccomp	13	SENT_350	[p27l1981t2242r2137b2321],
21	18	CD	NUMBER	18	num	22	SENT_350	[p27l1981t2242r2137b2321],
22	]	CD	NUMBER	]	dobj	20	SENT_350	[p27l1981t2242r2137b2321],
23	.	.	O	.	_	0	SENT_350	[p27l1981t2242r2137b2321],

1	In	IN	O	in	_	0	SENT_351	[p27l9t2354r80b2414],
2	accordance	NN	O	accordance	_	0	SENT_351	[p27l112t2352r505b2416],
3	with	IN	O	with	_	0	SENT_351	[p27l535t2352r692b2416],
4	previous	JJ	O	previous	amod	6	SENT_351	[p27l720t2352r1024b2433],
5	observational	JJ	O	observational	amod	6	SENT_351	[p27l1057t2352r1531b2416],
6	studies	NNS	O	study	prep_in_accordance_with	7	SENT_351	[p27l1564t2352r1803b2416],
7	[	VBP	O	[	_	0	SENT_351	[p27l1841t2353r1970b2432],
8	18	CD	NUMBER	18	dobj	7	SENT_351	[p27l1841t2353r1970b2432],
9	,	,	O	,	_	0	SENT_351	[p27l1841t2353r1970b2432],
10	19	CD	NUMBER	19	num	11	SENT_351	[p27l2013t2353r2139b2432],
11	]	NN	O	]	appos	8	SENT_351	[p27l2013t2353r2139b2432],
12	,	,	O	,	_	0	SENT_351	[p27l2013t2353r2139b2432],
13	the	DT	O	the	det	14	SENT_351	[p27l8t2463r113b2527],
14	present	JJ	DATE	present	appos	8	SENT_351	[p27l136t2472r393b2545],
15	randomized	VBN	O	randomize	partmod	14	SENT_351	[p27l414t2463r832b2527],
16	clinical	JJ	O	clinical	amod	17	SENT_351	[p27l857t2463r1112b2527],
17	trial	NN	O	trial	nsubj	19	SENT_351	[p27l1135t2463r1274b2527],
18	has	VBZ	O	have	aux	19	SENT_351	[p27l1297t2463r1412b2527],
19	confirmed	VBN	O	confirm	ccomp	15	SENT_351	[p27l1439t2463r1800b2527],
20	that	IN	O	that	complm	24	SENT_351	[p27l1823t2463r1955b2527],
21	slow	JJ	O	slow	amod	22	SENT_351	[p27l1980t2463r2143b2527],
22	acetylators	NNS	O	acetylator	nsubj	24	SENT_351	[p27l10t2574r387b2656],
23	are	VBP	O	be	cop	24	SENT_351	[p27l416t2595r518b2638],
24	prone	JJ	O	prone	ccomp	19	SENT_351	[p27l543t2595r744b2656],
25	to	TO	O	to	_	0	SENT_351	[p27l770t2583r835b2638],
26	INH-DILI	NN	O	inh-dili	prep_to	24	SENT_351	[p27l864t2577r1224b2638],
27	by	IN	O	by	_	0	SENT_351	[p27l1248t2574r1337b2656],
28	conventional	JJ	O	conventional	amod	30	SENT_351	[p27l1364t2574r1818b2638],
29	standard	JJ	O	standard	amod	30	SENT_351	[p27l1847t2574r2143b2638],
30	treatment	NN	O	treatment	prep_by	7	SENT_351	[p27l8t2693r341b2749],
31	with	IN	O	with	_	0	SENT_351	[p27l369t2685r526b2749],
32	the	DT	O	the	det	34	SENT_351	[p27l556t2685r662b2749],
33	relative	JJ	O	relative	amod	34	SENT_351	[p27l693t2685r954b2749],
34	risk	NN	O	risk	prep_with	7	SENT_351	[p27l985t2685r1117b2749],
35	of	IN	O	of	_	0	SENT_351	[p27l1149t2685r1230b2749],
36	4.5	CD	PERCENT	4.5	number	37	SENT_351	[p27l1250t2686r1354b2749],
37	(	CD	PERCENT	(	prep_of	34	SENT_351	[p27l1393t2685r1502b2766],
38	95	CD	PERCENT	95	num	40	SENT_351	[p27l1393t2685r1502b2766],
39	%	NN	PERCENT	%	nn	40	SENT_351	[p27l1539t2686r1608b2750],
40	CI	NN	O	ci	nsubj	7	SENT_351	[p27l1642t2686r1745b2762],
41	,	,	O	,	_	0	SENT_351	[p27l1642t2686r1745b2762],
42	1.3	CD	NUMBER	1.3	number	43	SENT_351	[p27l1789t2685r2137b2766],
43	—	CD	NUMBER	—	appos	40	SENT_351	[p27l1789t2685r2137b2766],
44	15.3	CD	NUMBER	15.3	num	45	SENT_351	[p27l1789t2685r2137b2766],
45	)	NN	O	)	dep	43	SENT_351	[p27l1789t2685r2137b2766],
46	.	.	O	.	_	0	SENT_351	[p27l1789t2685r2137b2766],

1	Importantly	RB	O	importantly	advmod	8	SENT_352	[p27l9t2796r448b2878],
2	,	,	O	,	_	0	SENT_352	[p27l9t2796r448b2878],
3	the	DT	O	the	det	5	SENT_352	[p27l506t2796r614b2860],
4	present	JJ	DATE	present	amod	5	SENT_352	[p27l669t2805r931b2878],
5	trial	NN	O	trial	nsubj	8	SENT_352	[p27l985t2796r1128b2860],
6	has	VBZ	O	have	aux	8	SENT_352	[p27l1184t2796r1301b2860],
7	clearly	RB	O	clearly	advmod	8	SENT_352	[p27l1360t2796r1603b2878],
8	demonstrated	VBN	O	demonstrate	_	0	SENT_352	[p27l1659t2796r2144b2860],
9	that	IN	O	that	complm	16	SENT_352	[p27l8t2907r143b2971],
10	the	DT	O	the	det	11	SENT_352	[p27l180t2907r288b2971],
11	incidence	NN	O	incidence	nsubjpass	16	SENT_352	[p27l329t2907r671b2971],
12	of	IN	O	of	_	0	SENT_352	[p27l712t2907r794b2971],
13	INH-DILI	NN	O	inh-dili	prep_of	11	SENT_352	[p27l823t2910r1189b2971],
14	was	VBD	O	be	auxpass	16	SENT_352	[p27l1227t2928r1364b2971],
15	strikingly	RB	O	strikingly	advmod	16	SENT_352	[p27l1407t2907r1751b2989],
16	decreased	VBN	O	decrease	ccomp	8	SENT_352	[p27l1790t2907r2144b2971],
17	by	IN	O	by	_	0	SENT_352	[p27l7t3018r97b3100],
18	the	DT	O	the	det	22	SENT_352	[p27l138t3018r246b3082],
19	NAT	NNP	O	NAT	nn	22	SENT_352	[p27l285t3020r458b3082],
20	2-guided	JJ	O	2-guided	amod	22	SENT_352	[p27l452t3018r773b3100],
21	dosing	NN	O	dosing	nn	22	SENT_352	[p27l816t3018r1054b3100],
22	stratiﬁcation	NN	O	stratiﬁcation	agent	16	SENT_352	[p27l1100t3018r1551b3082],
23	of	IN	O	of	_	0	SENT_352	[p27l1594t3018r1675b3082],
24	INH	NN	O	inh	prep_of	22	SENT_352	[p27l1708t3021r1882b3082],
25	.	.	O	.	_	0	SENT_352	[p27l1708t3021r1882b3082],

1	These	DT	O	these	det	2	SENT_353	[p27l1931t3018r2142b3082],
2	results	NNS	O	result	nsubj	3	SENT_353	[p27l7t3129r230b3193],
3	suggest	VBP	O	suggest	_	0	SENT_353	[p27l262t3137r520b3211],
4	that	IN	O	that	complm	11	SENT_353	[p27l545t3129r676b3192],
5	NAT2-guided	JJ	O	nat2-guided	amod	6	SENT_353	[p27l698t3129r1168b3210],
6	dosing	NN	O	dosing	nsubj	11	SENT_353	[p27l1197t3129r1426b3210],
7	for	IN	O	for	_	0	SENT_353	[p27l1456t3129r1555b3193],
8	slow	JJ	O	slow	amod	9	SENT_353	[p27l1583t3129r1745b3193],
9	acetylators	NNS	O	acetylator	prep_for	6	SENT_353	[p27l1773t3129r2141b3210],
10	would	MD	O	would	aux	11	SENT_353	[p27l7t3240r227b3304],
11	contribute	VB	O	contribute	ccomp	3	SENT_353	[p27l263t3240r610b3304],
12	to	TO	O	to	_	0	SENT_353	[p27l645t3249r711b3304],
13	the	DT	O	the	det	15	SENT_353	[p27l747t3240r851b3304],
14	preemptive	JJ	O	preemptive	amod	15	SENT_353	[p27l886t3240r1276b3321],
15	discontinuation	NN	O	discontinuation	prep_to	11	SENT_353	[p27l1313t3240r1845b3304],
16	of	IN	O	of	_	0	SENT_353	[p27l1883t3240r1964b3304],
17	antituberculous	JJ	O	antituberculous	amod	18	SENT_353	[p27l1989t3240r2141b3303, p27l8t3351r410b3415],
18	drugs	NNS	O	drug	prep_of	15	SENT_353	[p27l431t3351r640b3433],
19	,	,	O	,	_	0	SENT_353	[p27l431t3351r640b3433],
20	thereby	RB	O	thereby	advmod	21	SENT_353	[p27l661t3351r920b3432],
21	reducing	VBG	O	reduce	xcomp	3	SENT_353	[p27l937t3351r1241b3432],
22	the	DT	O	the	det	23	SENT_353	[p27l1258t3351r1362b3415],
23	incidence	NN	O	incidence	dobj	21	SENT_353	[p27l1383t3351r1711b3415],
24	of	IN	O	of	_	0	SENT_353	[p27l1731t3351r1812b3415],
25	treatment	NN	O	treatment	nn	28	SENT_353	[p27l1818t3359r2144b3415],
26	failure	NN	O	failure	nn	28	SENT_353	[p27l10t3462r230b3526],
27	and/or	NN	O	and/or	nn	28	SENT_353	[p27l257t3462r479b3526],
28	relapse	NN	O	relapse	prep_of	23	SENT_353	[p27l500t3462r743b3544],
29	of	IN	O	of	_	0	SENT_353	[p27l771t3462r852b3526],
30	tuberculosis	NN	O	tuberculosis	prep_of	28	SENT_353	[p27l864t3462r1298b3526],
31	.	.	O	.	_	0	SENT_353	[p27l864t3462r1298b3526],

1	It	PRP	O	it	nsubjpass	5	SENT_354	[p27l111t3575r162b3636],
2	has	VBZ	O	have	aux	5	SENT_354	[p27l186t3573r301b3637],
3	also	RB	O	also	advmod	5	SENT_354	[p27l329t3573r466b3637],
4	been	VBN	O	be	auxpass	5	SENT_354	[p27l492t3573r659b3637],
5	discussed	VBN	O	discuss	_	0	SENT_354	[p27l685t3573r1023b3637],
6	that	IN	O	that	complm	10	SENT_354	[p27l1046t3573r1179b3636],
7	rapid	JJ	O	rapid	amod	8	SENT_354	[p27l1201t3573r1383b3655],
8	acetylators	NNS	O	acetylator	nsubj	10	SENT_354	[p27l1409t3573r1786b3655],
9	are	VBP	O	be	cop	10	SENT_354	[p27l1814t3593r1916b3637],
10	prone	JJ	O	prone	ccomp	5	SENT_354	[p27l1941t3593r2141b3655],
11	to	TO	O	to	_	0	SENT_354	[p27l8t3693r73b3748],
12	treatment	NN	O	treatment	nn	13	SENT_354	[p27l112t3693r446b3748],
13	failure	NN	O	failure	prep_to	10	SENT_354	[p27l484t3684r708b3748],
14	during	IN	O	during	_	0	SENT_354	[p27l749t3684r976b3766],
15	anti-tuberculosis	JJ	O	anti-tuberculosis	amod	16	SENT_354	[p27l1017t3684r1601b3748],
16	therapy	NN	O	therapy	prep_during	10	SENT_354	[p27l1640t3684r1905b3766],
17	based	VBN	O	base	partmod	16	SENT_354	[p27l1941t3684r2143b3748],
18	on	IN	O	on	_	0	SENT_354	[p28l10t42r96b85],
19	INH	NN	O	inh	prep_on	17	SENT_354	[p28l129t24r283b85],
20	[	CD	NUMBER	[	number	21	SENT_354	[p28l322t23r452b102],
21	13	CD	NUMBER	13	dep	19	SENT_354	[p28l322t23r452b102],
22	,	,	O	,	_	0	SENT_354	[p28l322t23r452b102],
23	15	CD	NUMBER	15	appos	19	SENT_354	[p28l497t23r594b99],
24	,	,	O	,	_	0	SENT_354	[p28l497t23r594b99],
25	16	CD	NUMBER	16	num	26	SENT_354	[p28l639t23r763b102],
26	]	NN	O	]	appos	23	SENT_354	[p28l639t23r763b102],
27	.	.	O	.	_	0	SENT_354	[p28l639t23r763b102],

1	Consistent	JJ	O	consistent	ccomp	6	SENT_355	[p28l803t21r1176b85],
2	with	IN	O	with	_	0	SENT_355	[p28l1206t21r1363b85],
3	this	DT	O	this	prep_with	1	SENT_355	[p28l1395t21r1539b99],
4	,	,	O	,	_	0	SENT_355	[p28l1395t21r1539b99],
5	we	PRP	O	we	nsubj	6	SENT_355	[p28l1575t42r1676b85],
6	showed	VBD	O	show	_	0	SENT_355	[p28l1712t21r1981b85],
7	that	IN	O	that	complm	14	SENT_355	[p28l2012t21r2144b85],
8	the	DT	O	the	det	9	SENT_355	[p28l8t132r113b196],
9	risk	NN	O	risk	nsubj	14	SENT_355	[p28l148t132r281b196],
10	of	IN	O	of	_	0	SENT_355	[p28l316t132r397b196],
11	treatment	NN	O	treatment	nn	12	SENT_355	[p28l420t141r752b196],
12	failure	NN	O	failure	prep_of	9	SENT_355	[p28l788t132r1012b196],
13	was	VBD	O	be	cop	14	SENT_355	[p28l1047t153r1182b196],
14	higher	JJR	O	higher	ccomp	6	SENT_355	[p28l1218t132r1445b214],
15	in	IN	O	in	_	0	SENT_355	[p28l1479t132r1546b195],
16	genotypic	JJ	O	genotypic	amod	18	SENT_355	[p28l1581t132r1927b214],
17	rapid	JJ	O	rapid	amod	18	SENT_355	[p28l1962t132r2143b214],
18	acetylators	NNS	O	acetylator	prep_in	14	SENT_355	[p28l10t243r408b324],
19	,	,	O	,	_	0	SENT_355	[p28l10t243r408b324],
20	treated	VBN	O	treat	partmod	18	SENT_355	[p28l437t243r677b307],
21	with	IN	O	with	_	0	SENT_355	[p28l701t243r858b307],
22	the	DT	O	the	det	24	SENT_355	[p28l883t243r989b307],
23	conventional	JJ	O	conventional	amod	24	SENT_355	[p28l1019t243r1473b307],
24	dosage	NN	O	dosage	prep_with	20	SENT_355	[p28l1502t243r1745b324],
25	of	IN	O	of	_	0	SENT_355	[p28l1775t243r1856b307],
26	INH	NNP	MISC	INH	prep_of	24	SENT_355	[p28l1872t245r2045b320],
27	,	,	O	,	_	0	SENT_355	[p28l1872t245r2045b320],
28	in	IN	O	in	_	0	SENT_355	[p28l2077t243r2143b305],
29	the	DT	O	the	det	31	SENT_355	[p28l8t354r113b418],
30	present	JJ	DATE	present	amod	31	SENT_355	[p28l146t363r403b435],
31	study	NN	O	study	prep_in	14	SENT_355	[p28l438t354r637b435],
32	.	.	O	.	_	0	SENT_355	[p28l438t354r637b435],

1	Accumulating	VBG	O	accumulate	amod	2	SENT_356	[p28l675t354r1175b435],
2	evidence	NN	O	evidence	nsubj	4	SENT_356	[p28l1212t354r1522b418],
3	has	VBZ	O	have	aux	4	SENT_356	[p28l1555t354r1671b418],
4	revealed	VBN	O	reveal	_	0	SENT_356	[p28l1705t354r2005b418],
5	the	DT	O	the	det	6	SENT_356	[p28l2036t354r2141b418],
6	mechanisms	NNS	O	mechanism	dobj	4	SENT_356	[p28l8t465r442b529],
7	of	IN	O	of	_	0	SENT_356	[p28l471t465r552b529],
8	treatment	NN	O	treatment	nn	9	SENT_356	[p28l565t473r898b529],
9	failure	NN	O	failure	prep_of	6	SENT_356	[p28l923t465r1146b529],
10	with	IN	O	with	_	0	SENT_356	[p28l1172t465r1328b529],
11	the	DT	O	the	det	14	SENT_356	[p28l1352t465r1458b529],
12	four-drug	JJ	O	four-drug	amod	14	SENT_356	[p28l1485t465r1819b546],
13	standard	JJ	O	standard	amod	14	SENT_356	[p28l1847t465r2144b529],
14	regimen	NN	O	regimen	prep_with	4	SENT_356	[p28l7t576r313b658],
15	.	.	O	.	_	0	SENT_356	[p28l7t576r313b658],

1	Patients	NNS	O	patient	dep	7	SENT_357	[p28l344t576r620b640],
2	with	IN	O	with	_	0	SENT_357	[p28l645t576r802b640],
3	low	JJ	O	low	amod	6	SENT_357	[p28l828t576r959b640],
4	INH	NN	O	inh	nn	6	SENT_357	[p28l984t579r1138b640],
5	plasma	NN	O	plasma	nn	6	SENT_357	[p28l1162t576r1413b658],
6	concentrations	NNS	O	concentration	prep_with	7	SENT_357	[p28l1439t576r1950b640],
7	have	VBP	O	have	_	0	SENT_357	[p28l1976t576r2141b640],
8	a	DT	O	a	det	9	SENT_357	[p28l10t708r47b751],
9	propensity	NN	O	propensity	dobj	7	SENT_357	[p28l92t687r494b769],
10	for	IN	O	for	_	0	SENT_357	[p28l544t687r651b751],
11	treatment	NN	O	treatment	nn	12	SENT_357	[p28l697t696r1054b751],
12	failure	NN	O	failure	prep_for	9	SENT_357	[p28l1103t687r1346b751],
13	or	CC	O	or	_	0	SENT_357	[p28l1397t708r1472b751],
14	early	JJ	O	early	amod	15	SENT_357	[p28l1520t687r1705b769],
15	relapse	NN	O	relapse	dobj	7	SENT_357	[p28l1752t687r2019b769],
16	of	IN	O	of	_	0	SENT_357	[p28l2069t687r2153b751],
17	tuberculosis	NN	O	tuberculosis	prep_of	15	SENT_357	[p28l14t798r438b861],
18	[	CD	NUMBER	[	num	17	SENT_357	[p28l486t799r776b877],
19	27	CD	NUMBER	27	num	22	SENT_357	[p28l486t799r776b877],
20	—	NN	O	—	nn	22	SENT_357	[p28l486t799r776b877],
21	29	CD	NUMBER	29	num	22	SENT_357	[p28l486t799r776b877],
22	]	NN	O	]	nsubj	7	SENT_357	[p28l486t799r776b877],
23	.	.	O	.	_	0	SENT_357	[p28l486t799r776b877],

1	Indeed	RB	O	indeed	dep	9	SENT_358	[p28l822t798r1079b874],
2	,	,	O	,	_	0	SENT_358	[p28l822t798r1079b874],
3	in	IN	O	in	conj_and	1	SENT_358	[p28l1124t798r1190b860],
4	Vitro	NNP	O	Vitro	pobj	3	SENT_358	[p28l1229t798r1392b861],
5	and	CC	O	and	_	0	SENT_358	[p28l1437t798r1562b861],
6	in	FW	O	in	nn	7	SENT_358	[p28l1602t798r1668b860],
7	vivo	FW	O	vivo	dep	9	SENT_358	[p28l1708t798r1862b861],
8	animal	NN	O	animal	nn	9	SENT_358	[p28l1907t798r2142b860],
9	studies	NNS	O	study	nsubj	11	SENT_358	[p28l18t908r256b971],
10	have	VBP	O	have	aux	11	SENT_358	[p28l288t908r454b971],
11	demonstrated	VBN	O	demonstrate	_	0	SENT_358	[p28l488t908r960b971],
12	that	IN	O	that	complm	20	SENT_358	[p28l990t908r1122b971],
13	the	DT	O	the	det	16	SENT_358	[p28l1151t908r1257b971],
14	cumulative	JJ	O	cumulative	amod	16	SENT_358	[p28l1290t908r1678b971],
15	antibacterial	JJ	O	antibacterial	amod	16	SENT_358	[p28l1712t908r2143b971],
16	effect	NN	O	effect	nsubjpass	20	SENT_358	[p28l17t1018r212b1081],
17	of	IN	O	of	_	0	SENT_358	[p28l255t1018r336b1081],
18	INH	NN	MISC	inh	prep_of	16	SENT_358	[p28l368t1021r521b1081],
19	is	VBZ	O	be	auxpass	20	SENT_358	[p28l565t1018r619b1081],
20	associated	VBN	O	associate	ccomp	11	SENT_358	[p28l665t1018r1025b1081],
21	with	IN	O	with	_	0	SENT_358	[p28l1065t1018r1221b1081],
22	the	DT	O	the	det	23	SENT_358	[p28l1263t1018r1368b1081],
23	area	NN	O	area	prep_with	20	SENT_358	[p28l1413t1039r1556b1081],
24	under	IN	O	under	_	0	SENT_358	[p28l1596t1018r1800b1081],
25	the	DT	O	the	det	26	SENT_358	[p28l1839t1018r1944b1081],
26	INH	NN	MISC	inh	prep_under	20	SENT_358	[p28l1988t1021r2142b1081],

1	concentration	NN	O	concentration	nsubj	4	SENT_359	[p28l16t1128r494b1192],
2	versus	CC	O	versus	prep	1	SENT_359	[p28l521t1149r743b1192],
3	time	NN	O	time	dep	2	SENT_359	[p28l773t1128r926b1192],
4	curve	NN	O	curve	_	0	SENT_359	[p28l957t1149r1148b1192],
5	[	CD	NUMBER	[	num	7	SENT_359	[p28l1183t1129r1339b1209],
6	30	CD	NUMBER	30	num	7	SENT_359	[p28l1183t1129r1339b1209],
7	]	NN	O	]	dobj	4	SENT_359	[p28l1183t1129r1339b1209],
8	.	.	O	.	_	0	SENT_359	[p28l1183t1129r1339b1209],

1	In	IN	O	in	_	0	SENT_360	[p28l1373t1131r1444b1191],
2	combination	NN	O	combination	nn	3	SENT_360	[p28l1473t1128r1913b1192],
3	therapy	NN	O	therapy	prep_in	14	SENT_360	[p28l1940t1128r2141b1192, p28l13t1259r103b1320],
4	for	IN	O	for	_	0	SENT_360	[p28l134t1239r235b1303],
5	tuberculosis	NN	O	tuberculosis	prep_for	3	SENT_360	[p28l262t1239r707b1316],
6	,	,	O	,	_	0	SENT_360	[p28l262t1239r707b1316],
7	the	DT	O	the	det	9	SENT_360	[p28l740t1239r845b1303],
8	main	JJ	O	main	amod	9	SENT_360	[p28l876t1239r1052b1302],
9	population	NN	O	population	nsubj	14	SENT_360	[p28l1079t1239r1459b1320],
10	of	IN	O	of	_	0	SENT_360	[p28l1490t1239r1571b1303],
11	M.	NN	O	m.	nn	12	SENT_360	[p28l1587t1241r1675b1302],
12	tuberculosis	NN	O	tuberculosis	prep_of	9	SENT_360	[p28l1718t1239r2141b1302],
13	is	VBZ	O	be	cop	14	SENT_360	[p28l16t1350r72b1414],
14	susceptible	JJ	O	susceptible	_	0	SENT_360	[p28l123t1350r530b1432],
15	to	TO	O	to	_	0	SENT_360	[p28l576t1359r644b1414],
16	INH	NNP	MISC	INH	prep_to	14	SENT_360	[p28l693t1353r872b1428],
17	,	,	O	,	_	0	SENT_360	[p28l693t1353r872b1428],
18	while	IN	O	while	mark	21	SENT_360	[p28l920t1350r1123b1414],
19	pyrazinamide	NN	O	pyrazinamide	nsubj	21	SENT_360	[p28l1168t1350r1670b1432],
20	is	VBZ	O	be	cop	21	SENT_360	[p28l1719t1350r1774b1414],
21	effective	JJ	O	effective	advcl	14	SENT_360	[p28l1824t1350r2141b1414],
22	against	IN	O	against	_	0	SENT_360	[p28l17t1461r265b1543],
23	slower	JJR	O	slower	amod	25	SENT_360	[p28l296t1461r528b1525],
24	growing	VBG	O	grow	amod	25	SENT_360	[p28l556t1461r848b1543],
25	bacilli	NNS	O	bacillus	prep_against	21	SENT_360	[p28l877t1461r1096b1525],
26	in	IN	O	in	_	0	SENT_360	[p28l1127t1461r1193b1524],
27	acidic	JJ	O	acidic	amod	28	SENT_360	[p28l1224t1461r1429b1525],
28	milieus	NNS	O	milieu	prep_in	25	SENT_360	[p28l1460t1461r1736b1539],
29	,	,	O	,	_	0	SENT_360	[p28l1460t1461r1736b1539],
30	and	CC	O	and	_	0	SENT_360	[p28l1772t1461r1897b1525],
31	rifampicin	NN	O	rifampicin	prep_against	21	SENT_360	[p28l1925t1461r2140b1525, p28l13t1572r191b1654],
32	against	IN	O	against	_	0	SENT_360	[p28l235t1572r485b1654],
33	nonreplicating	JJ	O	nonreplicating	amod	34	SENT_360	[p28l525t1572r1038b1654],
34	bacilli	NNS	O	bacillus	prep_against	31	SENT_360	[p28l1079t1572r1317b1636],
35	.	.	O	.	_	0	SENT_360	[p28l1079t1572r1317b1636],

1	During	IN	O	during	_	0	SENT_361	[p28l1366t1572r1616b1654],
2	the	DT	DURATION	the	det	7	SENT_361	[p28l1658t1572r1764b1636],
3	first	JJ	DURATION	first	amod	7	SENT_361	[p28l1810t1572r1949b1636],
4	2	CD	DURATION	2	number	6	SENT_361	[p28l1991t1573r2030b1635],
5	to	TO	DURATION	to	dep	6	SENT_361	[p28l2075t1581r2140b1636],
6	5	CD	DURATION	5	num	7	SENT_361	[p28l18t1685r52b1747],
7	days	NNS	NUMBER	day	prep_during	17	SENT_361	[p28l91t1683r248b1765],
8	of	IN	O	of	_	0	SENT_361	[p28l284t1683r365b1747],
9	the	DT	O	the	det	11	SENT_361	[p28l385t1683r490b1747],
10	multidrug	JJ	O	multidrug	amod	11	SENT_361	[p28l523t1683r869b1765],
11	therapy	NN	O	therapy	prep_of	7	SENT_361	[p28l902t1683r1178b1765],
12	,	,	O	,	_	0	SENT_361	[p28l902t1683r1178b1765],
13	the	DT	O	the	det	15	SENT_361	[p28l1214t1683r1319b1747],
14	bactericidal	JJ	O	bactericidal	amod	15	SENT_361	[p28l1351t1683r1760b1747],
15	activity	NN	O	activity	nsubjpass	17	SENT_361	[p28l1793t1683r2054b1765],
16	is	VBZ	O	be	auxpass	17	SENT_361	[p28l2087t1683r2140b1747],
17	derived	VBN	O	derive	_	0	SENT_361	[p28l16t1794r279b1858],
18	mainly	RB	O	mainly	advmod	17	SENT_361	[p28l302t1794r546b1876],
19	from	IN	O	from	_	0	SENT_361	[p28l572t1794r740b1858],
20	INH	NN	O	inh	prep_from	17	SENT_361	[p28l764t1796r918b1858],
21	[	CD	NUMBER	[	number	22	SENT_361	[p28l948t1795r1078b1874],
22	31	CD	NUMBER	31	dep	20	SENT_361	[p28l948t1795r1078b1874],
23	,	,	O	,	_	0	SENT_361	[p28l948t1795r1078b1874],
24	32	CD	NUMBER	32	num	25	SENT_361	[p28l1108t1795r1239b1874],
25	]	NN	O	]	appos	20	SENT_361	[p28l1108t1795r1239b1874],
26	.	.	O	.	_	0	SENT_361	[p28l1108t1795r1239b1874],

1	This	DT	O	this	det	3	SENT_362	[p28l1270t1794r1422b1858],
2	bactericidal	JJ	O	bactericidal	amod	3	SENT_362	[p28l1447t1794r1856b1858],
3	activity	NN	O	activity	nsubj	4	SENT_362	[p28l1882t1794r2143b1876],
4	ceases	VBZ	O	cease	_	0	SENT_362	[p28l16t1926r236b1969],
5	due	JJ	O	due	_	0	SENT_362	[p28l267t1905r390b1969],
6	to	TO	O	to	_	0	SENT_362	[p28l418t1914r484b1969],
7	the	DT	O	the	det	8	SENT_362	[p28l513t1905r618b1969],
8	emergence	NN	O	emergence	prep_due_to	15	SENT_362	[p28l648t1926r1025b1987],
9	of	IN	O	of	_	0	SENT_362	[p28l1055t1905r1135b1969],
10	an	DT	O	a	det	12	SENT_362	[p28l1153t1926r1234b1969],
11	INH-resistant	JJ	O	inh-resistant	amod	12	SENT_362	[p28l1262t1905r1739b1969],
12	population	NN	O	population	prep_of	8	SENT_362	[p28l1763t1905r2143b1987],
13	[	CD	NUMBER	[	number	14	SENT_362	[p28l21t2018r181b2097],
14	33	CD	NUMBER	33	num	12	SENT_362	[p28l21t2018r181b2097],
15	]	NN	O	]	dobj	4	SENT_362	[p28l21t2018r181b2097],
16	,	,	O	,	_	0	SENT_362	[p28l21t2018r181b2097],
17	resulting	VBG	O	result	partmod	4	SENT_362	[p28l227t2016r539b2098],
18	in	IN	O	in	_	0	SENT_362	[p28l583t2016r650b2079],
19	treatment	NN	O	treatment	nn	20	SENT_362	[p28l692t2025r1029b2080],
20	failure	NN	O	failure	prep_in	17	SENT_362	[p28l1073t2016r1319b2080],
21	.	.	O	.	_	0	SENT_362	[p28l1073t2016r1319b2080],

1	In	IN	O	in	_	0	SENT_363	[p28l1368t2019r1440b2079],
2	the	DT	O	the	det	4	SENT_363	[p28l1482t2016r1588b2080],
3	present	JJ	DATE	present	amod	4	SENT_363	[p28l1631t2025r1890b2098],
4	study	NN	O	study	prep_in	13	SENT_363	[p28l1936t2016r2139b2098],
5	,	,	O	,	_	0	SENT_363	[p28l1936t2016r2139b2098],
6	NAT2	NN	O	nat2	nn	8	SENT_363	[p28l12t2128r227b2191],
7	genotype-guided	JJ	O	genotype-guided	amod	8	SENT_363	[p28l270t2127r863b2209],
8	dosing	NN	O	dosing	nn	9	SENT_363	[p28l903t2127r1136b2209],
9	stratiﬁcation	NN	O	stratiﬁcation	nsubj	13	SENT_363	[p28l1178t2127r1616b2191],
10	of	IN	O	of	_	0	SENT_363	[p28l1656t2127r1737b2191],
11	INH	NN	O	inh	prep_of	9	SENT_363	[p28l1765t2130r1919b2191],
12	obviously	RB	O	obviously	advmod	13	SENT_363	[p28l1959t2127r2140b2191, p28l16t2238r205b2319],
13	improves	VBZ	O	improve	_	0	SENT_363	[p28l246t2238r570b2319],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_363	[p28l612t2238r1000b2319],
15	efﬁcacy	NN	O	efﬁcacy	dobj	13	SENT_363	[p28l1044t2238r1321b2319],
16	against	IN	O	against	_	0	SENT_363	[p28l1364t2238r1612b2319],
17	INH-sensitive	JJ	MISC	inh-sensitive	amod	18	SENT_363	[p28l1650t2238r2141b2302],
18	tuberculosis	NN	O	tuberculosis	prep_against	15	SENT_363	[p28l14t2349r440b2413],
19	during	IN	O	during	_	0	SENT_363	[p28l485t2349r713b2431],
20	the	DT	DURATION	the	det	23	SENT_363	[p28l756t2349r862b2413],
21	first	JJ	DURATION	first	amod	23	SENT_363	[p28l907t2349r1046b2413],
22	8	CD	DURATION	8	num	23	SENT_363	[p28l1090t2351r1125b2413],
23	weeks	NNS	NUMBER	week	prep_during	13	SENT_363	[p28l1171t2349r1410b2427],
24	,	,	O	,	_	0	SENT_363	[p28l1171t2349r1410b2427],
25	although	IN	O	although	mark	30	SENT_363	[p28l1458t2349r1767b2431],
26	the	DT	O	the	det	27	SENT_363	[p28l1808t2349r1914b2413],
27	PGxtreatment	NN	O	pgxtreatment	nsubj	30	SENT_363	[p28l1957t2351r2141b2414, p28l14t2469r346b2524],
28	could	MD	O	could	aux	30	SENT_363	[p28l371t2460r566b2524],
29	not	RB	O	not	neg	30	SENT_363	[p28l590t2469r703b2524],
30	start	VB	O	start	advcl	13	SENT_363	[p28l730t2469r877b2524],
31	until	IN	O	until	_	0	SENT_363	[p28l899t2460r1060b2524],
32	a	DT	DURATION	a	det	33	SENT_363	[p28l1088t2481r1125b2524],
33	couple	NN	DURATION	couple	prep_until	30	SENT_363	[p28l1150t2460r1381b2542],
34	of	IN	DURATION	of	_	0	SENT_363	[p28l1409t2461r1490b2524],
35	days	NNS	DURATION	day	prep_of	33	SENT_363	[p28l1506t2460r1663b2542],
36	after	IN	O	after	_	0	SENT_363	[p28l1692t2460r1850b2524],
37	the	DT	O	the	det	39	SENT_363	[p28l1873t2460r1978b2524],
38	first	JJ	ORDINAL	first	amod	39	SENT_363	[p28l2006t2460r2144b2524],
39	dose	NN	O	dose	prep_after	30	SENT_363	[p28l16t2571r192b2635],
40	.	.	O	.	_	0	SENT_363	[p28l16t2571r192b2635],

1	This	DT	O	this	det	2	SENT_364	[p28l231t2571r384b2635],
2	fact	NN	O	fact	nsubj	4	SENT_364	[p28l420t2571r548b2635],
3	strongly	RB	O	strongly	advmod	4	SENT_364	[p28l583t2571r868b2653],
4	indicates	VBZ	O	indicate	_	0	SENT_364	[p28l901t2571r1210b2635],
5	that	IN	O	that	complm	17	SENT_364	[p28l1244t2571r1375b2634],
6	appropriate	JJ	O	appropriate	amod	8	SENT_364	[p28l1409t2571r1805b2653],
7	dose	NN	O	dose	nn	8	SENT_364	[p28l1840t2571r1998b2635],
8	adjustment	NN	O	adjustment	nsubj	17	SENT_364	[p28l2034t2571r2141b2635, p28l7t2682r318b2764],
9	of	IN	O	of	_	0	SENT_364	[p28l346t2682r427b2746],
10	INH	NN	O	inh	prep_of	8	SENT_364	[p28l445t2684r599b2745],
11	at	IN	O	at	_	0	SENT_364	[p28l629t2690r690b2745],
12	the	DT	O	the	det	13	SENT_364	[p28l716t2682r821b2746],
13	beginning	NN	O	beginning	prep_at	10	SENT_364	[p28l849t2682r1203b2764],
14	of	IN	O	of	_	0	SENT_364	[p28l1233t2682r1314b2746],
15	therapy	NN	O	therapy	prep_of	13	SENT_364	[p28l1331t2682r1594b2764],
16	is	VBZ	O	be	cop	17	SENT_364	[p28l1624t2682r1677b2746],
17	important	JJ	O	important	ccomp	4	SENT_364	[p28l1708t2682r2049b2764],
18	to	TO	O	to	aux	19	SENT_364	[p28l2075t2691r2140b2746],
19	avoid	VB	O	avoid	xcomp	17	SENT_364	[p28l17t2793r210b2857],
20	treatment	NN	O	treatment	nn	21	SENT_364	[p28l244t2801r576b2857],
21	failure	NN	O	failure	dobj	19	SENT_364	[p28l611t2793r835b2857],
22	and	CC	O	and	_	0	SENT_364	[p28l873t2793r998b2857],
23	the	DT	O	the	det	24	SENT_364	[p28l1031t2793r1137b2857],
24	relapse	NN	O	relapse	conj_and	21	SENT_364	[p28l1172t2793r1418b2875],
25	of	IN	O	of	_	0	SENT_364	[p28l1456t2793r1537b2857],
26	tuberculosis	NN	O	tuberculosis	prep_of	24	SENT_364	[p28l1560t2793r2004b2870],
27	,	,	O	,	_	0	SENT_364	[p28l1560t2793r2004b2870],
28	especially	RB	O	especially	advmod	19	SENT_364	[p28l2044t2813r2141b2857, p28l13t2904r292b2986],
29	for	IN	O	for	_	0	SENT_364	[p28l317t2904r418b2968],
30	patients	NNS	O	patient	prep_for	19	SENT_364	[p28l437t2904r710b2986],
31	infected	VBN	O	infect	partmod	30	SENT_364	[p28l737t2904r1018b2968],
32	with	IN	O	with	_	0	SENT_364	[p28l1040t2904r1196b2968],
33	M.	NN	O	m.	nn	34	SENT_364	[p28l1216t2907r1304b2968],
34	tubeculusosis	NN	O	tubeculusosis	prep_with	31	SENT_364	[p28l1340t2904r1811b2968],
35	sensitive	JJ	O	sensitive	amod	34	SENT_364	[p28l1839t2904r2142b2968],
36	to	TO	O	to	_	0	SENT_364	[p28l14t3024r79b3078],
37	INH	NN	O	inh	prep_to	35	SENT_364	[p28l111t3018r282b3078],
38	.	.	O	.	_	0	SENT_364	[p28l111t3018r282b3078],

1	Of	IN	O	of	_	0	SENT_365	[p28l118t3125r218b3188],
2	note	NN	O	note	prep_of	12	SENT_365	[p28l242t3134r412b3202],
3	,	,	O	,	_	0	SENT_365	[p28l242t3134r412b3202],
4	the	DT	O	the	det	6	SENT_365	[p28l450t3125r556b3188],
5	success	NN	O	success	nn	6	SENT_365	[p28l595t3146r854b3188],
6	rate	NN	O	rate	nsubj	12	SENT_365	[p28l890t3134r1019b3188],
7	for	IN	O	for	_	0	SENT_365	[p28l1057t3125r1158b3188],
8	anti-tuberculosis	JJ	O	anti-tuberculosis	amod	9	SENT_365	[p28l1193t3125r1775b3188],
9	treatment	NN	O	treatment	prep_for	6	SENT_365	[p28l1812t3134r2144b3188],
10	has	VBZ	O	have	aux	12	SENT_365	[p28l14t3235r129b3299],
11	been	VBN	O	be	cop	12	SENT_365	[p28l162t3235r329b3299],
12	lower	JJR	O	lower	_	0	SENT_365	[p28l363t3235r562b3299],
13	in	IN	O	in	_	0	SENT_365	[p28l594t3235r660b3298],
14	Japan	NNP	LOCATION	Japan	prep_in	12	SENT_365	[p28l692t3237r892b3316],
15	than	IN	O	than	mark	19	SENT_365	[p28l924t3235r1075b3298],
16	in	IN	O	in	_	0	SENT_365	[p28l1108t3235r1174b3297],
17	Western	JJ	MISC	western	amod	18	SENT_365	[p28l1206t3237r1492b3299],
18	countries	NNS	O	country	prep_in	19	SENT_365	[p28l1526t3235r1844b3299],
19	[	VBP	O	[	advcl	12	SENT_365	[p28l1884t3236r1968b3315],
20	1	CD	NUMBER	1	dobj	19	SENT_365	[p28l1884t3236r1968b3315],
21	,	,	O	,	_	0	SENT_365	[p28l1884t3236r1968b3315],
22	34	CD	NUMBER	34	num	23	SENT_365	[p28l2007t3236r2137b3315],
23	]	NN	O	]	appos	20	SENT_365	[p28l2007t3236r2137b3315],
24	.	.	O	.	_	0	SENT_365	[p28l2007t3236r2137b3315],

1	Although	IN	O	although	mark	10	SENT_366	[p28l14t3346r349b3428],
2	a	DT	O	a	det	4	SENT_366	[p28l386t3367r423b3410],
3	Japanese	JJ	MISC	japanese	amod	4	SENT_366	[p28l456t3349r767b3428],
4	authority	NN	O	authority	nsubj	10	SENT_366	[p28l806t3346r1134b3428],
5	,	,	O	,	_	0	SENT_366	[p28l806t3346r1134b3428],
6	JATA	NN	ORGANIZATION	ja	appos	4	SENT_366	[p28l1173t3348r1390b3424],
7	,	,	O	,	_	0	SENT_366	[p28l1173t3348r1390b3424],
8	has	VBZ	O	have	aux	10	SENT_366	[p28l1428t3346r1543b3410],
9	been	VBN	O	be	aux	10	SENT_366	[p28l1579t3346r1746b3410],
10	propelling	VBG	O	propel	advcl	34	SENT_366	[p28l1779t3346r2142b3428],
11	WHO-recommended	JJ	MISC	who-recommended	amod	12	SENT_366	[p28l14t3457r756b3521],
12	programs	NNS	O	program	dobj	10	SENT_366	[p28l790t3478r1143b3539],
13	,	,	O	,	_	0	SENT_366	[p28l790t3478r1143b3539],
14	and	CC	O	and	_	0	SENT_366	[p28l1185t3457r1310b3521],
15	has	VBZ	O	have	aux	16	SENT_366	[p28l1346t3457r1461b3521],
16	changed	VBN	O	change	advcl	34	SENT_366	[p28l1501t3457r1795b3539],
17	the	DT	O	the	det	20	SENT_366	[p28l1830t3457r1935b3521],
18	standard	JJ	O	standard	amod	20	SENT_366	[p28l1977t3466r2141b3521, p28l16t3568r170b3632],
19	INH	NN	O	inh	nn	20	SENT_366	[p28l196t3571r350b3632],
20	dose	NN	O	dose	dobj	16	SENT_366	[p28l377t3568r535b3632],
21	from	IN	O	from	_	0	SENT_366	[p28l563t3568r732b3632],
22	400-450	CD	NUMBER	400-450	num	23	SENT_366	[p28l756t3569r1064b3632],
23	mg	NN	O	mg	prep_from	16	SENT_366	[p28l1091t3589r1203b3650],
24	to	TO	O	to	_	0	SENT_366	[p28l1228t3577r1293b3632],
25	300	CD	NUMBER	300	num	26	SENT_366	[p28l1323t3570r1450b3632],
26	mg	NN	O	mg	prep_to	16	SENT_366	[p28l1477t3589r1608b3650],
27	,	,	O	,	_	0	SENT_366	[p28l1477t3589r1608b3650],
28	the	DT	O	the	det	30	SENT_366	[p28l1636t3568r1742b3632],
29	treatmentsuccess	NN	O	treatmentsuccess	nn	30	SENT_366	[p28l1767t3577r2145b3632, p28l18t3700r276b3743],
30	rate	NN	O	rate	nsubjpass	34	SENT_366	[p28l304t3688r433b3743],
31	has	VBZ	O	have	aux	34	SENT_366	[p28l460t3679r575b3743],
32	not	RB	O	not	neg	34	SENT_366	[p28l604t3688r718b3743],
33	been	VBN	O	be	auxpass	34	SENT_366	[p28l742t3679r909b3743],
34	improved	VBN	O	improve	_	0	SENT_366	[p28l937t3679r1274b3761],
35	in	IN	O	in	_	0	SENT_366	[p28l1302t3679r1368b3742],
36	Japan	NNP	LOCATION	Japan	prep_in	34	SENT_366	[p28l1395t3682r1611b3761],
37	.	.	O	.	_	0	SENT_366	[p28l1395t3682r1611b3761],

1	Global	NNP	O	Global	nn	2	SENT_367	[p28l1645t3679r1882b3743],
2	Health	NNP	O	Health	_	0	SENT_367	[p28l1909t3679r2142b3743],

1	Observatory	NNP	ORGANIZATION	Observatory	nn	2	SENT_368	[p29l17t21r450b103],
2	Data	NNP	ORGANIZATION	Data	nsubj	3	SENT_368	[p29l483t24r649b85],
3	reported	VBD	O	report	_	0	SENT_368	[p29l680t21r973b103],
4	that	IN	O	that	complm	11	SENT_368	[p29l1005t21r1137b85],
5	smear-positive	JJ	O	smear-positive	amod	8	SENT_368	[p29l1172t21r1684b103],
6	tuberculosis	NN	O	tuberculosis	nn	8	SENT_368	[p29l1717t21r2140b85],
7	treatment-success	NN	O	treatment-success	nn	8	SENT_368	[p29l14t141r637b196],
8	rates	NNS	O	rate	nsubj	11	SENT_368	[p29l664t142r826b196],
9	were	VBD	O	be	cop	11	SENT_368	[p29l853t153r1023b196],
10	52	CD	PERCENT	52	num	11	SENT_368	[p29l1052t134r1133b196],
11	%	NN	PERCENT	%	ccomp	3	SENT_368	[p29l1164t134r1233b198],
12	in	IN	O	in	_	0	SENT_368	[p29l1262t132r1328b195],
13	Japan	NNP	LOCATION	Japan	prep_in	11	SENT_368	[p29l1353t135r1553b214],
14	and	CC	O	and	_	0	SENT_368	[p29l1581t132r1706b196],
15	69-95	CD	PERCENT	69-95	num	16	SENT_368	[p29l1734t134r1948b196],
16	%	NN	PERCENT	%	conj_and	11	SENT_368	[p29l1980t134r2049b198],
17	in	IN	O	in	_	0	SENT_368	[p29l2077t132r2143b195],
18	Europe	NNP	LOCATION	Europe	prep_in	16	SENT_368	[p29l15t246r267b325],
19	in	IN	O	in	_	0	SENT_368	[p29l300t243r366b306],
20	2009	CD	DATE	2009	num	21	SENT_368	[p29l395t245r568b307],
21	[	CD	NUMBER	[	prep_in	18	SENT_368	[p29l607t245r718b324],
22	1	CD	NUMBER	1	num	23	SENT_368	[p29l607t245r718b324],
23	]	NN	O	]	dep	16	SENT_368	[p29l607t245r718b324],
24	.	.	O	.	_	0	SENT_368	[p29l607t245r718b324],

1	The	DT	O	the	det	4	SENT_369	[p29l754t243r888b307],
2	lower	JJR	O	lower	amod	4	SENT_369	[p29l920t243r1119b307],
3	success	NN	O	success	nn	4	SENT_369	[p29l1150t264r1408b307],
4	rate	NN	O	rate	nsubjpass	11	SENT_369	[p29l1439t252r1568b307],
5	in	IN	O	in	_	0	SENT_369	[p29l1600t243r1666b306],
6	the	DT	O	the	det	8	SENT_369	[p29l1694t243r1800b307],
7	Japanese	JJ	MISC	japanese	amod	8	SENT_369	[p29l1831t246r2142b325],
8	population	NN	O	population	prep_in	4	SENT_369	[p29l13t354r393b436],
9	might	MD	O	might	aux	11	SENT_369	[p29l424t354r630b436],
10	be	VB	O	be	auxpass	11	SENT_369	[p29l660t354r741b418],
11	explained	VBN	O	explain	_	0	SENT_369	[p29l777t354r1118b436],
12	by	IN	O	by	_	0	SENT_369	[p29l1148t354r1237b436],
13	an	DT	O	a	det	15	SENT_369	[p29l1271t374r1351b417],
14	interethnic	JJ	O	interethnic	amod	15	SENT_369	[p29l1384t354r1755b418],
15	difference	NN	O	difference	agent	11	SENT_369	[p29l1791t354r2141b418],
16	in	IN	O	in	_	0	SENT_369	[p29l16t465r82b527],
17	NAT2	NN	O	nat2	nn	19	SENT_369	[p29l107t466r311b529],
18	genotype	NN	O	genotype	nn	19	SENT_369	[p29l342t474r663b547],
19	frequencies	NNS	O	frequency	prep_in	15	SENT_369	[p29l695t465r1114b546],
20	.	.	O	.	_	0	SENT_369	[p29l695t465r1114b546],

1	The	DT	O	the	det	2	SENT_370	[p29l1149t465r1282b529],
2	frequency	NN	O	frequency	_	0	SENT_370	[p29l1313t465r1663b547],
3	of	IN	O	of	_	0	SENT_370	[p29l1693t465r1774b529],
4	rapid	JJ	O	rapid	amod	6	SENT_370	[p29l1790t465r1972b546],
5	acetylator	NN	O	acetylator	nn	6	SENT_370	[p29l2000t485r2141b529, p29l14t576r244b657],
6	genotypes	NNS	O	genotype	prep_of	2	SENT_370	[p29l268t585r622b657],
7	in	IN	O	in	_	0	SENT_370	[p29l650t576r716b638],
8	the	DT	O	the	det	10	SENT_370	[p29l740t576r845b640],
9	Japanese	JJ	MISC	japanese	amod	10	SENT_370	[p29l871t578r1182b657],
10	population	NN	O	population	prep_in	2	SENT_370	[p29l1206t576r1586b657],
11	(	CD	NUMBER	(	num	10	SENT_370	[p29l1613t576r1901b657],
12	approx	RB	O	approx	advmod	10	SENT_370	[p29l1613t576r1901b657],
13	.	.	O	.	_	0	SENT_370	[p29l1613t576r1901b657],

1	5	CD	PERCENT	5	num	3	SENT_371	[p29l1934t578r1968b639],
2	O	CD	PERCENT	o	num	3	SENT_371	[p29l1977t577r2016b639],
3	%	NN	PERCENT	%	nsubj	12	SENT_371	[p29l2044t576r2141b657],
4	)	CD	NUMBER	)	dep	3	SENT_371	[p29l2044t576r2141b657],
5	is	VBZ	O	be	cop	12	SENT_371	[p29l16t687r70b751],
6	much	RB	O	much	advmod	7	SENT_371	[p29l104t687r300b751],
7	higher	JJR	O	higher	advmod	12	SENT_371	[p29l332t687r559b769],
8	than	IN	O	than	_	0	SENT_371	[p29l589t687r741b751],
9	that	DT	O	that	prep_than	7	SENT_371	[p29l773t687r905b751],
10	in	IN	O	in	_	0	SENT_371	[p29l938t687r1004b750],
11	Caucasians	NNPS	MISC	Caucasians	prep_in	9	SENT_371	[p29l1039t687r1431b751],
12	(	CD	NUMBER	(	_	0	SENT_371	[p29l1468t687r1757b769],
13	approx	RB	O	approx	advmod	12	SENT_371	[p29l1468t687r1757b769],
14	.	.	O	.	_	0	SENT_371	[p29l1468t687r1757b769],

1	5	CD	PERCENT	5	num	2	SENT_372	[p29l1798t690r1832b751],
2	%	NN	PERCENT	%	_	0	SENT_372	[p29l1873t687r1969b768],
3	)	CD	NUMBER	)	number	4	SENT_372	[p29l1873t687r1969b768],
4	[	CD	NUMBER	[	num	2	SENT_372	[p29l2010t688r2139b767],
5	12	CD	NUMBER	12	dep	2	SENT_372	[p29l2010t688r2139b767],
6	,	,	O	,	_	0	SENT_372	[p29l2010t688r2139b767],
7	18	CD	NUMBER	18	appos	5	SENT_372	[p29l24t800r121b875],
8	,	,	O	,	_	0	SENT_372	[p29l24t800r121b875],
9	35	CD	NUMBER	35	appos	5	SENT_372	[p29l161t800r265b875],
10	,	,	O	,	_	0	SENT_372	[p29l161t800r265b875],
11	36	CD	NUMBER	36	num	12	SENT_372	[p29l304t799r435b878],
12	]	NN	O	]	appos	5	SENT_372	[p29l304t799r435b878],
13	.	.	O	.	_	0	SENT_372	[p29l304t799r435b878],

1	Taken	VBN	O	take	partmod	13	SENT_373	[p29l476t798r689b862],
2	together	RB	O	together	advmod	1	SENT_373	[p29l722t798r1026b880],
3	,	,	O	,	_	0	SENT_373	[p29l722t798r1026b880],
4	the	DT	O	the	det	5	SENT_373	[p29l1062t798r1168b862],
5	dose	NN	O	dose	nsubj	13	SENT_373	[p29l1204t798r1363b862],
6	of	IN	O	of	_	0	SENT_373	[p29l1399t798r1480b862],
7	INH	NNP	O	INH	prep_of	5	SENT_373	[p29l1503t801r1657b862],
8	used	VBN	O	use	partmod	7	SENT_373	[p29l1690t798r1853b862],
9	in	IN	O	in	_	0	SENT_373	[p29l1888t798r1954b861],
10	conventional	JJ	O	conventional	amod	11	SENT_373	[p29l1989t819r2141b862, p29l14t909r342b972],
11	treatment	NN	O	treatment	prep_in	8	SENT_373	[p29l376t918r708b972],
12	is	VBZ	O	be	cop	13	SENT_373	[p29l743t909r796b972],
13	insufficient	JJ	O	insufficient	dep	27	SENT_373	[p29l834t909r1232b972],
14	for	IN	O	for	_	0	SENT_373	[p29l1268t909r1368b972],
15	more	JJR	O	more	mwe	16	SENT_373	[p29l1400t929r1579b972],
16	than	IN	O	than	quantmod	18	SENT_373	[p29l1614t909r1766b972],
17	a	DT	O	a	quantmod	18	SENT_373	[p29l1802t930r1839b972],
18	third	JJ	ORDINAL	third	prep_for	13	SENT_373	[p29l1872t909r2037b972],
19	of	IN	O	of	_	0	SENT_373	[p29l2073t909r2154b972],
20	Japanese	JJ	MISC	japanese	prep_of	18	SENT_373	[p29l15t1022r348b1101],
21	with	IN	O	with	_	0	SENT_373	[p29l396t1019r562b1083],
22	NAT2	NN	O	nat2	prep_with	20	SENT_373	[p29l606t1019r1039b1084],
23	*	CD	NUMBER	*	number	24	SENT_373	[p29l606t1019r1039b1084],
24	4	CD	NUMBER	4	num	22	SENT_373	[p29l606t1019r1039b1084],
25	/	:	O	/	punct	27	SENT_373	[p29l606t1019r1039b1084],
26	*	CD	NUMBER	*	num	27	SENT_373	[p29l606t1019r1039b1084],
27	4	CD	NUMBER	4	_	0	SENT_373	[p29l606t1019r1039b1084],
28	in	IN	O	in	dep	27	SENT_373	[p29l1089t1019r1158b1082],
29	achieving	VBG	O	achieve	pcomp	28	SENT_373	[p29l1207t1019r1571b1101],
30	a	DT	O	a	det	33	SENT_373	[p29l1622t1040r1659b1083],
31	satisfactory	JJ	O	satisfactory	amod	33	SENT_373	[p29l1708t1019r2143b1101],
32	treatment-success	JJ	O	treatment-success	amod	33	SENT_373	[p29l14t1139r637b1194],
33	rate	NN	O	rate	dobj	29	SENT_373	[p29l667t1139r813b1194],
34	.	.	O	.	_	0	SENT_373	[p29l667t1139r813b1194],

1	NAT	NNP	ORGANIZATION	NAT	nsubj	7	SENT_374	[p29l844t1132r1015b1194],
2	2	CD	NUMBER	2	num	1	SENT_374	[p29l1007t1132r1048b1193],
3	genotype-guided	JJ	O	genotype-guided	amod	5	SENT_374	[p29l1080t1130r1673b1212],
4	dosing	NN	O	dosing	nn	5	SENT_374	[p29l1703t1130r1936b1212],
5	stratification	NN	O	stratification	dep	1	SENT_374	[p29l1968t1139r2140b1194, p29l16t1241r328b1305],
6	would	MD	O	would	aux	7	SENT_374	[p29l374t1241r607b1305],
7	improve	VB	O	improve	_	0	SENT_374	[p29l654t1241r961b1323],
8	early	JJ	O	early	amod	11	SENT_374	[p29l1012t1241r1195b1323],
9	treatment	NN	O	treatment	nn	11	SENT_374	[p29l1241t1250r1595b1305],
10	success	NN	O	success	nn	11	SENT_374	[p29l1644t1262r1919b1305],
11	rates	NNS	O	rate	dobj	7	SENT_374	[p29l1967t1250r2141b1305],
12	against	IN	O	against	_	0	SENT_374	[p29l17t1352r265b1434],
13	tuberculosis	NN	O	tuberculosis	prep_against	11	SENT_374	[p29l294t1352r737b1429],
14	,	,	O	,	_	0	SENT_374	[p29l294t1352r737b1429],
15	especially	RB	O	especially	advmod	7	SENT_374	[p29l774t1352r1123b1434],
16	in	IN	O	in	_	0	SENT_374	[p29l1155t1352r1221b1415],
17	highly-positive	JJ	O	highly-positive	amod	19	SENT_374	[p29l1251t1352r1784b1434],
18	excretion	NN	O	excretion	nn	19	SENT_374	[p29l1819t1352r2142b1416],
19	levels	NNS	O	level	prep_in	7	SENT_374	[p29l16t1463r216b1527],
20	of	IN	O	of	_	0	SENT_374	[p29l252t1463r332b1527],
21	bacilli	NNS	O	bacillus	prep_of	19	SENT_374	[p29l352t1463r589b1540],
22	,	,	O	,	_	0	SENT_374	[p29l352t1463r589b1540],
23	if	IN	O	if	mark	30	SENT_374	[p29l626t1463r687b1525],
24	the	DT	O	the	det	26	SENT_374	[p29l707t1463r812b1527],
25	high	JJ	O	high	amod	26	SENT_374	[p29l845t1463r1002b1544],
26	dose	NN	O	dose	nsubjpass	30	SENT_374	[p29l1035t1463r1193b1527],
27	of	IN	O	of	_	0	SENT_374	[p29l1227t1463r1308b1527],
28	INH	NN	MISC	inh	prep_of	26	SENT_374	[p29l1330t1465r1484b1526],
29	was	VBD	O	be	auxpass	30	SENT_374	[p29l1515t1483r1650b1527],
30	applied	VBN	O	apply	advcl	7	SENT_374	[p29l1685t1463r1943b1544],
31	from	IN	O	from	_	0	SENT_374	[p29l1976t1463r2144b1527],
32	the	DT	O	the	det	34	SENT_374	[p29l14t1574r120b1638],
33	first	JJ	ORDINAL	first	amod	34	SENT_374	[p29l151t1574r290b1638],
34	prescription	NN	O	prescription	prep_from	30	SENT_374	[p29l315t1574r736b1655],
35	exclusively	RB	O	exclusively	advmod	30	SENT_374	[p29l767t1574r1166b1655],
36	to	TO	O	to	_	0	SENT_374	[p29l1194t1582r1259b1638],
37	rapid	JJ	O	rapid	amod	38	SENT_374	[p29l1289t1574r1470b1655],
38	acetylators	NNS	O	acetylator	prep_to	30	SENT_374	[p29l1499t1574r1893b1655],
39	.	.	O	.	_	0	SENT_374	[p29l1499t1574r1893b1655],

1	In	IN	O	in	_	0	SENT_375	[p29l117t1688r188b1748],
2	conclusion	NN	O	conclusion	prep_in	12	SENT_375	[p29l216t1685r615b1762],
3	,	,	O	,	_	0	SENT_375	[p29l216t1685r615b1762],
4	the	DT	O	the	det	6	SENT_375	[p29l645t1685r750b1749],
5	present	JJ	DATE	present	amod	6	SENT_375	[p29l777t1694r1033b1767],
6	pharmacogenetics	NNS	O	pharmacogenetic	nn	8	SENT_375	[p29l1056t1685r1692b1767],
7	clinical	JJ	O	clinical	amod	8	SENT_375	[p29l1722t1685r1977b1749],
8	trial	NN	O	trial	nsubj	12	SENT_375	[p29l2004t1685r2142b1749],
9	with	IN	O	with	_	0	SENT_375	[p29l14t1796r170b1860],
10	a	DT	O	a	det	11	SENT_375	[p29l210t1817r247b1860],
11	PROBE-design	NN	O	probe-design	prep_with	8	SENT_375	[p29l284t1796r830b1878],
12	demonstrated	VBD	O	demonstrate	_	0	SENT_375	[p29l869t1796r1343b1860],
13	that	IN	O	that	complm	22	SENT_375	[p29l1380t1796r1512b1860],
14	NAT	NNP	ORGANIZATION	NAT	dep	16	SENT_375	[p29l1546t1797r1716b1860],
15	2	CD	NUMBER	2	num	14	SENT_375	[p29l1709t1798r1750b1859],
16	genotypeguided	JJ	O	genotypeguided	amod	18	SENT_375	[p29l1791t1805r2141b1878, p29l16t1907r255b1989],
17	dosing	NN	O	dosing	nn	18	SENT_375	[p29l280t1907r513b1989],
18	stratification	NN	O	stratification	nsubj	22	SENT_375	[p29l540t1907r980b1971],
19	of	IN	O	of	_	0	SENT_375	[p29l1004t1907r1085b1971],
20	INH	NN	O	inh	prep_of	18	SENT_375	[p29l1099t1910r1252b1971],
21	could	MD	O	could	aux	22	SENT_375	[p29l1279t1907r1473b1971],
22	improve	VB	O	improve	ccomp	12	SENT_375	[p29l1497t1907r1787b1989],
23	treatment	NN	O	treatment	nn	24	SENT_375	[p29l1812t1916r2144b1971],
24	outcomes	NNS	O	outcome	dobj	22	SENT_375	[p29l16t2027r351b2082],
25	in	IN	O	in	_	0	SENT_375	[p29l386t2018r452b2081],
26	patients	NNS	O	patient	prep_in	22	SENT_375	[p29l482t2018r755b2100],
27	with	IN	O	with	_	0	SENT_375	[p29l789t2018r945b2082],
28	drug-sensitive	JJ	O	drug-sensitive	amod	29	SENT_375	[p29l979t2018r1474b2100],
29	tuberculosis	NN	O	tuberculosis	prep_with	26	SENT_375	[p29l1508t2018r1950b2082],
30	.	.	O	.	_	0	SENT_375	[p29l1508t2018r1950b2082],

1	Half	NN	O	half	nsubj	10	SENT_376	[p29l1989t2018r2153b2082],
2	of	IN	O	of	_	0	SENT_376	[p29l16t2130r97b2193],
3	the	DT	O	the	det	6	SENT_376	[p29l123t2129r228b2193],
4	conventional	JJ	O	conventional	amod	6	SENT_376	[p29l268t2129r721b2193],
5	standard	NN	O	standard	nn	6	SENT_376	[p29l762t2129r1057b2193],
6	dose	NN	O	dose	prep_of	1	SENT_376	[p29l1095t2129r1254b2193],
7	for	IN	O	for	_	0	SENT_376	[p29l1294t2129r1394b2193],
8	slow	JJ	O	slow	amod	9	SENT_376	[p29l1432t2129r1595b2193],
9	acetylators	NNS	O	acetylator	prep_for	6	SENT_376	[p29l1633t2129r2009b2211],
10	reduced	VBD	O	reduce	_	0	SENT_376	[p29l2047t2150r2141b2193, p29l16t2240r225b2304],
11	INH-DILI	NN	O	inh-dili	dobj	10	SENT_376	[p29l267t2243r625b2304],
12	and	CC	O	and	_	0	SENT_376	[p29l669t2240r794b2304],
13	did	VBD	O	do	aux	15	SENT_376	[p29l836t2240r947b2304],
14	not	RB	O	not	neg	15	SENT_376	[p29l987t2249r1101b2304],
15	reduce	VB	O	reduce	conj_and	10	SENT_376	[p29l1140t2240r1373b2304],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_376	[p29l1415t2240r1803b2322],
17	efﬁcacy	NN	O	efﬁcacy	dobj	15	SENT_376	[p29l1848t2240r2138b2322],
18	.	.	O	.	_	0	SENT_376	[p29l1848t2240r2138b2322],

1	For	IN	O	for	_	0	SENT_377	[p29l15t2353r138b2415],
2	rapid	JJ	O	rapid	amod	3	SENT_377	[p29l173t2351r354b2433],
3	acetylators	NNS	O	acetylator	prep_for	13	SENT_377	[p29l393t2351r789b2433],
4	,	,	O	,	_	0	SENT_377	[p29l393t2351r789b2433],
5	1.5	CD	NUMBER	1.5	number	6	SENT_377	[p29l841t2352r936b2415],
6	times	NNS	O	time	nsubj	13	SENT_377	[p29l979t2351r1166b2415],
7	the	DT	O	the	det	10	SENT_377	[p29l1206t2351r1312b2415],
8	conventional	JJ	O	conventional	amod	10	SENT_377	[p29l1353t2351r1806b2415],
9	standard	NN	O	standard	nn	10	SENT_377	[p29l1848t2351r2143b2415],
10	dose	NN	O	dose	dep	6	SENT_377	[p29l16t2462r175b2526],
11	of	IN	O	of	_	0	SENT_377	[p29l220t2462r301b2526],
12	INH	NN	O	inh	prep_of	6	SENT_377	[p29l333t2464r487b2525],
13	reduced	VBD	O	reduce	_	0	SENT_377	[p29l530t2462r811b2526],
14	early	JJ	O	early	amod	16	SENT_377	[p29l855t2462r1027b2543],
15	treatment	NN	O	treatment	nn	16	SENT_377	[p29l1069t2470r1403b2526],
16	failures	NNS	O	failure	dobj	13	SENT_377	[p29l1445t2462r1704b2526],
17	without	IN	O	without	_	0	SENT_377	[p29l1748t2462r2020b2526],
18	an	DT	O	a	det	19	SENT_377	[p29l2063t2482r2143b2525],
19	increase	NN	O	increase	prep_without	13	SENT_377	[p29l16t2573r300b2637],
20	in	IN	O	in	_	0	SENT_377	[p29l344t2573r410b2635],
21	the	DT	O	the	det	22	SENT_377	[p29l451t2573r557b2637],
22	incidence	NN	O	incidence	prep_in	13	SENT_377	[p29l601t2573r935b2637],
23	of	IN	O	of	_	0	SENT_377	[p29l980t2573r1060b2637],
24	INH-DILI	NN	O	inh-dili	prep_of	22	SENT_377	[p29l1093t2575r1467b2637],
25	.	.	O	.	_	0	SENT_377	[p29l1093t2575r1467b2637],

1	We	PRP	O	we	nsubj	2	SENT_378	[p29l1515t2575r1629b2637],
2	propose	VBP	O	propose	_	0	SENT_378	[p29l1670t2593r1950b2654],
3	here	RB	O	here	advmod	2	SENT_378	[p29l1993t2573r2141b2637],
4	that	IN	O	that	complm	14	SENT_378	[p29l14t2684r149b2748],
5	the	DT	O	the	det	6	SENT_378	[p29l191t2684r298b2748],
6	pharmacotherapy	NN	O	pharmacotherapy	nsubjpass	14	SENT_378	[p29l341t2684r966b2766],
7	against	IN	O	against	_	0	SENT_378	[p29l1012t2684r1264b2766],
8	tuberculosis	NN	O	tuberculosis	prep_against	6	SENT_378	[p29l1306t2684r1739b2748],
9	with	IN	O	with	_	0	SENT_378	[p29l1783t2684r1943b2748],
10	INH	NN	O	inh	prep_with	8	SENT_378	[p29l1987t2687r2143b2748],
11	should	MD	O	should	aux	14	SENT_378	[p29l18t2795r251b2859],
12	be	VB	O	be	auxpass	14	SENT_378	[p29l285t2795r367b2859],
13	individually	RB	O	individually	advmod	14	SENT_378	[p29l406t2795r831b2877],
14	designed	VBN	O	design	ccomp	2	SENT_378	[p29l869t2795r1181b2877],
15	by	IN	O	by	_	0	SENT_378	[p29l1216t2795r1305b2877],
16	stratiﬁcation	NN	O	stratiﬁcation	agent	14	SENT_378	[p29l1344t2795r1783b2859],
17	based	VBN	O	base	_	0	SENT_378	[p29l1818t2795r2020b2859],
18	on	IN	O	on	prepc_based_on	14	SENT_378	[p29l2057t2816r2143b2859],

1	@	IN	O	@	_	0	SENT_379	[p29l1784t3029r1856b3118],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_379	[p29l1882t3051r2126b3121],

1	1100	CD	DATE	1100	dep	8	SENT_380	[p29l56t3196r120b3221],
2	Eur	NNP	O	Eur	nn	5	SENT_380	[p29l1486t3197r1536b3221],
3	J	NNP	O	J	nn	5	SENT_380	[p29l1547t3197r1560b3221],
4	Clin	NNP	PERSON	Clin	nn	5	SENT_380	[p29l1571t3196r1631b3221],
5	Pharmacol	NNP	PERSON	Pharmacol	dep	1	SENT_380	[p29l1642t3196r1790b3221],
6	(	CD	NUMBER	(	dep	8	SENT_380	[p29l1802t3196r1893b3228],
7	2013	CD	DATE	2013	num	8	SENT_380	[p29l1802t3196r1893b3228],
8	)	CD	NUMBER	)	dep	13	SENT_380	[p29l1802t3196r1893b3228],
9	69	CD	NUMBER	69	num	11	SENT_380	[p29l1906t3196r2103b3221],
10	:	:	O	:	_	0	SENT_380	[p29l1906t3196r2103b3221],
11	l09l	CD	NUMBER	l09l	dep	8	SENT_380	[p29l1906t3196r2103b3221],
12	—	CD	NUMBER	—	num	13	SENT_380	[p29l1906t3196r2103b3221],
13	ll0l	NN	O	ll0l	_	0	SENT_380	[p29l1906t3196r2103b3221],

1	NAT	NNP	O	NAT	_	0	SENT_381	[p29l8t3370r179b3433],
2	2	CD	NUMBER	2	num	1	SENT_381	[p29l171t3370r213b3432],
3	genetic	JJ	O	genetic	amod	4	SENT_381	[p29l252t3369r503b3451],
4	information	NN	O	information	dep	1	SENT_381	[p29l543t3369r956b3433],
5	in	IN	O	in	_	0	SENT_381	[p29l995t3369r1061b3432],
6	order	NN	O	order	prep_in	4	SENT_381	[p29l1099t3369r1284b3433],
7	to	TO	O	to	aux	8	SENT_381	[p29l1318t3378r1384b3433],
8	achieve	VB	O	achieve	infmod	1	SENT_381	[p29l1425t3369r1690b3433],
9	the	DT	O	the	det	12	SENT_381	[p29l1727t3369r1833b3433],
10	greatest	JJS	O	greatest	amod	12	SENT_381	[p29l1872t3378r2144b3451],
11	success	NN	O	success	nn	12	SENT_381	[p29l14t3500r273b3543],
12	outcome	NN	O	outcome	dobj	8	SENT_381	[p29l305t3488r606b3543],
13	for	IN	O	for	_	0	SENT_381	[p29l638t3480r739b3543],
14	each	DT	O	each	det	15	SENT_381	[p29l767t3479r925b3543],
15	patient	NN	O	patient	prep_for	12	SENT_381	[p29l953t3479r1210b3561],
16	.	.	O	.	_	0	SENT_381	[p29l953t3479r1210b3561],

1	Acknowledgements	NNS	O	acknowledgement	nsubj	3	SENT_382	[p30l10t89r635b157],
2	We	PRP	O	we	nsubj	3	SENT_382	[p30l714t89r810b142],
3	express	VBP	O	express	_	0	SENT_382	[p30l850t105r1072b157],
4	gratitude	NN	O	gratitude	dobj	3	SENT_382	[p30l1111t87r1376b157],
5	to	TO	O	to	_	0	SENT_382	[p30l1413t95r1468b142],
6	all	PDT	O	all	predet	8	SENT_382	[p30l1508t87r1580b141],
7	the	DT	O	the	det	8	SENT_382	[p30l1616t87r1706b142],
8	patients	NNS	O	patient	prep_to	3	SENT_382	[p30l1742t87r1976b157],
9	who	WP	O	who	nsubj	11	SENT_382	[p30l2013t87r2140b142],
10	voluntarily	RB	O	voluntarily	advmod	11	SENT_382	[p30l11t175r339b245],
11	contributed	VBD	O	contribute	ccomp	8	SENT_382	[p30l371t175r710b230],
12	to	TO	O	to	_	0	SENT_382	[p30l740t183r795b230],
13	the	DT	O	the	det	14	SENT_382	[p30l827t175r916b230],
14	trial	NN	O	trial	prep_to	11	SENT_382	[p30l947t175r1079b230],
15	.	.	O	.	_	0	SENT_382	[p30l947t175r1079b230],

1	We	PRP	O	we	nsubj	3	SENT_383	[p30l1114t178r1210b230],
2	are	VBP	O	be	cop	3	SENT_383	[p30l1242t193r1330b230],
3	grateful	JJ	O	grateful	_	0	SENT_383	[p30l1362t175r1591b245],
4	to	TO	O	to	_	0	SENT_383	[p30l1621t183r1677b230],
5	the	DT	O	the	det	6	SENT_383	[p30l1708t175r1797b230],
6	staff	NN	O	staff	prep_to	3	SENT_383	[p30l1831t176r1968b230],
7	at	IN	O	at	_	0	SENT_383	[p30l1990t183r2041b229],
8	all	PDT	O	all	predet	11	SENT_383	[p30l2072t175r2143b229],
9	the	DT	O	the	det	11	SENT_383	[p30l11t265r101b319],
10	various	JJ	O	various	amod	11	SENT_383	[p30l120t265r338b319],
11	sites	NNS	O	site	prep_at	6	SENT_383	[p30l361t265r488b319],
12	for	IN	O	for	_	0	SENT_383	[p30l509t265r595b319],
13	their	PRP$	O	they	poss	15	SENT_383	[p30l611t265r749b319],
14	hard	JJ	O	hard	amod	15	SENT_383	[p30l765t265r898b319],
15	work	NN	O	work	prep_for	11	SENT_383	[p30l915t265r1071b319],
16	and	CC	O	and	_	0	SENT_383	[p30l1089t265r1196b319],
17	attention	NN	O	attention	prep_for	11	SENT_383	[p30l1215t265r1475b319],
18	to	TO	O	to	_	0	SENT_383	[p30l1493t273r1548b319],
19	detail	NN	O	detail	prep_to	3	SENT_383	[p30l1569t265r1747b319],
20	.	.	O	.	_	0	SENT_383	[p30l1569t265r1747b319],

1	We	PRP	O	we	nsubj	2	SENT_384	[p30l1770t267r1867b319],
2	thank	VBP	O	thank	_	0	SENT_384	[p30l1885t265r2053b319],
3	all	PDT	O	all	predet	5	SENT_384	[p30l2072t265r2143b319],
4	the	DT	O	the	det	5	SENT_384	[p30l11t352r101b406],
5	colleagues	NNS	O	colleague	dobj	2	SENT_384	[p30l121t352r434b422],
6	of	IN	O	of	_	0	SENT_384	[p30l455t352r524b407],
7	our	PRP$	O	we	poss	8	SENT_384	[p30l535t370r634b407],
8	laboratory	NN	O	laboratory	prep_of	5	SENT_384	[p30l652t352r958b422],
9	for	IN	O	for	_	0	SENT_384	[p30l978t352r1064b406],
10	supporting	VBG	O	support	prepc_for	2	SENT_384	[p30l1083t352r1400b422],
11	the	DT	O	the	det	12	SENT_384	[p30l1420t352r1509b407],
12	study	NN	O	study	dobj	10	SENT_384	[p30l1531t352r1700b422],
13	.	.	O	.	_	0	SENT_384	[p30l1531t352r1700b422],

1	We	PRP	O	we	nsubj	3	SENT_385	[p30l1723t354r1820b407],
2	also	RB	O	also	advmod	3	SENT_385	[p30l1840t352r1956b407],
3	thank	VBP	O	thank	_	0	SENT_385	[p30l1977t352r2144b406],
4	Tsugutaka	NNP	PERSON	Tsugutaka	nn	5	SENT_385	[p30l12t440r320b510],
5	Ito	NNP	PERSON	Ito	dobj	3	SENT_385	[p30l347t443r443b506],
6	,	,	O	,	_	0	SENT_385	[p30l347t443r443b506],
7	Chuzo	NNP	PERSON	Chuzo	nn	8	SENT_385	[p30l475t440r667b495],
8	Iwata	NNP	PERSON	Iwata	conj_and	5	SENT_385	[p30l697t443r877b506],
9	,	,	O	,	_	0	SENT_385	[p30l697t443r877b506],
10	Masato	NNP	PERSON	Masato	nn	11	SENT_385	[p30l908t443r1125b495],
11	Takebe	NNP	PERSON	Takebe	conj_and	5	SENT_385	[p30l1156t440r1386b506],
12	,	,	O	,	_	0	SENT_385	[p30l1156t440r1386b506],
13	and	CC	O	and	_	0	SENT_385	[p30l1417t440r1524b495],
14	Tomoko	NNP	PERSON	Tomoko	nn	20	SENT_385	[p30l1552t440r1798b495],
15	Nishimura	NNP	PERSON	Nishimura	nn	20	SENT_385	[p30l1825t440r2144b495],
16	(	NNP	O	(	nn	20	SENT_385	[p30l13t528r476b598],
17	Pharrnacogene	NNP	ORGANIZATION	Pharrnacogene	nn	20	SENT_385	[p30l13t528r476b598],
18	Tip-Top	NNP	ORGANIZATION	Tip-Top	nn	20	SENT_385	[p30l502t529r742b598],
19	Inc.	NNP	ORGANIZATION	Inc.	nn	20	SENT_385	[p30l769t529r904b598],
20	)	NN	O	)	dobj	3	SENT_385	[p30l769t529r904b598],
21	for	IN	O	for	_	0	SENT_385	[p30l932t529r1018b583],
22	clinical	JJ	O	clinical	amod	24	SENT_385	[p30l1041t528r1258b583],
23	trial	NN	O	trial	nn	24	SENT_385	[p30l1282t528r1400b582],
24	support	NN	O	support	prep_for	20	SENT_385	[p30l1427t536r1664b598],
25	.	.	O	.	_	0	SENT_385	[p30l1427t536r1664b598],

1	Finally	RB	O	finally	advmod	5	SENT_386	[p30l1693t528r1915b598],
2	,	,	O	,	_	0	SENT_386	[p30l1693t528r1915b598],
3	we	PRP	O	we	nsubj	26	SENT_386	[p30l1942t546r2028b583],
4	are	VBP	O	be	cop	5	SENT_386	[p30l2055t546r2142b583],
5	grateful	JJ	O	grateful	_	0	SENT_386	[p30l12t616r242b686],
6	to	TO	O	to	_	0	SENT_386	[p30l264t624r319b670],
7	Uwe	NNP	PERSON	Uwe	nn	10	SENT_386	[p30l343t618r484b671],
8	Fuhr	NNP	PERSON	Fuhr	nn	10	SENT_386	[p30l507t616r650b671],
9	(	NNP	O	(	nn	10	SENT_386	[p30l672t616r1010b686],
10	University	NNP	ORGANIZATION	University	prep_to	5	SENT_386	[p30l672t616r1010b686],
11	of	IN	ORGANIZATION	of	_	0	SENT_386	[p30l1034t616r1103b671],
12	Cologne	NNP	ORGANIZATION	Cologne	nn	17	SENT_386	[p30l1117t616r1386b686],
13	,	,	O	,	_	0	SENT_386	[p30l1117t616r1386b686],
14	Koln	NNP	PERSON	Koln	appos	17	SENT_386	[p30l1411t616r1576b682],
15	,	,	O	,	_	0	SENT_386	[p30l1411t616r1576b682],
16	Germany	NNP	LOCATION	Germany	appos	17	SENT_386	[p30l1604t616r1903b686],
17	)	NNP	O	)	prep_of	10	SENT_386	[p30l1604t616r1903b686],
18	and	CC	O	and	_	0	SENT_386	[p30l1929t616r2035b671],
19	his	PRP$	O	he	poss	20	SENT_386	[p30l2056t616r2141b671],
20	colleagues	NNS	O	colleague	conj_and	10	SENT_386	[p30l12t704r325b774],
21	for	IN	O	for	_	0	SENT_386	[p30l356t704r442b758],
22	their	PRP$	O	they	poss	24	SENT_386	[p30l466t704r604b759],
23	kind	NN	O	kind	nn	24	SENT_386	[p30l628t704r762b759],
24	discussions	NNS	O	discussion	prep_for	20	SENT_386	[p30l790t704r1129b759],
25	and	CC	O	and	_	0	SENT_386	[p30l1159t704r1266b759],
26	conceiving	VBG	O	conceive	conj_and	5	SENT_386	[p30l1294t704r1620b774],
27	the	DT	O	the	det	29	SENT_386	[p30l1649t704r1738b759],
28	intemational	JJ	O	intemational	amod	29	SENT_386	[p30l1768t704r2143b758],
29	study	NN	O	study	dobj	26	SENT_386	[p30l14t792r174b862],
30	together	RB	O	together	advmod	26	SENT_386	[p30l197t792r452b862],
31	.	.	O	.	_	0	SENT_386	[p30l197t792r452b862],

1	Funding	NNP	O	Funding	nsubjpass	5	SENT_387	[p30l11t971r281b1040],
2	This	DT	O	this	det	3	SENT_387	[p30l360t970r487b1025],
3	study	NN	O	study	dep	1	SENT_387	[p30l511t970r667b1040],
4	was	VBD	O	be	auxpass	5	SENT_387	[p30l685t988r798b1025],
5	supported	VBN	O	support	_	0	SENT_387	[p30l821t970r1108b1040],
6	in	IN	O	in	_	0	SENT_387	[p30l1128t970r1183b1024],
7	part	NN	O	part	prep_in	5	SENT_387	[p30l1201t978r1316b1040],
8	by	IN	O	by	dep	14	SENT_387	[p30l1333t970r1409b1040],
9	Grants-in-Aid	NN	O	grants-in-aid	pobj	8	SENT_387	[p30l1428t970r1836b1025],
10	for	IN	O	for	_	0	SENT_387	[p30l1856t970r1940b1025],
11	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	nn	12	SENT_387	[p30l1961t970r2142b1025, p30l11t1059r124b1113],
12	Research	NNP	ORGANIZATION	Research	prep_for	9	SENT_387	[p30l151t1058r419b1113],
13	(	CD	NUMBER	(	num	12	SENT_387	[p30l445t1059r785b1128],
14	l9390042	NN	O	l9390042	rcmod	7	SENT_387	[p30l445t1059r785b1128],
15	)	CD	NUMBER	)	num	14	SENT_387	[p30l445t1059r785b1128],
16	from	IN	O	from	dep	14	SENT_387	[p30l813t1059r954b1113],
17	the	DT	O	the	det	19	SENT_387	[p30l978t1058r1066b1113],
18	Japan	NNP	ORGANIZATION	Japan	nn	19	SENT_387	[p30l1092t1061r1258b1128],
19	Society	NNP	ORGANIZATION	Society	pobj	16	SENT_387	[p30l1286t1059r1502b1128],
20	for	IN	O	for	_	0	SENT_387	[p30l1528t1059r1613b1113],
21	the	DT	O	the	det	22	SENT_387	[p30l1635t1058r1723b1113],
22	Promotion	NNP	O	Promotion	prep_for	19	SENT_387	[p30l1749t1059r2059b1113],
23	of	IN	O	of	_	0	SENT_387	[p30l2085t1059r2153b1113],
24	Science	NNP	O	Science	prep_of	22	SENT_387	[p30l15t1147r253b1212],
25	,	,	O	,	_	0	SENT_387	[p30l15t1147r253b1212],
26	by	IN	O	by	dep	14	SENT_387	[p30l280t1147r356b1216],
27	a	DT	O	a	det	28	SENT_387	[p30l382t1164r414b1201],
28	grant	NN	O	grant	pobj	26	SENT_387	[p30l439t1154r589b1216],
29	for	IN	O	for	_	0	SENT_387	[p30l615t1147r699b1201],
30	Research	NN	ORGANIZATION	research	prep_for	28	SENT_387	[p30l723t1147r990b1201],
31	on	IN	ORGANIZATION	on	_	0	SENT_387	[p30l1017t1164r1091b1201],
32	Health	NNP	ORGANIZATION	Health	nn	33	SENT_387	[p30l1115t1147r1310b1201],
33	Sciences	NNPS	ORGANIZATION	Sciences	prep_on	5	SENT_387	[p30l1338t1147r1588b1201],
34	focusing	VBG	O	focus	partmod	33	SENT_387	[p30l1618t1147r1867b1216],
35	on	IN	O	on	_	0	SENT_387	[p30l1895t1164r1968b1201],
36	Drug	NN	MISC	drug	prep_on	34	SENT_387	[p30l1992t1149r2143b1216],
37	Innovation	NN	MISC	innovation	dep	47	SENT_387	[p30l12t1235r330b1289],
38	from	IN	O	from	_	0	SENT_387	[p30l355t1235r497b1289],
39	the	DT	O	the	det	43	SENT_387	[p30l521t1235r608b1289],
40	Japan	NNP	ORGANIZATION	Japan	nn	43	SENT_387	[p30l635t1237r802b1304],
41	Health	NNP	ORGANIZATION	Health	nn	43	SENT_387	[p30l827t1235r1021b1289],
42	Sciences	NNPS	ORGANIZATION	Sciences	nn	43	SENT_387	[p30l1050t1235r1300b1289],
43	Foundation	NNP	ORGANIZATION	Foundation	prep_from	37	SENT_387	[p30l1327t1235r1663b1289],
44	(	CD	NUMBER	(	num	45	SENT_387	[p30l1689t1235r1849b1304],
45	KH3	NN	O	kh3	dep	47	SENT_387	[p30l1689t1235r1849b1304],
46	1036	CD	DATE	1036	num	47	SENT_387	[p30l1864t1235r2041b1304],
47	)	NN	O	)	dep	34	SENT_387	[p30l1864t1235r2041b1304],
48	,	,	O	,	_	0	SENT_387	[p30l1864t1235r2041b1304],
49	by	IN	O	by	_	0	SENT_387	[p30l2068t1235r2144b1304],
50	the	DT	O	the	det	54	SENT_387	[p30l11t1322r99b1377],
51	Pﬁzer	NNP	ORGANIZATION	Pﬁzer	nn	54	SENT_387	[p30l129t1323r304b1377],
52	Health	NNP	ORGANIZATION	Health	nn	54	SENT_387	[p30l330t1322r524b1377],
53	Research	NNP	ORGANIZATION	Research	nn	54	SENT_387	[p30l553t1322r822b1377],
54	Foundation	NNP	ORGANIZATION	Foundation	prep_by	47	SENT_387	[p30l850t1322r1200b1388],
55	,	,	O	,	_	0	SENT_387	[p30l850t1322r1200b1388],
56	and	CC	O	and	_	0	SENT_387	[p30l1234t1322r1339b1377],
57	by	IN	O	by	_	0	SENT_387	[p30l1366t1322r1441b1392],
58	the	DT	O	the	det	61	SENT_387	[p30l1469t1322r1558b1377],
59	Japanese	NNP	ORGANIZATION	Japanese	nn	61	SENT_387	[p30l1587t1325r1847b1392],
60	Research	NNP	ORGANIZATION	Research	nn	61	SENT_387	[p30l1876t1322r2143b1377],
61	Foundation	NNP	ORGANIZATION	Foundation	prep_by	47	SENT_387	[p30l11t1411r346b1465],
62	for	IN	ORGANIZATION	for	_	0	SENT_387	[p30l368t1411r453b1465],
63	Clinical	JJ	ORGANIZATION	clinical	amod	64	SENT_387	[p30l473t1411r701b1465],
64	Pharmacology	NN	ORGANIZATION	pharmacology	prep_for	34	SENT_387	[p30l722t1411r1154b1480],
65	.	.	O	.	_	0	SENT_387	[p30l722t1411r1154b1480],

1	Conﬂict	NN	O	conﬂict	nsubj	6	SENT_388	[p30l13t1642r268b1695],
2	of	IN	O	of	_	0	SENT_388	[p30l296t1642r362b1695],
3	interest	NN	O	interest	nn	4	SENT_388	[p30l382t1642r620b1695],
4	statement	NN	O	statement	prep_of	1	SENT_388	[p30l648t1646r957b1695],
5	We	PRP	O	we	nsubj	6	SENT_388	[p30l1033t1643r1130b1695],
6	have	VBP	O	have	_	0	SENT_388	[p30l1157t1641r1297b1695],
7	no	DT	O	no	det	8	SENT_388	[p30l1324t1659r1397b1695],
8	conﬂict	NN	O	conﬂict	dobj	6	SENT_388	[p30l1427t1641r1653b1695],
9	of	IN	O	of	_	0	SENT_388	[p30l1680t1641r1749b1695],
10	interest	NN	O	interest	prep_of	8	SENT_388	[p30l1768t1641r1985b1695],
11	with	IN	O	with	_	0	SENT_388	[p30l2010t1641r2143b1695],
12	respect	NN	O	respect	prep_with	10	SENT_388	[p30l11t1737r222b1799],
13	to	TO	O	to	_	0	SENT_388	[p30l246t1737r301b1784],
14	this	DT	O	this	det	15	SENT_388	[p30l327t1729r432b1784],
15	work	NN	O	work	prep_to	6	SENT_388	[p30l457t1729r626b1784],
16	.	.	O	.	_	0	SENT_388	[p30l457t1729r626b1784],

1	Authors	NNS	O	author	nsubj	10	SENT_389	[p30l10t1961r293b2014],
2	’	CD	NUMBER	’	num	3	SENT_389	[p30l10t1961r293b2014],
3	contributions	NNS	O	contribution	dep	1	SENT_389	[p30l321t1961r745b2014],
4	JA	NN	O	ja	dep	1	SENT_389	[p30l825t1961r923b2026],
5	,	,	O	,	_	0	SENT_389	[p30l825t1961r923b2026],
6	MO	NNP	DURATION	MO	dep	1	SENT_389	[p30l948t1961r1084b2026],
7	,	,	O	,	_	0	SENT_389	[p30l948t1961r1084b2026],
8	and	CC	O	and	_	0	SENT_389	[p30l1111t1960r1218b2014],
9	SY	NN	O	sy	conj_and	4	SENT_389	[p30l1242t1961r1334b2014],
10	conceived	VBD	O	conceive	_	0	SENT_389	[p30l1358t1960r1661b2014],
11	the	DT	O	the	det	12	SENT_389	[p30l1682t1960r1771b2014],
12	project	NN	O	project	dobj	10	SENT_389	[p30l1793t1960r2014b2029],
13	.	.	O	.	_	0	SENT_389	[p30l1793t1960r2014b2029],

1	JA	NNP	O	JA	nn	5	SENT_390	[p30l2042t1961r2140b2026],
2	,	,	O	,	_	0	SENT_390	[p30l2042t1961r2140b2026],
3	MO	NNP	DURATION	MO	appos	5	SENT_390	[p30l11t2049r147b2114],
4	,	,	O	,	_	0	SENT_390	[p30l11t2049r147b2114],
5	SY	NNP	O	SY	nsubj	9	SENT_390	[p30l177t2049r274b2114],
6	,	,	O	,	_	0	SENT_390	[p30l177t2049r274b2114],
7	and	CC	O	and	_	0	SENT_390	[p30l301t2048r407b2102],
8	RK	NN	O	rk	conj_and	5	SENT_390	[p30l429t2050r534b2101],
9	developed	VBD	O	develop	_	0	SENT_390	[p30l556t2048r864b2117],
10	the	DT	O	the	det	12	SENT_390	[p30l884t2048r974b2102],
11	study	NN	O	study	nn	12	SENT_390	[p30l999t2048r1160b2117],
12	design	NN	O	design	dobj	9	SENT_390	[p30l1183t2048r1377b2117],
13	and	CC	O	and	_	0	SENT_390	[p30l1400t2048r1507b2102],
14	were	VBD	O	be	cop	15	SENT_390	[p30l1528t2065r1672b2102],
15	responsible	JJ	O	responsible	conj_and	9	SENT_390	[p30l1694t2048r2034b2117],
16	for	IN	O	for	_	0	SENT_390	[p30l2059t2048r2145b2102],
17	development	NN	O	development	prep_for	15	SENT_390	[p30l12t2136r400b2205],
18	of	IN	O	of	_	0	SENT_390	[p30l420t2136r488b2190],
19	the	DT	O	the	det	21	SENT_390	[p30l498t2136r588b2190],
20	study	NN	O	study	nn	21	SENT_390	[p30l610t2136r770b2206],
21	protocol	NN	O	protocol	prep_of	17	SENT_390	[p30l788t2136r1052b2205],
22	.	.	O	.	_	0	SENT_390	[p30l788t2136r1052b2205],

1	SY	NNP	O	SY	nsubj	10	SENT_391	[p30l1080t2137r1178b2202],
2	,	,	O	,	_	0	SENT_391	[p30l1080t2137r1178b2202],
3	TN	NN	O	tn	nsubj	10	SENT_391	[p30l1201t2138r1315b2202],
4	,	,	O	,	_	0	SENT_391	[p30l1201t2138r1315b2202],
5	KT	NNP	O	KT	nsubj	10	SENT_391	[p30l1338t2138r1447b2202],
6	,	,	O	,	_	0	SENT_391	[p30l1338t2138r1447b2202],
7	Yo	NNP	O	Yo	conj_and	1	SENT_391	[p30l1469t2137r1575b2190],
8	and	CC	O	and	_	0	SENT_391	[p30l1597t2136r1704b2190],
9	TT	NN	O	tt	conj_and	1	SENT_391	[p30l1724t2138r1812b2189],
10	performed	VBD	O	perform	_	0	SENT_391	[p30l1831t2136r2143b2205],
11	this	DT	O	this	det	12	SENT_391	[p30l11t2223r116b2278],
12	study	NN	O	study	dobj	10	SENT_391	[p30l153t2223r313b2293],
13	as	IN	O	as	_	0	SENT_391	[p30l347t2241r404b2278],
14	site	NN	O	site	nn	16	SENT_391	[p30l441t2223r539b2278],
15	principal	JJ	O	principal	amod	16	SENT_391	[p30l571t2223r837b2293],
16	investigators	NNS	O	investigator	prep_as	10	SENT_391	[p30l871t2223r1266b2293],
17	.	.	O	.	_	0	SENT_391	[p30l871t2223r1266b2293],

1	MO	NNP	DURATION	MO	nsubj	8	SENT_392	[p30l1303t2224r1439b2289],
2	,	,	O	,	_	0	SENT_392	[p30l1303t2224r1439b2289],
3	RK	NNP	O	RK	conj_and	1	SENT_392	[p30l1475t2226r1595b2289],
4	,	,	O	,	_	0	SENT_392	[p30l1475t2226r1595b2289],
5	SK	NNP	O	SK	conj_and	1	SENT_392	[p30l1634t2224r1727b2278],
6	and	CC	O	and	_	0	SENT_392	[p30l1759t2223r1866b2278],
7	YF	NNP	O	YF	conj_and	1	SENT_392	[p30l1897t2226r1991b2277],
8	performed	VBD	O	perform	_	0	SENT_392	[p30l2024t2241r2142b2293, p30l13t2312r227b2366],
9	this	DT	O	this	det	10	SENT_392	[p30l254t2312r359b2366],
10	study	NN	O	study	dobj	8	SENT_392	[p30l391t2312r551b2381],
11	with	IN	O	with	_	0	SENT_392	[p30l578t2312r710b2366],
12	data	NNS	O	datum	prep_with	8	SENT_392	[p30l739t2312r863b2366],
13	monitoring	NN	O	monitoring	npadvmod	8	SENT_392	[p30l889t2312r1237b2381],
14	,	,	O	,	_	0	SENT_392	[p30l889t2312r1237b2381],
15	management	NN	O	management	conj_and	13	SENT_392	[p30l1268t2320r1652b2381],
16	and	CC	O	and	_	0	SENT_392	[p30l1681t2312r1787b2366],
17	analysis	NN	O	analysis	conj_and	13	SENT_392	[p30l1815t2312r2053b2381],
18	as	IN	O	as	_	0	SENT_392	[p30l2084t2329r2141b2366],
19	staff	NN	O	staff	prep_as	8	SENT_392	[p30l14t2400r151b2454],
20	at	IN	O	at	_	0	SENT_392	[p30l163t2408r215b2454],
21	the	DT	O	the	det	23	SENT_392	[p30l233t2400r322b2454],
22	central	JJ	O	central	amod	23	SENT_392	[p30l345t2400r545b2454],
23	laboratory	NN	O	laboratory	prep_at	8	SENT_392	[p30l566t2400r872b2470],
24	and	CC	O	and	_	0	SENT_392	[p30l894t2400r1000b2454],
25	ofﬁce	NN	O	ofﬁce	prep_at	8	SENT_392	[p30l1021t2400r1205b2454],
26	.	.	O	.	_	0	SENT_392	[p30l1021t2400r1205b2454],

1	1K	NN	O	1k	nsubj	4	SENT_393	[p30l1230t2402r1309b2453],
2	and	CC	O	and	_	0	SENT_393	[p30l1329t2400r1436b2454],
3	JA	NN	O	ja	conj_and	1	SENT_393	[p30l1456t2401r1538b2454],
4	oversaw	VBD	O	oversee	_	0	SENT_393	[p30l1559t2418r1807b2454],
5	the	DT	O	the	det	6	SENT_393	[p30l1826t2400r1916b2454],
6	project	NN	O	project	dobj	4	SENT_393	[p30l1936t2400r2144b2470],
7	with	IN	O	with	_	0	SENT_393	[p30l10t2487r144b2542],
8	co-principal	JJ	O	co-principal	amod	9	SENT_393	[p30l166t2487r525b2557],
9	investigators	NNS	O	investigator	prep_with	4	SENT_393	[p30l549t2487r943b2557],
10	.	.	O	.	_	0	SENT_393	[p30l549t2487r943b2557],

1	MO	NNP	PERSON	MO	nsubj	2	SENT_394	[p30l970t2488r1088b2542],
2	wrote	VBD	O	write	_	0	SENT_394	[p30l1111t2495r1280b2542],
3	the	DT	O	the	det	4	SENT_394	[p30l1302t2487r1392b2541],
4	manuscript	NN	O	manuscript	nsubjpass	14	SENT_394	[p30l1414t2487r1748b2557],
5	and	CC	O	and	_	0	SENT_394	[p30l1770t2487r1877b2542],
6	JA	NN	O	ja	nsubjpass	14	SENT_394	[p30l1898t2488r1996b2553],
7	,	,	O	,	_	0	SENT_394	[p30l1898t2488r1996b2553],
8	RK	NN	O	rk	conj_and	4	SENT_394	[p30l2021t2490r2140b2553],
9	,	,	O	,	_	0	SENT_394	[p30l2021t2490r2140b2553],
10	SY	NN	O	sy	conj_and	4	SENT_394	[p30l15t2578r106b2631],
11	and	CC	O	and	_	0	SENT_394	[p30l120t2577r227b2631],
12	YF	NN	O	yf	conj_and	4	SENT_394	[p30l245t2579r338b2630],
13	were	VBD	O	be	auxpass	14	SENT_394	[p30l359t2594r503b2631],
14	involved	VBN	O	involve	ccomp	2	SENT_394	[p30l524t2577r786b2631],
15	in	IN	O	in	_	0	SENT_394	[p30l806t2577r862b2630],
16	critical	JJ	O	critical	amod	17	SENT_394	[p30l882t2577r1085b2631],
17	revision	NN	O	revision	prep_in	14	SENT_394	[p30l1104t2577r1346b2631],
18	of	IN	O	of	_	0	SENT_394	[p30l1366t2577r1435b2631],
19	the	DT	O	the	det	21	SENT_394	[p30l1445t2577r1535b2631],
20	intellectual	JJ	O	intellectual	amod	21	SENT_394	[p30l1556t2577r1884b2631],
21	content	NN	O	content	prep_of	17	SENT_394	[p30l1906t2584r2138b2631],
22	.	.	O	.	_	0	SENT_394	[p30l1906t2584r2138b2631],

1	All	DT	O	all	det	2	SENT_395	[p30l10t2665r105b2718],
2	authors	NNS	O	author	nsubj	3	SENT_395	[p30l131t2665r348b2719],
3	approved	VBD	O	approve	_	0	SENT_395	[p30l376t2665r654b2735],
4	the	DT	O	the	det	6	SENT_395	[p30l677t2665r766b2719],
5	final	JJ	O	final	amod	6	SENT_395	[p30l793t2665r926b2719],
6	manuscript	NN	O	manuscript	dobj	3	SENT_395	[p30l951t2665r1297b2734],
7	.	.	O	.	_	0	SENT_395	[p30l951t2665r1297b2734],

1	The	DT	O	the	det	3	SENT_396	[p30l114t2752r227b2806],
2	study	NN	O	study	nn	3	SENT_396	[p30l262t2752r422b2822],
3	members	NNS	O	member	nsubjpass	12	SENT_396	[p30l453t2752r725b2807],
4	of	IN	O	of	_	0	SENT_396	[p30l759t2752r828b2807],
5	the	DT	O	the	det	10	SENT_396	[p30l850t2752r939b2806],
6	pharmacogenomics-based	JJ	O	pharmacogenomics-based	amod	10	SENT_396	[p30l970t2752r1751b2822],
7	tuberculosis	NN	O	tuberculosis	nn	10	SENT_396	[p30l1782t2752r2141b2807],
8	therapy	NN	O	therapy	nn	10	SENT_396	[p30l11t2840r235b2910],
9	research	NN	O	research	nn	10	SENT_396	[p30l259t2840r507b2895],
10	group	NN	O	group	prep_of	3	SENT_396	[p30l532t2858r704b2910],
11	are	VBP	O	be	auxpass	12	SENT_396	[p30l732t2858r819b2894],
12	listed	VBN	O	list	_	0	SENT_396	[p30l845t2840r1005b2895],
13	below	RB	O	below	advmod	12	SENT_396	[p30l1027t2840r1221b2895],
14	.	.	O	.	_	0	SENT_396	[p30l1027t2840r1221b2895],

1	Principal	NN	O	principal	dep	110	SENT_397	[p30l110t2930r403b2998],
2	investigator	NN	O	investigator	dep	110	SENT_397	[p30l427t2930r797b2999],
3	;	:	O	;	_	0	SENT_397	[p30l427t2930r797b2999],
4	chair	NN	O	chair	dep	110	SENT_397	[p30l830t2930r1006b2983],
5	:	:	O	:	_	0	SENT_397	[p30l830t2930r1006b2983],
6	Junichi	NNP	PERSON	Junichi	dep	110	SENT_397	[p30l1038t2929r1253b2983],
7	Azuma	NNP	PERSON	Azuma	dep	110	SENT_397	[p30l1280t2930r1513b2995],
8	;	:	O	;	_	0	SENT_397	[p30l1280t2930r1513b2995],
9	Co-principal	JJ	O	co-principal	dep	110	SENT_397	[p30l1548t2930r1939b2999],
10	investigators	NNS	O	investigator	dep	110	SENT_397	[p30l1962t2930r2143b2983, p30l11t3018r268b3086],
11	:	:	O	:	_	0	SENT_397	[p30l1962t2930r2143b2983, p30l11t3018r268b3086],
12	Soichiro	NNP	PERSON	Soichiro	dep	110	SENT_397	[p30l314t3016r569b3071],
13	Yokota	NNP	PERSON	Yokota	dep	110	SENT_397	[p30l609t3016r829b3071],
14	and	CC	O	and	dep	110	SENT_397	[p30l867t3016r976b3071],
15	Masako	NNP	PERSON	Masako	dep	110	SENT_397	[p30l1013t3016r1254b3071],
16	Ohno	NNP	PERSON	Ohno	dep	110	SENT_397	[p30l1295t3016r1482b3082],
17	;	:	O	;	_	0	SENT_397	[p30l1295t3016r1482b3082],
18	Super	NNP	O	Super	dep	110	SENT_397	[p30l1520t3017r1712b3086],
19	coordinator	NN	O	coordinator	dep	110	SENT_397	[p30l1749t3017r2138b3071],
20	:	:	O	:	_	0	SENT_397	[p30l1749t3017r2138b3071],
21	Ichiro	NNP	PERSON	Ichiro	dep	110	SENT_397	[p30l12t3104r197b3159],
22	Kawase	NNP	PERSON	Kawase	dep	110	SENT_397	[p30l239t3107r507b3170],
23	;	:	O	;	_	0	SENT_397	[p30l239t3107r507b3170],
24	Investigators	NNS	O	investigator	dep	110	SENT_397	[p30l547t3106r976b3174],
25	of	IN	O	of	dep	110	SENT_397	[p30l1017t3106r1094b3174],
26	participant	NN	O	participant	dep	110	SENT_397	[p30l1110t3106r1483b3174],
27	hospitals	NNS	O	hospital	dep	110	SENT_397	[p30l1519t3105r1830b3174],
28	:	:	O	:	_	0	SENT_397	[p30l1519t3105r1830b3174],
29	Soichiro	NNP	PERSON	Soichiro	dep	110	SENT_397	[p30l1878t3104r2141b3159],
30	Yokota	NNP	PERSON	Yokota	dep	110	SENT_397	[p30l11t3192r241b3258],
31	,	,	O	,	_	0	SENT_397	[p30l11t3192r241b3258],
32	Masami	NNP	PERSON	Masami	dep	110	SENT_397	[p30l279t3193r519b3247],
33	Ito	NNP	PERSON	Ito	dep	110	SENT_397	[p30l555t3195r651b3258],
34	,	,	O	,	_	0	SENT_397	[p30l555t3195r651b3258],
35	Masahide	NNP	PERSON	Masahide	dep	110	SENT_397	[p30l690t3192r980b3247],
36	Mori	NNP	PERSON	Mori	dep	110	SENT_397	[p30l1015t3193r1180b3258],
37	,	,	O	,	_	0	SENT_397	[p30l1015t3193r1180b3258],
38	Takeya	NNP	PERSON	Takeya	dep	110	SENT_397	[p30l1219t3192r1434b3262],
39	Fujikawa	NNP	PERSON	Fujikawa	dep	110	SENT_397	[p30l1468t3192r1762b3262],
40	,	,	O	,	_	0	SENT_397	[p30l1468t3192r1762b3262],
41	Mari	NNP	PERSON	Mari	dep	110	SENT_397	[p30l1800t3193r1944b3246],
42	Miki	NNP	PERSON	Miki	dep	110	SENT_397	[p30l1979t3192r2139b3258],
43	,	,	O	,	_	0	SENT_397	[p30l1979t3192r2139b3258],
44	Toshihiko	NNP	PERSON	Toshihiko	dep	110	SENT_397	[p30l12t3280r303b3335],
45	Yamaguchi	NNP	PERSON	Yamaguchi	dep	110	SENT_397	[p30l325t3280r671b3350],
46	,	,	O	,	_	0	SENT_397	[p30l325t3280r671b3350],
47	Yukihiro	NNP	PERSON	Yukihiro	dep	110	SENT_397	[p30l695t3280r950b3335],
48	Yano	NNP	PERSON	Yano	dep	110	SENT_397	[p30l972t3282r1141b3346],
49	,	,	O	,	_	0	SENT_397	[p30l972t3282r1141b3346],
50	Masaharu	NNP	PERSON	Masaharu	dep	110	SENT_397	[p30l1165t3280r1454b3335],
51	Motone	NNP	PERSON	Motone	dep	110	SENT_397	[p30l1475t3282r1719b3346],
52	,	,	O	,	_	0	SENT_397	[p30l1475t3282r1719b3346],
53	Seigo	NNP	PERSON	Seigo	dep	110	SENT_397	[p30l1747t3280r1908b3350],
54	Kitada	NNP	PERSON	Kitada	dep	110	SENT_397	[p30l1931t3280r2141b3346],
55	,	,	O	,	_	0	SENT_397	[p30l1931t3280r2141b3346],
56	Kenji	NNP	PERSON	Kenji	dep	110	SENT_397	[p30l11t3368r173b3438],
57	Fushitani	NNP	PERSON	Fushitani	dep	110	SENT_397	[p30l198t3368r484b3434],
58	,	,	O	,	_	0	SENT_397	[p30l198t3368r484b3434],
59	Yoshinobu	NNP	PERSON	Yoshinobu	dep	110	SENT_397	[p30l512t3368r830b3423],
60	Namba	NNP	PERSON	Namba	dep	110	SENT_397	[p30l852t3368r1081b3434],
61	,	,	O	,	_	0	SENT_397	[p30l852t3368r1081b3434],
62	Manabu	NNP	PERSON	Manabu	dep	110	SENT_397	[p30l1110t3368r1351b3423],
63	Niinaka	NNP	PERSON	Niinaka	dep	110	SENT_397	[p30l1374t3368r1622b3434],
64	,	,	O	,	_	0	SENT_397	[p30l1374t3368r1622b3434],
65	Nobuyuki	NNP	PERSON	Nobuyuki	dep	110	SENT_397	[p30l1648t3368r1945b3438],
66	Naka	NNP	PERSON	Naka	dep	110	SENT_397	[p30l1968t3368r2141b3434],
67	,	,	O	,	_	0	SENT_397	[p30l1968t3368r2141b3434],
68	Hiromi	NNP	PERSON	Hiromi	dep	110	SENT_397	[p30l11t3457r221b3511],
69	Kimura	NNP	PERSON	Kimura	dep	110	SENT_397	[p30l253t3457r492b3522],
70	,	,	O	,	_	0	SENT_397	[p30l253t3457r492b3522],
71	Hisako	NNP	PERSON	Hisako	dep	110	SENT_397	[p30l525t3456r731b3511],
72	Hashimoto	NN	PERSON	hashimoto	dep	110	SENT_397	[p30l764t3456r1084b3511],
73	and	CC	O	and	dep	110	SENT_397	[p30l1118t3456r1223b3511],
74	Shin-ichi	NN	PERSON	shin-ichus	dep	110	SENT_397	[p30l1257t3456r1520b3511],
75	Kagami	NNP	PERSON	Kagami	dep	110	SENT_397	[p30l1552t3457r1783b3526],
76	(	CD	NUMBER	(	dep	110	SENT_397	[p30l1816t3457r2145b3526],
77	Toneyama	NNP	ORGANIZATION	Toneyama	dep	110	SENT_397	[p30l1816t3457r2145b3526],
78	National	NNP	ORGANIZATION	National	dep	110	SENT_397	[p30l9t3545r270b3599],
79	Hospital	NNP	ORGANIZATION	Hospital	dep	110	SENT_397	[p30l307t3545r604b3614],
80	)	NN	O	)	dep	110	SENT_397	[p30l307t3545r604b3614],
81	,	,	O	,	_	0	SENT_397	[p30l307t3545r604b3614],
82	Takayuki	NNP	PERSON	Takayuki	dep	110	SENT_397	[p30l642t3545r923b3614],
83	Nagai	NNP	PERSON	Nagai	dep	110	SENT_397	[p30l956t3545r1154b3614],
84	,	,	O	,	_	0	SENT_397	[p30l956t3545r1154b3614],
85	T	NN	O	t	dep	110	SENT_397	[p30l1193t3547r1236b3598],
86	etsuya	NN	O	etsuya	dep	110	SENT_397	[p30l1236t3552r1427b3614],
87	Takashima	NNP	PERSON	Takashima	dep	110	SENT_397	[p30l1463t3545r1805b3610],
88	,	,	O	,	_	0	SENT_397	[p30l1463t3545r1805b3610],
89	Yoshitaka	NNP	PERSON	Yoshitaka	dep	110	SENT_397	[p30l1843t3545r2144b3599],
90	Tamura	NNP	PERSON	Tamura	dep	110	SENT_397	[p30l12t3635r253b3698],
91	,	,	O	,	_	0	SENT_397	[p30l12t3635r253b3698],
92	and	CC	O	and	dep	110	SENT_397	[p30l291t3632r398b3687],
93	Hanako	NNP	PERSON	Hanako	dep	110	SENT_397	[p30l430t3632r662b3687],
94	Kuhara	NNP	PERSON	Kuhara	dep	110	SENT_397	[p30l696t3632r917b3687],
95	(	NNP	O	(	dep	110	SENT_397	[p30l951t3632r1160b3701],
96	Osaka	NNP	ORGANIZATION	Osaka	dep	110	SENT_397	[p30l951t3632r1160b3701],
97	Prefectural	NNP	ORGANIZATION	Prefectural	dep	110	SENT_397	[p30l1193t3632r1517b3687],
98	Medical	NNP	ORGANIZATION	Medical	dep	110	SENT_397	[p30l1551t3632r1793b3687],
99	Center	NNP	ORGANIZATION	Center	dep	110	SENT_397	[p30l1828t3633r2027b3687],
100	for	IN	O	for	dep	110	SENT_397	[p30l2060t3632r2146b3687],
101	Respiratory	JJ	O	respiratory	dep	110	SENT_397	[p30l11t3721r358b3790],
102	and	CC	O	and	dep	110	SENT_397	[p30l393t3720r499b3775],
103	Allergic	JJ	O	allergic	dep	110	SENT_397	[p30l532t3720r773b3790],
104	Diseases	NNS	O	disease	dep	110	SENT_397	[p30l807t3720r1107b3790],
105	)	VBP	O	)	dep	110	SENT_397	[p30l807t3720r1107b3790],
106	,	,	O	,	_	0	SENT_397	[p30l807t3720r1107b3790],
107	Kazunari	NNP	PERSON	Kazunari	dep	110	SENT_397	[p30l1143t3721r1415b3775],
108	Tsuyuguchi	NNP	PERSON	Tsuyuguchi	dep	110	SENT_397	[p30l1451t3720r1813b3790],
109	,	,	O	,	_	0	SENT_397	[p30l1451t3720r1813b3790],
110	Mitsunori	NNP	PERSON	Mitsunori	_	0	SENT_397	[p30l1850t3720r2143b3775],

1	Sakatani	NNP	PERSON	Sakatani	dep	197	SENT_398	[p31l15t16r293b81],
2	,	,	O	,	_	0	SENT_398	[p31l15t16r293b81],
3	Katsuhiro	NNP	PERSON	Katsuhiro	dep	197	SENT_398	[p31l334t16r637b70],
4	Suzuki	NNP	PERSON	Suzuki	dep	197	SENT_398	[p31l679t16r907b81],
5	,	,	O	,	_	0	SENT_398	[p31l679t16r907b81],
6	Seijiro	NNP	PERSON	Seijiro	dep	197	SENT_398	[p31l951t16r1150b85],
7	Minamoto	NNP	PERSON	Minamoto	dep	197	SENT_398	[p31l1189t16r1527b81],
8	,	,	O	,	_	0	SENT_398	[p31l1189t16r1527b81],
9	and	CC	O	and	dep	197	SENT_398	[p31l1568t16r1678b70],
10	Seiji	NNP	PERSON	Seiji	dep	197	SENT_398	[p31l1717t16r1853b85],
11	Hayashi	NNP	PERSON	Hayashi	dep	197	SENT_398	[p31l1890t16r2143b85],
12	(	NNP	O	(	dep	197	SENT_398	[p31l13t103r291b172],
13	National	NNP	ORGANIZATION	National	dep	197	SENT_398	[p31l13t103r291b172],
14	Hospital	NNP	ORGANIZATION	Hospital	dep	197	SENT_398	[p31l325t103r577b173],
15	Organization	NNP	ORGANIZATION	Organization	dep	197	SENT_398	[p31l612t103r999b173],
16	Kinki-Chuo	NNP	ORGANIZATION	Kinki-Chuo	dep	197	SENT_398	[p31l1032t103r1388b158],
17	Chest	NN	ORGANIZATION	chest	dep	197	SENT_398	[p31l1424t103r1593b158],
18	Medical	NNP	ORGANIZATION	Medical	dep	197	SENT_398	[p31l1626t103r1868b158],
19	Center	NNP	ORGANIZATION	Center	dep	197	SENT_398	[p31l1904t104r2140b172],
20	)	NN	O	)	dep	197	SENT_398	[p31l1904t104r2140b172],
21	,	,	O	,	_	0	SENT_398	[p31l1904t104r2140b172],
22	Yasuhisa	NNP	PERSON	Yasuhisa	dep	197	SENT_398	[p31l11t191r274b246],
23	Okuda	NNP	PERSON	Okuda	dep	197	SENT_398	[p31l307t191r518b257],
24	,	,	O	,	_	0	SENT_398	[p31l307t191r518b257],
25	Koji	NNP	PERSON	Koji	dep	197	SENT_398	[p31l554t191r683b261],
26	Inoue	NNP	PERSON	Inoue	dep	197	SENT_398	[p31l717t194r898b257],
27	,	,	O	,	_	0	SENT_398	[p31l717t194r898b257],
28	Masataka	NNP	LOCATION	Masataka	dep	197	SENT_398	[p31l934t191r1216b246],
29	Miyake	NNP	LOCATION	Miyake	dep	197	SENT_398	[p31l1248t191r1488b261],
30	,	,	O	,	_	0	SENT_398	[p31l1248t191r1488b261],
31	and	CC	O	and	dep	197	SENT_398	[p31l1524t191r1630b246],
32	Tsuyoshi	NNP	PERSON	Tsuyoshi	dep	197	SENT_398	[p31l1663t191r1926b261],
33	Ogura	NNP	PERSON	Ogura	dep	197	SENT_398	[p31l1961t193r2144b261],
34	(	NNP	O	(	dep	197	SENT_398	[p31l13t280r206b349],
35	Japan	NNP	LOCATION	Japan	dep	197	SENT_398	[p31l13t280r206b349],
36	Anti-Tuberculosis	NNP	ORGANIZATION	Anti-Tuberculosis	dep	197	SENT_398	[p31l239t280r780b334],
37	Association	NNP	ORGANIZATION	Association	dep	197	SENT_398	[p31l815t280r1169b334],
38	Osaka	NNP	ORGANIZATION	Osaka	dep	197	SENT_398	[p31l1205t280r1391b334],
39	Hospital	NNP	ORGANIZATION	Hospital	dep	197	SENT_398	[p31l1424t280r1718b349],
40	)	NN	O	)	dep	197	SENT_398	[p31l1424t280r1718b349],
41	;	:	O	;	_	0	SENT_398	[p31l1424t280r1718b349],
42	Independent	NNP	O	Independent	dep	197	SENT_398	[p31l1753t281r2147b349],
43	Data	NNP	O	Data	dep	197	SENT_398	[p31l7t370r157b422],
44	and	CC	O	and	dep	197	SENT_398	[p31l176t369r294b422],
45	Safety	NNP	O	Safety	dep	197	SENT_398	[p31l305t369r494b437],
46	Monitoring	VBG	O	monitor	dep	197	SENT_398	[p31l507t369r858b437],
47	Board	NNP	O	Board	dep	197	SENT_398	[p31l870t369r1077b422],
48	:	:	O	:	_	0	SENT_398	[p31l870t369r1077b422],
49	Shigeru	NNP	PERSON	Shigeru	dep	197	SENT_398	[p31l1102t368r1327b437],
50	Kageyama	NNP	PERSON	Kageyama	dep	197	SENT_398	[p31l1343t370r1659b437],
51	(	CD	NUMBER	(	dep	197	SENT_398	[p31l1677t368r1855b437],
52	chair	NN	O	chair	dep	197	SENT_398	[p31l1677t368r1855b437],
53	,	,	O	,	_	0	SENT_398	[p31l1677t368r1855b437],
54	The	DT	O	the	dep	197	SENT_398	[p31l1877t368r1990b422],
55	J	NNP	O	J	dep	197	SENT_398	[p31l2007t370r2035b422],
56	ikei	NNP	O	ikei	dep	197	SENT_398	[p31l2037t368r2143b422],
57	University	NNP	ORGANIZATION	University	dep	197	SENT_398	[p31l10t456r379b525],
58	)	NN	O	)	dep	197	SENT_398	[p31l10t456r379b525],
59	;	:	O	;	_	0	SENT_398	[p31l10t456r379b525],
60	Central	NNP	ORGANIZATION	Central	dep	197	SENT_398	[p31l422t457r661b510],
61	Endpoint	NNP	ORGANIZATION	Endpoint	dep	197	SENT_398	[p31l689t457r992b525],
62	Evaluation	NN	ORGANIZATION	evaluation	dep	197	SENT_398	[p31l1020t457r1371b510],
63	Board	NNP	ORGANIZATION	Board	dep	197	SENT_398	[p31l1408t457r1628b510],
64	:	:	O	:	_	0	SENT_398	[p31l1408t457r1628b510],
65	Ryoji	NNP	PERSON	Ryoji	dep	197	SENT_398	[p31l1668t455r1835b525],
66	Maekura	NNP	PERSON	Maekura	dep	197	SENT_398	[p31l1871t455r2144b510],
67	(	CD	NUMBER	(	dep	197	SENT_398	[p31l13t544r346b613],
68	Toneyama	NNP	ORGANIZATION	Toneyama	dep	197	SENT_398	[p31l13t544r346b613],
69	National	NNP	ORGANIZATION	National	dep	197	SENT_398	[p31l377t543r634b598],
70	Hospital	NNP	ORGANIZATION	Hospital	dep	197	SENT_398	[p31l668t543r961b613],
71	)	NN	O	)	dep	197	SENT_398	[p31l668t543r961b613],
72	,	,	O	,	_	0	SENT_398	[p31l668t543r961b613],
73	Hideki	NNP	PERSON	Hideki	dep	197	SENT_398	[p31l997t543r1198b598],
74	Nishikawa	NNP	PERSON	Nishikawa	dep	197	SENT_398	[p31l1230t543r1552b598],
75	(	CD	NUMBER	(	dep	197	SENT_398	[p31l1586t544r1662b613],
76	N	NN	O	n	dep	197	SENT_398	[p31l1586t544r1662b613],
77	agahori	NNS	O	agahorus	dep	197	SENT_398	[p31l1665t543r1885b613],
78	Clinic	NNP	MISC	Clinic	dep	197	SENT_398	[p31l1921t543r2140b612],
79	)	CD	NUMBER	)	dep	197	SENT_398	[p31l1921t543r2140b612],
80	,	,	O	,	_	0	SENT_398	[p31l1921t543r2140b612],
81	and	CC	O	and	dep	197	SENT_398	[p31l13t632r118b686],
82	Hideki	NNP	PERSON	Hideki	dep	197	SENT_398	[p31l151t632r351b686],
83	Hara	NNP	PERSON	Hara	dep	197	SENT_398	[p31l385t634r529b686],
84	(	NNP	O	(	dep	197	SENT_398	[p31l563t632r968b701],
85	Nishinomiya	NNP	ORGANIZATION	Nishinomiya	dep	197	SENT_398	[p31l563t632r968b701],
86	Municipal	NNP	ORGANIZATION	Municipal	dep	197	SENT_398	[p31l1001t632r1304b701],
87	Central	NNP	ORGANIZATION	Central	dep	197	SENT_398	[p31l1339t632r1553b686],
88	Hospital	NNP	ORGANIZATION	Hospital	dep	197	SENT_398	[p31l1587t632r1878b701],
89	)	NN	O	)	dep	197	SENT_398	[p31l1587t632r1878b701],
90	;	:	O	;	_	0	SENT_398	[p31l1587t632r1878b701],
91	Central	NNP	O	Central	dep	197	SENT_398	[p31l1917t633r2148b686],
92	laboratory	NN	O	laboratory	dep	197	SENT_398	[p31l11t721r325b789],
93	and	CC	O	and	dep	197	SENT_398	[p31l352t721r470b774],
94	oﬂice	NN	O	oﬂice	dep	197	SENT_398	[p31l494t721r661b789],
95	(	CD	NUMBER	(	dep	197	SENT_398	[p31l689t720r940b789],
96	Clinical	JJ	O	clinical	dep	197	SENT_398	[p31l689t720r940b789],
97	Pharmacology	NN	O	pharmacology	dep	197	SENT_398	[p31l968t720r1392b789],
98	and	CC	O	and	dep	197	SENT_398	[p31l1420t720r1525b774],
99	Phannacogenomics	NNS	O	phannacogenomic	dep	197	SENT_398	[p31l1551t720r2140b789],
100	,	,	O	,	_	0	SENT_398	[p31l1551t720r2140b789],
101	Graduate	NNP	ORGANIZATION	Graduate	dep	197	SENT_398	[p31l12t807r278b862],
102	School	NNP	ORGANIZATION	School	dep	197	SENT_398	[p31l299t807r499b862],
103	of	IN	ORGANIZATION	of	dep	197	SENT_398	[p31l517t808r586b862],
104	Pharmaceutical	NNP	ORGANIZATION	Pharmaceutical	dep	197	SENT_398	[p31l593t807r1041b862],
105	Sciences	NNPS	ORGANIZATION	Sciences	dep	197	SENT_398	[p31l1061t808r1327b873],
106	,	,	O	,	_	0	SENT_398	[p31l1061t808r1327b873],
107	Osaka	NNP	ORGANIZATION	Osaka	dep	197	SENT_398	[p31l1349t807r1532b862],
108	University	NNP	ORGANIZATION	University	dep	197	SENT_398	[p31l1546t808r1893b877],
109	)	NN	O	)	dep	197	SENT_398	[p31l1546t808r1893b877],
110	:	:	O	:	_	0	SENT_398	[p31l1546t808r1893b877],
111	Yasushi	NNP	PERSON	Yasushi	dep	197	SENT_398	[p31l1914t807r2143b862],
112	Fujio	NNP	PERSON	Fujio	dep	197	SENT_398	[p31l11t896r180b965],
113	,	,	O	,	_	0	SENT_398	[p31l11t896r180b965],
114	Shinpei	NNP	PERSON	Shinpei	dep	197	SENT_398	[p31l211t896r431b965],
115	Nonen	NNP	PERSON	Nonen	dep	197	SENT_398	[p31l453t898r652b950],
116	and	CC	O	and	dep	197	SENT_398	[p31l677t896r782b950],
117	Makiko	NNP	PERSON	Makiko	dep	197	SENT_398	[p31l806t896r1034b950],
118	Maeda	NNP	PERSON	Maeda	dep	197	SENT_398	[p31l1058t896r1260b950],
119	[	NNP	O	[	dep	197	SENT_398	[p31l1287t896r1533b964],
120	Central	NNP	O	Central	dep	197	SENT_398	[p31l1287t896r1533b964],
121	registration	NN	O	registration	dep	197	SENT_398	[p31l1554t900r1906b965],
122	,	,	O	,	_	0	SENT_398	[p31l1554t900r1906b965],
123	allocation	NN	O	allocation	dep	197	SENT_398	[p31l1938t896r2143b950, p31l13t988r134b1047],
124	,	,	O	,	_	0	SENT_398	[p31l1938t896r2143b950, p31l13t988r134b1047],
125	and	CC	O	and	dep	197	SENT_398	[p31l169t984r283b1038],
126	management	NN	O	management	dep	197	SENT_398	[p31l306t994r685b1053],
127	of	IN	O	of	dep	197	SENT_398	[p31l710t984r782b1053],
128	privacy	NN	O	privacy	dep	197	SENT_398	[p31l781t988r1010b1053],
129	information	NN	O	information	dep	197	SENT_398	[p31l1038t984r1379b1053],
130	for	IN	O	for	dep	197	SENT_398	[p31l1394t984r1495b1053],
131	the	DT	O	the	dep	197	SENT_398	[p31l1521t984r1608b1038],
132	pharmacogenetic	JJ	O	pharmacogenetic	dep	197	SENT_398	[p31l1624t984r2143b1053],
133	study	NN	O	study	dep	197	SENT_398	[p31l9t1071r205b1141],
134	]	NN	O	]	dep	197	SENT_398	[p31l9t1071r205b1141],
135	,	,	O	,	_	0	SENT_398	[p31l9t1071r205b1141],
136	Miyuki	NNP	PERSON	Miyuki	dep	197	SENT_398	[p31l228t1071r444b1141],
137	Furutsuka	NNP	PERSON	Furutsuka	dep	197	SENT_398	[p31l465t1071r773b1137],
138	,	,	O	,	_	0	SENT_398	[p31l465t1071r773b1137],
139	Tomoko	NNP	PERSON	Tomoko	dep	197	SENT_398	[p31l797t1071r1041b1126],
140	Tanabe	NNP	PERSON	Tanabe	dep	197	SENT_398	[p31l1064t1071r1289b1137],
141	,	,	O	,	_	0	SENT_398	[p31l1064t1071r1289b1137],
142	Satoshi	NNP	PERSON	Satoshi	dep	197	SENT_398	[p31l1315t1071r1526b1126],
143	Nakayama	NNP	PERSON	Nakayama	dep	197	SENT_398	[p31l1545t1071r1877b1141],
144	,	,	O	,	_	0	SENT_398	[p31l1545t1071r1877b1141],
145	and	CC	O	and	dep	197	SENT_398	[p31l1902t1071r2007b1126],
146	Airi	NNP	PERSON	Airi	dep	197	SENT_398	[p31l2027t1071r2143b1125],
147	Tokuda	NNP	PERSON	Tokuda	dep	197	SENT_398	[p31l12t1160r233b1214],
148	[	NNP	O	[	dep	197	SENT_398	[p31l255t1161r500b1228],
149	Genetic	JJ	O	genetic	dep	197	SENT_398	[p31l255t1161r500b1228],
150	analysis	NN	O	analysis	dep	197	SENT_398	[p31l520t1160r796b1229],
151	]	NN	O	]	dep	197	SENT_398	[p31l520t1160r796b1229],
152	,	,	O	,	_	0	SENT_398	[p31l520t1160r796b1229],
153	Mika	NNP	PERSON	Mika	dep	197	SENT_398	[p31l819t1160r976b1214],
154	Takahashi	NNP	PERSON	Takahashi	dep	197	SENT_398	[p31l994t1160r1303b1226],
155	,	,	O	,	_	0	SENT_398	[p31l994t1160r1303b1226],
156	Akiko	NNP	PERSON	Akiko	dep	197	SENT_398	[p31l1325t1160r1508b1214],
157	Yamamoto	NNP	PERSON	Yamamoto	dep	197	SENT_398	[p31l1528t1162r1846b1214],
158	and	CC	O	and	dep	197	SENT_398	[p31l1868t1160r1974b1214],
159	Yuka	NNP	PERSON	Yuka	dep	197	SENT_398	[p31l1991t1160r2144b1214],
160	Nakamura	NNP	PERSON	Nakamura	dep	197	SENT_398	[p31l9t1248r323b1302],
161	[	NNP	O	[	dep	197	SENT_398	[p31l361t1249r528b1316],
162	Data	NNP	O	Data	dep	197	SENT_398	[p31l361t1249r528b1316],
163	monitoring	VBG	O	monitor	dep	197	SENT_398	[p31l564t1249r936b1317],
164	]	RB	O	]	dep	197	SENT_398	[p31l564t1249r936b1317],
165	,	,	O	,	_	0	SENT_398	[p31l564t1249r936b1317],
166	Masako	NNP	PERSON	Masako	dep	197	SENT_398	[p31l973t1248r1208b1302],
167	Ohno	NNP	PERSON	Ohno	dep	197	SENT_398	[p31l1245t1248r1426b1314],
168	,	,	O	,	_	0	SENT_398	[p31l1245t1248r1426b1314],
169	Ryuji	NNP	PERSON	Ryuji	dep	197	SENT_398	[p31l1463t1248r1626b1317],
170	Kubota	NNP	PERSON	Kubota	dep	197	SENT_398	[p31l1660t1248r1895b1314],
171	,	,	O	,	_	0	SENT_398	[p31l1660t1248r1895b1314],
172	Satomi	NNP	PERSON	Satomi	dep	197	SENT_398	[p31l1937t1248r2143b1302],
173	Kamo	NNP	PERSON	Kamo	dep	197	SENT_398	[p31l11t1338r206b1402],
174	,	,	O	,	_	0	SENT_398	[p31l11t1338r206b1402],
175	and	CC	O	and	dep	197	SENT_398	[p31l239t1336r344b1390],
176	Sayaka	NNP	PERSON	Sayaka	dep	197	SENT_398	[p31l375t1336r584b1406],
177	Kamirnura	NNP	PERSON	Kamirnura	dep	197	SENT_398	[p31l611t1336r925b1390],
178	[	VBZ	O	[	dep	197	SENT_398	[p31l957t1336r1268b1404],
179	Statistical	JJ	O	statistical	dep	197	SENT_398	[p31l957t1336r1268b1404],
180	analyses	NNS	O	analysis	dep	197	SENT_398	[p31l1293t1336r1544b1406],
181	and	CC	O	and	dep	197	SENT_398	[p31l1573t1336r1686b1390],
182	Data	NNS	O	datum	dep	197	SENT_398	[p31l1708t1338r1857b1390],
183	management	NN	O	management	dep	197	SENT_398	[p31l1886t1355r2142b1406, p31l11t1425r193b1492],
184	]	NN	O	]	dep	197	SENT_398	[p31l1886t1355r2142b1406, p31l11t1425r193b1492],
185	;	:	O	;	_	0	SENT_398	[p31l1886t1355r2142b1406, p31l11t1425r193b1492],
186	Clinical	JJ	O	clinical	dep	197	SENT_398	[p31l227t1425r465b1478],
187	research	NN	O	research	dep	197	SENT_398	[p31l487t1425r743b1478],
188	coordinator	NN	O	coordinator	dep	197	SENT_398	[p31l774t1425r1149b1478],
189	:	:	O	:	_	0	SENT_398	[p31l774t1425r1149b1478],
190	Hiroshi	NNP	ORGANIZATION	Hiroshi	dep	197	SENT_398	[p31l1177t1424r1395b1478],
191	T	NN	ORGANIZATION	t	dep	197	SENT_398	[p31l1422t1426r1465b1477],
192	amada	NN	ORGANIZATION	amada	dep	197	SENT_398	[p31l1464t1424r1655b1478],
193	(	CD	NUMBER	(	dep	197	SENT_398	[p31l1681t1424r2009b1493],
194	Toneyama	NNP	ORGANIZATION	Toneyama	dep	197	SENT_398	[p31l1681t1424r2009b1493],
195	National	NNP	ORGANIZATION	National	dep	197	SENT_398	[p31l2032t1426r2142b1478, p31l11t1512r177b1566],
196	Hospital	NNP	ORGANIZATION	Hospital	dep	197	SENT_398	[p31l197t1512r481b1581],
197	)	NN	O	)	_	0	SENT_398	[p31l197t1512r481b1581],
198	.	.	O	.	_	0	SENT_398	[p31l197t1512r481b1581],

1	@	IN	O	@	_	0	SENT_399	[p31l10t1736r83b1825],
2	Springer	NNP	MISC	Springer	nn	4	SENT_399	[p31l108t1758r352b1828],
3	Open	NNP	MISC	Open	nn	4	SENT_399	[p31l10t1843r181b1911],
4	Access	NN	MISC	access	prep_@	8	SENT_399	[p31l204t1843r414b1896],
5	This	DT	MISC	this	det	6	SENT_399	[p31l495t1842r621b1896],
6	article	NN	O	article	nsubjpass	8	SENT_399	[p31l643t1842r821b1896],
7	is	VBZ	O	be	auxpass	8	SENT_399	[p31l841t1842r887b1896],
8	distributed	VBN	O	distribute	ccomp	31	SENT_399	[p31l908t1842r1219b1896],
9	under	IN	O	under	_	0	SENT_399	[p31l1236t1842r1406b1896],
10	the	DT	O	the	det	11	SENT_399	[p31l1422t1842r1510b1896],
11	terms	NNS	O	term	prep_under	8	SENT_399	[p31l1530t1849r1690b1896],
12	of	IN	O	of	_	0	SENT_399	[p31l1711t1842r1781b1896],
13	the	DT	O	the	det	17	SENT_399	[p31l1789t1842r1877b1896],
14	Creative	NNP	O	Creative	nn	17	SENT_399	[p31l1899t1842r2143b1896],
15	Commons	NNP	O	Commons	nn	17	SENT_399	[p31l9t1931r311b1984],
16	Attribution	NNP	O	Attribution	nn	17	SENT_399	[p31l337t1929r662b1984],
17	License	NNP	O	License	prep_of	11	SENT_399	[p31l687t1930r912b1984],
18	which	WDT	O	which	nsubj	19	SENT_399	[p31l938t1929r1119b1984],
19	permits	VBZ	O	permit	rcmod	11	SENT_399	[p31l1142t1930r1360b1999],
20	any	DT	O	any	det	21	SENT_399	[p31l1388t1947r1493b1999],
21	use	NN	O	use	dobj	19	SENT_399	[p31l1517t1947r1631b1995],
22	,	,	O	,	_	0	SENT_399	[p31l1517t1947r1631b1995],
23	distribution	NN	O	distribution	conj_and	21	SENT_399	[p31l1660t1929r2009b1995],
24	,	,	O	,	_	0	SENT_399	[p31l1660t1929r2009b1995],
25	and	CC	O	and	_	0	SENT_399	[p31l2039t1929r2144b1984],
26	reproduction	NN	O	reproduction	conj_and	21	SENT_399	[p31l7t2018r385b2087],
27	in	IN	O	in	_	0	SENT_399	[p31l418t2018r474b2071],
28	any	DT	O	any	det	29	SENT_399	[p31l508t2035r613b2087],
29	medium	NN	O	medium	prep_in	21	SENT_399	[p31l646t2018r904b2083],
30	,	,	O	,	_	0	SENT_399	[p31l646t2018r904b2083],
31	provided	VBD	O	provide	_	0	SENT_399	[p31l938t2018r1202b2087],
32	the	DT	O	the	det	34	SENT_399	[p31l1235t2018r1323b2072],
33	original	JJ	O	original	amod	34	SENT_399	[p31l1358t2018r1585b2087],
34	author	NN	O	author	dobj	31	SENT_399	[p31l1619t2018r1880b2087],
35	(	CD	NUMBER	(	num	36	SENT_399	[p31l1619t2018r1880b2087],
36	s	NNS	O	s	nsubj	31	SENT_399	[p31l1619t2018r1880b2087],
37	)	CD	NUMBER	)	nsubjpass	42	SENT_399	[p31l1619t2018r1880b2087],
38	and	CC	O	and	_	0	SENT_399	[p31l1916t2018r2022b2072],
39	the	DT	O	the	det	40	SENT_399	[p31l2054t2018r2142b2072],
40	source	NN	O	source	conj_and	37	SENT_399	[p31l10t2124r198b2161],
41	are	VBP	O	be	auxpass	42	SENT_399	[p31l221t2124r307b2161],
42	credited	VBN	O	credit	rcmod	36	SENT_399	[p31l330t2107r576b2161],
43	.	.	O	.	_	0	SENT_399	[p31l330t2107r576b2161],

1	References	NNS	O	reference	_	0	SENT_400	[p31l8t2323r416b2385],

1	1	LS	NUMBER	1	_	0	SENT_401	[p31l55t2548r98b2601],
2	.	.	O	.	_	0	SENT_401	[p31l55t2548r98b2601],

1	Global	NNP	ORGANIZATION	Global	nn	6	SENT_402	[p31l137t2547r343b2601],
2	Health	NNP	ORGANIZATION	Health	nn	6	SENT_402	[p31l381t2547r585b2601],
3	Observatory	NNP	ORGANIZATION	Observatory	nn	6	SENT_402	[p31l624t2547r1003b2616],
4	(	NNP	O	(	nn	6	SENT_402	[p31l1043t2547r1275b2616],
5	GHO	NNP	O	GHO	nn	6	SENT_402	[p31l1043t2547r1275b2616],
6	)	NN	O	)	_	0	SENT_402	[p31l1043t2547r1275b2616],
7	;	:	O	;	_	0	SENT_402	[p31l1043t2547r1275b2616],
8	Tuberculosis	NN	O	tuberculosis	nn	11	SENT_402	[p31l1317t2547r1710b2601],
9	(	CD	NUMBER	(	num	11	SENT_402	[p31l1751t2547r1911b2616],
10	TB	NN	O	tb	nn	11	SENT_402	[p31l1751t2547r1911b2616],
11	)	NN	O	)	dep	6	SENT_402	[p31l1751t2547r1911b2616],
12	.	.	O	.	_	0	SENT_402	[p31l1751t2547r1911b2616],

1	World	NNP	O	World	nn	3	SENT_403	[p31l1954t2547r2144b2601],
2	Health	NNP	O	Health	nn	3	SENT_403	[p31l135t2634r344b2689],
3	Organization	NNP	O	Organization	_	0	SENT_403	[p31l384t2634r794b2704],
4	Web	NN	O	web	nn	5	SENT_403	[p31l833t2634r971b2689],
5	site	NN	O	site	dep	3	SENT_403	[p31l1015t2634r1136b2689],
6	.	.	O	.	_	0	SENT_403	[p31l1015t2634r1136b2689],

1	http://www.who.int/gho/tb/en/	NN	O	http://www.who.int/gho/tb/en/	_	0	SENT_404	[p31l1180t2634r2144b2704],
2	index	NN	O	index	dep	1	SENT_404	[p31l136t2723r457b2777],
3	.	.	O	.	_	0	SENT_404	[p31l136t2723r457b2777],

1	html	NN	O	html	nsubj	2	SENT_405	[p31l136t2723r457b2777],
2	Accessed	VBD	O	access	_	0	SENT_405	[p31l482t2723r766b2777],
3	Sep	NNP	DATE	Sep	dobj	2	SENT_405	[p31l793t2724r900b2792],
4	10	CD	DATE	10	num	3	SENT_405	[p31l934t2724r1016b2788],
5	,	,	DATE	,	_	0	SENT_405	[p31l934t2724r1016b2788],
6	2012	CD	DATE	2012	num	3	SENT_405	[p31l1044t2724r1209b2777],
7	.	.	O	.	_	0	SENT_405	[p31l1044t2724r1209b2777],

1	2	LS	NUMBER	2	_	0	SENT_406	[p31l47t2812r98b2865],
2	.	.	O	.	_	0	SENT_406	[p31l47t2812r98b2865],

1	The	DT	O	the	det	3	SENT_407	[p31l134t2811r248b2865],
2	Global	JJ	O	global	amod	3	SENT_407	[p31l273t2811r474b2865],
3	Plan	NN	O	plan	nsubj	5	SENT_407	[p31l497t2811r630b2865],
4	to	TO	O	to	aux	5	SENT_407	[p31l651t2818r706b2865],
5	Stop	VB	O	stop	_	0	SENT_407	[p31l734t2812r865b2880],
6	TB	NN	O	tb	dobj	5	SENT_407	[p31l891t2813r999b2865],
7	.	.	O	.	_	0	SENT_407	[p31l891t2813r999b2865],

1	Stop	VB	O	stop	dep	2	SENT_408	[p31l1030t2812r1161b2880],
2	TB	NN	O	tb	_	0	SENT_408	[p31l1186t2813r1277b2864],
3	Partnership	NNP	O	Partnership	nn	5	SENT_408	[p31l1302t2811r1641b2880],
4	Web	NN	O	web	nn	5	SENT_408	[p31l1665t2811r1798b2865],
5	site	NN	O	site	dep	2	SENT_408	[p31l1825t2811r1939b2865],
6	.	.	O	.	_	0	SENT_408	[p31l1825t2811r1939b2865],

1	http	NN	O	http	_	0	SENT_409	[p31l1965t2811r2144b2880],
2	:	:	O	:	_	0	SENT_409	[p31l1965t2811r2144b2880],
3	/	:	O	/	dep	1	SENT_409	[p31l1965t2811r2144b2880],
4	/	:	O	/	punct	3	SENT_409	[p31l1965t2811r2144b2880],

1	www.stoptb.org/global/plan/	NN	O	www.stoptb.org/global/plan/	nsubj	2	SENT_410	[p31l133t2899r995b2968],
2	Accessed	VBN	O	access	_	0	SENT_410	[p31l1017t2899r1301b2953],
3	Sep	NNP	DATE	Sep	dobj	2	SENT_410	[p31l1328t2900r1435b2968],
4	10	CD	DATE	10	num	3	SENT_410	[p31l1468t2900r1551b2965],
5	,	,	DATE	,	_	0	SENT_410	[p31l1468t2900r1551b2965],
6	2012	CD	DATE	2012	num	3	SENT_410	[p31l1579t2900r1743b2953],
7	.	.	O	.	_	0	SENT_410	[p31l1579t2900r1743b2953],

1	3	LS	NUMBER	3	_	0	SENT_411	[p31l49t2989r98b3042],
2	.	.	O	.	_	0	SENT_411	[p31l49t2989r98b3042],

1	Guidelines	NNS	O	guideline	_	0	SENT_412	[p31l136t2987r460b3042],
2	for	IN	O	for	_	0	SENT_412	[p31l500t2988r587b3042],
3	treatment	NN	O	treatment	prep_for	1	SENT_412	[p31l621t2995r906b3042],
4	of	IN	O	of	_	0	SENT_412	[p31l943t2988r1013b3042],
5	tuberculosis	NN	O	tuberculosis	prep_of	1	SENT_412	[p31l1039t2987r1422b3053],
6	,	,	O	,	_	0	SENT_412	[p31l1039t2987r1422b3053],
7	4th	JJ	ORDINAL	4th	amod	8	SENT_412	[p31l1461t2987r1557b3041],
8	ed	NN	O	ed	appos	5	SENT_412	[p31l1595t2987r1678b3042],
9	.	.	O	.	_	0	SENT_412	[p31l1595t2987r1678b3042],

1	World	NNP	O	World	nn	3	SENT_413	[p31l1719t2987r1907b3042],
2	Health	NNP	O	Health	nn	3	SENT_413	[p31l1943t2987r2143b3042],
3	Organization	NNP	O	Organization	_	0	SENT_413	[p31l136t3076r526b3145],
4	Web	NN	O	web	nn	5	SENT_413	[p31l562t3076r696b3130],
5	site	NN	O	site	dep	3	SENT_413	[p31l736t3076r851b3130],
6	.	.	O	.	_	0	SENT_413	[p31l736t3076r851b3130],

1	http://www.who.int/tb/publications/2010/	NN	O	http://www.who.int/tb/publications/2010/	nn	2	SENT_414	[p31l891t3076r2145b3145],
2	9789241547833/en	NN	O	9789241547833/en	_	0	SENT_414	[p31l136t3164r740b3218],
3	/	:	O	/	punct	2	SENT_414	[p31l136t3164r740b3218],
4	Accessed	VBN	O	access	dep	2	SENT_414	[p31l763t3164r1046b3218],
5	Sep	NN	DATE	sep	tmod	4	SENT_414	[p31l1074t3165r1180b3233],
6	10	CD	DATE	10	num	5	SENT_414	[p31l1215t3165r1297b3230],
7	,	,	DATE	,	_	0	SENT_414	[p31l1215t3165r1297b3230],
8	2012	CD	DATE	2012	appos	5	SENT_414	[p31l1324t3165r1489b3218],
9	.	.	O	.	_	0	SENT_414	[p31l1324t3165r1489b3218],

1	4	LS	NUMBER	4	_	0	SENT_415	[p31l47t3253r98b3306],
2	.	.	O	.	_	0	SENT_415	[p31l47t3253r98b3306],

1	Blumberg	NNP	ORGANIZATION	Blumberg	nn	2	SENT_416	[p31l133t3252r438b3322],
2	HM	NNS	ORGANIZATION	hm	_	0	SENT_416	[p31l476t3254r614b3318],
3	,	,	O	,	_	0	SENT_416	[p31l476t3254r614b3318],
4	Burman	NNP	PERSON	Burman	nn	5	SENT_416	[p31l654t3254r901b3306],
5	WJ	NNP	O	WJ	appos	2	SENT_416	[p31l938t3254r1055b3318],
6	,	,	O	,	_	0	SENT_416	[p31l938t3254r1055b3318],
7	Chaisson	NNP	PERSON	Chaisson	nn	8	SENT_416	[p31l1096t3252r1378b3306],
8	RE	NNP	O	RE	appos	2	SENT_416	[p31l1414t3254r1527b3318],
9	,	,	O	,	_	0	SENT_416	[p31l1414t3254r1527b3318],
10	Daley	NNP	ORGANIZATION	Daley	nn	11	SENT_416	[p31l1567t3252r1749b3322],
11	CL	NN	ORGANIZATION	cl	appos	2	SENT_416	[p31l1788t3253r1899b3318],
12	,	,	O	,	_	0	SENT_416	[p31l1788t3253r1899b3318],
13	Etkind	NN	ORGANIZATION	etkind	nn	14	SENT_416	[p31l1940t3252r2144b3306],
14	SC	NN	ORGANIZATION	sc	appos	2	SENT_416	[p31l136t3341r242b3406],
15	,	,	O	,	_	0	SENT_416	[p31l136t3341r242b3406],
16	Friedman	NNP	ORGANIZATION	Friedman	nn	17	SENT_416	[p31l290t3340r583b3394],
17	LN	NN	ORGANIZATION	ln	appos	2	SENT_416	[p31l627t3342r744b3405],
18	,	,	O	,	_	0	SENT_416	[p31l627t3342r744b3405],
19	Fujiwara	NNP	PERSON	Fujiwara	nn	20	SENT_416	[p31l792t3340r1065b3409],
20	P	NN	O	p	appos	2	SENT_416	[p31l1108t3342r1157b3405],
21	,	,	O	,	_	0	SENT_416	[p31l1108t3342r1157b3405],
22	Grzemska	NN	LOCATION	grzemska	nn	23	SENT_416	[p31l1206t3340r1515b3394],
23	M	NN	O	m	appos	2	SENT_416	[p31l1559t3342r1641b3405],
24	,	,	O	,	_	0	SENT_416	[p31l1559t3342r1641b3405],
25	Hopewell	NNP	ORGANIZATION	Hopewell	nn	26	SENT_416	[p31l1689t3340r1986b3409],
26	PC	NNP	ORGANIZATION	PC	appos	2	SENT_416	[p31l2031t3341r2140b3405],
27	,	,	O	,	_	0	SENT_416	[p31l2031t3341r2140b3405],
28	Iseman	NNP	PERSON	Iseman	nn	29	SENT_416	[p31l134t3430r354b3482],
29	MD	NNP	O	MD	appos	2	SENT_416	[p31l398t3430r536b3494],
30	,	,	O	,	_	0	SENT_416	[p31l398t3430r536b3494],
31	Jasmer	NNP	PERSON	Jasmer	nn	32	SENT_416	[p31l584t3430r796b3482],
32	RM	NN	PERSON	rm	appos	2	SENT_416	[p31l839t3430r973b3494],
33	,	,	O	,	_	0	SENT_416	[p31l839t3430r973b3494],
34	Koppaka	NNP	LOCATION	Koppaka	nn	35	SENT_416	[p31l1021t3428r1299b3497],
35	V	NNP	O	V	appos	2	SENT_416	[p31l1342t3430r1403b3494],
36	,	,	O	,	_	0	SENT_416	[p31l1342t3430r1403b3494],
37	Menzies	NNP	PERSON	Menzies	nn	38	SENT_416	[p31l1451t3428r1708b3482],
38	RI	NN	PERSON	rus	appos	2	SENT_416	[p31l1754t3430r1845b3494],
39	,	,	O	,	_	0	SENT_416	[p31l1754t3430r1845b3494],
40	O’Brien	NNP	O	O’Brien	nn	41	SENT_416	[p31l1894t3428r2144b3482],
41	RJ	NN	O	rj	appos	2	SENT_416	[p31l133t3519r229b3583],
42	,	,	O	,	_	0	SENT_416	[p31l133t3519r229b3583],
43	Reves	NNP	ORGANIZATION	Reves	nn	44	SENT_416	[p31l266t3519r451b3571],
44	RR	NNP	ORGANIZATION	RR	appos	2	SENT_416	[p31l485t3519r603b3583],
45	,	,	O	,	_	0	SENT_416	[p31l485t3519r603b3583],
46	Reichman	NNP	PERSON	Reichman	nn	47	SENT_416	[p31l640t3517r951b3571],
47	LB	NNP	O	LB	appos	2	SENT_416	[p31l983t3519r1096b3583],
48	,	,	O	,	_	0	SENT_416	[p31l983t3519r1096b3583],
49	Simone	NNP	ORGANIZATION	Simone	nn	50	SENT_416	[p31l1136t3517r1365b3571],
50	PM	NNP	ORGANIZATION	PM	appos	2	SENT_416	[p31l1399t3519r1525b3583],
51	,	,	O	,	_	0	SENT_416	[p31l1399t3519r1525b3583],
52	Starke	NNP	ORGANIZATION	Starke	nn	53	SENT_416	[p31l1565t3517r1755b3571],
53	JR	NNP	ORGANIZATION	JR	appos	2	SENT_416	[p31l1790t3519r1885b3583],
54	,	,	O	,	_	0	SENT_416	[p31l1790t3519r1885b3583],
55	Vernon	NNP	PERSON	Vernon	appos	2	SENT_416	[p31l1921t3519r2144b3571],

1	AA	NN	O	aa	nn	5	SENT_417	[p32l133t19r243b71],
2	(	CD	NUMBER	(	num	5	SENT_417	[p32l293t18r496b87],
3	2003	CD	DATE	2003	num	5	SENT_417	[p32l293t18r496b87],
4	)	NNP	O	)	nn	5	SENT_417	[p32l293t18r496b87],
5	American	NNP	MISC	American	_	0	SENT_417	[p32l546t18r851b72],
6	Thoracic	NNP	MISC	Thoracic	nn	7	SENT_417	[p32l900t18r1173b72],
7	Society/Centers	NNP	O	Society/Centers	dep	5	SENT_417	[p32l1226t18r1715b87],
8	for	IN	O	for	_	0	SENT_417	[p32l1767t18r1856b72],
9	Disease	NNP	O	Disease	nn	10	SENT_417	[p32l1903t18r2143b72],
10	Control	NNP	O	Control	prep_for	7	SENT_417	[p32l135t106r367b160],
11	and	CC	O	and	_	0	SENT_417	[p32l411t106r519b160],
12	Prevention/Infectious	NNP	O	Prevention/Infectious	nn	14	SENT_417	[p32l560t106r1222b160],
13	Diseases	NNP	O	Diseases	nn	14	SENT_417	[p32l1264t106r1530b160],
14	Society	NNP	O	Society	dep	5	SENT_417	[p32l1576t106r1802b175],
15	of	IN	O	of	_	0	SENT_417	[p32l1844t106r1914b160],
16	America	NNP	LOCATION	America	prep_of	14	SENT_417	[p32l1946t107r2141b160, p32l134t194r238b248],
17	:	:	O	:	_	0	SENT_417	[p32l1946t107r2141b160, p32l134t194r238b248],
18	treatment	NN	O	treatment	dep	5	SENT_417	[p32l276t201r552b248],
19	of	IN	O	of	_	0	SENT_417	[p32l570t194r639b248],
20	tuberculosis	NN	O	tuberculosis	prep_of	18	SENT_417	[p32l648t194r1014b248],
21	.	.	O	.	_	0	SENT_417	[p32l648t194r1014b248],

1	Am	NNP	O	Am	nn	5	SENT_418	[p32l1036t195r1150b247],
2	J	NNP	O	J	nn	5	SENT_418	[p32l1167t196r1195b248],
3	Respir	NNP	O	Respir	nn	5	SENT_418	[p32l1214t194r1407b264],
4	Crit	NNP	O	Crit	nn	5	SENT_418	[p32l1424t194r1537b248],
5	Care	NNP	O	Care	dep	6	SENT_418	[p32l1555t195r1691b248],
6	Med	VBD	O	med	_	0	SENT_418	[p32l1710t194r1846b248],
7	167:603	CD	NUMBER	167:603	num	8	SENT_418	[p32l1872t195r2145b248],
8	—	NN	O	—	dobj	6	SENT_418	[p32l1872t195r2145b248],
9	662	CD	NUMBER	662	nsubj	6	SENT_418	[p32l135t284r241b337],

1	.	.	O	.	_	0	SENT_419	[p32l89t416r98b425],

1	Yee	NN	PERSON	yee	nn	2	SENT_420	[p32l133t373r245b425],
2	D	NN	O	d	_	0	SENT_420	[p32l271t373r340b437],
3	,	,	O	,	_	0	SENT_420	[p32l271t373r340b437],
4	Valiquette	NN	PERSON	valiquette	nn	5	SENT_420	[p32l368t371r670b440],
5	C	NN	O	c	appos	2	SENT_420	[p32l698t372r761b437],
6	,	,	O	,	_	0	SENT_420	[p32l698t372r761b437],
7	Pelletier	NNP	PERSON	Pelletier	nn	8	SENT_420	[p32l790t371r1038b425],
8	M	NNP	O	M	appos	2	SENT_420	[p32l1061t373r1143b437],
9	,	,	O	,	_	0	SENT_420	[p32l1061t373r1143b437],
10	Parisien	NNP	PERSON	Parisien	appos	2	SENT_420	[p32l1172t371r1412b425],
11	I	PRP	O	I	dep	10	SENT_420	[p32l1437t373r1476b437],
12	,	,	O	,	_	0	SENT_420	[p32l1437t373r1476b437],
13	Rocher	NNP	PERSON	Rocher	appos	2	SENT_420	[p32l1503t371r1721b425],
14	I	PRP	O	I	dep	13	SENT_420	[p32l1746t373r1784b437],
15	,	,	O	,	_	0	SENT_420	[p32l1746t373r1784b437],
16	Menzies	NNPS	PERSON	Menzies	nn	17	SENT_420	[p32l1812t371r2063b425],
17	D	NNP	O	D	appos	2	SENT_420	[p32l2090t373r2141b424],
18	(	CD	NUMBER	(	num	19	SENT_420	[p32l135t459r332b528],
19	2003	CD	DATE	2003	rcmod	17	SENT_420	[p32l135t459r332b528],
20	)	CD	NUMBER	)	num	21	SENT_420	[p32l135t459r332b528],
21	Incidence	NN	O	incidence	dobj	19	SENT_420	[p32l355t459r644b513],
22	of	IN	O	of	_	0	SENT_420	[p32l668t459r736b513],
23	serious	JJ	O	serious	amod	25	SENT_420	[p32l751t459r958b513],
24	side	JJ	O	side	amod	25	SENT_420	[p32l984t459r1100b513],
25	effects	NNS	O	effect	prep_of	21	SENT_420	[p32l1124t459r1317b513],
26	from	IN	O	from	_	0	SENT_420	[p32l1342t459r1486b513],
27	ﬁrst-line	JJ	O	ﬁrst-line	amod	29	SENT_420	[p32l1508t459r1759b513],
28	antituberculosis	NN	O	antituberculosis	nn	29	SENT_420	[p32l1784t459r2141b513, p32l134t547r268b601],
29	drugs	NNS	O	drug	prep_from	19	SENT_420	[p32l303t547r466b617],
30	among	IN	O	among	_	0	SENT_420	[p32l501t565r703b617],
31	patients	NNS	O	patient	prep_among	29	SENT_420	[p32l734t547r966b617],
32	treated	VBN	O	treat	partmod	17	SENT_420	[p32l999t547r1201b601],
33	for	IN	O	for	_	0	SENT_420	[p32l1235t547r1321b601],
34	active	JJ	O	active	amod	35	SENT_420	[p32l1352t547r1526b601],
35	tuberculosis	NN	O	tuberculosis	prep_for	32	SENT_420	[p32l1559t547r1935b601],
36	.	.	O	.	_	0	SENT_420	[p32l1559t547r1935b601],

1	Am	NNP	O	Am	nn	5	SENT_421	[p32l1971t548r2084b600],
2	J	NNP	O	J	nn	5	SENT_421	[p32l2116t549r2144b601],
3	Respir	NNP	O	Respir	nn	5	SENT_421	[p32l133t634r330b704],
4	Crit	NNP	O	Crit	nn	5	SENT_421	[p32l354t634r468b689],
5	Care	NNP	O	Care	nsubj	6	SENT_421	[p32l493t635r631b689],
6	Med	VBD	O	med	_	0	SENT_421	[p32l656t634r794b689],
7	167:1472	CD	NUMBER	167:1472	number	8	SENT_421	[p32l825t635r1290b689],
8	—	CD	NUMBER	—	num	9	SENT_421	[p32l825t635r1290b689],
9	1477	CD	DATE	1477	dobj	6	SENT_421	[p32l825t635r1290b689],
10	.	.	O	.	_	0	SENT_421	[p32l89t768r98b777],

1	Steele	NNP	PERSON	Steele	nn	2	SENT_422	[p32l136t723r313b777],
2	MA	NNP	PERSON	MA	_	0	SENT_422	[p32l349t724r485b789],
3	,	,	O	,	_	0	SENT_422	[p32l349t724r485b789],
4	Burk	NNP	PERSON	Burk	nn	5	SENT_422	[p32l523t723r674b777],
5	RF	NNP	O	RF	appos	2	SENT_422	[p32l708t725r809b789],
6	,	,	O	,	_	0	SENT_422	[p32l708t725r809b789],
7	DeaPrez	NNP	O	DeaPrez	nn	8	SENT_422	[p32l847t725r1099b777],
8	RM	NN	O	rm	appos	2	SENT_422	[p32l1134t725r1250b776],
9	(	CD	NUMBER	(	num	10	SENT_422	[p32l1287t723r1483b792],
10	1991	CD	DATE	1991	dep	8	SENT_422	[p32l1287t723r1483b792],
11	)	CD	NUMBER	)	num	13	SENT_422	[p32l1287t723r1483b792],
12	Toxic	JJ	O	toxic	amod	13	SENT_422	[p32l1521t723r1688b777],
13	hepatitis	NN	O	hepatitis	dep	2	SENT_422	[p32l1723t723r1974b792],
14	with	IN	O	with	_	0	SENT_422	[p32l2010t723r2143b777],
15	isoniazid	NN	O	isoniazid	prep_with	13	SENT_422	[p32l134t811r403b865],
16	and	CC	O	and	_	0	SENT_422	[p32l429t811r536b865],
17	rifampin	NN	O	rifampin	prep_with	13	SENT_422	[p32l559t811r831b880],
18	.	.	O	.	_	0	SENT_422	[p32l559t811r831b880],

1	A	DT	O	a	det	2	SENT_423	[p32l859t812r913b864],
2	meta-analysis	NN	O	meta-analysis	_	0	SENT_423	[p32l937t811r1362b881],
3	.	.	O	.	_	0	SENT_423	[p32l937t811r1362b881],

1	Chest	NN	O	chest	_	0	SENT_424	[p32l1393t811r1563b865],
2	99:465	CD	NUMBER	99:465	number	3	SENT_424	[p32l1588t812r1900b865],
3	—	CD	NUMBER	—	dep	1	SENT_424	[p32l1588t812r1900b865],
4	7l	NN	O	7l	dep	3	SENT_424	[p32l1588t812r1900b865],
5	.	.	O	.	_	0	SENT_424	[p32l89t944r98b952],

1	Jindani	NNP	MISC	Jindani	nn	2	SENT_425	[p32l134t898r349b953],
2	A	NNP	MISC	A	_	0	SENT_425	[p32l376t899r445b964],
3	,	,	O	,	_	0	SENT_425	[p32l376t899r445b964],
4	Nunn	NNP	PERSON	Nunn	nn	8	SENT_425	[p32l473t900r642b953],
5	AJ	NNP	PERSON	AJ	nn	8	SENT_425	[p32l668t900r767b964],
6	,	,	O	,	_	0	SENT_425	[p32l668t900r767b964],
7	Enarson	NNP	ORGANIZATION	Enarson	appos	8	SENT_425	[p32l797t901r1042b953],
8	DA	NNP	ORGANIZATION	DA	appos	2	SENT_425	[p32l1069t900r1177b952],
9	(	CD	NUMBER	(	num	8	SENT_425	[p32l1205t898r1401b967],
10	2004	CD	DATE	2004	num	14	SENT_425	[p32l1205t898r1401b967],
11	)	CD	NUMBER	)	num	14	SENT_425	[p32l1205t898r1401b967],
12	Two	CD	NUMBER	two	num	14	SENT_425	[p32l1430t901r1560b953],
13	8-month	JJ	DURATION	8-month	amod	14	SENT_425	[p32l1592t898r1842b953],
14	regimens	NNS	O	regimen	dep	8	SENT_425	[p32l1869t898r2141b968],
15	of	IN	O	of	_	0	SENT_425	[p32l134t987r204b1041],
16	chemotherapy	NN	O	chemotherapy	prep_of	8	SENT_425	[p32l233t987r663b1056],
17	for	IN	O	for	_	0	SENT_425	[p32l702t987r789b1041],
18	treatment	NN	O	treatment	prep_for	16	SENT_425	[p32l823t994r1111b1041],
19	of	IN	O	of	_	0	SENT_425	[p32l1147t987r1217b1041],
20	newly	RB	O	newly	advmod	21	SENT_425	[p32l1244t987r1430b1056],
21	diagnosed	VBN	O	diagnose	amod	23	SENT_425	[p32l1468t987r1777b1056],
22	pulmonary	JJ	O	pulmonary	amod	23	SENT_425	[p32l1811t987r2143b1056],
23	tuberculosis	NN	O	tuberculosis	prep_of	18	SENT_425	[p32l133t1076r519b1130],
24	:	:	O	:	_	0	SENT_425	[p32l133t1076r519b1130],
25	intemational	JJ	O	intemational	amod	26	SENT_425	[p32l563t1076r946b1130],
26	multicentre	JJ	O	multicentre	amod	28	SENT_425	[p32l983t1076r1329b1130],
27	randomised	JJ	O	randomised	amod	28	SENT_425	[p32l1366t1076r1724b1130],
28	trial	NN	O	trial	dep	8	SENT_425	[p32l1760t1076r1896b1130],
29	.	.	O	.	_	0	SENT_425	[p32l1760t1076r1896b1130],

1	Lancet	NNP	O	Lancet	_	0	SENT_426	[p32l1937t1078r2144b1130],

1	364	CD	NUMBER	364	_	0	SENT_427	[p32l135t1165r600b1218],
2	:	:	O	:	_	0	SENT_427	[p32l135t1165r600b1218],
3	l244	CD	NUMBER	l244	num	5	SENT_427	[p32l135t1165r600b1218],
4	—	CD	NUMBER	—	num	5	SENT_427	[p32l135t1165r600b1218],
5	l25l	NN	O	l25l	dep	1	SENT_427	[p32l135t1165r600b1218],

1	.	.	O	.	_	0	SENT_428	[p32l89t1298r98b1306],

1	Durand	NNP	PERSON	Durand	nn	2	SENT_429	[p32l133t1252r358b1307],
2	F	NN	O	f	nsubj	15	SENT_429	[p32l389t1255r440b1318],
3	,	,	O	,	_	0	SENT_429	[p32l389t1255r440b1318],
4	Jebrak	NNP	PERSON	Jebrak	nn	5	SENT_429	[p32l474t1252r669b1307],
5	G	NNP	PERSON	G	appos	2	SENT_429	[p32l700t1253r768b1318],
6	,	,	O	,	_	0	SENT_429	[p32l700t1253r768b1318],
7	Pessayre	NNP	O	Pessayre	nn	8	SENT_429	[p32l802t1254r1062b1322],
8	D	NNP	O	D	appos	2	SENT_429	[p32l1094t1254r1163b1318],
9	,	,	O	,	_	0	SENT_429	[p32l1094t1254r1163b1318],
10	Fournier	NNP	PERSON	Fournier	nn	11	SENT_429	[p32l1197t1252r1456b1307],
11	M	NNP	O	M	appos	2	SENT_429	[p32l1485t1255r1566b1318],
12	,	,	O	,	_	0	SENT_429	[p32l1485t1255r1566b1318],
13	Bemuau	NNP	PERSON	Bemuau	nn	14	SENT_429	[p32l1600t1254r1855b1307],
14	J	NNP	PERSON	J	appos	2	SENT_429	[p32l1886t1255r1914b1307],
15	(	VBD	O	(	_	0	SENT_429	[p32l1945t1252r2142b1321],
16	1996	CD	DATE	1996	num	18	SENT_429	[p32l1945t1252r2142b1321],
17	)	CD	NUMBER	)	num	18	SENT_429	[p32l1945t1252r2142b1321],
18	Hepatotoxicity	NN	O	hepatotoxicity	dobj	15	SENT_429	[p32l133t1341r580b1411],
19	of	IN	O	of	_	0	SENT_429	[p32l601t1341r670b1395],
20	antitubercular	JJ	O	antitubercular	amod	21	SENT_429	[p32l683t1341r1098b1395],
21	treatments	NNS	O	treatment	prep_of	18	SENT_429	[p32l1118t1348r1442b1395],
22	.	.	O	.	_	0	SENT_429	[p32l1118t1348r1442b1395],

1	Rationale	NN	O	rationale	_	0	SENT_430	[p32l1468t1341r1754b1395],
2	for	IN	O	for	_	0	SENT_430	[p32l1777t1341r1863b1395],
3	monitoring	VBG	O	monitor	amod	5	SENT_430	[p32l1882t1341r2142b1395, p32l134t1428r228b1498],
4	liver	NN	O	liver	nn	5	SENT_430	[p32l254t1428r390b1483],
5	status	NN	O	status	prep_for	1	SENT_430	[p32l415t1436r596b1483],
6	.	.	O	.	_	0	SENT_430	[p32l415t1436r596b1483],

1	Drug	NN	O	drug	nn	2	SENT_431	[p32l625t1431r778b1498],
2	Saf	NN	O	saf	_	0	SENT_431	[p32l807t1428r911b1483],
3	151394-405	CD	NUMBER	151394-405	dep	2	SENT_431	[p32l934t1429r1282b1483],
4	.	.	O	.	_	0	SENT_431	[p32l89t1562r98b1570],

1	Evans	NNP	ORGANIZATION	Evans	nn	2	SENT_432	[p32l133t1519r315b1571],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_432	[p32l343t1518r466b1582],
3	,	,	O	,	_	0	SENT_432	[p32l343t1518r466b1582],
4	Manley	NNP	PERSON	Manley	nn	5	SENT_432	[p32l496t1516r725b1586],
5	KA	NN	O	ka	appos	2	SENT_432	[p32l751t1517r875b1582],
6	,	,	O	,	_	0	SENT_432	[p32l751t1517r875b1582],
7	Mc	NN	O	mc	nn	8	SENT_432	[p32l904t1518r1002b1571],
8	KV	NN	O	kv	appos	2	SENT_432	[p32l1030t1518r1138b1571],
9	(	CD	NUMBER	(	num	12	SENT_432	[p32l1166t1517r1362b1585],
10	1960	CD	DATE	1960	num	12	SENT_432	[p32l1166t1517r1362b1585],
11	)	NNP	O	)	nn	12	SENT_432	[p32l1166t1517r1362b1585],
12	Genetic	NNP	O	Genetic	dep	8	SENT_432	[p32l1391t1516r1620b1571],
13	control	NN	O	control	dep	2	SENT_432	[p32l1649t1516r1859b1571],
14	of	IN	O	of	_	0	SENT_432	[p32l1888t1516r1956b1571],
15	isoniazid	NN	O	isoniazid	nn	16	SENT_432	[p32l1975t1516r2141b1571, p32l135t1605r257b1660],
16	metabolism	NN	O	metabolism	prep_of	13	SENT_432	[p32l281t1605r631b1660],
17	in	IN	O	in	_	0	SENT_432	[p32l656t1605r712b1659],
18	man	NN	O	man	prep_in	16	SENT_432	[p32l736t1623r878b1660],
19	.	.	O	.	_	0	SENT_432	[p32l736t1623r878b1660],

1	Br	NNP	O	Br	dep	2	SENT_433	[p32l908t1608r984b1659],
2	Med	VBD	O	med	_	0	SENT_433	[p32l1006t1605r1143b1660],
3	J	NNP	O	J	dobj	2	SENT_433	[p32l1168t1608r1196b1660],
4	2:485	CD	NUMBER	2:485	num	3	SENT_433	[p32l1220t1607r1534b1660],
5	—	CD	NUMBER	—	num	6	SENT_433	[p32l1220t1607r1534b1660],
6	49l	NN	O	49l	nsubj	2	SENT_433	[p32l1220t1607r1534b1660],

1	Evans	NNP	ORGANIZATION	Evans	nn	2	SENT_434	[p32l136t1696r320b1748],
2	DA	NNP	ORGANIZATION	DA	_	0	SENT_434	[p32l358t1694r483b1759],
3	,	,	O	,	_	0	SENT_434	[p32l358t1694r483b1759],
4	Storey	NNP	ORGANIZATION	Storey	nn	5	SENT_434	[p32l527t1694r722b1763],
5	PB	NN	ORGANIZATION	pb	appos	2	SENT_434	[p32l758t1695r867b1759],
6	,	,	O	,	_	0	SENT_434	[p32l758t1695r867b1759],
7	Wittstadt	NNP	O	Wittstadt	nn	8	SENT_434	[p32l907t1693r1185b1748],
8	FB	NNP	O	FB	appos	2	SENT_434	[p32l1221t1695r1329b1759],
9	,	,	O	,	_	0	SENT_434	[p32l1221t1695r1329b1759],
10	Manley	NNP	ORGANIZATION	Manley	nn	11	SENT_434	[p32l1370t1693r1603b1763],
11	KA	NN	ORGANIZATION	ka	appos	2	SENT_434	[p32l1639t1695r1748b1747],
12	(	CD	NUMBER	(	num	11	SENT_434	[p32l1787t1694r1987b1762],
13	1960	CD	DATE	1960	num	14	SENT_434	[p32l1787t1694r1987b1762],
14	)	CD	NUMBER	)	dep	11	SENT_434	[p32l1787t1694r1987b1762],
15	The	DT	O	the	det	16	SENT_434	[p32l2027t1693r2142b1747],
16	determination	NN	O	determination	dep	2	SENT_434	[p32l136t1781r559b1836],
17	of	IN	O	of	_	0	SENT_434	[p32l597t1781r666b1835],
18	the	DT	O	the	det	21	SENT_434	[p32l693t1781r785b1835],
19	isoniazid	NN	O	isoniazid	nn	21	SENT_434	[p32l824t1781r1098b1836],
20	inactivator	NN	O	inactivator	nn	21	SENT_434	[p32l1135t1781r1462b1836],
21	phenotype	NN	O	phenotype	prep_of	16	SENT_434	[p32l1495t1781r1830b1851],
22	.	.	O	.	_	0	SENT_434	[p32l1495t1781r1830b1851],

1	Am	VBP	O	be	_	0	SENT_435	[p32l1871t1782r1985b1835],
2	Rev	NN	O	rev	nn	4	SENT_435	[p32l2021t1783r2142b1836],
3	Respir	NNP	O	Respir	nn	4	SENT_435	[p32l135t1870r332b1939],
4	Dis	NNP	O	Dis	nsubj	9	SENT_435	[p32l355t1870r456b1924],
5	822853-861	CD	NUMBER	822853-861	num	8	SENT_435	[p32l485t1871r834b1924],
6	Human	JJ	O	human	amod	8	SENT_435	[p32l133t1960r357b2012],
7	NAT2	NN	O	nat2	nn	8	SENT_435	[p32l404t1959r589b2012],
8	alleles	NNS	O	allele	dep	4	SENT_435	[p32l642t1958r832b2012],
9	(	VBP	O	(	ccomp	1	SENT_435	[p32l884t1958r1281b2027],
10	Haplotypes	NNS	O	haplotype	dobj	9	SENT_435	[p32l884t1958r1281b2027],
11	)	CD	NUMBER	)	number	12	SENT_435	[p32l884t1958r1281b2027],
12	(	CD	NUMBER	(	dep	10	SENT_435	[p32l1333t1958r1599b2027],
13	updated	VBN	O	update	partmod	10	SENT_435	[p32l1333t1958r1599b2027],
14	July	NNP	DATE	July	tmod	13	SENT_435	[p32l1648t1958r1774b2027],
15	22	CD	DATE	22	num	14	SENT_435	[p32l1824t1959r1915b2023],
16	,	,	DATE	,	_	0	SENT_435	[p32l1824t1959r1915b2023],
17	2011	CD	DATE	2011	num	14	SENT_435	[p32l1967t1958r2142b2027],
18	)	CD	NUMBER	)	num	21	SENT_435	[p32l1967t1958r2142b2027],
19	http://louisville.edu/medschool/pharmacology/consensushumanarylamine-n-acetyltransferase-gene-nomenclature/nat	NN	O	http://louisville.edu/medschool/pharmacology/consensushumanarylamine-n-acetyltransferase-gene-nomenclature/nat	nn	21	SENT_435	[p32l133t2045r2143b2115, p32l135t2133r1803b2203],
20	_	CD	NUMBER	_	num	21	SENT_435	[p32l1804t2133r2145b2203],
21	pdf_f1les	NNS	O	pdf_f1les	nsubj	1	SENT_435	[p32l1804t2133r2145b2203],
22	/	:	O	/	punct	23	SENT_435	[p32l1804t2133r2145b2203],
23	Human_NAT2_alleles	NNS	O	human_nat2_alleles	dep	21	SENT_435	[p32l133t2222r934b2291],
24	.	.	O	.	_	0	SENT_435	[p32l133t2222r934b2291],

1	pdf	NN	O	pdf	nsubj	2	SENT_436	[p32l133t2222r934b2291],
2	Accessed	VBN	O	access	_	0	SENT_436	[p32l961t2222r1244b2276],
3	Sep	NNP	DATE	Sep	dobj	2	SENT_436	[p32l1283t2223r1390b2291],
4	10	CD	DATE	10	num	3	SENT_436	[p32l1435t2223r1517b2288],
5	,	,	DATE	,	_	0	SENT_436	[p32l1435t2223r1517b2288],
6	2012	CD	DATE	2012	num	3	SENT_436	[p32l1556t2223r1721b2276],
7	.	.	O	.	_	0	SENT_436	[p32l1556t2223r1721b2276],

1	Mashimo	NNP	O	Mashimo	nn	2	SENT_437	[p32l135t2309r421b2363],
2	M	NNP	O	M	_	0	SENT_437	[p32l459t2312r542b2375],
3	,	,	O	,	_	0	SENT_437	[p32l459t2312r542b2375],
4	Suzuki	NNP	PERSON	Suzuki	nn	5	SENT_437	[p32l586t2309r793b2364],
5	T	NN	PERSON	t	appos	2	SENT_437	[p32l833t2312r887b2375],
6	,	,	O	,	_	0	SENT_437	[p32l833t2312r887b2375],
7	Abe	NN	ORGANIZATION	abe	nn	8	SENT_437	[p32l927t2309r1052b2364],
8	M	NN	ORGANIZATION	m	appos	2	SENT_437	[p32l1090t2312r1172b2375],
9	,	,	O	,	_	0	SENT_437	[p32l1090t2312r1172b2375],
10	Deguchi	NNP	PERSON	Deguchi	nn	11	SENT_437	[p32l1213t2309r1471b2379],
11	T	NN	PERSON	t	appos	2	SENT_437	[p32l1509t2311r1552b2363],
12	(	CD	NUMBER	(	num	11	SENT_437	[p32l1592t2309r1792b2378],
13	1992	CD	DATE	1992	number	14	SENT_437	[p32l1592t2309r1792b2378],
14	)	CD	NUMBER	)	num	16	SENT_437	[p32l1592t2309r1792b2378],
15	Molecular	JJ	MISC	molecular	amod	16	SENT_437	[p32l1830t2309r2145b2364],
16	genotyping	NN	O	genotyping	nsubj	21	SENT_437	[p32l136t2398r473b2467],
17	of	IN	O	of	_	0	SENT_437	[p32l503t2398r572b2452],
18	N-acetylation	NN	O	n-acetylation	nn	19	SENT_437	[p32l588t2397r998b2467],
19	polymorphism	NN	O	polymorphism	prep_of	16	SENT_437	[p32l1023t2397r1464b2467],
20	to	TO	O	to	aux	21	SENT_437	[p32l1491t2405r1547b2452],
21	predict	VB	O	predict	infmod	11	SENT_437	[p32l1575t2397r1784b2467],
22	phenotype	NN	O	phenotype	dobj	21	SENT_437	[p32l1809t2397r2138b2467],
23	.	.	O	.	_	0	SENT_437	[p32l1809t2397r2138b2467],

1	Hum	NNP	O	Hum	nn	2	SENT_438	[p32l135t2489r286b2541],
2	Genet	NNP	O	Genet	_	0	SENT_438	[p32l311t2488r488b2541],
3	90:139	CD	NUMBER	90:139	dep	2	SENT_438	[p32l513t2488r867b2541],
4	—	CD	NUMBER	—	number	5	SENT_438	[p32l513t2488r867b2541],
5	143	CD	NUMBER	143	dep	3	SENT_438	[p32l513t2488r867b2541],

1	Parkin	NNP	O	Parkin	nn	2	SENT_439	[p32l133t2575r328b2629],
2	DP	NN	O	dp	nsubj	31	SENT_439	[p32l357t2577r460b2640],
3	,	,	O	,	_	0	SENT_439	[p32l357t2577r460b2640],
4	Vandenplas	NNP	PERSON	Vandenplas	nn	5	SENT_439	[p32l492t2575r837b2644],
5	S	NNP	PERSON	S	appos	2	SENT_439	[p32l872t2576r925b2640],
6	,	,	O	,	_	0	SENT_439	[p32l872t2576r925b2640],
7	Botha	NNP	PERSON	Botha	nn	8	SENT_439	[p32l957t2575r1137b2629],
8	FJ	NNP	O	FJ	appos	2	SENT_439	[p32l1166t2577r1252b2641],
9	,	,	O	,	_	0	SENT_439	[p32l1166t2577r1252b2641],
10	Vandenplas	NNP	O	Vandenplas	nn	11	SENT_439	[p32l1283t2575r1629b2644],
11	ML	NNP	O	ML	appos	2	SENT_439	[p32l1660t2577r1787b2640],
12	,	,	O	,	_	0	SENT_439	[p32l1660t2577r1787b2640],
13	Seifart	NNP	ORGANIZATION	Seifart	nn	14	SENT_439	[p32l1823t2575r2018b2629],
14	HI	NNP	ORGANIZATION	HI	appos	2	SENT_439	[p32l2046t2577r2140b2640],
15	,	,	O	,	_	0	SENT_439	[p32l2046t2577r2140b2640],
16	van	NNP	PERSON	van	nn	18	SENT_439	[p32l133t2681r241b2718],
17	Helden	NNP	PERSON	Helden	nn	18	SENT_439	[p32l271t2663r487b2718],
18	PD	NN	O	pd	appos	2	SENT_439	[p32l518t2666r629b2729],
19	,	,	O	,	_	0	SENT_439	[p32l518t2666r629b2729],
20	van	NN	O	van	nn	23	SENT_439	[p32l662t2681r771b2718],
21	der	NN	ORGANIZATION	der	nn	23	SENT_439	[p32l802t2663r897b2718],
22	Walt	NNP	ORGANIZATION	Walt	nn	23	SENT_439	[p32l925t2663r1065b2718],
23	BJ	NNP	ORGANIZATION	BJ	appos	2	SENT_439	[p32l1094t2666r1188b2729],
24	,	,	O	,	_	0	SENT_439	[p32l1094t2666r1188b2729],
25	Donald	NNP	PERSON	Donald	nn	26	SENT_439	[p32l1223t2663r1444b2718],
26	PR	NNP	PERSON	PR	appos	2	SENT_439	[p32l1474t2666r1581b2729],
27	,	,	O	,	_	0	SENT_439	[p32l1474t2666r1581b2729],
28	van	NNP	PERSON	van	nn	30	SENT_439	[p32l1614t2681r1722b2718],
29	Jaarsveld	NNP	PERSON	Jaarsveld	nn	30	SENT_439	[p32l1753t2663r2031b2718],
30	PP	NNP	PERSON	PP	appos	2	SENT_439	[p32l2061t2666r2142b2717],
31	(	VBD	O	(	_	0	SENT_439	[p32l135t2752r331b2820],
32	1997	CD	DATE	1997	num	34	SENT_439	[p32l135t2752r331b2820],
33	)	CD	NUMBER	)	num	34	SENT_439	[p32l135t2752r331b2820],
34	Trimodality	NN	O	trimodality	dobj	31	SENT_439	[p32l358t2751r712b2821],
35	of	IN	O	of	_	0	SENT_439	[p32l738t2752r807b2806],
36	isoniazid	NN	O	isoniazid	nn	37	SENT_439	[p32l823t2751r1092b2806],
37	elimination	NN	O	elimination	prep_of	34	SENT_439	[p32l1118t2751r1472b2806],
38	:	:	O	:	_	0	SENT_439	[p32l1118t2751r1472b2806],
39	phenotype	NN	O	phenotype	dep	34	SENT_439	[p32l1501t2751r1815b2821],
40	and	CC	O	and	_	0	SENT_439	[p32l1842t2751r1949b2806],
41	genotype	NN	O	genotype	conj_and	39	SENT_439	[p32l1974t2769r2141b2821, p32l133t2847r261b2909],
42	in	IN	O	in	_	0	SENT_439	[p32l298t2840r354b2893],
43	patients	NNS	O	patient	prep_in	39	SENT_439	[p32l388t2840r619b2909],
44	with	IN	O	with	_	0	SENT_439	[p32l655t2840r789b2894],
45	tuberculosis	NN	O	tuberculosis	prep_with	31	SENT_439	[p32l823t2840r1200b2894],
46	.	.	O	.	_	0	SENT_439	[p32l823t2840r1200b2894],

1	Am	NNP	O	Am	nn	5	SENT_440	[p32l1240t2841r1353b2893],
2	J	NNP	O	J	nn	5	SENT_440	[p32l1387t2842r1416b2894],
3	Respir	NNP	O	Respir	nn	5	SENT_440	[p32l1450t2840r1647b2909],
4	Crit	NNP	O	Crit	nn	5	SENT_440	[p32l1682t2840r1796b2894],
5	Care	NNP	O	Care	nsubj	6	SENT_440	[p32l1832t2841r1970b2894],
6	Med	VBD	O	med	_	0	SENT_440	[p32l2006t2840r2144b2894],
7	155:1717	CD	NUMBER	155:1717	number	8	SENT_440	[p32l141t2930r606b2983],
8	—	CD	NUMBER	—	num	9	SENT_440	[p32l141t2930r606b2983],
9	1722	CD	DATE	1722	dobj	6	SENT_440	[p32l141t2930r606b2983],

1	Ellard	NNP	PERSON	Ellard	nn	2	SENT_441	[p32l133t3016r315b3071],
2	GA	NNP	O	GA	nsubj	4	SENT_441	[p32l341t3018r448b3071],
3	(	CD	NUMBER	(	num	4	SENT_441	[p32l474t3017r670b3085],
4	1976	CD	DATE	1976	_	0	SENT_441	[p32l474t3017r670b3085],
5	)	CD	NUMBER	)	num	6	SENT_441	[p32l474t3017r670b3085],
6	Variations	NNS	MISC	variation	dobj	4	SENT_441	[p32l697t3017r999b3071],
7	between	IN	O	between	_	0	SENT_441	[p32l1025t3016r1276b3071],
8	individuals	NNS	O	individual	prep_between	6	SENT_441	[p32l1302t3016r1632b3071],
9	and	CC	O	and	_	0	SENT_441	[p32l1661t3016r1768b3071],
10	populations	NNS	O	population	prep_between	6	SENT_441	[p32l1790t3016r2142b3086],
11	in	IN	O	in	_	0	SENT_441	[p32l134t3105r191b3158],
12	the	DT	O	the	det	13	SENT_441	[p32l211t3105r301b3159],
13	acetylation	NN	O	acetylation	prep_in	4	SENT_441	[p32l324t3105r650b3174],
14	of	IN	O	of	_	0	SENT_441	[p32l672t3105r741b3159],
15	isoniazid	NN	O	isoniazid	prep_of	13	SENT_441	[p32l754t3105r1023b3159],
16	and	CC	O	and	_	0	SENT_441	[p32l1045t3105r1152b3159],
17	its	PRP$	O	its	poss	18	SENT_441	[p32l1174t3105r1240b3159],
18	signiﬁcance	NN	O	signiﬁcance	conj_and	13	SENT_441	[p32l1265t3105r1622b3174],
19	for	IN	O	for	_	0	SENT_441	[p32l1646t3105r1731b3159],
20	the	DT	O	the	det	21	SENT_441	[p32l1750t3105r1840b3159],
21	treatment	NN	O	treatment	prep_for	18	SENT_441	[p32l1861t3112r2144b3159],
22	of	IN	O	of	_	0	SENT_441	[p32l134t3193r203b3247],
23	pulmonary	JJ	O	pulmonary	amod	24	SENT_441	[p32l217t3193r543b3262],
24	tuberculosis	NN	O	tuberculosis	prep_of	21	SENT_441	[p32l568t3193r944b3247],
25	.	.	O	.	_	0	SENT_441	[p32l568t3193r944b3247],

1	Clin	NNP	O	Clin	nn	3	SENT_442	[p32l975t3193r1102b3247],
2	Pharrnacol	NNP	O	Pharrnacol	nn	3	SENT_442	[p32l1126t3193r1445b3247],
3	Ther	NNP	O	Ther	_	0	SENT_442	[p32l1471t3193r1612b3247],
4	192610-625	CD	NUMBER	192610-625	num	6	SENT_442	[p32l1643t3194r1991b3247],
5	Donald	NNP	PERSON	Donald	nn	6	SENT_442	[p32l133t3280r355b3335],
6	PR	NNP	O	PR	dep	3	SENT_442	[p32l374t3283r481b3346],
7	,	,	O	,	_	0	SENT_442	[p32l374t3283r481b3346],
8	Sirgel	NNP	ORGANIZATION	Sirgel	nn	9	SENT_442	[p32l507t3280r680b3350],
9	FA	NNP	ORGANIZATION	FA	appos	6	SENT_442	[p32l700t3282r805b3346],
10	,	,	O	,	_	0	SENT_442	[p32l700t3282r805b3346],
11	Venter	NNP	PERSON	Venter	nn	12	SENT_442	[p32l827t3283r1025b3335],
12	A	NNP	O	A	appos	6	SENT_442	[p32l1042t3282r1112b3346],
13	,	,	O	,	_	0	SENT_442	[p32l1042t3282r1112b3346],
14	Parkin	NNP	ORGANIZATION	Parkin	nn	15	SENT_442	[p32l1134t3280r1329b3334],
15	DP	NN	ORGANIZATION	dp	appos	6	SENT_442	[p32l1349t3283r1452b3346],
16	,	,	O	,	_	0	SENT_442	[p32l1349t3283r1452b3346],
17	Seifart	NNP	PERSON	Seifart	nn	18	SENT_442	[p32l1478t3281r1673b3335],
18	HI	NNP	O	HI	appos	6	SENT_442	[p32l1692t3283r1785b3346],
19	,	,	O	,	_	0	SENT_442	[p32l1692t3283r1785b3346],
20	van	NNP	O	van	nn	22	SENT_442	[p32l1808t3298r1916b3335],
21	de	IN	O	de	amod	22	SENT_442	[p32l1937t3280r2005b3335],
22	Wal	NNP	O	Wal	appos	6	SENT_442	[p32l2025t3280r2143b3335],
23	BW	NN	O	bw	dep	3	SENT_442	[p32l133t3371r263b3434],
24	,	,	O	,	_	0	SENT_442	[p32l133t3371r263b3434],
25	Werely	NNP	O	Werely	nn	26	SENT_442	[p32l287t3369r501b3438],
26	C	NNP	O	C	appos	23	SENT_442	[p32l525t3370r588b3434],
27	,	,	O	,	_	0	SENT_442	[p32l525t3370r588b3434],
28	van	NNP	PERSON	van	nn	30	SENT_442	[p32l612t3386r721b3423],
29	Helden	NNP	PERSON	Helden	nn	30	SENT_442	[p32l741t3369r958b3423],
30	PD	NN	O	pd	appos	23	SENT_442	[p32l978t3371r1089b3434],
31	,	,	O	,	_	0	SENT_442	[p32l978t3371r1089b3434],
32	Maritz	NNP	PERSON	Maritz	nn	33	SENT_442	[p32l1115t3369r1312b3423],
33	J	NNP	PERSON	J	appos	23	SENT_442	[p32l1334t3371r1362b3423],
34	S	NN	PERSON	s	dep	3	SENT_442	[p32l1367t3370r1400b3423],
35	(	CD	NUMBER	(	num	34	SENT_442	[p32l1427t3369r1623b3438],
36	2004	CD	DATE	2004	num	37	SENT_442	[p32l1427t3369r1623b3438],
37	)	CD	NUMBER	)	dep	34	SENT_442	[p32l1427t3369r1623b3438],
38	The	DT	O	the	det	39	SENT_442	[p32l1647t3369r1760b3423],
39	inﬂuence	NN	O	inﬂuence	dep	3	SENT_442	[p32l1784t3369r2060b3423],
40	of	IN	O	of	_	0	SENT_442	[p32l2083t3369r2152b3423],
41	human	JJ	O	human	amod	43	SENT_442	[p32l133t3457r338b3511],
42	N-acetyltransferase	NN	MISC	n-acetyltransferase	nn	43	SENT_442	[p32l363t3457r944b3526],
43	genotype	NN	O	genotype	prep_of	39	SENT_442	[p32l976t3464r1249b3526],
44	on	IN	O	on	_	0	SENT_442	[p32l1280t3474r1354b3511],
45	the	DT	O	the	det	48	SENT_442	[p32l1382t3457r1472b3511],
46	early	JJ	O	early	amod	48	SENT_442	[p32l1502t3457r1649b3526],
47	bactericidal	JJ	O	bactericidal	amod	48	SENT_442	[p32l1677t3457r2025b3511],
48	activity	NN	O	activity	prep_on	43	SENT_442	[p32l2055t3474r2141b3511, p32l133t3545r290b3615],
49	of	IN	O	of	_	0	SENT_442	[p32l316t3545r385b3599],
50	isoniazid	NN	O	isoniazid	prep_of	48	SENT_442	[p32l401t3545r683b3599],
51	.	.	O	.	_	0	SENT_442	[p32l401t3545r683b3599],

1	Clin	NNP	O	Clin	nn	8	SENT_443	[p32l714t3545r841b3599],
2	Infect	NNP	O	Infect	nn	8	SENT_443	[p32l866t3545r1039b3599],
3	Dis	NNP	O	Dis	nn	8	SENT_443	[p32l1062t3545r1164b3599],
4	39:1425	CD	NUMBER	39:1425	num	8	SENT_443	[p32l1192t3546r1625b3599],
5	—	CD	NUMBER	—	num	8	SENT_443	[p32l1192t3546r1625b3599],
6	l430	NN	O	l430	nn	8	SENT_443	[p32l1192t3546r1625b3599],
7	Kubota	NN	ORGANIZATION	kubota	nn	8	SENT_443	[p32l135t3633r364b3687],
8	R	NN	ORGANIZATION	r	nsubj	24	SENT_443	[p32l412t3635r478b3699],
9	,	,	O	,	_	0	SENT_443	[p32l412t3635r478b3699],
10	Ohno	NNP	PERSON	Ohno	nn	11	SENT_443	[p32l532t3633r700b3687],
11	M	NNP	O	M	nsubj	24	SENT_443	[p32l751t3635r834b3699],
12	,	,	O	,	_	0	SENT_443	[p32l751t3635r834b3699],
13	Yasunaga	NNP	PERSON	Yasunaga	nn	14	SENT_443	[p32l886t3635r1187b3702],
14	M	NNP	PERSON	M	appos	11	SENT_443	[p32l1235t3635r1318b3698],
15	,	,	O	,	_	0	SENT_443	[p32l1235t3635r1318b3698],
16	Yokota	NNP	PERSON	Yokota	nn	17	SENT_443	[p32l1369t3633r1592b3687],
17	S	NNP	O	S	appos	11	SENT_443	[p32l1644t3634r1698b3698],
18	,	,	O	,	_	0	SENT_443	[p32l1644t3634r1698b3698],
19	Maekura	NNP	PERSON	Maekura	nn	20	SENT_443	[p32l1750t3633r2025b3687],
20	R	NNP	PERSON	R	appos	11	SENT_443	[p32l2073t3635r2140b3698],
21	,	,	O	,	_	0	SENT_443	[p32l2073t3635r2140b3698],
22	Azuma	NNP	PERSON	Azuma	nn	23	SENT_443	[p32l134t3722r355b3775],
23	J	NNP	PERSON	J	appos	11	SENT_443	[p32l401t3723r429b3775],
24	(	VBD	O	(	_	0	SENT_443	[p32l476t3721r677b3790],
25	2005	CD	DATE	2005	num	28	SENT_443	[p32l476t3721r677b3790],
26	)	CD	NUMBER	)	num	28	SENT_443	[p32l476t3721r677b3790],
27	Tentative	JJ	O	tentative	amod	28	SENT_443	[p32l725t3721r1008b3775],
28	treatments	NNS	O	treatment	dobj	24	SENT_443	[p32l1054t3728r1372b3775],
29	for	IN	O	for	_	0	SENT_443	[p32l1421t3721r1508b3775],
30	tuberculosis	NN	O	tuberculosis	prep_for	28	SENT_443	[p32l1552t3721r1922b3775],
31	based	VBN	O	base	partmod	30	SENT_443	[p32l1969t3721r2145b3775],

1	Eur	NNP	O	Eur	nn	4	SENT_444	[p33l53t61r103b85],
2	J	NNP	O	J	nn	4	SENT_444	[p33l114t61r127b85],
3	Clin	NNP	PERSON	Clin	nn	4	SENT_444	[p33l138t60r197b85],
4	Pharmacol	NNP	PERSON	Pharmacol	_	0	SENT_444	[p33l208t60r357b85],
5	(	CD	NUMBER	(	num	6	SENT_444	[p33l369t60r460b92],
6	2013	CD	DATE	2013	dep	4	SENT_444	[p33l369t60r460b92],
7	)	CD	NUMBER	)	number	8	SENT_444	[p33l369t60r460b92],
8	69:1091	CD	NUMBER	69:1091	num	10	SENT_444	[p33l473t60r670b85],
9	—	CD	NUMBER	—	number	10	SENT_444	[p33l473t60r670b85],
10	1101	CD	DATE	1101	dep	6	SENT_444	[p33l473t60r670b85],

1	l7	NN	O	l7	_	0	SENT_445	[p33l14t398r95b451],
2	.	.	O	.	_	0	SENT_445	[p33l14t398r95b451],

1	18	CD	NUMBER	18	_	0	SENT_446	[p33l14t486r97b539],
2	.	.	O	.	_	0	SENT_446	[p33l14t486r97b539],

1	on	IN	O	on	_	0	SENT_447	[p33l134t238r208b275],
2	N-acetyltransferase	NN	MISC	n-acetyltransferase	nn	4	SENT_447	[p33l226t221r793b290],
3	gene	NN	O	gene	nn	4	SENT_447	[p33l818t238r955b290],
4	polymorphism	NN	O	polymorphism	pobj	1	SENT_447	[p33l975t221r1420b290],
5	.	.	O	.	_	0	SENT_447	[p33l975t221r1420b290],

1	Jpn	NN	O	jpn	nn	2	SENT_448	[p33l1448t223r1550b290],
2	J	NN	O	j	nsubj	9	SENT_448	[p33l1572t223r1600b275],
3	Therapeutic	JJ	O	therapeutic	amod	5	SENT_448	[p33l1623t221r1969b290],
4	Drug	NN	O	drug	nn	5	SENT_448	[p33l1993t223r2144b290],
5	Monitoring	NN	O	monitoring	dep	2	SENT_448	[p33l133t308r467b378],
6	222336-340	CD	NUMBER	222336-340	dep	2	SENT_448	[p33l489t310r840b363],
7	Evans	NNP	ORGANIZATION	Evans	nn	8	SENT_448	[p33l132t399r310b451],
8	DA	NNP	ORGANIZATION	DA	dep	6	SENT_448	[p33l332t398r439b450],
9	(	VBD	O	(	_	0	SENT_448	[p33l462t397r655b466],
10	1989	CD	DATE	1989	num	12	SENT_448	[p33l462t397r655b466],
11	)	CD	NUMBER	)	num	12	SENT_448	[p33l462t397r655b466],
12	N-acetyltransferase	NN	O	n-acetyltransferase	dobj	9	SENT_448	[p33l674t396r1255b466],
13	.	.	O	.	_	0	SENT_448	[p33l674t396r1255b466],

1	Pharrnacol	NNP	O	Pharrnacol	nn	2	SENT_449	[p33l1281t396r1595b451],
2	Ther	NNP	O	Ther	_	0	SENT_449	[p33l1617t396r1755b451],
3	42	CD	NUMBER	42	num	2	SENT_449	[p33l1774t398r1863b451],
4	:	:	O	:	_	0	SENT_449	[p33l1774t398r1863b451],
5	157-234	CD	NUMBER	157-234	num	7	SENT_449	[p33l1877t398r2126b451],
6	Ohno	NNP	O	Ohno	nn	7	SENT_449	[p33l136t485r306b539],
7	M	NN	O	m	nsubj	44	SENT_449	[p33l351t487r434b550],
8	,	,	O	,	_	0	SENT_449	[p33l351t487r434b550],
9	Yamaguchi	NNP	PERSON	Yamaguchi	dep	35	SENT_449	[p33l479t485r835b554],
10	1	CD	NUMBER	1	num	9	SENT_449	[p33l878t487r919b550],
11	,	,	O	,	_	0	SENT_449	[p33l878t487r919b550],
12	Yamamoto	NNP	PERSON	Yamamoto	nn	13	SENT_449	[p33l964t487r1304b539],
13	I	NNP	O	I	appos	9	SENT_449	[p33l1349t487r1389b550],
14	,	,	O	,	_	0	SENT_449	[p33l1349t487r1389b550],
15	Fukuda	NNP	PERSON	Fukuda	nn	16	SENT_449	[p33l1435t485r1672b539],
16	T	NN	O	t	appos	9	SENT_449	[p33l1714t487r1770b550],
17	,	,	O	,	_	0	SENT_449	[p33l1714t487r1770b550],
18	Yokota	NNP	PERSON	Yokota	nn	19	SENT_449	[p33l1815t485r2041b539],
19	S	NNP	O	S	appos	9	SENT_449	[p33l2086t486r2141b550],
20	,	,	O	,	_	0	SENT_449	[p33l2086t486r2141b550],
21	Maekura	NNP	PERSON	Maekura	nn	22	SENT_449	[p33l134t573r412b627],
22	R	NNP	PERSON	R	appos	9	SENT_449	[p33l453t575r520b639],
23	,	,	O	,	_	0	SENT_449	[p33l453t575r520b639],
24	Ito	NNP	O	Ito	nn	25	SENT_449	[p33l566t575r648b627],
25	M	NNP	O	M	appos	9	SENT_449	[p33l692t575r776b639],
26	,	,	O	,	_	0	SENT_449	[p33l692t575r776b639],
27	Yamamoto	NNP	PERSON	Yamamoto	nn	28	SENT_449	[p33l820t575r1158b627],
28	Y	NN	PERSON	y	appos	9	SENT_449	[p33l1201t575r1262b639],
29	,	,	O	,	_	0	SENT_449	[p33l1201t575r1262b639],
30	Ogura	NNP	PERSON	Ogura	nn	31	SENT_449	[p33l1309t574r1503b642],
31	T	NN	O	t	appos	9	SENT_449	[p33l1545t575r1601b639],
32	,	,	O	,	_	0	SENT_449	[p33l1545t575r1601b639],
33	Maeda	NNP	PERSON	Maeda	appos	9	SENT_449	[p33l1646t573r1858b627],
34	K	NNP	O	K	dep	35	SENT_449	[p33l1899t575r1954b626],
35	et	FW	O	et	dep	38	SENT_449	[p33l1996t580r2050b627],
36	al	FW	O	al	nn	37	SENT_449	[p33l2092t573r2144b627],
37	(	FW	O	(	dep	35	SENT_449	[p33l136t661r338b730],
38	2000	CD	DATE	2000	dep	44	SENT_449	[p33l136t661r338b730],
39	)	CD	NUMBER	)	num	41	SENT_449	[p33l136t661r338b730],
40	Slow	NNP	MISC	Slow	nn	41	SENT_449	[p33l384t660r539b715],
41	N-acetyltransferase	NN	MISC	n-acetyltransferase	dep	38	SENT_449	[p33l577t660r1181b730],
42	2	CD	NUMBER	2	num	43	SENT_449	[p33l1223t662r1257b714],
43	genotype	NN	O	genotype	nsubj	44	SENT_449	[p33l1301t668r1584b730],
44	affects	VBZ	O	affect	dep	2	SENT_449	[p33l1627t661r1827b715],
45	the	DT	O	the	det	46	SENT_449	[p33l1869t660r1962b715],
46	incidence	NN	O	incidence	dobj	44	SENT_449	[p33l2005t660r2142b715, p33l136t749r313b803],
47	of	IN	O	of	_	0	SENT_449	[p33l357t749r427b803],
48	isoniazid	NN	O	isoniazid	nn	51	SENT_449	[p33l460t749r740b803],
49	and	CC	O	and	_	0	SENT_449	[p33l782t749r892b803],
50	rifampicin-induced	JJ	O	rifampicin-induced	conj_and	48	SENT_449	[p33l931t749r1500b818],
51	hepatotoxicity	NN	O	hepatotoxicity	prep_of	46	SENT_449	[p33l1531t749r1964b818],
52	.	.	O	.	_	0	SENT_449	[p33l1531t749r1964b818],

1	Int	NN	O	int	nn	3	SENT_450	[p33l2003t751r2085b802],
2	J	NN	O	j	nn	3	SENT_450	[p33l2117t751r2145b803],
3	Tuberc	NN	O	tuberc	nsubj	4	SENT_450	[p33l135t837r339b891],
4	Lung	NN	O	lung	_	0	SENT_450	[p33l361t839r516b906],
5	Dis	NN	O	di	nn	9	SENT_450	[p33l537t837r638b891],
6	4:256	CD	NUMBER	4:256	num	9	SENT_450	[p33l660t838r968b891],
7	-261	CD	NUMBER	-261	num	9	SENT_450	[p33l660t838r968b891],
8	Huang	NNP	O	Huang	nn	9	SENT_450	[p33l131t927r331b995],
9	YS	NNP	O	YS	dep	34	SENT_450	[p33l358t926r470b991],
10	,	,	O	,	_	0	SENT_450	[p33l358t926r470b991],
11	Chem	NNP	ORGANIZATION	Chem	nn	12	SENT_450	[p33l502t925r684b979],
12	HD	NNP	O	HD	appos	9	SENT_450	[p33l711t927r835b991],
13	,	,	O	,	_	0	SENT_450	[p33l711t927r835b991],
14	Su	NNP	O	Su	nn	15	SENT_450	[p33l869t926r944b979],
15	WJ	NNP	O	WJ	appos	9	SENT_450	[p33l971t927r1086b991],
16	,	,	O	,	_	0	SENT_450	[p33l971t927r1086b991],
17	Wu	NNP	PERSON	Wu	nn	18	SENT_450	[p33l1117t927r1222b979],
18	JC	NNP	PERSON	JC	appos	9	SENT_450	[p33l1250t926r1344b991],
19	,	,	O	,	_	0	SENT_450	[p33l1250t926r1344b991],
20	Lai	NNP	PERSON	Lai	nn	21	SENT_450	[p33l1374t925r1472b979],
21	SL	NNP	O	SL	appos	9	SENT_450	[p33l1503t926r1602b991],
22	,	,	O	,	_	0	SENT_450	[p33l1503t926r1602b991],
23	Yang	NNP	PERSON	Yang	nn	24	SENT_450	[p33l1632t927r1787b995],
24	SY	NNP	PERSON	SY	appos	9	SENT_450	[p33l1819t926r1917b991],
25	,	,	O	,	_	0	SENT_450	[p33l1819t926r1917b991],
26	Chang	NNP	PERSON	Chang	nn	27	SENT_450	[p33l1949t925r2143b995],
27	FY	NNP	O	FY	appos	9	SENT_450	[p33l131t1015r233b1078],
28	,	,	O	,	_	0	SENT_450	[p33l131t1015r233b1078],
29	Lee	NNP	PERSON	Lee	appos	9	SENT_450	[p33l272t1015r382b1067],
30	SD	NN	O	sd	dep	34	SENT_450	[p33l422t1014r513b1067],
31	(	CD	NUMBER	(	num	30	SENT_450	[p33l552t1013r749b1082],
32	2002	CD	DATE	2002	num	34	SENT_450	[p33l552t1013r749b1082],
33	)	CD	NUMBER	)	num	34	SENT_450	[p33l552t1013r749b1082],
34	Polymorphism	NN	O	polymorphism	dep	4	SENT_450	[p33l786t1013r1231b1082],
35	of	IN	O	of	_	0	SENT_450	[p33l1267t1013r1336b1067],
36	the	DT	O	the	det	39	SENT_450	[p33l1363t1013r1453b1067],
37	N-acetyltransferase	NN	O	n-acetyltransferase	nn	39	SENT_450	[p33l1487t1013r2071b1082],
38	2	CD	NUMBER	2	num	39	SENT_450	[p33l2108t1014r2141b1066],
39	gene	NN	O	gene	prep_of	34	SENT_450	[p33l132t1118r276b1170],
40	as	IN	O	as	_	0	SENT_450	[p33l317t1118r376b1155],
41	a	DT	O	a	det	44	SENT_450	[p33l418t1118r449b1155],
42	susceptibility	NN	O	susceptibility	nn	44	SENT_450	[p33l489t1101r905b1170],
43	risk	NN	O	risk	nn	44	SENT_450	[p33l942t1101r1060b1155],
44	factor	NN	O	factor	prep_as	4	SENT_450	[p33l1098t1101r1279b1155],
45	for	IN	O	for	_	0	SENT_450	[p33l1317t1101r1406b1155],
46	antituberculosis	JJ	O	antituberculosis	amod	48	SENT_450	[p33l1444t1101r1937b1155],
47	druginduced	JJ	O	druginduced	amod	48	SENT_450	[p33l1978t1101r2143b1170, p33l133t1188r370b1242],
48	hepatitis	NN	O	hepatitis	prep_for	44	SENT_450	[p33l393t1188r660b1257],
49	.	.	O	.	_	0	SENT_450	[p33l393t1188r660b1257],

1	Hepatology	NNP	O	Hepatology	nsubj	35	SENT_451	[p33l690t1188r1041b1258],
2	352883-889	CD	NUMBER	352883-889	num	1	SENT_451	[p33l1067t1189r1424b1242],
3	Kinzig-Schippers	NNP	O	Kinzig-Schippers	dep	1	SENT_451	[p33l132t1277r662b1346],
4	M	NN	O	m	dep	1	SENT_451	[p33l700t1279r782b1342],
5	,	,	O	,	_	0	SENT_451	[p33l700t1279r782b1342],
6	Tomalik-Scharte	NN	O	tomalik-scharte	nn	7	SENT_451	[p33l822t1277r1325b1331],
7	D	NN	O	d	appos	4	SENT_451	[p33l1362t1279r1431b1342],
8	,	,	O	,	_	0	SENT_451	[p33l1362t1279r1431b1342],
9	Jetter	NNP	PERSON	Jetter	nn	10	SENT_451	[p33l1471t1279r1635b1331],
10	A	NNP	O	A	appos	4	SENT_451	[p33l1669t1278r1739b1342],
11	,	,	O	,	_	0	SENT_451	[p33l1669t1278r1739b1342],
12	Scheidel	NNP	O	Scheidel	nn	13	SENT_451	[p33l1782t1277r2039b1331],
13	B	NNP	O	B	appos	4	SENT_451	[p33l2075t1279r2141b1342],
14	,	,	O	,	_	0	SENT_451	[p33l2075t1279r2141b1342],
15	Jakob	NNP	PERSON	Jakob	nn	16	SENT_451	[p33l133t1365r306b1419],
16	V	NNP	PERSON	V	appos	4	SENT_451	[p33l331t1367r391b1431],
17	,	,	O	,	_	0	SENT_451	[p33l331t1367r391b1431],
18	Rodamer	NNP	O	Rodamer	nn	19	SENT_451	[p33l418t1365r694b1419],
19	M	NNP	O	M	appos	4	SENT_451	[p33l717t1367r799b1431],
20	,	,	O	,	_	0	SENT_451	[p33l717t1367r799b1431],
21	Cascorbi	NNP	O	Cascorbi	nn	22	SENT_451	[p33l827t1365r1091b1419],
22	I	NNP	O	I	appos	4	SENT_451	[p33l1116t1367r1154b1431],
23	,	,	O	,	_	0	SENT_451	[p33l1116t1367r1154b1431],
24	Doroshyenko	NNP	O	Doroshyenko	nn	25	SENT_451	[p33l1181t1365r1585b1434],
25	O	NNP	O	O	appos	4	SENT_451	[p33l1613t1366r1680b1431],
26	,	,	O	,	_	0	SENT_451	[p33l1613t1366r1680b1431],
27	Sorgel	NNP	O	Sorgel	nn	28	SENT_451	[p33l1711t1365r1901b1434],
28	F	NN	O	f	appos	4	SENT_451	[p33l1925t1367r1976b1431],
29	,	,	O	,	_	0	SENT_451	[p33l1925t1367r1976b1431],
30	Fuhr	NNP	PERSON	Fuhr	nn	34	SENT_451	[p33l2003t1365r2146b1419],
31	U	NNP	O	U	nn	34	SENT_451	[p33l131t1455r185b1507],
32	(	NNP	O	(	nn	34	SENT_451	[p33l212t1453r408b1522],
33	2005	CD	DATE	2005	num	34	SENT_451	[p33l212t1453r408b1522],
34	)	NNP	O	)	appos	4	SENT_451	[p33l212t1453r408b1522],
35	Should	MD	O	should	_	0	SENT_451	[p33l437t1453r648b1507],
36	we	PRP	O	we	dobj	35	SENT_451	[p33l670t1470r756b1507],
37	use	VB	O	use	dep	35	SENT_451	[p33l780t1470r880b1507],
38	N-acetyltransferase	NN	MISC	n-acetyltransferase	nn	39	SENT_451	[p33l902t1453r1485b1522],
39	type	NN	O	type	nsubj	43	SENT_451	[p33l1510t1460r1638b1522],
40	2	CD	NUMBER	2	num	41	SENT_451	[p33l1663t1454r1697b1506],
41	genotyping	NN	O	genotyping	dep	39	SENT_451	[p33l1725t1453r2062b1522],
42	to	TO	O	to	aux	43	SENT_451	[p33l2087t1460r2142b1507],
43	personalize	VB	O	personalize	xcomp	37	SENT_451	[p33l131t1541r496b1611],
44	isoniazid	NN	O	isoniazid	nn	45	SENT_451	[p33l539t1541r827b1595],
45	doses	NNS	O	dose	dobj	43	SENT_451	[p33l868t1541r1077b1595],
46	?	.	O	?	_	0	SENT_451	[p33l868t1541r1077b1595],

1	Antimicrob	NNP	MISC	Antimicrob	nn	3	SENT_452	[p33l1119t1541r1484b1595],
2	Agents	NNPS	MISC	Agents	nn	3	SENT_452	[p33l1526t1542r1750b1611],
3	Chemother	NNP	MISC	Chemother	nsubj	20	SENT_452	[p33l1793t1541r2147b1595],
4	49:1733	CD	DURATION	49:1733	dep	3	SENT_452	[p33l132t1631r566b1684],
5	-1738	CD	DURATION	-1738	num	7	SENT_452	[p33l132t1631r566b1684],
6	Kubota	NNP	ORGANIZATION	Kubota	nn	7	SENT_452	[p33l131t1718r353b1772],
7	R	NN	ORGANIZATION	r	dep	3	SENT_452	[p33l372t1720r437b1784],
8	,	,	O	,	_	0	SENT_452	[p33l372t1720r437b1784],
9	Ohno	NNP	PERSON	Ohno	nn	10	SENT_452	[p33l462t1718r626b1772],
10	M	NNP	O	M	appos	7	SENT_452	[p33l648t1720r730b1784],
11	,	,	O	,	_	0	SENT_452	[p33l648t1720r730b1784],
12	Hasunuma	NNP	ORGANIZATION	Hasunuma	nn	13	SENT_452	[p33l753t1720r1076b1772],
13	T	NN	ORGANIZATION	t	appos	7	SENT_452	[p33l1096t1720r1149b1784],
14	,	,	O	,	_	0	SENT_452	[p33l1096t1720r1149b1784],
15	Iijima	NNP	PERSON	Iijima	nn	16	SENT_452	[p33l1173t1718r1350b1787],
16	H	NNP	O	H	appos	7	SENT_452	[p33l1369t1720r1438b1784],
17	,	,	O	,	_	0	SENT_452	[p33l1369t1720r1438b1784],
18	Azuma	NNP	PERSON	Azuma	nn	19	SENT_452	[p33l1461t1719r1679b1772],
19	J	NNP	PERSON	J	appos	7	SENT_452	[p33l1698t1720r1726b1772],
20	(	VBD	O	(	_	0	SENT_452	[p33l1747t1718r1944b1787],
21	2007	CD	DATE	2007	number	22	SENT_452	[p33l1747t1718r1944b1787],
22	)	CD	NUMBER	)	num	24	SENT_452	[p33l1747t1718r1944b1787],
23	Doseescalation	NN	O	doseescalation	nn	24	SENT_452	[p33l1966t1720r2143b1772, p33l133t1806r430b1860],
24	study	NN	O	study	dobj	20	SENT_452	[p33l461t1806r621b1876],
25	of	IN	O	of	_	0	SENT_452	[p33l651t1806r719b1860],
26	isoniazid	NN	O	isoniazid	prep_of	24	SENT_452	[p33l740t1806r1009b1860],
27	in	IN	O	in	_	0	SENT_452	[p33l1039t1806r1095b1859],
28	healthy	JJ	O	healthy	amod	29	SENT_452	[p33l1122t1806r1343b1876],
29	volunteers	NNS	O	volunteer	prep_in	20	SENT_452	[p33l1371t1806r1682b1860],
30	with	IN	O	with	_	0	SENT_452	[p33l1711t1806r1844b1860],
31	the	DT	O	the	det	34	SENT_452	[p33l1872t1806r1962b1860],
32	rapid	JJ	O	rapid	amod	34	SENT_452	[p33l1991t1806r2145b1875],
33	acetylator	NN	O	acetylator	nn	34	SENT_452	[p33l133t1893r427b1963],
34	genotype	NN	O	genotype	prep_with	20	SENT_452	[p33l449t1901r723b1963],
35	of	IN	O	of	_	0	SENT_452	[p33l749t1893r818b1947],
36	arylamine	NN	O	arylamine	nn	37	SENT_452	[p33l833t1893r1130b1963],
37	N-acetyltransferase	NN	O	n-acetyltransferase	prep_of	34	SENT_452	[p33l1151t1893r1730b1963],
38	2	CD	NUMBER	2	num	37	SENT_452	[p33l1755t1895r1806b1947],
39	.	.	O	.	_	0	SENT_452	[p33l1755t1895r1806b1947],

1	Eur	NNP	MISC	Eur	nn	4	SENT_453	[p33l1834t1896r1943b1948],
2	J	NNP	O	J	nn	4	SENT_453	[p33l1965t1896r1993b1948],
3	Clin	NNP	O	Clin	nn	4	SENT_453	[p33l2017t1893r2145b1948],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_453	[p33l131t1983r451b2037],
5	632927-933	CD	NUMBER	632927-933	num	7	SENT_453	[p33l478t1984r832b2037],
6	http://www.info.pmda.go.jp/juutoku/ﬁle/j	NN	O	http://www.info.pmda.go.jp/juutoku/ﬁle/j	nn	7	SENT_453	[p33l132t2071r1361b2141],
7	fm0804002	NN	O	fm0804002	dep	4	SENT_453	[p33l1370t2071r1840b2140],
8	.	.	O	.	_	0	SENT_453	[p33l1370t2071r1840b2140],

1	pdf	NN	O	pdf	nsubj	2	SENT_454	[p33l1370t2071r1840b2140],
2	Accessed	VBN	O	access	_	0	SENT_454	[p33l1863t2071r2146b2125],
3	Sep	NNP	DATE	Sep	dobj	2	SENT_454	[p33l136t2159r241b2228],
4	10	CD	DATE	10	num	3	SENT_454	[p33l272t2159r353b2224],
5	,	,	DATE	,	_	0	SENT_454	[p33l272t2159r353b2224],
6	2012	CD	DATE	2012	num	3	SENT_454	[p33l377t2160r539b2212],
7	.	.	O	.	_	0	SENT_454	[p33l377t2160r539b2212],

1	Takikawa	NN	O	takikawa	_	0	SENT_455	[p33l132t2246r423b2300],
2	H	NN	O	h	dep	1	SENT_455	[p33l441t2249r510b2312],
3	,	,	O	,	_	0	SENT_455	[p33l441t2249r510b2312],
4	Onj	NN	O	onj	appos	2	SENT_455	[p33l534t2246r639b2316],
5	i	FW	O	i	nn	6	SENT_455	[p33l647t2246r664b2300],
6	M	NN	O	m	dep	1	SENT_455	[p33l684t2248r749b2300],
7	(	CD	NUMBER	(	num	9	SENT_455	[p33l770t2247r967b2315],
8	2005	CD	DATE	2005	num	9	SENT_455	[p33l770t2247r967b2315],
9	)	NN	O	)	dep	6	SENT_455	[p33l770t2247r967b2315],
10	A	DT	O	a	det	11	SENT_455	[p33l987t2247r1041b2300],
11	proposal	NN	O	proposal	dep	1	SENT_455	[p33l1058t2246r1318b2316],
12	of	IN	O	of	_	0	SENT_455	[p33l1339t2246r1408b2301],
13	the	DT	O	the	det	15	SENT_455	[p33l1417t2246r1507b2300],
14	diagnostic	JJ	O	diagnostic	amod	15	SENT_455	[p33l1528t2246r1834b2316],
15	criteria	NNS	O	criterion	prep_of	11	SENT_455	[p33l1856t2246r2065b2300],
16	of	IN	O	of	_	0	SENT_455	[p33l2084t2246r2153b2300],
17	drug-induced	JJ	O	drug-induced	amod	19	SENT_455	[p33l133t2335r533b2405],
18	liver	NN	O	liver	nn	19	SENT_455	[p33l558t2335r694b2389],
19	injury	NN	O	injury	prep_of	15	SENT_455	[p33l718t2335r905b2405],
20	.	.	O	.	_	0	SENT_455	[p33l718t2335r905b2405],

1	Hepatol	NNP	ORGANIZATION	Hepatol	nn	2	SENT_456	[p33l934t2335r1171b2405],
2	Res	NNP	ORGANIZATION	Res	_	0	SENT_456	[p33l1195t2337r1305b2389],
3	322250-1	CD	NUMBER	322250-1	dep	2	SENT_456	[p33l1333t2336r1609b2389],
4	Danan	NNP	PERSON	Danan	nn	8	SENT_456	[p33l132t2425r329b2476],
5	G	NNP	PERSON	G	nn	8	SENT_456	[p33l367t2423r434b2488],
6	,	,	O	,	_	0	SENT_456	[p33l367t2423r434b2488],
7	Benichou	NNP	PERSON	Benichou	appos	8	SENT_456	[p33l474t2422r765b2477],
8	C	NNP	O	C	dep	3	SENT_456	[p33l803t2423r848b2477],
9	(	CD	NUMBER	(	num	8	SENT_456	[p33l888t2423r1085b2491],
10	1993	CD	DATE	1993	num	13	SENT_456	[p33l888t2423r1085b2491],
11	)	NNP	O	)	nn	13	SENT_456	[p33l888t2423r1085b2491],
12	Causality	NNP	O	Causality	nn	13	SENT_456	[p33l1125t2422r1409b2492],
13	assessment	NN	O	assessment	dep	2	SENT_456	[p33l1446t2430r1781b2477],
14	of	IN	O	of	_	0	SENT_456	[p33l1818t2422r1887b2477],
15	adverse	JJ	O	adverse	amod	16	SENT_456	[p33l1916t2422r2143b2477],
16	reactions	NNS	O	reaction	prep_of	13	SENT_456	[p33l131t2510r400b2565],
17	to	TO	O	to	_	0	SENT_456	[p33l432t2518r487b2565],
18	drugs	NNS	O	drug	prep_to	16	SENT_456	[p33l521t2510r700b2580],
19	.	.	O	.	_	0	SENT_456	[p33l521t2510r700b2580],

1	A	DT	O	a	det	3	SENT_457	[p33l735t2511r788b2564],
2	novel	JJ	O	novel	amod	3	SENT_457	[p33l818t2510r985b2565],
3	method	NN	O	method	_	0	SENT_457	[p33l1015t2510r1241b2565],
4	based	VBN	O	base	partmod	3	SENT_457	[p33l1270t2510r1442b2565],
5	on	IN	O	on	_	0	SENT_457	[p33l1473t2528r1547b2565],
6	the	DT	O	the	det	7	SENT_457	[p33l1576t2510r1666b2564],
7	conclusions	NNS	O	conclusion	prep_on	4	SENT_457	[p33l1699t2510r2051b2565],
8	of	IN	O	of	_	0	SENT_457	[p33l2084t2510r2153b2564],
9	international	JJ	O	international	amod	11	SENT_457	[p33l133t2599r518b2653],
10	consensus	NN	O	consensus	nn	11	SENT_457	[p33l557t2617r865b2653],
11	meetings	NNS	O	meeting	prep_of	7	SENT_457	[p33l903t2599r1195b2669],
12	:	:	O	:	_	0	SENT_457	[p33l903t2599r1195b2669],
13	Application	NN	O	application	dep	3	SENT_457	[p33l1237t2599r1600b2668],
14	to	TO	O	to	_	0	SENT_457	[p33l1636t2606r1692b2653],
15	drug-Induced	JJ	O	drug-induced	amod	17	SENT_457	[p33l1732t2599r2145b2669],
16	liver	NN	O	liver	nn	17	SENT_457	[p33l133t2686r269b2741],
17	injuries	NNS	O	injury	prep_to	13	SENT_457	[p33l293t2686r529b2756],
18	.	.	O	.	_	0	SENT_457	[p33l293t2686r529b2756],

1	J	NNP	O	J	nn	3	SENT_458	[p33l559t2689r587b2741],
2	Clin	NNP	PERSON	Clin	nn	3	SENT_458	[p33l613t2686r740b2741],
3	Epidemiol	NNP	PERSON	Epidemiol	dep	32	SENT_458	[p33l764t2686r1076b2756],
4	46	CD	NUMBER	46	dep	3	SENT_458	[p33l1101t2688r1460b2740],
5	:	:	O	:	_	0	SENT_458	[p33l1101t2688r1460b2740],
6	l323	CD	NUMBER	l323	num	10	SENT_458	[p33l1101t2688r1460b2740],
7	—	CD	NUMBER	—	num	10	SENT_458	[p33l1101t2688r1460b2740],
8	30	CD	NUMBER	30	num	10	SENT_458	[p33l1101t2688r1460b2740],
9	Tokuda	NNP	PERSON	Tokuda	nn	10	SENT_458	[p33l132t2774r358b2829],
10	A	NNP	O	A	dep	3	SENT_458	[p33l375t2775r445b2840],
11	,	,	O	,	_	0	SENT_458	[p33l375t2775r445b2840],
12	Ohno	NNP	PERSON	Ohno	nn	13	SENT_458	[p33l468t2774r633b2829],
13	M	NNP	O	M	appos	10	SENT_458	[p33l654t2776r736b2840],
14	,	,	O	,	_	0	SENT_458	[p33l654t2776r736b2840],
15	Furutsuka	NNP	O	Furutsuka	nn	16	SENT_458	[p33l758t2774r1060b2829],
16	M	NNP	O	M	appos	10	SENT_458	[p33l1079t2776r1160b2840],
17	,	,	O	,	_	0	SENT_458	[p33l1079t2776r1160b2840],
18	Kubota	NNP	PERSON	Kubota	nn	19	SENT_458	[p33l1182t2774r1405b2829],
19	R	NNP	PERSON	R	appos	10	SENT_458	[p33l1423t2777r1489b2840],
20	,	,	O	,	_	0	SENT_458	[p33l1423t2777r1489b2840],
21	Nakayama	NNP	PERSON	Nakayama	nn	22	SENT_458	[p33l1508t2774r1833b2844],
22	S	NNP	O	S	appos	10	SENT_458	[p33l1855t2776r1907b2840],
23	,	,	O	,	_	0	SENT_458	[p33l1855t2776r1907b2840],
24	Yokota	NNP	PERSON	Yokota	nn	25	SENT_458	[p33l1930t2774r2145b2829],
25	S	NNP	O	S	appos	10	SENT_458	[p33l135t2864r188b2928],
26	,	,	O	,	_	0	SENT_458	[p33l135t2864r188b2928],
27	Maekura	NNP	PERSON	Maekura	nn	28	SENT_458	[p33l220t2862r488b2917],
28	R	NNP	PERSON	R	appos	10	SENT_458	[p33l516t2865r582b2928],
29	,	,	O	,	_	0	SENT_458	[p33l516t2865r582b2928],
30	Azuma	NNP	PERSON	Azuma	nn	31	SENT_458	[p33l614t2864r832b2917],
31	J	NNP	PERSON	J	nsubj	32	SENT_458	[p33l861t2865r889b2917],
32	(	VBD	O	(	_	0	SENT_458	[p33l920t2863r1117b2932],
33	2006	CD	DATE	2006	num	35	SENT_458	[p33l920t2863r1117b2932],
34	)	CD	NUMBER	)	num	35	SENT_458	[p33l920t2863r1117b2932],
35	GSTs	NNS	O	gst	nsubj	42	SENT_458	[p33l1150t2864r1312b2917],
36	and	CC	O	and	_	0	SENT_458	[p33l1345t2862r1452b2917],
37	NAT2	NN	O	nat2	nn	39	SENT_458	[p33l1479t2864r1663b2916],
38	gene	NN	O	gene	nn	39	SENT_458	[p33l1696t2880r1835b2932],
39	polymorphisms	NNS	O	polymorphism	nsubj	42	SENT_458	[p33l1865t2862r2143b2932, p33l130t2951r342b3020],
40	and	CC	O	and	_	0	SENT_458	[p33l373t2951r480b3005],
41	drug	NN	O	drug	conj_and	39	SENT_458	[p33l507t2951r643b3021],
42	induced	VBD	O	induce	ccomp	32	SENT_458	[p33l672t2951r910b3005],
43	hepatotoxicity	NN	O	hepatotoxicity	dobj	42	SENT_458	[p33l936t2951r1366b3021],
44	in	IN	O	in	_	0	SENT_458	[p33l1395t2951r1451b3004],
45	anti-tuberculosis	JJ	O	anti-tuberculosis	amod	46	SENT_458	[p33l1480t2951r1975b3005],
46	therapy	NN	O	therapy	prep_in	42	SENT_458	[p33l2005t2951r2144b3005, p33l133t3056r249b3108],
47	.	.	O	.	_	0	SENT_458	[p33l2005t2951r2144b3005, p33l133t3056r249b3108],

1	Jpn	NNP	PERSON	Jpn	nn	5	SENT_459	[p33l278t3041r382b3108],
2	J	NNP	PERSON	J	nn	5	SENT_459	[p33l406t3040r434b3093],
3	Clin	NNP	PERSON	Clin	nn	5	SENT_459	[p33l460t3038r586b3093],
4	Pharmacol	NNP	PERSON	Pharmacol	nn	5	SENT_459	[p33l611t3038r930b3093],
5	Ther	NNP	O	Ther	_	0	SENT_459	[p33l957t3038r1098b3092],
6	37	CD	NUMBER	37	num	5	SENT_459	[p33l1122t3040r1369b3093],
7	:	:	O	:	_	0	SENT_459	[p33l1122t3040r1369b3093],
8	S224	NN	O	s224	dep	5	SENT_459	[p33l1122t3040r1369b3093],
9	Mitchison	NNP	ORGANIZATION	Mitchison	nn	10	SENT_459	[p33l132t3126r440b3181],
10	DA	NNP	ORGANIZATION	DA	nsubj	11	SENT_459	[p33l477t3128r584b3180],
11	(	VBD	O	(	rcmod	8	SENT_459	[p33l623t3127r822b3196],
12	1993	CD	DATE	1993	num	13	SENT_459	[p33l623t3127r822b3196],
13	)	CD	NUMBER	)	dobj	11	SENT_459	[p33l623t3127r822b3196],
14	Assessment	NNP	O	Assessment	dep	8	SENT_459	[p33l859t3128r1219b3181],
15	of	IN	O	of	_	0	SENT_459	[p33l1256t3127r1325b3181],
16	new	JJ	O	new	amod	18	SENT_459	[p33l1352t3144r1477b3181],
17	sterilizing	VBG	O	sterilize	amod	18	SENT_459	[p33l1517t3126r1816b3196],
18	drugs	NNS	O	drug	prep_of	14	SENT_459	[p33l1854t3126r2019b3196],
19	for	IN	O	for	_	0	SENT_459	[p33l2059t3127r2146b3181],
20	treating	VBG	O	treat	prepc_for	18	SENT_459	[p33l132t3215r359b3284],
21	pulmonary	JJ	O	pulmonary	amod	22	SENT_459	[p33l386t3215r714b3284],
22	tuberculosis	NN	O	tuberculosis	dobj	20	SENT_459	[p33l742t3215r1103b3269],
23	by	IN	O	by	_	0	SENT_459	[p33l1131t3215r1207b3284],
24	culture	NN	O	culture	prep_by	20	SENT_459	[p33l1236t3215r1441b3269],
25	at	IN	O	at	_	0	SENT_459	[p33l1471t3222r1523b3269],
26	2	CD	DURATION	2	num	27	SENT_459	[p33l1551t3216r1585b3268],
27	months	NNS	NUMBER	month	prep_at	24	SENT_459	[p33l1615t3215r1851b3269],
28	.	.	O	.	_	0	SENT_459	[p33l1615t3215r1851b3269],

1	Am	VBP	O	be	dep	4	SENT_460	[p33l1883t3216r1997b3268],
2	Rev	NN	MISC	rev	nn	4	SENT_460	[p33l2023t3217r2144b3269],
3	Respir	NNP	MISC	Respir	nn	4	SENT_460	[p33l132t3302r329b3372],
4	Dis	NNP	MISC	Dis	dep	25	SENT_460	[p33l352t3302r453b3357],
5	147	CD	NUMBER	147	num	4	SENT_460	[p33l487t3303r950b3357],
6	:	:	O	:	_	0	SENT_460	[p33l487t3303r950b3357],
7	l062-1063	CD	NUMBER	l062-1063	num	9	SENT_460	[p33l487t3303r950b3357],
8	Kimerling	NNP	O	Kimerling	nn	9	SENT_460	[p33l132t3391r441b3460],
9	ME	NNP	O	ME	dep	4	SENT_460	[p33l478t3393r607b3457],
10	,	,	O	,	_	0	SENT_460	[p33l478t3393r607b3457],
11	Phillips	NNP	PERSON	Phillips	nn	12	SENT_460	[p33l646t3391r875b3460],
12	P	NN	O	p	appos	9	SENT_460	[p33l913t3393r962b3457],
13	,	,	O	,	_	0	SENT_460	[p33l913t3393r962b3457],
14	Patterson	NNP	PERSON	Patterson	nn	15	SENT_460	[p33l1001t3393r1282b3445],
15	P	NN	O	p	appos	9	SENT_460	[p33l1318t3393r1367b3457],
16	,	,	O	,	_	0	SENT_460	[p33l1318t3393r1367b3457],
17	Hall	NNP	O	Hall	nn	18	SENT_460	[p33l1407t3391r1535b3445],
18	M	NNP	O	M	appos	9	SENT_460	[p33l1571t3393r1653b3457],
19	,	,	O	,	_	0	SENT_460	[p33l1571t3393r1653b3457],
20	Robinson	NNP	PERSON	Robinson	nn	21	SENT_460	[p33l1693t3391r1985b3445],
21	CA	NNP	O	CA	appos	9	SENT_460	[p33l2022t3392r2141b3457],
22	,	,	O	,	_	0	SENT_460	[p33l2022t3392r2141b3457],
23	Dunlap	NNP	ORGANIZATION	Dunlap	nn	24	SENT_460	[p33l132t3478r351b3548],
24	NE	NNS	ORGANIZATION	ne	nsubj	25	SENT_460	[p33l384t3481r485b3533],
25	(	VBP	O	(	_	0	SENT_460	[p33l521t3479r718b3548],
26	1998	CD	DATE	1998	number	27	SENT_460	[p33l521t3479r718b3548],
27	)	CD	NUMBER	)	num	32	SENT_460	[p33l521t3479r718b3548],
28	Low	JJ	O	low	amod	32	SENT_460	[p33l752t3481r890b3533],
29	serum	NN	O	serum	nn	32	SENT_460	[p33l926t3496r1106b3533],
30	antimycobacterial	JJ	O	antimycobacterial	amod	32	SENT_460	[p33l1140t3478r1675b3548],
31	drug	NN	O	drug	nn	32	SENT_460	[p33l1710t3478r1846b3548],
32	levels	NNS	O	level	dobj	25	SENT_460	[p33l1881t3478r2052b3533],
33	in	IN	O	in	_	0	SENT_460	[p33l2088t3478r2144b3532],
34	non-HIV-infected	JJ	O	non-hiv-infected	amod	36	SENT_460	[p33l131t3567r663b3621],
35	tuberculosis	NN	O	tuberculosis	nn	36	SENT_460	[p33l687t3567r1048b3621],
36	patients	NNS	O	patient	prep_in	32	SENT_460	[p33l1073t3567r1321b3636],
37	.	.	O	.	_	0	SENT_460	[p33l1073t3567r1321b3636],

1	Chest	NN	O	chest	nn	2	SENT_461	[p33l1352t3567r1521b3621],
2	ll3	NN	O	ll3	_	0	SENT_461	[p33l1553t3568r1785b3621],
3	:	:	O	:	_	0	SENT_461	[p33l1553t3568r1785b3621],
4	ll7	CD	NUMBER	ll7	num	5	SENT_461	[p33l1553t3568r1785b3621],
5	8-1183	CD	NUMBER	8-1183	dep	2	SENT_461	[p33l1793t3568r2008b3621],
6	Weiner	NNP	ORGANIZATION	Weiner	dep	5	SENT_461	[p33l131t3655r338b3709],
7	M	NN	ORGANIZATION	m	dep	36	SENT_461	[p33l357t3657r438b3720],
8	,	,	O	,	_	0	SENT_461	[p33l357t3657r438b3720],
9	Bunnan	NNP	PERSON	Bunnan	nn	10	SENT_461	[p33l462t3657r696b3709],
10	W	NNP	PERSON	W	appos	7	SENT_461	[p33l716t3657r794b3720],
11	,	,	O	,	_	0	SENT_461	[p33l716t3657r794b3720],
12	Vemon	NNP	O	Vemon	nn	13	SENT_461	[p33l818t3657r1027b3709],
13	A	NNP	O	A	appos	7	SENT_461	[p33l1047t3656r1115b3720],
14	,	,	O	,	_	0	SENT_461	[p33l1047t3656r1115b3720],
15	Benator	NNP	PERSON	Benator	nn	16	SENT_461	[p33l1139t3657r1368b3709],
16	D	NNP	PERSON	D	appos	7	SENT_461	[p33l1387t3657r1455b3720],
17	,	,	O	,	_	0	SENT_461	[p33l1387t3657r1455b3720],
18	Peloquin	NNP	PERSON	Peloquin	nn	19	SENT_461	[p33l1479t3655r1735b3724],
19	CA	NNP	O	CA	appos	7	SENT_461	[p33l1757t3656r1872b3720],
20	,	,	O	,	_	0	SENT_461	[p33l1757t3656r1872b3720],
21	Khan	NNP	PERSON	Khan	nn	22	SENT_461	[p33l1895t3655r2054b3709],
22	A	NNP	O	A	appos	7	SENT_461	[p33l2074t3656r2141b3720],
23	,	,	O	,	_	0	SENT_461	[p33l2074t3656r2141b3720],
24	Weis	NNP	PERSON	Weis	nn	25	SENT_461	[p33l131t3743r272b3797],
25	S	NNP	O	S	appos	7	SENT_461	[p33l301t3744r352b3809],
26	,	,	O	,	_	0	SENT_461	[p33l301t3744r352b3809],
27	King	NNP	O	King	nn	28	SENT_461	[p33l379t3743r524b3812],
28	B	NNP	O	B	appos	7	SENT_461	[p33l548t3745r612b3809],
29	,	,	O	,	_	0	SENT_461	[p33l548t3745r612b3809],
30	Shah	NNP	PERSON	Shah	nn	31	SENT_461	[p33l643t3743r785b3797],
31	N	NNP	O	N	appos	7	SENT_461	[p33l806t3745r876b3809],
32	,	,	O	,	_	0	SENT_461	[p33l806t3745r876b3809],
33	Hodge	NNP	ORGANIZATION	Hodge	appos	7	SENT_461	[p33l902t3743r1096b3812],
34	T	NN	ORGANIZATION	t	dep	36	SENT_461	[p33l1122t3745r1164b3796],
35	(	CD	NUMBER	(	num	34	SENT_461	[p33l1191t3743r1380b3812],
36	2003	CD	DATE	2003	dep	2	SENT_461	[p33l1191t3743r1380b3812],
37	)	CD	NUMBER	)	num	40	SENT_461	[p33l1191t3743r1380b3812],
38	Low	JJ	O	low	amod	40	SENT_461	[p33l1406t3745r1539b3797],
39	isoniazid	NN	O	isoniazid	nn	40	SENT_461	[p33l1564t3743r1821b3797],
40	concentrations	NNS	O	concentration	dep	36	SENT_461	[p33l1846t3750r2143b3797, p34l131t16r268b70],

1	and	CC	O	and	dep	2	SENT_462	[p34l291t16r395b70],
2	outcome	NN	O	outcome	_	0	SENT_462	[p34l416t23r663b70],
3	of	IN	O	of	_	0	SENT_462	[p34l685t16r752b70],
4	tuberculosis	NN	O	tuberculosis	nn	5	SENT_462	[p34l763t16r1106b70],
5	treatment	NN	O	treatment	prep_of	2	SENT_462	[p34l1128t23r1396b70],
6	with	IN	O	with	_	0	SENT_462	[p34l1416t16r1544b70],
7	once-weekly	JJ	O	once-weekly	amod	8	SENT_462	[p34l1565t16r1932b85],
8	isoniazid	NN	O	isoniazid	prep_with	2	SENT_462	[p34l1953t16r2143b70, p34l131t104r219b158],
9	and	CC	O	and	_	0	SENT_462	[p34l240t104r344b158],
10	rifapentine	NN	O	rifapentine	conj_and	8	SENT_462	[p34l363t104r682b173],
11	.	.	O	.	_	0	SENT_462	[p34l363t104r682b173],

1	Am	NNP	O	Am	nn	5	SENT_463	[p34l707t105r818b157],
2	J	NNP	O	J	nn	5	SENT_463	[p34l838t106r866b158],
3	Respir	NNP	MISC	Respir	nn	5	SENT_463	[p34l886t104r1075b173],
4	Crit	NNP	MISC	Crit	nn	5	SENT_463	[p34l1094t104r1203b158],
5	Care	NNP	MISC	Care	nsubj	6	SENT_463	[p34l1225t105r1357b158],
6	Med	VBD	MISC	med	_	0	SENT_463	[p34l1379t104r1513b158],
7	167	CD	NUMBER	167	dobj	6	SENT_463	[p34l1541t105r1640b158],
8	:	:	O	:	_	0	SENT_463	[p34l1647t105r1986b158],
9	l341-1347	CD	NUMBER	l341-1347	num	11	SENT_463	[p34l1647t105r1986b158],
10	Weiner	NNP	O	Weiner	nn	11	SENT_463	[p34l131t192r347b246],
11	M	NN	O	m	dep	40	SENT_463	[p34l369t194r451b258],
12	,	,	O	,	_	0	SENT_463	[p34l369t194r451b258],
13	Benator	NNP	PERSON	Benator	nn	14	SENT_463	[p34l478t194r717b246],
14	D	NNP	O	D	appos	11	SENT_463	[p34l738t194r807b258],
15	,	,	O	,	_	0	SENT_463	[p34l738t194r807b258],
16	Burman	NNP	PERSON	Burman	nn	17	SENT_463	[p34l835t194r1077b246],
17	W	NNP	PERSON	W	appos	11	SENT_463	[p34l1100t194r1180b258],
18	,	,	O	,	_	0	SENT_463	[p34l1100t194r1180b258],
19	Peloquin	NNP	PERSON	Peloquin	nn	20	SENT_463	[p34l1207t192r1475b261],
20	CA	NNP	O	CA	appos	11	SENT_463	[p34l1499t193r1617b258],
21	,	,	O	,	_	0	SENT_463	[p34l1499t193r1617b258],
22	Khan	NNP	PERSON	Khan	nn	23	SENT_463	[p34l1644t192r1807b246],
23	A	NNP	O	A	appos	11	SENT_463	[p34l1830t193r1900b258],
24	,	,	O	,	_	0	SENT_463	[p34l1830t193r1900b258],
25	Vernon	NNP	O	Vernon	nn	26	SENT_463	[p34l1926t194r2145b246],
26	A	NNP	O	A	appos	11	SENT_463	[p34l131t281r200b346],
27	,	,	O	,	_	0	SENT_463	[p34l131t281r200b346],
28	Jones	NNP	PERSON	Jones	nn	29	SENT_463	[p34l231t282r396b334],
29	B	NNP	O	B	appos	11	SENT_463	[p34l426t282r491b346],
30	,	,	O	,	_	0	SENT_463	[p34l426t282r491b346],
31	Silva-Trigo	NNP	O	Silva-Trigo	nn	32	SENT_463	[p34l525t280r862b350],
32	C	NNP	O	C	appos	11	SENT_463	[p34l893t281r957b346],
33	,	,	O	,	_	0	SENT_463	[p34l893t281r957b346],
34	Zhao	NNP	PERSON	Zhao	nn	35	SENT_463	[p34l988t280r1140b334],
35	Z	NNP	O	Z	appos	11	SENT_463	[p34l1170t282r1230b346],
36	,	,	O	,	_	0	SENT_463	[p34l1170t282r1230b346],
37	Hodge	NNP	ORGANIZATION	Hodge	appos	11	SENT_463	[p34l1261t280r1461b350],
38	T	NN	ORGANIZATION	t	dep	40	SENT_463	[p34l1491t282r1533b333],
39	(	CD	NUMBER	(	num	38	SENT_463	[p34l1564t280r1760b349],
40	2005	CD	DATE	2005	dep	43	SENT_463	[p34l1564t280r1760b349],
41	)	NNP	O	)	nn	42	SENT_463	[p34l1564t280r1760b349],
42	Association	NNP	O	Association	dep	40	SENT_463	[p34l1789t280r2144b334],
43	between	IN	O	between	dep	6	SENT_463	[p34l130t368r381b422],
44	acquired	VBN	O	acquire	amod	46	SENT_463	[p34l401t368r658b437],
45	rifamycin	NN	O	rifamycin	nn	46	SENT_463	[p34l676t368r967b437],
46	resistance	NN	O	resistance	pobj	43	SENT_463	[p34l985t368r1279b422],
47	and	CC	O	and	_	0	SENT_463	[p34l1300t368r1407b422],
48	the	DT	O	the	det	49	SENT_463	[p34l1425t368r1515b422],
49	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	46	SENT_463	[p34l1533t368r2062b437],
50	of	IN	O	of	_	0	SENT_463	[p34l2084t368r2153b422],
51	rifabutin	NN	O	rifabutin	prep_of	49	SENT_463	[p34l131t456r388b510],
52	and	CC	O	and	_	0	SENT_463	[p34l414t456r521b510],
53	isoniazid	NN	O	isoniazid	prep_of	49	SENT_463	[p34l546t456r815b510],
54	among	IN	O	among	_	0	SENT_463	[p34l841t473r1043b525],
55	patients	NNS	O	patient	prep_among	49	SENT_463	[p34l1067t456r1299b525],
56	with	IN	O	with	_	0	SENT_463	[p34l1324t456r1458b510],
57	HIV	NN	MISC	hiv	prep_with	55	SENT_463	[p34l1482t458r1614b510],
58	and	CC	O	and	_	0	SENT_463	[p34l1632t456r1739b510],
59	tuberculosis	NN	O	tuberculosis	prep_with	55	SENT_463	[p34l1762t456r2139b510],
60	.	.	O	.	_	0	SENT_463	[p34l1762t456r2139b510],

1	Clin	NNP	O	Clin	nn	3	SENT_464	[p34l133t545r260b599],
2	Infect	NNP	O	Infect	nn	3	SENT_464	[p34l285t545r458b599],
3	Dis	NNP	O	Dis	_	0	SENT_464	[p34l481t545r583b599],
4	40	CD	NUMBER	40	num	3	SENT_464	[p34l609t546r1038b599],
5	:	:	O	:	_	0	SENT_464	[p34l609t546r1038b599],
6	l48l	CD	NUMBER	l48l	dep	3	SENT_464	[p34l609t546r1038b599],
7	—	CD	NUMBER	—	num	8	SENT_464	[p34l609t546r1038b599],
8	l49l	NN	O	l49l	dep	6	SENT_464	[p34l609t546r1038b599],
9	Jayaram	NNP	PERSON	Jayaram	nn	10	SENT_464	[p34l132t635r381b702],
10	R	NNP	PERSON	R	dep	46	SENT_464	[p34l407t635r472b698],
11	,	,	O	,	_	0	SENT_464	[p34l407t635r472b698],
12	Shandil	NNP	O	Shandil	nn	13	SENT_464	[p34l506t633r731b687],
13	RK	NNP	O	RK	appos	10	SENT_464	[p34l758t635r878b698],
14	,	,	O	,	_	0	SENT_464	[p34l758t635r878b698],
15	Gaonkar	NNP	O	Gaonkar	nn	16	SENT_464	[p34l910t633r1169b687],
16	S	NNP	O	S	appos	10	SENT_464	[p34l1197t634r1250b698],
17	,	,	O	,	_	0	SENT_464	[p34l1197t634r1250b698],
18	Kaur	NNP	PERSON	Kaur	nn	19	SENT_464	[p34l1280t635r1431b687],
19	P	NN	PERSON	p	appos	10	SENT_464	[p34l1456t635r1504b699],
20	,	,	O	,	_	0	SENT_464	[p34l1456t635r1504b699],
21	Suresh	NNP	PERSON	Suresh	nn	22	SENT_464	[p34l1538t633r1738b687],
22	BL	NN	PERSON	bl	appos	10	SENT_464	[p34l1765t635r1876b698],
23	,	,	O	,	_	0	SENT_464	[p34l1765t635r1876b698],
24	Mahesh	NNP	ORGANIZATION	Mahesh	nn	25	SENT_464	[p34l1906t633r2144b687],
25	BN	NNP	ORGANIZATION	BN	appos	10	SENT_464	[p34l131t723r251b787],
26	,	,	O	,	_	0	SENT_464	[p34l131t723r251b787],
27	J	NNP	O	J	nn	29	SENT_464	[p34l279t723r306b775],
28	ayashree	NN	O	ayashree	nn	29	SENT_464	[p34l309t721r568b790],
29	R	NN	O	r	appos	10	SENT_464	[p34l592t723r657b786],
30	,	,	O	,	_	0	SENT_464	[p34l592t723r657b786],
31	Nandi	NNP	MISC	Nandi	nn	32	SENT_464	[p34l682t721r867b775],
32	V	NNP	O	V	appos	10	SENT_464	[p34l891t723r951b787],
33	,	,	O	,	_	0	SENT_464	[p34l891t723r951b787],
34	Bharath	NNP	PERSON	Bharath	nn	35	SENT_464	[p34l978t721r1215b775],
35	S	NNP	PERSON	S	appos	10	SENT_464	[p34l1243t722r1296b787],
36	,	,	O	,	_	0	SENT_464	[p34l1243t722r1296b787],
37	Kantharaj	NNP	O	Kantharaj	nn	38	SENT_464	[p34l1322t721r1612b790],
38	E	NNP	O	E	appos	10	SENT_464	[p34l1641t723r1701b787],
39	,	,	O	,	_	0	SENT_464	[p34l1641t723r1701b787],
40	Balasubramanian	NNP	PERSON	Balasubramanian	nn	41	SENT_464	[p34l1728t721r2142b775, p34l131t809r260b863],
41	V	NNP	O	V	appos	10	SENT_464	[p34l291t811r345b863],
42	(	CD	NUMBER	(	num	46	SENT_464	[p34l378t809r574b878],
43	2004	CD	DATE	2004	num	46	SENT_464	[p34l378t809r574b878],
44	)	NNP	O	)	nn	46	SENT_464	[p34l378t809r574b878],
45	Isoniazid	NNP	O	Isoniazid	nn	46	SENT_464	[p34l609t809r883b863],
46	pharrnacokinetics-pharmacodynamics	NNS	O	pharrnacokinetics-pharmacodynamic	dep	3	SENT_464	[p34l913t809r2052b879],
47	in	IN	O	in	_	0	SENT_464	[p34l2088t809r2145b862],
48	an	DT	O	a	det	51	SENT_464	[p34l133t915r202b951],
49	aerosol	NN	O	aerosol	nn	51	SENT_464	[p34l239t897r456b951],
50	infection	NN	O	infection	nn	51	SENT_464	[p34l494t897r762b951],
51	model	NN	O	model	prep_in	46	SENT_464	[p34l797t897r985b951],
52	of	IN	O	of	_	0	SENT_464	[p34l1025t897r1094b951],
53	tuberculosis	NN	O	tuberculosis	prep_of	51	SENT_464	[p34l1121t897r1503b951],
54	.	.	O	.	_	0	SENT_464	[p34l1121t897r1503b951],

1	Antimicrob	NNP	O	Antimicrob	nn	3	SENT_465	[p34l1543t897r1891b951],
2	Agents	NNPS	O	Agents	nn	3	SENT_465	[p34l1929t898r2142b967],
3	Chemother	NNP	O	Chemother	_	0	SENT_465	[p34l133t986r467b1040],
4	4822951-2957	CD	NUMBER	4822951-2957	num	6	SENT_465	[p34l489t987r924b1040],
5	Jindani	NNP	O	Jindani	nn	6	SENT_465	[p34l132t1074r347b1128],
6	A	NNP	O	A	dep	3	SENT_465	[p34l370t1075r440b1140],
7	,	,	O	,	_	0	SENT_465	[p34l370t1075r440b1140],
8	Aber	NNP	PERSON	Aber	nn	9	SENT_465	[p34l466t1074r618b1128],
9	VR	NN	O	vr	dep	3	SENT_465	[p34l639t1076r760b1140],
10	,	,	O	,	_	0	SENT_465	[p34l639t1076r760b1140],
11	Edwards	NNP	ORGANIZATION	Edwards	nn	12	SENT_465	[p34l786t1074r1047b1128],
12	EA	NN	ORGANIZATION	ea	dep	3	SENT_465	[p34l1072t1075r1187b1140],
13	,	,	O	,	_	0	SENT_465	[p34l1072t1075r1187b1140],
14	and	CC	O	and	_	0	SENT_465	[p34l1216t1074r1323b1128],
15	Mitchison	NNP	PERSON	Mitchison	nn	16	SENT_465	[p34l1345t1074r1650b1128],
16	DA	NNP	PERSON	DA	conj_and	6	SENT_465	[p34l1673t1075r1781b1127],
17	(	CD	NUMBER	(	dep	3	SENT_465	[p34l1807t1074r2003b1143],
18	1980	CD	DATE	1980	num	19	SENT_465	[p34l1807t1074r2003b1143],
19	)	CD	NUMBER	)	dep	17	SENT_465	[p34l1807t1074r2003b1143],
20	The	DT	O	the	det	23	SENT_465	[p34l2030t1074r2143b1128],
21	early	JJ	O	early	amod	23	SENT_465	[p34l133t1162r281b1232],
22	bactericidal	JJ	O	bactericidal	amod	23	SENT_465	[p34l317t1162r672b1216],
23	activity	NN	O	activity	dep	3	SENT_465	[p34l710t1162r936b1232],
24	of	IN	O	of	_	0	SENT_465	[p34l974t1162r1044b1216],
25	drugs	NNS	O	drug	prep_of	23	SENT_465	[p34l1072t1162r1238b1232],
26	in	IN	O	in	_	0	SENT_465	[p34l1278t1162r1334b1215],
27	patients	NNS	O	patient	prep_in	25	SENT_465	[p34l1369t1162r1604b1232],
28	with	IN	O	with	_	0	SENT_465	[p34l1643t1162r1777b1216],
29	pulmonary	JJ	O	pulmonary	amod	30	SENT_465	[p34l1812t1162r2144b1232],
30	tuberculosis	NN	O	tuberculosis	prep_with	27	SENT_465	[p34l131t1249r508b1304],
31	.	.	O	.	_	0	SENT_465	[p34l131t1249r508b1304],

1	Am	VBP	O	be	dep	2	SENT_466	[p34l536t1251r650b1303],
2	Rev	NN	O	rev	_	0	SENT_466	[p34l673t1252r793b1304],
3	Respir	NNP	O	Respir	nn	4	SENT_466	[p34l818t1249r1015b1319],
4	Dis	NNP	O	Dis	dep	2	SENT_466	[p34l1038t1249r1139b1303],
5	121-939-949	CD	NUMBER	121-939-949	rcmod	4	SENT_466	[p34l1173t1251r1569b1304],
6	.	.	O	.	_	0	SENT_466	[p34l1173t1251r1569b1304],

1	Jindani	NNP	MISC	Jindani	nn	2	SENT_467	[p34l132t1338r347b1392],
2	A	NNP	MISC	A	_	0	SENT_467	[p34l369t1339r440b1404],
3	,	,	O	,	_	0	SENT_467	[p34l369t1339r440b1404],
4	Cj	NN	O	cj	nn	5	SENT_467	[p34l466t1338r530b1407],
5	D	NN	O	d	appos	2	SENT_467	[p34l557t1340r626b1404],
6	,	,	O	,	_	0	SENT_467	[p34l557t1340r626b1404],
7	Mitchison	NNP	PERSON	Mitchison	nn	8	SENT_467	[p34l652t1338r956b1392],
8	DA	NNP	PERSON	DA	appos	2	SENT_467	[p34l979t1339r1087b1391],
9	(	CD	NUMBER	(	num	12	SENT_467	[p34l1112t1338r1308b1407],
10	2003	CD	DATE	2003	num	12	SENT_467	[p34l1112t1338r1308b1407],
11	)	NNP	O	)	nn	12	SENT_467	[p34l1112t1338r1308b1407],
12	Bactericidal	NNP	O	Bactericidal	dep	8	SENT_467	[p34l1332t1338r1692b1392],
13	and	CC	O	and	_	0	SENT_467	[p34l1717t1338r1824b1392],
14	sterilizing	VBG	O	sterilize	amod	15	SENT_467	[p34l1849t1338r2143b1407],
15	activities	NNS	O	activity	appos	2	SENT_467	[p34l133t1426r398b1480],
16	of	IN	O	of	_	0	SENT_467	[p34l428t1426r497b1480],
17	antituberculosis	JJ	O	antituberculosis	amod	18	SENT_467	[p34l516t1426r987b1480],
18	drugs	NNS	O	drug	prep_of	15	SENT_467	[p34l1017t1426r1181b1496],
19	during	IN	O	during	_	0	SENT_467	[p34l1210t1426r1405b1496],
20	the	DT	DURATION	the	det	23	SENT_467	[p34l1431t1426r1521b1480],
21	first	JJ	DURATION	first	amod	23	SENT_467	[p34l1550t1426r1668b1480],
22	14	CD	DURATION	14	num	23	SENT_467	[p34l1702t1427r1767b1479],
23	days	NNS	NUMBER	day	prep_during	15	SENT_467	[p34l1796t1426r1946b1496],
24	.	.	O	.	_	0	SENT_467	[p34l1796t1426r1946b1496],

1	Am	VBP	O	be	dep	6	SENT_468	[p34l1977t1427r2091b1479],
2	J	NN	O	j	nn	6	SENT_468	[p34l2116t1428r2144b1480],
3	Resp	NN	O	resp	nn	6	SENT_468	[p34l131t1516r279b1583],
4	Crit	NNP	O	Crit	nn	6	SENT_468	[p34l307t1513r421b1568],
5	Care	NNP	O	Care	nn	6	SENT_468	[p34l446t1514r584b1568],
6	Med	NNP	O	Med	dep	11	SENT_468	[p34l610t1513r748b1568],
7	l67	NN	O	l67	dep	6	SENT_468	[p34l779t1514r1245b1568],
8	:	:	O	:	_	0	SENT_468	[p34l779t1514r1245b1568],
9	l348-1354	NN	O	l348-1354	nn	11	SENT_468	[p34l779t1514r1245b1568],
10	Gumbo	NN	ORGANIZATION	gumbo	nn	11	SENT_468	[p34l133t1602r355b1657],
11	T	NN	ORGANIZATION	t	dep	37	SENT_468	[p34l378t1605r432b1668],
12	,	,	O	,	_	0	SENT_468	[p34l378t1605r432b1668],
13	Louie	NNP	PERSON	Louie	nn	14	SENT_468	[p34l454t1603r628b1657],
14	A	NNP	PERSON	A	appos	11	SENT_468	[p34l648t1604r717b1668],
15	,	,	O	,	_	0	SENT_468	[p34l648t1604r717b1668],
16	Liu	NNP	PERSON	Liu	nn	17	SENT_468	[p34l740t1603r844b1657],
17	W	NNP	O	W	appos	11	SENT_468	[p34l862t1605r942b1668],
18	,	,	O	,	_	0	SENT_468	[p34l862t1605r942b1668],
19	Ambrose	NNP	ORGANIZATION	Ambrose	nn	20	SENT_468	[p34l964t1602r1239b1657],
20	PG	NNP	ORGANIZATION	PG	appos	17	SENT_468	[p34l1259t1604r1370b1668],
21	,	,	O	,	_	0	SENT_468	[p34l1259t1604r1370b1668],
22	Bhavnani	NNP	PERSON	Bhavnani	nn	23	SENT_468	[p34l1393t1602r1681b1657],
23	SM	NNP	O	SM	appos	17	SENT_468	[p34l1705t1604r1825b1668],
24	,	,	O	,	_	0	SENT_468	[p34l1705t1604r1825b1668],
25	Brown	NNP	PERSON	Brown	nn	26	SENT_468	[p34l1848t1605r2053b1657],
26	D	NNP	O	D	appos	17	SENT_468	[p34l2072t1605r2141b1668],
27	,	,	O	,	_	0	SENT_468	[p34l2072t1605r2141b1668],
28	Drusano	NNP	ORGANIZATION	Drusano	nn	29	SENT_468	[p34l131t1693r384b1745],
29	GL	NNP	ORGANIZATION	GL	appos	17	SENT_468	[p34l406t1692r503b1745],
30	(	CD	NUMBER	(	num	31	SENT_468	[p34l526t1691r722b1760],
31	2007	CD	DATE	2007	dep	29	SENT_468	[p34l526t1691r722b1760],
32	)	NNP	O	)	nn	33	SENT_468	[p34l526t1691r722b1760],
33	Isoniazid	NNP	O	Isoniazid	poss	36	SENT_468	[p34l744t1691r1066b1745],
34	’s	POS	O	’s	_	0	SENT_468	[p34l744t1691r1066b1745],
35	bactericidal	JJ	O	bactericidal	amod	36	SENT_468	[p34l1085t1691r1434b1745],
36	activity	NN	O	activity	nsubj	37	SENT_468	[p34l1456t1691r1678b1761],
37	ceases	VBZ	O	cease	_	0	SENT_468	[p34l1699t1709r1886b1745],
38	because	IN	O	because	_	0	SENT_468	[p34l1906t1691r2143b1745],
39	of	IN	O	of	_	0	SENT_468	[p34l133t1778r202b1832],
40	the	DT	O	the	det	41	SENT_468	[p34l224t1778r313b1833],
41	emergence	NN	O	emergence	prep_because_of	37	SENT_468	[p34l349t1796r669b1848],
42	of	IN	O	of	_	0	SENT_468	[p34l704t1778r773b1832],
43	resistance	NN	O	resistance	prep_of	41	SENT_468	[p34l795t1778r1105b1844],
44	,	,	O	,	_	0	SENT_468	[p34l795t1778r1105b1844],
45	not	RB	O	not	neg	41	SENT_468	[p34l1140t1786r1237b1832],
46	depletion	NN	O	depletion	dep	41	SENT_468	[p34l1269t1778r1547b1848],
47	of	IN	O	of	_	0	SENT_468	[p34l1580t1778r1650b1833],
48	Mycobacterium	NN	O	mycobacterium	nn	49	SENT_468	[p34l1669t1778r2141b1848],
49	tuberculosis	NN	O	tuberculosis	prep_of	46	SENT_468	[p34l133t1867r495b1921],
50	in	IN	O	in	_	0	SENT_468	[p34l520t1866r577b1920],
51	the	DT	O	the	det	53	SENT_468	[p34l600t1866r691b1921],
52	log	NN	O	log	nn	53	SENT_468	[p34l716t1866r810b1936],
53	phase	NN	O	phase	prep_in	37	SENT_468	[p34l833t1866r1004b1936],
54	of	IN	O	of	_	0	SENT_468	[p34l1030t1867r1099b1921],
55	growth	NN	O	growth	prep_of	53	SENT_468	[p34l1115t1866r1340b1936],
56	.	.	O	.	_	0	SENT_468	[p34l1115t1866r1340b1936],

1	J	NNP	O	J	nn	4	SENT_469	[p34l1370t1869r1397b1921],
2	Infect	NNP	O	Infect	nn	4	SENT_469	[p34l1421t1867r1594b1921],
3	Dis	NNP	O	Dis	nn	4	SENT_469	[p34l1617t1867r1719b1921],
4	l95	NN	O	l95	_	0	SENT_469	[p34l1753t1868r2136b1921],
5	:	:	O	:	_	0	SENT_469	[p34l1753t1868r2136b1921],
6	l94	NN	O	l94	nn	7	SENT_469	[p34l1753t1868r2136b1921],
7	—	NN	O	—	dep	4	SENT_469	[p34l1753t1868r2136b1921],
8	201	CD	NUMBER	201	num	10	SENT_469	[p34l1753t1868r2136b1921],
9	Abe	NN	O	abe	nn	10	SENT_469	[p34l131t1955r255b2009],
10	C	NN	O	c	dep	4	SENT_469	[p34l285t1956r349b2021],
11	,	,	O	,	_	0	SENT_469	[p34l285t1956r349b2021],
12	Hirano	NNP	PERSON	Hirano	nn	13	SENT_469	[p34l380t1955r586b2009],
13	K	NNP	PERSON	K	appos	4	SENT_469	[p34l616t1957r685b2021],
14	,	,	O	,	_	0	SENT_469	[p34l616t1957r685b2021],
15	Wada	NNP	PERSON	Wada	nn	16	SENT_469	[p34l717t1955r887b2009],
16	M	NNP	O	M	appos	4	SENT_469	[p34l914t1957r996b2021],
17	,	,	O	,	_	0	SENT_469	[p34l914t1957r996b2021],
18	Aoyagi	NNP	PERSON	Aoyagi	nn	19	SENT_469	[p34l1027t1955r1248b2025],
19	T	NN	O	t	appos	4	SENT_469	[p34l1278t1957r1321b2008],
20	(	CD	NUMBER	(	num	21	SENT_469	[p34l1351t1955r1548b2024],
21	2001	CD	DATE	2001	dep	19	SENT_469	[p34l1351t1955r1548b2024],
22	)	CD	NUMBER	)	num	23	SENT_469	[p34l1351t1955r1548b2024],
23	Resistance	NN	O	resistance	dep	4	SENT_469	[p34l1578t1955r1897b2009],
24	of	IN	O	of	_	0	SENT_469	[p34l1927t1955r1997b2009],
25	Mycobacterium	NN	O	mycobacterium	nn	26	SENT_469	[p34l2016t1957r2143b2025, p34l132t2042r502b2097],
26	tuberculosis	NN	O	tuberculosis	prep_of	23	SENT_469	[p34l530t2042r891b2097],
27	of	IN	O	of	_	0	SENT_469	[p34l923t2042r992b2097],
28	four	CD	NUMBER	four	num	31	SENT_469	[p34l1013t2042r1137b2097],
29	ﬁrst-line	JJ	O	ﬁrst-line	amod	31	SENT_469	[p34l1166t2042r1418b2096],
30	anti-tuberculosis	JJ	O	anti-tuberculosis	amod	31	SENT_469	[p34l1450t2042r1946b2097],
31	drugs	NNS	O	drug	prep_of	26	SENT_469	[p34l1979t2042r2142b2112],
32	in	IN	O	in	_	0	SENT_469	[p34l132t2130r189b2184],
33	Japan	NNP	LOCATION	Japan	prep_in	31	SENT_469	[p34l213t2133r399b2200],
34	,	,	O	,	_	0	SENT_469	[p34l213t2133r399b2200],
35	1997	CD	DATE	1997	appos	4	SENT_469	[p34l434t2132r592b2185],
36	.	.	O	.	_	0	SENT_469	[p34l434t2132r592b2185],

1	Int	NN	O	int	nn	2	SENT_470	[p34l621t2133r703b2184],
2	J	NN	O	j	dep	9	SENT_470	[p34l727t2133r756b2185],
3	Tuberc	NN	O	tuberc	nn	4	SENT_470	[p34l780t2130r987b2185],
4	Lung	NN	O	lung	dep	2	SENT_470	[p34l1013t2133r1171b2200],
5	Dis	NN	O	di	dep	9	SENT_470	[p34l1195t2130r1297b2185],
6	5:46	CD	TIME	5:46	num	5	SENT_470	[p34l1326t2131r1568b2184],
7	-52	CD	NUMBER	-52	num	9	SENT_470	[p34l1326t2131r1568b2184],
8	Sunahara	NNP	PERSON	Sunahara	nn	9	SENT_470	[p34l135t2218r411b2273],
9	S	NN	O	s	dep	16	SENT_470	[p34l435t2220r488b2284],
10	,	,	O	,	_	0	SENT_470	[p34l435t2220r488b2284],
11	Urano	NNP	O	Urano	nn	12	SENT_470	[p34l513t2221r698b2273],
12	M	NNP	O	M	appos	9	SENT_470	[p34l722t2221r804b2284],
13	,	,	O	,	_	0	SENT_470	[p34l722t2221r804b2284],
14	Ogawa	NNP	PERSON	Ogawa	nn	15	SENT_470	[p34l830t2220r1042b2288],
15	M	NNP	O	M	appos	9	SENT_470	[p34l1063t2221r1129b2272],
16	(	VBD	O	(	_	0	SENT_470	[p34l1152t2219r1350b2288],
17	1961	CD	DATE	1961	num	18	SENT_470	[p34l1152t2219r1350b2288],
18	)	CD	NUMBER	)	dobj	16	SENT_470	[p34l1152t2219r1350b2288],
19	Genetical	JJ	ORGANIZATION	genetical	amod	22	SENT_470	[p34l1374t2218r1658b2273],
20	and	CC	O	and	_	0	SENT_470	[p34l1682t2218r1789b2273],
21	geographic	JJ	O	geographic	conj_and	19	SENT_470	[p34l1811t2218r2142b2288],
22	studies	NNS	O	study	npadvmod	16	SENT_470	[p34l134t2307r337b2362],
23	on	IN	O	on	_	0	SENT_470	[p34l364t2325r438b2362],
24	isoniazid	NN	O	isoniazid	nn	25	SENT_470	[p34l463t2307r733b2362],
25	inactivation	NN	O	inactivation	prep_on	16	SENT_470	[p34l758t2307r1124b2362],
26	.	.	O	.	_	0	SENT_470	[p34l758t2307r1124b2362],

1	Science	NNP	O	Science	nn	2	SENT_471	[p34l1157t2307r1385b2362],
2	l34	NN	O	l34	_	0	SENT_471	[p34l1418t2309r1878b2362],
3	:	:	O	:	_	0	SENT_471	[p34l1418t2309r1878b2362],
4	l530	CD	NUMBER	l530	number	5	SENT_471	[p34l1418t2309r1878b2362],
5	—	CD	NUMBER	—	num	22	SENT_471	[p34l1418t2309r1878b2362],
6	l53l	NN	O	l53l	nn	22	SENT_471	[p34l1418t2309r1878b2362],
7	Cascorbi	NNP	O	Cascorbi	nn	22	SENT_471	[p34l133t2395r397b2450],
8	I	NNP	O	I	nn	22	SENT_471	[p34l431t2397r469b2461],
9	,	,	O	,	_	0	SENT_471	[p34l431t2397r469b2461],
10	Drakoulis	NNP	O	Drakoulis	nn	11	SENT_471	[p34l505t2395r799b2450],
11	N	NNP	O	N	dep	22	SENT_471	[p34l831t2397r902b2461],
12	,	,	O	,	_	0	SENT_471	[p34l831t2397r902b2461],
13	Brockmoller	NNP	PERSON	Brockmoller	nn	14	SENT_471	[p34l938t2395r1318b2450],
14	J	NNP	PERSON	J	appos	11	SENT_471	[p34l1350t2398r1393b2461],
15	,	,	O	,	_	0	SENT_471	[p34l1350t2398r1393b2461],
16	Maurer	NNP	O	Maurer	nn	17	SENT_471	[p34l1429t2398r1651b2450],
17	A	NNP	O	A	appos	11	SENT_471	[p34l1680t2396r1750b2461],
18	,	,	O	,	_	0	SENT_471	[p34l1680t2396r1750b2461],
19	Sperling	NNP	O	Sperling	nn	20	SENT_471	[p34l1789t2395r2038b2465],
20	K	NNP	O	K	appos	11	SENT_471	[p34l2072t2397r2141b2461],
21	,	,	O	,	_	0	SENT_471	[p34l2072t2397r2141b2461],
22	Roots	NNS	O	root	dep	2	SENT_471	[p34l131t2486r305b2538],
23	I	PRP	O	I	nsubj	24	SENT_471	[p34l338t2486r360b2537],
24	(	VBP	O	(	rcmod	22	SENT_471	[p34l393t2484r590b2553],
25	1995	CD	DATE	1995	num	27	SENT_471	[p34l393t2484r590b2553],
26	)	CD	NUMBER	)	num	27	SENT_471	[p34l393t2484r590b2553],
27	Arylamine	NN	O	arylamine	nn	28	SENT_471	[p34l621t2483r940b2553],
28	N-acetyltransferase	NN	O	n-acetyltransferase	dobj	24	SENT_471	[p34l970t2483r1552b2553],
29	(	CD	NUMBER	(	num	32	SENT_471	[p34l1586t2484r1816b2553],
30	NAT2	NN	O	nat2	nn	32	SENT_471	[p34l1586t2484r1816b2553],
31	)	NN	O	)	nn	32	SENT_471	[p34l1586t2484r1816b2553],
32	mutations	NNS	O	mutation	dep	28	SENT_471	[p34l1848t2483r2142b2538],
33	and	CC	O	and	_	0	SENT_471	[p34l133t2572r240b2626],
34	their	PRP$	O	they	poss	36	SENT_471	[p34l263t2572r401b2626],
35	allelic	JJ	O	allelic	amod	36	SENT_471	[p34l424t2572r602b2626],
36	linkage	NN	O	linkage	conj_and	28	SENT_471	[p34l629t2572r847b2641],
37	in	IN	O	in	_	0	SENT_471	[p34l874t2572r930b2625],
38	unrelated	JJ	O	unrelated	amod	40	SENT_471	[p34l953t2572r1232b2626],
39	Caucasian	JJ	MISC	caucasian	amod	40	SENT_471	[p34l1258t2572r1565b2626],
40	individuals	NNS	O	individual	prep_in	36	SENT_471	[p34l1590t2572r1938b2626],
41	:	:	O	:	_	0	SENT_471	[p34l1590t2572r1938b2626],
42	correlation	NN	O	correlation	dep	2	SENT_471	[p34l1969t2589r2142b2626, p34l133t2659r301b2713],
43	with	IN	O	with	_	0	SENT_471	[p34l325t2659r458b2714],
44	phenotypic	JJ	O	phenotypic	amod	45	SENT_471	[p34l480t2659r815b2729],
45	activity	NN	O	activity	prep_with	42	SENT_471	[p34l843t2659r1075b2729],
46	.	.	O	.	_	0	SENT_471	[p34l843t2659r1075b2729],

1	Am	VBP	O	be	dep	4	SENT_472	[p34l1103t2661r1216b2713],
2	J	NN	O	j	nn	4	SENT_472	[p34l1240t2661r1268b2714],
3	Hum	NNP	O	Hum	nn	4	SENT_472	[p34l1292t2661r1443b2714],
4	Genet	NNP	O	Genet	_	0	SENT_472	[p34l1467t2660r1645b2714],
5	572581-592	CD	NUMBER	572581-592	dep	4	SENT_472	[p34l1672t2660r2027b2714],

1	@	IN	O	@	_	0	SENT_473	[p34l1783t2891r1856b2981],
2	Springer	NNP	PERSON	Springer	pobj	1	SENT_473	[p34l1882t2914r2127b2984],

